data_2kxl_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kxl _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 16.5 t80 . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.481 0.181 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -71.52 -43.22 72.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.515 1.134 . . . . 0.0 109.319 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.422 ' HA ' ' NE2' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -65.86 -29.05 69.45 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.5 1.125 . . . . 0.0 110.328 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -79.76 -30.37 40.73 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.541 1.151 . . . . 0.0 109.271 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' TRP . . . . . 0.541 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 2.1 t90 -68.09 -43.96 77.33 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.13 . . . . 0.0 107.985 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.496 ' O ' ' CB ' ' A' ' 232' ' ' ALA . 9.8 pt20 -70.63 -36.93 73.69 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.513 1.133 . . . . 0.0 110.315 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.99 -47.6 85.68 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.488 1.118 . . . . 0.0 109.323 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 64.5 t -73.23 -44.09 56.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.504 1.128 . . . . 0.0 109.307 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -68.28 -13.91 62.61 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.493 1.121 . . . . 0.0 109.282 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 228' ' ' GLN . . . -81.64 -24.89 36.06 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.51 1.131 . . . . 0.0 109.288 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 91.0 t -64.73 135.03 96.22 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.505 1.128 . . . . 0.0 109.316 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 233' ' ' VAL . 18.3 Cg_endo -75.02 -40.43 0.89 Allowed 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.42 1.747 . . . . 0.0 110.967 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.47 ' CD2' HD13 ' A' ' 302' ' ' ILE . 1.1 tp -63.56 -14.11 48.09 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.445 1.091 . . . . 0.0 109.302 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . 0.462 ' CB ' HD13 ' A' ' 239' ' ' LEU . 16.8 m-30 -113.24 5.28 16.87 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.473 1.108 . . . . 0.0 110.973 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.52 -29.43 62.47 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.492 1.12 . . . . 0.0 110.325 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.44 ' CB ' HG22 ' A' ' 340' ' ' ILE . 0.0 OUTLIER -89.31 7.09 37.42 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.517 1.136 . . . . 0.0 109.298 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.462 HD13 ' CB ' ' A' ' 236' ' ' PHE . 74.4 mt -85.58 176.64 8.09 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.504 1.128 . . . . 0.0 109.265 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -101.03 176.19 26.78 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.509 1.131 . . . . 0.0 111.03 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.515 ' O ' ' CG2' ' A' ' 245' ' ' VAL . 18.3 Cg_endo -74.99 -36.35 2.6 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.513 1.796 . . . . 0.0 110.993 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -69.54 -35.12 75.15 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.53 1.144 . . . . 0.0 109.271 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.442 ' CG1' HD13 ' A' ' 247' ' ' ILE . 57.0 t -73.25 -40.16 56.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.463 1.102 . . . . 0.0 109.297 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.45 HD22 ' N ' ' A' ' 244' ' ' LEU . 3.5 mm? -67.61 -37.55 82.7 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 0.0 109.269 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.541 HG22 ' CZ2' ' A' ' 227' ' ' TRP . 74.3 t -65.84 -45.98 89.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.519 1.137 . . . . 0.0 109.328 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -64.89 -40.78 95.64 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.125 . . . . 0.0 110.251 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.469 ' O ' ' CD1' ' A' ' 251' ' ' LEU . 44.2 mt -62.27 -47.97 90.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.456 1.098 . . . . 0.0 109.306 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 27.3 t -61.98 -34.65 64.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.469 1.105 . . . . 0.0 109.296 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.02 -13.01 60.04 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.463 1.102 . . . . 0.0 110.291 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -99.6 -7.0 26.38 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.502 1.126 . . . . 0.0 109.312 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.469 ' CD1' ' O ' ' A' ' 247' ' ' ILE . 6.2 mp -75.31 146.51 40.93 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.533 1.146 . . . . 0.0 109.281 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -116.33 113.6 23.17 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.502 1.127 . . . . 0.0 110.314 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -80.03 126.79 31.5 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.51 1.131 . . . . 0.0 109.258 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -139.09 137.74 36.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.464 1.102 . . . . 0.0 110.305 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 4.1 m -90.85 123.56 34.48 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.471 1.107 . . . . 0.0 110.385 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.475 HG13 ' CB ' ' A' ' 313' ' ' ALA . 4.7 t -106.8 112.76 63.32 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.467 1.104 . . . . 0.0 109.291 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.481 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.3 Cg_endo -75.03 169.27 22.98 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.524 1.802 . . . . 0.0 111.011 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.475 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -64.92 126.77 29.05 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.496 1.123 . . . . 0.0 109.334 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 100.63 -25.3 28.84 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.486 1.116 . . . . 0.0 111.006 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . 0.481 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -67.65 131.07 44.9 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.504 0.767 . . . . 0.0 109.303 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 2.9 p -87.72 135.43 25.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.529 1.143 . . . . 0.0 109.326 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.444 ' CD1' HG11 ' A' ' 280' ' ' VAL . 35.6 mt -82.38 -44.12 19.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.542 1.151 . . . . 0.0 109.294 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 10.5 p -152.12 147.07 26.02 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.538 1.149 . . . . 0.0 108.28 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -85.65 -179.9 6.96 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.485 1.115 . . . . 0.0 110.298 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.483 HG22 ' CB ' ' A' ' 310' ' ' THR . 0.1 OUTLIER -77.21 134.71 28.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.563 1.164 . . . . 0.0 109.289 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 56.32 51.48 55.85 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.458 1.099 . . . . 0.0 110.969 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.95 165.65 45.3 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.495 0.762 . . . . 0.0 110.298 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.3 Cg_endo -75.01 82.98 1.89 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.45 1.763 . . . . 0.0 111.002 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -38.0 93.31 0.01 OUTLIER Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.534 1.146 . . . . 0.0 110.997 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 268' ' ' PRO . 0.7 OUTLIER -171.61 37.51 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.482 0.754 . . . . 0.0 109.307 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . 0.429 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 1.9 ttt180 -169.81 147.74 3.44 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.49 1.119 . . . . 0.0 110.276 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.494 ' SD ' ' CZ ' ' A' ' 274' ' ' PHE . 2.1 ttm -118.04 156.26 28.9 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.534 1.147 . . . . 0.0 110.986 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.571 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 32.8 m-85 -146.02 136.61 24.15 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.519 1.137 . . . . 0.0 111.023 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . 0.494 ' CZ ' ' SD ' ' A' ' 272' ' ' MET . 19.6 m-85 -125.71 137.8 53.85 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.538 1.149 . . . . 0.0 111.007 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 4.3 t -94.24 135.34 28.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.473 1.108 . . . . 0.0 109.318 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . 0.49 ' CG2' HD11 ' A' ' 320' ' ' LEU . 42.0 t -109.49 -49.16 7.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.481 1.113 . . . . 0.0 109.246 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -142.04 132.77 25.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.486 1.116 . . . . 0.0 110.281 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 120.96 -176.35 16.24 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.483 1.115 . . . . 0.0 111.023 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' SER . . . . . 0.418 ' N ' HG23 ' A' ' 317' ' ' VAL . 5.2 t -131.2 118.8 20.95 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.498 0.764 . . . . 0.0 110.026 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.444 HG11 ' CD1' ' A' ' 262' ' ' ILE . 16.2 m -98.43 162.17 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.496 1.122 . . . . 0.0 109.313 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 31.1 t -127.71 153.76 46.13 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.493 1.12 . . . . 0.0 109.957 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.95 129.23 73.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.463 1.102 . . . . 0.0 109.327 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.405 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -77.97 101.62 6.97 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.469 1.106 . . . . 0.0 109.298 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' THR . . . . . 0.651 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.7 OUTLIER -148.62 -168.31 0.18 Allowed Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.568 1.168 . . . . 0.0 110.399 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.651 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -75.07 4.59 4.63 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.474 1.776 . . . . 0.0 110.956 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -151.5 156.67 34.85 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.521 1.138 . . . . 0.0 109.265 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.95 94.79 0.95 Allowed 'Trans proline' 0 C--N 1.36 1.184 0 O-C-N 124.509 1.794 . . . . 0.0 110.987 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 45.4 t -98.37 118.83 45.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.494 1.121 . . . . 0.0 109.327 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -125.22 136.96 54.08 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.475 1.109 . . . . 0.0 110.278 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -117.23 139.73 50.42 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.474 1.109 . . . . 0.0 109.312 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -90.6 -160.18 36.3 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.497 1.123 . . . . 0.0 111.005 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 148.21 34.91 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.546 1.814 . . . . 0.0 111.038 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 83.61 4.42 89.09 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.569 1.168 . . . . 0.0 110.99 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -86.03 130.67 34.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.472 0.748 . . . . 0.0 109.295 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . 0.484 ' HB3' ' CD1' ' A' ' 274' ' ' PHE . 0.8 OUTLIER -116.16 153.02 32.56 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.504 1.127 . . . . 0.0 110.993 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . 0.571 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 40.4 p90 -159.64 146.17 16.32 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.527 1.142 . . . . 0.0 110.992 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 127.81 -7.07 6.93 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.472 1.107 . . . . 0.0 111.015 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . 0.428 ' N ' ' HE1' ' A' ' 272' ' ' MET . 6.0 pt-20 -52.49 -48.76 65.75 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.511 0.771 . . . . 0.0 110.336 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' MET . . . . . 0.415 ' HA ' ' CE ' ' A' ' 299' ' ' MET . 3.1 mmt -48.91 -39.26 25.36 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.541 1.151 . . . . 0.0 111.002 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -67.79 -37.42 82.0 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.504 1.128 . . . . 0.0 109.252 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.479 ' CD1' ' SD ' ' A' ' 272' ' ' MET . 10.6 mt -79.02 -9.07 59.43 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.527 1.142 . . . . 0.0 109.267 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . 0.47 HD13 ' CD2' ' A' ' 235' ' ' LEU . 3.1 mm -82.25 -54.17 10.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.478 1.111 . . . . 0.0 109.294 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 304' ' ' GLY . 1.0 OUTLIER -153.47 42.97 0.58 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 0.0 109.989 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 303' ' ' SER . . . 36.21 42.28 0.58 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.479 1.112 . . . . 0.0 111.042 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.19 157.13 83.43 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.441 0.73 . . . . 0.0 110.276 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.11 131.99 14.78 Favored 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.481 1.779 . . . . 0.0 110.976 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -44.38 -43.32 7.54 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.516 1.135 . . . . 0.0 110.34 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 25.3 m 67.74 39.41 2.69 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.454 1.096 . . . . 0.0 109.99 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . 173.42 160.2 0.14 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.541 1.151 . . . . 0.0 109.307 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.483 ' CB ' HG22 ' A' ' 265' ' ' ILE . 0.6 OUTLIER -105.19 122.3 45.62 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.505 1.128 . . . . 0.0 110.441 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 58.6 t -102.7 128.25 55.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.5 1.125 . . . . 0.0 109.3 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 9.7 p -141.24 156.66 45.87 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.557 1.161 . . . . 0.0 110.037 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . 0.475 ' CB ' HG13 ' A' ' 256' ' ' VAL . . . -90.31 124.37 34.84 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.543 1.152 . . . . 0.0 109.284 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -70.45 -26.33 63.59 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.468 1.105 . . . . 0.0 109.293 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' THR . . . . . 0.475 ' HA ' ' CB ' ' A' ' 258' ' ' ALA . 6.2 t -152.98 -169.79 3.44 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.51 1.131 . . . . 0.0 110.415 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 93.0 m -58.67 85.36 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 0.0 110.409 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.453 HG11 ' CD1' ' A' ' 319' ' ' LEU . 48.3 t -105.42 159.45 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.461 1.101 . . . . 0.0 109.246 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' SER . . . . . 0.408 ' N ' HG11 ' A' ' 317' ' ' VAL . 49.3 m -136.88 123.62 21.17 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.508 1.13 . . . . 0.0 109.984 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . 0.492 ' CB ' ' O ' ' A' ' 274' ' ' PHE . 0.0 OUTLIER -134.56 170.46 15.76 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.508 1.13 . . . . 0.0 109.278 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.49 HD11 ' CG2' ' A' ' 276' ' ' VAL . 0.0 OUTLIER -124.4 131.82 53.51 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.478 1.111 . . . . 0.0 109.295 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 63.5 p -90.15 158.88 17.05 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.552 1.157 . . . . 0.0 110.017 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.483 ' CD1' ' O ' ' A' ' 322' ' ' LEU . 0.9 OUTLIER -151.23 104.75 3.14 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.52 1.137 . . . . 0.0 109.338 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . 0.495 ' CE1' ' HB2' ' A' ' 326' ' ' ASP . 8.2 p80 -57.55 131.2 49.46 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.538 1.149 . . . . 0.0 109.609 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 23.0 t -58.96 -16.77 19.55 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.488 1.118 . . . . 0.0 109.993 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -66.71 -31.71 72.54 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.431 1.082 . . . . 0.0 109.305 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . 0.495 ' HB2' ' CE1' ' A' ' 323' ' ' HIS . 35.0 t70 -65.59 -47.52 75.44 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.543 1.152 . . . . 0.0 109.304 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' PHE . . . . . 0.469 ' CZ ' ' CE2' ' A' ' 341' ' ' PHE . 1.8 t80 -65.38 -35.74 81.88 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.431 1.082 . . . . 0.0 110.999 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -71.13 -32.29 68.8 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.505 1.128 . . . . 0.0 110.286 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 14.9 tmm? -68.29 -44.82 74.65 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.451 1.094 . . . . 0.0 110.991 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 2.4 mt -73.85 -31.57 63.25 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.504 1.128 . . . . 0.0 109.34 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 28.7 t -69.84 -38.14 76.41 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 0.0 108.322 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 11.3 t -76.86 -29.07 55.69 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.492 1.12 . . . . 0.0 109.984 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.9 -38.7 73.02 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.5 1.125 . . . . 0.0 109.974 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.8 124.07 32.51 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.483 1.114 . . . . 0.0 109.998 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 -27.87 9.64 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.417 1.746 . . . . 0.0 110.991 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.86 -32.61 72.4 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 0.0 110.315 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.502 ' O ' ' CB ' ' A' ' 341' ' ' PHE . 71.2 mt -75.14 -32.88 27.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.506 1.129 . . . . 0.0 109.316 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.29 -34.97 66.04 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.447 1.092 . . . . 0.0 109.295 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -73.77 -43.42 59.04 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.531 1.144 . . . . 0.0 110.308 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.44 HG22 ' CB ' ' A' ' 238' ' ' LYS . 97.7 mt -71.64 -38.06 65.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 0.0 109.339 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.502 ' CB ' ' O ' ' A' ' 337' ' ' ILE . 4.7 t80 -67.0 -39.22 87.07 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 0.0 111.042 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.06 -35.59 69.33 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.506 1.129 . . . . 0.0 110.311 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -46.17 83.66 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.45 1.094 . . . . 0.0 109.307 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 6.6 t -71.23 -33.98 70.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.543 1.152 . . . . 0.0 110.399 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -70.21 -37.23 75.02 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.452 1.095 . . . . 0.0 109.366 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 12.4 mt -71.43 -37.02 71.49 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.523 1.139 . . . . 0.0 109.29 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -72.68 -37.34 67.91 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.487 1.117 . . . . 0.0 110.335 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 . . . . . 0 C--N 1.324 -0.504 0 O-C-N 124.559 1.162 . . . . 0.0 110.251 179.997 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 31.7 t80 . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 120.484 0.183 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.12 -40.05 50.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.494 1.121 . . . . 0.0 109.322 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.464 ' HD3' ' CD1' ' A' ' 229' ' ' LEU . 0.0 OUTLIER -66.22 -31.87 72.95 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.519 1.137 . . . . 0.0 110.339 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . 0.406 ' ND2' HD22 ' A' ' 320' ' ' LEU . 12.4 t-20 -80.61 -30.84 36.78 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.538 1.149 . . . . 0.0 109.335 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' TRP . . . . . 0.579 ' CZ2' ' CG2' ' A' ' 245' ' ' VAL . 2.8 t90 -67.24 -42.66 83.61 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.127 . . . . 0.0 107.994 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.405 ' HG3' ' N ' ' A' ' 229' ' ' LEU . 8.9 pt20 -71.02 -40.77 71.56 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.478 1.111 . . . . 0.0 110.333 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.464 ' CD1' ' HD3' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -61.87 -48.65 79.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.471 1.107 . . . . 0.0 109.304 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.475 HG11 ' CD1' ' A' ' 244' ' ' LEU . 5.7 p -68.09 -39.63 81.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.503 1.127 . . . . 0.0 109.309 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -72.11 -16.53 62.01 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.502 1.126 . . . . 0.0 109.264 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 228' ' ' GLN . . . -81.25 -10.45 59.59 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.473 1.108 . . . . 0.0 109.282 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 6.7 t -80.85 121.04 80.54 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.561 1.163 . . . . 0.0 109.29 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 -18.35 18.75 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.501 1.79 . . . . 0.0 111.018 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 5.7 tp -75.87 -20.96 57.67 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.511 1.132 . . . . 0.0 109.281 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . 0.523 ' CD2' HD12 ' A' ' 239' ' ' LEU . 3.3 m-85 -108.97 8.9 26.55 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.495 1.122 . . . . 0.0 110.998 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.26 -19.92 65.58 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.572 1.17 . . . . 0.0 110.311 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.479 ' CB ' HG21 ' A' ' 340' ' ' ILE . 69.5 mmtt -80.63 -17.95 49.64 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.523 1.139 . . . . 0.0 109.313 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.523 HD12 ' CD2' ' A' ' 236' ' ' PHE . 75.1 mt -70.49 172.81 7.82 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.457 1.098 . . . . 0.0 109.284 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -107.42 -172.54 22.26 Favored Glycine 0 CA--C 1.529 0.952 0 O-C-N 124.509 1.131 . . . . 0.0 111.07 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.487 ' O ' ' CG2' ' A' ' 245' ' ' VAL . 18.3 Cg_endo -75.05 -35.16 3.27 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.487 1.783 . . . . 0.0 110.986 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -69.56 -34.08 73.66 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.475 1.11 . . . . 0.0 109.301 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.6 t -74.93 -40.58 45.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.493 1.12 . . . . 0.0 109.298 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.475 ' CD1' HG11 ' A' ' 230' ' ' VAL . 0.7 OUTLIER -64.83 -40.1 94.65 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.478 1.111 . . . . 0.0 109.262 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.579 ' CG2' ' CZ2' ' A' ' 227' ' ' TRP . 63.0 t -70.65 -42.13 77.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.459 1.099 . . . . 0.0 109.299 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -64.95 -35.65 81.86 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.492 1.12 . . . . 0.0 110.262 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 36.7 mt -71.75 -44.84 68.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.559 1.162 . . . . 0.0 109.321 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.465 ' CG2' HG12 ' A' ' 230' ' ' VAL . 96.4 t -68.17 -32.15 54.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.454 1.096 . . . . 0.0 109.292 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.93 -21.97 46.48 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.493 1.121 . . . . 0.0 110.327 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -89.94 -21.26 22.55 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.473 1.108 . . . . 0.0 109.276 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.411 ' CD2' ' HB2' ' A' ' 322' ' ' LEU . 0.2 OUTLIER -67.3 149.77 49.92 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.469 1.106 . . . . 0.0 109.304 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -121.08 119.57 32.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.442 1.088 . . . . 0.0 110.334 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.437 ' CB ' HD23 ' A' ' 320' ' ' LEU . . . -80.99 122.83 27.77 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.495 1.122 . . . . 0.0 109.324 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.96 142.9 49.12 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.506 1.129 . . . . 0.0 110.293 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.3 m -94.18 125.36 38.77 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.496 1.123 . . . . 0.0 110.359 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 47.6 t -106.92 112.44 63.32 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.534 1.146 . . . . 0.0 109.334 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.3 Cg_endo -75.01 171.38 18.43 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.485 1.781 . . . . 0.0 110.993 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.498 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -66.25 130.21 42.44 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.487 1.117 . . . . 0.0 109.336 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 94.97 -25.09 25.52 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.478 1.111 . . . . 0.0 111.031 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . 0.518 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -64.75 119.94 11.53 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.527 0.781 . . . . 0.0 109.297 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.17 136.03 24.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.539 1.15 . . . . 0.0 109.284 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 39.9 mt -82.12 -52.64 13.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.492 1.12 . . . . 0.0 109.334 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 17.1 p -147.43 146.26 29.51 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.512 1.133 . . . . 0.0 108.291 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -83.36 -177.8 6.86 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.115 . . . . 0.0 110.291 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.454 ' N ' ' OG1' ' A' ' 310' ' ' THR . 0.0 OUTLIER -76.08 133.21 31.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.507 1.129 . . . . 0.0 109.301 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 55.5 53.9 38.14 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.486 1.116 . . . . 0.0 110.983 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.81 165.75 43.65 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.467 0.745 . . . . 0.0 110.313 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . 0.486 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.3 Cg_endo -75.01 87.12 1.35 Allowed 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.498 1.788 . . . . 0.0 110.947 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -39.79 93.4 0.01 OUTLIER Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.506 1.129 . . . . 0.0 111.02 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 268' ' ' PRO . 17.9 p30 -170.82 38.48 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.513 0.773 . . . . 0.0 109.261 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . 0.415 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 12.8 mtt180 -169.51 154.45 5.63 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.477 1.11 . . . . 0.0 110.309 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.41 ' SD ' ' CD1' ' A' ' 301' ' ' LEU . 1.2 ttt -126.09 149.66 48.75 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.506 1.129 . . . . 0.0 110.985 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 296' ' ' PHE . 12.1 m-85 -135.63 138.2 42.65 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.475 1.109 . . . . 0.0 110.98 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -128.36 126.15 40.12 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.552 1.158 . . . . 0.0 110.973 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.408 HG21 ' CG1' ' A' ' 280' ' ' VAL . 41.7 t -85.47 129.64 37.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.467 1.104 . . . . 0.0 109.298 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . 0.468 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 46.3 t -104.94 -46.97 9.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.467 1.105 . . . . 0.0 109.322 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . 0.401 ' O ' ' CG2' ' A' ' 317' ' ' VAL . 0.0 OUTLIER -148.52 140.51 23.9 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.482 1.114 . . . . 0.0 110.336 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 116.46 -154.1 17.02 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.554 1.159 . . . . 0.0 110.994 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 4.5 m -147.83 131.4 16.79 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.466 0.745 . . . . 0.0 109.967 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.408 ' CG1' HG21 ' A' ' 275' ' ' VAL . 20.3 m -117.17 135.58 57.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.484 1.115 . . . . 0.0 109.332 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 29.3 t -102.5 149.6 24.23 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.519 1.137 . . . . 0.0 109.983 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -113.35 130.42 67.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.502 1.127 . . . . 0.0 109.291 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.413 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -76.77 101.84 6.0 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.541 1.15 . . . . 0.0 109.31 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' THR . . . . . 0.648 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -149.07 -168.63 0.19 Allowed Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.47 1.106 . . . . 0.0 110.427 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.648 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -75.01 3.83 5.28 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.553 1.817 . . . . 0.0 110.975 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -151.91 157.68 34.22 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.533 1.146 . . . . 0.0 109.325 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 92.59 0.98 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.533 1.807 . . . . 0.0 111.0 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 29.0 t -95.49 118.97 42.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.506 1.129 . . . . 0.0 109.311 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -124.34 138.69 54.35 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.482 1.114 . . . . 0.0 110.313 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -121.37 140.92 51.48 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.464 1.103 . . . . 0.0 109.311 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -97.55 -155.01 29.91 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.459 1.1 . . . . 0.0 110.985 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.94 147.04 33.65 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.498 1.789 . . . . 0.0 111.018 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 85.26 5.77 85.0 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.474 1.109 . . . . 0.0 111.011 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -90.44 121.42 32.39 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.495 0.762 . . . . 0.0 109.323 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -116.16 152.89 32.8 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.541 1.151 . . . . 0.0 110.994 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . 0.559 ' CZ ' ' HB3' ' A' ' 273' ' ' PHE . 33.7 p90 -163.71 148.95 10.88 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.486 1.116 . . . . 0.0 111.018 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 132.98 -11.58 5.1 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.454 1.096 . . . . 0.0 110.976 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -52.82 -44.91 67.01 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.452 0.737 . . . . 0.0 110.3 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.67 -39.21 57.81 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.438 1.086 . . . . 0.0 110.965 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . 0.457 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -68.49 -39.03 81.48 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.516 1.135 . . . . 0.0 109.304 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.512 HD22 ' CG ' ' A' ' 327' ' ' PHE . 13.3 mt -76.76 -8.78 57.96 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.516 1.135 . . . . 0.0 109.334 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 6.5 mm -85.01 -52.95 11.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.488 1.117 . . . . 0.0 109.341 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 304' ' ' GLY . 0.4 OUTLIER -153.51 41.13 0.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.5 1.125 . . . . 0.0 109.967 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 36.48 36.4 0.15 Allowed Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.494 1.121 . . . . 0.0 110.956 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.93 155.76 85.84 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.511 0.771 . . . . 0.0 110.266 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 130.87 13.63 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.539 1.81 . . . . 0.0 110.999 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -45.16 -31.32 1.4 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.528 1.143 . . . . 0.0 110.288 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 2.4 m 59.1 33.1 22.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 0.0 110.03 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . 176.35 160.63 0.34 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.498 1.124 . . . . 0.0 109.317 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.454 ' OG1' ' N ' ' A' ' 265' ' ' ILE . 0.7 OUTLIER -109.98 127.2 54.65 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.471 1.107 . . . . 0.0 110.396 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 57.6 t -107.21 131.64 56.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.496 1.122 . . . . 0.0 109.301 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 1.9 p -137.03 150.55 48.16 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.473 1.108 . . . . 0.0 110.036 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . 0.502 ' CB ' ' CG1' ' A' ' 317' ' ' VAL . . . -80.04 111.09 16.05 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.518 1.137 . . . . 0.0 109.278 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -58.61 -26.69 63.96 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.461 1.101 . . . . 0.0 109.285 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' THR . . . . . 0.498 ' HA ' ' CB ' ' A' ' 258' ' ' ALA . 8.8 t -160.18 -164.01 1.21 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.514 1.133 . . . . 0.0 110.379 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' THR . . . . . 0.433 ' N ' ' OG1' ' A' ' 315' ' ' THR . 65.2 m -64.08 74.61 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.504 1.128 . . . . 0.0 110.417 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.502 ' CG1' ' CB ' ' A' ' 313' ' ' ALA . 2.7 p -104.14 137.81 31.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.125 . . . . 0.0 109.319 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 71.1 m -106.19 134.83 48.7 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.542 1.151 . . . . 0.0 109.972 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . 0.447 HD21 ' CG2' ' A' ' 317' ' ' VAL . 0.0 OUTLIER -141.5 174.23 10.75 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.535 1.147 . . . . 0.0 109.319 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.468 ' CD1' ' CG2' ' A' ' 276' ' ' VAL . 0.6 OUTLIER -124.83 134.01 52.9 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.517 1.135 . . . . 0.0 109.262 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 29.5 t -98.03 146.82 25.15 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.529 1.143 . . . . 0.0 109.972 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.411 ' HB2' ' CD2' ' A' ' 251' ' ' LEU . 2.2 tm? -138.06 104.64 5.29 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.518 1.136 . . . . 0.0 109.318 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . 0.415 ' HA ' ' CG ' ' A' ' 271' ' ' ARG . 5.8 p80 -63.71 134.31 55.12 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.557 1.161 . . . . 0.0 109.631 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 86.4 p -55.56 -18.47 7.55 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.54 1.15 . . . . 0.0 109.978 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -58.12 -36.99 73.73 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.466 1.104 . . . . 0.0 109.291 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -65.32 -38.87 91.5 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.499 1.125 . . . . 0.0 109.312 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' PHE . . . . . 0.512 ' CG ' HD22 ' A' ' 301' ' ' LEU . 17.7 t80 -68.63 -35.64 77.55 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.478 1.111 . . . . 0.0 110.991 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -69.33 -33.84 73.74 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.5 1.125 . . . . 0.0 110.326 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.418 ' O ' ' CB ' ' A' ' 333' ' ' SER . 32.2 ttp -70.59 -43.21 69.85 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.457 1.098 . . . . 0.0 110.987 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 2.6 mt -70.58 -34.7 72.47 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.435 1.085 . . . . 0.0 109.342 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 1.3 m -73.22 -44.12 60.14 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.473 1.108 . . . . 0.0 108.3 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 7.6 t -73.09 -27.86 61.96 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.529 1.143 . . . . 0.0 110.04 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 329' ' ' MET . 11.7 t -74.04 -38.38 64.03 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.537 1.148 . . . . 0.0 110.028 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.92 120.52 22.72 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 0.0 109.977 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -23.62 13.57 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.503 1.791 . . . . 0.0 111.038 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -72.32 -33.66 67.52 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.481 1.113 . . . . 0.0 110.263 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 87.3 mt -71.07 -40.34 75.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.556 1.16 . . . . 0.0 109.337 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.98 -30.7 64.02 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.443 1.089 . . . . 0.0 109.286 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.89 -37.34 70.16 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.529 1.143 . . . . 0.0 110.294 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.479 HG21 ' CB ' ' A' ' 238' ' ' LYS . 30.6 mt -72.93 -45.64 54.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.526 1.141 . . . . 0.0 109.295 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -67.65 -30.9 70.57 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.463 1.102 . . . . 0.0 110.997 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -72.54 -44.58 61.95 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.133 . . . . 0.0 110.258 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -45.26 76.88 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.521 1.138 . . . . 0.0 109.371 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.53 -40.12 92.57 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 0.0 110.409 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -69.09 -32.96 72.75 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.135 . . . . 0.0 109.28 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 13.1 mt -73.64 -31.18 63.37 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.519 1.137 . . . . 0.0 109.308 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -72.72 -40.56 66.03 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.14 . . . . 0.0 110.353 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 . . . . . 0 C--N 1.325 -0.472 0 O-C-N 124.466 1.104 . . . . 0.0 110.273 179.995 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.565 ' CE1' ' HD3' ' A' ' 249' ' ' ARG . 68.3 t80 . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.516 0.198 . . . . 0.0 110.969 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.62 -39.29 81.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.474 1.109 . . . . 0.0 109.315 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.66 -34.41 76.87 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.512 1.132 . . . . 0.0 110.281 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . 0.504 ' O ' ' CG1' ' A' ' 230' ' ' VAL . 36.9 t30 -78.73 -30.49 45.89 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.506 1.129 . . . . 0.0 109.271 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' TRP . . . . . 0.622 ' CZ2' HG23 ' A' ' 245' ' ' VAL . 5.5 t90 -66.99 -44.4 80.5 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.522 1.139 . . . . 0.0 108.011 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -71.78 -33.99 69.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.444 1.09 . . . . 0.0 110.332 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.63 -55.39 17.84 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.544 1.152 . . . . 0.0 109.308 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.504 ' CG1' ' O ' ' A' ' 226' ' ' ASN . 7.4 p -65.51 -35.01 74.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.509 1.131 . . . . 0.0 109.287 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.475 ' CB ' ' O ' ' A' ' 227' ' ' TRP . . . -75.29 -18.88 59.94 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.485 1.115 . . . . 0.0 109.297 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -80.72 -20.31 43.12 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.102 . . . . 0.0 109.264 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . 0.403 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 60.3 t -62.78 128.58 92.08 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.507 1.13 . . . . 0.0 109.308 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 233' ' ' VAL . 18.4 Cg_endo -74.99 -35.97 2.83 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.485 1.782 . . . . 0.0 111.078 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 1.2 tp -63.91 -19.22 64.94 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.5 1.125 . . . . 0.0 109.323 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . 0.534 ' CD1' HD12 ' A' ' 239' ' ' LEU . 4.3 m-30 -114.28 8.5 16.77 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.468 1.105 . . . . 0.0 110.988 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -71.18 -22.61 62.01 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.508 1.13 . . . . 0.0 110.304 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.4 ' CB ' HG23 ' A' ' 340' ' ' ILE . 65.9 mmtt -83.41 -19.37 36.11 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.476 1.11 . . . . 0.0 109.265 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.534 HD12 ' CD1' ' A' ' 236' ' ' PHE . 67.7 mt -63.79 -179.98 0.44 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.549 1.155 . . . . 0.0 109.296 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -103.95 178.2 24.66 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.487 1.117 . . . . 0.0 111.04 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -34.54 3.72 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.486 1.782 . . . . 0.0 111.006 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -71.8 -35.4 69.96 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.499 1.125 . . . . 0.0 109.337 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 71.6 t -72.73 -40.62 61.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.528 1.142 . . . . 0.0 109.291 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.458 ' CD2' ' HB2' ' A' ' 239' ' ' LEU . 3.9 mm? -69.08 -40.51 78.39 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.515 1.134 . . . . 0.0 109.308 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.622 HG23 ' CZ2' ' A' ' 227' ' ' TRP . 20.5 t -66.17 -37.05 78.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.487 1.117 . . . . 0.0 109.296 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -74.3 -30.78 62.23 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.55 1.156 . . . . 0.0 110.298 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.439 ' CG1' HD11 ' A' ' 330' ' ' LEU . 44.2 mt -70.93 -48.59 55.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.542 1.151 . . . . 0.0 109.308 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.405 HG23 ' ND2' ' A' ' 226' ' ' ASN . 14.5 p -65.56 -36.14 76.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.525 1.14 . . . . 0.0 109.286 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.565 ' HD3' ' CE1' ' A' ' 223' ' ' PHE . 1.4 mmm180 -72.44 -25.2 61.37 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.495 1.122 . . . . 0.0 110.311 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -91.41 0.33 57.53 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.472 1.108 . . . . 0.0 109.261 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.69 151.61 25.18 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 0.0 109.269 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.08 125.16 46.57 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.46 1.1 . . . . 0.0 110.291 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -82.97 122.72 28.66 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.523 1.139 . . . . 0.0 109.267 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.405 ' O ' ' O ' ' A' ' 319' ' ' LEU . 0.0 OUTLIER -127.72 139.35 52.74 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.436 1.085 . . . . 0.0 110.265 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 6.6 m -95.55 128.07 42.11 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.479 1.112 . . . . 0.0 110.405 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 22.0 t -106.54 115.78 60.13 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.458 1.099 . . . . 0.0 109.251 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.502 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.95 154.44 42.76 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.52 1.8 . . . . 0.0 111.036 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.479 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -57.51 126.27 26.59 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.475 1.11 . . . . 0.0 109.266 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 98.7 -25.19 29.01 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.511 1.132 . . . . 0.0 110.995 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . 0.502 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -66.3 146.58 54.44 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.479 0.752 . . . . 0.0 109.254 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 2.4 p -97.18 136.29 28.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.461 1.101 . . . . 0.0 109.319 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 7.4 mt -81.65 -45.42 20.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.489 1.118 . . . . 0.0 109.33 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' CYS . . . . . 0.493 ' SG ' ' CG2' ' A' ' 311' ' ' VAL . 14.1 p -147.4 153.53 39.73 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.479 1.112 . . . . 0.0 108.331 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.41 179.91 5.0 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.513 1.133 . . . . 0.0 110.304 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.463 HG21 ' CB ' ' A' ' 310' ' ' THR . 0.1 OUTLIER -76.67 135.95 25.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.471 1.107 . . . . 0.0 109.311 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 52.27 53.55 30.77 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.539 1.149 . . . . 0.0 111.027 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . 0.417 ' CD ' ' CD ' ' A' ' 268' ' ' PRO . 5.7 mm-40 -71.57 166.1 42.73 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.512 0.772 . . . . 0.0 110.313 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . 0.517 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.2 Cg_endo -74.96 82.52 1.98 Allowed 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.515 1.797 . . . . 0.0 111.024 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 268' ' ' PRO . . . -36.86 92.39 0.01 OUTLIER Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.471 1.107 . . . . 0.0 110.976 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 268' ' ' PRO . 36.6 m-20 -171.92 37.84 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.526 0.78 . . . . 0.0 109.322 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.8 148.57 2.93 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.476 1.11 . . . . 0.0 110.299 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.454 ' HE3' ' CA ' ' A' ' 298' ' ' GLU . 2.1 ttt -123.26 146.65 47.68 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.543 1.152 . . . . 0.0 110.971 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.568 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 92.4 m-85 -133.4 136.98 45.6 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.512 1.133 . . . . 0.0 110.982 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . 0.501 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 20.5 m-85 -124.72 135.06 52.69 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.451 1.094 . . . . 0.0 111.004 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 276' ' ' VAL . 38.6 t -90.43 137.93 20.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.471 1.107 . . . . 0.0 109.321 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . 0.417 ' N ' HG12 ' A' ' 275' ' ' VAL . 3.4 t -115.86 -48.99 4.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.484 1.115 . . . . 0.0 109.329 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -139.01 136.57 35.47 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.51 1.131 . . . . 0.0 110.306 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.464 ' HA3' ' CG2' ' A' ' 317' ' ' VAL . . . 110.87 -173.31 15.93 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.486 1.116 . . . . 0.0 110.957 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' SER . . . . . 0.441 ' N ' HG23 ' A' ' 317' ' ' VAL . 5.5 t -134.34 126.67 30.14 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.481 0.754 . . . . 0.0 109.992 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.437 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 17.4 m -104.18 166.32 3.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.485 1.116 . . . . 0.0 109.286 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 30.8 t -129.81 154.79 46.9 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.502 1.126 . . . . 0.0 110.022 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.449 ' CG2' ' HB ' ' A' ' 288' ' ' VAL . 0.5 OUTLIER -118.03 127.84 75.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.502 1.126 . . . . 0.0 109.301 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.408 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -77.0 101.37 5.99 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.44 1.088 . . . . 0.0 109.338 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' THR . . . . . 0.651 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.63 -168.35 0.18 Allowed Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.525 1.141 . . . . 0.0 110.392 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.651 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.3 Cg_endo -74.97 4.17 4.96 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.528 1.804 . . . . 0.0 111.017 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -150.68 156.16 36.13 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.509 1.131 . . . . 0.0 109.299 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 94.19 0.96 Allowed 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.517 1.798 . . . . 0.0 111.032 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.449 ' HB ' ' CG2' ' A' ' 282' ' ' VAL . 2.1 t -98.13 119.26 45.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.54 1.15 . . . . 0.0 109.322 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -124.5 135.44 53.21 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.547 1.154 . . . . 0.0 110.337 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.437 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 3.9 mm? -115.3 142.61 46.45 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.52 1.137 . . . . 0.0 109.308 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -97.96 -162.56 30.98 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.434 1.084 . . . . 0.0 111.025 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 144.99 30.91 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.467 1.772 . . . . 0.0 110.999 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 90.21 -1.84 80.43 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.502 1.126 . . . . 0.0 111.022 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -83.76 139.31 32.8 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.51 0.77 . . . . 0.0 109.321 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . 0.405 ' CB ' ' CD1' ' A' ' 274' ' ' PHE . 1.5 p90 -126.4 152.74 45.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.491 1.119 . . . . 0.0 110.998 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . 0.568 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 33.4 p90 -160.85 149.71 16.6 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.446 1.091 . . . . 0.0 111.013 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 126.23 -8.55 7.5 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.479 1.112 . . . . 0.0 111.025 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . 0.454 ' CA ' ' HE3' ' A' ' 272' ' ' MET . 27.0 tt0 -52.87 -44.19 66.66 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.525 0.779 . . . . 0.0 110.283 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' MET . . . . . 0.463 ' HB3' ' CG ' ' A' ' 305' ' ' GLU . 0.0 OUTLIER -56.34 -37.13 69.59 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.497 1.123 . . . . 0.0 111.037 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -66.36 -38.38 87.46 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.503 1.127 . . . . 0.0 109.227 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 1.8 mp -81.98 -10.22 59.32 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.124 . . . . 0.0 109.328 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 3.9 mm -76.9 -56.42 8.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.464 1.102 . . . . 0.0 109.33 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 305' ' ' GLU . 1.5 m -151.53 48.37 0.81 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.526 1.141 . . . . 0.0 109.992 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 303' ' ' SER . . . 36.57 31.66 0.05 OUTLIER Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.516 1.135 . . . . 0.0 110.99 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' GLU . . . . . 0.463 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 0.0 OUTLIER -65.24 151.67 93.41 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.517 0.775 . . . . 0.0 110.28 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 129.51 12.45 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.434 1.755 . . . . 0.0 111.022 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.88 -22.92 0.93 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.491 1.119 . . . . 0.0 110.288 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.511 ' O ' ' CB ' ' A' ' 309' ' ' ALA . 27.4 m 41.79 57.24 3.18 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.566 1.166 . . . . 0.0 110.03 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 308' ' ' SER . . . 162.68 159.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.463 1.102 . . . . 0.0 109.349 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.463 ' CB ' HG21 ' A' ' 265' ' ' ILE . 0.3 OUTLIER -112.7 122.06 46.56 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.509 1.131 . . . . 0.0 110.408 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.493 ' CG2' ' SG ' ' A' ' 263' ' ' CYS . 23.0 t -102.79 131.51 50.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.524 1.14 . . . . 0.0 109.302 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 33.8 p -138.37 154.07 48.93 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.494 1.121 . . . . 0.0 109.984 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -91.15 120.55 32.19 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.497 1.123 . . . . 0.0 109.297 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -61.94 -33.79 74.91 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.481 1.113 . . . . 0.0 109.316 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' THR . . . . . 0.479 ' HA ' ' CB ' ' A' ' 258' ' ' ALA . 9.9 t -149.78 -176.22 5.34 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.517 1.136 . . . . 0.0 110.425 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 13.9 p -49.8 92.36 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.525 1.14 . . . . 0.0 110.361 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.464 ' CG2' ' HA3' ' A' ' 278' ' ' GLY . 43.0 t -108.56 158.49 8.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.509 1.131 . . . . 0.0 109.312 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' SER . . . . . 0.416 ' N ' HG13 ' A' ' 317' ' ' VAL . 68.4 m -132.92 118.16 18.56 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.487 1.117 . . . . 0.0 110.014 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . 0.501 ' CB ' ' O ' ' A' ' 274' ' ' PHE . 0.2 OUTLIER -131.65 172.94 11.65 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.49 1.119 . . . . 0.0 109.286 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.1 137.14 54.19 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.451 1.095 . . . . 0.0 109.31 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 4.0 t -95.51 156.41 16.34 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.463 1.102 . . . . 0.0 110.021 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.94 103.51 3.22 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 0.0 109.289 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . 0.559 ' CE1' ' HB2' ' A' ' 326' ' ' ASP . 9.1 p80 -57.72 136.46 56.88 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.494 1.121 . . . . 0.0 109.584 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 42.0 t -62.12 -21.46 65.03 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.448 1.092 . . . . 0.0 109.984 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -62.97 -30.43 71.57 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.506 1.129 . . . . 0.0 109.307 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . 0.559 ' HB2' ' CE1' ' A' ' 323' ' ' HIS . 27.7 t70 -65.98 -47.91 73.0 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.506 1.129 . . . . 0.0 109.339 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' PHE . . . . . 0.503 ' CZ ' ' CE2' ' A' ' 341' ' ' PHE . 2.5 t80 -64.95 -34.26 78.0 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.494 1.121 . . . . 0.0 110.996 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . 0.486 ' O ' ' CB ' ' A' ' 332' ' ' SER . 67.5 mt-30 -70.53 -33.37 71.1 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.509 1.13 . . . . 0.0 110.264 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 14.3 tmm? -68.98 -44.83 72.08 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.513 1.133 . . . . 0.0 110.989 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.504 ' CD1' ' O ' ' A' ' 326' ' ' ASP . 0.6 OUTLIER -73.47 -41.87 62.61 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.479 1.112 . . . . 0.0 109.275 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 22.7 t -66.11 -38.57 88.52 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.479 1.112 . . . . 0.0 108.257 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 328' ' ' GLN . 38.7 t -76.72 -25.62 53.77 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.462 1.101 . . . . 0.0 109.953 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 17.7 t -71.73 -38.87 70.4 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.123 . . . . 0.0 110.034 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.19 127.65 26.63 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.477 1.11 . . . . 0.0 109.965 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 -28.8 8.86 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.525 1.803 . . . . 0.0 110.981 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -67.22 -29.82 69.58 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.502 1.126 . . . . 0.0 110.263 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.511 ' O ' ' CB ' ' A' ' 341' ' ' PHE . 87.4 mt -75.0 -34.46 32.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.543 1.152 . . . . 0.0 109.257 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.73 -30.65 64.35 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.528 1.142 . . . . 0.0 109.3 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -74.93 -46.23 37.1 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.491 1.119 . . . . 0.0 110.317 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.4 HG23 ' CB ' ' A' ' 238' ' ' LYS . 87.4 mt -71.59 -36.45 59.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.459 1.099 . . . . 0.0 109.278 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.511 ' CB ' ' O ' ' A' ' 337' ' ' ILE . 6.0 t80 -67.39 -41.96 84.14 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.514 1.134 . . . . 0.0 110.991 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . 0.466 ' HG3' ' CD1' ' A' ' 346' ' ' LEU . 0.7 OUTLIER -70.63 -35.84 73.15 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.492 1.12 . . . . 0.0 110.26 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -50.86 65.36 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.492 1.12 . . . . 0.0 109.277 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 10.2 t -65.04 -33.02 75.03 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.474 1.108 . . . . 0.0 110.389 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -66.09 -44.92 83.0 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.484 1.115 . . . . 0.0 109.283 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.466 ' CD1' ' HG3' ' A' ' 342' ' ' ARG . 1.0 OUTLIER -65.34 -36.46 84.1 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.502 1.126 . . . . 0.0 109.329 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -73.53 -35.4 65.55 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.499 1.124 . . . . 0.0 110.317 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.476 0 O-C-N 124.495 1.122 . . . . 0.0 110.255 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.492 ' O ' ' CB ' ' A' ' 227' ' ' TRP . 28.9 t80 . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.495 0.188 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -86.39 -21.06 7.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.519 1.137 . . . . 0.0 109.311 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.463 ' HG3' ' CG1' ' A' ' 276' ' ' VAL . 0.0 OUTLIER -77.33 -44.15 30.5 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.527 1.142 . . . . 0.0 110.284 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . 0.471 ' CG ' ' CG2' ' A' ' 248' ' ' VAL . 18.4 p-10 -81.02 -30.73 34.85 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.52 1.137 . . . . 0.0 109.317 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' TRP . . . . . 0.492 ' CB ' ' O ' ' A' ' 223' ' ' PHE . 1.0 OUTLIER -68.86 -45.27 71.5 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 0.0 107.981 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.467 ' O ' ' N ' ' A' ' 232' ' ' ALA . 3.5 pt20 -71.98 -32.18 67.0 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.568 1.167 . . . . 0.0 110.282 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.403 ' CD1' ' O ' ' A' ' 225' ' ' ARG . 1.2 mt -63.4 -47.71 80.84 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.534 1.146 . . . . 0.0 109.306 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.478 ' O ' ' CG2' ' A' ' 233' ' ' VAL . 34.1 m -66.98 -41.24 87.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.483 1.115 . . . . 0.0 109.324 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.443 ' N ' HG23 ' A' ' 230' ' ' VAL . . . -76.76 -11.4 59.83 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.535 1.147 . . . . 0.0 109.277 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 228' ' ' GLN . . . -81.24 -26.01 36.18 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.479 1.112 . . . . 0.0 109.298 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . 0.478 ' CG2' ' O ' ' A' ' 230' ' ' VAL . 34.1 m -86.46 135.9 35.85 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.493 1.121 . . . . 0.0 109.279 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.94 -13.48 21.54 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.497 1.788 . . . . 0.0 111.046 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.86 -28.65 66.9 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.485 1.116 . . . . 0.0 109.334 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . 0.465 ' HA ' ' CD1' ' A' ' 239' ' ' LEU . 11.6 m-30 -110.82 -17.01 13.44 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.518 1.136 . . . . 0.0 111.033 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.4 -26.65 65.31 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.467 1.104 . . . . 0.0 110.335 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -83.45 7.56 16.54 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.465 1.103 . . . . 0.0 109.291 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.465 ' CD1' ' HA ' ' A' ' 236' ' ' PHE . 34.0 mt -101.65 -179.48 4.03 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.538 1.149 . . . . 0.0 109.294 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -92.06 176.84 39.4 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.479 1.112 . . . . 0.0 110.992 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -30.34 7.24 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.457 1.767 . . . . 0.0 111.009 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 0.44 ' O ' HG11 ' A' ' 245' ' ' VAL . . . -70.91 -31.49 68.13 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 0.0 109.322 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.479 HG22 ' CD1' ' A' ' 337' ' ' ILE . 2.7 t -76.89 -43.0 33.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.504 1.128 . . . . 0.0 109.327 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.3 -45.16 77.34 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.529 1.143 . . . . 0.0 109.321 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.49 ' CG2' ' CZ3' ' A' ' 227' ' ' TRP . 2.9 p -64.49 -44.83 96.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.529 1.143 . . . . 0.0 109.32 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.405 ' N ' ' CG1' ' A' ' 245' ' ' VAL . 19.7 tp10 -66.01 -34.66 78.61 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.45 1.094 . . . . 0.0 110.301 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.441 ' CG1' HD13 ' A' ' 330' ' ' LEU . 15.5 mt -68.81 -55.17 16.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.548 1.155 . . . . 0.0 109.31 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.474 ' HA ' ' CD1' ' A' ' 251' ' ' LEU . 13.7 p -64.81 -30.36 50.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.532 1.145 . . . . 0.0 109.318 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.484 ' CG ' ' O ' ' A' ' 245' ' ' VAL . 5.8 mmm180 -70.17 -28.76 65.58 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.526 1.141 . . . . 0.0 110.308 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -86.86 -21.06 26.61 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.475 1.109 . . . . 0.0 109.309 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.474 ' CD1' ' HA ' ' A' ' 248' ' ' VAL . 1.7 mt -54.72 144.85 20.88 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.527 1.142 . . . . 0.0 109.256 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.66 124.88 50.82 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.485 1.116 . . . . 0.0 110.302 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -81.94 124.25 29.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.486 1.116 . . . . 0.0 109.267 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.46 136.56 48.04 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.523 1.139 . . . . 0.0 110.295 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 55.7 m -94.16 125.04 38.55 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 0.0 110.384 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 42.1 t -106.8 113.95 62.23 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.47 1.106 . . . . 0.0 109.301 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.493 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.2 Cg_endo -75.03 158.11 42.27 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.49 1.784 . . . . 0.0 110.983 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.482 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -57.85 125.39 22.82 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.491 1.119 . . . . 0.0 109.314 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 101.52 -24.08 32.85 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.513 1.133 . . . . 0.0 110.99 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . 0.493 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -61.35 147.44 44.75 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.554 0.796 . . . . 0.0 109.291 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.9 t -97.11 131.3 44.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.51 1.131 . . . . 0.0 109.298 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.404 HG21 ' CD1' ' A' ' 319' ' ' LEU . 86.2 mt -83.11 -47.96 17.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.457 1.098 . . . . 0.0 109.33 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 14.3 p -153.88 145.48 23.26 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.478 1.111 . . . . 0.0 108.289 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -89.25 178.96 6.22 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.542 1.151 . . . . 0.0 110.28 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.468 HG22 ' CB ' ' A' ' 310' ' ' THR . 0.1 OUTLIER -77.89 130.69 35.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.48 1.112 . . . . 0.0 109.261 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 59.9 49.4 78.94 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.497 1.123 . . . . 0.0 111.012 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.12 164.3 58.11 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.521 0.777 . . . . 0.0 110.325 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.5 Cg_endo -74.98 80.6 2.39 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.517 1.799 . . . . 0.0 111.043 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 268' ' ' PRO . . . -37.14 95.82 0.01 OUTLIER Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.488 1.117 . . . . 0.0 111.024 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 268' ' ' PRO . 1.0 OUTLIER -170.2 37.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.499 0.764 . . . . 0.0 109.311 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 6.5 ttt180 -171.57 146.33 2.17 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.506 1.129 . . . . 0.0 110.309 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' MET . . . . . . . . . . . . . 2.6 ttt -116.69 146.51 42.71 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.533 1.146 . . . . 0.0 111.023 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.561 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 44.5 m-85 -133.92 137.03 44.64 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.124 . . . . 0.0 111.023 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . 0.437 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 21.1 m-85 -126.38 133.48 51.3 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.519 1.137 . . . . 0.0 111.003 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 3.2 t -91.07 133.11 33.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.475 1.109 . . . . 0.0 109.294 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . 0.463 ' CG1' ' HG3' ' A' ' 225' ' ' ARG . 40.2 t -110.27 -35.35 2.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.576 1.173 . . . . 0.0 109.268 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . 0.401 ' O ' ' CG1' ' A' ' 317' ' ' VAL . 0.3 OUTLIER -156.27 137.84 14.09 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.516 1.135 . . . . 0.0 110.309 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.455 ' HA3' ' CG2' ' A' ' 317' ' ' VAL . . . 117.15 -177.53 16.7 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.483 1.114 . . . . 0.0 110.987 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' SER . . . . . 0.412 ' N ' HG23 ' A' ' 317' ' ' VAL . 2.7 m -126.35 113.49 16.98 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.478 0.752 . . . . 0.0 109.97 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 32.7 m -99.26 135.1 35.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.493 1.121 . . . . 0.0 109.325 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 29.3 t -104.16 148.49 26.23 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.475 1.109 . . . . 0.0 109.997 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 1.7 t -112.27 128.92 68.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.482 1.113 . . . . 0.0 109.319 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.415 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -77.34 100.96 6.11 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.538 1.149 . . . . 0.0 109.282 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' THR . . . . . 0.661 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.9 OUTLIER -149.37 -167.99 0.17 Allowed Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.455 1.097 . . . . 0.0 110.382 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.661 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.4 Cg_endo -75.0 3.93 5.19 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.51 1.794 . . . . 0.0 111.028 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -152.21 154.82 32.76 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.448 1.093 . . . . 0.0 109.276 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 95.48 0.98 Allowed 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.515 1.797 . . . . 0.0 110.981 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 1.3 t -100.03 118.53 46.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.491 1.119 . . . . 0.0 109.303 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -125.16 133.53 52.76 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.498 1.124 . . . . 0.0 110.312 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -115.41 139.66 49.82 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.506 1.129 . . . . 0.0 109.324 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -95.77 -155.96 31.31 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.502 1.126 . . . . 0.0 110.98 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 138.37 22.82 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.53 1.805 . . . . 0.0 110.972 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 95.23 6.19 60.2 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.481 1.113 . . . . 0.0 110.965 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -90.58 130.75 36.58 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.461 0.742 . . . . 0.0 109.238 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 295' ' ' PHE . 2.3 p90 -120.75 152.92 37.7 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.506 1.129 . . . . 0.0 111.018 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . 0.561 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 36.9 p90 -164.72 148.27 8.92 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.13 . . . . 0.0 110.975 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 128.07 -8.45 6.74 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.457 1.098 . . . . 0.0 110.989 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -54.94 -53.35 56.76 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.474 0.749 . . . . 0.0 110.319 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -46.98 -35.03 6.12 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.512 1.133 . . . . 0.0 110.979 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . 0.458 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -68.74 -46.91 67.64 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.515 1.134 . . . . 0.0 109.324 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 1.1 mp -75.21 -3.21 31.76 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.475 1.11 . . . . 0.0 109.312 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . 0.565 HD12 ' CZ ' ' A' ' 341' ' ' PHE . 8.8 mm -86.85 -54.35 8.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.509 1.131 . . . . 0.0 109.296 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 304' ' ' GLY . 0.9 OUTLIER -149.44 40.89 0.86 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.47 1.106 . . . . 0.0 110.036 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 37.03 34.04 0.1 OUTLIER Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.54 1.15 . . . . 0.0 110.989 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.72 155.23 89.88 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.502 0.766 . . . . 0.0 110.266 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 129.66 12.52 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.468 1.773 . . . . 0.0 111.013 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.98 -29.64 1.52 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.503 1.127 . . . . 0.0 110.273 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 50.65 40.88 25.01 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.444 1.09 . . . . 0.0 109.957 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . 175.26 160.82 0.24 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.497 1.123 . . . . 0.0 109.311 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.468 ' CB ' HG22 ' A' ' 265' ' ' ILE . 0.9 OUTLIER -117.78 123.43 45.97 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.539 1.149 . . . . 0.0 110.392 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 95.1 t -103.99 131.39 52.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.506 1.129 . . . . 0.0 109.279 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 65.2 p -131.54 151.27 51.72 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.475 1.109 . . . . 0.0 109.997 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.26 109.65 19.65 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.515 1.134 . . . . 0.0 109.282 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -56.41 -32.19 64.61 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.503 1.127 . . . . 0.0 109.304 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' THR . . . . . 0.482 ' HA ' ' CB ' ' A' ' 258' ' ' ALA . 8.2 t -153.86 -171.76 3.99 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.526 1.141 . . . . 0.0 110.416 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' THR . . . . . 0.452 ' N ' ' OG1' ' A' ' 315' ' ' THR . 43.1 p -54.74 87.91 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.554 1.159 . . . . 0.0 110.39 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.455 ' CG2' ' HA3' ' A' ' 278' ' ' GLY . 44.9 t -107.71 144.25 16.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.482 1.113 . . . . 0.0 109.265 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 69.1 m -117.99 117.87 30.4 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.529 1.143 . . . . 0.0 109.958 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . 0.437 ' CB ' ' O ' ' A' ' 274' ' ' PHE . 0.0 OUTLIER -128.48 173.33 10.32 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.49 1.119 . . . . 0.0 109.328 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.403 HD12 ' CG2' ' A' ' 276' ' ' VAL . 0.2 OUTLIER -124.49 136.3 53.9 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.471 1.107 . . . . 0.0 109.298 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 14.1 t -96.23 154.63 17.15 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.513 1.133 . . . . 0.0 110.01 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.469 ' HB2' ' CD2' ' A' ' 251' ' ' LEU . 1.2 tm? -145.28 87.66 1.82 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.506 1.129 . . . . 0.0 109.268 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -49.69 139.1 13.34 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.557 1.16 . . . . 0.0 109.602 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 36.0 t -59.52 -23.87 63.17 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.466 1.104 . . . . 0.0 110.006 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -55.95 -31.03 62.58 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.474 1.108 . . . . 0.0 109.325 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -70.11 -38.88 75.72 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.532 1.145 . . . . 0.0 109.357 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -67.5 -36.51 81.23 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.517 1.136 . . . . 0.0 110.965 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -70.32 -37.01 74.63 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.525 1.14 . . . . 0.0 110.297 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 5.1 ttp -68.86 -40.39 79.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 0.0 111.009 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.441 HD13 ' CG1' ' A' ' 247' ' ' ILE . 9.3 mt -72.14 -34.52 68.6 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.462 1.101 . . . . 0.0 109.299 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 16.0 m -74.18 -33.32 63.41 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.488 1.117 . . . . 0.0 108.318 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 8.6 t -75.91 -36.52 59.41 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.129 . . . . 0.0 110.004 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 10.0 t -74.51 -34.34 63.01 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.487 1.117 . . . . 0.0 110.03 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' SER . . . . . 0.445 ' CB ' ' CD1' ' A' ' 337' ' ' ILE . 0.3 OUTLIER -128.1 114.62 20.22 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.562 1.164 . . . . 0.0 110.036 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -18.95 18.29 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.499 1.789 . . . . 0.0 111.013 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -72.37 -28.92 63.33 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 0.0 110.329 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.479 ' CD1' HG22 ' A' ' 243' ' ' VAL . 46.2 mt -72.69 -41.43 62.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.554 1.159 . . . . 0.0 109.257 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.97 -32.41 65.18 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.455 1.097 . . . . 0.0 109.27 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.53 -39.75 62.16 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.491 1.12 . . . . 0.0 110.293 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 48.6 mt -73.23 -42.69 57.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.551 1.157 . . . . 0.0 109.286 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.565 ' CZ ' HD12 ' A' ' 302' ' ' ILE . 46.7 t80 -69.24 -34.26 74.55 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.55 1.157 . . . . 0.0 111.009 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . 0.46 ' HG3' ' CD1' ' A' ' 346' ' ' LEU . 1.4 ttp-105 -72.78 -39.54 66.64 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.538 1.149 . . . . 0.0 110.276 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -50.59 65.93 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.509 1.13 . . . . 0.0 109.291 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 7.6 t -65.37 -32.98 74.9 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.47 1.106 . . . . 0.0 110.453 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -66.74 -44.99 80.05 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.521 1.138 . . . . 0.0 109.334 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.46 ' CD1' ' HG3' ' A' ' 342' ' ' ARG . 0.6 OUTLIER -65.14 -37.03 86.12 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.503 1.127 . . . . 0.0 109.289 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.08 -39.22 92.89 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.472 1.107 . . . . 0.0 110.31 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 49.6 mtt-85 . . . . . 0 C--N 1.325 -0.457 0 O-C-N 124.481 1.113 . . . . 0.0 110.296 -179.998 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.437 ' CZ ' HG12 ' A' ' 248' ' ' VAL . 40.0 t80 . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 120.534 0.206 . . . . 0.0 111.046 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.98 -33.29 58.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.471 1.107 . . . . 0.0 109.339 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -35.02 77.74 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.498 1.124 . . . . 0.0 110.308 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . 0.454 ' OD1' ' CD1' ' A' ' 320' ' ' LEU . 3.7 m-20 -77.46 -30.44 53.23 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.487 1.117 . . . . 0.0 109.279 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' TRP . . . . . 0.481 ' CZ2' HG23 ' A' ' 245' ' ' VAL . 1.9 t90 -67.58 -44.81 77.26 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.513 1.133 . . . . 0.0 108.04 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 232' ' ' ALA . 5.7 pt20 -71.14 -35.75 71.81 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.493 1.12 . . . . 0.0 110.307 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.45 -47.43 85.76 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.509 1.131 . . . . 0.0 109.323 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 99.7 t -71.76 -40.76 70.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.473 1.108 . . . . 0.0 109.274 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.58 -15.94 62.81 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.481 1.113 . . . . 0.0 109.251 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 228' ' ' GLN . . . -81.34 -11.09 59.42 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.553 1.158 . . . . 0.0 109.31 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 31.2 t -89.64 123.33 66.81 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.514 1.134 . . . . 0.0 109.308 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 -16.09 20.31 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.481 1.78 . . . . 0.0 110.997 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.573 HD13 ' CE2' ' A' ' 341' ' ' PHE . 0.0 OUTLIER -79.6 -24.66 41.85 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.498 1.124 . . . . 0.0 109.268 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -108.51 -11.88 15.08 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.537 1.148 . . . . 0.0 111.022 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.66 -24.65 66.87 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.488 1.118 . . . . 0.0 110.338 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -74.62 -4.45 37.21 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.516 1.135 . . . . 0.0 109.333 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.493 ' HB2' ' CD2' ' A' ' 244' ' ' LEU . 12.5 mt -85.0 -179.65 7.1 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.45 1.094 . . . . 0.0 109.321 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -103.24 -172.66 26.15 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.489 1.118 . . . . 0.0 111.012 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.492 ' O ' ' CG2' ' A' ' 245' ' ' VAL . 18.2 Cg_endo -75.02 -36.14 2.71 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.464 1.77 . . . . 0.0 111.02 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.04 -35.31 78.04 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.533 1.146 . . . . 0.0 109.299 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.432 ' CG1' ' HB3' ' A' ' 239' ' ' LEU . 13.0 t -75.33 -36.58 36.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.451 1.095 . . . . 0.0 109.258 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.493 ' CD2' ' HB2' ' A' ' 239' ' ' LEU . 1.6 mm? -70.54 -35.48 73.16 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.499 1.125 . . . . 0.0 109.304 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.492 ' CG2' ' O ' ' A' ' 241' ' ' PRO . 96.4 t -72.85 -38.28 56.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.473 1.108 . . . . 0.0 109.334 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -69.06 -49.7 55.1 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.514 1.134 . . . . 0.0 110.235 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.42 ' CD1' HG12 ' A' ' 243' ' ' VAL . 14.1 mt -63.13 -35.63 72.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.502 1.127 . . . . 0.0 109.319 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 244' ' ' LEU . 4.6 t -67.51 -41.13 85.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.526 1.141 . . . . 0.0 109.309 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -77.23 -13.03 60.01 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.489 1.118 . . . . 0.0 110.298 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -89.18 -17.46 29.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.461 1.101 . . . . 0.0 109.311 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.462 ' CD2' ' HB2' ' A' ' 322' ' ' LEU . 3.2 mt -65.89 144.53 56.75 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.456 1.097 . . . . 0.0 109.294 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.75 133.15 55.72 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.535 1.147 . . . . 0.0 110.284 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -80.63 130.91 35.38 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.462 1.101 . . . . 0.0 109.284 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.22 125.03 19.63 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.489 1.118 . . . . 0.0 110.295 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 13.4 m -91.07 116.53 28.88 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.49 1.119 . . . . 0.0 110.381 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.492 HG11 ' CB ' ' A' ' 313' ' ' ALA . 24.4 t -107.05 111.63 63.5 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 124.533 1.145 . . . . 0.0 109.315 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.528 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.96 176.38 9.98 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.482 1.78 . . . . 0.0 111.039 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.504 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -67.8 134.14 50.44 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.505 1.128 . . . . 0.0 109.304 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 89.15 -25.53 10.13 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.501 1.126 . . . . 0.0 110.981 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . 0.528 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -55.43 148.49 15.15 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.489 0.758 . . . . 0.0 109.285 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 2.7 t -96.93 129.7 46.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.536 1.148 . . . . 0.0 109.309 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 65.7 mt -84.81 -45.77 17.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.533 1.145 . . . . 0.0 109.303 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 13.5 p -154.97 149.71 26.58 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.486 1.116 . . . . 0.0 108.333 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -89.53 175.9 7.1 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.128 . . . . 0.0 110.308 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -76.97 141.16 16.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.503 1.127 . . . . 0.0 109.321 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 45.67 49.46 12.11 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.524 1.14 . . . . 0.0 110.974 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . 0.471 ' HG3' ' N ' ' A' ' 268' ' ' PRO . 2.9 pt-20 -73.1 173.75 5.58 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.48 0.753 . . . . 0.0 110.275 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . 0.471 ' N ' ' HG3' ' A' ' 267' ' ' GLU . 18.2 Cg_endo -75.01 97.1 1.05 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.493 1.786 . . . . 0.0 110.967 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -50.88 89.46 0.01 OUTLIER Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.465 1.103 . . . . 0.0 110.964 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 268' ' ' PRO . 40.6 m-20 -170.39 38.36 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.48 0.753 . . . . 0.0 109.3 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -171.23 149.21 2.78 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.504 1.128 . . . . 0.0 110.353 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.519 ' HE2' ' CE1' ' A' ' 274' ' ' PHE . 8.3 ptm -138.74 146.97 42.1 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.5 1.125 . . . . 0.0 110.97 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 296' ' ' PHE . 34.0 m-85 -124.98 151.48 45.46 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.528 1.143 . . . . 0.0 110.943 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . 0.519 ' CE1' ' HE2' ' A' ' 272' ' ' MET . 23.6 m-85 -129.48 124.89 35.14 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.497 1.123 . . . . 0.0 110.99 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 76.2 t -79.7 138.19 20.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.477 1.11 . . . . 0.0 109.278 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . 0.41 ' CG2' HD12 ' A' ' 320' ' ' LEU . 2.9 t -116.14 -47.54 4.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.443 1.089 . . . . 0.0 109.304 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -145.62 135.9 23.94 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.533 1.146 . . . . 0.0 110.318 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.404 ' HA3' ' HB ' ' A' ' 317' ' ' VAL . . . 115.63 -155.11 16.5 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.535 1.147 . . . . 0.0 110.99 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 3.1 m -151.32 138.62 19.36 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.461 0.742 . . . . 0.0 109.982 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.475 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 17.6 m -117.59 166.77 11.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.496 1.122 . . . . 0.0 109.287 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 29.4 t -131.9 155.47 47.83 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.475 1.109 . . . . 0.0 109.983 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -119.12 129.37 75.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.474 1.109 . . . . 0.0 109.308 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.4 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -77.77 101.85 6.9 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.512 1.133 . . . . 0.0 109.271 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' THR . . . . . 0.649 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.39 -168.62 0.19 Allowed Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.509 1.13 . . . . 0.0 110.392 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.649 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -74.98 4.88 4.33 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.469 1.773 . . . . 0.0 110.965 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -151.83 157.12 34.53 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.455 1.097 . . . . 0.0 109.31 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.98 94.89 0.96 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.488 1.783 . . . . 0.0 110.981 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 31.2 t -99.04 119.45 47.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.498 1.123 . . . . 0.0 109.323 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -124.33 136.89 54.44 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.491 1.119 . . . . 0.0 110.296 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.475 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 3.9 mm? -114.76 142.83 45.99 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.533 1.145 . . . . 0.0 109.288 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -98.44 -164.97 30.78 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.497 1.123 . . . . 0.0 110.981 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 156.23 43.07 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.454 1.765 . . . . 0.0 110.974 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 77.37 2.17 78.44 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.508 1.13 . . . . 0.0 110.973 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -87.79 136.05 33.12 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.518 0.775 . . . . 0.0 109.325 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . 0.502 ' HB3' ' CD1' ' A' ' 274' ' ' PHE . 0.7 OUTLIER -123.76 153.05 41.47 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.508 1.13 . . . . 0.0 110.983 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 273' ' ' PHE . 51.7 p90 -163.52 143.35 8.54 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.515 1.134 . . . . 0.0 110.962 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . 0.469 ' HA3' ' CB ' ' A' ' 272' ' ' MET . . . 137.57 -14.31 3.67 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.499 1.125 . . . . 0.0 110.943 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -52.84 -44.41 66.72 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.514 0.773 . . . . 0.0 110.311 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' MET . . . . . 0.426 ' HB3' ' CG ' ' A' ' 305' ' ' GLU . 0.1 OUTLIER -47.37 -39.11 14.41 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.487 1.117 . . . . 0.0 111.003 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -72.64 -37.16 68.08 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.489 1.118 . . . . 0.0 109.31 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.489 ' CD1' ' SD ' ' A' ' 272' ' ' MET . 4.5 mt -76.67 -5.47 48.06 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.485 1.116 . . . . 0.0 109.34 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 22.0 mt -91.81 -51.43 11.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.475 1.109 . . . . 0.0 109.261 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.442 ' O ' ' C ' ' A' ' 304' ' ' GLY . 1.2 m -151.94 41.01 0.65 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.506 1.129 . . . . 0.0 109.954 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 34.7 39.97 0.18 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.498 1.123 . . . . 0.0 110.99 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' GLU . . . . . 0.426 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 0.5 OUTLIER -68.17 151.05 97.48 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.505 0.768 . . . . 0.0 110.292 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 132.36 15.37 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.532 1.806 . . . . 0.0 111.03 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . 0.425 ' NH2' ' HA2' ' A' ' 297' ' ' GLY . 10.5 mmp_? -44.39 -44.92 8.65 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.436 1.085 . . . . 0.0 110.309 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.31 38.18 4.58 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.483 1.114 . . . . 0.0 109.991 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . 171.73 160.88 0.1 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.532 1.145 . . . . 0.0 109.308 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.89 125.48 52.85 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.529 1.143 . . . . 0.0 110.409 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 77.7 t -103.3 127.7 56.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 0.0 109.318 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 87.5 p -127.86 157.45 40.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.516 1.135 . . . . 0.0 109.994 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . 0.501 ' CB ' ' CG1' ' A' ' 317' ' ' VAL . . . -89.19 112.99 24.14 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.502 1.126 . . . . 0.0 109.319 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -54.3 -32.71 57.12 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.55 1.156 . . . . 0.0 109.35 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' THR . . . . . 0.504 ' HA ' ' CB ' ' A' ' 258' ' ' ALA . 9.8 t -158.63 -159.05 0.75 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.462 1.101 . . . . 0.0 110.44 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' THR . . . . . 0.443 ' N ' ' OG1' ' A' ' 315' ' ' THR . 86.6 m -66.03 81.26 0.08 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.525 1.141 . . . . 0.0 110.38 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.501 ' CG1' ' CB ' ' A' ' 313' ' ' ALA . 1.3 p -108.26 140.98 24.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.491 1.12 . . . . 0.0 109.265 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 49.2 m -112.3 127.73 56.07 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.511 1.132 . . . . 0.0 110.003 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . 0.48 HD13 ' CG2' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -134.81 174.71 10.28 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.555 1.159 . . . . 0.0 109.295 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.454 ' CD1' ' OD1' ' A' ' 226' ' ' ASN . 1.0 OUTLIER -124.18 135.27 53.35 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.499 1.124 . . . . 0.0 109.312 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 53.9 p -96.86 150.66 20.49 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.531 1.144 . . . . 0.0 109.994 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.462 ' HB2' ' CD2' ' A' ' 251' ' ' LEU . 2.6 tm? -146.17 104.02 3.77 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.529 1.143 . . . . 0.0 109.304 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -65.15 138.53 58.34 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.448 1.092 . . . . 0.0 109.578 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 89.2 p -59.81 -19.65 52.03 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.48 1.113 . . . . 0.0 109.985 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -51.22 -35.36 36.3 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.514 1.134 . . . . 0.0 109.261 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -65.84 -38.38 88.72 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.508 1.13 . . . . 0.0 109.295 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -67.85 -37.79 82.33 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.5 1.125 . . . . 0.0 110.981 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -68.81 -32.49 72.23 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.515 1.134 . . . . 0.0 110.31 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 15.6 tmm? -70.58 -43.2 69.9 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.519 1.137 . . . . 0.0 111.022 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.82 -31.2 61.63 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.124 . . . . 0.0 109.278 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 1.8 m -75.0 -39.74 61.03 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.457 1.098 . . . . 0.0 108.297 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 26.3 t -70.8 -32.55 69.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.53 1.144 . . . . 0.0 110.013 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 31.9 t -79.16 -35.68 41.59 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.511 1.132 . . . . 0.0 109.988 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 1.5 m -128.96 109.16 18.3 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.522 1.139 . . . . 0.0 109.972 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 -20.26 17.04 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.504 1.792 . . . . 0.0 111.052 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.453 ' O ' ' CG1' ' A' ' 340' ' ' ILE . 1.2 tt0 -66.1 -37.26 85.31 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 0.0 110.347 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.407 ' CG2' ' CD2' ' A' ' 239' ' ' LEU . 88.1 mt -75.97 -42.8 39.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.44 1.088 . . . . 0.0 109.285 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -64.83 -45.23 87.02 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.484 1.115 . . . . 0.0 109.315 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.52 -33.37 74.0 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.49 1.119 . . . . 0.0 110.314 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.453 ' CG1' ' O ' ' A' ' 336' ' ' GLU . 21.1 mt -70.17 -40.66 78.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.519 1.137 . . . . 0.0 109.341 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.573 ' CE2' HD13 ' A' ' 235' ' ' LEU . 2.7 t80 -69.08 -35.13 76.15 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.499 1.125 . . . . 0.0 111.036 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 27.7 ttt-85 -70.37 -38.94 74.85 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.494 1.121 . . . . 0.0 110.318 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -51.07 63.16 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.535 1.147 . . . . 0.0 109.328 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 13.1 t -68.64 -33.32 73.82 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.497 1.123 . . . . 0.0 110.43 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . 0.503 ' CB ' ' O ' ' A' ' 341' ' ' PHE . . . -70.18 -36.44 74.66 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.445 1.091 . . . . 0.0 109.301 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 11.7 mt -69.28 -40.94 77.47 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.471 1.107 . . . . 0.0 109.318 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -68.42 -34.05 75.31 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.486 1.116 . . . . 0.0 110.323 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 34.3 mtt-85 . . . . . 0 C--N 1.325 -0.48 0 O-C-N 124.474 1.109 . . . . 0.0 110.285 179.97 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 46.9 t80 . . . . . 0 N--CA 1.453 -0.284 0 CA-C-O 120.505 0.193 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 225' ' ' ARG . 0.3 OUTLIER -75.55 -39.64 40.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.124 . . . . 0.0 109.252 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.414 ' HA ' ' NE2' ' A' ' 228' ' ' GLN . 13.6 tpp85 -68.37 -30.64 69.63 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.115 . . . . 0.0 110.275 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . 0.501 ' HB3' ' CG2' ' A' ' 248' ' ' VAL . 2.2 m-20 -79.3 -41.4 28.12 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.408 1.068 . . . . 0.0 109.302 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -66.68 -44.52 81.54 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.527 1.142 . . . . 0.0 107.977 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.452 ' O ' ' CB ' ' A' ' 232' ' ' ALA . 2.6 pt20 -67.71 -31.63 71.71 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.478 1.111 . . . . 0.0 110.31 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.6 mt -63.54 -45.08 92.2 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.514 1.133 . . . . 0.0 109.316 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.426 HG23 ' N ' ' A' ' 231' ' ' ALA . 35.2 m -74.55 -38.78 46.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.528 1.143 . . . . 0.0 109.33 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.426 ' N ' HG23 ' A' ' 230' ' ' VAL . . . -75.42 -11.78 60.11 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.47 1.106 . . . . 0.0 109.336 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 228' ' ' GLN . . . -81.32 -23.99 37.44 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.525 1.14 . . . . 0.0 109.247 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.35 130.93 60.23 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.475 1.109 . . . . 0.0 109.263 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -16.75 19.98 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.513 1.796 . . . . 0.0 110.982 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.448 HD11 ' CE2' ' A' ' 341' ' ' PHE . 0.1 OUTLIER -63.34 -30.04 71.24 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.456 1.098 . . . . 0.0 109.33 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . 0.521 ' CG ' HD13 ' A' ' 239' ' ' LEU . 16.1 m-30 -112.95 17.08 19.18 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.538 1.149 . . . . 0.0 111.003 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -70.01 -20.02 63.29 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.549 1.155 . . . . 0.0 110.282 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -92.58 -12.37 31.94 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.508 1.13 . . . . 0.0 109.302 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.521 HD13 ' CG ' ' A' ' 236' ' ' PHE . 46.0 mt -70.11 179.26 2.41 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.46 1.1 . . . . 0.0 109.276 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -109.79 -174.89 20.94 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.509 1.131 . . . . 0.0 111.006 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 -32.84 5.13 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.485 1.782 . . . . 0.0 111.065 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 0.426 ' O ' HG12 ' A' ' 245' ' ' VAL . . . -73.09 -33.2 65.47 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.457 1.098 . . . . 0.0 109.284 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.438 HG12 ' CD2' ' A' ' 239' ' ' LEU . 63.5 t -77.09 -36.59 24.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.474 1.109 . . . . 0.0 109.334 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.439 ' N ' HD23 ' A' ' 244' ' ' LEU . 3.8 mm? -72.57 -42.65 64.4 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.497 1.123 . . . . 0.0 109.289 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.454 ' O ' ' CG ' ' A' ' 249' ' ' ARG . 2.8 p -68.21 -39.51 81.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.465 1.103 . . . . 0.0 109.261 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -70.88 -40.99 71.91 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.52 1.138 . . . . 0.0 110.284 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.452 HG12 ' CD1' ' A' ' 330' ' ' LEU . 25.6 mt -66.56 -51.97 51.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.503 1.127 . . . . 0.0 109.278 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.501 ' CG2' ' HB3' ' A' ' 226' ' ' ASN . 10.0 p -62.87 -30.74 50.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.48 1.113 . . . . 0.0 109.315 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.454 ' CG ' ' O ' ' A' ' 245' ' ' VAL . 16.6 mmm-85 -73.55 -25.77 60.54 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.542 1.151 . . . . 0.0 110.283 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -85.2 -17.98 35.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 0.0 109.297 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.41 144.24 47.43 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 0.0 109.339 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -118.18 135.09 54.45 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.558 1.161 . . . . 0.0 110.331 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -80.68 123.18 27.96 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.532 1.145 . . . . 0.0 109.303 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.6 ttm-85 -125.05 123.49 39.9 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.462 1.101 . . . . 0.0 110.34 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 50.2 m -91.51 117.65 29.89 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.484 1.115 . . . . 0.0 110.428 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.471 ' CG1' ' HB2' ' A' ' 313' ' ' ALA . 2.6 t -109.41 113.46 58.36 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.524 1.14 . . . . 0.0 109.285 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -75.0 168.71 24.24 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.543 1.812 . . . . 0.0 111.011 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.493 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -65.93 126.34 28.24 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.524 1.14 . . . . 0.0 109.286 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 100.59 -25.32 28.75 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.489 1.118 . . . . 0.0 111.003 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . 0.491 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -67.27 145.08 55.52 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.497 0.763 . . . . 0.0 109.301 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 5.8 t -94.82 135.02 30.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.504 1.128 . . . . 0.0 109.299 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 17.8 mt -82.95 -42.74 18.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.541 1.151 . . . . 0.0 109.29 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' CYS . . . . . 0.493 ' SG ' ' CG2' ' A' ' 311' ' ' VAL . 11.3 p -152.4 142.61 22.4 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.49 1.119 . . . . 0.0 108.289 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 3.4 mmt85 -84.87 178.58 7.56 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.5 1.125 . . . . 0.0 110.277 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.47 ' CG2' ' HB ' ' A' ' 310' ' ' THR . 0.1 OUTLIER -76.57 137.44 22.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.513 1.133 . . . . 0.0 109.327 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 52.95 50.81 49.34 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.46 1.1 . . . . 0.0 111.026 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -70.37 163.89 58.6 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.486 0.756 . . . . 0.0 110.302 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . 0.507 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.3 Cg_endo -74.98 82.77 1.93 Allowed 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.532 1.806 . . . . 0.0 111.051 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 268' ' ' PRO . . . -36.07 93.16 0.01 OUTLIER Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.477 1.111 . . . . 0.0 110.994 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 268' ' ' PRO . 12.3 m-20 -171.63 37.93 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.528 0.781 . . . . 0.0 109.335 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . 0.442 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 3.3 mtp180 -169.89 144.54 2.79 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.537 1.148 . . . . 0.0 110.359 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.492 ' SD ' ' CD1' ' A' ' 301' ' ' LEU . 2.2 ttt -118.34 147.63 43.3 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.505 1.128 . . . . 0.0 110.99 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.57 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 28.4 m-85 -135.8 136.65 40.86 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.506 1.128 . . . . 0.0 111.006 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . 0.454 ' CD1' ' CB ' ' A' ' 295' ' ' PHE . 22.1 m-85 -125.98 127.49 46.0 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.117 . . . . 0.0 110.998 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 13.7 t -83.96 135.03 25.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.481 1.113 . . . . 0.0 109.319 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 40.3 t -111.75 -49.42 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.492 1.12 . . . . 0.0 109.355 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -139.67 137.96 35.65 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.52 1.137 . . . . 0.0 110.337 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 112.75 -175.47 16.82 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.491 1.12 . . . . 0.0 111.003 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' SER . . . . . 0.415 ' N ' HG21 ' A' ' 317' ' ' VAL . 3.6 m -131.17 120.26 23.05 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.497 0.763 . . . . 0.0 109.964 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.451 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 28.9 m -99.03 164.67 2.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.505 1.128 . . . . 0.0 109.293 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 31.6 t -131.97 148.13 52.5 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.476 1.11 . . . . 0.0 110.017 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -111.26 129.93 65.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.44 1.087 . . . . 0.0 109.295 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -77.96 101.87 7.08 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.505 1.128 . . . . 0.0 109.306 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' THR . . . . . 0.647 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -147.76 -168.55 0.19 Allowed Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.466 1.104 . . . . 0.0 110.427 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.647 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.4 Cg_endo -74.99 4.89 4.33 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.57 1.826 . . . . 0.0 111.025 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -151.37 157.29 35.01 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.496 1.123 . . . . 0.0 109.271 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.1 93.85 0.97 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.51 1.795 . . . . 0.0 110.98 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 4.1 t -97.94 119.37 45.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.115 . . . . 0.0 109.293 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -124.7 140.25 53.11 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.557 1.161 . . . . 0.0 110.315 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.451 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 4.5 mm? -121.81 141.71 50.95 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.505 1.128 . . . . 0.0 109.304 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -96.9 -160.06 31.69 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.498 1.124 . . . . 0.0 111.038 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 142.02 27.24 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.478 1.778 . . . . 0.0 110.982 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 91.46 4.39 68.19 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.508 1.13 . . . . 0.0 111.002 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -92.04 127.76 37.63 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.436 0.727 . . . . 0.0 109.293 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . 0.454 ' CB ' ' CD1' ' A' ' 274' ' ' PHE . 2.4 p90 -114.36 152.8 30.9 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.468 1.105 . . . . 0.0 110.979 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . 0.57 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 33.7 p90 -158.07 148.75 20.67 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.534 1.146 . . . . 0.0 111.018 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 123.54 -5.64 9.25 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.474 1.109 . . . . 0.0 110.955 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -55.83 -46.31 78.14 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.504 0.767 . . . . 0.0 110.305 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 36.9 mmt -51.89 -37.14 51.21 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 0.0 110.984 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -67.42 -41.27 85.11 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.489 1.118 . . . . 0.0 109.278 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.492 ' CD1' ' SD ' ' A' ' 272' ' ' MET . 1.5 mt -77.32 -11.32 59.82 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.563 1.164 . . . . 0.0 109.331 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 7.0 mm -77.17 -56.09 8.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.483 1.114 . . . . 0.0 109.272 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.46 ' O ' ' N ' ' A' ' 305' ' ' GLU . 53.2 p -151.32 48.37 0.83 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.458 1.099 . . . . 0.0 110.026 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 303' ' ' SER . . . 35.08 34.22 0.05 OUTLIER Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.574 1.172 . . . . 0.0 110.991 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' GLU . . . . . 0.46 ' N ' ' O ' ' A' ' 303' ' ' SER . 0.0 OUTLIER -70.24 151.52 95.84 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.522 0.778 . . . . 0.0 110.297 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 134.15 17.46 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.477 1.777 . . . . 0.0 110.991 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -44.39 -42.47 6.94 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.468 1.105 . . . . 0.0 110.322 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 2.2 t 67.35 28.56 7.84 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 0.0 110.009 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . -176.61 160.55 2.01 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.447 1.092 . . . . 0.0 109.282 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.47 ' HB ' ' CG2' ' A' ' 265' ' ' ILE . 0.3 OUTLIER -108.59 123.64 49.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.512 1.132 . . . . 0.0 110.392 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.493 ' CG2' ' SG ' ' A' ' 263' ' ' CYS . 43.5 t -103.17 130.31 53.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.52 1.138 . . . . 0.0 109.298 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 56.9 p -134.94 157.42 46.94 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.463 1.102 . . . . 0.0 109.993 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . 0.471 ' HB2' ' CG1' ' A' ' 256' ' ' VAL . . . -95.52 116.13 28.39 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.457 1.098 . . . . 0.0 109.299 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -60.22 -33.42 72.23 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.496 1.123 . . . . 0.0 109.276 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' THR . . . . . 0.493 ' HA ' ' CB ' ' A' ' 258' ' ' ALA . 10.2 t -149.77 -173.49 4.43 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.436 1.085 . . . . 0.0 110.403 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' THR . . . . . 0.412 ' N ' ' OG1' ' A' ' 315' ' ' THR . 43.8 p -53.76 88.18 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.513 1.133 . . . . 0.0 110.417 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.472 HG13 ' CD1' ' A' ' 319' ' ' LEU . 57.8 t -107.56 145.82 14.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.533 1.145 . . . . 0.0 109.257 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' SER . . . . . 0.419 ' N ' HG13 ' A' ' 317' ' ' VAL . 50.3 m -122.95 118.31 27.53 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.492 1.12 . . . . 0.0 109.982 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . 0.498 ' CD1' ' N ' ' A' ' 319' ' ' LEU . 0.0 OUTLIER -126.22 175.09 8.04 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.125 . . . . 0.0 109.309 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 273' ' ' PHE . 0.5 OUTLIER -124.55 130.95 53.4 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.441 1.088 . . . . 0.0 109.314 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 73.6 p -92.23 157.06 16.89 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 0.0 109.997 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -148.55 92.03 1.96 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.458 1.099 . . . . 0.0 109.293 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . 0.442 ' HA ' ' CG ' ' A' ' 271' ' ' ARG . 5.8 p80 -54.61 135.18 46.77 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.534 1.146 . . . . 0.0 109.615 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 3.4 t -53.66 -26.45 22.52 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.505 1.128 . . . . 0.0 109.984 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -50.66 -35.48 30.99 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.546 1.154 . . . . 0.0 109.285 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -64.73 -41.5 95.9 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.517 1.136 . . . . 0.0 109.318 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' PHE . . . . . 0.465 ' CE1' ' CE2' ' A' ' 341' ' ' PHE . 80.3 t80 -67.38 -32.77 73.91 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.467 1.105 . . . . 0.0 111.046 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -70.49 -37.71 74.24 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.469 1.106 . . . . 0.0 110.343 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 16.5 tmm? -67.98 -41.34 82.48 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.467 1.104 . . . . 0.0 111.032 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.452 ' CD1' HG12 ' A' ' 247' ' ' ILE . 6.4 mt -73.23 -35.03 66.22 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.492 1.12 . . . . 0.0 109.284 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 41.4 t -68.84 -35.19 76.64 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.499 1.125 . . . . 0.0 108.296 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.8 t -72.97 -39.2 66.33 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.127 . . . . 0.0 109.979 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.2 t -73.49 -28.43 61.91 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.503 1.127 . . . . 0.0 109.979 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.92 103.78 18.71 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 124.51 1.131 . . . . 0.0 110.016 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -21.64 15.61 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.469 1.773 . . . . 0.0 111.01 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.87 -28.78 60.79 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.539 1.149 . . . . 0.0 110.312 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 34.4 mt -68.69 -30.84 48.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.126 . . . . 0.0 109.302 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -69.81 -37.54 76.29 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.476 1.11 . . . . 0.0 109.34 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -72.87 -36.73 67.45 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.458 1.099 . . . . 0.0 110.326 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 31.1 mt -71.68 -42.71 71.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.445 1.091 . . . . 0.0 109.305 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.465 ' CE2' ' CE1' ' A' ' 327' ' ' PHE . 40.2 t80 -66.95 -36.88 83.22 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.45 1.094 . . . . 0.0 111.04 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -72.94 -34.79 66.77 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.489 1.118 . . . . 0.0 110.269 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -50.75 65.3 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.511 1.132 . . . . 0.0 109.344 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 8.8 t -65.13 -38.0 89.22 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.498 1.124 . . . . 0.0 110.372 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -67.17 -35.74 80.31 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.536 1.147 . . . . 0.0 109.301 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 9.3 mt -71.48 -33.87 69.66 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.492 1.12 . . . . 0.0 109.317 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.6 -34.73 70.13 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.531 1.145 . . . . 0.0 110.285 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 39.0 mtt-85 . . . . . 0 C--N 1.325 -0.467 0 O-C-N 124.48 1.112 . . . . 0.0 110.328 179.975 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 35.0 t80 . . . . . 0 N--CA 1.453 -0.307 0 CA-C-O 120.474 0.178 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.86 -36.56 52.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.532 1.145 . . . . 0.0 109.309 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.48 -37.05 82.3 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.511 1.132 . . . . 0.0 110.296 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . 0.404 ' ND2' HD22 ' A' ' 320' ' ' LEU . 4.0 t30 -76.37 -30.64 57.63 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.551 1.157 . . . . 0.0 109.29 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' TRP . . . . . 0.63 ' CZ2' ' CG2' ' A' ' 245' ' ' VAL . 3.0 t90 -66.31 -45.59 79.84 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.485 1.116 . . . . 0.0 108.019 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.506 ' O ' ' CB ' ' A' ' 232' ' ' ALA . 6.4 pt20 -71.27 -34.82 71.06 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.517 1.135 . . . . 0.0 110.35 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -48.49 77.24 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.482 1.114 . . . . 0.0 109.267 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.462 ' CG1' HD13 ' A' ' 244' ' ' LEU . 38.3 t -69.89 -43.08 79.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.432 1.082 . . . . 0.0 109.271 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.34 -16.63 63.01 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.476 1.11 . . . . 0.0 109.309 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' A' ' 228' ' ' GLN . . . -80.67 -19.32 45.5 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.448 1.092 . . . . 0.0 109.332 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 84.4 t -81.25 137.02 49.17 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.485 1.116 . . . . 0.0 109.276 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -40.32 0.93 Allowed 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.59 1.837 . . . . 0.0 111.001 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.467 HD11 ' CD1' ' A' ' 302' ' ' ILE . 11.0 mt -60.81 -15.48 30.42 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.444 1.09 . . . . 0.0 109.333 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . 0.543 ' CE1' HD13 ' A' ' 247' ' ' ILE . 1.4 m-85 -106.56 -22.94 12.61 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.51 1.131 . . . . 0.0 110.959 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.1 -18.73 64.69 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.483 1.115 . . . . 0.0 110.362 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -75.15 -9.67 58.76 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.498 1.124 . . . . 0.0 109.252 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.462 ' HB2' ' CD2' ' A' ' 244' ' ' LEU . 12.0 mt -96.66 -179.19 4.51 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.493 1.12 . . . . 0.0 109.325 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -100.99 -173.56 29.0 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.487 1.117 . . . . 0.0 110.976 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.503 ' O ' ' CG2' ' A' ' 245' ' ' VAL . 18.3 Cg_endo -74.97 -34.47 3.83 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.474 1.776 . . . . 0.0 110.98 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.96 -36.41 80.03 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.502 1.126 . . . . 0.0 109.311 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.415 ' CG1' ' HB3' ' A' ' 239' ' ' LEU . 3.0 t -72.64 -42.83 62.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.53 1.144 . . . . 0.0 109.296 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.462 ' CD2' ' HB2' ' A' ' 239' ' ' LEU . 0.9 OUTLIER -66.37 -37.68 85.83 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.502 1.126 . . . . 0.0 109.287 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.63 ' CG2' ' CZ2' ' A' ' 227' ' ' TRP . 53.6 t -66.11 -42.94 92.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.497 1.123 . . . . 0.0 109.287 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.59 -45.24 87.81 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.507 1.129 . . . . 0.0 110.302 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.543 HD13 ' CE1' ' A' ' 236' ' ' PHE . 38.3 mt -62.93 -45.41 98.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.439 1.087 . . . . 0.0 109.259 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 45.6 t -62.8 -33.39 59.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 0.0 109.297 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -77.34 -19.48 56.26 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.514 1.134 . . . . 0.0 110.277 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -95.91 2.86 53.86 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.469 1.106 . . . . 0.0 109.308 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.17 148.31 25.23 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.524 1.14 . . . . 0.0 109.328 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.34 126.82 50.39 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.512 1.132 . . . . 0.0 110.265 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -83.26 122.75 28.83 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.509 1.131 . . . . 0.0 109.318 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.57 134.79 47.93 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.49 1.119 . . . . 0.0 110.289 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 52.3 m -93.46 121.05 34.46 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.505 1.128 . . . . 0.0 110.414 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.422 HG21 ' CD1' ' A' ' 319' ' ' LEU . 92.2 t -106.79 113.72 62.49 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.513 1.133 . . . . 0.0 109.329 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.497 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.98 173.48 14.43 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.44 1.758 . . . . 0.0 110.976 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.493 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -66.06 131.04 45.27 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.506 1.128 . . . . 0.0 109.322 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 94.24 -25.52 21.93 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.537 1.148 . . . . 0.0 110.969 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . 0.497 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -57.92 146.28 32.75 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.518 0.775 . . . . 0.0 109.302 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.7 t -97.33 131.58 43.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.486 1.116 . . . . 0.0 109.301 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.437 ' CD1' HG11 ' A' ' 311' ' ' VAL . 67.9 mt -84.44 -42.27 16.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.5 1.125 . . . . 0.0 109.281 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 14.0 p -157.5 148.91 21.82 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.492 1.12 . . . . 0.0 108.311 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' ARG . . . . . 0.407 ' C ' ' OG1' ' A' ' 310' ' ' THR . 3.3 mmt85 -88.16 179.85 6.3 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.484 1.115 . . . . 0.0 110.315 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.455 ' N ' ' OG1' ' A' ' 310' ' ' THR . 0.0 OUTLIER -77.96 140.07 17.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.447 1.092 . . . . 0.0 109.301 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 47.78 50.1 20.89 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.498 1.123 . . . . 0.0 111.012 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . 0.448 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.0 OUTLIER -70.75 164.06 58.8 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.451 0.736 . . . . 0.0 110.301 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . 0.448 ' HD2' ' HB2' ' A' ' 267' ' ' GLU . 18.1 Cg_endo -75.01 91.78 1.01 Allowed 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.474 1.776 . . . . 0.0 110.942 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -43.93 94.4 0.01 OUTLIER Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.489 1.118 . . . . 0.0 110.945 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 268' ' ' PRO . 0.5 OUTLIER -170.2 38.28 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.471 0.748 . . . . 0.0 109.286 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . 0.422 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 6.0 mtt180 -170.34 145.17 2.64 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.483 1.115 . . . . 0.0 110.313 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.46 ' SD ' ' CD1' ' A' ' 301' ' ' LEU . 12.1 ttt -117.96 147.28 43.31 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.527 1.142 . . . . 0.0 110.964 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.57 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 56.9 m-85 -136.28 136.52 39.87 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.531 1.145 . . . . 0.0 110.998 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . 0.472 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 20.5 m-85 -125.71 134.3 51.84 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.495 1.122 . . . . 0.0 111.009 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 4.5 t -91.94 129.76 42.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.517 1.135 . . . . 0.0 109.323 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . 0.4 ' CG2' HD13 ' A' ' 320' ' ' LEU . 13.9 t -105.63 -44.02 7.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.515 1.134 . . . . 0.0 109.307 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.84 134.33 18.6 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.139 . . . . 0.0 110.308 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.461 ' HA3' ' CG2' ' A' ' 317' ' ' VAL . . . 121.06 178.65 15.95 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.44 1.087 . . . . 0.0 111.042 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' SER . . . . . 0.419 ' N ' HG21 ' A' ' 317' ' ' VAL . 3.3 m -124.15 114.96 20.35 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.532 0.783 . . . . 0.0 109.974 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.471 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 25.5 m -96.73 163.33 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.492 1.12 . . . . 0.0 109.35 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 30.5 t -129.25 154.64 46.62 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.453 1.096 . . . . 0.0 110.032 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.24 130.04 73.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.519 1.137 . . . . 0.0 109.271 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.4 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -77.46 102.15 6.75 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.475 1.11 . . . . 0.0 109.269 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' THR . . . . . 0.644 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.51 -168.67 0.19 Allowed Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.492 1.12 . . . . 0.0 110.413 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.644 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.3 Cg_endo -74.96 4.33 4.82 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.527 1.804 . . . . 0.0 110.993 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -151.84 157.75 34.27 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.526 1.141 . . . . 0.0 109.282 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 94.26 0.96 Allowed 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.464 1.771 . . . . 0.0 110.995 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.34 119.42 46.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.517 1.136 . . . . 0.0 109.334 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -124.1 140.83 52.59 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 0.0 110.306 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.471 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 4.5 mm? -121.38 141.02 51.37 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.498 1.124 . . . . 0.0 109.3 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -93.97 -157.25 32.94 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.521 1.138 . . . . 0.0 110.95 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.02 148.8 35.68 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.511 1.795 . . . . 0.0 111.01 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 83.0 5.9 88.86 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.498 1.124 . . . . 0.0 111.018 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -86.68 122.76 31.03 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.511 0.771 . . . . 0.0 109.328 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -114.86 153.18 30.92 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 0.0 110.954 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . 0.57 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 32.7 p90 -163.29 149.65 12.1 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.535 1.147 . . . . 0.0 111.004 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 129.57 -9.74 6.13 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.539 1.149 . . . . 0.0 110.986 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 299' ' ' MET . 12.1 pt-20 -52.36 -45.26 65.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.548 0.793 . . . . 0.0 110.29 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' MET . . . . . 0.418 ' N ' ' HG3' ' A' ' 298' ' ' GLU . 0.1 OUTLIER -52.4 -38.3 58.64 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.546 1.154 . . . . 0.0 111.039 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . 0.441 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -67.64 -38.16 83.46 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.498 1.123 . . . . 0.0 109.284 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.475 ' O ' ' CE2' ' A' ' 341' ' ' PHE . 0.8 OUTLIER -76.57 -14.39 60.01 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.485 1.116 . . . . 0.0 109.333 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . 0.467 ' CD1' HD11 ' A' ' 235' ' ' LEU . 11.0 mm -76.79 -55.5 10.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.49 1.119 . . . . 0.0 109.332 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 304' ' ' GLY . 0.5 OUTLIER -153.78 42.16 0.54 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.422 1.076 . . . . 0.0 110.011 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 35.82 43.09 0.58 Allowed Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.48 1.113 . . . . 0.0 111.012 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.17 157.61 88.1 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.549 0.793 . . . . 0.0 110.306 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 129.61 12.45 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.547 1.814 . . . . 0.0 110.968 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -43.92 -36.7 2.53 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.457 1.098 . . . . 0.0 110.272 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 8.0 t 66.75 23.16 10.19 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.49 1.119 . . . . 0.0 109.996 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . -179.11 160.93 1.09 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 0.0 109.318 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.455 ' OG1' ' N ' ' A' ' 265' ' ' ILE . 0.8 OUTLIER -108.55 137.33 46.67 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.5 1.125 . . . . 0.0 110.395 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.437 HG11 ' CD1' ' A' ' 262' ' ' ILE . 57.5 t -110.87 131.05 63.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.525 1.14 . . . . 0.0 109.31 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 96.5 p -130.19 153.95 48.04 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.524 1.14 . . . . 0.0 109.992 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . 0.419 ' HB1' ' CG1' ' A' ' 256' ' ' VAL . . . -94.46 107.26 19.24 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.521 1.138 . . . . 0.0 109.312 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -50.75 -33.4 22.95 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.48 1.112 . . . . 0.0 109.305 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' THR . . . . . 0.493 ' HA ' ' CB ' ' A' ' 258' ' ' ALA . 9.8 t -148.28 -170.03 3.49 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.486 1.116 . . . . 0.0 110.388 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' THR . . . . . 0.448 ' N ' ' OG1' ' A' ' 315' ' ' THR . 0.0 OUTLIER -61.37 78.08 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.532 1.145 . . . . 0.0 110.373 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' A' ' 315' ' ' THR . 44.5 t -94.65 140.18 17.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.481 1.113 . . . . 0.0 109.275 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 49.3 m -111.16 117.57 33.59 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.502 1.126 . . . . 0.0 110.0 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . 0.472 ' CB ' ' O ' ' A' ' 274' ' ' PHE . 0.1 OUTLIER -128.67 173.18 10.53 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.486 1.116 . . . . 0.0 109.302 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.404 HD22 ' ND2' ' A' ' 226' ' ' ASN . 0.7 OUTLIER -124.46 133.85 53.23 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.554 1.159 . . . . 0.0 109.269 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 19.9 t -96.09 157.57 15.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.527 1.142 . . . . 0.0 110.001 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.454 HD23 ' CB ' ' A' ' 326' ' ' ASP . 1.4 tm? -150.01 103.67 3.22 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.436 1.085 . . . . 0.0 109.34 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . 0.422 ' HA ' ' CG ' ' A' ' 271' ' ' ARG . 0.3 OUTLIER -62.15 138.35 58.39 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.478 1.111 . . . . 0.0 109.587 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 22.8 t -54.21 -22.36 11.33 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.549 1.156 . . . . 0.0 109.973 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -52.59 -36.61 56.53 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.457 1.098 . . . . 0.0 109.28 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . 0.454 ' CB ' HD23 ' A' ' 322' ' ' LEU . 8.0 t70 -63.77 -46.15 86.55 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.475 1.109 . . . . 0.0 109.299 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' PHE . . . . . 0.473 ' HB2' ' CD2' ' A' ' 301' ' ' LEU . 20.1 t80 -65.41 -31.17 72.13 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.503 1.127 . . . . 0.0 111.049 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -70.71 -32.36 69.53 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.523 1.14 . . . . 0.0 110.334 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.494 ' O ' ' CB ' ' A' ' 333' ' ' SER . 37.1 ttp -74.5 -37.49 63.1 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.536 1.147 . . . . 0.0 110.998 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.524 ' N ' ' CD2' ' A' ' 330' ' ' LEU . 0.1 OUTLIER -72.5 -42.52 64.75 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 0.0 109.273 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' CYS . . . . . 0.506 ' SG ' ' CB ' ' A' ' 338' ' ' ALA . 26.1 t -66.04 -45.13 82.51 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 0.0 108.318 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 44.4 t -73.3 -22.84 60.26 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.509 1.131 . . . . 0.0 110.031 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 329' ' ' MET . 9.1 t -78.43 -39.44 38.78 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.438 1.086 . . . . 0.0 109.977 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.24 121.6 20.62 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.13 . . . . 0.0 110.05 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 -26.15 11.25 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.535 1.808 . . . . 0.0 111.028 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.74 -29.18 69.66 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.484 1.115 . . . . 0.0 110.274 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 96.9 mt -74.59 -35.89 39.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.534 1.146 . . . . 0.0 109.294 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . 0.506 ' CB ' ' SG ' ' A' ' 331' ' ' CYS . . . -68.0 -43.54 78.63 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.51 1.131 . . . . 0.0 109.311 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -69.21 -35.33 76.09 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.475 1.109 . . . . 0.0 110.322 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 17.3 mt -70.94 -41.51 77.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.515 1.134 . . . . 0.0 109.27 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.475 ' CE2' ' O ' ' A' ' 301' ' ' LEU . 27.8 t80 -67.73 -34.7 77.36 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.472 1.107 . . . . 0.0 111.02 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -72.48 -37.02 68.57 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.538 1.149 . . . . 0.0 110.294 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.59 -51.81 60.79 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.505 1.128 . . . . 0.0 109.316 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 9.9 t -65.91 -38.86 89.8 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.475 1.109 . . . . 0.0 110.362 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -68.52 -34.83 76.55 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.527 1.142 . . . . 0.0 109.283 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 12.0 mt -68.64 -36.85 79.15 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.489 1.118 . . . . 0.0 109.328 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.05 -35.67 69.39 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.462 1.101 . . . . 0.0 110.262 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.474 1.109 . . . . 0.0 110.265 -179.971 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 50.7 t80 . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 120.499 0.19 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.16 -40.98 78.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.522 1.139 . . . . 0.0 109.27 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.13 -29.39 69.1 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.529 1.143 . . . . 0.0 110.303 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -79.24 -30.88 43.39 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.496 1.123 . . . . 0.0 109.322 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' TRP . . . . . 0.422 ' CH2' HG22 ' A' ' 245' ' ' VAL . 2.6 t90 -70.64 -46.65 62.91 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -68.12 -31.87 71.77 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 0.0 110.263 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 3.5 mt -64.36 -45.59 87.11 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 0.0 109.257 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.421 HG22 ' N ' ' A' ' 231' ' ' ALA . 33.1 m -73.55 -36.63 48.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.464 1.103 . . . . 0.0 109.328 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.421 ' N ' HG22 ' A' ' 230' ' ' VAL . . . -74.98 -15.55 60.66 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.522 1.139 . . . . 0.0 109.245 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -80.83 -1.87 44.94 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.511 1.132 . . . . 0.0 109.322 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 4.9 t -101.03 118.85 59.58 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.501 1.126 . . . . 0.0 109.276 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 -17.92 19.04 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.494 1.787 . . . . 0.0 110.989 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.561 HD12 ' CE1' ' A' ' 341' ' ' PHE . 0.1 OUTLIER -65.06 -29.46 70.35 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.574 1.171 . . . . 0.0 109.302 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . 0.57 ' CD1' HD11 ' A' ' 239' ' ' LEU . 15.4 m-85 -113.74 19.76 16.44 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.44 1.087 . . . . 0.0 111.0 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.22 -23.43 62.01 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.515 1.134 . . . . 0.0 110.345 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 50.0 mmtt -80.2 0.7 31.35 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.456 1.097 . . . . 0.0 109.295 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.57 HD11 ' CD1' ' A' ' 236' ' ' PHE . 15.1 mt -82.13 175.18 10.53 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.542 1.151 . . . . 0.0 109.29 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -107.73 -173.8 22.17 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.478 1.111 . . . . 0.0 110.981 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.94 -33.66 4.5 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.46 1.769 . . . . 0.0 111.051 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 0.419 ' O ' HG11 ' A' ' 245' ' ' VAL . . . -71.22 -31.97 68.23 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.482 1.114 . . . . 0.0 109.318 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.436 ' CG1' ' HB3' ' A' ' 239' ' ' LEU . 4.8 t -75.9 -42.17 39.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.486 1.116 . . . . 0.0 109.272 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.24 -46.22 74.42 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.476 1.11 . . . . 0.0 109.289 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.422 HG22 ' CH2' ' A' ' 227' ' ' TRP . 2.8 p -65.05 -45.14 95.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.497 1.123 . . . . 0.0 109.273 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.405 ' N ' ' CG1' ' A' ' 245' ' ' VAL . 4.9 tp10 -64.87 -36.12 83.33 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.114 . . . . 0.0 110.325 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.453 ' CG1' HD12 ' A' ' 330' ' ' LEU . 26.4 mt -67.85 -48.0 77.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.514 1.134 . . . . 0.0 109.329 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 55.2 t -63.26 -33.07 58.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.123 . . . . 0.0 109.323 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.1 mmm180 -74.61 -25.13 59.04 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.434 1.084 . . . . 0.0 110.294 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -87.15 -18.54 30.18 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.481 1.113 . . . . 0.0 109.344 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.82 146.16 54.72 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.575 1.172 . . . . 0.0 109.321 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -120.54 135.08 55.19 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 0.0 110.368 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -80.57 122.4 27.0 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.459 1.099 . . . . 0.0 109.262 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.7 ttm-85 -124.25 121.95 36.43 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.543 1.152 . . . . 0.0 110.276 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.6 m -91.28 117.81 29.96 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 0.0 110.373 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 69.3 t -106.69 112.02 63.71 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.461 1.101 . . . . 0.0 109.329 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.516 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.97 173.65 14.14 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.472 1.775 . . . . 0.0 111.023 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.47 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -67.51 131.33 45.44 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.488 1.117 . . . . 0.0 109.263 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 93.27 -25.39 20.59 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 124.556 1.16 . . . . 0.0 110.984 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . 0.516 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -61.07 149.04 38.31 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.52 0.776 . . . . 0.0 109.332 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.2 t -97.47 131.35 44.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.483 1.114 . . . . 0.0 109.324 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 43.3 mt -83.9 -40.09 15.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.53 1.144 . . . . 0.0 109.308 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 13.8 p -156.12 150.71 25.89 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.503 1.127 . . . . 0.0 108.276 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -94.42 179.67 5.21 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.566 1.166 . . . . 0.0 110.339 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.438 ' N ' ' OG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -77.49 140.34 17.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.467 1.104 . . . . 0.0 109.326 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 46.54 52.71 10.64 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.5 1.125 . . . . 0.0 111.045 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . 0.46 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.2 OUTLIER -71.03 168.08 23.86 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.548 0.793 . . . . 0.0 110.357 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 267' ' ' GLU . 18.4 Cg_endo -74.98 88.49 1.23 Allowed 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.458 1.767 . . . . 0.0 111.005 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . 0.401 ' O ' ' CA ' ' A' ' 304' ' ' GLY . . . -45.23 93.5 0.01 OUTLIER Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.553 1.158 . . . . 0.0 110.988 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 268' ' ' PRO . 0.6 OUTLIER -170.47 36.68 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.51 0.771 . . . . 0.0 109.345 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -173.35 162.27 4.32 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.566 1.166 . . . . 0.0 110.295 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.555 ' HE3' ' CE1' ' A' ' 274' ' ' PHE . 9.3 ptm -145.84 146.66 31.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.538 1.149 . . . . 0.0 110.996 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.566 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 33.2 m-85 -128.37 154.08 46.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.484 1.115 . . . . 0.0 111.017 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . 0.555 ' CE1' ' HE3' ' A' ' 272' ' ' MET . 23.6 m-85 -129.87 137.37 50.39 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.481 1.113 . . . . 0.0 111.017 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.41 ' HA ' ' HB3' ' A' ' 319' ' ' LEU . 42.7 t -90.71 136.72 23.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.52 1.137 . . . . 0.0 109.295 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 39.8 t -116.03 -43.78 3.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.535 1.147 . . . . 0.0 109.326 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -146.61 136.74 23.55 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.517 1.136 . . . . 0.0 110.272 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.464 ' HA3' ' CG2' ' A' ' 317' ' ' VAL . . . 114.46 -173.22 14.72 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.502 1.126 . . . . 0.0 111.004 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' SER . . . . . 0.441 ' N ' HG21 ' A' ' 317' ' ' VAL . 3.2 m -134.9 119.92 18.65 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.539 0.788 . . . . 0.0 109.989 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.42 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 16.5 m -99.0 165.82 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.499 1.125 . . . . 0.0 109.323 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 30.5 t -131.52 154.97 48.23 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.504 1.128 . . . . 0.0 110.009 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.92 131.21 72.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.503 1.127 . . . . 0.0 109.306 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -79.41 102.03 8.48 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 0.0 109.325 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' THR . . . . . 0.655 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.18 -168.25 0.18 Allowed Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.525 1.14 . . . . 0.0 110.391 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.655 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -75.04 4.48 4.72 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.566 1.824 . . . . 0.0 110.964 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -151.75 157.2 34.59 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.548 1.155 . . . . 0.0 109.263 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.06 95.36 0.98 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.472 1.775 . . . . 0.0 110.937 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 4.6 t -99.39 119.23 47.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.47 1.106 . . . . 0.0 109.263 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -124.44 135.85 53.58 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.426 1.079 . . . . 0.0 110.29 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.42 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 3.9 mm? -115.11 142.11 47.1 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.451 1.095 . . . . 0.0 109.307 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -98.79 -161.24 29.82 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.494 1.121 . . . . 0.0 110.983 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 145.88 31.98 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.491 1.785 . . . . 0.0 110.999 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 88.09 4.63 77.9 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.459 1.099 . . . . 0.0 110.95 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -91.25 127.77 36.81 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.501 0.765 . . . . 0.0 109.315 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . 0.451 ' HB3' ' CD1' ' A' ' 274' ' ' PHE . 1.2 p90 -116.34 153.38 32.09 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.52 1.138 . . . . 0.0 110.987 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 48.1 p90 -161.63 146.38 13.19 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.452 1.095 . . . . 0.0 110.977 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 129.66 -9.99 6.09 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 124.527 1.142 . . . . 0.0 111.001 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -52.77 -51.21 61.54 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.457 0.74 . . . . 0.0 110.295 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.2 mmt -50.48 -32.89 19.37 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.523 1.139 . . . . 0.0 111.008 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -68.85 -42.64 76.84 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.535 1.147 . . . . 0.0 109.337 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.439 ' N ' HD23 ' A' ' 301' ' ' LEU . 6.0 mt -75.01 -11.68 60.16 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.475 1.109 . . . . 0.0 109.283 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . 0.556 HD12 ' CZ ' ' A' ' 341' ' ' PHE . 14.5 mm -77.83 -56.63 7.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.484 1.115 . . . . 0.0 109.291 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 304' ' ' GLY . 2.4 m -151.46 42.57 0.74 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.445 1.091 . . . . 0.0 110.0 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 34.93 51.21 0.82 Allowed Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.462 1.101 . . . . 0.0 110.969 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.58 151.34 80.15 Favored Pre-proline 0 C--N 1.326 -0.436 0 O-C-N 124.524 0.779 . . . . 0.0 110.33 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 130.29 13.11 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.461 1.769 . . . . 0.0 110.955 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -44.04 -33.09 1.34 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.536 1.147 . . . . 0.0 110.301 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 59.38 15.9 4.73 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.525 1.14 . . . . 0.0 109.989 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . -170.15 160.75 8.17 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.544 1.153 . . . . 0.0 109.333 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.438 ' OG1' ' N ' ' A' ' 265' ' ' ILE . 0.9 OUTLIER -110.29 139.68 45.23 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.469 1.106 . . . . 0.0 110.42 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 91.1 t -115.57 131.62 67.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.493 1.121 . . . . 0.0 109.269 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 56.3 p -128.6 153.75 46.92 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.491 1.119 . . . . 0.0 110.018 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.95 114.3 26.75 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.556 1.16 . . . . 0.0 109.286 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -57.73 -35.19 70.34 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.521 1.138 . . . . 0.0 109.304 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' THR . . . . . 0.47 ' HA ' ' CB ' ' A' ' 258' ' ' ALA . 8.7 t -153.96 -173.91 4.76 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.559 1.162 . . . . 0.0 110.424 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 29.0 m -49.9 91.36 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 0.0 110.378 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.464 ' CG2' ' HA3' ' A' ' 278' ' ' GLY . 41.6 t -106.75 154.54 7.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.53 1.144 . . . . 0.0 109.31 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 69.3 m -129.79 114.93 16.55 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.534 1.146 . . . . 0.0 109.965 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . 0.505 ' CB ' ' O ' ' A' ' 274' ' ' PHE . 0.2 OUTLIER -130.43 173.17 11.09 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.484 1.115 . . . . 0.0 109.289 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 273' ' ' PHE . 0.8 OUTLIER -124.29 136.41 54.11 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.532 1.145 . . . . 0.0 109.29 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' SER . . . . . 0.477 ' HB2' ' CE2' ' A' ' 273' ' ' PHE . 36.7 t -96.07 148.53 22.58 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.466 1.104 . . . . 0.0 110.02 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -146.49 98.54 3.09 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.5 1.125 . . . . 0.0 109.302 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -60.02 146.9 41.02 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.485 1.116 . . . . 0.0 109.582 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 37.8 t -63.68 -13.71 45.39 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.504 1.127 . . . . 0.0 110.02 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . 0.413 ' HA ' ' NE2' ' A' ' 328' ' ' GLN . . . -61.67 -27.8 68.94 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.486 1.116 . . . . 0.0 109.331 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.66 -39.52 61.99 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.504 1.127 . . . . 0.0 109.277 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' PHE . . . . . 0.483 ' C ' ' CD1' ' A' ' 327' ' ' PHE . 0.8 OUTLIER -70.47 -42.68 71.11 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.504 1.127 . . . . 0.0 110.995 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . 0.413 ' NE2' ' HA ' ' A' ' 325' ' ' ALA . 1.8 pt20 -67.15 -35.61 80.07 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.512 1.133 . . . . 0.0 110.266 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 17.9 tmm? -66.8 -42.12 86.48 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.515 1.135 . . . . 0.0 110.985 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.453 HD12 ' CG1' ' A' ' 247' ' ' ILE . 5.2 mt -72.51 -37.42 68.38 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.456 1.097 . . . . 0.0 109.307 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 6.2 m -72.57 -31.64 65.4 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.478 1.111 . . . . 0.0 108.329 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 47.1 t -71.83 -37.91 70.25 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 0.0 109.981 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 42.6 t -72.17 -36.0 69.16 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.464 1.103 . . . . 0.0 109.981 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -123.02 114.32 29.53 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.51 1.131 . . . . 0.0 110.005 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -19.04 18.2 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.537 1.809 . . . . 0.0 111.005 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -72.57 -32.13 65.8 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.548 1.155 . . . . 0.0 110.31 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 77.6 mt -74.87 -44.95 44.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.485 1.116 . . . . 0.0 109.286 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -66.6 -35.33 79.94 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.131 . . . . 0.0 109.338 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . 0.478 ' O ' ' CG ' ' A' ' 343' ' ' LYS . 50.2 mm-40 -72.3 -42.78 65.09 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.516 1.135 . . . . 0.0 110.279 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 58.5 mt -68.35 -36.52 75.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.523 1.14 . . . . 0.0 109.256 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.561 ' CE1' HD12 ' A' ' 235' ' ' LEU . 49.7 t80 -69.55 -37.2 76.94 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.101 . . . . 0.0 110.982 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -69.76 -37.99 76.6 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.474 1.109 . . . . 0.0 110.335 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' LYS . . . . . 0.478 ' CG ' ' O ' ' A' ' 339' ' ' GLU . 0.5 OUTLIER -65.0 -50.65 65.45 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.496 1.123 . . . . 0.0 109.344 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 4.5 t -64.83 -32.86 74.76 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.51 1.131 . . . . 0.0 110.4 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -70.07 -39.05 75.85 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.466 1.104 . . . . 0.0 109.29 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 12.6 mt -68.93 -34.04 74.71 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.434 1.084 . . . . 0.0 109.312 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.75 -31.68 61.87 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.467 1.105 . . . . 0.0 110.299 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . 0.416 ' CZ ' HD22 ' A' ' 235' ' ' LEU . 7.0 mtt180 . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.535 1.147 . . . . 0.0 110.304 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 14.6 t80 . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 120.498 0.19 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.81 -35.89 44.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.543 1.152 . . . . 0.0 109.289 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -32.12 71.02 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.559 1.162 . . . . 0.0 110.333 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . 0.409 ' ND2' HG11 ' A' ' 248' ' ' VAL . 46.6 t30 -79.89 -30.63 40.19 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.471 1.107 . . . . 0.0 109.256 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' TRP . . . . . 0.583 ' CZ2' ' CG2' ' A' ' 245' ' ' VAL . 2.5 t90 -67.8 -43.65 79.19 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.538 1.149 . . . . 0.0 107.974 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -71.03 -38.38 72.58 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.585 1.178 . . . . 0.0 110.339 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -62.43 -46.25 89.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.146 . . . . 0.0 109.3 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.439 HG23 ' CD1' ' A' ' 251' ' ' LEU . 59.1 t -72.69 -37.01 54.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.466 1.104 . . . . 0.0 109.316 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -73.5 -15.86 61.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.487 1.117 . . . . 0.0 109.328 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -81.86 -12.74 58.33 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.511 1.132 . . . . 0.0 109.318 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 38.2 t -70.9 132.3 86.86 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.122 . . . . 0.0 109.298 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.98 -30.4 7.23 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.482 1.78 . . . . 0.0 110.979 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.441 ' CD1' HD11 ' A' ' 302' ' ' ILE . 0.7 OUTLIER -68.87 -28.21 66.5 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.447 1.092 . . . . 0.0 109.29 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . 0.57 ' CD1' HD13 ' A' ' 239' ' ' LEU . 13.8 m-30 -104.63 14.32 30.04 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.497 1.123 . . . . 0.0 111.016 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -72.17 -26.15 61.97 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.492 1.12 . . . . 0.0 110.286 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.469 ' HB2' ' CG2' ' A' ' 340' ' ' ILE . 6.6 mmpt? -100.47 7.62 44.06 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.528 1.143 . . . . 0.0 109.314 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.57 HD13 ' CD1' ' A' ' 236' ' ' PHE . 16.9 mt -81.51 171.24 14.92 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 0.0 109.258 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -95.16 173.68 31.82 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.51 1.131 . . . . 0.0 110.981 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.494 ' O ' ' CG2' ' A' ' 245' ' ' VAL . 18.2 Cg_endo -75.05 -35.29 3.19 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.494 1.786 . . . . 0.0 111.015 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.4 -34.66 76.41 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.474 1.109 . . . . 0.0 109.3 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.479 HG23 ' CD1' ' A' ' 337' ' ' ILE . 25.6 t -74.17 -42.07 51.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.44 1.087 . . . . 0.0 109.301 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -64.81 -34.58 78.68 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.511 1.132 . . . . 0.0 109.293 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.583 ' CG2' ' CZ2' ' A' ' 227' ' ' TRP . 70.4 t -70.72 -44.56 76.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.547 1.155 . . . . 0.0 109.311 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -65.3 -31.18 72.18 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.478 1.111 . . . . 0.0 110.293 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 56.0 mt -75.14 -40.54 44.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.451 1.095 . . . . 0.0 109.317 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.409 HG11 ' ND2' ' A' ' 226' ' ' ASN . 55.8 t -70.96 -33.32 51.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.503 1.127 . . . . 0.0 109.309 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.428 ' NH1' ' HB3' ' A' ' 249' ' ' ARG . 5.6 mmm180 -78.94 -25.84 43.63 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.471 1.107 . . . . 0.0 110.275 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -86.87 -21.68 26.21 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.523 1.139 . . . . 0.0 109.332 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.439 ' CD1' HG23 ' A' ' 230' ' ' VAL . 0.2 OUTLIER -61.49 152.35 30.31 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.46 1.1 . . . . 0.0 109.339 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -121.13 119.1 31.41 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.495 1.122 . . . . 0.0 110.299 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.439 ' CB ' HD23 ' A' ' 320' ' ' LEU . . . -81.17 122.43 27.37 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.502 1.126 . . . . 0.0 109.298 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.96 142.75 50.38 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.453 1.096 . . . . 0.0 110.299 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 4.5 m -96.64 125.83 41.39 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.517 1.136 . . . . 0.0 110.386 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 86.7 t -106.58 115.73 60.17 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.473 1.108 . . . . 0.0 109.3 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.5 Cg_endo -74.96 168.41 24.89 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.535 1.808 . . . . 0.0 111.038 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.507 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -66.81 128.5 36.53 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.511 1.132 . . . . 0.0 109.302 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 96.06 -25.57 24.85 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.486 1.116 . . . . 0.0 110.989 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . 0.506 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -64.35 134.1 53.96 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.505 0.767 . . . . 0.0 109.313 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 2.5 p -90.21 134.98 27.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.485 1.116 . . . . 0.0 109.295 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 11.3 mt -82.47 -52.6 13.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.121 . . . . 0.0 109.377 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' CYS . . . . . 0.506 ' SG ' ' CG2' ' A' ' 311' ' ' VAL . 14.0 p -137.48 157.68 46.03 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.511 1.132 . . . . 0.0 108.31 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 1.8 mmt85 -100.98 178.43 4.67 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.58 1.175 . . . . 0.0 110.302 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.405 ' CG2' ' HB ' ' A' ' 310' ' ' THR . 0.2 OUTLIER -77.74 130.73 35.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.56 1.162 . . . . 0.0 109.308 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 59.9 47.51 90.64 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.533 1.146 . . . . 0.0 111.028 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . 0.417 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.2 OUTLIER -71.53 164.37 58.38 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.473 0.749 . . . . 0.0 110.302 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . 0.449 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.3 Cg_endo -74.96 81.52 2.18 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.469 1.773 . . . . 0.0 111.05 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 268' ' ' PRO . . . -37.08 95.86 0.01 OUTLIER Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.537 1.148 . . . . 0.0 111.039 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 268' ' ' PRO . 51.5 m-20 -170.45 38.67 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.507 0.769 . . . . 0.0 109.288 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . 0.471 ' HD3' ' CE1' ' A' ' 273' ' ' PHE . 3.8 ttm180 -170.78 151.83 3.55 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.505 1.128 . . . . 0.0 110.298 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.49 ' SD ' ' CD1' ' A' ' 301' ' ' LEU . 3.4 ttt -121.5 155.33 35.17 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.505 1.128 . . . . 0.0 111.031 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.568 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 25.8 m-85 -140.42 136.74 33.37 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.49 1.119 . . . . 0.0 111.006 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -128.47 126.84 41.32 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.476 1.11 . . . . 0.0 111.018 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 53.9 t -85.58 132.71 31.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.459 1.1 . . . . 0.0 109.32 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . 0.412 ' CG2' HD13 ' A' ' 320' ' ' LEU . 48.3 t -107.15 -52.84 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.485 1.116 . . . . 0.0 109.302 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -139.81 137.9 35.37 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.51 1.131 . . . . 0.0 110.254 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.401 ' HA3' ' HB ' ' A' ' 317' ' ' VAL . . . 116.27 -158.0 14.7 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.458 1.099 . . . . 0.0 110.952 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 8.7 t -148.3 134.07 18.95 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.54 0.788 . . . . 0.0 109.998 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 11.3 m -114.02 165.41 9.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.516 1.135 . . . . 0.0 109.283 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 29.3 t -131.59 148.54 52.62 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.529 1.143 . . . . 0.0 109.991 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.46 HG21 ' CG1' ' A' ' 288' ' ' VAL . 0.6 OUTLIER -110.91 129.79 65.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.461 1.101 . . . . 0.0 109.262 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -78.52 101.46 7.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.479 1.112 . . . . 0.0 109.32 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' THR . . . . . 0.659 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.9 OUTLIER -147.14 -168.05 0.17 Allowed Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.505 1.128 . . . . 0.0 110.38 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.659 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.6 Cg_endo -74.96 3.98 5.12 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.502 1.791 . . . . 0.0 111.022 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -150.37 157.2 37.03 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.482 1.114 . . . . 0.0 109.302 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.91 94.1 0.95 Allowed 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.493 1.786 . . . . 0.0 110.989 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.46 ' CG1' HG21 ' A' ' 282' ' ' VAL . 72.1 t -98.09 118.94 45.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.544 1.152 . . . . 0.0 109.29 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -125.11 134.49 52.44 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.443 1.089 . . . . 0.0 110.291 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -116.73 141.48 48.15 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.536 1.148 . . . . 0.0 109.308 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -95.72 -158.47 32.36 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.518 1.136 . . . . 0.0 110.974 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 152.63 40.88 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.466 1.772 . . . . 0.0 110.994 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 79.66 6.78 88.91 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.501 1.125 . . . . 0.0 110.971 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -88.98 128.71 35.7 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.489 0.758 . . . . 0.0 109.278 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -117.45 153.01 33.84 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.471 1.107 . . . . 0.0 111.005 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . 0.568 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 45.5 p90 -166.28 145.7 5.94 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.512 1.133 . . . . 0.0 111.024 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 133.21 -10.53 5.06 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.514 1.133 . . . . 0.0 111.004 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . 0.435 ' CA ' ' HE2' ' A' ' 272' ' ' MET . 32.8 tt0 -52.75 -53.22 51.05 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.493 0.761 . . . . 0.0 110.242 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -47.58 -35.56 9.32 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.467 1.104 . . . . 0.0 110.99 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -68.4 -43.21 77.75 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.513 1.133 . . . . 0.0 109.327 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.49 ' CD1' ' SD ' ' A' ' 272' ' ' MET . 1.2 mt -77.26 -5.98 51.41 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.498 1.124 . . . . 0.0 109.285 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . 0.441 HD11 ' CD1' ' A' ' 235' ' ' LEU . 8.1 mm -83.37 -53.92 10.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 0.0 109.282 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 304' ' ' GLY . 78.5 p -151.89 43.2 0.72 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.511 1.132 . . . . 0.0 109.968 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 303' ' ' SER . . . 36.16 35.0 0.09 OUTLIER Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.474 1.109 . . . . 0.0 111.009 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 303' ' ' SER . 0.1 OUTLIER -62.4 151.55 82.36 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.498 0.763 . . . . 0.0 110.318 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 127.57 10.79 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.435 1.755 . . . . 0.0 110.974 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . 0.4 ' NE ' ' HG2' ' A' ' 267' ' ' GLU . 0.0 OUTLIER -46.16 -24.9 0.51 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 0.0 110.295 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 43.18 36.85 1.07 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.475 1.11 . . . . 0.0 110.012 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . -177.99 161.07 1.5 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.474 1.108 . . . . 0.0 109.283 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.405 ' HB ' ' CG2' ' A' ' 265' ' ' ILE . 0.3 OUTLIER -113.89 121.4 43.87 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.472 1.107 . . . . 0.0 110.355 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.506 ' CG2' ' SG ' ' A' ' 263' ' ' CYS . 31.5 t -102.69 131.79 50.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.116 . . . . 0.0 109.267 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 6.0 p -136.11 158.29 44.76 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.538 1.149 . . . . 0.0 110.007 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . 0.547 ' CB ' ' CG1' ' A' ' 317' ' ' VAL . . . -88.29 111.86 22.17 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.471 1.107 . . . . 0.0 109.259 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -55.55 -26.34 42.87 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.507 1.129 . . . . 0.0 109.286 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' THR . . . . . 0.507 ' HA ' ' CB ' ' A' ' 258' ' ' ALA . 10.0 t -164.43 -165.08 0.9 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.49 1.119 . . . . 0.0 110.41 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' THR . . . . . 0.418 ' N ' ' OG1' ' A' ' 315' ' ' THR . 31.5 p -60.26 80.7 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.516 1.135 . . . . 0.0 110.426 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.547 ' CG1' ' CB ' ' A' ' 313' ' ' ALA . 2.5 p -113.0 138.5 42.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.129 . . . . 0.0 109.266 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' SER . . . . . 0.407 ' N ' HG21 ' A' ' 317' ' ' VAL . 49.7 m -107.26 139.05 42.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.556 1.16 . . . . 0.0 109.998 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . 0.472 HD21 ' CG2' ' A' ' 317' ' ' VAL . 0.0 OUTLIER -143.73 173.51 11.61 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.498 1.124 . . . . 0.0 109.306 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.439 HD23 ' CB ' ' A' ' 253' ' ' ALA . 1.2 mp -124.37 133.99 53.26 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.448 1.092 . . . . 0.0 109.308 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 20.9 t -97.99 151.34 20.41 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.469 1.106 . . . . 0.0 109.985 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -144.8 106.87 4.32 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.494 1.121 . . . . 0.0 109.34 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . 0.423 ' CE1' ' HB2' ' A' ' 326' ' ' ASP . 10.2 p80 -66.4 132.99 49.55 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.502 1.126 . . . . 0.0 109.615 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 96.1 p -56.64 -21.95 30.91 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.469 1.106 . . . . 0.0 110.004 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -58.84 -35.47 72.98 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.5 1.125 . . . . 0.0 109.29 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . 0.434 ' O ' ' CG ' ' A' ' 329' ' ' MET . 23.8 t70 -66.1 -41.05 91.13 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.502 1.126 . . . . 0.0 109.34 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' PHE . . . . . 0.482 ' CD1' ' O ' ' A' ' 327' ' ' PHE . 2.6 t80 -70.53 -29.77 66.34 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.47 1.106 . . . . 0.0 110.998 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -70.92 -45.73 63.74 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.523 1.139 . . . . 0.0 110.319 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.454 ' HG3' ' N ' ' A' ' 330' ' ' LEU . 3.9 ptm -66.47 -34.6 78.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.49 1.119 . . . . 0.0 110.978 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.454 ' N ' ' HG3' ' A' ' 329' ' ' MET . 16.5 mt -72.77 -37.74 67.54 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.486 1.116 . . . . 0.0 109.275 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' CYS . . . . . 0.402 ' O ' ' O ' ' A' ' 334' ' ' SER . 14.2 t -66.26 -41.47 89.85 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.549 1.156 . . . . 0.0 108.336 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.28 -23.36 51.15 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.486 1.116 . . . . 0.0 109.992 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 19.9 t -71.65 -39.33 70.42 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.532 1.145 . . . . 0.0 110.032 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' SER . . . . . 0.402 ' O ' ' O ' ' A' ' 331' ' ' CYS . 0.1 OUTLIER -121.98 131.9 24.34 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.491 1.12 . . . . 0.0 109.957 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -28.5 9.14 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.495 1.787 . . . . 0.0 110.999 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.78 -28.57 67.72 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.477 1.111 . . . . 0.0 110.259 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.479 ' CD1' HG23 ' A' ' 243' ' ' VAL . 95.7 mt -72.28 -35.77 53.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.486 1.116 . . . . 0.0 109.254 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.22 -33.98 65.64 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.536 1.147 . . . . 0.0 109.309 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -74.54 -42.35 59.0 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.511 1.132 . . . . 0.0 110.272 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.469 ' CG2' ' HB2' ' A' ' 238' ' ' LYS . 43.2 mt -71.7 -40.24 70.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.524 1.14 . . . . 0.0 109.27 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.481 ' CE2' ' CZ ' ' A' ' 327' ' ' PHE . 10.2 t80 -70.04 -34.94 73.89 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.547 1.154 . . . . 0.0 111.009 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.18 -41.47 73.7 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.484 1.115 . . . . 0.0 110.257 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.05 -40.57 71.58 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.498 1.124 . . . . 0.0 109.295 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.1 m -67.46 -42.39 83.12 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.457 1.098 . . . . 0.0 110.403 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -70.87 -35.08 72.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.557 1.161 . . . . 0.0 109.293 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 15.8 mt -71.46 -31.99 67.79 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.546 1.154 . . . . 0.0 109.277 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -73.71 -39.02 64.64 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.539 1.149 . . . . 0.0 110.281 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 16.0 mtt-85 . . . . . 0 C--N 1.325 -0.489 0 O-C-N 124.477 1.111 . . . . 0.0 110.349 179.976 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.7 t80 . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.494 0.187 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -71.16 -37.76 67.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.525 1.14 . . . . 0.0 109.27 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.57 -33.14 75.02 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.536 1.147 . . . . 0.0 110.334 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . 0.45 ' O ' ' CG2' ' A' ' 230' ' ' VAL . 10.4 t-20 -79.21 -30.3 43.24 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.471 1.107 . . . . 0.0 109.321 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' TRP . . . . . 0.572 ' CH2' HG21 ' A' ' 245' ' ' VAL . 3.1 t90 -66.45 -44.44 82.77 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.52 1.137 . . . . 0.0 108.01 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.44 ' HG3' ' N ' ' A' ' 229' ' ' LEU . 7.7 pt20 -71.67 -44.95 63.37 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.533 1.146 . . . . 0.0 110.359 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.44 ' N ' ' HG3' ' A' ' 228' ' ' GLN . 0.3 OUTLIER -57.75 -44.76 86.34 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.468 1.105 . . . . 0.0 109.3 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.45 ' CG2' ' O ' ' A' ' 226' ' ' ASN . 95.7 t -70.34 -38.99 76.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.48 1.113 . . . . 0.0 109.244 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -75.29 -10.18 59.23 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.48 1.113 . . . . 0.0 109.254 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 228' ' ' GLN . . . -80.06 -25.07 40.27 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.451 1.094 . . . . 0.0 109.223 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . 0.585 HG11 ' CD1' ' A' ' 236' ' ' PHE . 61.9 t -70.05 138.14 87.32 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.469 1.106 . . . . 0.0 109.298 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 -50.24 0.13 Allowed 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.478 1.778 . . . . 0.0 110.998 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.566 ' HB3' ' CE2' ' A' ' 341' ' ' PHE . 18.2 mt -50.84 -37.13 41.28 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.489 1.118 . . . . 0.0 109.275 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . 0.585 ' CD1' HG11 ' A' ' 233' ' ' VAL . 4.3 m-85 -78.88 -21.99 46.64 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.465 1.103 . . . . 0.0 110.979 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -22.72 61.31 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.514 1.134 . . . . 0.0 110.282 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -75.11 -23.27 57.91 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.495 1.122 . . . . 0.0 109.275 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.48 ' CD2' ' CG2' ' A' ' 337' ' ' ILE . 16.3 mt -74.51 -179.83 4.26 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.483 1.114 . . . . 0.0 109.275 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -107.72 -172.6 22.04 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.517 1.136 . . . . 0.0 111.005 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.437 ' O ' ' CG2' ' A' ' 245' ' ' VAL . 18.1 Cg_endo -75.0 -36.96 2.24 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.5 1.789 . . . . 0.0 111.015 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.09 -34.83 78.48 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.493 1.121 . . . . 0.0 109.327 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.462 ' CG1' HD12 ' A' ' 247' ' ' ILE . 13.6 t -75.38 -39.21 41.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.531 1.144 . . . . 0.0 109.329 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 244' ' ' LEU . 1.4 mm? -66.28 -37.94 86.62 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.498 1.124 . . . . 0.0 109.253 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.572 HG21 ' CH2' ' A' ' 227' ' ' TRP . 94.1 t -68.95 -44.67 81.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.478 1.111 . . . . 0.0 109.274 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -64.74 -36.94 85.93 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.468 1.105 . . . . 0.0 110.301 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.462 HD12 ' CG1' ' A' ' 243' ' ' VAL . 41.7 mt -69.09 -49.07 65.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.47 1.106 . . . . 0.0 109.285 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 63.9 t -62.58 -31.09 50.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 0.0 109.308 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -78.92 -22.67 45.5 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.549 1.155 . . . . 0.0 110.282 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -91.86 -12.59 33.21 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.48 1.113 . . . . 0.0 109.25 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.61 148.89 47.63 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.535 1.147 . . . . 0.0 109.318 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 2.4 tpt85 -120.64 116.11 24.68 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.471 1.107 . . . . 0.0 110.288 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -80.7 122.28 26.93 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.414 1.072 . . . . 0.0 109.355 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.4 ' O ' ' O ' ' A' ' 319' ' ' LEU . 13.5 ptp180 -130.27 142.97 50.52 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.486 1.116 . . . . 0.0 110.303 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 10.5 m -95.36 129.19 42.59 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.51 1.131 . . . . 0.0 110.383 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 51.5 t -106.46 117.67 56.52 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.521 1.138 . . . . 0.0 109.276 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.2 Cg_endo -75.03 164.6 32.98 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.473 1.775 . . . . 0.0 110.988 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.486 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -66.85 125.21 25.18 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.495 1.122 . . . . 0.0 109.287 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 99.03 -24.91 30.32 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 124.5 1.125 . . . . 0.0 111.002 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . 0.515 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -63.64 144.74 56.77 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.49 0.759 . . . . 0.0 109.299 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 2.7 p -97.54 135.82 30.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 0.0 109.288 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 12.2 mt -82.3 -49.17 17.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.541 1.15 . . . . 0.0 109.328 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' CYS . . . . . 0.495 ' SG ' ' CG2' ' A' ' 311' ' ' VAL . 12.8 p -142.96 163.63 32.27 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.522 1.139 . . . . 0.0 108.28 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 1.1 mmt-85 -103.81 178.34 4.59 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.515 1.135 . . . . 0.0 110.313 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.468 ' N ' ' HG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -77.79 142.02 14.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.458 1.099 . . . . 0.0 109.317 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 46.82 43.92 17.12 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.536 1.148 . . . . 0.0 111.009 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . 0.436 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.2 OUTLIER -71.38 166.93 34.32 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.485 0.756 . . . . 0.0 110.311 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . 0.436 ' HD2' ' HB2' ' A' ' 267' ' ' GLU . 18.1 Cg_endo -75.01 86.91 1.37 Allowed 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.487 1.783 . . . . 0.0 111.0 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -45.54 97.9 0.01 OUTLIER Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.499 1.124 . . . . 0.0 110.979 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -170.19 38.11 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.539 0.788 . . . . 0.0 109.284 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.46 144.55 6.42 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.139 . . . . 0.0 110.299 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.492 ' CE ' ' HG2' ' A' ' 298' ' ' GLU . 2.1 ttt -113.94 146.65 39.78 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.501 1.125 . . . . 0.0 111.008 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.565 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 86.6 m-85 -138.07 136.63 37.0 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.488 1.117 . . . . 0.0 110.984 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . 0.469 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 23.0 m-85 -126.65 133.67 50.92 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.123 . . . . 0.0 110.986 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.42 ' HA ' ' HB3' ' A' ' 319' ' ' LEU . 36.9 t -89.67 135.2 26.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.495 1.122 . . . . 0.0 109.311 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 9.8 t -110.4 -49.1 6.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.535 1.147 . . . . 0.0 109.334 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -143.59 132.74 23.05 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.483 1.115 . . . . 0.0 110.253 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.488 ' HA3' ' CG2' ' A' ' 317' ' ' VAL . . . 121.95 -169.25 14.72 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.492 1.12 . . . . 0.0 111.023 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' SER . . . . . 0.416 ' N ' HG22 ' A' ' 317' ' ' VAL . 7.6 t -138.33 117.0 12.2 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.555 0.797 . . . . 0.0 110.007 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.469 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 30.0 m -98.76 161.47 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.504 1.127 . . . . 0.0 109.28 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 28.9 t -127.97 151.18 49.44 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.414 1.071 . . . . 0.0 110.018 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.475 HG23 ' CG1' ' A' ' 288' ' ' VAL . 1.4 t -114.81 130.75 68.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.468 1.105 . . . . 0.0 109.328 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -77.99 102.14 7.24 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.469 1.106 . . . . 0.0 109.298 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' THR . . . . . 0.655 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.29 -168.46 0.19 Allowed Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.502 1.126 . . . . 0.0 110.403 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.655 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -75.0 3.77 5.33 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.483 1.781 . . . . 0.0 110.936 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -151.45 157.48 34.82 Favored Pre-proline 0 C--N 1.324 -0.529 0 O-C-N 124.501 1.126 . . . . 0.0 109.302 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 94.73 0.96 Allowed 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.493 1.786 . . . . 0.0 110.95 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.475 ' CG1' HG23 ' A' ' 282' ' ' VAL . 61.5 t -98.94 118.92 46.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 0.0 109.3 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -124.28 139.11 54.22 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.433 1.083 . . . . 0.0 110.275 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.469 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 3.7 mm? -117.15 140.34 49.64 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.465 1.103 . . . . 0.0 109.299 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -96.5 -162.58 32.75 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.527 1.142 . . . . 0.0 111.061 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 141.47 26.68 Favored 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.567 1.825 . . . . 0.0 110.999 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 90.23 6.56 68.7 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.55 1.156 . . . . 0.0 110.971 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -91.69 131.8 36.82 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.484 0.756 . . . . 0.0 109.287 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -119.3 152.71 36.24 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.489 1.118 . . . . 0.0 110.995 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . 0.565 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 45.2 p90 -163.57 145.63 9.58 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.483 1.114 . . . . 0.0 111.02 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . 0.441 ' HA2' ' NH2' ' A' ' 307' ' ' ARG . . . 132.26 -3.53 5.17 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.513 1.133 . . . . 0.0 110.99 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . 0.492 ' HG2' ' CE ' ' A' ' 272' ' ' MET . 1.7 mt-10 -59.41 -46.06 89.76 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.497 0.763 . . . . 0.0 110.294 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' MET . . . . . 0.408 ' HB3' ' CG ' ' A' ' 305' ' ' GLU . 0.0 OUTLIER -52.03 -34.36 42.73 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.486 1.116 . . . . 0.0 110.997 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -69.08 -45.06 71.23 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 0.0 109.289 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.462 ' CD2' ' HB2' ' A' ' 327' ' ' PHE . 1.0 OUTLIER -75.37 -6.96 52.64 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.506 1.128 . . . . 0.0 109.251 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 3.0 mm -82.25 -55.6 7.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.538 1.149 . . . . 0.0 109.337 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 304' ' ' GLY . 1.6 m -151.57 38.16 0.61 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.468 1.105 . . . . 0.0 110.011 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 36.68 53.14 1.44 Allowed Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.527 1.142 . . . . 0.0 111.005 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' GLU . . . . . 0.408 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 1.3 pt-20 -82.48 157.17 67.95 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.534 0.785 . . . . 0.0 110.312 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.07 133.82 16.95 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.467 1.772 . . . . 0.0 110.982 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . 0.441 ' NH2' ' HA2' ' A' ' 297' ' ' GLY . 0.0 OUTLIER -50.59 -26.0 4.82 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.45 1.094 . . . . 0.0 110.239 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 46.73 39.14 6.71 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.486 1.116 . . . . 0.0 110.025 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . 173.91 161.05 0.16 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.514 1.134 . . . . 0.0 109.344 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.468 ' HG1' ' N ' ' A' ' 265' ' ' ILE . 0.6 OUTLIER -109.14 132.87 53.71 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.539 1.149 . . . . 0.0 110.388 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.495 ' CG2' ' SG ' ' A' ' 263' ' ' CYS . 44.5 t -111.7 131.56 62.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.483 1.115 . . . . 0.0 109.296 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 6.2 p -141.62 151.64 43.29 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.461 1.101 . . . . 0.0 109.991 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.42 118.48 26.89 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.526 1.141 . . . . 0.0 109.318 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -59.92 -32.24 70.58 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.505 1.128 . . . . 0.0 109.267 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' THR . . . . . 0.486 ' HA ' ' CB ' ' A' ' 258' ' ' ALA . 13.1 t -153.97 -175.58 5.45 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.515 1.135 . . . . 0.0 110.362 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 41.7 p -49.29 92.46 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.531 1.144 . . . . 0.0 110.394 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.488 ' CG2' ' HA3' ' A' ' 278' ' ' GLY . 53.5 t -109.33 162.41 7.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.472 1.108 . . . . 0.0 109.273 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' SER . . . . . 0.433 ' N ' ' CG1' ' A' ' 317' ' ' VAL . 64.0 m -136.29 116.64 13.63 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.514 1.134 . . . . 0.0 109.989 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . 0.469 ' CB ' ' O ' ' A' ' 274' ' ' PHE . 0.2 OUTLIER -132.0 172.25 12.59 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.472 1.107 . . . . 0.0 109.341 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.425 HD23 ' ND2' ' A' ' 226' ' ' ASN . 0.2 OUTLIER -124.66 135.74 53.32 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.495 1.122 . . . . 0.0 109.341 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 45.5 t -93.36 158.25 15.83 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.525 1.141 . . . . 0.0 110.01 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -151.77 94.6 2.0 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.483 1.115 . . . . 0.0 109.329 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -55.39 135.32 50.36 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 0.0 109.624 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 8.1 t -57.78 -17.07 13.53 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.499 1.124 . . . . 0.0 110.0 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -58.31 -36.74 73.82 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.533 1.145 . . . . 0.0 109.297 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -42.61 95.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.491 1.119 . . . . 0.0 109.285 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' PHE . . . . . 0.462 ' HB2' ' CD2' ' A' ' 301' ' ' LEU . 83.7 t80 -65.19 -36.14 83.28 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.46 1.1 . . . . 0.0 110.981 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -69.65 -31.75 70.0 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.464 1.102 . . . . 0.0 110.328 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -69.86 -45.12 68.42 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.538 1.149 . . . . 0.0 110.995 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 1.2 mt -71.27 -30.89 66.84 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.492 1.12 . . . . 0.0 109.274 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 1.6 m -72.29 -37.52 68.99 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.535 1.147 . . . . 0.0 108.303 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.87 -36.28 64.81 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.44 1.088 . . . . 0.0 110.005 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.77 -33.56 70.9 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.517 1.135 . . . . 0.0 109.98 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' SER . . . . . 0.434 ' CB ' HD13 ' A' ' 337' ' ' ILE . 0.6 OUTLIER -128.68 113.22 19.16 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.531 1.145 . . . . 0.0 109.985 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -22.27 14.97 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.429 1.752 . . . . 0.0 110.988 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -73.53 -31.57 63.75 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.467 1.105 . . . . 0.0 110.337 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.48 ' CG2' ' CD2' ' A' ' 239' ' ' LEU . 60.5 mt -73.69 -45.53 50.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.542 1.151 . . . . 0.0 109.331 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . 0.406 ' O ' ' CB ' ' A' ' 342' ' ' ARG . . . -69.26 -32.17 71.18 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 0.0 109.298 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -71.4 -38.38 71.46 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.469 1.105 . . . . 0.0 110.334 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 78.5 mt -73.1 -42.67 58.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.467 1.105 . . . . 0.0 109.341 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.566 ' CE2' ' HB3' ' A' ' 235' ' ' LEU . 2.5 t80 -72.39 -30.72 64.93 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.513 1.133 . . . . 0.0 110.997 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . 0.47 ' HG3' ' CD1' ' A' ' 346' ' ' LEU . 0.0 OUTLIER -72.58 -43.21 63.67 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.511 1.132 . . . . 0.0 110.264 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -51.07 63.43 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.461 1.101 . . . . 0.0 109.323 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' THR . . . . . 0.422 ' CG2' ' HA ' ' A' ' 341' ' ' PHE . 9.0 t -65.02 -34.06 77.54 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.513 1.133 . . . . 0.0 110.355 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . 0.493 ' CB ' ' O ' ' A' ' 341' ' ' PHE . . . -65.22 -43.4 91.62 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.542 1.151 . . . . 0.0 109.291 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.47 ' CD1' ' HG3' ' A' ' 342' ' ' ARG . 0.5 OUTLIER -65.03 -38.87 92.3 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.482 1.114 . . . . 0.0 109.286 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -68.88 -37.95 79.37 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.46 1.1 . . . . 0.0 110.32 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 40.0 mtt-85 . . . . . 0 C--N 1.326 -0.431 0 O-C-N 124.472 1.107 . . . . 0.0 110.345 179.983 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 25.3 t80 . . . . . 0 N--CA 1.454 -0.264 0 CA-C-O 120.524 0.202 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.26 -32.58 58.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.485 1.115 . . . . 0.0 109.258 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.34 -35.39 71.17 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.532 1.145 . . . . 0.0 110.291 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -78.95 -30.43 44.6 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.498 1.123 . . . . 0.0 109.25 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' TRP . . . . . 0.569 ' CZ2' ' CG2' ' A' ' 245' ' ' VAL . 2.5 t90 -67.79 -45.52 74.59 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.502 1.126 . . . . 0.0 107.982 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.494 ' O ' ' CB ' ' A' ' 232' ' ' ALA . 6.1 pt20 -71.54 -34.41 69.99 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.535 1.147 . . . . 0.0 110.339 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 6.2 mt -60.55 -43.83 96.8 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.479 1.112 . . . . 0.0 109.318 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 82.7 t -75.5 -45.86 38.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.498 1.124 . . . . 0.0 109.324 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -69.16 -10.26 56.81 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.544 1.152 . . . . 0.0 109.299 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 228' ' ' GLN . . . -80.42 -20.52 43.71 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.459 1.099 . . . . 0.0 109.268 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . 0.431 ' CG1' ' HB2' ' A' ' 236' ' ' PHE . 0.3 OUTLIER -91.74 126.92 52.15 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.491 1.12 . . . . 0.0 109.299 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -0.34 9.85 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.551 1.816 . . . . 0.0 111.029 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -24.12 32.06 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.508 1.13 . . . . 0.0 109.311 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . 0.437 ' CD1' HD11 ' A' ' 239' ' ' LEU . 1.4 m-30 -120.4 -8.49 9.6 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.528 1.143 . . . . 0.0 111.029 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.66 -26.71 68.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.464 1.102 . . . . 0.0 110.258 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -74.71 -3.69 32.96 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.539 1.149 . . . . 0.0 109.342 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.483 ' HB2' ' CD2' ' A' ' 244' ' ' LEU . 66.5 mt -81.84 -179.32 7.34 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.509 1.131 . . . . 0.0 109.327 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -100.73 -176.76 29.62 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.5 1.125 . . . . 0.0 111.016 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.5 ' O ' ' CG2' ' A' ' 245' ' ' VAL . 18.1 Cg_endo -75.05 -38.84 1.39 Allowed 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.469 1.773 . . . . 0.0 110.991 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -66.37 -33.13 75.04 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 0.0 109.286 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.461 HG23 ' CD1' ' A' ' 337' ' ' ILE . 4.5 t -75.13 -42.02 44.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.503 1.127 . . . . 0.0 109.286 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.483 ' CD2' ' HB2' ' A' ' 239' ' ' LEU . 1.3 mm? -65.34 -37.91 88.52 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.487 1.117 . . . . 0.0 109.271 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.569 ' CG2' ' CZ2' ' A' ' 227' ' ' TRP . 58.4 t -71.82 -38.33 65.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.504 1.128 . . . . 0.0 109.247 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -67.64 -40.1 84.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.502 1.126 . . . . 0.0 110.289 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.446 ' CD1' HG12 ' A' ' 243' ' ' VAL . 31.6 mt -68.48 -48.9 70.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.461 1.1 . . . . 0.0 109.312 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 68.6 t -64.32 -33.15 60.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.132 . . . . 0.0 109.286 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.496 ' CG ' ' O ' ' A' ' 245' ' ' VAL . 0.9 OUTLIER -75.84 -22.85 55.84 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.489 1.118 . . . . 0.0 110.332 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.411 ' CB ' ' OD2' ' A' ' 326' ' ' ASP . . . -90.53 -18.08 25.91 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.446 1.091 . . . . 0.0 109.282 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.4 147.82 50.18 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.475 1.109 . . . . 0.0 109.288 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.97 134.26 55.29 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.541 1.15 . . . . 0.0 110.322 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -80.75 122.46 27.18 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.543 1.152 . . . . 0.0 109.323 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -123.73 123.3 40.21 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.482 1.113 . . . . 0.0 110.301 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 9.3 m -92.13 116.94 29.37 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.533 1.146 . . . . 0.0 110.41 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 77.4 t -106.67 112.22 63.65 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.548 1.155 . . . . 0.0 109.324 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.529 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.2 Cg_endo -75.0 175.37 11.33 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.501 1.79 . . . . 0.0 110.997 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.483 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -66.97 133.27 49.63 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.499 1.124 . . . . 0.0 109.359 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 90.42 -25.14 13.61 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.456 1.097 . . . . 0.0 110.99 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . 0.529 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -57.66 147.24 28.07 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.53 0.783 . . . . 0.0 109.301 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.7 t -97.25 128.96 48.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.113 . . . . 0.0 109.307 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 38.7 mt -82.96 -39.17 15.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.467 1.105 . . . . 0.0 109.291 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 14.2 p -159.47 151.27 20.46 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.507 1.129 . . . . 0.0 108.27 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 -95.16 -179.46 4.81 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.512 1.133 . . . . 0.0 110.303 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.508 ' N ' ' HG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -75.95 139.26 19.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.526 1.141 . . . . 0.0 109.354 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 47.82 51.46 18.15 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.519 1.137 . . . . 0.0 110.999 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . 0.413 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.2 OUTLIER -71.47 164.42 57.83 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.491 0.76 . . . . 0.0 110.306 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . 0.43 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.3 Cg_endo -74.94 78.5 2.86 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.488 1.783 . . . . 0.0 111.045 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 268' ' ' PRO . . . -36.58 96.54 0.01 OUTLIER Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.514 1.134 . . . . 0.0 111.009 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 268' ' ' PRO . 0.3 OUTLIER -170.26 37.6 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.506 0.768 . . . . 0.0 109.283 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . 0.437 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 0.2 OUTLIER -168.09 144.93 4.07 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.484 1.115 . . . . 0.0 110.291 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.487 ' SD ' ' CD1' ' A' ' 301' ' ' LEU . 0.1 OUTLIER -114.85 146.47 41.03 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 0.0 110.948 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.572 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 66.9 m-85 -133.46 136.7 45.31 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.474 1.109 . . . . 0.0 111.037 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . 0.449 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 22.0 m-85 -127.13 131.02 50.88 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.53 1.144 . . . . 0.0 111.046 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.408 ' HA ' ' HB3' ' A' ' 319' ' ' LEU . 45.7 t -87.07 137.7 20.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.501 1.126 . . . . 0.0 109.295 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . 0.436 ' CG2' HD12 ' A' ' 320' ' ' LEU . 4.2 t -118.56 -40.54 2.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.533 1.145 . . . . 0.0 109.301 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -147.52 136.16 21.87 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.511 1.132 . . . . 0.0 110.339 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.457 ' HA3' ' CG2' ' A' ' 317' ' ' VAL . . . 112.31 -167.33 12.35 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.513 1.133 . . . . 0.0 110.999 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' SER . . . . . 0.441 ' N ' HG22 ' A' ' 317' ' ' VAL . 11.2 t -140.97 122.12 14.72 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.569 0.805 . . . . 0.0 109.997 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.467 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 21.1 m -99.27 163.56 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.511 1.132 . . . . 0.0 109.308 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 31.6 t -130.25 151.85 50.32 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.492 1.12 . . . . 0.0 110.03 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.418 ' CG2' ' HB ' ' A' ' 288' ' ' VAL . 0.8 OUTLIER -114.77 129.01 71.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.463 1.102 . . . . 0.0 109.316 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.42 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -80.06 101.06 8.49 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.517 1.135 . . . . 0.0 109.318 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' THR . . . . . 0.661 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -149.04 -168.13 0.18 Allowed Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.554 1.159 . . . . 0.0 110.409 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.661 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.3 Cg_endo -74.98 5.49 3.94 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.448 1.762 . . . . 0.0 111.011 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -151.59 153.37 31.98 Favored Pre-proline 0 C--N 1.324 -0.529 0 O-C-N 124.511 1.132 . . . . 0.0 109.348 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.95 97.48 1.08 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.509 1.794 . . . . 0.0 111.044 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.418 ' HB ' ' CG2' ' A' ' 282' ' ' VAL . 2.3 t -102.78 119.24 50.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.469 1.106 . . . . 0.0 109.324 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -124.46 134.8 52.94 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.477 1.11 . . . . 0.0 110.271 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.467 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 3.9 mm? -112.97 141.59 46.62 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.488 1.118 . . . . 0.0 109.336 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -98.12 -164.72 31.13 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.466 1.104 . . . . 0.0 110.953 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.0 139.68 24.57 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.541 1.811 . . . . 0.0 111.007 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 96.6 1.93 60.19 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.509 1.131 . . . . 0.0 111.016 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -87.64 144.68 26.54 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.529 0.782 . . . . 0.0 109.301 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -134.83 153.11 52.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.468 1.105 . . . . 0.0 110.958 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . 0.572 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 45.9 p90 -163.89 146.25 9.38 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.508 1.13 . . . . 0.0 110.992 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 137.34 -10.33 3.8 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.455 1.097 . . . . 0.0 111.026 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . 0.44 ' HG2' ' N ' ' A' ' 299' ' ' MET . 0.9 OUTLIER -52.46 -34.85 50.81 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.482 0.754 . . . . 0.0 110.282 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' MET . . . . . 0.446 ' HB3' ' CG ' ' A' ' 305' ' ' GLU . 0.5 OUTLIER -64.27 -41.5 96.89 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.458 1.099 . . . . 0.0 111.032 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -63.67 -29.9 71.07 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.473 1.108 . . . . 0.0 109.296 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.487 ' CD1' ' SD ' ' A' ' 272' ' ' MET . 1.2 mt -86.34 -19.04 30.39 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.548 1.155 . . . . 0.0 109.286 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 298' ' ' GLU . 3.9 mm -68.56 -57.4 9.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.426 1.079 . . . . 0.0 109.33 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 304' ' ' GLY . 2.7 m -155.02 44.99 0.5 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.484 1.115 . . . . 0.0 110.021 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 303' ' ' SER . . . 35.4 51.15 0.98 Allowed Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.481 1.113 . . . . 0.0 111.005 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' GLU . . . . . 0.446 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 0.1 OUTLIER -78.76 155.02 78.37 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.504 0.767 . . . . 0.0 110.295 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 130.2 13.08 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.496 1.788 . . . . 0.0 111.003 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . 0.411 ' NE ' ' HG2' ' A' ' 267' ' ' GLU . 0.2 OUTLIER -44.61 -36.37 3.02 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.495 1.122 . . . . 0.0 110.321 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.482 ' O ' ' CB ' ' A' ' 309' ' ' ALA . 0.8 OUTLIER 59.9 42.49 16.21 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.459 1.1 . . . . 0.0 109.967 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' ALA . . . . . 0.482 ' CB ' ' O ' ' A' ' 308' ' ' SER . . . 164.59 160.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.517 1.135 . . . . 0.0 109.315 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.508 ' HG1' ' N ' ' A' ' 265' ' ' ILE . 0.9 OUTLIER -108.36 137.38 46.43 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.484 1.115 . . . . 0.0 110.387 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 61.6 t -116.92 131.38 69.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.459 1.1 . . . . 0.0 109.303 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 61.9 p -132.16 159.11 39.92 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.534 1.146 . . . . 0.0 110.008 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -93.6 118.3 31.2 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.547 1.155 . . . . 0.0 109.302 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -58.59 -35.26 72.13 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.499 1.124 . . . . 0.0 109.311 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' THR . . . . . 0.483 ' HA ' ' CB ' ' A' ' 258' ' ' ALA . 9.8 t -155.62 -172.5 4.17 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.491 1.119 . . . . 0.0 110.373 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' THR . . . . . 0.426 ' N ' ' OG1' ' A' ' 315' ' ' THR . 32.0 m -49.49 91.33 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.508 1.13 . . . . 0.0 110.396 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.457 ' CG2' ' HA3' ' A' ' 278' ' ' GLY . 38.6 t -107.79 155.98 8.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.444 1.09 . . . . 0.0 109.281 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 31.0 m -132.56 114.25 14.03 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.491 1.119 . . . . 0.0 110.045 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . 0.449 ' CB ' ' O ' ' A' ' 274' ' ' PHE . 0.2 OUTLIER -129.28 173.29 10.64 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 0.0 109.261 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.436 HD12 ' CG2' ' A' ' 276' ' ' VAL . 0.3 OUTLIER -124.2 138.18 54.44 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.434 1.084 . . . . 0.0 109.303 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 30.9 t -97.59 155.29 17.04 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.501 1.126 . . . . 0.0 109.976 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.457 HD23 ' CB ' ' A' ' 326' ' ' ASP . 1.4 tm? -145.69 92.99 2.29 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.441 1.088 . . . . 0.0 109.282 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . 0.509 ' CE1' ' OD1' ' A' ' 326' ' ' ASP . 13.8 p80 -54.99 126.77 25.95 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.464 1.103 . . . . 0.0 109.638 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' SER . . . . . 0.407 ' OG ' ' CG ' ' A' ' 270' ' ' ASP . 2.1 p -49.38 -26.92 3.55 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.476 1.11 . . . . 0.0 109.974 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -52.0 -30.46 25.25 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.492 1.12 . . . . 0.0 109.324 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . 0.509 ' OD1' ' CE1' ' A' ' 323' ' ' HIS . 0.2 OUTLIER -70.41 -41.85 72.41 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.448 1.092 . . . . 0.0 109.288 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' PHE . . . . . 0.672 ' CZ ' ' CE2' ' A' ' 341' ' ' PHE . 2.5 t80 -64.82 -38.82 92.28 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.486 1.116 . . . . 0.0 110.994 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -69.53 -34.13 73.8 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.424 1.077 . . . . 0.0 110.252 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 28.7 ttp -71.22 -32.24 68.56 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.465 1.103 . . . . 0.0 111.013 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.491 ' N ' HD21 ' A' ' 330' ' ' LEU . 0.2 OUTLIER -72.78 -46.2 54.55 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.546 1.154 . . . . 0.0 109.278 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' CYS . . . . . 0.401 ' O ' ' O ' ' A' ' 334' ' ' SER . 1.5 m -65.92 -32.38 73.85 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.527 1.142 . . . . 0.0 108.259 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 4.7 t -76.27 -29.8 57.57 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.486 1.116 . . . . 0.0 110.04 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 12.8 t -72.38 -38.19 68.54 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 0.0 109.983 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' SER . . . . . 0.401 ' O ' ' O ' ' A' ' 331' ' ' CYS . 0.3 OUTLIER -127.86 130.15 23.66 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.461 1.101 . . . . 0.0 109.97 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 -23.79 13.45 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.514 1.797 . . . . 0.0 111.035 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.55 -30.27 68.04 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.495 1.122 . . . . 0.0 110.351 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 341' ' ' PHE . 49.4 mt -73.36 -36.86 50.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.498 1.124 . . . . 0.0 109.317 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -71.53 -34.63 70.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.502 1.126 . . . . 0.0 109.291 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -74.05 -45.13 51.48 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.512 1.132 . . . . 0.0 110.273 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 94.5 mt -69.82 -35.55 65.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.517 1.136 . . . . 0.0 109.316 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.672 ' CE2' ' CZ ' ' A' ' 327' ' ' PHE . 1.6 t80 -69.14 -39.46 78.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.523 1.14 . . . . 0.0 110.996 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.46 -38.05 77.57 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.479 1.112 . . . . 0.0 110.336 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -43.52 78.29 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.516 1.135 . . . . 0.0 109.311 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.91 -40.78 83.36 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.517 1.136 . . . . 0.0 110.414 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -66.37 -38.02 86.62 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.511 1.132 . . . . 0.0 109.282 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 9.6 mt -68.59 -35.1 76.9 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.538 1.149 . . . . 0.0 109.344 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -69.69 -40.1 76.53 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.124 . . . . 0.0 110.286 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 13.9 mtt180 . . . . . 0 C--N 1.325 -0.498 0 O-C-N 124.506 1.129 . . . . 0.0 110.314 -179.966 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 43.0 t80 . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.514 0.197 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.78 -37.94 43.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.439 1.087 . . . . 0.0 109.271 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -31.1 70.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.144 . . . . 0.0 110.335 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . 0.493 ' O ' ' CG1' ' A' ' 230' ' ' VAL . 6.4 t-20 -80.3 -31.55 38.19 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.532 1.145 . . . . 0.0 109.286 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' TRP . . . . . 0.432 ' O ' ' CB ' ' A' ' 231' ' ' ALA . 2.0 t90 -68.68 -43.98 75.0 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.504 ' O ' ' CB ' ' A' ' 232' ' ' ALA . 4.1 pt20 -72.02 -33.82 68.34 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.454 1.096 . . . . 0.0 110.308 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 2.4 mt -64.94 -55.37 19.6 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 0.0 109.269 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.493 ' CG1' ' O ' ' A' ' 226' ' ' ASN . 5.7 p -65.09 -37.66 80.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.523 1.139 . . . . 0.0 109.34 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 227' ' ' TRP . . . -76.03 -15.1 60.19 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.478 1.111 . . . . 0.0 109.235 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.504 ' CB ' ' O ' ' A' ' 228' ' ' GLN . . . -80.71 -11.33 59.64 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.503 1.127 . . . . 0.0 109.307 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . 0.433 HG13 ' CD2' ' A' ' 236' ' ' PHE . 0.6 OUTLIER -89.02 132.61 37.46 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.547 1.155 . . . . 0.0 109.32 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -0.08 9.51 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.457 1.767 . . . . 0.0 111.028 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.25 -24.4 22.1 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 0.0 109.32 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . 0.559 ' CD1' HD11 ' A' ' 239' ' ' LEU . 21.2 m-30 -122.92 8.14 9.32 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.478 1.111 . . . . 0.0 110.987 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -73.16 -19.53 61.1 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.483 1.114 . . . . 0.0 110.286 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.428 ' NZ ' ' HA ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -97.57 4.99 50.14 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.527 1.142 . . . . 0.0 109.326 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.559 HD11 ' CD1' ' A' ' 236' ' ' PHE . 19.3 mt -80.28 -179.42 7.09 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.465 1.103 . . . . 0.0 109.316 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -103.23 -178.48 26.3 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.499 1.124 . . . . 0.0 110.991 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 -32.9 5.04 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.53 1.805 . . . . 0.0 110.98 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 0.416 ' O ' HG13 ' A' ' 245' ' ' VAL . . . -73.62 -32.81 64.26 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.445 1.09 . . . . 0.0 109.297 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.467 HG21 ' CD1' ' A' ' 337' ' ' ILE . 63.0 t -76.6 -38.39 31.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.126 . . . . 0.0 109.271 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.435 ' CD2' ' HB2' ' A' ' 239' ' ' LEU . 3.6 mm? -71.31 -45.47 62.96 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.488 1.118 . . . . 0.0 109.289 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 242' ' ' ALA . 3.3 p -64.65 -45.09 96.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.528 1.142 . . . . 0.0 109.317 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.402 ' N ' ' CG1' ' A' ' 245' ' ' VAL . 15.3 tp10 -65.0 -40.89 95.62 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.509 1.13 . . . . 0.0 110.262 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.403 ' CG1' HD11 ' A' ' 330' ' ' LEU . 26.5 mt -65.16 -43.83 95.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.493 1.121 . . . . 0.0 109.303 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.436 ' CG2' HG12 ' A' ' 230' ' ' VAL . 75.7 t -69.51 -30.99 47.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.504 1.128 . . . . 0.0 109.277 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -76.87 -19.6 57.27 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.55 1.156 . . . . 0.0 110.324 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.471 ' CB ' ' OD1' ' A' ' 326' ' ' ASP . . . -93.82 -14.84 25.71 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.539 1.149 . . . . 0.0 109.302 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.12 146.35 54.76 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.541 1.151 . . . . 0.0 109.293 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -117.82 117.96 30.73 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.555 1.159 . . . . 0.0 110.288 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -80.79 125.03 29.56 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.436 1.085 . . . . 0.0 109.289 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -132.56 143.89 50.02 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.491 1.119 . . . . 0.0 110.275 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 20.1 m -96.64 125.93 41.45 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 0.0 110.413 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.449 ' CG2' HD11 ' A' ' 319' ' ' LEU . 93.4 t -106.39 116.14 59.7 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.537 1.148 . . . . 0.0 109.345 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.9 162.12 37.86 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.513 1.796 . . . . 0.0 111.026 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.49 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -63.71 125.19 23.52 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.475 1.109 . . . . 0.0 109.317 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 100.7 -25.27 28.96 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.489 1.118 . . . . 0.0 110.988 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . 0.484 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -64.02 139.15 58.74 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.459 0.74 . . . . 0.0 109.295 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 2.7 p -93.25 135.64 27.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.466 1.104 . . . . 0.0 109.282 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 11.2 mt -82.49 -49.35 17.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.531 1.144 . . . . 0.0 109.284 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' CYS . . . . . 0.5 ' SG ' ' CG2' ' A' ' 311' ' ' VAL . 12.4 p -141.7 162.43 35.5 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.531 1.144 . . . . 0.0 108.255 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -103.93 -179.01 3.83 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.449 1.093 . . . . 0.0 110.28 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.32 137.41 22.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 0.0 109.299 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 47.01 48.91 18.87 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.504 1.128 . . . . 0.0 111.028 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . 0.416 ' OE1' ' C ' ' A' ' 268' ' ' PRO . 0.0 OUTLIER -71.26 162.6 71.71 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.455 0.738 . . . . 0.0 110.333 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 269' ' ' GLY . 18.5 Cg_endo -74.98 78.07 2.98 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.521 1.801 . . . . 0.0 111.041 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . 0.464 ' O ' ' CA ' ' A' ' 304' ' ' GLY . . . -35.23 102.73 0.01 OUTLIER Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.527 1.142 . . . . 0.0 110.973 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -170.33 38.31 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 0.765 . . . . 0.0 109.293 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.45 144.86 2.01 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.131 . . . . 0.0 110.293 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.97 146.56 37.62 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.511 1.132 . . . . 0.0 111.057 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.562 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 20.1 m-85 -137.55 136.78 37.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.486 1.117 . . . . 0.0 111.021 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . 0.484 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 21.4 m-85 -127.25 135.95 51.32 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.537 1.148 . . . . 0.0 111.005 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.405 ' HA ' ' HB3' ' A' ' 319' ' ' LEU . 25.4 t -93.57 138.65 19.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.46 1.1 . . . . 0.0 109.305 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . 0.48 ' CG2' HD12 ' A' ' 320' ' ' LEU . 2.7 t -115.99 -48.49 4.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.469 1.106 . . . . 0.0 109.274 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -140.2 132.99 29.07 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.528 1.143 . . . . 0.0 110.304 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.456 ' HA3' ' CG2' ' A' ' 317' ' ' VAL . . . 118.34 -173.35 14.83 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.531 1.144 . . . . 0.0 110.997 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' SER . . . . . 0.413 ' N ' HG23 ' A' ' 317' ' ' VAL . 8.4 t -134.73 122.29 21.95 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.52 0.776 . . . . 0.0 110.012 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.455 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 26.1 m -100.08 163.86 2.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.492 1.12 . . . . 0.0 109.302 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 31.1 t -129.24 152.51 48.74 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 0.0 109.993 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 1.5 t -115.96 128.87 73.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.467 1.105 . . . . 0.0 109.3 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.411 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -78.43 101.66 7.4 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.48 1.113 . . . . 0.0 109.319 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' THR . . . . . 0.664 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.9 OUTLIER -148.54 -167.96 0.17 Allowed Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.485 1.116 . . . . 0.0 110.366 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.664 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.5 Cg_endo -74.96 4.77 4.42 Favored 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.524 1.802 . . . . 0.0 111.057 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -152.0 155.25 33.45 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.477 1.11 . . . . 0.0 109.31 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 96.52 1.02 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.545 1.813 . . . . 0.0 111.032 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 2.1 t -101.52 119.54 49.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.536 1.148 . . . . 0.0 109.281 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -124.29 136.09 53.87 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.484 1.115 . . . . 0.0 110.321 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.455 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 3.8 mm? -115.44 141.77 47.6 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.483 1.115 . . . . 0.0 109.341 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -94.11 -160.21 34.51 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.505 1.128 . . . . 0.0 110.982 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 148.27 35.01 Favored 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.513 1.796 . . . . 0.0 111.009 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 86.46 -0.62 87.06 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.499 1.125 . . . . 0.0 110.984 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -83.49 123.43 29.71 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.478 0.752 . . . . 0.0 109.279 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . 0.467 ' CB ' ' CD1' ' A' ' 274' ' ' PHE . 3.8 p90 -114.82 152.92 31.33 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.482 1.114 . . . . 0.0 111.006 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . 0.562 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 37.5 p90 -160.57 147.99 15.91 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.518 1.136 . . . . 0.0 111.046 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 134.72 -8.35 4.56 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.548 1.155 . . . . 0.0 111.007 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -52.58 -41.9 64.02 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.458 0.74 . . . . 0.0 110.284 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' MET . . . . . 0.466 ' HB3' ' CG ' ' A' ' 305' ' ' GLU . 0.1 OUTLIER -54.92 -41.08 70.54 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.494 1.121 . . . . 0.0 111.006 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . 0.434 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -66.92 -35.7 80.6 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.509 1.131 . . . . 0.0 109.258 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.45 ' O ' ' CZ ' ' A' ' 341' ' ' PHE . 6.5 mt -75.01 -20.31 59.68 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.511 1.132 . . . . 0.0 109.261 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 3.3 mm -73.06 -54.97 14.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.129 . . . . 0.0 109.329 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.85 40.39 0.23 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.456 1.098 . . . . 0.0 110.015 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.464 ' CA ' ' O ' ' A' ' 269' ' ' GLY . . . 39.6 40.65 1.52 Allowed Glycine 0 CA--C 1.531 1.052 0 O-C-N 124.497 1.123 . . . . 0.0 110.989 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' GLU . . . . . 0.466 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 0.0 OUTLIER -66.11 158.65 75.67 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.509 0.77 . . . . 0.0 110.292 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . 0.403 ' O ' ' OE2' ' A' ' 305' ' ' GLU . 18.5 Cg_endo -74.95 130.69 13.56 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.528 1.804 . . . . 0.0 111.02 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.9 -40.89 14.95 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.516 1.135 . . . . 0.0 110.318 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 68.19 34.43 3.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.493 1.121 . . . . 0.0 110.044 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . 172.78 161.98 0.12 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.521 1.138 . . . . 0.0 109.282 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.71 130.99 54.89 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.538 1.149 . . . . 0.0 110.416 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.5 ' CG2' ' SG ' ' A' ' 263' ' ' CYS . 41.6 t -109.75 131.48 60.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.472 1.108 . . . . 0.0 109.343 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 3.2 p -139.2 152.33 47.28 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.11 . . . . 0.0 109.993 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.94 117.17 26.61 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.474 1.109 . . . . 0.0 109.297 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -59.62 -31.48 69.53 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.547 1.154 . . . . 0.0 109.317 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' THR . . . . . 0.49 ' HA ' ' CB ' ' A' ' 258' ' ' ALA . 8.1 t -154.59 -175.36 5.37 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.472 1.108 . . . . 0.0 110.405 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 65.1 p -49.73 92.81 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.514 1.134 . . . . 0.0 110.392 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.456 ' CG2' ' HA3' ' A' ' 278' ' ' GLY . 75.8 t -110.23 152.07 12.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.498 1.124 . . . . 0.0 109.31 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 70.3 m -123.96 117.42 24.73 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.548 1.155 . . . . 0.0 109.988 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . 0.484 ' CB ' ' O ' ' A' ' 274' ' ' PHE . 0.2 OUTLIER -134.06 169.38 17.22 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.481 1.113 . . . . 0.0 109.293 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.48 HD12 ' CG2' ' A' ' 276' ' ' VAL . 0.0 OUTLIER -124.35 139.05 54.27 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.473 1.108 . . . . 0.0 109.314 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 3.2 p -95.04 158.17 15.58 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.534 1.146 . . . . 0.0 110.002 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -151.0 77.69 1.28 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.471 1.107 . . . . 0.0 109.305 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -42.54 141.46 1.01 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.416 1.072 . . . . 0.0 109.577 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -24.82 63.57 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.447 1.092 . . . . 0.0 109.963 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -52.21 -35.87 50.53 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.521 1.138 . . . . 0.0 109.292 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . 0.471 ' OD1' ' CB ' ' A' ' 250' ' ' ALA . 0.4 OUTLIER -71.6 -37.33 70.97 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.542 1.151 . . . . 0.0 109.329 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' PHE . . . . . 0.417 ' CE2' ' CE2' ' A' ' 341' ' ' PHE . 38.4 t80 -66.51 -41.18 89.23 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.484 1.115 . . . . 0.0 111.031 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -71.29 -31.52 67.55 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.503 1.127 . . . . 0.0 110.297 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.403 ' SD ' ' C ' ' A' ' 329' ' ' MET . 15.6 tmm? -68.54 -43.74 76.03 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.548 1.155 . . . . 0.0 111.014 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.403 HD11 ' CG1' ' A' ' 247' ' ' ILE . 5.0 mt -71.39 -37.78 71.53 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.521 1.138 . . . . 0.0 109.265 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 73.6 m -65.88 -41.68 91.25 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.531 1.144 . . . . 0.0 108.29 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.4 t -77.55 -24.42 49.86 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.471 1.107 . . . . 0.0 110.01 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 47.6 t -72.21 -39.02 68.87 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.533 1.145 . . . . 0.0 110.034 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.03 133.83 25.64 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.482 1.114 . . . . 0.0 109.978 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 -23.75 13.53 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.54 1.81 . . . . 0.0 110.974 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -72.26 -29.32 63.79 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.5 1.125 . . . . 0.0 110.328 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.467 ' CD1' HG21 ' A' ' 243' ' ' VAL . 30.9 mt -72.98 -42.71 59.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.483 1.114 . . . . 0.0 109.281 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.74 -30.72 67.32 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.55 1.157 . . . . 0.0 109.297 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -73.61 -43.76 58.79 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.564 1.165 . . . . 0.0 110.36 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 76.1 mt -70.76 -39.42 75.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.513 1.133 . . . . 0.0 109.298 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.491 ' CD1' ' C ' ' A' ' 341' ' ' PHE . 0.5 OUTLIER -66.95 -41.46 86.91 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.488 1.118 . . . . 0.0 111.005 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 -70.48 -33.41 71.22 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.504 1.128 . . . . 0.0 110.303 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -50.54 66.53 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.504 1.127 . . . . 0.0 109.323 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 6.0 t -65.11 -39.12 92.68 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.541 1.151 . . . . 0.0 110.433 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -66.77 -33.78 76.37 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.471 1.107 . . . . 0.0 109.282 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 10.2 mt -71.83 -36.9 70.34 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.514 1.134 . . . . 0.0 109.314 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -76.26 -30.8 57.98 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.535 1.147 . . . . 0.0 110.3 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 7.0 mtt-85 . . . . . 0 C--N 1.325 -0.499 0 O-C-N 124.472 1.107 . . . . 0.0 110.335 179.964 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 46.4 t80 . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 120.515 0.198 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.411 HG11 ' N ' ' A' ' 225' ' ' ARG . 0.3 OUTLIER -72.65 -39.45 60.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.467 1.104 . . . . 0.0 109.321 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.411 ' N ' HG11 ' A' ' 224' ' ' VAL . 0.1 OUTLIER -69.21 -29.78 67.81 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.493 1.121 . . . . 0.0 110.322 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . 0.4 ' CG ' ' CG2' ' A' ' 248' ' ' VAL . 39.6 t-20 -78.12 -32.66 50.55 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.452 1.095 . . . . 0.0 109.299 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' TRP . . . . . 0.576 ' CZ3' HG23 ' A' ' 245' ' ' VAL . 2.8 t90 -73.99 -42.94 59.66 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.519 1.137 . . . . 0.0 108.026 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -70.38 -28.79 65.37 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.505 1.128 . . . . 0.0 110.314 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 3.3 mt -69.14 -54.96 12.21 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.515 1.134 . . . . 0.0 109.316 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.452 HG23 ' N ' ' A' ' 231' ' ' ALA . 33.0 m -65.02 -32.04 56.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.497 1.123 . . . . 0.0 109.323 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.452 ' N ' HG23 ' A' ' 230' ' ' VAL . . . -76.13 -24.63 54.91 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.111 . . . . 0.0 109.271 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -80.54 1.21 30.49 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.488 1.117 . . . . 0.0 109.289 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 96.7 t -92.07 118.75 68.34 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.518 1.136 . . . . 0.0 109.311 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 -21.96 15.3 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.536 1.808 . . . . 0.0 110.989 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.98 -30.56 71.63 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.496 1.123 . . . . 0.0 109.325 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . 0.568 ' CD1' HD13 ' A' ' 239' ' ' LEU . 24.4 m-85 -112.42 20.31 16.81 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.482 1.114 . . . . 0.0 110.985 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.12 -18.57 64.67 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.485 1.116 . . . . 0.0 110.316 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -86.99 -14.16 42.46 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.465 1.103 . . . . 0.0 109.322 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.568 HD13 ' CD1' ' A' ' 236' ' ' PHE . 55.6 mt -68.5 176.29 2.97 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.507 1.129 . . . . 0.0 109.277 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -109.63 -171.97 20.53 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.445 1.09 . . . . 0.0 110.974 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -32.39 5.43 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.463 1.77 . . . . 0.0 111.004 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 0.417 ' O ' HG12 ' A' ' 245' ' ' VAL . . . -72.9 -32.92 65.69 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.48 1.112 . . . . 0.0 109.309 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.475 HG21 ' CD1' ' A' ' 337' ' ' ILE . 54.5 t -76.82 -38.64 29.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.491 1.119 . . . . 0.0 109.295 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.426 ' N ' HD23 ' A' ' 244' ' ' LEU . 2.9 mm? -71.0 -44.41 65.95 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.521 1.138 . . . . 0.0 109.239 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.576 HG23 ' CZ3' ' A' ' 227' ' ' TRP . 3.0 p -66.27 -39.77 85.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.448 1.093 . . . . 0.0 109.271 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -69.87 -40.29 75.8 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.543 1.152 . . . . 0.0 110.319 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.486 ' O ' ' CD1' ' A' ' 251' ' ' LEU . 46.0 mt -65.63 -55.16 21.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.497 1.123 . . . . 0.0 109.271 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.438 HG13 ' N ' ' A' ' 249' ' ' ARG . 4.2 p -60.81 -30.63 47.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.54 1.15 . . . . 0.0 109.363 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.517 ' CG ' ' O ' ' A' ' 245' ' ' VAL . 14.3 mmt180 -79.21 -16.84 55.93 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.527 1.142 . . . . 0.0 110.287 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -95.56 -16.05 22.41 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.513 1.133 . . . . 0.0 109.286 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.486 ' CD1' ' O ' ' A' ' 247' ' ' ILE . 7.9 mp -65.28 151.76 45.4 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.563 1.164 . . . . 0.0 109.316 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 6.0 tpt85 -121.12 116.18 24.5 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.496 1.123 . . . . 0.0 110.283 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.43 ' CB ' HD21 ' A' ' 320' ' ' LEU . . . -80.59 122.73 27.42 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.493 1.12 . . . . 0.0 109.266 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.45 141.07 52.26 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.48 1.112 . . . . 0.0 110.297 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.2 m -91.51 118.24 30.41 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.494 1.121 . . . . 0.0 110.349 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.494 HG12 ' CB ' ' A' ' 313' ' ' ALA . 4.0 t -106.36 114.19 62.47 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.536 1.148 . . . . 0.0 109.329 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.505 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.93 171.64 17.9 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.493 1.786 . . . . 0.0 110.978 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.509 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -67.73 129.13 38.95 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.535 1.147 . . . . 0.0 109.316 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 96.07 -25.55 24.95 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.55 1.156 . . . . 0.0 110.994 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . 0.505 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -58.95 138.3 57.51 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.516 0.774 . . . . 0.0 109.262 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 9.3 t -83.34 126.65 40.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.496 1.123 . . . . 0.0 109.334 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.464 ' CD1' ' CG1' ' A' ' 280' ' ' VAL . 94.9 mt -82.92 -45.49 19.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.476 1.11 . . . . 0.0 109.307 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' CYS . . . . . 0.451 ' SG ' ' CG2' ' A' ' 311' ' ' VAL . 7.9 p -152.72 143.87 23.13 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.493 1.12 . . . . 0.0 108.321 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -86.81 176.67 7.6 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.513 1.133 . . . . 0.0 110.281 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.474 HG23 ' CB ' ' A' ' 310' ' ' THR . 0.1 OUTLIER -78.25 148.56 6.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.492 1.12 . . . . 0.0 109.286 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 37.08 47.44 1.36 Allowed Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.469 1.106 . . . . 0.0 110.981 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . 0.444 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.0 OUTLIER -70.25 165.21 46.19 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.516 0.774 . . . . 0.0 110.3 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . 0.444 ' HD2' ' HB2' ' A' ' 267' ' ' GLU . 18.2 Cg_endo -75.06 76.39 3.44 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.525 1.803 . . . . 0.0 110.983 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . 0.473 ' CA ' ' HB2' ' A' ' 300' ' ' ALA . . . -36.71 105.95 0.04 OUTLIER Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.576 1.173 . . . . 0.0 110.994 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -170.51 37.37 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.481 0.754 . . . . 0.0 109.29 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -172.31 156.83 3.94 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.476 1.11 . . . . 0.0 110.301 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.452 ' O ' ' N ' ' A' ' 322' ' ' LEU . 0.0 OUTLIER -122.6 146.47 47.41 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.467 1.105 . . . . 0.0 111.022 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.591 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 13.6 m-85 -133.21 143.37 49.11 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.471 1.107 . . . . 0.0 111.033 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -133.15 125.2 28.95 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.515 1.134 . . . . 0.0 110.987 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 56.4 t -78.22 129.32 37.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.431 1.082 . . . . 0.0 109.319 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . 0.461 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 59.3 t -101.55 -54.05 7.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.506 1.129 . . . . 0.0 109.323 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -141.83 140.71 33.02 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.542 1.151 . . . . 0.0 110.274 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 113.15 -155.87 16.01 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.526 1.142 . . . . 0.0 111.01 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 1.8 m -145.96 139.36 26.13 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.487 0.757 . . . . 0.0 110.001 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.464 ' CG1' ' CD1' ' A' ' 262' ' ' ILE . 27.1 m -120.76 135.57 60.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.555 1.159 . . . . 0.0 109.266 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 29.9 t -104.27 139.77 38.81 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.429 1.08 . . . . 0.0 109.968 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 1.3 t -103.88 129.66 55.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.471 1.107 . . . . 0.0 109.322 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.413 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -78.05 101.36 6.92 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.543 1.152 . . . . 0.0 109.358 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' THR . . . . . 0.662 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -149.0 -168.0 0.17 Allowed Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.5 1.125 . . . . 0.0 110.427 -179.974 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.662 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -75.01 4.43 4.75 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.502 1.79 . . . . 0.0 111.007 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -152.27 154.59 32.37 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.529 1.143 . . . . 0.0 109.309 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 95.12 0.96 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.46 1.769 . . . . 0.0 110.983 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 19.3 t -100.15 118.39 46.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.56 1.163 . . . . 0.0 109.331 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -125.38 133.74 52.42 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.489 1.118 . . . . 0.0 110.324 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -114.51 139.71 49.34 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.52 1.138 . . . . 0.0 109.289 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -93.72 -157.43 33.17 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.564 1.165 . . . . 0.0 111.007 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 147.86 34.49 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.509 1.794 . . . . 0.0 111.005 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 85.95 5.85 83.02 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.532 1.145 . . . . 0.0 111.034 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -85.61 146.27 26.95 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.539 0.788 . . . . 0.0 109.332 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 295' ' ' PHE . 1.0 OUTLIER -132.95 152.81 51.87 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.549 1.156 . . . . 0.0 110.99 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . 0.591 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 46.3 p90 -165.77 143.88 5.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.553 1.158 . . . . 0.0 110.958 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 129.59 -6.73 6.22 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.48 1.113 . . . . 0.0 110.994 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -52.09 -48.43 64.71 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.503 0.767 . . . . 0.0 110.275 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' MET . . . . . 0.443 ' HB3' ' CG ' ' A' ' 305' ' ' GLU . 0.0 OUTLIER -50.21 -37.45 35.28 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.502 1.126 . . . . 0.0 111.047 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . 0.473 ' HB2' ' CA ' ' A' ' 269' ' ' GLY . . . -66.13 -40.34 90.58 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.466 1.104 . . . . 0.0 109.298 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 27.7 mt -74.84 -21.64 59.15 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 0.0 109.306 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 15.0 mm -67.16 -57.64 9.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.458 1.099 . . . . 0.0 109.303 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 304' ' ' GLY . 7.4 m -155.96 44.85 0.44 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.532 1.145 . . . . 0.0 109.98 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 35.69 49.9 1.04 Allowed Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.531 1.144 . . . . 0.0 111.041 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' GLU . . . . . 0.443 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 0.0 OUTLIER -80.26 158.8 71.45 Favored Pre-proline 0 C--N 1.326 -0.443 0 O-C-N 124.497 0.763 . . . . 0.0 110.271 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.01 130.25 13.09 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.525 1.802 . . . . 0.0 111.032 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -47.07 -39.34 12.82 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.5 1.125 . . . . 0.0 110.275 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 15.0 m 67.77 30.34 6.4 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.478 1.111 . . . . 0.0 109.995 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . 175.67 162.26 0.3 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.532 1.145 . . . . 0.0 109.299 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.474 ' CB ' HG23 ' A' ' 265' ' ' ILE . 0.9 OUTLIER -113.04 137.6 51.17 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.515 1.135 . . . . 0.0 110.398 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.451 ' CG2' ' SG ' ' A' ' 263' ' ' CYS . 95.1 t -109.43 127.62 66.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.504 1.128 . . . . 0.0 109.318 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 48.3 p -121.94 145.28 48.26 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.501 1.126 . . . . 0.0 110.026 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . 0.494 ' CB ' HG12 ' A' ' 256' ' ' VAL . . . -79.53 106.23 11.41 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.536 1.148 . . . . 0.0 109.28 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -52.99 -24.64 9.89 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.473 1.108 . . . . 0.0 109.325 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' THR . . . . . 0.509 ' HA ' ' CB ' ' A' ' 258' ' ' ALA . 8.8 t -168.09 -164.64 0.55 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.495 1.122 . . . . 0.0 110.38 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' THR . . . . . 0.438 ' N ' ' OG1' ' A' ' 315' ' ' THR . 29.2 p -61.35 79.11 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.508 1.13 . . . . 0.0 110.443 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.471 ' CG1' ' HB2' ' A' ' 313' ' ' ALA . 2.7 p -110.74 141.88 24.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.5 1.125 . . . . 0.0 109.277 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' SER . . . . . 0.51 ' C ' ' CD1' ' A' ' 319' ' ' LEU . 53.4 m -117.57 136.51 53.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.454 1.096 . . . . 0.0 109.949 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . 0.51 ' CD1' ' C ' ' A' ' 318' ' ' SER . 0.0 OUTLIER -135.86 173.77 11.35 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.479 1.112 . . . . 0.0 109.309 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.461 ' CD1' ' CG2' ' A' ' 276' ' ' VAL . 0.1 OUTLIER -124.22 125.19 44.0 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.528 1.143 . . . . 0.0 109.292 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 25.8 p -86.97 158.67 19.22 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.518 1.136 . . . . 0.0 110.036 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.511 ' CD1' ' O ' ' A' ' 322' ' ' LEU . 3.1 tm? -145.44 86.71 1.76 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.491 1.119 . . . . 0.0 109.311 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . 0.536 ' CE1' ' OD1' ' A' ' 326' ' ' ASP . 6.0 p80 -50.7 137.31 20.26 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.535 1.147 . . . . 0.0 109.605 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.19 -26.11 62.39 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.473 1.108 . . . . 0.0 110.004 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -53.6 -36.76 62.31 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.459 1.1 . . . . 0.0 109.311 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . 0.536 ' OD1' ' CE1' ' A' ' 323' ' ' HIS . 0.6 OUTLIER -64.99 -41.45 95.4 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.485 1.116 . . . . 0.0 109.317 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' PHE . . . . . 0.49 ' CE1' ' CE2' ' A' ' 341' ' ' PHE . 71.9 t80 -66.84 -34.96 78.95 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.439 1.087 . . . . 0.0 110.965 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -69.86 -33.99 73.0 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.482 1.113 . . . . 0.0 110.288 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 30.4 ttp -70.19 -43.88 69.84 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.441 1.088 . . . . 0.0 111.014 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.407 HD11 ' CG1' ' A' ' 247' ' ' ILE . 2.7 mt -71.66 -35.38 70.31 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.505 1.128 . . . . 0.0 109.286 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 41.6 m -72.31 -30.63 64.95 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.52 1.137 . . . . 0.0 108.278 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 33.0 t -75.78 -34.49 60.23 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.518 1.136 . . . . 0.0 110.021 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.48 -36.3 65.79 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.528 1.142 . . . . 0.0 109.97 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.5 114.32 27.25 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 0.0 109.975 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -22.51 14.81 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.448 1.762 . . . . 0.0 111.007 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -71.91 -29.34 64.21 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.562 1.164 . . . . 0.0 110.286 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.475 ' CD1' HG21 ' A' ' 243' ' ' VAL . 44.5 mt -71.95 -40.14 67.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.134 . . . . 0.0 109.26 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.55 -31.84 65.59 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 0.0 109.278 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -74.95 -42.15 58.2 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.562 1.164 . . . . 0.0 110.288 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 86.3 mt -70.96 -42.81 77.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.486 1.116 . . . . 0.0 109.287 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.49 ' CE2' ' CE1' ' A' ' 327' ' ' PHE . 24.8 t80 -67.46 -39.61 85.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.521 1.138 . . . . 0.0 111.039 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -68.12 -37.32 80.99 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.526 1.141 . . . . 0.0 110.303 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -44.09 84.16 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.52 1.137 . . . . 0.0 109.281 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.99 -32.62 73.15 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.465 1.103 . . . . 0.0 110.377 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -69.91 -41.15 75.07 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.45 1.094 . . . . 0.0 109.333 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 14.5 mt -65.2 -41.42 94.55 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 0.0 109.283 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -65.81 -37.64 86.81 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.112 . . . . 0.0 110.3 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 28.3 mtt-85 . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.512 1.133 . . . . 0.0 110.325 -179.999 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 1.6 t80 . . . . . 0 N--CA 1.452 -0.332 0 CA-C-O 120.541 0.21 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.57 -35.44 56.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.466 1.104 . . . . 0.0 109.276 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.72 -31.56 68.44 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.478 1.111 . . . . 0.0 110.311 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . 0.455 ' ND2' ' CD1' ' A' ' 320' ' ' LEU . 4.1 m-20 -81.23 -31.57 33.77 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.532 1.145 . . . . 0.0 109.276 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' TRP . . . . . 0.606 ' CZ2' ' CG2' ' A' ' 245' ' ' VAL . 2.0 t90 -70.61 -43.75 68.67 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.455 ' O ' ' N ' ' A' ' 232' ' ' ALA . 1.5 pt20 -70.89 -37.28 73.0 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.494 1.121 . . . . 0.0 110.278 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.45 ' CD1' ' HB3' ' A' ' 274' ' ' PHE . 1.6 mm? -60.18 -42.75 95.69 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.51 1.131 . . . . 0.0 109.314 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.483 HG11 ' CD1' ' A' ' 244' ' ' LEU . 12.7 p -74.23 -38.74 48.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.515 1.135 . . . . 0.0 109.284 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.445 ' N ' HG11 ' A' ' 230' ' ' VAL . . . -75.15 -11.51 60.1 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.472 1.107 . . . . 0.0 109.33 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 228' ' ' GLN . . . -81.15 -7.83 59.64 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.496 1.123 . . . . 0.0 109.297 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 1.5 t -98.64 130.06 28.74 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.522 1.139 . . . . 0.0 109.298 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 -16.0 20.33 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.472 1.775 . . . . 0.0 110.971 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.579 HD12 ' CE2' ' A' ' 341' ' ' PHE . 0.0 OUTLIER -81.08 -23.84 38.18 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.519 1.137 . . . . 0.0 109.314 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . 0.529 ' CD1' HD12 ' A' ' 247' ' ' ILE . 30.7 m-85 -102.95 -19.22 14.69 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.454 1.096 . . . . 0.0 111.018 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.51 -22.91 67.1 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.463 1.102 . . . . 0.0 110.28 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -76.77 -1.59 28.85 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.502 1.126 . . . . 0.0 109.294 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.464 ' HB3' ' CG1' ' A' ' 243' ' ' VAL . 8.4 mt -94.38 -179.78 5.03 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.437 1.086 . . . . 0.0 109.278 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -98.45 -174.42 32.61 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.518 1.136 . . . . 0.0 110.969 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.51 ' O ' ' CG2' ' A' ' 245' ' ' VAL . 18.4 Cg_endo -75.01 -35.48 3.1 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.451 1.764 . . . . 0.0 110.97 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.1 -33.37 75.32 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.461 1.101 . . . . 0.0 109.299 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.464 ' CG1' ' HB3' ' A' ' 239' ' ' LEU . 2.7 t -75.18 -42.4 44.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.535 1.147 . . . . 0.0 109.327 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.483 ' CD1' HG11 ' A' ' 230' ' ' VAL . 0.3 OUTLIER -65.63 -36.82 84.8 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.524 1.14 . . . . 0.0 109.289 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.606 ' CG2' ' CZ2' ' A' ' 227' ' ' TRP . 87.8 t -69.15 -43.18 81.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.449 1.093 . . . . 0.0 109.278 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -44.17 91.68 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 0.0 110.312 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.529 HD12 ' CD1' ' A' ' 236' ' ' PHE . 90.0 mt -65.6 -37.16 79.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.495 1.122 . . . . 0.0 109.3 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.461 ' CG2' ' HA ' ' A' ' 227' ' ' TRP . 14.4 t -67.54 -34.97 71.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.506 1.128 . . . . 0.0 109.31 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -24.84 59.92 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.49 1.118 . . . . 0.0 110.274 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.472 ' CB ' ' OD1' ' A' ' 326' ' ' ASP . . . -87.22 -21.59 25.75 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.477 1.111 . . . . 0.0 109.291 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 3.0 mt -55.9 136.48 51.56 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.484 1.115 . . . . 0.0 109.283 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.42 134.76 55.06 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.494 1.121 . . . . 0.0 110.265 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -80.15 129.6 34.62 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.525 1.141 . . . . 0.0 109.323 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 319' ' ' LEU . 6.7 ttm-85 -133.62 121.28 21.8 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.513 1.133 . . . . 0.0 110.333 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 20.0 m -91.79 116.57 29.0 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.532 1.145 . . . . 0.0 110.436 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.446 ' CG2' HD12 ' A' ' 319' ' ' LEU . 97.3 t -106.68 113.14 63.22 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.473 1.108 . . . . 0.0 109.263 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.51 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -75.0 171.45 18.31 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.5 1.789 . . . . 0.0 111.04 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.498 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -67.33 128.58 36.93 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.465 1.103 . . . . 0.0 109.325 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 96.85 -25.11 28.11 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.489 1.118 . . . . 0.0 110.992 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . 0.51 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -60.64 149.14 36.04 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.532 0.784 . . . . 0.0 109.306 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.3 t -97.28 131.61 43.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 124.494 1.121 . . . . 0.0 109.331 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 45.8 mt -83.41 -41.65 17.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.468 1.105 . . . . 0.0 109.309 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 14.9 p -158.34 151.09 22.35 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.452 1.095 . . . . 0.0 108.273 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -94.32 -178.81 4.71 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.472 1.108 . . . . 0.0 110.305 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.538 ' N ' ' HG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -74.64 143.99 12.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.101 . . . . 0.0 109.321 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 41.47 53.95 4.13 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.537 1.148 . . . . 0.0 110.987 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . 0.409 ' OE1' ' C ' ' A' ' 268' ' ' PRO . 0.3 OUTLIER -70.61 163.5 63.13 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.498 0.764 . . . . 0.0 110.295 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . 0.452 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.1 Cg_endo -75.01 81.43 2.22 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.476 1.777 . . . . 0.0 110.965 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -36.65 95.76 0.01 OUTLIER Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.559 1.162 . . . . 0.0 111.037 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 268' ' ' PRO . 6.8 m-20 -170.83 38.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.519 0.776 . . . . 0.0 109.305 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . 0.434 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 0.0 OUTLIER -170.01 144.62 2.74 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.508 1.13 . . . . 0.0 110.233 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.593 ' SD ' ' CZ ' ' A' ' 274' ' ' PHE . 0.0 OUTLIER -114.4 147.38 39.29 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.126 . . . . 0.0 111.003 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.552 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 50.3 m-85 -135.91 137.64 41.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.452 1.095 . . . . 0.0 111.026 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . 0.593 ' CZ ' ' SD ' ' A' ' 272' ' ' MET . 17.8 m-85 -129.11 130.29 46.27 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.548 1.155 . . . . 0.0 111.014 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.425 ' HA ' ' HB3' ' A' ' 319' ' ' LEU . 29.1 t -86.28 130.48 36.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.488 1.117 . . . . 0.0 109.33 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.87 -44.39 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.479 1.112 . . . . 0.0 109.274 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -145.85 132.79 20.2 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 0.0 110.299 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.454 ' HA3' ' CG2' ' A' ' 317' ' ' VAL . . . 117.06 -177.68 16.79 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.545 1.153 . . . . 0.0 111.003 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' SER . . . . . 0.424 ' N ' HG22 ' A' ' 317' ' ' VAL . 5.4 t -128.94 121.79 28.81 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.497 0.763 . . . . 0.0 110.014 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.465 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 24.1 m -99.87 161.18 3.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.474 1.109 . . . . 0.0 109.286 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 29.4 t -129.41 149.6 51.12 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.537 1.148 . . . . 0.0 110.006 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 1.4 t -112.45 131.44 63.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.493 1.121 . . . . 0.0 109.331 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.403 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -79.85 101.92 8.81 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.46 1.1 . . . . 0.0 109.268 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' THR . . . . . 0.654 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.41 -168.32 0.18 Allowed Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.508 1.13 . . . . 0.0 110.396 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.654 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.4 Cg_endo -75.0 4.8 4.42 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.491 1.785 . . . . 0.0 111.038 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -151.59 155.69 34.27 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.481 1.113 . . . . 0.0 109.286 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.07 95.85 1.0 Allowed 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.517 1.798 . . . . 0.0 111.029 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 6.0 t -100.42 119.3 48.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.455 1.097 . . . . 0.0 109.33 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -124.9 141.68 51.96 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.493 1.121 . . . . 0.0 110.332 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.465 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 4.4 mm? -120.69 142.5 49.43 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.546 1.154 . . . . 0.0 109.276 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -93.79 -163.43 36.34 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.529 1.143 . . . . 0.0 111.023 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.94 149.63 37.28 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.502 1.791 . . . . 0.0 110.995 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 86.95 -0.07 85.99 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.481 1.113 . . . . 0.0 110.974 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -79.65 146.21 32.6 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.488 0.757 . . . . 0.0 109.362 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -132.84 152.69 51.78 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.516 1.135 . . . . 0.0 111.012 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . 0.552 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 40.7 p90 -166.57 147.65 6.23 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.496 1.123 . . . . 0.0 110.959 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . 0.474 ' CA ' ' HE1' ' A' ' 272' ' ' MET . . . 129.8 -10.38 6.03 Favored Glycine 0 CA--C 1.531 1.053 0 O-C-N 124.544 1.153 . . . . 0.0 110.995 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -52.57 -41.78 63.89 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.532 0.784 . . . . 0.0 110.316 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -54.83 -37.28 65.97 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.503 1.127 . . . . 0.0 111.015 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -67.72 -39.21 84.31 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.496 1.123 . . . . 0.0 109.284 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.466 ' CD1' ' HG3' ' A' ' 272' ' ' MET . 5.7 mt -76.44 -13.67 60.1 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.503 1.127 . . . . 0.0 109.265 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 32.2 mt -77.3 -54.5 12.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.514 1.134 . . . . 0.0 109.295 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.441 ' O ' ' N ' ' A' ' 305' ' ' GLU . 46.4 p -155.07 42.05 0.45 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.506 1.129 . . . . 0.0 109.986 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 37.07 31.56 0.06 OUTLIER Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.501 1.126 . . . . 0.0 110.998 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 303' ' ' SER . 0.1 OUTLIER -61.71 157.12 50.8 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.52 0.777 . . . . 0.0 110.322 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 128.99 11.91 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.51 1.795 . . . . 0.0 111.044 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.52 -40.29 5.53 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.506 1.129 . . . . 0.0 110.294 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 309' ' ' ALA . 22.8 t 64.87 43.31 4.0 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.486 1.117 . . . . 0.0 110.02 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' ALA . . . . . 0.466 ' CB ' ' O ' ' A' ' 308' ' ' SER . . . 165.86 159.76 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.48 1.113 . . . . 0.0 109.291 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.538 ' HG1' ' N ' ' A' ' 265' ' ' ILE . 1.0 OUTLIER -110.38 133.92 52.8 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.465 1.103 . . . . 0.0 110.416 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 55.3 t -113.06 129.39 68.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.525 1.14 . . . . 0.0 109.294 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 60.3 p -129.59 156.71 43.76 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.542 1.151 . . . . 0.0 110.02 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -92.53 115.57 28.22 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.515 1.135 . . . . 0.0 109.312 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -59.5 -32.65 70.48 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.481 1.113 . . . . 0.0 109.287 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' THR . . . . . 0.498 ' HA ' ' CB ' ' A' ' 258' ' ' ALA . 11.0 t -154.6 -173.14 4.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.506 1.129 . . . . 0.0 110.385 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 65.4 p -52.2 88.54 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.503 1.127 . . . . 0.0 110.391 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.466 ' N ' ' O ' ' A' ' 315' ' ' THR . 68.9 t -103.57 154.35 5.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 O-C-N 124.539 1.149 . . . . 0.0 109.308 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 49.1 m -129.07 113.89 15.69 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.482 1.114 . . . . 0.0 109.998 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . 0.495 ' C ' ' CD2' ' A' ' 320' ' ' LEU . 0.2 OUTLIER -129.0 170.44 13.46 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.136 . . . . 0.0 109.266 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.495 ' CD2' ' C ' ' A' ' 319' ' ' LEU . 0.6 OUTLIER -121.79 139.87 53.06 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.518 1.136 . . . . 0.0 109.327 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 64.8 p -95.6 158.79 15.3 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.122 . . . . 0.0 109.982 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -148.64 82.36 1.46 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.496 1.122 . . . . 0.0 109.312 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . 0.434 ' HA ' ' CG ' ' A' ' 271' ' ' ARG . 8.5 p80 -47.63 136.99 9.7 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.504 1.127 . . . . 0.0 109.599 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.95 -20.93 6.89 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.504 1.128 . . . . 0.0 109.981 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -51.9 -38.24 55.48 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.522 1.139 . . . . 0.0 109.291 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . 0.472 ' OD1' ' CB ' ' A' ' 250' ' ' ALA . 36.0 t70 -63.94 -37.08 86.09 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.541 1.151 . . . . 0.0 109.257 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' PHE . . . . . 0.472 ' CZ ' ' CE2' ' A' ' 341' ' ' PHE . 6.1 t80 -66.96 -40.02 87.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.48 1.112 . . . . 0.0 110.96 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -66.0 -33.24 75.35 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.527 1.142 . . . . 0.0 110.301 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.404 ' HE3' ' CD2' ' A' ' 330' ' ' LEU . 50.9 ttp -70.91 -39.33 72.79 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.549 1.155 . . . . 0.0 111.004 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.506 HD23 ' N ' ' A' ' 330' ' ' LEU . 0.1 OUTLIER -68.7 -39.23 80.58 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.487 1.117 . . . . 0.0 109.293 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 19.8 t -70.97 -32.97 69.99 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.45 1.093 . . . . 0.0 108.268 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 19.1 t -72.87 -31.08 64.47 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.482 1.114 . . . . 0.0 110.039 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.9 t -83.3 -37.86 22.88 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.447 1.092 . . . . 0.0 110.022 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.12 107.94 17.94 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.539 1.149 . . . . 0.0 110.009 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -21.01 16.33 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.466 1.772 . . . . 0.0 110.978 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -72.58 -28.52 62.85 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.519 1.137 . . . . 0.0 110.319 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 46.2 mt -65.46 -32.88 60.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 0.0 109.308 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.74 -35.06 72.5 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.536 1.147 . . . . 0.0 109.31 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -71.42 -34.79 70.63 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.518 1.136 . . . . 0.0 110.338 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 66.1 mt -73.06 -42.53 59.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.124 . . . . 0.0 109.303 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.579 ' CE2' HD12 ' A' ' 235' ' ' LEU . 1.0 OUTLIER -70.98 -31.2 67.68 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 0.0 111.02 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . 0.431 ' HG3' ' CD1' ' A' ' 346' ' ' LEU . 0.0 OUTLIER -73.24 -41.07 64.13 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.48 1.113 . . . . 0.0 110.282 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.13 -50.51 65.73 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.423 1.077 . . . . 0.0 109.305 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' THR . . . . . 0.403 ' CG2' ' HA ' ' A' ' 341' ' ' PHE . 7.4 t -64.97 -37.68 88.45 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.514 1.134 . . . . 0.0 110.429 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 341' ' ' PHE . . . -65.15 -43.32 92.24 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.504 1.127 . . . . 0.0 109.335 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.431 ' CD1' ' HG3' ' A' ' 342' ' ' ARG . 0.4 OUTLIER -64.9 -35.12 80.13 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 0.0 109.256 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -69.42 -37.77 77.58 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.543 1.152 . . . . 0.0 110.33 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 . . . . . 0 C--N 1.326 -0.442 0 O-C-N 124.464 1.102 . . . . 0.0 110.309 179.967 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 35.3 t80 . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 120.503 0.192 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.74 -35.15 59.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.486 1.117 . . . . 0.0 109.283 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -36.61 81.2 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.509 1.131 . . . . 0.0 110.323 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . 0.439 ' HB3' ' CD1' ' A' ' 251' ' ' LEU . 1.6 m-20 -75.1 -30.19 60.83 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.478 1.111 . . . . 0.0 109.288 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' TRP . . . . . 0.455 ' HA ' ' CG2' ' A' ' 248' ' ' VAL . 1.6 t90 -67.63 -49.51 62.64 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.405 ' O ' ' N ' ' A' ' 232' ' ' ALA . 6.0 pt20 -67.22 -30.94 70.99 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.54 1.15 . . . . 0.0 110.312 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.54 -47.14 79.93 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.508 1.13 . . . . 0.0 109.3 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.477 ' CG2' ' CD1' ' A' ' 244' ' ' LEU . 34.9 m -70.11 -37.63 72.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.501 1.125 . . . . 0.0 109.304 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.469 ' N ' HG21 ' A' ' 230' ' ' VAL . . . -75.83 -14.97 60.3 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.479 1.112 . . . . 0.0 109.308 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 228' ' ' GLN . . . -82.27 -25.15 34.3 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.567 1.167 . . . . 0.0 109.337 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . 0.539 HG13 ' CD2' ' A' ' 236' ' ' PHE . 0.3 OUTLIER -86.94 133.51 39.11 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.483 1.114 . . . . 0.0 109.311 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 -4.35 15.27 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.498 1.789 . . . . 0.0 111.012 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.98 -24.07 33.08 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.492 1.12 . . . . 0.0 109.32 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . 0.539 ' CD2' HG13 ' A' ' 233' ' ' VAL . 17.4 m-30 -119.73 -1.26 10.59 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.467 1.105 . . . . 0.0 110.986 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -71.69 -23.39 61.65 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.513 1.133 . . . . 0.0 110.309 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.442 ' NZ ' ' HA ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -92.55 7.59 42.58 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.482 1.114 . . . . 0.0 109.316 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.484 HD11 ' CG1' ' A' ' 243' ' ' VAL . 86.4 mt -89.26 179.76 6.04 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.48 1.113 . . . . 0.0 109.265 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -98.21 -176.94 33.18 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.506 1.129 . . . . 0.0 111.036 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.504 ' O ' ' CG2' ' A' ' 245' ' ' VAL . 18.3 Cg_endo -75.0 -37.33 2.07 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.5 1.789 . . . . 0.0 110.985 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.84 -34.68 77.19 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.464 1.102 . . . . 0.0 109.3 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.484 ' CG1' HD11 ' A' ' 239' ' ' LEU . 14.1 t -75.4 -38.02 39.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.514 1.134 . . . . 0.0 109.317 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.477 ' CD1' ' CG2' ' A' ' 230' ' ' VAL . 1.4 mm? -66.79 -35.84 81.0 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.514 1.133 . . . . 0.0 109.305 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.504 ' CG2' ' O ' ' A' ' 241' ' ' PRO . 60.9 t -74.39 -38.88 47.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.485 1.116 . . . . 0.0 109.296 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -65.25 -48.39 73.43 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.519 1.137 . . . . 0.0 110.268 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 32.1 mt -63.15 -43.27 98.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.524 1.14 . . . . 0.0 109.316 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.455 ' CG2' ' HA ' ' A' ' 227' ' ' TRP . 41.2 t -65.29 -38.21 82.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.459 1.1 . . . . 0.0 109.269 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -72.49 -19.25 61.58 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.422 1.076 . . . . 0.0 110.292 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -91.82 -16.3 26.96 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.521 1.138 . . . . 0.0 109.303 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.439 ' CD1' ' HB3' ' A' ' 226' ' ' ASN . 2.2 mt -66.84 129.27 39.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.495 1.122 . . . . 0.0 109.313 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 3.2 tpt85 -110.15 118.08 35.41 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.492 1.12 . . . . 0.0 110.308 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.465 ' CB ' HD21 ' A' ' 320' ' ' LEU . . . -80.15 136.77 36.58 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.458 1.099 . . . . 0.0 109.311 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.06 139.67 30.6 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.547 1.155 . . . . 0.0 110.339 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.0 m -92.4 117.92 30.41 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.561 1.163 . . . . 0.0 110.373 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.481 HG22 ' CD2' ' A' ' 319' ' ' LEU . 37.1 t -107.33 112.77 62.57 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.499 1.124 . . . . 0.0 109.285 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.457 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.3 Cg_endo -74.99 173.33 14.7 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.485 1.782 . . . . 0.0 111.006 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.474 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -67.37 130.38 42.89 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.543 1.152 . . . . 0.0 109.301 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 95.48 -25.28 25.37 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.519 1.137 . . . . 0.0 111.01 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . 0.457 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -56.43 140.59 45.27 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.496 0.762 . . . . 0.0 109.326 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.7 t -92.28 127.17 44.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.491 1.119 . . . . 0.0 109.34 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 40.8 mt -85.03 -41.91 16.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.477 1.111 . . . . 0.0 109.325 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 11.9 p -155.81 148.87 24.43 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.536 1.147 . . . . 0.0 108.296 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 2.0 mmt85 -92.35 178.57 5.8 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.491 1.119 . . . . 0.0 110.329 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.523 ' N ' ' HG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -76.42 141.59 15.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.495 1.122 . . . . 0.0 109.304 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 46.23 46.83 16.08 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.52 1.138 . . . . 0.0 111.006 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . 0.452 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.0 OUTLIER -70.19 164.91 48.8 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 124.451 0.736 . . . . 0.0 110.299 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 267' ' ' GLU . 18.4 Cg_endo -75.0 77.04 3.22 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.502 1.791 . . . . 0.0 111.03 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . 0.473 ' CA ' ' HB1' ' A' ' 300' ' ' ALA . . . -35.84 100.21 0.01 OUTLIER Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.452 1.095 . . . . 0.0 111.016 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -169.76 38.09 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.545 0.791 . . . . 0.0 109.315 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -171.33 147.14 2.42 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.129 . . . . 0.0 110.281 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.468 ' SD ' ' CD1' ' A' ' 301' ' ' LEU . 2.0 ttt -116.67 150.45 38.13 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.479 1.112 . . . . 0.0 111.003 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.577 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 14.8 m-85 -135.43 136.9 41.73 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.453 1.095 . . . . 0.0 110.973 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . 0.47 ' CD1' ' CB ' ' A' ' 295' ' ' PHE . 22.8 m-30 -125.66 124.38 41.02 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.494 1.121 . . . . 0.0 110.959 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 85.2 t -80.03 135.81 24.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.515 1.134 . . . . 0.0 109.255 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . 0.465 ' CG2' HD11 ' A' ' 320' ' ' LEU . 99.1 t -108.73 -56.01 4.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.461 1.101 . . . . 0.0 109.27 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -139.98 138.88 35.88 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.456 1.097 . . . . 0.0 110.314 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.01 -154.72 16.59 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.452 1.095 . . . . 0.0 111.03 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 3.7 m -150.76 135.92 17.67 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.511 0.771 . . . . 0.0 110.029 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.409 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 13.6 m -115.16 166.06 9.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.5 1.125 . . . . 0.0 109.321 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 28.8 t -131.33 149.44 52.55 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.457 1.098 . . . . 0.0 110.007 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.51 131.17 66.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.533 1.145 . . . . 0.0 109.304 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.4 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -79.7 101.87 8.65 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.52 1.137 . . . . 0.0 109.31 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' THR . . . . . 0.648 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.7 OUTLIER -148.27 -168.5 0.19 Allowed Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.458 1.099 . . . . 0.0 110.423 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.648 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.4 Cg_endo -74.95 4.89 4.31 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.533 1.807 . . . . 0.0 111.063 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -151.58 156.65 34.72 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.459 1.1 . . . . 0.0 109.293 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.91 95.37 0.97 Allowed 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.466 1.772 . . . . 0.0 111.032 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 24.1 t -99.53 118.9 46.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.105 . . . . 0.0 109.346 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -124.76 138.16 54.29 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.511 1.132 . . . . 0.0 110.321 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.417 HD21 ' N ' ' A' ' 290' ' ' LEU . 4.3 mm? -119.84 142.19 48.87 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.51 1.131 . . . . 0.0 109.275 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -96.28 -153.25 29.65 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.53 1.144 . . . . 0.0 110.981 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 151.88 39.98 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.491 1.785 . . . . 0.0 111.021 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 76.99 6.35 85.82 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.52 1.138 . . . . 0.0 110.956 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -87.4 113.72 23.36 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.528 0.781 . . . . 0.0 109.279 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . 0.47 ' CB ' ' CD1' ' A' ' 274' ' ' PHE . 15.1 p90 -107.15 152.98 23.33 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.488 1.117 . . . . 0.0 110.986 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 20.6 p90 -159.07 153.65 24.38 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.465 1.103 . . . . 0.0 110.98 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 123.17 -9.02 8.98 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.522 1.139 . . . . 0.0 111.041 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . 0.436 ' HG2' ' N ' ' A' ' 299' ' ' MET . 0.4 OUTLIER -52.37 -37.21 55.69 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.469 0.747 . . . . 0.0 110.273 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' MET . . . . . 0.436 ' N ' ' HG2' ' A' ' 298' ' ' GLU . 1.2 mmt -60.13 -32.09 70.68 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 0.0 110.976 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . 0.473 ' HB1' ' CA ' ' A' ' 269' ' ' GLY . . . -75.02 -37.27 61.83 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.446 1.091 . . . . 0.0 109.298 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.522 ' CD2' ' CG ' ' A' ' 327' ' ' PHE . 0.9 OUTLIER -78.11 -11.61 59.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.546 1.154 . . . . 0.0 109.321 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 35.0 mt -83.82 -52.87 12.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.495 1.122 . . . . 0.0 109.274 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.454 ' O ' ' C ' ' A' ' 304' ' ' GLY . 3.4 m -153.21 39.08 0.51 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.528 1.143 . . . . 0.0 110.02 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 33.07 43.76 0.21 Allowed Glycine 0 CA--C 1.529 0.966 0 O-C-N 124.493 1.121 . . . . 0.0 111.061 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.61 157.71 88.51 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.487 0.757 . . . . 0.0 110.287 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 129.95 12.83 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.503 1.791 . . . . 0.0 111.034 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -46.59 -34.98 5.4 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.506 1.129 . . . . 0.0 110.328 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 1.3 m 60.39 20.53 10.14 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.485 1.115 . . . . 0.0 109.962 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . -171.26 160.66 6.3 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 0.0 109.322 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.523 ' HG1' ' N ' ' A' ' 265' ' ' ILE . 0.9 OUTLIER -107.68 137.22 46.1 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.523 1.14 . . . . 0.0 110.372 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 86.5 t -114.79 127.51 72.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.459 1.1 . . . . 0.0 109.317 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 32.3 m -128.18 159.24 35.79 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.505 1.128 . . . . 0.0 109.96 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . 0.544 ' CB ' ' CG1' ' A' ' 317' ' ' VAL . . . -90.92 110.45 21.69 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.461 1.101 . . . . 0.0 109.275 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -53.19 -32.06 46.07 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.511 1.132 . . . . 0.0 109.287 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' THR . . . . . 0.474 ' HA ' ' CB ' ' A' ' 258' ' ' ALA . 12.7 t -156.68 -163.74 1.49 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.487 1.117 . . . . 0.0 110.407 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 96.6 m -63.07 76.78 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.48 1.112 . . . . 0.0 110.35 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.544 ' CG1' ' CB ' ' A' ' 313' ' ' ALA . 2.8 p -107.38 141.14 23.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.491 1.12 . . . . 0.0 109.353 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' SER . . . . . 0.515 ' C ' ' CD1' ' A' ' 319' ' ' LEU . 66.1 m -116.12 134.59 54.77 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.534 1.146 . . . . 0.0 110.04 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . 0.515 ' CD1' ' C ' ' A' ' 318' ' ' SER . 0.0 OUTLIER -132.54 177.98 7.19 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.49 1.119 . . . . 0.0 109.324 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.465 HD21 ' CB ' ' A' ' 253' ' ' ALA . 0.2 OUTLIER -124.5 128.62 49.24 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.502 1.126 . . . . 0.0 109.326 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 13.1 p -90.12 155.18 19.23 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.534 1.146 . . . . 0.0 110.036 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -149.02 90.86 1.79 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.517 1.136 . . . . 0.0 109.311 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . 0.534 ' CE1' ' HB2' ' A' ' 326' ' ' ASP . 7.9 p80 -49.98 136.54 18.49 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.538 1.149 . . . . 0.0 109.63 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 43.7 t -59.93 -25.56 65.25 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.545 1.153 . . . . 0.0 109.984 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -57.03 -34.06 67.83 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.496 1.123 . . . . 0.0 109.308 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . 0.534 ' HB2' ' CE1' ' A' ' 323' ' ' HIS . 31.6 t70 -68.83 -37.15 78.98 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.49 1.119 . . . . 0.0 109.337 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' PHE . . . . . 0.522 ' CG ' ' CD2' ' A' ' 301' ' ' LEU . 33.3 t80 -68.75 -40.38 79.83 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.499 1.124 . . . . 0.0 110.975 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -70.54 -31.92 69.15 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 0.0 110.327 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 17.6 tmm? -69.38 -44.7 70.98 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.467 1.105 . . . . 0.0 111.03 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 13.3 mt -70.6 -38.86 74.04 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.465 1.103 . . . . 0.0 109.31 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 1.8 m -64.43 -38.12 89.9 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.472 1.107 . . . . 0.0 108.279 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 7.6 t -77.24 -26.24 52.39 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.494 1.121 . . . . 0.0 109.98 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.18 -39.2 71.99 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.129 . . . . 0.0 110.057 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.19 129.94 23.36 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.529 1.143 . . . . 0.0 109.979 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -25.44 11.92 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.464 1.771 . . . . 0.0 111.023 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.26 -28.57 67.32 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.123 . . . . 0.0 110.299 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.459 ' CD1' HG22 ' A' ' 243' ' ' VAL . 59.9 mt -71.43 -42.47 73.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.514 1.134 . . . . 0.0 109.294 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.11 -30.49 67.7 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.492 1.12 . . . . 0.0 109.303 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -72.1 -43.51 64.67 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 0.0 110.316 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 68.2 mt -72.08 -40.06 66.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.537 1.148 . . . . 0.0 109.306 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.478 ' CD1' ' O ' ' A' ' 341' ' ' PHE . 0.4 OUTLIER -68.66 -39.33 80.69 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.534 1.146 . . . . 0.0 110.994 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -68.65 -39.08 80.85 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.465 1.103 . . . . 0.0 110.275 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.7 -48.07 70.43 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.526 1.141 . . . . 0.0 109.341 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.24 -41.77 94.04 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.47 1.106 . . . . 0.0 110.424 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -68.65 -34.4 75.65 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.528 1.143 . . . . 0.0 109.315 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 13.5 mt -69.9 -33.52 72.3 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.482 1.114 . . . . 0.0 109.262 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.4 -37.01 66.1 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.549 1.156 . . . . 0.0 110.334 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 4.4 mtt85 . . . . . 0 C--N 1.325 -0.457 0 O-C-N 124.527 1.142 . . . . 0.0 110.249 -179.984 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.992 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.13 160.87 14.99 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.499 0.764 . . . . 0.0 109.979 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -151.89 171.61 17.51 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.519 1.137 . . . . 0.0 110.317 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -118.43 168.45 10.63 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.51 1.131 . . . . 0.0 110.294 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 1.1 p -138.24 137.83 43.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.523 1.139 . . . . 0.0 109.31 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -63.84 175.35 1.17 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.492 1.12 . . . . 0.0 110.312 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.86 128.91 16.55 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.504 1.127 . . . . 0.0 110.288 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -112.1 -31.36 2.68 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.492 1.12 . . . . 0.0 110.978 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -91.22 19.27 6.04 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.545 0.791 . . . . 0.0 109.305 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -53.26 -39.29 63.76 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.526 1.141 . . . . 0.0 110.997 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -71.52 -43.22 72.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.515 1.134 . . . . 0.0 109.319 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.422 ' HA ' ' NE2' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -65.86 -29.05 69.45 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.5 1.125 . . . . 0.0 110.328 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -79.76 -30.37 40.73 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.541 1.151 . . . . 0.0 109.271 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' TRP . . . . . 0.541 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 2.1 t90 -68.09 -43.96 77.33 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.13 . . . . 0.0 107.985 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.496 ' O ' ' CB ' ' A' ' 232' ' ' ALA . 9.8 pt20 -70.63 -36.93 73.69 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.513 1.133 . . . . 0.0 110.315 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.99 -47.6 85.68 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.488 1.118 . . . . 0.0 109.323 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 64.5 t -73.23 -44.09 56.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.504 1.128 . . . . 0.0 109.307 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -68.28 -13.91 62.61 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.493 1.121 . . . . 0.0 109.282 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 228' ' ' GLN . . . -81.64 -24.89 36.06 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.51 1.131 . . . . 0.0 109.288 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 91.0 t -64.73 135.03 96.22 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.505 1.128 . . . . 0.0 109.316 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 233' ' ' VAL . 18.3 Cg_endo -75.02 -40.43 0.89 Allowed 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.42 1.747 . . . . 0.0 110.967 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.47 ' CD2' HD13 ' A' ' 302' ' ' ILE . 1.1 tp -63.56 -14.11 48.09 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.445 1.091 . . . . 0.0 109.302 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . 0.462 ' CB ' HD13 ' A' ' 239' ' ' LEU . 16.8 m-30 -113.24 5.28 16.87 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.473 1.108 . . . . 0.0 110.973 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.52 -29.43 62.47 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.492 1.12 . . . . 0.0 110.325 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.44 ' CB ' HG22 ' A' ' 340' ' ' ILE . 0.0 OUTLIER -89.31 7.09 37.42 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.517 1.136 . . . . 0.0 109.298 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.462 HD13 ' CB ' ' A' ' 236' ' ' PHE . 74.4 mt -85.58 176.64 8.09 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.504 1.128 . . . . 0.0 109.265 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -101.03 176.19 26.78 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.509 1.131 . . . . 0.0 111.03 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.515 ' O ' ' CG2' ' A' ' 245' ' ' VAL . 18.3 Cg_endo -74.99 -36.35 2.6 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.513 1.796 . . . . 0.0 110.993 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -69.54 -35.12 75.15 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.53 1.144 . . . . 0.0 109.271 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.442 ' CG1' HD13 ' A' ' 247' ' ' ILE . 57.0 t -73.25 -40.16 56.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.463 1.102 . . . . 0.0 109.297 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.45 HD22 ' N ' ' A' ' 244' ' ' LEU . 3.5 mm? -67.61 -37.55 82.7 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 0.0 109.269 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.541 HG22 ' CZ2' ' A' ' 227' ' ' TRP . 74.3 t -65.84 -45.98 89.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.519 1.137 . . . . 0.0 109.328 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -64.89 -40.78 95.64 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.125 . . . . 0.0 110.251 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.469 ' O ' ' CD1' ' A' ' 251' ' ' LEU . 44.2 mt -62.27 -47.97 90.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.456 1.098 . . . . 0.0 109.306 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 27.3 t -61.98 -34.65 64.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.469 1.105 . . . . 0.0 109.296 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.02 -13.01 60.04 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.463 1.102 . . . . 0.0 110.291 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -99.6 -7.0 26.38 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.502 1.126 . . . . 0.0 109.312 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.469 ' CD1' ' O ' ' A' ' 247' ' ' ILE . 6.2 mp -75.31 146.51 40.93 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.533 1.146 . . . . 0.0 109.281 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -116.33 113.6 23.17 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.502 1.127 . . . . 0.0 110.314 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -80.03 126.79 31.5 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.51 1.131 . . . . 0.0 109.258 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -139.09 137.74 36.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.464 1.102 . . . . 0.0 110.305 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 4.1 m -90.85 123.56 34.48 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.471 1.107 . . . . 0.0 110.385 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.475 HG13 ' CB ' ' A' ' 313' ' ' ALA . 4.7 t -106.8 112.76 63.32 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.467 1.104 . . . . 0.0 109.291 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.481 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.3 Cg_endo -75.03 169.27 22.98 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.524 1.802 . . . . 0.0 111.011 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.475 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -64.92 126.77 29.05 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.496 1.123 . . . . 0.0 109.334 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 100.63 -25.3 28.84 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.486 1.116 . . . . 0.0 111.006 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . 0.481 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -67.65 131.07 44.9 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.504 0.767 . . . . 0.0 109.303 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 2.9 p -87.72 135.43 25.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.529 1.143 . . . . 0.0 109.326 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.444 ' CD1' HG11 ' A' ' 280' ' ' VAL . 35.6 mt -82.38 -44.12 19.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.542 1.151 . . . . 0.0 109.294 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 10.5 p -152.12 147.07 26.02 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.538 1.149 . . . . 0.0 108.28 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -85.65 -179.9 6.96 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.485 1.115 . . . . 0.0 110.298 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.483 HG22 ' CB ' ' A' ' 310' ' ' THR . 0.1 OUTLIER -77.21 134.71 28.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.563 1.164 . . . . 0.0 109.289 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 56.32 51.48 55.85 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.458 1.099 . . . . 0.0 110.969 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.95 165.65 45.3 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.495 0.762 . . . . 0.0 110.298 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.3 Cg_endo -75.01 82.98 1.89 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.45 1.763 . . . . 0.0 111.002 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -38.0 93.31 0.01 OUTLIER Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.534 1.146 . . . . 0.0 110.997 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 268' ' ' PRO . 0.7 OUTLIER -171.61 37.51 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.482 0.754 . . . . 0.0 109.307 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.429 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 1.9 ttt180 -169.81 147.74 3.44 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.49 1.119 . . . . 0.0 110.276 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.494 ' SD ' ' CZ ' ' A' ' 274' ' ' PHE . 2.1 ttm -118.04 156.26 28.9 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.534 1.147 . . . . 0.0 110.986 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.571 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 32.8 m-85 -146.02 136.61 24.15 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.519 1.137 . . . . 0.0 111.023 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . 0.494 ' CZ ' ' SD ' ' A' ' 272' ' ' MET . 19.6 m-85 -125.71 137.8 53.85 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.538 1.149 . . . . 0.0 111.007 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 4.3 t -94.24 135.34 28.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.473 1.108 . . . . 0.0 109.318 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . 0.49 ' CG2' HD11 ' A' ' 320' ' ' LEU . 42.0 t -109.49 -49.16 7.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.481 1.113 . . . . 0.0 109.246 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -142.04 132.77 25.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.486 1.116 . . . . 0.0 110.281 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 120.96 -176.35 16.24 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.483 1.115 . . . . 0.0 111.023 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' SER . . . . . 0.418 ' N ' HG23 ' A' ' 317' ' ' VAL . 5.2 t -131.2 118.8 20.95 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.498 0.764 . . . . 0.0 110.026 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.444 HG11 ' CD1' ' A' ' 262' ' ' ILE . 16.2 m -98.43 162.17 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.496 1.122 . . . . 0.0 109.313 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 31.1 t -127.71 153.76 46.13 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.493 1.12 . . . . 0.0 109.957 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.95 129.23 73.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.463 1.102 . . . . 0.0 109.327 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.405 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -77.97 101.62 6.97 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.469 1.106 . . . . 0.0 109.298 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' THR . . . . . 0.651 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.7 OUTLIER -148.62 -168.31 0.18 Allowed Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.568 1.168 . . . . 0.0 110.399 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.651 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -75.07 4.59 4.63 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.474 1.776 . . . . 0.0 110.956 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -151.5 156.67 34.85 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.521 1.138 . . . . 0.0 109.265 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.95 94.79 0.95 Allowed 'Trans proline' 0 C--N 1.36 1.184 0 O-C-N 124.509 1.794 . . . . 0.0 110.987 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 45.4 t -98.37 118.83 45.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.494 1.121 . . . . 0.0 109.327 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -125.22 136.96 54.08 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.475 1.109 . . . . 0.0 110.278 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -117.23 139.73 50.42 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.474 1.109 . . . . 0.0 109.312 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -90.6 -160.18 36.3 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.497 1.123 . . . . 0.0 111.005 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 148.21 34.91 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.546 1.814 . . . . 0.0 111.038 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 83.61 4.42 89.09 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.569 1.168 . . . . 0.0 110.99 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -86.03 130.67 34.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.472 0.748 . . . . 0.0 109.295 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . 0.484 ' HB3' ' CD1' ' A' ' 274' ' ' PHE . 0.8 OUTLIER -116.16 153.02 32.56 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.504 1.127 . . . . 0.0 110.993 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . 0.571 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 40.4 p90 -159.64 146.17 16.32 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.527 1.142 . . . . 0.0 110.992 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 127.81 -7.07 6.93 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.472 1.107 . . . . 0.0 111.015 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . 0.428 ' N ' ' HE1' ' A' ' 272' ' ' MET . 6.0 pt-20 -52.49 -48.76 65.75 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.511 0.771 . . . . 0.0 110.336 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' MET . . . . . 0.415 ' HA ' ' CE ' ' A' ' 299' ' ' MET . 3.1 mmt -48.91 -39.26 25.36 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.541 1.151 . . . . 0.0 111.002 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -67.79 -37.42 82.0 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.504 1.128 . . . . 0.0 109.252 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.479 ' CD1' ' SD ' ' A' ' 272' ' ' MET . 10.6 mt -79.02 -9.07 59.43 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.527 1.142 . . . . 0.0 109.267 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . 0.47 HD13 ' CD2' ' A' ' 235' ' ' LEU . 3.1 mm -82.25 -54.17 10.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.478 1.111 . . . . 0.0 109.294 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 304' ' ' GLY . 1.0 OUTLIER -153.47 42.97 0.58 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 0.0 109.989 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 303' ' ' SER . . . 36.21 42.28 0.58 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.479 1.112 . . . . 0.0 111.042 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.19 157.13 83.43 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.441 0.73 . . . . 0.0 110.276 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.11 131.99 14.78 Favored 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.481 1.779 . . . . 0.0 110.976 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -44.38 -43.32 7.54 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.516 1.135 . . . . 0.0 110.34 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 25.3 m 67.74 39.41 2.69 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.454 1.096 . . . . 0.0 109.99 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . 173.42 160.2 0.14 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.541 1.151 . . . . 0.0 109.307 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.483 ' CB ' HG22 ' A' ' 265' ' ' ILE . 0.6 OUTLIER -105.19 122.3 45.62 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.505 1.128 . . . . 0.0 110.441 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 58.6 t -102.7 128.25 55.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.5 1.125 . . . . 0.0 109.3 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 9.7 p -141.24 156.66 45.87 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.557 1.161 . . . . 0.0 110.037 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . 0.475 ' CB ' HG13 ' A' ' 256' ' ' VAL . . . -90.31 124.37 34.84 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.543 1.152 . . . . 0.0 109.284 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -70.45 -26.33 63.59 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.468 1.105 . . . . 0.0 109.293 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' THR . . . . . 0.475 ' HA ' ' CB ' ' A' ' 258' ' ' ALA . 6.2 t -152.98 -169.79 3.44 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.51 1.131 . . . . 0.0 110.415 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 93.0 m -58.67 85.36 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 0.0 110.409 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.453 HG11 ' CD1' ' A' ' 319' ' ' LEU . 48.3 t -105.42 159.45 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.461 1.101 . . . . 0.0 109.246 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' SER . . . . . 0.408 ' N ' HG11 ' A' ' 317' ' ' VAL . 49.3 m -136.88 123.62 21.17 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.508 1.13 . . . . 0.0 109.984 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . 0.492 ' CB ' ' O ' ' A' ' 274' ' ' PHE . 0.0 OUTLIER -134.56 170.46 15.76 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.508 1.13 . . . . 0.0 109.278 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.49 HD11 ' CG2' ' A' ' 276' ' ' VAL . 0.0 OUTLIER -124.4 131.82 53.51 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.478 1.111 . . . . 0.0 109.295 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 63.5 p -90.15 158.88 17.05 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.552 1.157 . . . . 0.0 110.017 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.483 ' CD1' ' O ' ' A' ' 322' ' ' LEU . 0.9 OUTLIER -151.23 104.75 3.14 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.52 1.137 . . . . 0.0 109.338 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . 0.495 ' CE1' ' HB2' ' A' ' 326' ' ' ASP . 8.2 p80 -57.55 131.2 49.46 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.538 1.149 . . . . 0.0 109.609 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 23.0 t -58.96 -16.77 19.55 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.488 1.118 . . . . 0.0 109.993 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -66.71 -31.71 72.54 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.431 1.082 . . . . 0.0 109.305 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . 0.495 ' HB2' ' CE1' ' A' ' 323' ' ' HIS . 35.0 t70 -65.59 -47.52 75.44 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.543 1.152 . . . . 0.0 109.304 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' PHE . . . . . 0.469 ' CZ ' ' CE2' ' A' ' 341' ' ' PHE . 1.8 t80 -65.38 -35.74 81.88 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.431 1.082 . . . . 0.0 110.999 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -71.13 -32.29 68.8 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.505 1.128 . . . . 0.0 110.286 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 14.9 tmm? -68.29 -44.82 74.65 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.451 1.094 . . . . 0.0 110.991 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 2.4 mt -73.85 -31.57 63.25 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.504 1.128 . . . . 0.0 109.34 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 28.7 t -69.84 -38.14 76.41 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 0.0 108.322 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 11.3 t -76.86 -29.07 55.69 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.492 1.12 . . . . 0.0 109.984 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.9 -38.7 73.02 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.5 1.125 . . . . 0.0 109.974 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.8 124.07 32.51 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.483 1.114 . . . . 0.0 109.998 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 -27.87 9.64 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.417 1.746 . . . . 0.0 110.991 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.86 -32.61 72.4 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 0.0 110.315 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.502 ' O ' ' CB ' ' A' ' 341' ' ' PHE . 71.2 mt -75.14 -32.88 27.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.506 1.129 . . . . 0.0 109.316 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.29 -34.97 66.04 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.447 1.092 . . . . 0.0 109.295 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -73.77 -43.42 59.04 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.531 1.144 . . . . 0.0 110.308 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.44 HG22 ' CB ' ' A' ' 238' ' ' LYS . 97.7 mt -71.64 -38.06 65.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 0.0 109.339 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.502 ' CB ' ' O ' ' A' ' 337' ' ' ILE . 4.7 t80 -67.0 -39.22 87.07 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 0.0 111.042 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.06 -35.59 69.33 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.506 1.129 . . . . 0.0 110.311 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -46.17 83.66 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.45 1.094 . . . . 0.0 109.307 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 6.6 t -71.23 -33.98 70.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.543 1.152 . . . . 0.0 110.399 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -70.21 -37.23 75.02 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.452 1.095 . . . . 0.0 109.366 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 12.4 mt -71.43 -37.02 71.49 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.523 1.139 . . . . 0.0 109.29 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -72.68 -37.34 67.91 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.487 1.117 . . . . 0.0 110.335 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -72.46 -40.16 67.21 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.559 1.162 . . . . 0.0 110.251 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.5 -34.73 70.37 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.498 1.124 . . . . 0.0 110.314 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -43.65 -46.33 7.25 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 124.495 1.122 . . . . 0.0 110.96 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -154.81 121.19 5.33 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.546 0.792 . . . . 0.0 109.276 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -65.51 173.31 2.76 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.504 1.127 . . . . 0.0 109.308 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -120.18 120.13 35.27 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.116 . . . . 0.0 109.326 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 49.9 m -154.91 172.38 18.14 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.508 1.13 . . . . 0.0 110.007 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.457 0 O-C-N 124.48 1.113 . . . . 0.0 109.321 179.971 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.028 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.17 165.05 11.3 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.487 0.757 . . . . 0.0 109.977 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -128.75 170.43 13.34 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.527 1.142 . . . . 0.0 110.296 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -88.23 154.03 20.75 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.487 1.117 . . . . 0.0 110.323 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 61.8 t -138.32 134.43 43.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.539 1.149 . . . . 0.0 109.277 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -89.35 162.7 15.67 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.489 1.118 . . . . 0.0 110.3 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.11 120.08 5.76 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.523 1.14 . . . . 0.0 110.235 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -113.86 -32.47 2.06 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.468 1.105 . . . . 0.0 110.965 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -91.09 17.17 8.4 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.499 0.764 . . . . 0.0 109.326 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -52.78 -39.03 61.93 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.566 1.166 . . . . 0.0 110.997 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.12 -40.05 50.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.494 1.121 . . . . 0.0 109.322 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.464 ' HD3' ' CD1' ' A' ' 229' ' ' LEU . 0.0 OUTLIER -66.22 -31.87 72.95 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.519 1.137 . . . . 0.0 110.339 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . 0.406 ' ND2' HD22 ' A' ' 320' ' ' LEU . 12.4 t-20 -80.61 -30.84 36.78 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.538 1.149 . . . . 0.0 109.335 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' TRP . . . . . 0.579 ' CZ2' ' CG2' ' A' ' 245' ' ' VAL . 2.8 t90 -67.24 -42.66 83.61 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.127 . . . . 0.0 107.994 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.405 ' HG3' ' N ' ' A' ' 229' ' ' LEU . 8.9 pt20 -71.02 -40.77 71.56 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.478 1.111 . . . . 0.0 110.333 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.464 ' CD1' ' HD3' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -61.87 -48.65 79.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.471 1.107 . . . . 0.0 109.304 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.475 HG11 ' CD1' ' A' ' 244' ' ' LEU . 5.7 p -68.09 -39.63 81.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.503 1.127 . . . . 0.0 109.309 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -72.11 -16.53 62.01 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.502 1.126 . . . . 0.0 109.264 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 228' ' ' GLN . . . -81.25 -10.45 59.59 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.473 1.108 . . . . 0.0 109.282 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 6.7 t -80.85 121.04 80.54 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.561 1.163 . . . . 0.0 109.29 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 -18.35 18.75 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.501 1.79 . . . . 0.0 111.018 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 5.7 tp -75.87 -20.96 57.67 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.511 1.132 . . . . 0.0 109.281 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . 0.523 ' CD2' HD12 ' A' ' 239' ' ' LEU . 3.3 m-85 -108.97 8.9 26.55 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.495 1.122 . . . . 0.0 110.998 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.26 -19.92 65.58 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.572 1.17 . . . . 0.0 110.311 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.479 ' CB ' HG21 ' A' ' 340' ' ' ILE . 69.5 mmtt -80.63 -17.95 49.64 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.523 1.139 . . . . 0.0 109.313 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.523 HD12 ' CD2' ' A' ' 236' ' ' PHE . 75.1 mt -70.49 172.81 7.82 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.457 1.098 . . . . 0.0 109.284 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -107.42 -172.54 22.26 Favored Glycine 0 CA--C 1.529 0.952 0 O-C-N 124.509 1.131 . . . . 0.0 111.07 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.487 ' O ' ' CG2' ' A' ' 245' ' ' VAL . 18.3 Cg_endo -75.05 -35.16 3.27 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.487 1.783 . . . . 0.0 110.986 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -69.56 -34.08 73.66 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.475 1.11 . . . . 0.0 109.301 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.6 t -74.93 -40.58 45.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.493 1.12 . . . . 0.0 109.298 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.475 ' CD1' HG11 ' A' ' 230' ' ' VAL . 0.7 OUTLIER -64.83 -40.1 94.65 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.478 1.111 . . . . 0.0 109.262 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.579 ' CG2' ' CZ2' ' A' ' 227' ' ' TRP . 63.0 t -70.65 -42.13 77.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.459 1.099 . . . . 0.0 109.299 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -64.95 -35.65 81.86 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.492 1.12 . . . . 0.0 110.262 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 36.7 mt -71.75 -44.84 68.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.559 1.162 . . . . 0.0 109.321 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.465 ' CG2' HG12 ' A' ' 230' ' ' VAL . 96.4 t -68.17 -32.15 54.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.454 1.096 . . . . 0.0 109.292 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.93 -21.97 46.48 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.493 1.121 . . . . 0.0 110.327 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -89.94 -21.26 22.55 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.473 1.108 . . . . 0.0 109.276 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.411 ' CD2' ' HB2' ' A' ' 322' ' ' LEU . 0.2 OUTLIER -67.3 149.77 49.92 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.469 1.106 . . . . 0.0 109.304 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -121.08 119.57 32.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.442 1.088 . . . . 0.0 110.334 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.437 ' CB ' HD23 ' A' ' 320' ' ' LEU . . . -80.99 122.83 27.77 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.495 1.122 . . . . 0.0 109.324 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.96 142.9 49.12 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.506 1.129 . . . . 0.0 110.293 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.3 m -94.18 125.36 38.77 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.496 1.123 . . . . 0.0 110.359 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 47.6 t -106.92 112.44 63.32 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.534 1.146 . . . . 0.0 109.334 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.3 Cg_endo -75.01 171.38 18.43 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.485 1.781 . . . . 0.0 110.993 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.498 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -66.25 130.21 42.44 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.487 1.117 . . . . 0.0 109.336 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 94.97 -25.09 25.52 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.478 1.111 . . . . 0.0 111.031 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . 0.518 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -64.75 119.94 11.53 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.527 0.781 . . . . 0.0 109.297 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.17 136.03 24.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.539 1.15 . . . . 0.0 109.284 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 39.9 mt -82.12 -52.64 13.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.492 1.12 . . . . 0.0 109.334 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 17.1 p -147.43 146.26 29.51 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.512 1.133 . . . . 0.0 108.291 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -83.36 -177.8 6.86 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.115 . . . . 0.0 110.291 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.454 ' N ' ' OG1' ' A' ' 310' ' ' THR . 0.0 OUTLIER -76.08 133.21 31.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.507 1.129 . . . . 0.0 109.301 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 55.5 53.9 38.14 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.486 1.116 . . . . 0.0 110.983 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.81 165.75 43.65 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.467 0.745 . . . . 0.0 110.313 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . 0.486 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.3 Cg_endo -75.01 87.12 1.35 Allowed 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.498 1.788 . . . . 0.0 110.947 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -39.79 93.4 0.01 OUTLIER Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.506 1.129 . . . . 0.0 111.02 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 268' ' ' PRO . 17.9 p30 -170.82 38.48 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.513 0.773 . . . . 0.0 109.261 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.415 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 12.8 mtt180 -169.51 154.45 5.63 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.477 1.11 . . . . 0.0 110.309 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.41 ' SD ' ' CD1' ' A' ' 301' ' ' LEU . 1.2 ttt -126.09 149.66 48.75 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.506 1.129 . . . . 0.0 110.985 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 296' ' ' PHE . 12.1 m-85 -135.63 138.2 42.65 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.475 1.109 . . . . 0.0 110.98 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -128.36 126.15 40.12 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.552 1.158 . . . . 0.0 110.973 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.408 HG21 ' CG1' ' A' ' 280' ' ' VAL . 41.7 t -85.47 129.64 37.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.467 1.104 . . . . 0.0 109.298 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . 0.468 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 46.3 t -104.94 -46.97 9.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.467 1.105 . . . . 0.0 109.322 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . 0.401 ' O ' ' CG2' ' A' ' 317' ' ' VAL . 0.0 OUTLIER -148.52 140.51 23.9 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.482 1.114 . . . . 0.0 110.336 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 116.46 -154.1 17.02 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.554 1.159 . . . . 0.0 110.994 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 4.5 m -147.83 131.4 16.79 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.466 0.745 . . . . 0.0 109.967 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.408 ' CG1' HG21 ' A' ' 275' ' ' VAL . 20.3 m -117.17 135.58 57.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.484 1.115 . . . . 0.0 109.332 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 29.3 t -102.5 149.6 24.23 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.519 1.137 . . . . 0.0 109.983 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -113.35 130.42 67.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.502 1.127 . . . . 0.0 109.291 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.413 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -76.77 101.84 6.0 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.541 1.15 . . . . 0.0 109.31 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' THR . . . . . 0.648 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -149.07 -168.63 0.19 Allowed Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.47 1.106 . . . . 0.0 110.427 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.648 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -75.01 3.83 5.28 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.553 1.817 . . . . 0.0 110.975 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -151.91 157.68 34.22 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.533 1.146 . . . . 0.0 109.325 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 92.59 0.98 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.533 1.807 . . . . 0.0 111.0 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 29.0 t -95.49 118.97 42.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.506 1.129 . . . . 0.0 109.311 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -124.34 138.69 54.35 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.482 1.114 . . . . 0.0 110.313 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -121.37 140.92 51.48 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.464 1.103 . . . . 0.0 109.311 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -97.55 -155.01 29.91 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.459 1.1 . . . . 0.0 110.985 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.94 147.04 33.65 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.498 1.789 . . . . 0.0 111.018 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 85.26 5.77 85.0 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.474 1.109 . . . . 0.0 111.011 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -90.44 121.42 32.39 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.495 0.762 . . . . 0.0 109.323 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -116.16 152.89 32.8 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.541 1.151 . . . . 0.0 110.994 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . 0.559 ' CZ ' ' HB3' ' A' ' 273' ' ' PHE . 33.7 p90 -163.71 148.95 10.88 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.486 1.116 . . . . 0.0 111.018 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 132.98 -11.58 5.1 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.454 1.096 . . . . 0.0 110.976 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -52.82 -44.91 67.01 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.452 0.737 . . . . 0.0 110.3 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.67 -39.21 57.81 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.438 1.086 . . . . 0.0 110.965 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . 0.457 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -68.49 -39.03 81.48 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.516 1.135 . . . . 0.0 109.304 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.512 HD22 ' CG ' ' A' ' 327' ' ' PHE . 13.3 mt -76.76 -8.78 57.96 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.516 1.135 . . . . 0.0 109.334 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 6.5 mm -85.01 -52.95 11.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.488 1.117 . . . . 0.0 109.341 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 304' ' ' GLY . 0.4 OUTLIER -153.51 41.13 0.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.5 1.125 . . . . 0.0 109.967 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 36.48 36.4 0.15 Allowed Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.494 1.121 . . . . 0.0 110.956 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.93 155.76 85.84 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.511 0.771 . . . . 0.0 110.266 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 130.87 13.63 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.539 1.81 . . . . 0.0 110.999 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -45.16 -31.32 1.4 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.528 1.143 . . . . 0.0 110.288 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 2.4 m 59.1 33.1 22.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 0.0 110.03 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . 176.35 160.63 0.34 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.498 1.124 . . . . 0.0 109.317 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.454 ' OG1' ' N ' ' A' ' 265' ' ' ILE . 0.7 OUTLIER -109.98 127.2 54.65 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.471 1.107 . . . . 0.0 110.396 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 57.6 t -107.21 131.64 56.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.496 1.122 . . . . 0.0 109.301 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 1.9 p -137.03 150.55 48.16 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.473 1.108 . . . . 0.0 110.036 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . 0.502 ' CB ' ' CG1' ' A' ' 317' ' ' VAL . . . -80.04 111.09 16.05 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.518 1.137 . . . . 0.0 109.278 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -58.61 -26.69 63.96 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.461 1.101 . . . . 0.0 109.285 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' THR . . . . . 0.498 ' HA ' ' CB ' ' A' ' 258' ' ' ALA . 8.8 t -160.18 -164.01 1.21 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.514 1.133 . . . . 0.0 110.379 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' THR . . . . . 0.433 ' N ' ' OG1' ' A' ' 315' ' ' THR . 65.2 m -64.08 74.61 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.504 1.128 . . . . 0.0 110.417 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.502 ' CG1' ' CB ' ' A' ' 313' ' ' ALA . 2.7 p -104.14 137.81 31.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.125 . . . . 0.0 109.319 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 71.1 m -106.19 134.83 48.7 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.542 1.151 . . . . 0.0 109.972 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . 0.447 HD21 ' CG2' ' A' ' 317' ' ' VAL . 0.0 OUTLIER -141.5 174.23 10.75 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.535 1.147 . . . . 0.0 109.319 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.468 ' CD1' ' CG2' ' A' ' 276' ' ' VAL . 0.6 OUTLIER -124.83 134.01 52.9 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.517 1.135 . . . . 0.0 109.262 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 29.5 t -98.03 146.82 25.15 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.529 1.143 . . . . 0.0 109.972 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.411 ' HB2' ' CD2' ' A' ' 251' ' ' LEU . 2.2 tm? -138.06 104.64 5.29 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.518 1.136 . . . . 0.0 109.318 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . 0.415 ' HA ' ' CG ' ' A' ' 271' ' ' ARG . 5.8 p80 -63.71 134.31 55.12 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.557 1.161 . . . . 0.0 109.631 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 86.4 p -55.56 -18.47 7.55 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.54 1.15 . . . . 0.0 109.978 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -58.12 -36.99 73.73 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.466 1.104 . . . . 0.0 109.291 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -65.32 -38.87 91.5 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.499 1.125 . . . . 0.0 109.312 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' PHE . . . . . 0.512 ' CG ' HD22 ' A' ' 301' ' ' LEU . 17.7 t80 -68.63 -35.64 77.55 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.478 1.111 . . . . 0.0 110.991 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -69.33 -33.84 73.74 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.5 1.125 . . . . 0.0 110.326 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.418 ' O ' ' CB ' ' A' ' 333' ' ' SER . 32.2 ttp -70.59 -43.21 69.85 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.457 1.098 . . . . 0.0 110.987 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 2.6 mt -70.58 -34.7 72.47 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.435 1.085 . . . . 0.0 109.342 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 1.3 m -73.22 -44.12 60.14 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.473 1.108 . . . . 0.0 108.3 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 7.6 t -73.09 -27.86 61.96 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.529 1.143 . . . . 0.0 110.04 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 329' ' ' MET . 11.7 t -74.04 -38.38 64.03 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.537 1.148 . . . . 0.0 110.028 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.92 120.52 22.72 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 0.0 109.977 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -23.62 13.57 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.503 1.791 . . . . 0.0 111.038 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -72.32 -33.66 67.52 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.481 1.113 . . . . 0.0 110.263 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 87.3 mt -71.07 -40.34 75.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.556 1.16 . . . . 0.0 109.337 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.98 -30.7 64.02 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.443 1.089 . . . . 0.0 109.286 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.89 -37.34 70.16 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.529 1.143 . . . . 0.0 110.294 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.479 HG21 ' CB ' ' A' ' 238' ' ' LYS . 30.6 mt -72.93 -45.64 54.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.526 1.141 . . . . 0.0 109.295 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -67.65 -30.9 70.57 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.463 1.102 . . . . 0.0 110.997 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -72.54 -44.58 61.95 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.133 . . . . 0.0 110.258 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -45.26 76.88 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.521 1.138 . . . . 0.0 109.371 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.53 -40.12 92.57 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 0.0 110.409 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -69.09 -32.96 72.75 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.135 . . . . 0.0 109.28 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 13.1 mt -73.64 -31.18 63.37 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.519 1.137 . . . . 0.0 109.308 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -72.72 -40.56 66.03 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.14 . . . . 0.0 110.353 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -69.83 -40.9 75.6 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.466 1.104 . . . . 0.0 110.273 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 350' ' ' GLY . 0.0 OUTLIER -73.11 -34.7 66.32 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.479 1.112 . . . . 0.0 110.316 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 349' ' ' ARG . . . -37.04 -46.97 1.3 Allowed Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.536 1.147 . . . . 0.0 111.0 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -154.61 121.6 5.56 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.48 0.753 . . . . 0.0 109.341 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -62.9 166.91 5.14 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.498 1.123 . . . . 0.0 109.345 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -102.63 120.72 41.04 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.538 1.149 . . . . 0.0 109.309 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 10.7 m -64.12 138.62 58.54 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.47 1.106 . . . . 0.0 109.973 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.446 0 O-C-N 124.46 1.1 . . . . 0.0 109.287 179.963 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.048 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 25.5 p -60.56 140.58 57.29 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.528 0.781 . . . . 0.0 109.994 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.82 173.1 7.24 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.54 1.15 . . . . 0.0 110.278 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -110.57 170.42 8.1 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.485 1.116 . . . . 0.0 110.29 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 32.9 m -131.67 166.98 27.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.464 1.103 . . . . 0.0 109.303 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 15.2 mtt180 -107.66 170.85 7.73 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.506 1.129 . . . . 0.0 110.264 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.27 137.4 35.85 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.532 1.145 . . . . 0.0 110.341 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -110.32 -26.05 5.03 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.517 1.135 . . . . 0.0 110.987 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -99.12 17.23 20.35 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.505 0.768 . . . . 0.0 109.294 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.565 ' CE1' ' HD3' ' A' ' 249' ' ' ARG . 68.3 t80 -53.78 -39.89 65.8 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.481 1.113 . . . . 0.0 110.969 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.62 -39.29 81.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.474 1.109 . . . . 0.0 109.315 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.66 -34.41 76.87 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.512 1.132 . . . . 0.0 110.281 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . 0.504 ' O ' ' CG1' ' A' ' 230' ' ' VAL . 36.9 t30 -78.73 -30.49 45.89 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.506 1.129 . . . . 0.0 109.271 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' TRP . . . . . 0.622 ' CZ2' HG23 ' A' ' 245' ' ' VAL . 5.5 t90 -66.99 -44.4 80.5 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.522 1.139 . . . . 0.0 108.011 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -71.78 -33.99 69.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.444 1.09 . . . . 0.0 110.332 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.63 -55.39 17.84 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.544 1.152 . . . . 0.0 109.308 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.504 ' CG1' ' O ' ' A' ' 226' ' ' ASN . 7.4 p -65.51 -35.01 74.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.509 1.131 . . . . 0.0 109.287 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.475 ' CB ' ' O ' ' A' ' 227' ' ' TRP . . . -75.29 -18.88 59.94 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.485 1.115 . . . . 0.0 109.297 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -80.72 -20.31 43.12 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.102 . . . . 0.0 109.264 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . 0.403 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 60.3 t -62.78 128.58 92.08 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.507 1.13 . . . . 0.0 109.308 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 233' ' ' VAL . 18.4 Cg_endo -74.99 -35.97 2.83 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.485 1.782 . . . . 0.0 111.078 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 1.2 tp -63.91 -19.22 64.94 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.5 1.125 . . . . 0.0 109.323 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . 0.534 ' CD1' HD12 ' A' ' 239' ' ' LEU . 4.3 m-30 -114.28 8.5 16.77 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.468 1.105 . . . . 0.0 110.988 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -71.18 -22.61 62.01 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.508 1.13 . . . . 0.0 110.304 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.4 ' CB ' HG23 ' A' ' 340' ' ' ILE . 65.9 mmtt -83.41 -19.37 36.11 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.476 1.11 . . . . 0.0 109.265 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.534 HD12 ' CD1' ' A' ' 236' ' ' PHE . 67.7 mt -63.79 -179.98 0.44 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.549 1.155 . . . . 0.0 109.296 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -103.95 178.2 24.66 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.487 1.117 . . . . 0.0 111.04 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -34.54 3.72 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.486 1.782 . . . . 0.0 111.006 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -71.8 -35.4 69.96 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.499 1.125 . . . . 0.0 109.337 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 71.6 t -72.73 -40.62 61.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.528 1.142 . . . . 0.0 109.291 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.458 ' CD2' ' HB2' ' A' ' 239' ' ' LEU . 3.9 mm? -69.08 -40.51 78.39 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.515 1.134 . . . . 0.0 109.308 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.622 HG23 ' CZ2' ' A' ' 227' ' ' TRP . 20.5 t -66.17 -37.05 78.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.487 1.117 . . . . 0.0 109.296 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -74.3 -30.78 62.23 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.55 1.156 . . . . 0.0 110.298 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.439 ' CG1' HD11 ' A' ' 330' ' ' LEU . 44.2 mt -70.93 -48.59 55.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.542 1.151 . . . . 0.0 109.308 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.405 HG23 ' ND2' ' A' ' 226' ' ' ASN . 14.5 p -65.56 -36.14 76.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.525 1.14 . . . . 0.0 109.286 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.565 ' HD3' ' CE1' ' A' ' 223' ' ' PHE . 1.4 mmm180 -72.44 -25.2 61.37 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.495 1.122 . . . . 0.0 110.311 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -91.41 0.33 57.53 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.472 1.108 . . . . 0.0 109.261 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.69 151.61 25.18 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 0.0 109.269 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.08 125.16 46.57 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.46 1.1 . . . . 0.0 110.291 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -82.97 122.72 28.66 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.523 1.139 . . . . 0.0 109.267 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.405 ' O ' ' O ' ' A' ' 319' ' ' LEU . 0.0 OUTLIER -127.72 139.35 52.74 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.436 1.085 . . . . 0.0 110.265 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 6.6 m -95.55 128.07 42.11 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.479 1.112 . . . . 0.0 110.405 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 22.0 t -106.54 115.78 60.13 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.458 1.099 . . . . 0.0 109.251 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.502 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.95 154.44 42.76 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.52 1.8 . . . . 0.0 111.036 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.479 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -57.51 126.27 26.59 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.475 1.11 . . . . 0.0 109.266 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 98.7 -25.19 29.01 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.511 1.132 . . . . 0.0 110.995 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . 0.502 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -66.3 146.58 54.44 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.479 0.752 . . . . 0.0 109.254 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 2.4 p -97.18 136.29 28.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.461 1.101 . . . . 0.0 109.319 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 7.4 mt -81.65 -45.42 20.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.489 1.118 . . . . 0.0 109.33 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' CYS . . . . . 0.493 ' SG ' ' CG2' ' A' ' 311' ' ' VAL . 14.1 p -147.4 153.53 39.73 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.479 1.112 . . . . 0.0 108.331 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.41 179.91 5.0 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.513 1.133 . . . . 0.0 110.304 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.463 HG21 ' CB ' ' A' ' 310' ' ' THR . 0.1 OUTLIER -76.67 135.95 25.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.471 1.107 . . . . 0.0 109.311 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 52.27 53.55 30.77 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.539 1.149 . . . . 0.0 111.027 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.417 ' CD ' ' CD ' ' A' ' 268' ' ' PRO . 5.7 mm-40 -71.57 166.1 42.73 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.512 0.772 . . . . 0.0 110.313 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . 0.517 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.2 Cg_endo -74.96 82.52 1.98 Allowed 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.515 1.797 . . . . 0.0 111.024 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 268' ' ' PRO . . . -36.86 92.39 0.01 OUTLIER Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.471 1.107 . . . . 0.0 110.976 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 268' ' ' PRO . 36.6 m-20 -171.92 37.84 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.526 0.78 . . . . 0.0 109.322 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.8 148.57 2.93 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.476 1.11 . . . . 0.0 110.299 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.454 ' HE3' ' CA ' ' A' ' 298' ' ' GLU . 2.1 ttt -123.26 146.65 47.68 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.543 1.152 . . . . 0.0 110.971 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.568 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 92.4 m-85 -133.4 136.98 45.6 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.512 1.133 . . . . 0.0 110.982 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . 0.501 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 20.5 m-85 -124.72 135.06 52.69 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.451 1.094 . . . . 0.0 111.004 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 276' ' ' VAL . 38.6 t -90.43 137.93 20.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.471 1.107 . . . . 0.0 109.321 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . 0.417 ' N ' HG12 ' A' ' 275' ' ' VAL . 3.4 t -115.86 -48.99 4.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.484 1.115 . . . . 0.0 109.329 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -139.01 136.57 35.47 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.51 1.131 . . . . 0.0 110.306 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.464 ' HA3' ' CG2' ' A' ' 317' ' ' VAL . . . 110.87 -173.31 15.93 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.486 1.116 . . . . 0.0 110.957 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' SER . . . . . 0.441 ' N ' HG23 ' A' ' 317' ' ' VAL . 5.5 t -134.34 126.67 30.14 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.481 0.754 . . . . 0.0 109.992 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.437 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 17.4 m -104.18 166.32 3.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.485 1.116 . . . . 0.0 109.286 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 30.8 t -129.81 154.79 46.9 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.502 1.126 . . . . 0.0 110.022 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.449 ' CG2' ' HB ' ' A' ' 288' ' ' VAL . 0.5 OUTLIER -118.03 127.84 75.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.502 1.126 . . . . 0.0 109.301 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.408 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -77.0 101.37 5.99 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.44 1.088 . . . . 0.0 109.338 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' THR . . . . . 0.651 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.63 -168.35 0.18 Allowed Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.525 1.141 . . . . 0.0 110.392 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.651 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.3 Cg_endo -74.97 4.17 4.96 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.528 1.804 . . . . 0.0 111.017 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -150.68 156.16 36.13 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.509 1.131 . . . . 0.0 109.299 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 94.19 0.96 Allowed 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.517 1.798 . . . . 0.0 111.032 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.449 ' HB ' ' CG2' ' A' ' 282' ' ' VAL . 2.1 t -98.13 119.26 45.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.54 1.15 . . . . 0.0 109.322 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -124.5 135.44 53.21 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.547 1.154 . . . . 0.0 110.337 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.437 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 3.9 mm? -115.3 142.61 46.45 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.52 1.137 . . . . 0.0 109.308 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -97.96 -162.56 30.98 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.434 1.084 . . . . 0.0 111.025 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 144.99 30.91 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.467 1.772 . . . . 0.0 110.999 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 90.21 -1.84 80.43 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.502 1.126 . . . . 0.0 111.022 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -83.76 139.31 32.8 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.51 0.77 . . . . 0.0 109.321 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . 0.405 ' CB ' ' CD1' ' A' ' 274' ' ' PHE . 1.5 p90 -126.4 152.74 45.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.491 1.119 . . . . 0.0 110.998 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . 0.568 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 33.4 p90 -160.85 149.71 16.6 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.446 1.091 . . . . 0.0 111.013 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 126.23 -8.55 7.5 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.479 1.112 . . . . 0.0 111.025 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . 0.454 ' CA ' ' HE3' ' A' ' 272' ' ' MET . 27.0 tt0 -52.87 -44.19 66.66 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.525 0.779 . . . . 0.0 110.283 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' MET . . . . . 0.463 ' HB3' ' CG ' ' A' ' 305' ' ' GLU . 0.0 OUTLIER -56.34 -37.13 69.59 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.497 1.123 . . . . 0.0 111.037 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -66.36 -38.38 87.46 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.503 1.127 . . . . 0.0 109.227 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 1.8 mp -81.98 -10.22 59.32 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.124 . . . . 0.0 109.328 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 3.9 mm -76.9 -56.42 8.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.464 1.102 . . . . 0.0 109.33 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 305' ' ' GLU . 1.5 m -151.53 48.37 0.81 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.526 1.141 . . . . 0.0 109.992 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 303' ' ' SER . . . 36.57 31.66 0.05 OUTLIER Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.516 1.135 . . . . 0.0 110.99 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . 0.463 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 0.0 OUTLIER -65.24 151.67 93.41 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.517 0.775 . . . . 0.0 110.28 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 129.51 12.45 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.434 1.755 . . . . 0.0 111.022 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.88 -22.92 0.93 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.491 1.119 . . . . 0.0 110.288 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.511 ' O ' ' CB ' ' A' ' 309' ' ' ALA . 27.4 m 41.79 57.24 3.18 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.566 1.166 . . . . 0.0 110.03 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 308' ' ' SER . . . 162.68 159.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.463 1.102 . . . . 0.0 109.349 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.463 ' CB ' HG21 ' A' ' 265' ' ' ILE . 0.3 OUTLIER -112.7 122.06 46.56 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.509 1.131 . . . . 0.0 110.408 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.493 ' CG2' ' SG ' ' A' ' 263' ' ' CYS . 23.0 t -102.79 131.51 50.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.524 1.14 . . . . 0.0 109.302 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 33.8 p -138.37 154.07 48.93 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.494 1.121 . . . . 0.0 109.984 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -91.15 120.55 32.19 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.497 1.123 . . . . 0.0 109.297 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -61.94 -33.79 74.91 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.481 1.113 . . . . 0.0 109.316 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' THR . . . . . 0.479 ' HA ' ' CB ' ' A' ' 258' ' ' ALA . 9.9 t -149.78 -176.22 5.34 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.517 1.136 . . . . 0.0 110.425 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 13.9 p -49.8 92.36 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.525 1.14 . . . . 0.0 110.361 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.464 ' CG2' ' HA3' ' A' ' 278' ' ' GLY . 43.0 t -108.56 158.49 8.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.509 1.131 . . . . 0.0 109.312 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' SER . . . . . 0.416 ' N ' HG13 ' A' ' 317' ' ' VAL . 68.4 m -132.92 118.16 18.56 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.487 1.117 . . . . 0.0 110.014 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . 0.501 ' CB ' ' O ' ' A' ' 274' ' ' PHE . 0.2 OUTLIER -131.65 172.94 11.65 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.49 1.119 . . . . 0.0 109.286 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.1 137.14 54.19 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.451 1.095 . . . . 0.0 109.31 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 4.0 t -95.51 156.41 16.34 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.463 1.102 . . . . 0.0 110.021 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.94 103.51 3.22 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 0.0 109.289 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . 0.559 ' CE1' ' HB2' ' A' ' 326' ' ' ASP . 9.1 p80 -57.72 136.46 56.88 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.494 1.121 . . . . 0.0 109.584 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 42.0 t -62.12 -21.46 65.03 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.448 1.092 . . . . 0.0 109.984 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -62.97 -30.43 71.57 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.506 1.129 . . . . 0.0 109.307 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . 0.559 ' HB2' ' CE1' ' A' ' 323' ' ' HIS . 27.7 t70 -65.98 -47.91 73.0 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.506 1.129 . . . . 0.0 109.339 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' PHE . . . . . 0.503 ' CZ ' ' CE2' ' A' ' 341' ' ' PHE . 2.5 t80 -64.95 -34.26 78.0 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.494 1.121 . . . . 0.0 110.996 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.486 ' O ' ' CB ' ' A' ' 332' ' ' SER . 67.5 mt-30 -70.53 -33.37 71.1 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.509 1.13 . . . . 0.0 110.264 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 14.3 tmm? -68.98 -44.83 72.08 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.513 1.133 . . . . 0.0 110.989 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.504 ' CD1' ' O ' ' A' ' 326' ' ' ASP . 0.6 OUTLIER -73.47 -41.87 62.61 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.479 1.112 . . . . 0.0 109.275 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 22.7 t -66.11 -38.57 88.52 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.479 1.112 . . . . 0.0 108.257 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 328' ' ' GLN . 38.7 t -76.72 -25.62 53.77 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.462 1.101 . . . . 0.0 109.953 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 17.7 t -71.73 -38.87 70.4 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.123 . . . . 0.0 110.034 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.19 127.65 26.63 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.477 1.11 . . . . 0.0 109.965 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 -28.8 8.86 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.525 1.803 . . . . 0.0 110.981 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -67.22 -29.82 69.58 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.502 1.126 . . . . 0.0 110.263 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.511 ' O ' ' CB ' ' A' ' 341' ' ' PHE . 87.4 mt -75.0 -34.46 32.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.543 1.152 . . . . 0.0 109.257 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.73 -30.65 64.35 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.528 1.142 . . . . 0.0 109.3 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -74.93 -46.23 37.1 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.491 1.119 . . . . 0.0 110.317 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.4 HG23 ' CB ' ' A' ' 238' ' ' LYS . 87.4 mt -71.59 -36.45 59.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.459 1.099 . . . . 0.0 109.278 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.511 ' CB ' ' O ' ' A' ' 337' ' ' ILE . 6.0 t80 -67.39 -41.96 84.14 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.514 1.134 . . . . 0.0 110.991 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . 0.466 ' HG3' ' CD1' ' A' ' 346' ' ' LEU . 0.7 OUTLIER -70.63 -35.84 73.15 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.492 1.12 . . . . 0.0 110.26 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -50.86 65.36 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.492 1.12 . . . . 0.0 109.277 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 10.2 t -65.04 -33.02 75.03 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.474 1.108 . . . . 0.0 110.389 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -66.09 -44.92 83.0 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.484 1.115 . . . . 0.0 109.283 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.466 ' CD1' ' HG3' ' A' ' 342' ' ' ARG . 1.0 OUTLIER -65.34 -36.46 84.1 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.502 1.126 . . . . 0.0 109.329 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -73.53 -35.4 65.55 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.499 1.124 . . . . 0.0 110.317 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.95 -44.69 60.84 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.495 1.122 . . . . 0.0 110.255 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -34.82 78.21 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.453 1.096 . . . . 0.0 110.312 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -38.18 -46.65 1.91 Allowed Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.529 1.143 . . . . 0.0 110.989 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -154.31 121.9 5.82 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.499 0.764 . . . . 0.0 109.31 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -64.12 169.07 4.72 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.509 1.131 . . . . 0.0 109.329 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -106.42 120.7 42.58 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.473 1.108 . . . . 0.0 109.316 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.64 121.32 15.13 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.471 1.107 . . . . 0.0 110.021 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.493 0 O-C-N 124.468 1.105 . . . . 0.0 109.317 -179.925 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.985 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 18.1 p -129.53 171.48 12.54 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.473 0.749 . . . . 0.0 109.964 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -114.64 146.48 40.8 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.464 1.103 . . . . 0.0 110.309 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -115.27 157.29 23.97 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.447 1.092 . . . . 0.0 110.326 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 34.8 m -112.12 171.67 3.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.504 1.127 . . . . 0.0 109.286 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.57 164.9 11.68 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.532 1.145 . . . . 0.0 110.327 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 3.2 mtt-85 -140.99 143.64 34.58 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.484 1.115 . . . . 0.0 110.341 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -110.32 -17.72 9.18 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.51 1.131 . . . . 0.0 111.005 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.413 ' O ' ' OD1' ' A' ' 226' ' ' ASN . 0.7 OUTLIER -102.2 16.85 24.91 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.427 0.722 . . . . 0.0 109.315 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.492 ' O ' ' CB ' ' A' ' 227' ' ' TRP . 28.9 t80 -53.12 -32.4 47.19 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.488 1.117 . . . . 0.0 111.007 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -86.39 -21.06 7.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.519 1.137 . . . . 0.0 109.311 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.463 ' HG3' ' CG1' ' A' ' 276' ' ' VAL . 0.0 OUTLIER -77.33 -44.15 30.5 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.527 1.142 . . . . 0.0 110.284 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . 0.471 ' CG ' ' CG2' ' A' ' 248' ' ' VAL . 18.4 p-10 -81.02 -30.73 34.85 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.52 1.137 . . . . 0.0 109.317 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' TRP . . . . . 0.492 ' CB ' ' O ' ' A' ' 223' ' ' PHE . 1.0 OUTLIER -68.86 -45.27 71.5 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 0.0 107.981 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.467 ' O ' ' N ' ' A' ' 232' ' ' ALA . 3.5 pt20 -71.98 -32.18 67.0 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.568 1.167 . . . . 0.0 110.282 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.403 ' CD1' ' O ' ' A' ' 225' ' ' ARG . 1.2 mt -63.4 -47.71 80.84 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.534 1.146 . . . . 0.0 109.306 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.478 ' O ' ' CG2' ' A' ' 233' ' ' VAL . 34.1 m -66.98 -41.24 87.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.483 1.115 . . . . 0.0 109.324 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.443 ' N ' HG23 ' A' ' 230' ' ' VAL . . . -76.76 -11.4 59.83 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.535 1.147 . . . . 0.0 109.277 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 228' ' ' GLN . . . -81.24 -26.01 36.18 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.479 1.112 . . . . 0.0 109.298 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . 0.478 ' CG2' ' O ' ' A' ' 230' ' ' VAL . 34.1 m -86.46 135.9 35.85 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.493 1.121 . . . . 0.0 109.279 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.94 -13.48 21.54 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.497 1.788 . . . . 0.0 111.046 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.86 -28.65 66.9 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.485 1.116 . . . . 0.0 109.334 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . 0.465 ' HA ' ' CD1' ' A' ' 239' ' ' LEU . 11.6 m-30 -110.82 -17.01 13.44 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.518 1.136 . . . . 0.0 111.033 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.4 -26.65 65.31 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.467 1.104 . . . . 0.0 110.335 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -83.45 7.56 16.54 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.465 1.103 . . . . 0.0 109.291 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.465 ' CD1' ' HA ' ' A' ' 236' ' ' PHE . 34.0 mt -101.65 -179.48 4.03 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.538 1.149 . . . . 0.0 109.294 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -92.06 176.84 39.4 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.479 1.112 . . . . 0.0 110.992 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -30.34 7.24 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.457 1.767 . . . . 0.0 111.009 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 0.44 ' O ' HG11 ' A' ' 245' ' ' VAL . . . -70.91 -31.49 68.13 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 0.0 109.322 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.479 HG22 ' CD1' ' A' ' 337' ' ' ILE . 2.7 t -76.89 -43.0 33.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.504 1.128 . . . . 0.0 109.327 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.3 -45.16 77.34 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.529 1.143 . . . . 0.0 109.321 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.49 ' CG2' ' CZ3' ' A' ' 227' ' ' TRP . 2.9 p -64.49 -44.83 96.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.529 1.143 . . . . 0.0 109.32 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.405 ' N ' ' CG1' ' A' ' 245' ' ' VAL . 19.7 tp10 -66.01 -34.66 78.61 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.45 1.094 . . . . 0.0 110.301 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.441 ' CG1' HD13 ' A' ' 330' ' ' LEU . 15.5 mt -68.81 -55.17 16.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.548 1.155 . . . . 0.0 109.31 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.474 ' HA ' ' CD1' ' A' ' 251' ' ' LEU . 13.7 p -64.81 -30.36 50.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.532 1.145 . . . . 0.0 109.318 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.484 ' CG ' ' O ' ' A' ' 245' ' ' VAL . 5.8 mmm180 -70.17 -28.76 65.58 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.526 1.141 . . . . 0.0 110.308 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -86.86 -21.06 26.61 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.475 1.109 . . . . 0.0 109.309 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.474 ' CD1' ' HA ' ' A' ' 248' ' ' VAL . 1.7 mt -54.72 144.85 20.88 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.527 1.142 . . . . 0.0 109.256 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.66 124.88 50.82 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.485 1.116 . . . . 0.0 110.302 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -81.94 124.25 29.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.486 1.116 . . . . 0.0 109.267 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.46 136.56 48.04 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.523 1.139 . . . . 0.0 110.295 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 55.7 m -94.16 125.04 38.55 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 0.0 110.384 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 42.1 t -106.8 113.95 62.23 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.47 1.106 . . . . 0.0 109.301 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.493 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.2 Cg_endo -75.03 158.11 42.27 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.49 1.784 . . . . 0.0 110.983 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.482 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -57.85 125.39 22.82 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.491 1.119 . . . . 0.0 109.314 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 101.52 -24.08 32.85 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.513 1.133 . . . . 0.0 110.99 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . 0.493 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -61.35 147.44 44.75 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.554 0.796 . . . . 0.0 109.291 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.9 t -97.11 131.3 44.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.51 1.131 . . . . 0.0 109.298 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.404 HG21 ' CD1' ' A' ' 319' ' ' LEU . 86.2 mt -83.11 -47.96 17.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.457 1.098 . . . . 0.0 109.33 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 14.3 p -153.88 145.48 23.26 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.478 1.111 . . . . 0.0 108.289 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -89.25 178.96 6.22 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.542 1.151 . . . . 0.0 110.28 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.468 HG22 ' CB ' ' A' ' 310' ' ' THR . 0.1 OUTLIER -77.89 130.69 35.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.48 1.112 . . . . 0.0 109.261 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 59.9 49.4 78.94 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.497 1.123 . . . . 0.0 111.012 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.12 164.3 58.11 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.521 0.777 . . . . 0.0 110.325 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.5 Cg_endo -74.98 80.6 2.39 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.517 1.799 . . . . 0.0 111.043 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 268' ' ' PRO . . . -37.14 95.82 0.01 OUTLIER Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.488 1.117 . . . . 0.0 111.024 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 268' ' ' PRO . 1.0 OUTLIER -170.2 37.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.499 0.764 . . . . 0.0 109.311 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 6.5 ttt180 -171.57 146.33 2.17 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.506 1.129 . . . . 0.0 110.309 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' MET . . . . . . . . . . . . . 2.6 ttt -116.69 146.51 42.71 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.533 1.146 . . . . 0.0 111.023 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.561 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 44.5 m-85 -133.92 137.03 44.64 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.124 . . . . 0.0 111.023 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . 0.437 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 21.1 m-85 -126.38 133.48 51.3 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.519 1.137 . . . . 0.0 111.003 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 3.2 t -91.07 133.11 33.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.475 1.109 . . . . 0.0 109.294 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . 0.463 ' CG1' ' HG3' ' A' ' 225' ' ' ARG . 40.2 t -110.27 -35.35 2.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.576 1.173 . . . . 0.0 109.268 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . 0.401 ' O ' ' CG1' ' A' ' 317' ' ' VAL . 0.3 OUTLIER -156.27 137.84 14.09 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.516 1.135 . . . . 0.0 110.309 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.455 ' HA3' ' CG2' ' A' ' 317' ' ' VAL . . . 117.15 -177.53 16.7 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.483 1.114 . . . . 0.0 110.987 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' SER . . . . . 0.412 ' N ' HG23 ' A' ' 317' ' ' VAL . 2.7 m -126.35 113.49 16.98 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.478 0.752 . . . . 0.0 109.97 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 32.7 m -99.26 135.1 35.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.493 1.121 . . . . 0.0 109.325 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 29.3 t -104.16 148.49 26.23 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.475 1.109 . . . . 0.0 109.997 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 1.7 t -112.27 128.92 68.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.482 1.113 . . . . 0.0 109.319 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.415 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -77.34 100.96 6.11 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.538 1.149 . . . . 0.0 109.282 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' THR . . . . . 0.661 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.9 OUTLIER -149.37 -167.99 0.17 Allowed Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.455 1.097 . . . . 0.0 110.382 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.661 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.4 Cg_endo -75.0 3.93 5.19 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.51 1.794 . . . . 0.0 111.028 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -152.21 154.82 32.76 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.448 1.093 . . . . 0.0 109.276 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 95.48 0.98 Allowed 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.515 1.797 . . . . 0.0 110.981 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 1.3 t -100.03 118.53 46.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.491 1.119 . . . . 0.0 109.303 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -125.16 133.53 52.76 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.498 1.124 . . . . 0.0 110.312 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -115.41 139.66 49.82 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.506 1.129 . . . . 0.0 109.324 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -95.77 -155.96 31.31 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.502 1.126 . . . . 0.0 110.98 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 138.37 22.82 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.53 1.805 . . . . 0.0 110.972 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 95.23 6.19 60.2 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.481 1.113 . . . . 0.0 110.965 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -90.58 130.75 36.58 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.461 0.742 . . . . 0.0 109.238 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 295' ' ' PHE . 2.3 p90 -120.75 152.92 37.7 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.506 1.129 . . . . 0.0 111.018 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . 0.561 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 36.9 p90 -164.72 148.27 8.92 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.13 . . . . 0.0 110.975 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 128.07 -8.45 6.74 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.457 1.098 . . . . 0.0 110.989 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -54.94 -53.35 56.76 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.474 0.749 . . . . 0.0 110.319 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -46.98 -35.03 6.12 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.512 1.133 . . . . 0.0 110.979 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . 0.458 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -68.74 -46.91 67.64 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.515 1.134 . . . . 0.0 109.324 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 1.1 mp -75.21 -3.21 31.76 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.475 1.11 . . . . 0.0 109.312 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . 0.565 HD12 ' CZ ' ' A' ' 341' ' ' PHE . 8.8 mm -86.85 -54.35 8.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.509 1.131 . . . . 0.0 109.296 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 304' ' ' GLY . 0.9 OUTLIER -149.44 40.89 0.86 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.47 1.106 . . . . 0.0 110.036 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 37.03 34.04 0.1 OUTLIER Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.54 1.15 . . . . 0.0 110.989 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.72 155.23 89.88 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.502 0.766 . . . . 0.0 110.266 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 129.66 12.52 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.468 1.773 . . . . 0.0 111.013 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.98 -29.64 1.52 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.503 1.127 . . . . 0.0 110.273 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 50.65 40.88 25.01 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.444 1.09 . . . . 0.0 109.957 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . 175.26 160.82 0.24 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.497 1.123 . . . . 0.0 109.311 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.468 ' CB ' HG22 ' A' ' 265' ' ' ILE . 0.9 OUTLIER -117.78 123.43 45.97 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.539 1.149 . . . . 0.0 110.392 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 95.1 t -103.99 131.39 52.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.506 1.129 . . . . 0.0 109.279 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 65.2 p -131.54 151.27 51.72 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.475 1.109 . . . . 0.0 109.997 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.26 109.65 19.65 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.515 1.134 . . . . 0.0 109.282 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -56.41 -32.19 64.61 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.503 1.127 . . . . 0.0 109.304 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' THR . . . . . 0.482 ' HA ' ' CB ' ' A' ' 258' ' ' ALA . 8.2 t -153.86 -171.76 3.99 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.526 1.141 . . . . 0.0 110.416 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' THR . . . . . 0.452 ' N ' ' OG1' ' A' ' 315' ' ' THR . 43.1 p -54.74 87.91 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.554 1.159 . . . . 0.0 110.39 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.455 ' CG2' ' HA3' ' A' ' 278' ' ' GLY . 44.9 t -107.71 144.25 16.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.482 1.113 . . . . 0.0 109.265 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 69.1 m -117.99 117.87 30.4 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.529 1.143 . . . . 0.0 109.958 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . 0.437 ' CB ' ' O ' ' A' ' 274' ' ' PHE . 0.0 OUTLIER -128.48 173.33 10.32 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.49 1.119 . . . . 0.0 109.328 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.403 HD12 ' CG2' ' A' ' 276' ' ' VAL . 0.2 OUTLIER -124.49 136.3 53.9 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.471 1.107 . . . . 0.0 109.298 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 14.1 t -96.23 154.63 17.15 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.513 1.133 . . . . 0.0 110.01 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.469 ' HB2' ' CD2' ' A' ' 251' ' ' LEU . 1.2 tm? -145.28 87.66 1.82 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.506 1.129 . . . . 0.0 109.268 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -49.69 139.1 13.34 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.557 1.16 . . . . 0.0 109.602 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 36.0 t -59.52 -23.87 63.17 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.466 1.104 . . . . 0.0 110.006 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -55.95 -31.03 62.58 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.474 1.108 . . . . 0.0 109.325 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -70.11 -38.88 75.72 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.532 1.145 . . . . 0.0 109.357 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -67.5 -36.51 81.23 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.517 1.136 . . . . 0.0 110.965 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -70.32 -37.01 74.63 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.525 1.14 . . . . 0.0 110.297 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 5.1 ttp -68.86 -40.39 79.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 0.0 111.009 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.441 HD13 ' CG1' ' A' ' 247' ' ' ILE . 9.3 mt -72.14 -34.52 68.6 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.462 1.101 . . . . 0.0 109.299 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 16.0 m -74.18 -33.32 63.41 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.488 1.117 . . . . 0.0 108.318 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 8.6 t -75.91 -36.52 59.41 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.129 . . . . 0.0 110.004 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 10.0 t -74.51 -34.34 63.01 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.487 1.117 . . . . 0.0 110.03 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' SER . . . . . 0.445 ' CB ' ' CD1' ' A' ' 337' ' ' ILE . 0.3 OUTLIER -128.1 114.62 20.22 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.562 1.164 . . . . 0.0 110.036 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -18.95 18.29 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.499 1.789 . . . . 0.0 111.013 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -72.37 -28.92 63.33 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 0.0 110.329 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.479 ' CD1' HG22 ' A' ' 243' ' ' VAL . 46.2 mt -72.69 -41.43 62.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.554 1.159 . . . . 0.0 109.257 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.97 -32.41 65.18 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.455 1.097 . . . . 0.0 109.27 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.53 -39.75 62.16 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.491 1.12 . . . . 0.0 110.293 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 48.6 mt -73.23 -42.69 57.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.551 1.157 . . . . 0.0 109.286 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.565 ' CZ ' HD12 ' A' ' 302' ' ' ILE . 46.7 t80 -69.24 -34.26 74.55 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.55 1.157 . . . . 0.0 111.009 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . 0.46 ' HG3' ' CD1' ' A' ' 346' ' ' LEU . 1.4 ttp-105 -72.78 -39.54 66.64 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.538 1.149 . . . . 0.0 110.276 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -50.59 65.93 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.509 1.13 . . . . 0.0 109.291 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 7.6 t -65.37 -32.98 74.9 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.47 1.106 . . . . 0.0 110.453 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -66.74 -44.99 80.05 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.521 1.138 . . . . 0.0 109.334 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.46 ' CD1' ' HG3' ' A' ' 342' ' ' ARG . 0.6 OUTLIER -65.14 -37.03 86.12 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.503 1.127 . . . . 0.0 109.289 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.08 -39.22 92.89 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.472 1.107 . . . . 0.0 110.31 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 49.6 mtt-85 -72.8 -43.3 62.92 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.481 1.113 . . . . 0.0 110.296 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 350' ' ' GLY . 0.0 OUTLIER -71.46 -34.52 70.29 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 0.0 110.311 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 349' ' ' ARG . . . -36.08 -46.99 1.0 Allowed Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.547 1.155 . . . . 0.0 110.966 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -155.19 120.64 4.99 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.482 0.754 . . . . 0.0 109.325 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -60.46 170.05 1.51 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.469 1.105 . . . . 0.0 109.258 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -115.79 132.25 56.7 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.492 1.12 . . . . 0.0 109.33 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 48.3 m -77.95 125.93 30.09 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.545 1.153 . . . . 0.0 110.014 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.47 0 O-C-N 124.472 1.108 . . . . 0.0 109.303 -179.973 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.999 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 5.4 m -97.11 149.99 21.35 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.501 0.765 . . . . 0.0 110.012 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -154.94 146.56 23.23 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.51 1.131 . . . . 0.0 110.279 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.6 157.52 18.42 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.451 1.095 . . . . 0.0 110.299 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.1 m -107.24 166.38 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.488 1.118 . . . . 0.0 109.309 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 7.9 mtt85 -103.66 168.59 9.05 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.497 1.123 . . . . 0.0 110.329 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.55 154.36 39.33 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.504 1.127 . . . . 0.0 110.319 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -110.73 19.05 26.36 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.516 1.135 . . . . 0.0 111.002 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.2 19.64 6.76 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.496 0.762 . . . . 0.0 109.283 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.437 ' CZ ' HG12 ' A' ' 248' ' ' VAL . 40.0 t80 -52.98 -36.61 60.45 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.48 1.113 . . . . 0.0 111.046 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.98 -33.29 58.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.471 1.107 . . . . 0.0 109.339 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -35.02 77.74 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.498 1.124 . . . . 0.0 110.308 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . 0.454 ' OD1' ' CD1' ' A' ' 320' ' ' LEU . 3.7 m-20 -77.46 -30.44 53.23 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.487 1.117 . . . . 0.0 109.279 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' TRP . . . . . 0.481 ' CZ2' HG23 ' A' ' 245' ' ' VAL . 1.9 t90 -67.58 -44.81 77.26 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.513 1.133 . . . . 0.0 108.04 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 232' ' ' ALA . 5.7 pt20 -71.14 -35.75 71.81 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.493 1.12 . . . . 0.0 110.307 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.45 -47.43 85.76 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.509 1.131 . . . . 0.0 109.323 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 99.7 t -71.76 -40.76 70.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.473 1.108 . . . . 0.0 109.274 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.58 -15.94 62.81 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.481 1.113 . . . . 0.0 109.251 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 228' ' ' GLN . . . -81.34 -11.09 59.42 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.553 1.158 . . . . 0.0 109.31 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 31.2 t -89.64 123.33 66.81 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.514 1.134 . . . . 0.0 109.308 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 -16.09 20.31 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.481 1.78 . . . . 0.0 110.997 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.573 HD13 ' CE2' ' A' ' 341' ' ' PHE . 0.0 OUTLIER -79.6 -24.66 41.85 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.498 1.124 . . . . 0.0 109.268 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -108.51 -11.88 15.08 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.537 1.148 . . . . 0.0 111.022 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.66 -24.65 66.87 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.488 1.118 . . . . 0.0 110.338 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -74.62 -4.45 37.21 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.516 1.135 . . . . 0.0 109.333 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.493 ' HB2' ' CD2' ' A' ' 244' ' ' LEU . 12.5 mt -85.0 -179.65 7.1 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.45 1.094 . . . . 0.0 109.321 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -103.24 -172.66 26.15 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.489 1.118 . . . . 0.0 111.012 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.492 ' O ' ' CG2' ' A' ' 245' ' ' VAL . 18.2 Cg_endo -75.02 -36.14 2.71 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.464 1.77 . . . . 0.0 111.02 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.04 -35.31 78.04 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.533 1.146 . . . . 0.0 109.299 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.432 ' CG1' ' HB3' ' A' ' 239' ' ' LEU . 13.0 t -75.33 -36.58 36.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.451 1.095 . . . . 0.0 109.258 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.493 ' CD2' ' HB2' ' A' ' 239' ' ' LEU . 1.6 mm? -70.54 -35.48 73.16 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.499 1.125 . . . . 0.0 109.304 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.492 ' CG2' ' O ' ' A' ' 241' ' ' PRO . 96.4 t -72.85 -38.28 56.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.473 1.108 . . . . 0.0 109.334 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -69.06 -49.7 55.1 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.514 1.134 . . . . 0.0 110.235 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.42 ' CD1' HG12 ' A' ' 243' ' ' VAL . 14.1 mt -63.13 -35.63 72.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.502 1.127 . . . . 0.0 109.319 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 244' ' ' LEU . 4.6 t -67.51 -41.13 85.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.526 1.141 . . . . 0.0 109.309 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -77.23 -13.03 60.01 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.489 1.118 . . . . 0.0 110.298 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -89.18 -17.46 29.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.461 1.101 . . . . 0.0 109.311 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.462 ' CD2' ' HB2' ' A' ' 322' ' ' LEU . 3.2 mt -65.89 144.53 56.75 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.456 1.097 . . . . 0.0 109.294 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.75 133.15 55.72 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.535 1.147 . . . . 0.0 110.284 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -80.63 130.91 35.38 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.462 1.101 . . . . 0.0 109.284 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.22 125.03 19.63 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.489 1.118 . . . . 0.0 110.295 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 13.4 m -91.07 116.53 28.88 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.49 1.119 . . . . 0.0 110.381 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.492 HG11 ' CB ' ' A' ' 313' ' ' ALA . 24.4 t -107.05 111.63 63.5 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 124.533 1.145 . . . . 0.0 109.315 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.528 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.96 176.38 9.98 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.482 1.78 . . . . 0.0 111.039 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.504 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -67.8 134.14 50.44 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.505 1.128 . . . . 0.0 109.304 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 89.15 -25.53 10.13 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.501 1.126 . . . . 0.0 110.981 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . 0.528 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -55.43 148.49 15.15 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.489 0.758 . . . . 0.0 109.285 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 2.7 t -96.93 129.7 46.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.536 1.148 . . . . 0.0 109.309 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 65.7 mt -84.81 -45.77 17.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.533 1.145 . . . . 0.0 109.303 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 13.5 p -154.97 149.71 26.58 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.486 1.116 . . . . 0.0 108.333 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -89.53 175.9 7.1 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.128 . . . . 0.0 110.308 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -76.97 141.16 16.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.503 1.127 . . . . 0.0 109.321 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 45.67 49.46 12.11 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.524 1.14 . . . . 0.0 110.974 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.471 ' HG3' ' N ' ' A' ' 268' ' ' PRO . 2.9 pt-20 -73.1 173.75 5.58 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.48 0.753 . . . . 0.0 110.275 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . 0.471 ' N ' ' HG3' ' A' ' 267' ' ' GLU . 18.2 Cg_endo -75.01 97.1 1.05 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.493 1.786 . . . . 0.0 110.967 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -50.88 89.46 0.01 OUTLIER Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.465 1.103 . . . . 0.0 110.964 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 268' ' ' PRO . 40.6 m-20 -170.39 38.36 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.48 0.753 . . . . 0.0 109.3 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -171.23 149.21 2.78 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.504 1.128 . . . . 0.0 110.353 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.519 ' HE2' ' CE1' ' A' ' 274' ' ' PHE . 8.3 ptm -138.74 146.97 42.1 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.5 1.125 . . . . 0.0 110.97 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 296' ' ' PHE . 34.0 m-85 -124.98 151.48 45.46 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.528 1.143 . . . . 0.0 110.943 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . 0.519 ' CE1' ' HE2' ' A' ' 272' ' ' MET . 23.6 m-85 -129.48 124.89 35.14 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.497 1.123 . . . . 0.0 110.99 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 76.2 t -79.7 138.19 20.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.477 1.11 . . . . 0.0 109.278 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . 0.41 ' CG2' HD12 ' A' ' 320' ' ' LEU . 2.9 t -116.14 -47.54 4.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.443 1.089 . . . . 0.0 109.304 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -145.62 135.9 23.94 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.533 1.146 . . . . 0.0 110.318 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.404 ' HA3' ' HB ' ' A' ' 317' ' ' VAL . . . 115.63 -155.11 16.5 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.535 1.147 . . . . 0.0 110.99 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 3.1 m -151.32 138.62 19.36 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.461 0.742 . . . . 0.0 109.982 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.475 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 17.6 m -117.59 166.77 11.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.496 1.122 . . . . 0.0 109.287 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 29.4 t -131.9 155.47 47.83 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.475 1.109 . . . . 0.0 109.983 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -119.12 129.37 75.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.474 1.109 . . . . 0.0 109.308 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.4 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -77.77 101.85 6.9 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.512 1.133 . . . . 0.0 109.271 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' THR . . . . . 0.649 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.39 -168.62 0.19 Allowed Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.509 1.13 . . . . 0.0 110.392 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.649 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -74.98 4.88 4.33 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.469 1.773 . . . . 0.0 110.965 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -151.83 157.12 34.53 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.455 1.097 . . . . 0.0 109.31 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.98 94.89 0.96 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.488 1.783 . . . . 0.0 110.981 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 31.2 t -99.04 119.45 47.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.498 1.123 . . . . 0.0 109.323 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -124.33 136.89 54.44 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.491 1.119 . . . . 0.0 110.296 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.475 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 3.9 mm? -114.76 142.83 45.99 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.533 1.145 . . . . 0.0 109.288 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -98.44 -164.97 30.78 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.497 1.123 . . . . 0.0 110.981 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 156.23 43.07 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.454 1.765 . . . . 0.0 110.974 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 77.37 2.17 78.44 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.508 1.13 . . . . 0.0 110.973 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -87.79 136.05 33.12 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.518 0.775 . . . . 0.0 109.325 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . 0.502 ' HB3' ' CD1' ' A' ' 274' ' ' PHE . 0.7 OUTLIER -123.76 153.05 41.47 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.508 1.13 . . . . 0.0 110.983 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 273' ' ' PHE . 51.7 p90 -163.52 143.35 8.54 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.515 1.134 . . . . 0.0 110.962 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . 0.469 ' HA3' ' CB ' ' A' ' 272' ' ' MET . . . 137.57 -14.31 3.67 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.499 1.125 . . . . 0.0 110.943 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -52.84 -44.41 66.72 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.514 0.773 . . . . 0.0 110.311 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' MET . . . . . 0.426 ' HB3' ' CG ' ' A' ' 305' ' ' GLU . 0.1 OUTLIER -47.37 -39.11 14.41 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.487 1.117 . . . . 0.0 111.003 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -72.64 -37.16 68.08 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.489 1.118 . . . . 0.0 109.31 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.489 ' CD1' ' SD ' ' A' ' 272' ' ' MET . 4.5 mt -76.67 -5.47 48.06 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.485 1.116 . . . . 0.0 109.34 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 22.0 mt -91.81 -51.43 11.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.475 1.109 . . . . 0.0 109.261 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.442 ' O ' ' C ' ' A' ' 304' ' ' GLY . 1.2 m -151.94 41.01 0.65 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.506 1.129 . . . . 0.0 109.954 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 34.7 39.97 0.18 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.498 1.123 . . . . 0.0 110.99 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . 0.426 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 0.5 OUTLIER -68.17 151.05 97.48 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.505 0.768 . . . . 0.0 110.292 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 132.36 15.37 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.532 1.806 . . . . 0.0 111.03 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . 0.425 ' NH2' ' HA2' ' A' ' 297' ' ' GLY . 10.5 mmp_? -44.39 -44.92 8.65 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.436 1.085 . . . . 0.0 110.309 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.31 38.18 4.58 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.483 1.114 . . . . 0.0 109.991 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . 171.73 160.88 0.1 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.532 1.145 . . . . 0.0 109.308 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.89 125.48 52.85 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.529 1.143 . . . . 0.0 110.409 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 77.7 t -103.3 127.7 56.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 0.0 109.318 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 87.5 p -127.86 157.45 40.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.516 1.135 . . . . 0.0 109.994 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . 0.501 ' CB ' ' CG1' ' A' ' 317' ' ' VAL . . . -89.19 112.99 24.14 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.502 1.126 . . . . 0.0 109.319 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -54.3 -32.71 57.12 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.55 1.156 . . . . 0.0 109.35 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' THR . . . . . 0.504 ' HA ' ' CB ' ' A' ' 258' ' ' ALA . 9.8 t -158.63 -159.05 0.75 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.462 1.101 . . . . 0.0 110.44 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' THR . . . . . 0.443 ' N ' ' OG1' ' A' ' 315' ' ' THR . 86.6 m -66.03 81.26 0.08 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.525 1.141 . . . . 0.0 110.38 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.501 ' CG1' ' CB ' ' A' ' 313' ' ' ALA . 1.3 p -108.26 140.98 24.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.491 1.12 . . . . 0.0 109.265 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 49.2 m -112.3 127.73 56.07 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.511 1.132 . . . . 0.0 110.003 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . 0.48 HD13 ' CG2' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -134.81 174.71 10.28 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.555 1.159 . . . . 0.0 109.295 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.454 ' CD1' ' OD1' ' A' ' 226' ' ' ASN . 1.0 OUTLIER -124.18 135.27 53.35 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.499 1.124 . . . . 0.0 109.312 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 53.9 p -96.86 150.66 20.49 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.531 1.144 . . . . 0.0 109.994 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.462 ' HB2' ' CD2' ' A' ' 251' ' ' LEU . 2.6 tm? -146.17 104.02 3.77 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.529 1.143 . . . . 0.0 109.304 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -65.15 138.53 58.34 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.448 1.092 . . . . 0.0 109.578 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 89.2 p -59.81 -19.65 52.03 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.48 1.113 . . . . 0.0 109.985 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -51.22 -35.36 36.3 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.514 1.134 . . . . 0.0 109.261 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -65.84 -38.38 88.72 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.508 1.13 . . . . 0.0 109.295 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -67.85 -37.79 82.33 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.5 1.125 . . . . 0.0 110.981 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -68.81 -32.49 72.23 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.515 1.134 . . . . 0.0 110.31 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 15.6 tmm? -70.58 -43.2 69.9 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.519 1.137 . . . . 0.0 111.022 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.82 -31.2 61.63 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.124 . . . . 0.0 109.278 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 1.8 m -75.0 -39.74 61.03 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.457 1.098 . . . . 0.0 108.297 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 26.3 t -70.8 -32.55 69.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.53 1.144 . . . . 0.0 110.013 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 31.9 t -79.16 -35.68 41.59 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.511 1.132 . . . . 0.0 109.988 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 1.5 m -128.96 109.16 18.3 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.522 1.139 . . . . 0.0 109.972 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 -20.26 17.04 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.504 1.792 . . . . 0.0 111.052 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.453 ' O ' ' CG1' ' A' ' 340' ' ' ILE . 1.2 tt0 -66.1 -37.26 85.31 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 0.0 110.347 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.407 ' CG2' ' CD2' ' A' ' 239' ' ' LEU . 88.1 mt -75.97 -42.8 39.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.44 1.088 . . . . 0.0 109.285 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -64.83 -45.23 87.02 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.484 1.115 . . . . 0.0 109.315 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.52 -33.37 74.0 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.49 1.119 . . . . 0.0 110.314 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.453 ' CG1' ' O ' ' A' ' 336' ' ' GLU . 21.1 mt -70.17 -40.66 78.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.519 1.137 . . . . 0.0 109.341 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.573 ' CE2' HD13 ' A' ' 235' ' ' LEU . 2.7 t80 -69.08 -35.13 76.15 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.499 1.125 . . . . 0.0 111.036 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 27.7 ttt-85 -70.37 -38.94 74.85 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.494 1.121 . . . . 0.0 110.318 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -51.07 63.16 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.535 1.147 . . . . 0.0 109.328 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 13.1 t -68.64 -33.32 73.82 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.497 1.123 . . . . 0.0 110.43 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . 0.503 ' CB ' ' O ' ' A' ' 341' ' ' PHE . . . -70.18 -36.44 74.66 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.445 1.091 . . . . 0.0 109.301 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 11.7 mt -69.28 -40.94 77.47 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.471 1.107 . . . . 0.0 109.318 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -68.42 -34.05 75.31 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.486 1.116 . . . . 0.0 110.323 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 34.3 mtt-85 -73.05 -42.83 62.67 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.474 1.109 . . . . 0.0 110.285 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 4.9 tpt85 -68.54 -39.13 81.23 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.513 1.133 . . . . 0.0 110.266 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -39.84 -46.65 3.1 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.509 1.131 . . . . 0.0 110.979 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -155.0 120.67 5.08 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.477 0.751 . . . . 0.0 109.264 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -60.04 166.74 2.63 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.475 1.109 . . . . 0.0 109.303 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -102.8 135.45 44.44 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.509 1.131 . . . . 0.0 109.268 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 58.1 m -135.08 168.21 19.54 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.535 1.147 . . . . 0.0 109.984 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.463 0 O-C-N 124.469 1.106 . . . . 0.0 109.297 -179.992 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.993 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.91 159.29 37.87 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.51 0.771 . . . . 0.0 110.019 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -135.63 170.09 16.5 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.549 1.156 . . . . 0.0 110.275 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -124.09 134.43 53.38 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.473 1.108 . . . . 0.0 110.307 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 1.4 p -137.87 157.59 32.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.511 1.132 . . . . 0.0 109.309 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 37.2 mtp180 -81.65 144.67 31.04 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.444 1.09 . . . . 0.0 110.28 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.83 172.67 6.76 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 0.0 110.302 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.78 -11.89 84.26 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.48 1.112 . . . . 0.0 110.984 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -109.47 13.15 24.19 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.499 0.764 . . . . 0.0 109.306 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -52.76 -34.5 53.35 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.483 1.114 . . . . 0.0 110.954 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 225' ' ' ARG . 0.3 OUTLIER -75.55 -39.64 40.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.124 . . . . 0.0 109.252 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.414 ' HA ' ' NE2' ' A' ' 228' ' ' GLN . 13.6 tpp85 -68.37 -30.64 69.63 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.115 . . . . 0.0 110.275 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . 0.501 ' HB3' ' CG2' ' A' ' 248' ' ' VAL . 2.2 m-20 -79.3 -41.4 28.12 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.408 1.068 . . . . 0.0 109.302 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -66.68 -44.52 81.54 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.527 1.142 . . . . 0.0 107.977 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.452 ' O ' ' CB ' ' A' ' 232' ' ' ALA . 2.6 pt20 -67.71 -31.63 71.71 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.478 1.111 . . . . 0.0 110.31 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.6 mt -63.54 -45.08 92.2 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.514 1.133 . . . . 0.0 109.316 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.426 HG23 ' N ' ' A' ' 231' ' ' ALA . 35.2 m -74.55 -38.78 46.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.528 1.143 . . . . 0.0 109.33 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.426 ' N ' HG23 ' A' ' 230' ' ' VAL . . . -75.42 -11.78 60.11 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.47 1.106 . . . . 0.0 109.336 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 228' ' ' GLN . . . -81.32 -23.99 37.44 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.525 1.14 . . . . 0.0 109.247 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.35 130.93 60.23 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.475 1.109 . . . . 0.0 109.263 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -16.75 19.98 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.513 1.796 . . . . 0.0 110.982 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.448 HD11 ' CE2' ' A' ' 341' ' ' PHE . 0.1 OUTLIER -63.34 -30.04 71.24 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.456 1.098 . . . . 0.0 109.33 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . 0.521 ' CG ' HD13 ' A' ' 239' ' ' LEU . 16.1 m-30 -112.95 17.08 19.18 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.538 1.149 . . . . 0.0 111.003 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -70.01 -20.02 63.29 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.549 1.155 . . . . 0.0 110.282 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -92.58 -12.37 31.94 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.508 1.13 . . . . 0.0 109.302 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.521 HD13 ' CG ' ' A' ' 236' ' ' PHE . 46.0 mt -70.11 179.26 2.41 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.46 1.1 . . . . 0.0 109.276 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -109.79 -174.89 20.94 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.509 1.131 . . . . 0.0 111.006 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 -32.84 5.13 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.485 1.782 . . . . 0.0 111.065 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 0.426 ' O ' HG12 ' A' ' 245' ' ' VAL . . . -73.09 -33.2 65.47 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.457 1.098 . . . . 0.0 109.284 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.438 HG12 ' CD2' ' A' ' 239' ' ' LEU . 63.5 t -77.09 -36.59 24.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.474 1.109 . . . . 0.0 109.334 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.439 ' N ' HD23 ' A' ' 244' ' ' LEU . 3.8 mm? -72.57 -42.65 64.4 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.497 1.123 . . . . 0.0 109.289 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.454 ' O ' ' CG ' ' A' ' 249' ' ' ARG . 2.8 p -68.21 -39.51 81.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.465 1.103 . . . . 0.0 109.261 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -70.88 -40.99 71.91 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.52 1.138 . . . . 0.0 110.284 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.452 HG12 ' CD1' ' A' ' 330' ' ' LEU . 25.6 mt -66.56 -51.97 51.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.503 1.127 . . . . 0.0 109.278 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.501 ' CG2' ' HB3' ' A' ' 226' ' ' ASN . 10.0 p -62.87 -30.74 50.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.48 1.113 . . . . 0.0 109.315 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.454 ' CG ' ' O ' ' A' ' 245' ' ' VAL . 16.6 mmm-85 -73.55 -25.77 60.54 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.542 1.151 . . . . 0.0 110.283 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -85.2 -17.98 35.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 0.0 109.297 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.41 144.24 47.43 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 0.0 109.339 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -118.18 135.09 54.45 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.558 1.161 . . . . 0.0 110.331 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -80.68 123.18 27.96 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.532 1.145 . . . . 0.0 109.303 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.6 ttm-85 -125.05 123.49 39.9 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.462 1.101 . . . . 0.0 110.34 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 50.2 m -91.51 117.65 29.89 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.484 1.115 . . . . 0.0 110.428 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.471 ' CG1' ' HB2' ' A' ' 313' ' ' ALA . 2.6 t -109.41 113.46 58.36 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.524 1.14 . . . . 0.0 109.285 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -75.0 168.71 24.24 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.543 1.812 . . . . 0.0 111.011 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.493 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -65.93 126.34 28.24 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.524 1.14 . . . . 0.0 109.286 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 100.59 -25.32 28.75 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.489 1.118 . . . . 0.0 111.003 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . 0.491 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -67.27 145.08 55.52 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.497 0.763 . . . . 0.0 109.301 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 5.8 t -94.82 135.02 30.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.504 1.128 . . . . 0.0 109.299 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 17.8 mt -82.95 -42.74 18.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.541 1.151 . . . . 0.0 109.29 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' CYS . . . . . 0.493 ' SG ' ' CG2' ' A' ' 311' ' ' VAL . 11.3 p -152.4 142.61 22.4 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.49 1.119 . . . . 0.0 108.289 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 3.4 mmt85 -84.87 178.58 7.56 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.5 1.125 . . . . 0.0 110.277 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.47 ' CG2' ' HB ' ' A' ' 310' ' ' THR . 0.1 OUTLIER -76.57 137.44 22.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.513 1.133 . . . . 0.0 109.327 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 52.95 50.81 49.34 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.46 1.1 . . . . 0.0 111.026 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -70.37 163.89 58.6 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.486 0.756 . . . . 0.0 110.302 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . 0.507 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.3 Cg_endo -74.98 82.77 1.93 Allowed 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.532 1.806 . . . . 0.0 111.051 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 268' ' ' PRO . . . -36.07 93.16 0.01 OUTLIER Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.477 1.111 . . . . 0.0 110.994 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 268' ' ' PRO . 12.3 m-20 -171.63 37.93 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.528 0.781 . . . . 0.0 109.335 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.442 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 3.3 mtp180 -169.89 144.54 2.79 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.537 1.148 . . . . 0.0 110.359 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.492 ' SD ' ' CD1' ' A' ' 301' ' ' LEU . 2.2 ttt -118.34 147.63 43.3 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.505 1.128 . . . . 0.0 110.99 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.57 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 28.4 m-85 -135.8 136.65 40.86 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.506 1.128 . . . . 0.0 111.006 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . 0.454 ' CD1' ' CB ' ' A' ' 295' ' ' PHE . 22.1 m-85 -125.98 127.49 46.0 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.117 . . . . 0.0 110.998 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 13.7 t -83.96 135.03 25.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.481 1.113 . . . . 0.0 109.319 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 40.3 t -111.75 -49.42 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.492 1.12 . . . . 0.0 109.355 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -139.67 137.96 35.65 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.52 1.137 . . . . 0.0 110.337 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 112.75 -175.47 16.82 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.491 1.12 . . . . 0.0 111.003 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' SER . . . . . 0.415 ' N ' HG21 ' A' ' 317' ' ' VAL . 3.6 m -131.17 120.26 23.05 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.497 0.763 . . . . 0.0 109.964 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.451 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 28.9 m -99.03 164.67 2.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.505 1.128 . . . . 0.0 109.293 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 31.6 t -131.97 148.13 52.5 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.476 1.11 . . . . 0.0 110.017 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -111.26 129.93 65.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.44 1.087 . . . . 0.0 109.295 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -77.96 101.87 7.08 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.505 1.128 . . . . 0.0 109.306 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' THR . . . . . 0.647 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -147.76 -168.55 0.19 Allowed Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.466 1.104 . . . . 0.0 110.427 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.647 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.4 Cg_endo -74.99 4.89 4.33 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.57 1.826 . . . . 0.0 111.025 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -151.37 157.29 35.01 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.496 1.123 . . . . 0.0 109.271 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.1 93.85 0.97 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.51 1.795 . . . . 0.0 110.98 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 4.1 t -97.94 119.37 45.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.115 . . . . 0.0 109.293 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -124.7 140.25 53.11 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.557 1.161 . . . . 0.0 110.315 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.451 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 4.5 mm? -121.81 141.71 50.95 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.505 1.128 . . . . 0.0 109.304 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -96.9 -160.06 31.69 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.498 1.124 . . . . 0.0 111.038 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 142.02 27.24 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.478 1.778 . . . . 0.0 110.982 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 91.46 4.39 68.19 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.508 1.13 . . . . 0.0 111.002 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -92.04 127.76 37.63 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.436 0.727 . . . . 0.0 109.293 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . 0.454 ' CB ' ' CD1' ' A' ' 274' ' ' PHE . 2.4 p90 -114.36 152.8 30.9 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.468 1.105 . . . . 0.0 110.979 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . 0.57 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 33.7 p90 -158.07 148.75 20.67 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.534 1.146 . . . . 0.0 111.018 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 123.54 -5.64 9.25 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.474 1.109 . . . . 0.0 110.955 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -55.83 -46.31 78.14 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.504 0.767 . . . . 0.0 110.305 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 36.9 mmt -51.89 -37.14 51.21 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 0.0 110.984 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -67.42 -41.27 85.11 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.489 1.118 . . . . 0.0 109.278 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.492 ' CD1' ' SD ' ' A' ' 272' ' ' MET . 1.5 mt -77.32 -11.32 59.82 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.563 1.164 . . . . 0.0 109.331 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 7.0 mm -77.17 -56.09 8.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.483 1.114 . . . . 0.0 109.272 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.46 ' O ' ' N ' ' A' ' 305' ' ' GLU . 53.2 p -151.32 48.37 0.83 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.458 1.099 . . . . 0.0 110.026 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 303' ' ' SER . . . 35.08 34.22 0.05 OUTLIER Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.574 1.172 . . . . 0.0 110.991 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . 0.46 ' N ' ' O ' ' A' ' 303' ' ' SER . 0.0 OUTLIER -70.24 151.52 95.84 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.522 0.778 . . . . 0.0 110.297 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 134.15 17.46 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.477 1.777 . . . . 0.0 110.991 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -44.39 -42.47 6.94 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.468 1.105 . . . . 0.0 110.322 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 2.2 t 67.35 28.56 7.84 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 0.0 110.009 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . -176.61 160.55 2.01 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.447 1.092 . . . . 0.0 109.282 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.47 ' HB ' ' CG2' ' A' ' 265' ' ' ILE . 0.3 OUTLIER -108.59 123.64 49.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.512 1.132 . . . . 0.0 110.392 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.493 ' CG2' ' SG ' ' A' ' 263' ' ' CYS . 43.5 t -103.17 130.31 53.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.52 1.138 . . . . 0.0 109.298 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 56.9 p -134.94 157.42 46.94 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.463 1.102 . . . . 0.0 109.993 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . 0.471 ' HB2' ' CG1' ' A' ' 256' ' ' VAL . . . -95.52 116.13 28.39 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.457 1.098 . . . . 0.0 109.299 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -60.22 -33.42 72.23 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.496 1.123 . . . . 0.0 109.276 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' THR . . . . . 0.493 ' HA ' ' CB ' ' A' ' 258' ' ' ALA . 10.2 t -149.77 -173.49 4.43 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.436 1.085 . . . . 0.0 110.403 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' THR . . . . . 0.412 ' N ' ' OG1' ' A' ' 315' ' ' THR . 43.8 p -53.76 88.18 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.513 1.133 . . . . 0.0 110.417 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.472 HG13 ' CD1' ' A' ' 319' ' ' LEU . 57.8 t -107.56 145.82 14.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.533 1.145 . . . . 0.0 109.257 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' SER . . . . . 0.419 ' N ' HG13 ' A' ' 317' ' ' VAL . 50.3 m -122.95 118.31 27.53 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.492 1.12 . . . . 0.0 109.982 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . 0.498 ' CD1' ' N ' ' A' ' 319' ' ' LEU . 0.0 OUTLIER -126.22 175.09 8.04 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.125 . . . . 0.0 109.309 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 273' ' ' PHE . 0.5 OUTLIER -124.55 130.95 53.4 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.441 1.088 . . . . 0.0 109.314 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 73.6 p -92.23 157.06 16.89 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 0.0 109.997 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -148.55 92.03 1.96 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.458 1.099 . . . . 0.0 109.293 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . 0.442 ' HA ' ' CG ' ' A' ' 271' ' ' ARG . 5.8 p80 -54.61 135.18 46.77 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.534 1.146 . . . . 0.0 109.615 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 3.4 t -53.66 -26.45 22.52 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.505 1.128 . . . . 0.0 109.984 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -50.66 -35.48 30.99 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.546 1.154 . . . . 0.0 109.285 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -64.73 -41.5 95.9 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.517 1.136 . . . . 0.0 109.318 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' PHE . . . . . 0.465 ' CE1' ' CE2' ' A' ' 341' ' ' PHE . 80.3 t80 -67.38 -32.77 73.91 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.467 1.105 . . . . 0.0 111.046 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -70.49 -37.71 74.24 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.469 1.106 . . . . 0.0 110.343 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 16.5 tmm? -67.98 -41.34 82.48 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.467 1.104 . . . . 0.0 111.032 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.452 ' CD1' HG12 ' A' ' 247' ' ' ILE . 6.4 mt -73.23 -35.03 66.22 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.492 1.12 . . . . 0.0 109.284 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 41.4 t -68.84 -35.19 76.64 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.499 1.125 . . . . 0.0 108.296 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.8 t -72.97 -39.2 66.33 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.127 . . . . 0.0 109.979 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.2 t -73.49 -28.43 61.91 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.503 1.127 . . . . 0.0 109.979 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.92 103.78 18.71 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 124.51 1.131 . . . . 0.0 110.016 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -21.64 15.61 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.469 1.773 . . . . 0.0 111.01 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.87 -28.78 60.79 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.539 1.149 . . . . 0.0 110.312 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 34.4 mt -68.69 -30.84 48.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.126 . . . . 0.0 109.302 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -69.81 -37.54 76.29 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.476 1.11 . . . . 0.0 109.34 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -72.87 -36.73 67.45 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.458 1.099 . . . . 0.0 110.326 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 31.1 mt -71.68 -42.71 71.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.445 1.091 . . . . 0.0 109.305 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.465 ' CE2' ' CE1' ' A' ' 327' ' ' PHE . 40.2 t80 -66.95 -36.88 83.22 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.45 1.094 . . . . 0.0 111.04 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -72.94 -34.79 66.77 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.489 1.118 . . . . 0.0 110.269 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -50.75 65.3 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.511 1.132 . . . . 0.0 109.344 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 8.8 t -65.13 -38.0 89.22 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.498 1.124 . . . . 0.0 110.372 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -67.17 -35.74 80.31 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.536 1.147 . . . . 0.0 109.301 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 9.3 mt -71.48 -33.87 69.66 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.492 1.12 . . . . 0.0 109.317 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.6 -34.73 70.13 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.531 1.145 . . . . 0.0 110.285 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 39.0 mtt-85 -71.8 -44.04 64.63 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.48 1.112 . . . . 0.0 110.328 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.01 -34.67 76.95 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.453 1.096 . . . . 0.0 110.288 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -37.31 -44.01 1.09 Allowed Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.556 1.16 . . . . 0.0 111.003 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -154.59 123.16 6.12 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.452 0.736 . . . . 0.0 109.329 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -61.01 164.3 5.11 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.51 1.132 . . . . 0.0 109.281 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -111.17 122.98 49.27 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.516 1.135 . . . . 0.0 109.302 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 15.7 m -151.41 167.77 26.93 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.532 1.145 . . . . 0.0 109.994 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.457 0 O-C-N 124.539 1.149 . . . . 0.0 109.292 179.988 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.988 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 1.4 t -142.35 157.75 44.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.509 0.77 . . . . 0.0 110.004 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -117.11 174.04 6.33 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.494 1.121 . . . . 0.0 110.309 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -150.86 154.55 37.43 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.511 1.132 . . . . 0.0 110.291 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 9.7 p -146.62 166.2 7.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.452 1.095 . . . . 0.0 109.308 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.96 173.41 11.82 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.521 1.138 . . . . 0.0 110.331 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 61.3 mtt-85 -140.54 179.42 6.68 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.545 1.153 . . . . 0.0 110.313 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -110.32 -42.37 1.17 Allowed Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.51 1.131 . . . . 0.0 111.012 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -93.11 19.91 7.43 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.45 0.735 . . . . 0.0 109.322 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -58.17 -34.35 70.23 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.499 1.125 . . . . 0.0 110.989 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.86 -36.56 52.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.532 1.145 . . . . 0.0 109.309 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.48 -37.05 82.3 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.511 1.132 . . . . 0.0 110.296 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . 0.404 ' ND2' HD22 ' A' ' 320' ' ' LEU . 4.0 t30 -76.37 -30.64 57.63 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.551 1.157 . . . . 0.0 109.29 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' TRP . . . . . 0.63 ' CZ2' ' CG2' ' A' ' 245' ' ' VAL . 3.0 t90 -66.31 -45.59 79.84 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.485 1.116 . . . . 0.0 108.019 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.506 ' O ' ' CB ' ' A' ' 232' ' ' ALA . 6.4 pt20 -71.27 -34.82 71.06 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.517 1.135 . . . . 0.0 110.35 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -48.49 77.24 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.482 1.114 . . . . 0.0 109.267 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.462 ' CG1' HD13 ' A' ' 244' ' ' LEU . 38.3 t -69.89 -43.08 79.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.432 1.082 . . . . 0.0 109.271 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.34 -16.63 63.01 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.476 1.11 . . . . 0.0 109.309 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' A' ' 228' ' ' GLN . . . -80.67 -19.32 45.5 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.448 1.092 . . . . 0.0 109.332 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 84.4 t -81.25 137.02 49.17 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.485 1.116 . . . . 0.0 109.276 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -40.32 0.93 Allowed 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.59 1.837 . . . . 0.0 111.001 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.467 HD11 ' CD1' ' A' ' 302' ' ' ILE . 11.0 mt -60.81 -15.48 30.42 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.444 1.09 . . . . 0.0 109.333 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . 0.543 ' CE1' HD13 ' A' ' 247' ' ' ILE . 1.4 m-85 -106.56 -22.94 12.61 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.51 1.131 . . . . 0.0 110.959 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.1 -18.73 64.69 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.483 1.115 . . . . 0.0 110.362 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -75.15 -9.67 58.76 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.498 1.124 . . . . 0.0 109.252 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.462 ' HB2' ' CD2' ' A' ' 244' ' ' LEU . 12.0 mt -96.66 -179.19 4.51 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.493 1.12 . . . . 0.0 109.325 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -100.99 -173.56 29.0 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.487 1.117 . . . . 0.0 110.976 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.503 ' O ' ' CG2' ' A' ' 245' ' ' VAL . 18.3 Cg_endo -74.97 -34.47 3.83 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.474 1.776 . . . . 0.0 110.98 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.96 -36.41 80.03 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.502 1.126 . . . . 0.0 109.311 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.415 ' CG1' ' HB3' ' A' ' 239' ' ' LEU . 3.0 t -72.64 -42.83 62.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.53 1.144 . . . . 0.0 109.296 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.462 ' CD2' ' HB2' ' A' ' 239' ' ' LEU . 0.9 OUTLIER -66.37 -37.68 85.83 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.502 1.126 . . . . 0.0 109.287 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.63 ' CG2' ' CZ2' ' A' ' 227' ' ' TRP . 53.6 t -66.11 -42.94 92.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.497 1.123 . . . . 0.0 109.287 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.59 -45.24 87.81 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.507 1.129 . . . . 0.0 110.302 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.543 HD13 ' CE1' ' A' ' 236' ' ' PHE . 38.3 mt -62.93 -45.41 98.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.439 1.087 . . . . 0.0 109.259 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 45.6 t -62.8 -33.39 59.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 0.0 109.297 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -77.34 -19.48 56.26 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.514 1.134 . . . . 0.0 110.277 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -95.91 2.86 53.86 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.469 1.106 . . . . 0.0 109.308 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.17 148.31 25.23 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.524 1.14 . . . . 0.0 109.328 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.34 126.82 50.39 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.512 1.132 . . . . 0.0 110.265 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -83.26 122.75 28.83 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.509 1.131 . . . . 0.0 109.318 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.57 134.79 47.93 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.49 1.119 . . . . 0.0 110.289 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 52.3 m -93.46 121.05 34.46 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.505 1.128 . . . . 0.0 110.414 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.422 HG21 ' CD1' ' A' ' 319' ' ' LEU . 92.2 t -106.79 113.72 62.49 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.513 1.133 . . . . 0.0 109.329 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.497 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.98 173.48 14.43 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.44 1.758 . . . . 0.0 110.976 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.493 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -66.06 131.04 45.27 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.506 1.128 . . . . 0.0 109.322 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 94.24 -25.52 21.93 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.537 1.148 . . . . 0.0 110.969 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . 0.497 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -57.92 146.28 32.75 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.518 0.775 . . . . 0.0 109.302 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.7 t -97.33 131.58 43.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.486 1.116 . . . . 0.0 109.301 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.437 ' CD1' HG11 ' A' ' 311' ' ' VAL . 67.9 mt -84.44 -42.27 16.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.5 1.125 . . . . 0.0 109.281 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 14.0 p -157.5 148.91 21.82 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.492 1.12 . . . . 0.0 108.311 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ARG . . . . . 0.407 ' C ' ' OG1' ' A' ' 310' ' ' THR . 3.3 mmt85 -88.16 179.85 6.3 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.484 1.115 . . . . 0.0 110.315 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.455 ' N ' ' OG1' ' A' ' 310' ' ' THR . 0.0 OUTLIER -77.96 140.07 17.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.447 1.092 . . . . 0.0 109.301 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 47.78 50.1 20.89 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.498 1.123 . . . . 0.0 111.012 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.448 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.0 OUTLIER -70.75 164.06 58.8 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.451 0.736 . . . . 0.0 110.301 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . 0.448 ' HD2' ' HB2' ' A' ' 267' ' ' GLU . 18.1 Cg_endo -75.01 91.78 1.01 Allowed 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.474 1.776 . . . . 0.0 110.942 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -43.93 94.4 0.01 OUTLIER Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.489 1.118 . . . . 0.0 110.945 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 268' ' ' PRO . 0.5 OUTLIER -170.2 38.28 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.471 0.748 . . . . 0.0 109.286 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.422 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 6.0 mtt180 -170.34 145.17 2.64 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.483 1.115 . . . . 0.0 110.313 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.46 ' SD ' ' CD1' ' A' ' 301' ' ' LEU . 12.1 ttt -117.96 147.28 43.31 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.527 1.142 . . . . 0.0 110.964 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.57 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 56.9 m-85 -136.28 136.52 39.87 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.531 1.145 . . . . 0.0 110.998 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . 0.472 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 20.5 m-85 -125.71 134.3 51.84 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.495 1.122 . . . . 0.0 111.009 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 4.5 t -91.94 129.76 42.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.517 1.135 . . . . 0.0 109.323 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . 0.4 ' CG2' HD13 ' A' ' 320' ' ' LEU . 13.9 t -105.63 -44.02 7.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.515 1.134 . . . . 0.0 109.307 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.84 134.33 18.6 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.139 . . . . 0.0 110.308 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.461 ' HA3' ' CG2' ' A' ' 317' ' ' VAL . . . 121.06 178.65 15.95 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.44 1.087 . . . . 0.0 111.042 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' SER . . . . . 0.419 ' N ' HG21 ' A' ' 317' ' ' VAL . 3.3 m -124.15 114.96 20.35 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.532 0.783 . . . . 0.0 109.974 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.471 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 25.5 m -96.73 163.33 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.492 1.12 . . . . 0.0 109.35 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 30.5 t -129.25 154.64 46.62 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.453 1.096 . . . . 0.0 110.032 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.24 130.04 73.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.519 1.137 . . . . 0.0 109.271 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.4 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -77.46 102.15 6.75 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.475 1.11 . . . . 0.0 109.269 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' THR . . . . . 0.644 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.51 -168.67 0.19 Allowed Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.492 1.12 . . . . 0.0 110.413 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.644 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.3 Cg_endo -74.96 4.33 4.82 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.527 1.804 . . . . 0.0 110.993 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -151.84 157.75 34.27 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.526 1.141 . . . . 0.0 109.282 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 94.26 0.96 Allowed 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.464 1.771 . . . . 0.0 110.995 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.34 119.42 46.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.517 1.136 . . . . 0.0 109.334 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -124.1 140.83 52.59 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 0.0 110.306 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.471 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 4.5 mm? -121.38 141.02 51.37 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.498 1.124 . . . . 0.0 109.3 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -93.97 -157.25 32.94 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.521 1.138 . . . . 0.0 110.95 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.02 148.8 35.68 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.511 1.795 . . . . 0.0 111.01 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 83.0 5.9 88.86 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.498 1.124 . . . . 0.0 111.018 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -86.68 122.76 31.03 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.511 0.771 . . . . 0.0 109.328 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -114.86 153.18 30.92 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 0.0 110.954 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . 0.57 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 32.7 p90 -163.29 149.65 12.1 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.535 1.147 . . . . 0.0 111.004 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 129.57 -9.74 6.13 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.539 1.149 . . . . 0.0 110.986 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 299' ' ' MET . 12.1 pt-20 -52.36 -45.26 65.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.548 0.793 . . . . 0.0 110.29 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' MET . . . . . 0.418 ' N ' ' HG3' ' A' ' 298' ' ' GLU . 0.1 OUTLIER -52.4 -38.3 58.64 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.546 1.154 . . . . 0.0 111.039 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . 0.441 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -67.64 -38.16 83.46 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.498 1.123 . . . . 0.0 109.284 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.475 ' O ' ' CE2' ' A' ' 341' ' ' PHE . 0.8 OUTLIER -76.57 -14.39 60.01 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.485 1.116 . . . . 0.0 109.333 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . 0.467 ' CD1' HD11 ' A' ' 235' ' ' LEU . 11.0 mm -76.79 -55.5 10.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.49 1.119 . . . . 0.0 109.332 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 304' ' ' GLY . 0.5 OUTLIER -153.78 42.16 0.54 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.422 1.076 . . . . 0.0 110.011 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 35.82 43.09 0.58 Allowed Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.48 1.113 . . . . 0.0 111.012 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.17 157.61 88.1 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.549 0.793 . . . . 0.0 110.306 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 129.61 12.45 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.547 1.814 . . . . 0.0 110.968 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -43.92 -36.7 2.53 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.457 1.098 . . . . 0.0 110.272 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 8.0 t 66.75 23.16 10.19 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.49 1.119 . . . . 0.0 109.996 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . -179.11 160.93 1.09 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 0.0 109.318 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.455 ' OG1' ' N ' ' A' ' 265' ' ' ILE . 0.8 OUTLIER -108.55 137.33 46.67 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.5 1.125 . . . . 0.0 110.395 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.437 HG11 ' CD1' ' A' ' 262' ' ' ILE . 57.5 t -110.87 131.05 63.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.525 1.14 . . . . 0.0 109.31 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 96.5 p -130.19 153.95 48.04 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.524 1.14 . . . . 0.0 109.992 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . 0.419 ' HB1' ' CG1' ' A' ' 256' ' ' VAL . . . -94.46 107.26 19.24 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.521 1.138 . . . . 0.0 109.312 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -50.75 -33.4 22.95 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.48 1.112 . . . . 0.0 109.305 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' THR . . . . . 0.493 ' HA ' ' CB ' ' A' ' 258' ' ' ALA . 9.8 t -148.28 -170.03 3.49 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.486 1.116 . . . . 0.0 110.388 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' THR . . . . . 0.448 ' N ' ' OG1' ' A' ' 315' ' ' THR . 0.0 OUTLIER -61.37 78.08 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.532 1.145 . . . . 0.0 110.373 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' A' ' 315' ' ' THR . 44.5 t -94.65 140.18 17.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.481 1.113 . . . . 0.0 109.275 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 49.3 m -111.16 117.57 33.59 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.502 1.126 . . . . 0.0 110.0 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . 0.472 ' CB ' ' O ' ' A' ' 274' ' ' PHE . 0.1 OUTLIER -128.67 173.18 10.53 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.486 1.116 . . . . 0.0 109.302 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.404 HD22 ' ND2' ' A' ' 226' ' ' ASN . 0.7 OUTLIER -124.46 133.85 53.23 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.554 1.159 . . . . 0.0 109.269 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 19.9 t -96.09 157.57 15.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.527 1.142 . . . . 0.0 110.001 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.454 HD23 ' CB ' ' A' ' 326' ' ' ASP . 1.4 tm? -150.01 103.67 3.22 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.436 1.085 . . . . 0.0 109.34 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . 0.422 ' HA ' ' CG ' ' A' ' 271' ' ' ARG . 0.3 OUTLIER -62.15 138.35 58.39 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.478 1.111 . . . . 0.0 109.587 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 22.8 t -54.21 -22.36 11.33 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.549 1.156 . . . . 0.0 109.973 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -52.59 -36.61 56.53 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.457 1.098 . . . . 0.0 109.28 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . 0.454 ' CB ' HD23 ' A' ' 322' ' ' LEU . 8.0 t70 -63.77 -46.15 86.55 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.475 1.109 . . . . 0.0 109.299 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' PHE . . . . . 0.473 ' HB2' ' CD2' ' A' ' 301' ' ' LEU . 20.1 t80 -65.41 -31.17 72.13 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.503 1.127 . . . . 0.0 111.049 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -70.71 -32.36 69.53 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.523 1.14 . . . . 0.0 110.334 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.494 ' O ' ' CB ' ' A' ' 333' ' ' SER . 37.1 ttp -74.5 -37.49 63.1 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.536 1.147 . . . . 0.0 110.998 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.524 ' N ' ' CD2' ' A' ' 330' ' ' LEU . 0.1 OUTLIER -72.5 -42.52 64.75 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 0.0 109.273 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' CYS . . . . . 0.506 ' SG ' ' CB ' ' A' ' 338' ' ' ALA . 26.1 t -66.04 -45.13 82.51 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 0.0 108.318 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 44.4 t -73.3 -22.84 60.26 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.509 1.131 . . . . 0.0 110.031 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 329' ' ' MET . 9.1 t -78.43 -39.44 38.78 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.438 1.086 . . . . 0.0 109.977 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.24 121.6 20.62 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.13 . . . . 0.0 110.05 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 -26.15 11.25 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.535 1.808 . . . . 0.0 111.028 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.74 -29.18 69.66 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.484 1.115 . . . . 0.0 110.274 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 96.9 mt -74.59 -35.89 39.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.534 1.146 . . . . 0.0 109.294 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . 0.506 ' CB ' ' SG ' ' A' ' 331' ' ' CYS . . . -68.0 -43.54 78.63 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.51 1.131 . . . . 0.0 109.311 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -69.21 -35.33 76.09 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.475 1.109 . . . . 0.0 110.322 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 17.3 mt -70.94 -41.51 77.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.515 1.134 . . . . 0.0 109.27 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.475 ' CE2' ' O ' ' A' ' 301' ' ' LEU . 27.8 t80 -67.73 -34.7 77.36 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.472 1.107 . . . . 0.0 111.02 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -72.48 -37.02 68.57 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.538 1.149 . . . . 0.0 110.294 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.59 -51.81 60.79 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.505 1.128 . . . . 0.0 109.316 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 9.9 t -65.91 -38.86 89.8 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.475 1.109 . . . . 0.0 110.362 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -68.52 -34.83 76.55 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.527 1.142 . . . . 0.0 109.283 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 12.0 mt -68.64 -36.85 79.15 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.489 1.118 . . . . 0.0 109.328 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.05 -35.67 69.39 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.462 1.101 . . . . 0.0 110.262 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -73.15 -45.0 59.24 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.474 1.109 . . . . 0.0 110.265 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . 0.474 ' O ' ' C ' ' A' ' 350' ' ' GLY . 0.1 OUTLIER -72.63 -33.34 66.56 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.482 1.114 . . . . 0.0 110.283 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . 0.474 ' C ' ' O ' ' A' ' 349' ' ' ARG . . . -31.75 -39.06 0.05 OUTLIER Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.459 1.1 . . . . 0.0 110.961 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 349' ' ' ARG . . . -127.61 119.93 27.01 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.519 0.776 . . . . 0.0 109.262 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -59.94 157.72 12.09 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.5 1.125 . . . . 0.0 109.315 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -150.6 130.83 13.6 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.499 1.125 . . . . 0.0 109.292 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.15 139.11 35.28 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.466 1.104 . . . . 0.0 110.049 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.476 1.11 . . . . 0.0 109.287 -179.965 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.032 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 11.8 p -154.69 145.09 22.1 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.52 0.776 . . . . 0.0 110.027 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -138.85 170.47 15.93 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.122 . . . . 0.0 110.337 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.98 131.19 12.76 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.501 1.126 . . . . 0.0 110.278 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 15.8 m -107.2 137.41 38.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.525 1.141 . . . . 0.0 109.294 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -115.77 126.18 53.7 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.512 1.133 . . . . 0.0 110.292 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.47 175.67 5.4 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.477 1.111 . . . . 0.0 110.313 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -104.89 8.31 45.96 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.478 1.111 . . . . 0.0 111.015 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -91.97 20.12 6.07 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.488 0.758 . . . . 0.0 109.284 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -52.72 -37.8 59.77 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.525 1.141 . . . . 0.0 111.022 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.16 -40.98 78.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.522 1.139 . . . . 0.0 109.27 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.13 -29.39 69.1 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.529 1.143 . . . . 0.0 110.303 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -79.24 -30.88 43.39 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.496 1.123 . . . . 0.0 109.322 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' TRP . . . . . 0.422 ' CH2' HG22 ' A' ' 245' ' ' VAL . 2.6 t90 -70.64 -46.65 62.91 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -68.12 -31.87 71.77 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 0.0 110.263 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 3.5 mt -64.36 -45.59 87.11 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 0.0 109.257 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.421 HG22 ' N ' ' A' ' 231' ' ' ALA . 33.1 m -73.55 -36.63 48.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.464 1.103 . . . . 0.0 109.328 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.421 ' N ' HG22 ' A' ' 230' ' ' VAL . . . -74.98 -15.55 60.66 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.522 1.139 . . . . 0.0 109.245 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -80.83 -1.87 44.94 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.511 1.132 . . . . 0.0 109.322 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 4.9 t -101.03 118.85 59.58 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.501 1.126 . . . . 0.0 109.276 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 -17.92 19.04 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.494 1.787 . . . . 0.0 110.989 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.561 HD12 ' CE1' ' A' ' 341' ' ' PHE . 0.1 OUTLIER -65.06 -29.46 70.35 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.574 1.171 . . . . 0.0 109.302 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . 0.57 ' CD1' HD11 ' A' ' 239' ' ' LEU . 15.4 m-85 -113.74 19.76 16.44 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.44 1.087 . . . . 0.0 111.0 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.22 -23.43 62.01 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.515 1.134 . . . . 0.0 110.345 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 50.0 mmtt -80.2 0.7 31.35 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.456 1.097 . . . . 0.0 109.295 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.57 HD11 ' CD1' ' A' ' 236' ' ' PHE . 15.1 mt -82.13 175.18 10.53 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.542 1.151 . . . . 0.0 109.29 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -107.73 -173.8 22.17 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.478 1.111 . . . . 0.0 110.981 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.94 -33.66 4.5 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.46 1.769 . . . . 0.0 111.051 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 0.419 ' O ' HG11 ' A' ' 245' ' ' VAL . . . -71.22 -31.97 68.23 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.482 1.114 . . . . 0.0 109.318 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.436 ' CG1' ' HB3' ' A' ' 239' ' ' LEU . 4.8 t -75.9 -42.17 39.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.486 1.116 . . . . 0.0 109.272 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.24 -46.22 74.42 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.476 1.11 . . . . 0.0 109.289 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.422 HG22 ' CH2' ' A' ' 227' ' ' TRP . 2.8 p -65.05 -45.14 95.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.497 1.123 . . . . 0.0 109.273 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.405 ' N ' ' CG1' ' A' ' 245' ' ' VAL . 4.9 tp10 -64.87 -36.12 83.33 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.114 . . . . 0.0 110.325 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.453 ' CG1' HD12 ' A' ' 330' ' ' LEU . 26.4 mt -67.85 -48.0 77.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.514 1.134 . . . . 0.0 109.329 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 55.2 t -63.26 -33.07 58.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.123 . . . . 0.0 109.323 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.1 mmm180 -74.61 -25.13 59.04 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.434 1.084 . . . . 0.0 110.294 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -87.15 -18.54 30.18 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.481 1.113 . . . . 0.0 109.344 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.82 146.16 54.72 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.575 1.172 . . . . 0.0 109.321 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -120.54 135.08 55.19 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 0.0 110.368 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -80.57 122.4 27.0 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.459 1.099 . . . . 0.0 109.262 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.7 ttm-85 -124.25 121.95 36.43 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.543 1.152 . . . . 0.0 110.276 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.6 m -91.28 117.81 29.96 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 0.0 110.373 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 69.3 t -106.69 112.02 63.71 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.461 1.101 . . . . 0.0 109.329 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.516 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.97 173.65 14.14 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.472 1.775 . . . . 0.0 111.023 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.47 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -67.51 131.33 45.44 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.488 1.117 . . . . 0.0 109.263 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 93.27 -25.39 20.59 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 124.556 1.16 . . . . 0.0 110.984 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . 0.516 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -61.07 149.04 38.31 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.52 0.776 . . . . 0.0 109.332 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.2 t -97.47 131.35 44.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.483 1.114 . . . . 0.0 109.324 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 43.3 mt -83.9 -40.09 15.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.53 1.144 . . . . 0.0 109.308 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 13.8 p -156.12 150.71 25.89 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.503 1.127 . . . . 0.0 108.276 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -94.42 179.67 5.21 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.566 1.166 . . . . 0.0 110.339 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.438 ' N ' ' OG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -77.49 140.34 17.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.467 1.104 . . . . 0.0 109.326 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 46.54 52.71 10.64 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.5 1.125 . . . . 0.0 111.045 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.46 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.2 OUTLIER -71.03 168.08 23.86 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.548 0.793 . . . . 0.0 110.357 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 267' ' ' GLU . 18.4 Cg_endo -74.98 88.49 1.23 Allowed 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.458 1.767 . . . . 0.0 111.005 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . 0.401 ' O ' ' CA ' ' A' ' 304' ' ' GLY . . . -45.23 93.5 0.01 OUTLIER Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.553 1.158 . . . . 0.0 110.988 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 268' ' ' PRO . 0.6 OUTLIER -170.47 36.68 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.51 0.771 . . . . 0.0 109.345 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -173.35 162.27 4.32 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.566 1.166 . . . . 0.0 110.295 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.555 ' HE3' ' CE1' ' A' ' 274' ' ' PHE . 9.3 ptm -145.84 146.66 31.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.538 1.149 . . . . 0.0 110.996 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.566 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 33.2 m-85 -128.37 154.08 46.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.484 1.115 . . . . 0.0 111.017 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . 0.555 ' CE1' ' HE3' ' A' ' 272' ' ' MET . 23.6 m-85 -129.87 137.37 50.39 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.481 1.113 . . . . 0.0 111.017 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.41 ' HA ' ' HB3' ' A' ' 319' ' ' LEU . 42.7 t -90.71 136.72 23.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.52 1.137 . . . . 0.0 109.295 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 39.8 t -116.03 -43.78 3.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.535 1.147 . . . . 0.0 109.326 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -146.61 136.74 23.55 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.517 1.136 . . . . 0.0 110.272 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.464 ' HA3' ' CG2' ' A' ' 317' ' ' VAL . . . 114.46 -173.22 14.72 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.502 1.126 . . . . 0.0 111.004 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' SER . . . . . 0.441 ' N ' HG21 ' A' ' 317' ' ' VAL . 3.2 m -134.9 119.92 18.65 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.539 0.788 . . . . 0.0 109.989 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.42 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 16.5 m -99.0 165.82 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.499 1.125 . . . . 0.0 109.323 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 30.5 t -131.52 154.97 48.23 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.504 1.128 . . . . 0.0 110.009 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.92 131.21 72.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.503 1.127 . . . . 0.0 109.306 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -79.41 102.03 8.48 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 0.0 109.325 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' THR . . . . . 0.655 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.18 -168.25 0.18 Allowed Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.525 1.14 . . . . 0.0 110.391 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.655 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -75.04 4.48 4.72 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.566 1.824 . . . . 0.0 110.964 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -151.75 157.2 34.59 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.548 1.155 . . . . 0.0 109.263 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.06 95.36 0.98 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.472 1.775 . . . . 0.0 110.937 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 4.6 t -99.39 119.23 47.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.47 1.106 . . . . 0.0 109.263 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -124.44 135.85 53.58 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.426 1.079 . . . . 0.0 110.29 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.42 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 3.9 mm? -115.11 142.11 47.1 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.451 1.095 . . . . 0.0 109.307 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -98.79 -161.24 29.82 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.494 1.121 . . . . 0.0 110.983 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 145.88 31.98 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.491 1.785 . . . . 0.0 110.999 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 88.09 4.63 77.9 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.459 1.099 . . . . 0.0 110.95 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -91.25 127.77 36.81 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.501 0.765 . . . . 0.0 109.315 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . 0.451 ' HB3' ' CD1' ' A' ' 274' ' ' PHE . 1.2 p90 -116.34 153.38 32.09 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.52 1.138 . . . . 0.0 110.987 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 48.1 p90 -161.63 146.38 13.19 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.452 1.095 . . . . 0.0 110.977 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 129.66 -9.99 6.09 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 124.527 1.142 . . . . 0.0 111.001 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -52.77 -51.21 61.54 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.457 0.74 . . . . 0.0 110.295 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.2 mmt -50.48 -32.89 19.37 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.523 1.139 . . . . 0.0 111.008 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -68.85 -42.64 76.84 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.535 1.147 . . . . 0.0 109.337 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.439 ' N ' HD23 ' A' ' 301' ' ' LEU . 6.0 mt -75.01 -11.68 60.16 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.475 1.109 . . . . 0.0 109.283 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . 0.556 HD12 ' CZ ' ' A' ' 341' ' ' PHE . 14.5 mm -77.83 -56.63 7.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.484 1.115 . . . . 0.0 109.291 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 304' ' ' GLY . 2.4 m -151.46 42.57 0.74 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.445 1.091 . . . . 0.0 110.0 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 34.93 51.21 0.82 Allowed Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.462 1.101 . . . . 0.0 110.969 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.58 151.34 80.15 Favored Pre-proline 0 C--N 1.326 -0.436 0 O-C-N 124.524 0.779 . . . . 0.0 110.33 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 130.29 13.11 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.461 1.769 . . . . 0.0 110.955 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -44.04 -33.09 1.34 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.536 1.147 . . . . 0.0 110.301 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 59.38 15.9 4.73 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.525 1.14 . . . . 0.0 109.989 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . -170.15 160.75 8.17 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.544 1.153 . . . . 0.0 109.333 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.438 ' OG1' ' N ' ' A' ' 265' ' ' ILE . 0.9 OUTLIER -110.29 139.68 45.23 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.469 1.106 . . . . 0.0 110.42 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 91.1 t -115.57 131.62 67.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.493 1.121 . . . . 0.0 109.269 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 56.3 p -128.6 153.75 46.92 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.491 1.119 . . . . 0.0 110.018 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.95 114.3 26.75 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.556 1.16 . . . . 0.0 109.286 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -57.73 -35.19 70.34 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.521 1.138 . . . . 0.0 109.304 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' THR . . . . . 0.47 ' HA ' ' CB ' ' A' ' 258' ' ' ALA . 8.7 t -153.96 -173.91 4.76 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.559 1.162 . . . . 0.0 110.424 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 29.0 m -49.9 91.36 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 0.0 110.378 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.464 ' CG2' ' HA3' ' A' ' 278' ' ' GLY . 41.6 t -106.75 154.54 7.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.53 1.144 . . . . 0.0 109.31 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 69.3 m -129.79 114.93 16.55 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.534 1.146 . . . . 0.0 109.965 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . 0.505 ' CB ' ' O ' ' A' ' 274' ' ' PHE . 0.2 OUTLIER -130.43 173.17 11.09 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.484 1.115 . . . . 0.0 109.289 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 273' ' ' PHE . 0.8 OUTLIER -124.29 136.41 54.11 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.532 1.145 . . . . 0.0 109.29 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.477 ' HB2' ' CE2' ' A' ' 273' ' ' PHE . 36.7 t -96.07 148.53 22.58 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.466 1.104 . . . . 0.0 110.02 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -146.49 98.54 3.09 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.5 1.125 . . . . 0.0 109.302 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -60.02 146.9 41.02 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.485 1.116 . . . . 0.0 109.582 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 37.8 t -63.68 -13.71 45.39 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.504 1.127 . . . . 0.0 110.02 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.413 ' HA ' ' NE2' ' A' ' 328' ' ' GLN . . . -61.67 -27.8 68.94 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.486 1.116 . . . . 0.0 109.331 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.66 -39.52 61.99 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.504 1.127 . . . . 0.0 109.277 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' PHE . . . . . 0.483 ' C ' ' CD1' ' A' ' 327' ' ' PHE . 0.8 OUTLIER -70.47 -42.68 71.11 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.504 1.127 . . . . 0.0 110.995 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.413 ' NE2' ' HA ' ' A' ' 325' ' ' ALA . 1.8 pt20 -67.15 -35.61 80.07 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.512 1.133 . . . . 0.0 110.266 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 17.9 tmm? -66.8 -42.12 86.48 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.515 1.135 . . . . 0.0 110.985 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.453 HD12 ' CG1' ' A' ' 247' ' ' ILE . 5.2 mt -72.51 -37.42 68.38 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.456 1.097 . . . . 0.0 109.307 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 6.2 m -72.57 -31.64 65.4 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.478 1.111 . . . . 0.0 108.329 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 47.1 t -71.83 -37.91 70.25 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 0.0 109.981 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 42.6 t -72.17 -36.0 69.16 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.464 1.103 . . . . 0.0 109.981 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -123.02 114.32 29.53 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.51 1.131 . . . . 0.0 110.005 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -19.04 18.2 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.537 1.809 . . . . 0.0 111.005 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -72.57 -32.13 65.8 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.548 1.155 . . . . 0.0 110.31 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 77.6 mt -74.87 -44.95 44.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.485 1.116 . . . . 0.0 109.286 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -66.6 -35.33 79.94 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.131 . . . . 0.0 109.338 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . 0.478 ' O ' ' CG ' ' A' ' 343' ' ' LYS . 50.2 mm-40 -72.3 -42.78 65.09 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.516 1.135 . . . . 0.0 110.279 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 58.5 mt -68.35 -36.52 75.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.523 1.14 . . . . 0.0 109.256 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.561 ' CE1' HD12 ' A' ' 235' ' ' LEU . 49.7 t80 -69.55 -37.2 76.94 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.101 . . . . 0.0 110.982 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -69.76 -37.99 76.6 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.474 1.109 . . . . 0.0 110.335 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . 0.478 ' CG ' ' O ' ' A' ' 339' ' ' GLU . 0.5 OUTLIER -65.0 -50.65 65.45 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.496 1.123 . . . . 0.0 109.344 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 4.5 t -64.83 -32.86 74.76 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.51 1.131 . . . . 0.0 110.4 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -70.07 -39.05 75.85 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.466 1.104 . . . . 0.0 109.29 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 12.6 mt -68.93 -34.04 74.71 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.434 1.084 . . . . 0.0 109.312 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.75 -31.68 61.87 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.467 1.105 . . . . 0.0 110.299 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . 0.416 ' CZ ' HD22 ' A' ' 235' ' ' LEU . 7.0 mtt180 -72.31 -43.94 63.44 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.535 1.147 . . . . 0.0 110.304 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 350' ' ' GLY . 0.0 OUTLIER -72.44 -34.76 68.03 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.479 1.112 . . . . 0.0 110.302 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 349' ' ' ARG . . . -37.4 -45.12 1.28 Allowed Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.512 1.132 . . . . 0.0 110.987 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -155.01 121.9 5.46 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.51 0.77 . . . . 0.0 109.283 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -63.51 168.53 4.56 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.484 1.115 . . . . 0.0 109.336 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -113.51 120.9 42.57 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.498 1.124 . . . . 0.0 109.282 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 67.3 m -73.2 145.09 46.51 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.447 1.092 . . . . 0.0 109.969 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.529 1.143 . . . . 0.0 109.294 -179.987 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.974 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 1.1 t -80.22 134.45 36.12 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.47 0.747 . . . . 0.0 109.997 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -105.09 170.89 7.61 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.471 1.107 . . . . 0.0 110.27 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.72 167.05 11.9 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.492 1.12 . . . . 0.0 110.319 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 58.4 t -120.4 155.02 23.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.527 1.142 . . . . 0.0 109.309 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.6 153.99 17.54 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.491 1.119 . . . . 0.0 110.318 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.83 141.65 50.34 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.502 1.126 . . . . 0.0 110.289 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -99.36 -19.53 20.56 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.498 1.124 . . . . 0.0 110.988 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 10.4 p30 -97.15 19.36 13.1 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.495 0.762 . . . . 0.0 109.316 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -53.91 -41.98 68.24 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.14 . . . . 0.0 110.967 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.81 -35.89 44.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.543 1.152 . . . . 0.0 109.289 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -32.12 71.02 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.559 1.162 . . . . 0.0 110.333 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . 0.409 ' ND2' HG11 ' A' ' 248' ' ' VAL . 46.6 t30 -79.89 -30.63 40.19 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.471 1.107 . . . . 0.0 109.256 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' TRP . . . . . 0.583 ' CZ2' ' CG2' ' A' ' 245' ' ' VAL . 2.5 t90 -67.8 -43.65 79.19 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.538 1.149 . . . . 0.0 107.974 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -71.03 -38.38 72.58 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.585 1.178 . . . . 0.0 110.339 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -62.43 -46.25 89.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.146 . . . . 0.0 109.3 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.439 HG23 ' CD1' ' A' ' 251' ' ' LEU . 59.1 t -72.69 -37.01 54.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.466 1.104 . . . . 0.0 109.316 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -73.5 -15.86 61.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.487 1.117 . . . . 0.0 109.328 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -81.86 -12.74 58.33 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.511 1.132 . . . . 0.0 109.318 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 38.2 t -70.9 132.3 86.86 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.122 . . . . 0.0 109.298 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.98 -30.4 7.23 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.482 1.78 . . . . 0.0 110.979 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.441 ' CD1' HD11 ' A' ' 302' ' ' ILE . 0.7 OUTLIER -68.87 -28.21 66.5 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.447 1.092 . . . . 0.0 109.29 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . 0.57 ' CD1' HD13 ' A' ' 239' ' ' LEU . 13.8 m-30 -104.63 14.32 30.04 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.497 1.123 . . . . 0.0 111.016 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -72.17 -26.15 61.97 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.492 1.12 . . . . 0.0 110.286 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.469 ' HB2' ' CG2' ' A' ' 340' ' ' ILE . 6.6 mmpt? -100.47 7.62 44.06 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.528 1.143 . . . . 0.0 109.314 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.57 HD13 ' CD1' ' A' ' 236' ' ' PHE . 16.9 mt -81.51 171.24 14.92 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 0.0 109.258 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -95.16 173.68 31.82 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.51 1.131 . . . . 0.0 110.981 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.494 ' O ' ' CG2' ' A' ' 245' ' ' VAL . 18.2 Cg_endo -75.05 -35.29 3.19 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.494 1.786 . . . . 0.0 111.015 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.4 -34.66 76.41 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.474 1.109 . . . . 0.0 109.3 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.479 HG23 ' CD1' ' A' ' 337' ' ' ILE . 25.6 t -74.17 -42.07 51.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.44 1.087 . . . . 0.0 109.301 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -64.81 -34.58 78.68 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.511 1.132 . . . . 0.0 109.293 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.583 ' CG2' ' CZ2' ' A' ' 227' ' ' TRP . 70.4 t -70.72 -44.56 76.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.547 1.155 . . . . 0.0 109.311 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -65.3 -31.18 72.18 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.478 1.111 . . . . 0.0 110.293 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 56.0 mt -75.14 -40.54 44.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.451 1.095 . . . . 0.0 109.317 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.409 HG11 ' ND2' ' A' ' 226' ' ' ASN . 55.8 t -70.96 -33.32 51.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.503 1.127 . . . . 0.0 109.309 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.428 ' NH1' ' HB3' ' A' ' 249' ' ' ARG . 5.6 mmm180 -78.94 -25.84 43.63 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.471 1.107 . . . . 0.0 110.275 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -86.87 -21.68 26.21 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.523 1.139 . . . . 0.0 109.332 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.439 ' CD1' HG23 ' A' ' 230' ' ' VAL . 0.2 OUTLIER -61.49 152.35 30.31 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.46 1.1 . . . . 0.0 109.339 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -121.13 119.1 31.41 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.495 1.122 . . . . 0.0 110.299 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.439 ' CB ' HD23 ' A' ' 320' ' ' LEU . . . -81.17 122.43 27.37 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.502 1.126 . . . . 0.0 109.298 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.96 142.75 50.38 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.453 1.096 . . . . 0.0 110.299 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 4.5 m -96.64 125.83 41.39 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.517 1.136 . . . . 0.0 110.386 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 86.7 t -106.58 115.73 60.17 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.473 1.108 . . . . 0.0 109.3 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.5 Cg_endo -74.96 168.41 24.89 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.535 1.808 . . . . 0.0 111.038 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.507 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -66.81 128.5 36.53 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.511 1.132 . . . . 0.0 109.302 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 96.06 -25.57 24.85 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.486 1.116 . . . . 0.0 110.989 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . 0.506 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -64.35 134.1 53.96 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.505 0.767 . . . . 0.0 109.313 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 2.5 p -90.21 134.98 27.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.485 1.116 . . . . 0.0 109.295 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 11.3 mt -82.47 -52.6 13.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.121 . . . . 0.0 109.377 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' CYS . . . . . 0.506 ' SG ' ' CG2' ' A' ' 311' ' ' VAL . 14.0 p -137.48 157.68 46.03 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.511 1.132 . . . . 0.0 108.31 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 1.8 mmt85 -100.98 178.43 4.67 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.58 1.175 . . . . 0.0 110.302 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.405 ' CG2' ' HB ' ' A' ' 310' ' ' THR . 0.2 OUTLIER -77.74 130.73 35.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.56 1.162 . . . . 0.0 109.308 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 59.9 47.51 90.64 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.533 1.146 . . . . 0.0 111.028 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.417 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.2 OUTLIER -71.53 164.37 58.38 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.473 0.749 . . . . 0.0 110.302 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . 0.449 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.3 Cg_endo -74.96 81.52 2.18 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.469 1.773 . . . . 0.0 111.05 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 268' ' ' PRO . . . -37.08 95.86 0.01 OUTLIER Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.537 1.148 . . . . 0.0 111.039 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 268' ' ' PRO . 51.5 m-20 -170.45 38.67 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.507 0.769 . . . . 0.0 109.288 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.471 ' HD3' ' CE1' ' A' ' 273' ' ' PHE . 3.8 ttm180 -170.78 151.83 3.55 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.505 1.128 . . . . 0.0 110.298 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.49 ' SD ' ' CD1' ' A' ' 301' ' ' LEU . 3.4 ttt -121.5 155.33 35.17 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.505 1.128 . . . . 0.0 111.031 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.568 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 25.8 m-85 -140.42 136.74 33.37 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.49 1.119 . . . . 0.0 111.006 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -128.47 126.84 41.32 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.476 1.11 . . . . 0.0 111.018 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 53.9 t -85.58 132.71 31.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.459 1.1 . . . . 0.0 109.32 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . 0.412 ' CG2' HD13 ' A' ' 320' ' ' LEU . 48.3 t -107.15 -52.84 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.485 1.116 . . . . 0.0 109.302 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -139.81 137.9 35.37 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.51 1.131 . . . . 0.0 110.254 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.401 ' HA3' ' HB ' ' A' ' 317' ' ' VAL . . . 116.27 -158.0 14.7 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.458 1.099 . . . . 0.0 110.952 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 8.7 t -148.3 134.07 18.95 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.54 0.788 . . . . 0.0 109.998 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 11.3 m -114.02 165.41 9.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.516 1.135 . . . . 0.0 109.283 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 29.3 t -131.59 148.54 52.62 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.529 1.143 . . . . 0.0 109.991 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.46 HG21 ' CG1' ' A' ' 288' ' ' VAL . 0.6 OUTLIER -110.91 129.79 65.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.461 1.101 . . . . 0.0 109.262 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -78.52 101.46 7.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.479 1.112 . . . . 0.0 109.32 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' THR . . . . . 0.659 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.9 OUTLIER -147.14 -168.05 0.17 Allowed Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.505 1.128 . . . . 0.0 110.38 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.659 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.6 Cg_endo -74.96 3.98 5.12 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.502 1.791 . . . . 0.0 111.022 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -150.37 157.2 37.03 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.482 1.114 . . . . 0.0 109.302 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.91 94.1 0.95 Allowed 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.493 1.786 . . . . 0.0 110.989 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.46 ' CG1' HG21 ' A' ' 282' ' ' VAL . 72.1 t -98.09 118.94 45.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.544 1.152 . . . . 0.0 109.29 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -125.11 134.49 52.44 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.443 1.089 . . . . 0.0 110.291 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -116.73 141.48 48.15 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.536 1.148 . . . . 0.0 109.308 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -95.72 -158.47 32.36 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.518 1.136 . . . . 0.0 110.974 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 152.63 40.88 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.466 1.772 . . . . 0.0 110.994 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 79.66 6.78 88.91 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.501 1.125 . . . . 0.0 110.971 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -88.98 128.71 35.7 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.489 0.758 . . . . 0.0 109.278 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -117.45 153.01 33.84 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.471 1.107 . . . . 0.0 111.005 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . 0.568 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 45.5 p90 -166.28 145.7 5.94 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.512 1.133 . . . . 0.0 111.024 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 133.21 -10.53 5.06 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.514 1.133 . . . . 0.0 111.004 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . 0.435 ' CA ' ' HE2' ' A' ' 272' ' ' MET . 32.8 tt0 -52.75 -53.22 51.05 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.493 0.761 . . . . 0.0 110.242 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -47.58 -35.56 9.32 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.467 1.104 . . . . 0.0 110.99 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -68.4 -43.21 77.75 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.513 1.133 . . . . 0.0 109.327 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.49 ' CD1' ' SD ' ' A' ' 272' ' ' MET . 1.2 mt -77.26 -5.98 51.41 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.498 1.124 . . . . 0.0 109.285 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . 0.441 HD11 ' CD1' ' A' ' 235' ' ' LEU . 8.1 mm -83.37 -53.92 10.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 0.0 109.282 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 304' ' ' GLY . 78.5 p -151.89 43.2 0.72 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.511 1.132 . . . . 0.0 109.968 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 303' ' ' SER . . . 36.16 35.0 0.09 OUTLIER Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.474 1.109 . . . . 0.0 111.009 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 303' ' ' SER . 0.1 OUTLIER -62.4 151.55 82.36 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.498 0.763 . . . . 0.0 110.318 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 127.57 10.79 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.435 1.755 . . . . 0.0 110.974 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . 0.4 ' NE ' ' HG2' ' A' ' 267' ' ' GLU . 0.0 OUTLIER -46.16 -24.9 0.51 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 0.0 110.295 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 43.18 36.85 1.07 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.475 1.11 . . . . 0.0 110.012 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . -177.99 161.07 1.5 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.474 1.108 . . . . 0.0 109.283 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.405 ' HB ' ' CG2' ' A' ' 265' ' ' ILE . 0.3 OUTLIER -113.89 121.4 43.87 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.472 1.107 . . . . 0.0 110.355 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.506 ' CG2' ' SG ' ' A' ' 263' ' ' CYS . 31.5 t -102.69 131.79 50.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.116 . . . . 0.0 109.267 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 6.0 p -136.11 158.29 44.76 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.538 1.149 . . . . 0.0 110.007 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . 0.547 ' CB ' ' CG1' ' A' ' 317' ' ' VAL . . . -88.29 111.86 22.17 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.471 1.107 . . . . 0.0 109.259 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -55.55 -26.34 42.87 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.507 1.129 . . . . 0.0 109.286 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' THR . . . . . 0.507 ' HA ' ' CB ' ' A' ' 258' ' ' ALA . 10.0 t -164.43 -165.08 0.9 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.49 1.119 . . . . 0.0 110.41 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' THR . . . . . 0.418 ' N ' ' OG1' ' A' ' 315' ' ' THR . 31.5 p -60.26 80.7 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.516 1.135 . . . . 0.0 110.426 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.547 ' CG1' ' CB ' ' A' ' 313' ' ' ALA . 2.5 p -113.0 138.5 42.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.129 . . . . 0.0 109.266 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' SER . . . . . 0.407 ' N ' HG21 ' A' ' 317' ' ' VAL . 49.7 m -107.26 139.05 42.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.556 1.16 . . . . 0.0 109.998 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . 0.472 HD21 ' CG2' ' A' ' 317' ' ' VAL . 0.0 OUTLIER -143.73 173.51 11.61 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.498 1.124 . . . . 0.0 109.306 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.439 HD23 ' CB ' ' A' ' 253' ' ' ALA . 1.2 mp -124.37 133.99 53.26 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.448 1.092 . . . . 0.0 109.308 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 20.9 t -97.99 151.34 20.41 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.469 1.106 . . . . 0.0 109.985 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -144.8 106.87 4.32 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.494 1.121 . . . . 0.0 109.34 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . 0.423 ' CE1' ' HB2' ' A' ' 326' ' ' ASP . 10.2 p80 -66.4 132.99 49.55 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.502 1.126 . . . . 0.0 109.615 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 96.1 p -56.64 -21.95 30.91 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.469 1.106 . . . . 0.0 110.004 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -58.84 -35.47 72.98 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.5 1.125 . . . . 0.0 109.29 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . 0.434 ' O ' ' CG ' ' A' ' 329' ' ' MET . 23.8 t70 -66.1 -41.05 91.13 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.502 1.126 . . . . 0.0 109.34 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' PHE . . . . . 0.482 ' CD1' ' O ' ' A' ' 327' ' ' PHE . 2.6 t80 -70.53 -29.77 66.34 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.47 1.106 . . . . 0.0 110.998 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -70.92 -45.73 63.74 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.523 1.139 . . . . 0.0 110.319 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.454 ' HG3' ' N ' ' A' ' 330' ' ' LEU . 3.9 ptm -66.47 -34.6 78.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.49 1.119 . . . . 0.0 110.978 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.454 ' N ' ' HG3' ' A' ' 329' ' ' MET . 16.5 mt -72.77 -37.74 67.54 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.486 1.116 . . . . 0.0 109.275 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' CYS . . . . . 0.402 ' O ' ' O ' ' A' ' 334' ' ' SER . 14.2 t -66.26 -41.47 89.85 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.549 1.156 . . . . 0.0 108.336 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.28 -23.36 51.15 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.486 1.116 . . . . 0.0 109.992 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 19.9 t -71.65 -39.33 70.42 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.532 1.145 . . . . 0.0 110.032 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' SER . . . . . 0.402 ' O ' ' O ' ' A' ' 331' ' ' CYS . 0.1 OUTLIER -121.98 131.9 24.34 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.491 1.12 . . . . 0.0 109.957 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -28.5 9.14 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.495 1.787 . . . . 0.0 110.999 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.78 -28.57 67.72 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.477 1.111 . . . . 0.0 110.259 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.479 ' CD1' HG23 ' A' ' 243' ' ' VAL . 95.7 mt -72.28 -35.77 53.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.486 1.116 . . . . 0.0 109.254 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.22 -33.98 65.64 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.536 1.147 . . . . 0.0 109.309 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -74.54 -42.35 59.0 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.511 1.132 . . . . 0.0 110.272 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.469 ' CG2' ' HB2' ' A' ' 238' ' ' LYS . 43.2 mt -71.7 -40.24 70.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.524 1.14 . . . . 0.0 109.27 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.481 ' CE2' ' CZ ' ' A' ' 327' ' ' PHE . 10.2 t80 -70.04 -34.94 73.89 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.547 1.154 . . . . 0.0 111.009 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.18 -41.47 73.7 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.484 1.115 . . . . 0.0 110.257 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.05 -40.57 71.58 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.498 1.124 . . . . 0.0 109.295 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.1 m -67.46 -42.39 83.12 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.457 1.098 . . . . 0.0 110.403 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -70.87 -35.08 72.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.557 1.161 . . . . 0.0 109.293 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 15.8 mt -71.46 -31.99 67.79 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.546 1.154 . . . . 0.0 109.277 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -73.71 -39.02 64.64 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.539 1.149 . . . . 0.0 110.281 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 16.0 mtt-85 -70.24 -39.68 74.9 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.477 1.111 . . . . 0.0 110.349 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 350' ' ' GLY . 0.0 OUTLIER -72.79 -36.79 67.68 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.495 1.122 . . . . 0.0 110.271 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 349' ' ' ARG . . . -35.69 -46.53 0.85 Allowed Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.513 1.133 . . . . 0.0 111.005 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -155.3 122.57 5.53 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.5 0.765 . . . . 0.0 109.312 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -64.34 163.69 12.59 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.481 1.113 . . . . 0.0 109.319 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -110.24 121.48 45.37 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.519 1.137 . . . . 0.0 109.295 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 3.6 m -62.01 136.8 58.11 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.537 1.148 . . . . 0.0 109.997 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.465 0 O-C-N 124.562 1.164 . . . . 0.0 109.301 -179.981 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.976 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 74.1 m -122.14 165.98 15.27 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.484 0.755 . . . . 0.0 110.039 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -111.55 160.35 17.26 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.529 1.143 . . . . 0.0 110.317 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -93.8 170.6 9.44 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.505 1.128 . . . . 0.0 110.291 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 9.7 p -120.5 162.95 18.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.515 1.135 . . . . 0.0 109.314 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.32 161.88 25.96 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.473 1.108 . . . . 0.0 110.309 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.93 165.0 16.63 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.486 1.116 . . . . 0.0 110.322 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -80.04 -39.58 16.07 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.498 1.124 . . . . 0.0 110.998 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -98.5 14.8 26.99 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.458 0.74 . . . . 0.0 109.307 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -53.91 -37.39 63.75 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.542 1.151 . . . . 0.0 110.982 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -71.16 -37.76 67.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.525 1.14 . . . . 0.0 109.27 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.57 -33.14 75.02 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.536 1.147 . . . . 0.0 110.334 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . 0.45 ' O ' ' CG2' ' A' ' 230' ' ' VAL . 10.4 t-20 -79.21 -30.3 43.24 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.471 1.107 . . . . 0.0 109.321 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' TRP . . . . . 0.572 ' CH2' HG21 ' A' ' 245' ' ' VAL . 3.1 t90 -66.45 -44.44 82.77 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.52 1.137 . . . . 0.0 108.01 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.44 ' HG3' ' N ' ' A' ' 229' ' ' LEU . 7.7 pt20 -71.67 -44.95 63.37 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.533 1.146 . . . . 0.0 110.359 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.44 ' N ' ' HG3' ' A' ' 228' ' ' GLN . 0.3 OUTLIER -57.75 -44.76 86.34 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.468 1.105 . . . . 0.0 109.3 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.45 ' CG2' ' O ' ' A' ' 226' ' ' ASN . 95.7 t -70.34 -38.99 76.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.48 1.113 . . . . 0.0 109.244 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -75.29 -10.18 59.23 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.48 1.113 . . . . 0.0 109.254 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 228' ' ' GLN . . . -80.06 -25.07 40.27 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.451 1.094 . . . . 0.0 109.223 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . 0.585 HG11 ' CD1' ' A' ' 236' ' ' PHE . 61.9 t -70.05 138.14 87.32 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.469 1.106 . . . . 0.0 109.298 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 -50.24 0.13 Allowed 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.478 1.778 . . . . 0.0 110.998 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.566 ' HB3' ' CE2' ' A' ' 341' ' ' PHE . 18.2 mt -50.84 -37.13 41.28 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.489 1.118 . . . . 0.0 109.275 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . 0.585 ' CD1' HG11 ' A' ' 233' ' ' VAL . 4.3 m-85 -78.88 -21.99 46.64 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.465 1.103 . . . . 0.0 110.979 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -22.72 61.31 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.514 1.134 . . . . 0.0 110.282 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -75.11 -23.27 57.91 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.495 1.122 . . . . 0.0 109.275 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.48 ' CD2' ' CG2' ' A' ' 337' ' ' ILE . 16.3 mt -74.51 -179.83 4.26 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.483 1.114 . . . . 0.0 109.275 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -107.72 -172.6 22.04 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.517 1.136 . . . . 0.0 111.005 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.437 ' O ' ' CG2' ' A' ' 245' ' ' VAL . 18.1 Cg_endo -75.0 -36.96 2.24 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.5 1.789 . . . . 0.0 111.015 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.09 -34.83 78.48 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.493 1.121 . . . . 0.0 109.327 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.462 ' CG1' HD12 ' A' ' 247' ' ' ILE . 13.6 t -75.38 -39.21 41.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.531 1.144 . . . . 0.0 109.329 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 244' ' ' LEU . 1.4 mm? -66.28 -37.94 86.62 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.498 1.124 . . . . 0.0 109.253 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.572 HG21 ' CH2' ' A' ' 227' ' ' TRP . 94.1 t -68.95 -44.67 81.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.478 1.111 . . . . 0.0 109.274 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -64.74 -36.94 85.93 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.468 1.105 . . . . 0.0 110.301 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.462 HD12 ' CG1' ' A' ' 243' ' ' VAL . 41.7 mt -69.09 -49.07 65.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.47 1.106 . . . . 0.0 109.285 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 63.9 t -62.58 -31.09 50.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 0.0 109.308 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -78.92 -22.67 45.5 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.549 1.155 . . . . 0.0 110.282 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -91.86 -12.59 33.21 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.48 1.113 . . . . 0.0 109.25 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.61 148.89 47.63 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.535 1.147 . . . . 0.0 109.318 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 2.4 tpt85 -120.64 116.11 24.68 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.471 1.107 . . . . 0.0 110.288 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -80.7 122.28 26.93 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.414 1.072 . . . . 0.0 109.355 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.4 ' O ' ' O ' ' A' ' 319' ' ' LEU . 13.5 ptp180 -130.27 142.97 50.52 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.486 1.116 . . . . 0.0 110.303 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 10.5 m -95.36 129.19 42.59 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.51 1.131 . . . . 0.0 110.383 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 51.5 t -106.46 117.67 56.52 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.521 1.138 . . . . 0.0 109.276 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.2 Cg_endo -75.03 164.6 32.98 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.473 1.775 . . . . 0.0 110.988 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.486 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -66.85 125.21 25.18 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.495 1.122 . . . . 0.0 109.287 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 99.03 -24.91 30.32 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 124.5 1.125 . . . . 0.0 111.002 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . 0.515 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -63.64 144.74 56.77 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.49 0.759 . . . . 0.0 109.299 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 2.7 p -97.54 135.82 30.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 0.0 109.288 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 12.2 mt -82.3 -49.17 17.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.541 1.15 . . . . 0.0 109.328 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' CYS . . . . . 0.495 ' SG ' ' CG2' ' A' ' 311' ' ' VAL . 12.8 p -142.96 163.63 32.27 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.522 1.139 . . . . 0.0 108.28 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 1.1 mmt-85 -103.81 178.34 4.59 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.515 1.135 . . . . 0.0 110.313 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.468 ' N ' ' HG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -77.79 142.02 14.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.458 1.099 . . . . 0.0 109.317 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 46.82 43.92 17.12 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.536 1.148 . . . . 0.0 111.009 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.436 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.2 OUTLIER -71.38 166.93 34.32 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.485 0.756 . . . . 0.0 110.311 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . 0.436 ' HD2' ' HB2' ' A' ' 267' ' ' GLU . 18.1 Cg_endo -75.01 86.91 1.37 Allowed 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.487 1.783 . . . . 0.0 111.0 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -45.54 97.9 0.01 OUTLIER Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.499 1.124 . . . . 0.0 110.979 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -170.19 38.11 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.539 0.788 . . . . 0.0 109.284 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.46 144.55 6.42 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.139 . . . . 0.0 110.299 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.492 ' CE ' ' HG2' ' A' ' 298' ' ' GLU . 2.1 ttt -113.94 146.65 39.78 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.501 1.125 . . . . 0.0 111.008 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.565 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 86.6 m-85 -138.07 136.63 37.0 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.488 1.117 . . . . 0.0 110.984 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . 0.469 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 23.0 m-85 -126.65 133.67 50.92 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.123 . . . . 0.0 110.986 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.42 ' HA ' ' HB3' ' A' ' 319' ' ' LEU . 36.9 t -89.67 135.2 26.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.495 1.122 . . . . 0.0 109.311 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 9.8 t -110.4 -49.1 6.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.535 1.147 . . . . 0.0 109.334 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -143.59 132.74 23.05 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.483 1.115 . . . . 0.0 110.253 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.488 ' HA3' ' CG2' ' A' ' 317' ' ' VAL . . . 121.95 -169.25 14.72 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.492 1.12 . . . . 0.0 111.023 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' SER . . . . . 0.416 ' N ' HG22 ' A' ' 317' ' ' VAL . 7.6 t -138.33 117.0 12.2 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.555 0.797 . . . . 0.0 110.007 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.469 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 30.0 m -98.76 161.47 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.504 1.127 . . . . 0.0 109.28 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 28.9 t -127.97 151.18 49.44 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.414 1.071 . . . . 0.0 110.018 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.475 HG23 ' CG1' ' A' ' 288' ' ' VAL . 1.4 t -114.81 130.75 68.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.468 1.105 . . . . 0.0 109.328 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -77.99 102.14 7.24 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.469 1.106 . . . . 0.0 109.298 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' THR . . . . . 0.655 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.29 -168.46 0.19 Allowed Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.502 1.126 . . . . 0.0 110.403 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.655 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -75.0 3.77 5.33 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.483 1.781 . . . . 0.0 110.936 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -151.45 157.48 34.82 Favored Pre-proline 0 C--N 1.324 -0.529 0 O-C-N 124.501 1.126 . . . . 0.0 109.302 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 94.73 0.96 Allowed 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.493 1.786 . . . . 0.0 110.95 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.475 ' CG1' HG23 ' A' ' 282' ' ' VAL . 61.5 t -98.94 118.92 46.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 0.0 109.3 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -124.28 139.11 54.22 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.433 1.083 . . . . 0.0 110.275 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.469 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 3.7 mm? -117.15 140.34 49.64 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.465 1.103 . . . . 0.0 109.299 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -96.5 -162.58 32.75 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.527 1.142 . . . . 0.0 111.061 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 141.47 26.68 Favored 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.567 1.825 . . . . 0.0 110.999 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 90.23 6.56 68.7 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.55 1.156 . . . . 0.0 110.971 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -91.69 131.8 36.82 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.484 0.756 . . . . 0.0 109.287 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -119.3 152.71 36.24 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.489 1.118 . . . . 0.0 110.995 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . 0.565 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 45.2 p90 -163.57 145.63 9.58 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.483 1.114 . . . . 0.0 111.02 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . 0.441 ' HA2' ' NH2' ' A' ' 307' ' ' ARG . . . 132.26 -3.53 5.17 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.513 1.133 . . . . 0.0 110.99 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . 0.492 ' HG2' ' CE ' ' A' ' 272' ' ' MET . 1.7 mt-10 -59.41 -46.06 89.76 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.497 0.763 . . . . 0.0 110.294 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' MET . . . . . 0.408 ' HB3' ' CG ' ' A' ' 305' ' ' GLU . 0.0 OUTLIER -52.03 -34.36 42.73 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.486 1.116 . . . . 0.0 110.997 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -69.08 -45.06 71.23 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 0.0 109.289 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.462 ' CD2' ' HB2' ' A' ' 327' ' ' PHE . 1.0 OUTLIER -75.37 -6.96 52.64 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.506 1.128 . . . . 0.0 109.251 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 3.0 mm -82.25 -55.6 7.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.538 1.149 . . . . 0.0 109.337 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 304' ' ' GLY . 1.6 m -151.57 38.16 0.61 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.468 1.105 . . . . 0.0 110.011 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 36.68 53.14 1.44 Allowed Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.527 1.142 . . . . 0.0 111.005 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . 0.408 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 1.3 pt-20 -82.48 157.17 67.95 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.534 0.785 . . . . 0.0 110.312 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.07 133.82 16.95 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.467 1.772 . . . . 0.0 110.982 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . 0.441 ' NH2' ' HA2' ' A' ' 297' ' ' GLY . 0.0 OUTLIER -50.59 -26.0 4.82 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.45 1.094 . . . . 0.0 110.239 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 46.73 39.14 6.71 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.486 1.116 . . . . 0.0 110.025 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . 173.91 161.05 0.16 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.514 1.134 . . . . 0.0 109.344 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.468 ' HG1' ' N ' ' A' ' 265' ' ' ILE . 0.6 OUTLIER -109.14 132.87 53.71 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.539 1.149 . . . . 0.0 110.388 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.495 ' CG2' ' SG ' ' A' ' 263' ' ' CYS . 44.5 t -111.7 131.56 62.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.483 1.115 . . . . 0.0 109.296 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 6.2 p -141.62 151.64 43.29 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.461 1.101 . . . . 0.0 109.991 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.42 118.48 26.89 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.526 1.141 . . . . 0.0 109.318 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -59.92 -32.24 70.58 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.505 1.128 . . . . 0.0 109.267 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' THR . . . . . 0.486 ' HA ' ' CB ' ' A' ' 258' ' ' ALA . 13.1 t -153.97 -175.58 5.45 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.515 1.135 . . . . 0.0 110.362 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 41.7 p -49.29 92.46 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.531 1.144 . . . . 0.0 110.394 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.488 ' CG2' ' HA3' ' A' ' 278' ' ' GLY . 53.5 t -109.33 162.41 7.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.472 1.108 . . . . 0.0 109.273 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' SER . . . . . 0.433 ' N ' ' CG1' ' A' ' 317' ' ' VAL . 64.0 m -136.29 116.64 13.63 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.514 1.134 . . . . 0.0 109.989 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . 0.469 ' CB ' ' O ' ' A' ' 274' ' ' PHE . 0.2 OUTLIER -132.0 172.25 12.59 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.472 1.107 . . . . 0.0 109.341 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.425 HD23 ' ND2' ' A' ' 226' ' ' ASN . 0.2 OUTLIER -124.66 135.74 53.32 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.495 1.122 . . . . 0.0 109.341 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 45.5 t -93.36 158.25 15.83 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.525 1.141 . . . . 0.0 110.01 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -151.77 94.6 2.0 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.483 1.115 . . . . 0.0 109.329 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -55.39 135.32 50.36 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 0.0 109.624 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 8.1 t -57.78 -17.07 13.53 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.499 1.124 . . . . 0.0 110.0 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -58.31 -36.74 73.82 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.533 1.145 . . . . 0.0 109.297 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -42.61 95.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.491 1.119 . . . . 0.0 109.285 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' PHE . . . . . 0.462 ' HB2' ' CD2' ' A' ' 301' ' ' LEU . 83.7 t80 -65.19 -36.14 83.28 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.46 1.1 . . . . 0.0 110.981 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -69.65 -31.75 70.0 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.464 1.102 . . . . 0.0 110.328 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -69.86 -45.12 68.42 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.538 1.149 . . . . 0.0 110.995 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 1.2 mt -71.27 -30.89 66.84 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.492 1.12 . . . . 0.0 109.274 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 1.6 m -72.29 -37.52 68.99 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.535 1.147 . . . . 0.0 108.303 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.87 -36.28 64.81 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.44 1.088 . . . . 0.0 110.005 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.77 -33.56 70.9 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.517 1.135 . . . . 0.0 109.98 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' SER . . . . . 0.434 ' CB ' HD13 ' A' ' 337' ' ' ILE . 0.6 OUTLIER -128.68 113.22 19.16 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.531 1.145 . . . . 0.0 109.985 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -22.27 14.97 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.429 1.752 . . . . 0.0 110.988 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -73.53 -31.57 63.75 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.467 1.105 . . . . 0.0 110.337 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.48 ' CG2' ' CD2' ' A' ' 239' ' ' LEU . 60.5 mt -73.69 -45.53 50.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.542 1.151 . . . . 0.0 109.331 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . 0.406 ' O ' ' CB ' ' A' ' 342' ' ' ARG . . . -69.26 -32.17 71.18 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 0.0 109.298 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -71.4 -38.38 71.46 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.469 1.105 . . . . 0.0 110.334 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 78.5 mt -73.1 -42.67 58.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.467 1.105 . . . . 0.0 109.341 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.566 ' CE2' ' HB3' ' A' ' 235' ' ' LEU . 2.5 t80 -72.39 -30.72 64.93 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.513 1.133 . . . . 0.0 110.997 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . 0.47 ' HG3' ' CD1' ' A' ' 346' ' ' LEU . 0.0 OUTLIER -72.58 -43.21 63.67 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.511 1.132 . . . . 0.0 110.264 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -51.07 63.43 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.461 1.101 . . . . 0.0 109.323 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' THR . . . . . 0.422 ' CG2' ' HA ' ' A' ' 341' ' ' PHE . 9.0 t -65.02 -34.06 77.54 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.513 1.133 . . . . 0.0 110.355 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . 0.493 ' CB ' ' O ' ' A' ' 341' ' ' PHE . . . -65.22 -43.4 91.62 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.542 1.151 . . . . 0.0 109.291 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.47 ' CD1' ' HG3' ' A' ' 342' ' ' ARG . 0.5 OUTLIER -65.03 -38.87 92.3 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.482 1.114 . . . . 0.0 109.286 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -68.88 -37.95 79.37 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.46 1.1 . . . . 0.0 110.32 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 40.0 mtt-85 -72.43 -42.97 64.46 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.472 1.107 . . . . 0.0 110.345 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . 0.405 ' O ' ' C ' ' A' ' 350' ' ' GLY . 0.0 OUTLIER -72.56 -34.77 67.72 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.464 1.103 . . . . 0.0 110.31 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 349' ' ' ARG . . . -37.35 -47.95 1.57 Allowed Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.514 1.133 . . . . 0.0 110.99 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -154.95 120.07 4.94 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.555 0.797 . . . . 0.0 109.263 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -61.16 171.67 1.26 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.473 1.108 . . . . 0.0 109.297 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -134.16 123.28 24.12 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.439 1.087 . . . . 0.0 109.322 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 68.7 m -152.69 162.7 40.9 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.472 1.107 . . . . 0.0 109.991 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.53 0 O-C-N 124.572 1.17 . . . . 0.0 109.362 179.977 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.009 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 24.1 p -86.7 158.12 19.5 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.51 0.771 . . . . 0.0 109.997 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -141.34 147.47 38.16 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.53 1.144 . . . . 0.0 110.323 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.61 171.81 16.06 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.512 1.132 . . . . 0.0 110.315 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.57 178.98 3.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.509 1.13 . . . . 0.0 109.344 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -78.37 160.55 27.74 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.502 1.126 . . . . 0.0 110.268 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.27 157.2 45.01 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.521 1.138 . . . . 0.0 110.33 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -119.92 -37.67 0.75 Allowed Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.543 1.152 . . . . 0.0 110.983 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 35.0 p30 -92.09 19.38 6.89 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.459 0.741 . . . . 0.0 109.287 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -56.09 -40.5 73.76 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.518 1.137 . . . . 0.0 111.034 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.26 -32.58 58.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.485 1.115 . . . . 0.0 109.258 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.34 -35.39 71.17 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.532 1.145 . . . . 0.0 110.291 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -78.95 -30.43 44.6 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.498 1.123 . . . . 0.0 109.25 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' TRP . . . . . 0.569 ' CZ2' ' CG2' ' A' ' 245' ' ' VAL . 2.5 t90 -67.79 -45.52 74.59 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.502 1.126 . . . . 0.0 107.982 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.494 ' O ' ' CB ' ' A' ' 232' ' ' ALA . 6.1 pt20 -71.54 -34.41 69.99 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.535 1.147 . . . . 0.0 110.339 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 6.2 mt -60.55 -43.83 96.8 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.479 1.112 . . . . 0.0 109.318 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 82.7 t -75.5 -45.86 38.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.498 1.124 . . . . 0.0 109.324 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -69.16 -10.26 56.81 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.544 1.152 . . . . 0.0 109.299 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 228' ' ' GLN . . . -80.42 -20.52 43.71 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.459 1.099 . . . . 0.0 109.268 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . 0.431 ' CG1' ' HB2' ' A' ' 236' ' ' PHE . 0.3 OUTLIER -91.74 126.92 52.15 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.491 1.12 . . . . 0.0 109.299 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -0.34 9.85 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.551 1.816 . . . . 0.0 111.029 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -24.12 32.06 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.508 1.13 . . . . 0.0 109.311 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . 0.437 ' CD1' HD11 ' A' ' 239' ' ' LEU . 1.4 m-30 -120.4 -8.49 9.6 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.528 1.143 . . . . 0.0 111.029 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.66 -26.71 68.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.464 1.102 . . . . 0.0 110.258 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -74.71 -3.69 32.96 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.539 1.149 . . . . 0.0 109.342 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.483 ' HB2' ' CD2' ' A' ' 244' ' ' LEU . 66.5 mt -81.84 -179.32 7.34 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.509 1.131 . . . . 0.0 109.327 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -100.73 -176.76 29.62 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.5 1.125 . . . . 0.0 111.016 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.5 ' O ' ' CG2' ' A' ' 245' ' ' VAL . 18.1 Cg_endo -75.05 -38.84 1.39 Allowed 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.469 1.773 . . . . 0.0 110.991 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -66.37 -33.13 75.04 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 0.0 109.286 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.461 HG23 ' CD1' ' A' ' 337' ' ' ILE . 4.5 t -75.13 -42.02 44.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.503 1.127 . . . . 0.0 109.286 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.483 ' CD2' ' HB2' ' A' ' 239' ' ' LEU . 1.3 mm? -65.34 -37.91 88.52 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.487 1.117 . . . . 0.0 109.271 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.569 ' CG2' ' CZ2' ' A' ' 227' ' ' TRP . 58.4 t -71.82 -38.33 65.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.504 1.128 . . . . 0.0 109.247 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -67.64 -40.1 84.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.502 1.126 . . . . 0.0 110.289 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.446 ' CD1' HG12 ' A' ' 243' ' ' VAL . 31.6 mt -68.48 -48.9 70.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.461 1.1 . . . . 0.0 109.312 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 68.6 t -64.32 -33.15 60.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.132 . . . . 0.0 109.286 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.496 ' CG ' ' O ' ' A' ' 245' ' ' VAL . 0.9 OUTLIER -75.84 -22.85 55.84 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.489 1.118 . . . . 0.0 110.332 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.411 ' CB ' ' OD2' ' A' ' 326' ' ' ASP . . . -90.53 -18.08 25.91 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.446 1.091 . . . . 0.0 109.282 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.4 147.82 50.18 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.475 1.109 . . . . 0.0 109.288 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.97 134.26 55.29 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.541 1.15 . . . . 0.0 110.322 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -80.75 122.46 27.18 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.543 1.152 . . . . 0.0 109.323 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -123.73 123.3 40.21 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.482 1.113 . . . . 0.0 110.301 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 9.3 m -92.13 116.94 29.37 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.533 1.146 . . . . 0.0 110.41 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 77.4 t -106.67 112.22 63.65 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.548 1.155 . . . . 0.0 109.324 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.529 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.2 Cg_endo -75.0 175.37 11.33 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.501 1.79 . . . . 0.0 110.997 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.483 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -66.97 133.27 49.63 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.499 1.124 . . . . 0.0 109.359 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 90.42 -25.14 13.61 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.456 1.097 . . . . 0.0 110.99 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . 0.529 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -57.66 147.24 28.07 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.53 0.783 . . . . 0.0 109.301 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.7 t -97.25 128.96 48.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.113 . . . . 0.0 109.307 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 38.7 mt -82.96 -39.17 15.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.467 1.105 . . . . 0.0 109.291 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 14.2 p -159.47 151.27 20.46 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.507 1.129 . . . . 0.0 108.27 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 -95.16 -179.46 4.81 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.512 1.133 . . . . 0.0 110.303 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.508 ' N ' ' HG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -75.95 139.26 19.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.526 1.141 . . . . 0.0 109.354 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 47.82 51.46 18.15 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.519 1.137 . . . . 0.0 110.999 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.413 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.2 OUTLIER -71.47 164.42 57.83 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.491 0.76 . . . . 0.0 110.306 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . 0.43 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.3 Cg_endo -74.94 78.5 2.86 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.488 1.783 . . . . 0.0 111.045 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 268' ' ' PRO . . . -36.58 96.54 0.01 OUTLIER Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.514 1.134 . . . . 0.0 111.009 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 268' ' ' PRO . 0.3 OUTLIER -170.26 37.6 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.506 0.768 . . . . 0.0 109.283 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.437 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 0.2 OUTLIER -168.09 144.93 4.07 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.484 1.115 . . . . 0.0 110.291 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.487 ' SD ' ' CD1' ' A' ' 301' ' ' LEU . 0.1 OUTLIER -114.85 146.47 41.03 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 0.0 110.948 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.572 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 66.9 m-85 -133.46 136.7 45.31 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.474 1.109 . . . . 0.0 111.037 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . 0.449 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 22.0 m-85 -127.13 131.02 50.88 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.53 1.144 . . . . 0.0 111.046 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.408 ' HA ' ' HB3' ' A' ' 319' ' ' LEU . 45.7 t -87.07 137.7 20.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.501 1.126 . . . . 0.0 109.295 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . 0.436 ' CG2' HD12 ' A' ' 320' ' ' LEU . 4.2 t -118.56 -40.54 2.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.533 1.145 . . . . 0.0 109.301 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -147.52 136.16 21.87 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.511 1.132 . . . . 0.0 110.339 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.457 ' HA3' ' CG2' ' A' ' 317' ' ' VAL . . . 112.31 -167.33 12.35 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.513 1.133 . . . . 0.0 110.999 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' SER . . . . . 0.441 ' N ' HG22 ' A' ' 317' ' ' VAL . 11.2 t -140.97 122.12 14.72 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.569 0.805 . . . . 0.0 109.997 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.467 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 21.1 m -99.27 163.56 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.511 1.132 . . . . 0.0 109.308 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 31.6 t -130.25 151.85 50.32 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.492 1.12 . . . . 0.0 110.03 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.418 ' CG2' ' HB ' ' A' ' 288' ' ' VAL . 0.8 OUTLIER -114.77 129.01 71.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.463 1.102 . . . . 0.0 109.316 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.42 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -80.06 101.06 8.49 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.517 1.135 . . . . 0.0 109.318 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' THR . . . . . 0.661 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -149.04 -168.13 0.18 Allowed Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.554 1.159 . . . . 0.0 110.409 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.661 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.3 Cg_endo -74.98 5.49 3.94 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.448 1.762 . . . . 0.0 111.011 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -151.59 153.37 31.98 Favored Pre-proline 0 C--N 1.324 -0.529 0 O-C-N 124.511 1.132 . . . . 0.0 109.348 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.95 97.48 1.08 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.509 1.794 . . . . 0.0 111.044 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.418 ' HB ' ' CG2' ' A' ' 282' ' ' VAL . 2.3 t -102.78 119.24 50.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.469 1.106 . . . . 0.0 109.324 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -124.46 134.8 52.94 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.477 1.11 . . . . 0.0 110.271 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.467 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 3.9 mm? -112.97 141.59 46.62 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.488 1.118 . . . . 0.0 109.336 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -98.12 -164.72 31.13 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.466 1.104 . . . . 0.0 110.953 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.0 139.68 24.57 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.541 1.811 . . . . 0.0 111.007 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 96.6 1.93 60.19 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.509 1.131 . . . . 0.0 111.016 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -87.64 144.68 26.54 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.529 0.782 . . . . 0.0 109.301 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -134.83 153.11 52.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.468 1.105 . . . . 0.0 110.958 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . 0.572 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 45.9 p90 -163.89 146.25 9.38 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.508 1.13 . . . . 0.0 110.992 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 137.34 -10.33 3.8 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.455 1.097 . . . . 0.0 111.026 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . 0.44 ' HG2' ' N ' ' A' ' 299' ' ' MET . 0.9 OUTLIER -52.46 -34.85 50.81 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.482 0.754 . . . . 0.0 110.282 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' MET . . . . . 0.446 ' HB3' ' CG ' ' A' ' 305' ' ' GLU . 0.5 OUTLIER -64.27 -41.5 96.89 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.458 1.099 . . . . 0.0 111.032 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -63.67 -29.9 71.07 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.473 1.108 . . . . 0.0 109.296 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.487 ' CD1' ' SD ' ' A' ' 272' ' ' MET . 1.2 mt -86.34 -19.04 30.39 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.548 1.155 . . . . 0.0 109.286 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 298' ' ' GLU . 3.9 mm -68.56 -57.4 9.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.426 1.079 . . . . 0.0 109.33 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 304' ' ' GLY . 2.7 m -155.02 44.99 0.5 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.484 1.115 . . . . 0.0 110.021 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 303' ' ' SER . . . 35.4 51.15 0.98 Allowed Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.481 1.113 . . . . 0.0 111.005 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . 0.446 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 0.1 OUTLIER -78.76 155.02 78.37 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.504 0.767 . . . . 0.0 110.295 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 130.2 13.08 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.496 1.788 . . . . 0.0 111.003 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . 0.411 ' NE ' ' HG2' ' A' ' 267' ' ' GLU . 0.2 OUTLIER -44.61 -36.37 3.02 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.495 1.122 . . . . 0.0 110.321 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.482 ' O ' ' CB ' ' A' ' 309' ' ' ALA . 0.8 OUTLIER 59.9 42.49 16.21 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.459 1.1 . . . . 0.0 109.967 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' ALA . . . . . 0.482 ' CB ' ' O ' ' A' ' 308' ' ' SER . . . 164.59 160.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.517 1.135 . . . . 0.0 109.315 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.508 ' HG1' ' N ' ' A' ' 265' ' ' ILE . 0.9 OUTLIER -108.36 137.38 46.43 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.484 1.115 . . . . 0.0 110.387 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 61.6 t -116.92 131.38 69.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.459 1.1 . . . . 0.0 109.303 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 61.9 p -132.16 159.11 39.92 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.534 1.146 . . . . 0.0 110.008 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -93.6 118.3 31.2 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.547 1.155 . . . . 0.0 109.302 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -58.59 -35.26 72.13 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.499 1.124 . . . . 0.0 109.311 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' THR . . . . . 0.483 ' HA ' ' CB ' ' A' ' 258' ' ' ALA . 9.8 t -155.62 -172.5 4.17 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.491 1.119 . . . . 0.0 110.373 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' THR . . . . . 0.426 ' N ' ' OG1' ' A' ' 315' ' ' THR . 32.0 m -49.49 91.33 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.508 1.13 . . . . 0.0 110.396 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.457 ' CG2' ' HA3' ' A' ' 278' ' ' GLY . 38.6 t -107.79 155.98 8.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.444 1.09 . . . . 0.0 109.281 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 31.0 m -132.56 114.25 14.03 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.491 1.119 . . . . 0.0 110.045 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . 0.449 ' CB ' ' O ' ' A' ' 274' ' ' PHE . 0.2 OUTLIER -129.28 173.29 10.64 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 0.0 109.261 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.436 HD12 ' CG2' ' A' ' 276' ' ' VAL . 0.3 OUTLIER -124.2 138.18 54.44 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.434 1.084 . . . . 0.0 109.303 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 30.9 t -97.59 155.29 17.04 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.501 1.126 . . . . 0.0 109.976 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.457 HD23 ' CB ' ' A' ' 326' ' ' ASP . 1.4 tm? -145.69 92.99 2.29 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.441 1.088 . . . . 0.0 109.282 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . 0.509 ' CE1' ' OD1' ' A' ' 326' ' ' ASP . 13.8 p80 -54.99 126.77 25.95 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.464 1.103 . . . . 0.0 109.638 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' SER . . . . . 0.407 ' OG ' ' CG ' ' A' ' 270' ' ' ASP . 2.1 p -49.38 -26.92 3.55 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.476 1.11 . . . . 0.0 109.974 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -52.0 -30.46 25.25 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.492 1.12 . . . . 0.0 109.324 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . 0.509 ' OD1' ' CE1' ' A' ' 323' ' ' HIS . 0.2 OUTLIER -70.41 -41.85 72.41 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.448 1.092 . . . . 0.0 109.288 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' PHE . . . . . 0.672 ' CZ ' ' CE2' ' A' ' 341' ' ' PHE . 2.5 t80 -64.82 -38.82 92.28 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.486 1.116 . . . . 0.0 110.994 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -69.53 -34.13 73.8 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.424 1.077 . . . . 0.0 110.252 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 28.7 ttp -71.22 -32.24 68.56 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.465 1.103 . . . . 0.0 111.013 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.491 ' N ' HD21 ' A' ' 330' ' ' LEU . 0.2 OUTLIER -72.78 -46.2 54.55 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.546 1.154 . . . . 0.0 109.278 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' CYS . . . . . 0.401 ' O ' ' O ' ' A' ' 334' ' ' SER . 1.5 m -65.92 -32.38 73.85 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.527 1.142 . . . . 0.0 108.259 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 4.7 t -76.27 -29.8 57.57 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.486 1.116 . . . . 0.0 110.04 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 12.8 t -72.38 -38.19 68.54 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 0.0 109.983 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' SER . . . . . 0.401 ' O ' ' O ' ' A' ' 331' ' ' CYS . 0.3 OUTLIER -127.86 130.15 23.66 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.461 1.101 . . . . 0.0 109.97 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 -23.79 13.45 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.514 1.797 . . . . 0.0 111.035 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.55 -30.27 68.04 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.495 1.122 . . . . 0.0 110.351 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 341' ' ' PHE . 49.4 mt -73.36 -36.86 50.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.498 1.124 . . . . 0.0 109.317 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -71.53 -34.63 70.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.502 1.126 . . . . 0.0 109.291 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -74.05 -45.13 51.48 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.512 1.132 . . . . 0.0 110.273 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 94.5 mt -69.82 -35.55 65.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.517 1.136 . . . . 0.0 109.316 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.672 ' CE2' ' CZ ' ' A' ' 327' ' ' PHE . 1.6 t80 -69.14 -39.46 78.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.523 1.14 . . . . 0.0 110.996 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.46 -38.05 77.57 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.479 1.112 . . . . 0.0 110.336 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -43.52 78.29 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.516 1.135 . . . . 0.0 109.311 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.91 -40.78 83.36 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.517 1.136 . . . . 0.0 110.414 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -66.37 -38.02 86.62 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.511 1.132 . . . . 0.0 109.282 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 9.6 mt -68.59 -35.1 76.9 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.538 1.149 . . . . 0.0 109.344 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -69.69 -40.1 76.53 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.124 . . . . 0.0 110.286 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 13.9 mtt180 -70.19 -40.22 74.74 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.506 1.129 . . . . 0.0 110.314 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.72 -34.74 67.31 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.509 1.131 . . . . 0.0 110.327 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -38.37 -50.29 2.3 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.532 1.145 . . . . 0.0 110.986 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -153.67 121.1 5.85 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.471 0.748 . . . . 0.0 109.31 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -61.11 166.28 3.74 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.496 1.122 . . . . 0.0 109.287 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -119.3 120.15 36.12 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.491 1.119 . . . . 0.0 109.319 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 1.5 t -132.64 169.83 16.08 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.461 1.101 . . . . 0.0 110.027 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.537 1.148 . . . . 0.0 109.289 179.994 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.023 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 18.6 m -128.34 171.97 11.52 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.55 0.794 . . . . 0.0 110.029 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -100.78 172.65 6.93 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.581 1.176 . . . . 0.0 110.267 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -116.06 163.05 16.5 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.524 1.14 . . . . 0.0 110.324 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 11.2 p -151.61 159.73 3.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.498 1.124 . . . . 0.0 109.269 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.37 162.87 14.08 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.445 1.091 . . . . 0.0 110.339 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -136.75 158.63 44.01 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.446 1.091 . . . . 0.0 110.334 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -108.99 -34.4 2.57 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.509 1.13 . . . . 0.0 110.983 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -92.07 19.39 6.86 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.457 0.739 . . . . 0.0 109.263 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -54.52 -40.05 68.22 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.455 1.097 . . . . 0.0 111.018 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.78 -37.94 43.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.439 1.087 . . . . 0.0 109.271 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -31.1 70.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.144 . . . . 0.0 110.335 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . 0.493 ' O ' ' CG1' ' A' ' 230' ' ' VAL . 6.4 t-20 -80.3 -31.55 38.19 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.532 1.145 . . . . 0.0 109.286 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' TRP . . . . . 0.432 ' O ' ' CB ' ' A' ' 231' ' ' ALA . 2.0 t90 -68.68 -43.98 75.0 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.504 ' O ' ' CB ' ' A' ' 232' ' ' ALA . 4.1 pt20 -72.02 -33.82 68.34 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.454 1.096 . . . . 0.0 110.308 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 2.4 mt -64.94 -55.37 19.6 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 0.0 109.269 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.493 ' CG1' ' O ' ' A' ' 226' ' ' ASN . 5.7 p -65.09 -37.66 80.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.523 1.139 . . . . 0.0 109.34 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 227' ' ' TRP . . . -76.03 -15.1 60.19 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.478 1.111 . . . . 0.0 109.235 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.504 ' CB ' ' O ' ' A' ' 228' ' ' GLN . . . -80.71 -11.33 59.64 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.503 1.127 . . . . 0.0 109.307 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . 0.433 HG13 ' CD2' ' A' ' 236' ' ' PHE . 0.6 OUTLIER -89.02 132.61 37.46 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.547 1.155 . . . . 0.0 109.32 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -0.08 9.51 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.457 1.767 . . . . 0.0 111.028 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.25 -24.4 22.1 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 0.0 109.32 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . 0.559 ' CD1' HD11 ' A' ' 239' ' ' LEU . 21.2 m-30 -122.92 8.14 9.32 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.478 1.111 . . . . 0.0 110.987 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -73.16 -19.53 61.1 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.483 1.114 . . . . 0.0 110.286 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.428 ' NZ ' ' HA ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -97.57 4.99 50.14 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.527 1.142 . . . . 0.0 109.326 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.559 HD11 ' CD1' ' A' ' 236' ' ' PHE . 19.3 mt -80.28 -179.42 7.09 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.465 1.103 . . . . 0.0 109.316 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -103.23 -178.48 26.3 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.499 1.124 . . . . 0.0 110.991 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 -32.9 5.04 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.53 1.805 . . . . 0.0 110.98 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 0.416 ' O ' HG13 ' A' ' 245' ' ' VAL . . . -73.62 -32.81 64.26 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.445 1.09 . . . . 0.0 109.297 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.467 HG21 ' CD1' ' A' ' 337' ' ' ILE . 63.0 t -76.6 -38.39 31.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.126 . . . . 0.0 109.271 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.435 ' CD2' ' HB2' ' A' ' 239' ' ' LEU . 3.6 mm? -71.31 -45.47 62.96 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.488 1.118 . . . . 0.0 109.289 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 242' ' ' ALA . 3.3 p -64.65 -45.09 96.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.528 1.142 . . . . 0.0 109.317 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.402 ' N ' ' CG1' ' A' ' 245' ' ' VAL . 15.3 tp10 -65.0 -40.89 95.62 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.509 1.13 . . . . 0.0 110.262 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.403 ' CG1' HD11 ' A' ' 330' ' ' LEU . 26.5 mt -65.16 -43.83 95.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.493 1.121 . . . . 0.0 109.303 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.436 ' CG2' HG12 ' A' ' 230' ' ' VAL . 75.7 t -69.51 -30.99 47.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.504 1.128 . . . . 0.0 109.277 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -76.87 -19.6 57.27 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.55 1.156 . . . . 0.0 110.324 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.471 ' CB ' ' OD1' ' A' ' 326' ' ' ASP . . . -93.82 -14.84 25.71 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.539 1.149 . . . . 0.0 109.302 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.12 146.35 54.76 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.541 1.151 . . . . 0.0 109.293 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -117.82 117.96 30.73 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.555 1.159 . . . . 0.0 110.288 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -80.79 125.03 29.56 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.436 1.085 . . . . 0.0 109.289 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -132.56 143.89 50.02 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.491 1.119 . . . . 0.0 110.275 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 20.1 m -96.64 125.93 41.45 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 0.0 110.413 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.449 ' CG2' HD11 ' A' ' 319' ' ' LEU . 93.4 t -106.39 116.14 59.7 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.537 1.148 . . . . 0.0 109.345 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.9 162.12 37.86 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.513 1.796 . . . . 0.0 111.026 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.49 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -63.71 125.19 23.52 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.475 1.109 . . . . 0.0 109.317 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 100.7 -25.27 28.96 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.489 1.118 . . . . 0.0 110.988 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . 0.484 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -64.02 139.15 58.74 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.459 0.74 . . . . 0.0 109.295 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 2.7 p -93.25 135.64 27.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.466 1.104 . . . . 0.0 109.282 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 11.2 mt -82.49 -49.35 17.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.531 1.144 . . . . 0.0 109.284 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' CYS . . . . . 0.5 ' SG ' ' CG2' ' A' ' 311' ' ' VAL . 12.4 p -141.7 162.43 35.5 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.531 1.144 . . . . 0.0 108.255 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -103.93 -179.01 3.83 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.449 1.093 . . . . 0.0 110.28 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.32 137.41 22.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 0.0 109.299 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 47.01 48.91 18.87 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.504 1.128 . . . . 0.0 111.028 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.416 ' OE1' ' C ' ' A' ' 268' ' ' PRO . 0.0 OUTLIER -71.26 162.6 71.71 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.455 0.738 . . . . 0.0 110.333 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 269' ' ' GLY . 18.5 Cg_endo -74.98 78.07 2.98 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.521 1.801 . . . . 0.0 111.041 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . 0.464 ' O ' ' CA ' ' A' ' 304' ' ' GLY . . . -35.23 102.73 0.01 OUTLIER Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.527 1.142 . . . . 0.0 110.973 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -170.33 38.31 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 0.765 . . . . 0.0 109.293 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.45 144.86 2.01 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.131 . . . . 0.0 110.293 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.97 146.56 37.62 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.511 1.132 . . . . 0.0 111.057 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.562 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 20.1 m-85 -137.55 136.78 37.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.486 1.117 . . . . 0.0 111.021 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . 0.484 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 21.4 m-85 -127.25 135.95 51.32 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.537 1.148 . . . . 0.0 111.005 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.405 ' HA ' ' HB3' ' A' ' 319' ' ' LEU . 25.4 t -93.57 138.65 19.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.46 1.1 . . . . 0.0 109.305 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . 0.48 ' CG2' HD12 ' A' ' 320' ' ' LEU . 2.7 t -115.99 -48.49 4.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.469 1.106 . . . . 0.0 109.274 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -140.2 132.99 29.07 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.528 1.143 . . . . 0.0 110.304 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.456 ' HA3' ' CG2' ' A' ' 317' ' ' VAL . . . 118.34 -173.35 14.83 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.531 1.144 . . . . 0.0 110.997 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' SER . . . . . 0.413 ' N ' HG23 ' A' ' 317' ' ' VAL . 8.4 t -134.73 122.29 21.95 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.52 0.776 . . . . 0.0 110.012 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.455 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 26.1 m -100.08 163.86 2.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.492 1.12 . . . . 0.0 109.302 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 31.1 t -129.24 152.51 48.74 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 0.0 109.993 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 1.5 t -115.96 128.87 73.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.467 1.105 . . . . 0.0 109.3 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.411 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -78.43 101.66 7.4 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.48 1.113 . . . . 0.0 109.319 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' THR . . . . . 0.664 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.9 OUTLIER -148.54 -167.96 0.17 Allowed Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.485 1.116 . . . . 0.0 110.366 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.664 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.5 Cg_endo -74.96 4.77 4.42 Favored 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.524 1.802 . . . . 0.0 111.057 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -152.0 155.25 33.45 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.477 1.11 . . . . 0.0 109.31 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 96.52 1.02 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.545 1.813 . . . . 0.0 111.032 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 2.1 t -101.52 119.54 49.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.536 1.148 . . . . 0.0 109.281 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -124.29 136.09 53.87 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.484 1.115 . . . . 0.0 110.321 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.455 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 3.8 mm? -115.44 141.77 47.6 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.483 1.115 . . . . 0.0 109.341 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -94.11 -160.21 34.51 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.505 1.128 . . . . 0.0 110.982 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 148.27 35.01 Favored 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.513 1.796 . . . . 0.0 111.009 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 86.46 -0.62 87.06 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.499 1.125 . . . . 0.0 110.984 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -83.49 123.43 29.71 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.478 0.752 . . . . 0.0 109.279 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . 0.467 ' CB ' ' CD1' ' A' ' 274' ' ' PHE . 3.8 p90 -114.82 152.92 31.33 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.482 1.114 . . . . 0.0 111.006 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . 0.562 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 37.5 p90 -160.57 147.99 15.91 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.518 1.136 . . . . 0.0 111.046 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 134.72 -8.35 4.56 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.548 1.155 . . . . 0.0 111.007 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -52.58 -41.9 64.02 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.458 0.74 . . . . 0.0 110.284 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' MET . . . . . 0.466 ' HB3' ' CG ' ' A' ' 305' ' ' GLU . 0.1 OUTLIER -54.92 -41.08 70.54 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.494 1.121 . . . . 0.0 111.006 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . 0.434 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -66.92 -35.7 80.6 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.509 1.131 . . . . 0.0 109.258 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.45 ' O ' ' CZ ' ' A' ' 341' ' ' PHE . 6.5 mt -75.01 -20.31 59.68 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.511 1.132 . . . . 0.0 109.261 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 3.3 mm -73.06 -54.97 14.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.129 . . . . 0.0 109.329 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.85 40.39 0.23 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.456 1.098 . . . . 0.0 110.015 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.464 ' CA ' ' O ' ' A' ' 269' ' ' GLY . . . 39.6 40.65 1.52 Allowed Glycine 0 CA--C 1.531 1.052 0 O-C-N 124.497 1.123 . . . . 0.0 110.989 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . 0.466 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 0.0 OUTLIER -66.11 158.65 75.67 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.509 0.77 . . . . 0.0 110.292 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.403 ' O ' ' OE2' ' A' ' 305' ' ' GLU . 18.5 Cg_endo -74.95 130.69 13.56 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.528 1.804 . . . . 0.0 111.02 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.9 -40.89 14.95 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.516 1.135 . . . . 0.0 110.318 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 68.19 34.43 3.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.493 1.121 . . . . 0.0 110.044 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . 172.78 161.98 0.12 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.521 1.138 . . . . 0.0 109.282 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.71 130.99 54.89 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.538 1.149 . . . . 0.0 110.416 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.5 ' CG2' ' SG ' ' A' ' 263' ' ' CYS . 41.6 t -109.75 131.48 60.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.472 1.108 . . . . 0.0 109.343 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 3.2 p -139.2 152.33 47.28 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.11 . . . . 0.0 109.993 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.94 117.17 26.61 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.474 1.109 . . . . 0.0 109.297 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -59.62 -31.48 69.53 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.547 1.154 . . . . 0.0 109.317 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' THR . . . . . 0.49 ' HA ' ' CB ' ' A' ' 258' ' ' ALA . 8.1 t -154.59 -175.36 5.37 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.472 1.108 . . . . 0.0 110.405 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 65.1 p -49.73 92.81 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.514 1.134 . . . . 0.0 110.392 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.456 ' CG2' ' HA3' ' A' ' 278' ' ' GLY . 75.8 t -110.23 152.07 12.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.498 1.124 . . . . 0.0 109.31 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 70.3 m -123.96 117.42 24.73 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.548 1.155 . . . . 0.0 109.988 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . 0.484 ' CB ' ' O ' ' A' ' 274' ' ' PHE . 0.2 OUTLIER -134.06 169.38 17.22 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.481 1.113 . . . . 0.0 109.293 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.48 HD12 ' CG2' ' A' ' 276' ' ' VAL . 0.0 OUTLIER -124.35 139.05 54.27 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.473 1.108 . . . . 0.0 109.314 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 3.2 p -95.04 158.17 15.58 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.534 1.146 . . . . 0.0 110.002 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -151.0 77.69 1.28 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.471 1.107 . . . . 0.0 109.305 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -42.54 141.46 1.01 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.416 1.072 . . . . 0.0 109.577 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -24.82 63.57 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.447 1.092 . . . . 0.0 109.963 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -52.21 -35.87 50.53 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.521 1.138 . . . . 0.0 109.292 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . 0.471 ' OD1' ' CB ' ' A' ' 250' ' ' ALA . 0.4 OUTLIER -71.6 -37.33 70.97 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.542 1.151 . . . . 0.0 109.329 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' PHE . . . . . 0.417 ' CE2' ' CE2' ' A' ' 341' ' ' PHE . 38.4 t80 -66.51 -41.18 89.23 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.484 1.115 . . . . 0.0 111.031 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -71.29 -31.52 67.55 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.503 1.127 . . . . 0.0 110.297 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.403 ' SD ' ' C ' ' A' ' 329' ' ' MET . 15.6 tmm? -68.54 -43.74 76.03 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.548 1.155 . . . . 0.0 111.014 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.403 HD11 ' CG1' ' A' ' 247' ' ' ILE . 5.0 mt -71.39 -37.78 71.53 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.521 1.138 . . . . 0.0 109.265 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 73.6 m -65.88 -41.68 91.25 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.531 1.144 . . . . 0.0 108.29 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.4 t -77.55 -24.42 49.86 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.471 1.107 . . . . 0.0 110.01 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 47.6 t -72.21 -39.02 68.87 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.533 1.145 . . . . 0.0 110.034 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.03 133.83 25.64 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.482 1.114 . . . . 0.0 109.978 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 -23.75 13.53 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.54 1.81 . . . . 0.0 110.974 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -72.26 -29.32 63.79 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.5 1.125 . . . . 0.0 110.328 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.467 ' CD1' HG21 ' A' ' 243' ' ' VAL . 30.9 mt -72.98 -42.71 59.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.483 1.114 . . . . 0.0 109.281 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.74 -30.72 67.32 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.55 1.157 . . . . 0.0 109.297 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -73.61 -43.76 58.79 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.564 1.165 . . . . 0.0 110.36 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 76.1 mt -70.76 -39.42 75.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.513 1.133 . . . . 0.0 109.298 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.491 ' CD1' ' C ' ' A' ' 341' ' ' PHE . 0.5 OUTLIER -66.95 -41.46 86.91 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.488 1.118 . . . . 0.0 111.005 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 -70.48 -33.41 71.22 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.504 1.128 . . . . 0.0 110.303 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -50.54 66.53 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.504 1.127 . . . . 0.0 109.323 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 6.0 t -65.11 -39.12 92.68 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.541 1.151 . . . . 0.0 110.433 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -66.77 -33.78 76.37 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.471 1.107 . . . . 0.0 109.282 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 10.2 mt -71.83 -36.9 70.34 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.514 1.134 . . . . 0.0 109.314 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -76.26 -30.8 57.98 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.535 1.147 . . . . 0.0 110.3 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 7.0 mtt-85 -72.05 -41.12 67.83 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.472 1.107 . . . . 0.0 110.335 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.81 -34.86 67.14 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.519 1.137 . . . . 0.0 110.272 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -38.58 -48.87 2.38 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.515 1.135 . . . . 0.0 110.976 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -154.92 121.97 5.53 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.514 0.773 . . . . 0.0 109.246 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -64.68 175.95 1.29 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.484 1.115 . . . . 0.0 109.29 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -143.1 120.03 11.31 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.502 1.126 . . . . 0.0 109.347 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 3.6 m -155.0 170.2 22.31 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.526 1.141 . . . . 0.0 109.985 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.45 1.094 . . . . 0.0 109.334 179.982 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.988 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.66 172.72 6.67 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.534 0.785 . . . . 0.0 110.013 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.89 168.74 11.81 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.495 1.122 . . . . 0.0 110.291 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -128.78 155.63 44.83 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.547 1.155 . . . . 0.0 110.303 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 14.7 p -151.77 145.72 15.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.477 1.111 . . . . 0.0 109.293 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.35 158.45 41.54 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.483 1.114 . . . . 0.0 110.31 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -121.98 159.4 27.04 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.563 1.164 . . . . 0.0 110.278 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -96.6 -37.81 4.65 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.552 1.157 . . . . 0.0 111.045 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 226' ' ' ASN . 41.2 p30 -91.59 18.44 7.43 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.542 0.79 . . . . 0.0 109.293 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -53.58 -40.87 65.99 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.521 1.138 . . . . 0.0 110.98 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.411 HG11 ' N ' ' A' ' 225' ' ' ARG . 0.3 OUTLIER -72.65 -39.45 60.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.467 1.104 . . . . 0.0 109.321 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.411 ' N ' HG11 ' A' ' 224' ' ' VAL . 0.1 OUTLIER -69.21 -29.78 67.81 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.493 1.121 . . . . 0.0 110.322 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 222' ' ' ASP . 39.6 t-20 -78.12 -32.66 50.55 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.452 1.095 . . . . 0.0 109.299 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' TRP . . . . . 0.576 ' CZ3' HG23 ' A' ' 245' ' ' VAL . 2.8 t90 -73.99 -42.94 59.66 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.519 1.137 . . . . 0.0 108.026 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -70.38 -28.79 65.37 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.505 1.128 . . . . 0.0 110.314 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 3.3 mt -69.14 -54.96 12.21 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.515 1.134 . . . . 0.0 109.316 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.452 HG23 ' N ' ' A' ' 231' ' ' ALA . 33.0 m -65.02 -32.04 56.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.497 1.123 . . . . 0.0 109.323 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.452 ' N ' HG23 ' A' ' 230' ' ' VAL . . . -76.13 -24.63 54.91 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.111 . . . . 0.0 109.271 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -80.54 1.21 30.49 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.488 1.117 . . . . 0.0 109.289 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 96.7 t -92.07 118.75 68.34 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.518 1.136 . . . . 0.0 109.311 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 -21.96 15.3 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.536 1.808 . . . . 0.0 110.989 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.98 -30.56 71.63 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.496 1.123 . . . . 0.0 109.325 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . 0.568 ' CD1' HD13 ' A' ' 239' ' ' LEU . 24.4 m-85 -112.42 20.31 16.81 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.482 1.114 . . . . 0.0 110.985 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.12 -18.57 64.67 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.485 1.116 . . . . 0.0 110.316 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -86.99 -14.16 42.46 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.465 1.103 . . . . 0.0 109.322 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.568 HD13 ' CD1' ' A' ' 236' ' ' PHE . 55.6 mt -68.5 176.29 2.97 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.507 1.129 . . . . 0.0 109.277 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -109.63 -171.97 20.53 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.445 1.09 . . . . 0.0 110.974 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -32.39 5.43 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.463 1.77 . . . . 0.0 111.004 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 0.417 ' O ' HG12 ' A' ' 245' ' ' VAL . . . -72.9 -32.92 65.69 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.48 1.112 . . . . 0.0 109.309 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.475 HG21 ' CD1' ' A' ' 337' ' ' ILE . 54.5 t -76.82 -38.64 29.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.491 1.119 . . . . 0.0 109.295 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.426 ' N ' HD23 ' A' ' 244' ' ' LEU . 2.9 mm? -71.0 -44.41 65.95 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.521 1.138 . . . . 0.0 109.239 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.576 HG23 ' CZ3' ' A' ' 227' ' ' TRP . 3.0 p -66.27 -39.77 85.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.448 1.093 . . . . 0.0 109.271 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -69.87 -40.29 75.8 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.543 1.152 . . . . 0.0 110.319 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.486 ' O ' ' CD1' ' A' ' 251' ' ' LEU . 46.0 mt -65.63 -55.16 21.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.497 1.123 . . . . 0.0 109.271 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.438 HG13 ' N ' ' A' ' 249' ' ' ARG . 4.2 p -60.81 -30.63 47.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.54 1.15 . . . . 0.0 109.363 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.517 ' CG ' ' O ' ' A' ' 245' ' ' VAL . 14.3 mmt180 -79.21 -16.84 55.93 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.527 1.142 . . . . 0.0 110.287 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -95.56 -16.05 22.41 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.513 1.133 . . . . 0.0 109.286 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.486 ' CD1' ' O ' ' A' ' 247' ' ' ILE . 7.9 mp -65.28 151.76 45.4 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.563 1.164 . . . . 0.0 109.316 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 6.0 tpt85 -121.12 116.18 24.5 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.496 1.123 . . . . 0.0 110.283 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.43 ' CB ' HD21 ' A' ' 320' ' ' LEU . . . -80.59 122.73 27.42 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.493 1.12 . . . . 0.0 109.266 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.45 141.07 52.26 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.48 1.112 . . . . 0.0 110.297 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.2 m -91.51 118.24 30.41 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.494 1.121 . . . . 0.0 110.349 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.494 HG12 ' CB ' ' A' ' 313' ' ' ALA . 4.0 t -106.36 114.19 62.47 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.536 1.148 . . . . 0.0 109.329 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.505 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.93 171.64 17.9 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.493 1.786 . . . . 0.0 110.978 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.509 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -67.73 129.13 38.95 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.535 1.147 . . . . 0.0 109.316 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 96.07 -25.55 24.95 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.55 1.156 . . . . 0.0 110.994 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . 0.505 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -58.95 138.3 57.51 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.516 0.774 . . . . 0.0 109.262 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 9.3 t -83.34 126.65 40.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.496 1.123 . . . . 0.0 109.334 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.464 ' CD1' ' CG1' ' A' ' 280' ' ' VAL . 94.9 mt -82.92 -45.49 19.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.476 1.11 . . . . 0.0 109.307 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' CYS . . . . . 0.451 ' SG ' ' CG2' ' A' ' 311' ' ' VAL . 7.9 p -152.72 143.87 23.13 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.493 1.12 . . . . 0.0 108.321 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -86.81 176.67 7.6 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.513 1.133 . . . . 0.0 110.281 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.474 HG23 ' CB ' ' A' ' 310' ' ' THR . 0.1 OUTLIER -78.25 148.56 6.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.492 1.12 . . . . 0.0 109.286 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 37.08 47.44 1.36 Allowed Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.469 1.106 . . . . 0.0 110.981 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.444 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.0 OUTLIER -70.25 165.21 46.19 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.516 0.774 . . . . 0.0 110.3 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . 0.444 ' HD2' ' HB2' ' A' ' 267' ' ' GLU . 18.2 Cg_endo -75.06 76.39 3.44 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.525 1.803 . . . . 0.0 110.983 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . 0.473 ' CA ' ' HB2' ' A' ' 300' ' ' ALA . . . -36.71 105.95 0.04 OUTLIER Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.576 1.173 . . . . 0.0 110.994 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -170.51 37.37 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.481 0.754 . . . . 0.0 109.29 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -172.31 156.83 3.94 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.476 1.11 . . . . 0.0 110.301 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.452 ' O ' ' N ' ' A' ' 322' ' ' LEU . 0.0 OUTLIER -122.6 146.47 47.41 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.467 1.105 . . . . 0.0 111.022 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.591 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 13.6 m-85 -133.21 143.37 49.11 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.471 1.107 . . . . 0.0 111.033 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -133.15 125.2 28.95 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.515 1.134 . . . . 0.0 110.987 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 56.4 t -78.22 129.32 37.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.431 1.082 . . . . 0.0 109.319 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . 0.461 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 59.3 t -101.55 -54.05 7.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.506 1.129 . . . . 0.0 109.323 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -141.83 140.71 33.02 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.542 1.151 . . . . 0.0 110.274 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 113.15 -155.87 16.01 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.526 1.142 . . . . 0.0 111.01 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 1.8 m -145.96 139.36 26.13 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.487 0.757 . . . . 0.0 110.001 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.464 ' CG1' ' CD1' ' A' ' 262' ' ' ILE . 27.1 m -120.76 135.57 60.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.555 1.159 . . . . 0.0 109.266 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 29.9 t -104.27 139.77 38.81 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.429 1.08 . . . . 0.0 109.968 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 1.3 t -103.88 129.66 55.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.471 1.107 . . . . 0.0 109.322 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.413 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -78.05 101.36 6.92 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.543 1.152 . . . . 0.0 109.358 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' THR . . . . . 0.662 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -149.0 -168.0 0.17 Allowed Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.5 1.125 . . . . 0.0 110.427 -179.974 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.662 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -75.01 4.43 4.75 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.502 1.79 . . . . 0.0 111.007 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -152.27 154.59 32.37 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.529 1.143 . . . . 0.0 109.309 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 95.12 0.96 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.46 1.769 . . . . 0.0 110.983 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 19.3 t -100.15 118.39 46.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.56 1.163 . . . . 0.0 109.331 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -125.38 133.74 52.42 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.489 1.118 . . . . 0.0 110.324 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -114.51 139.71 49.34 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.52 1.138 . . . . 0.0 109.289 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -93.72 -157.43 33.17 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.564 1.165 . . . . 0.0 111.007 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 147.86 34.49 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.509 1.794 . . . . 0.0 111.005 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 85.95 5.85 83.02 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.532 1.145 . . . . 0.0 111.034 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -85.61 146.27 26.95 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.539 0.788 . . . . 0.0 109.332 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 295' ' ' PHE . 1.0 OUTLIER -132.95 152.81 51.87 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.549 1.156 . . . . 0.0 110.99 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . 0.591 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 46.3 p90 -165.77 143.88 5.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.553 1.158 . . . . 0.0 110.958 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 129.59 -6.73 6.22 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.48 1.113 . . . . 0.0 110.994 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -52.09 -48.43 64.71 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.503 0.767 . . . . 0.0 110.275 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' MET . . . . . 0.443 ' HB3' ' CG ' ' A' ' 305' ' ' GLU . 0.0 OUTLIER -50.21 -37.45 35.28 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.502 1.126 . . . . 0.0 111.047 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . 0.473 ' HB2' ' CA ' ' A' ' 269' ' ' GLY . . . -66.13 -40.34 90.58 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.466 1.104 . . . . 0.0 109.298 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 27.7 mt -74.84 -21.64 59.15 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 0.0 109.306 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 15.0 mm -67.16 -57.64 9.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.458 1.099 . . . . 0.0 109.303 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 304' ' ' GLY . 7.4 m -155.96 44.85 0.44 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.532 1.145 . . . . 0.0 109.98 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 35.69 49.9 1.04 Allowed Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.531 1.144 . . . . 0.0 111.041 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . 0.443 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 0.0 OUTLIER -80.26 158.8 71.45 Favored Pre-proline 0 C--N 1.326 -0.443 0 O-C-N 124.497 0.763 . . . . 0.0 110.271 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.01 130.25 13.09 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.525 1.802 . . . . 0.0 111.032 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -47.07 -39.34 12.82 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.5 1.125 . . . . 0.0 110.275 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 15.0 m 67.77 30.34 6.4 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.478 1.111 . . . . 0.0 109.995 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . 175.67 162.26 0.3 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.532 1.145 . . . . 0.0 109.299 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.474 ' CB ' HG23 ' A' ' 265' ' ' ILE . 0.9 OUTLIER -113.04 137.6 51.17 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.515 1.135 . . . . 0.0 110.398 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.451 ' CG2' ' SG ' ' A' ' 263' ' ' CYS . 95.1 t -109.43 127.62 66.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.504 1.128 . . . . 0.0 109.318 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 48.3 p -121.94 145.28 48.26 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.501 1.126 . . . . 0.0 110.026 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . 0.494 ' CB ' HG12 ' A' ' 256' ' ' VAL . . . -79.53 106.23 11.41 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.536 1.148 . . . . 0.0 109.28 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -52.99 -24.64 9.89 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.473 1.108 . . . . 0.0 109.325 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' THR . . . . . 0.509 ' HA ' ' CB ' ' A' ' 258' ' ' ALA . 8.8 t -168.09 -164.64 0.55 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.495 1.122 . . . . 0.0 110.38 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' THR . . . . . 0.438 ' N ' ' OG1' ' A' ' 315' ' ' THR . 29.2 p -61.35 79.11 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.508 1.13 . . . . 0.0 110.443 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.471 ' CG1' ' HB2' ' A' ' 313' ' ' ALA . 2.7 p -110.74 141.88 24.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.5 1.125 . . . . 0.0 109.277 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' SER . . . . . 0.51 ' C ' ' CD1' ' A' ' 319' ' ' LEU . 53.4 m -117.57 136.51 53.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.454 1.096 . . . . 0.0 109.949 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . 0.51 ' CD1' ' C ' ' A' ' 318' ' ' SER . 0.0 OUTLIER -135.86 173.77 11.35 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.479 1.112 . . . . 0.0 109.309 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.461 ' CD1' ' CG2' ' A' ' 276' ' ' VAL . 0.1 OUTLIER -124.22 125.19 44.0 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.528 1.143 . . . . 0.0 109.292 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 25.8 p -86.97 158.67 19.22 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.518 1.136 . . . . 0.0 110.036 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.511 ' CD1' ' O ' ' A' ' 322' ' ' LEU . 3.1 tm? -145.44 86.71 1.76 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.491 1.119 . . . . 0.0 109.311 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . 0.536 ' CE1' ' OD1' ' A' ' 326' ' ' ASP . 6.0 p80 -50.7 137.31 20.26 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.535 1.147 . . . . 0.0 109.605 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.19 -26.11 62.39 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.473 1.108 . . . . 0.0 110.004 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -53.6 -36.76 62.31 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.459 1.1 . . . . 0.0 109.311 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . 0.536 ' OD1' ' CE1' ' A' ' 323' ' ' HIS . 0.6 OUTLIER -64.99 -41.45 95.4 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.485 1.116 . . . . 0.0 109.317 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' PHE . . . . . 0.49 ' CE1' ' CE2' ' A' ' 341' ' ' PHE . 71.9 t80 -66.84 -34.96 78.95 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.439 1.087 . . . . 0.0 110.965 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -69.86 -33.99 73.0 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.482 1.113 . . . . 0.0 110.288 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 30.4 ttp -70.19 -43.88 69.84 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.441 1.088 . . . . 0.0 111.014 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.407 HD11 ' CG1' ' A' ' 247' ' ' ILE . 2.7 mt -71.66 -35.38 70.31 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.505 1.128 . . . . 0.0 109.286 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 41.6 m -72.31 -30.63 64.95 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.52 1.137 . . . . 0.0 108.278 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 33.0 t -75.78 -34.49 60.23 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.518 1.136 . . . . 0.0 110.021 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.48 -36.3 65.79 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.528 1.142 . . . . 0.0 109.97 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.5 114.32 27.25 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 0.0 109.975 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -22.51 14.81 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.448 1.762 . . . . 0.0 111.007 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -71.91 -29.34 64.21 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.562 1.164 . . . . 0.0 110.286 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.475 ' CD1' HG21 ' A' ' 243' ' ' VAL . 44.5 mt -71.95 -40.14 67.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.134 . . . . 0.0 109.26 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.55 -31.84 65.59 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 0.0 109.278 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -74.95 -42.15 58.2 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.562 1.164 . . . . 0.0 110.288 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 86.3 mt -70.96 -42.81 77.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.486 1.116 . . . . 0.0 109.287 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.49 ' CE2' ' CE1' ' A' ' 327' ' ' PHE . 24.8 t80 -67.46 -39.61 85.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.521 1.138 . . . . 0.0 111.039 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -68.12 -37.32 80.99 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.526 1.141 . . . . 0.0 110.303 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -44.09 84.16 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.52 1.137 . . . . 0.0 109.281 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.99 -32.62 73.15 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.465 1.103 . . . . 0.0 110.377 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -69.91 -41.15 75.07 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.45 1.094 . . . . 0.0 109.333 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 14.5 mt -65.2 -41.42 94.55 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 0.0 109.283 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -65.81 -37.64 86.81 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.112 . . . . 0.0 110.3 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 28.3 mtt-85 -72.76 -44.72 61.26 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.512 1.133 . . . . 0.0 110.325 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -34.77 77.56 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.515 1.134 . . . . 0.0 110.302 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -37.52 -46.22 1.48 Allowed Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.53 1.144 . . . . 0.0 111.046 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -155.01 120.03 4.9 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.575 0.809 . . . . 0.0 109.3 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -60.61 172.24 0.95 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.501 1.125 . . . . 0.0 109.313 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -130.13 125.15 34.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.503 1.127 . . . . 0.0 109.317 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 29.7 p -129.65 154.76 46.8 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.496 1.123 . . . . 0.0 110.01 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.499 0 O-C-N 124.521 1.138 . . . . 0.0 109.278 -179.982 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.986 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 13.1 m -139.5 167.72 21.45 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.44 0.729 . . . . 0.0 110.025 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.72 170.9 12.74 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.529 1.143 . . . . 0.0 110.314 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -121.86 162.71 20.48 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.502 1.126 . . . . 0.0 110.301 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 76.0 t -145.65 150.22 15.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.555 1.159 . . . . 0.0 109.3 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -68.1 174.52 3.79 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.528 1.142 . . . . 0.0 110.299 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 10.9 mtt180 -140.9 157.45 45.35 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.456 1.097 . . . . 0.0 110.233 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -111.08 -33.15 2.42 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.478 1.111 . . . . 0.0 110.985 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 41.8 p30 -94.68 19.62 9.71 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.519 0.776 . . . . 0.0 109.293 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -56.36 -38.63 71.69 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.499 1.124 . . . . 0.0 111.024 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.57 -35.44 56.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.466 1.104 . . . . 0.0 109.276 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.72 -31.56 68.44 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.478 1.111 . . . . 0.0 110.311 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . 0.455 ' ND2' ' CD1' ' A' ' 320' ' ' LEU . 4.1 m-20 -81.23 -31.57 33.77 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.532 1.145 . . . . 0.0 109.276 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' TRP . . . . . 0.606 ' CZ2' ' CG2' ' A' ' 245' ' ' VAL . 2.0 t90 -70.61 -43.75 68.67 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.455 ' O ' ' N ' ' A' ' 232' ' ' ALA . 1.5 pt20 -70.89 -37.28 73.0 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.494 1.121 . . . . 0.0 110.278 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.45 ' CD1' ' HB3' ' A' ' 274' ' ' PHE . 1.6 mm? -60.18 -42.75 95.69 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.51 1.131 . . . . 0.0 109.314 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.483 HG11 ' CD1' ' A' ' 244' ' ' LEU . 12.7 p -74.23 -38.74 48.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.515 1.135 . . . . 0.0 109.284 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.445 ' N ' HG11 ' A' ' 230' ' ' VAL . . . -75.15 -11.51 60.1 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.472 1.107 . . . . 0.0 109.33 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 228' ' ' GLN . . . -81.15 -7.83 59.64 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.496 1.123 . . . . 0.0 109.297 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 1.5 t -98.64 130.06 28.74 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.522 1.139 . . . . 0.0 109.298 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 -16.0 20.33 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.472 1.775 . . . . 0.0 110.971 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.579 HD12 ' CE2' ' A' ' 341' ' ' PHE . 0.0 OUTLIER -81.08 -23.84 38.18 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.519 1.137 . . . . 0.0 109.314 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . 0.529 ' CD1' HD12 ' A' ' 247' ' ' ILE . 30.7 m-85 -102.95 -19.22 14.69 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.454 1.096 . . . . 0.0 111.018 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.51 -22.91 67.1 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.463 1.102 . . . . 0.0 110.28 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -76.77 -1.59 28.85 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.502 1.126 . . . . 0.0 109.294 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.464 ' HB3' ' CG1' ' A' ' 243' ' ' VAL . 8.4 mt -94.38 -179.78 5.03 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.437 1.086 . . . . 0.0 109.278 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -98.45 -174.42 32.61 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.518 1.136 . . . . 0.0 110.969 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.51 ' O ' ' CG2' ' A' ' 245' ' ' VAL . 18.4 Cg_endo -75.01 -35.48 3.1 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.451 1.764 . . . . 0.0 110.97 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.1 -33.37 75.32 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.461 1.101 . . . . 0.0 109.299 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.464 ' CG1' ' HB3' ' A' ' 239' ' ' LEU . 2.7 t -75.18 -42.4 44.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.535 1.147 . . . . 0.0 109.327 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.483 ' CD1' HG11 ' A' ' 230' ' ' VAL . 0.3 OUTLIER -65.63 -36.82 84.8 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.524 1.14 . . . . 0.0 109.289 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.606 ' CG2' ' CZ2' ' A' ' 227' ' ' TRP . 87.8 t -69.15 -43.18 81.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.449 1.093 . . . . 0.0 109.278 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -44.17 91.68 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 0.0 110.312 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.529 HD12 ' CD1' ' A' ' 236' ' ' PHE . 90.0 mt -65.6 -37.16 79.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.495 1.122 . . . . 0.0 109.3 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.461 ' CG2' ' HA ' ' A' ' 227' ' ' TRP . 14.4 t -67.54 -34.97 71.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.506 1.128 . . . . 0.0 109.31 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -24.84 59.92 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.49 1.118 . . . . 0.0 110.274 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.472 ' CB ' ' OD1' ' A' ' 326' ' ' ASP . . . -87.22 -21.59 25.75 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.477 1.111 . . . . 0.0 109.291 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 3.0 mt -55.9 136.48 51.56 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.484 1.115 . . . . 0.0 109.283 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.42 134.76 55.06 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.494 1.121 . . . . 0.0 110.265 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -80.15 129.6 34.62 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.525 1.141 . . . . 0.0 109.323 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 319' ' ' LEU . 6.7 ttm-85 -133.62 121.28 21.8 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.513 1.133 . . . . 0.0 110.333 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 20.0 m -91.79 116.57 29.0 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.532 1.145 . . . . 0.0 110.436 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.446 ' CG2' HD12 ' A' ' 319' ' ' LEU . 97.3 t -106.68 113.14 63.22 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.473 1.108 . . . . 0.0 109.263 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.51 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -75.0 171.45 18.31 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.5 1.789 . . . . 0.0 111.04 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.498 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -67.33 128.58 36.93 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.465 1.103 . . . . 0.0 109.325 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 96.85 -25.11 28.11 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.489 1.118 . . . . 0.0 110.992 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . 0.51 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -60.64 149.14 36.04 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.532 0.784 . . . . 0.0 109.306 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.3 t -97.28 131.61 43.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 124.494 1.121 . . . . 0.0 109.331 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 45.8 mt -83.41 -41.65 17.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.468 1.105 . . . . 0.0 109.309 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 14.9 p -158.34 151.09 22.35 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.452 1.095 . . . . 0.0 108.273 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -94.32 -178.81 4.71 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.472 1.108 . . . . 0.0 110.305 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.538 ' N ' ' HG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -74.64 143.99 12.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.101 . . . . 0.0 109.321 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 41.47 53.95 4.13 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.537 1.148 . . . . 0.0 110.987 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.409 ' OE1' ' C ' ' A' ' 268' ' ' PRO . 0.3 OUTLIER -70.61 163.5 63.13 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.498 0.764 . . . . 0.0 110.295 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . 0.452 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.1 Cg_endo -75.01 81.43 2.22 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.476 1.777 . . . . 0.0 110.965 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -36.65 95.76 0.01 OUTLIER Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.559 1.162 . . . . 0.0 111.037 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 268' ' ' PRO . 6.8 m-20 -170.83 38.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.519 0.776 . . . . 0.0 109.305 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.434 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 0.0 OUTLIER -170.01 144.62 2.74 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.508 1.13 . . . . 0.0 110.233 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.593 ' SD ' ' CZ ' ' A' ' 274' ' ' PHE . 0.0 OUTLIER -114.4 147.38 39.29 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.126 . . . . 0.0 111.003 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.552 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 50.3 m-85 -135.91 137.64 41.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.452 1.095 . . . . 0.0 111.026 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . 0.593 ' CZ ' ' SD ' ' A' ' 272' ' ' MET . 17.8 m-85 -129.11 130.29 46.27 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.548 1.155 . . . . 0.0 111.014 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.425 ' HA ' ' HB3' ' A' ' 319' ' ' LEU . 29.1 t -86.28 130.48 36.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.488 1.117 . . . . 0.0 109.33 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.87 -44.39 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.479 1.112 . . . . 0.0 109.274 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -145.85 132.79 20.2 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 0.0 110.299 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.454 ' HA3' ' CG2' ' A' ' 317' ' ' VAL . . . 117.06 -177.68 16.79 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.545 1.153 . . . . 0.0 111.003 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' SER . . . . . 0.424 ' N ' HG22 ' A' ' 317' ' ' VAL . 5.4 t -128.94 121.79 28.81 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.497 0.763 . . . . 0.0 110.014 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.465 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 24.1 m -99.87 161.18 3.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.474 1.109 . . . . 0.0 109.286 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 29.4 t -129.41 149.6 51.12 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.537 1.148 . . . . 0.0 110.006 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 1.4 t -112.45 131.44 63.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.493 1.121 . . . . 0.0 109.331 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.403 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -79.85 101.92 8.81 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.46 1.1 . . . . 0.0 109.268 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' THR . . . . . 0.654 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.41 -168.32 0.18 Allowed Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.508 1.13 . . . . 0.0 110.396 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.654 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.4 Cg_endo -75.0 4.8 4.42 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.491 1.785 . . . . 0.0 111.038 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -151.59 155.69 34.27 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.481 1.113 . . . . 0.0 109.286 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.07 95.85 1.0 Allowed 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.517 1.798 . . . . 0.0 111.029 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 6.0 t -100.42 119.3 48.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.455 1.097 . . . . 0.0 109.33 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -124.9 141.68 51.96 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.493 1.121 . . . . 0.0 110.332 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.465 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 4.4 mm? -120.69 142.5 49.43 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.546 1.154 . . . . 0.0 109.276 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -93.79 -163.43 36.34 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.529 1.143 . . . . 0.0 111.023 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.94 149.63 37.28 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.502 1.791 . . . . 0.0 110.995 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 86.95 -0.07 85.99 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.481 1.113 . . . . 0.0 110.974 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -79.65 146.21 32.6 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.488 0.757 . . . . 0.0 109.362 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -132.84 152.69 51.78 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.516 1.135 . . . . 0.0 111.012 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . 0.552 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 40.7 p90 -166.57 147.65 6.23 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.496 1.123 . . . . 0.0 110.959 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . 0.474 ' CA ' ' HE1' ' A' ' 272' ' ' MET . . . 129.8 -10.38 6.03 Favored Glycine 0 CA--C 1.531 1.053 0 O-C-N 124.544 1.153 . . . . 0.0 110.995 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -52.57 -41.78 63.89 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.532 0.784 . . . . 0.0 110.316 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -54.83 -37.28 65.97 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.503 1.127 . . . . 0.0 111.015 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -67.72 -39.21 84.31 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.496 1.123 . . . . 0.0 109.284 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.466 ' CD1' ' HG3' ' A' ' 272' ' ' MET . 5.7 mt -76.44 -13.67 60.1 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.503 1.127 . . . . 0.0 109.265 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 32.2 mt -77.3 -54.5 12.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.514 1.134 . . . . 0.0 109.295 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.441 ' O ' ' N ' ' A' ' 305' ' ' GLU . 46.4 p -155.07 42.05 0.45 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.506 1.129 . . . . 0.0 109.986 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 37.07 31.56 0.06 OUTLIER Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.501 1.126 . . . . 0.0 110.998 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 303' ' ' SER . 0.1 OUTLIER -61.71 157.12 50.8 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.52 0.777 . . . . 0.0 110.322 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 128.99 11.91 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.51 1.795 . . . . 0.0 111.044 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.52 -40.29 5.53 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.506 1.129 . . . . 0.0 110.294 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 309' ' ' ALA . 22.8 t 64.87 43.31 4.0 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.486 1.117 . . . . 0.0 110.02 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' ALA . . . . . 0.466 ' CB ' ' O ' ' A' ' 308' ' ' SER . . . 165.86 159.76 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.48 1.113 . . . . 0.0 109.291 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.538 ' HG1' ' N ' ' A' ' 265' ' ' ILE . 1.0 OUTLIER -110.38 133.92 52.8 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.465 1.103 . . . . 0.0 110.416 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 55.3 t -113.06 129.39 68.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.525 1.14 . . . . 0.0 109.294 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 60.3 p -129.59 156.71 43.76 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.542 1.151 . . . . 0.0 110.02 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -92.53 115.57 28.22 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.515 1.135 . . . . 0.0 109.312 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -59.5 -32.65 70.48 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.481 1.113 . . . . 0.0 109.287 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' THR . . . . . 0.498 ' HA ' ' CB ' ' A' ' 258' ' ' ALA . 11.0 t -154.6 -173.14 4.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.506 1.129 . . . . 0.0 110.385 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 65.4 p -52.2 88.54 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.503 1.127 . . . . 0.0 110.391 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.466 ' N ' ' O ' ' A' ' 315' ' ' THR . 68.9 t -103.57 154.35 5.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 O-C-N 124.539 1.149 . . . . 0.0 109.308 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 49.1 m -129.07 113.89 15.69 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.482 1.114 . . . . 0.0 109.998 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . 0.495 ' C ' ' CD2' ' A' ' 320' ' ' LEU . 0.2 OUTLIER -129.0 170.44 13.46 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.136 . . . . 0.0 109.266 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.495 ' CD2' ' C ' ' A' ' 319' ' ' LEU . 0.6 OUTLIER -121.79 139.87 53.06 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.518 1.136 . . . . 0.0 109.327 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 64.8 p -95.6 158.79 15.3 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.122 . . . . 0.0 109.982 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -148.64 82.36 1.46 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.496 1.122 . . . . 0.0 109.312 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . 0.434 ' HA ' ' CG ' ' A' ' 271' ' ' ARG . 8.5 p80 -47.63 136.99 9.7 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.504 1.127 . . . . 0.0 109.599 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.95 -20.93 6.89 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.504 1.128 . . . . 0.0 109.981 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -51.9 -38.24 55.48 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.522 1.139 . . . . 0.0 109.291 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . 0.472 ' OD1' ' CB ' ' A' ' 250' ' ' ALA . 36.0 t70 -63.94 -37.08 86.09 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.541 1.151 . . . . 0.0 109.257 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' PHE . . . . . 0.472 ' CZ ' ' CE2' ' A' ' 341' ' ' PHE . 6.1 t80 -66.96 -40.02 87.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.48 1.112 . . . . 0.0 110.96 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -66.0 -33.24 75.35 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.527 1.142 . . . . 0.0 110.301 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.404 ' HE3' ' CD2' ' A' ' 330' ' ' LEU . 50.9 ttp -70.91 -39.33 72.79 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.549 1.155 . . . . 0.0 111.004 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.506 HD23 ' N ' ' A' ' 330' ' ' LEU . 0.1 OUTLIER -68.7 -39.23 80.58 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.487 1.117 . . . . 0.0 109.293 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 19.8 t -70.97 -32.97 69.99 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.45 1.093 . . . . 0.0 108.268 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 19.1 t -72.87 -31.08 64.47 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.482 1.114 . . . . 0.0 110.039 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.9 t -83.3 -37.86 22.88 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.447 1.092 . . . . 0.0 110.022 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.12 107.94 17.94 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.539 1.149 . . . . 0.0 110.009 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -21.01 16.33 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.466 1.772 . . . . 0.0 110.978 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -72.58 -28.52 62.85 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.519 1.137 . . . . 0.0 110.319 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 46.2 mt -65.46 -32.88 60.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 0.0 109.308 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.74 -35.06 72.5 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.536 1.147 . . . . 0.0 109.31 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -71.42 -34.79 70.63 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.518 1.136 . . . . 0.0 110.338 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 66.1 mt -73.06 -42.53 59.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.124 . . . . 0.0 109.303 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.579 ' CE2' HD12 ' A' ' 235' ' ' LEU . 1.0 OUTLIER -70.98 -31.2 67.68 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 0.0 111.02 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . 0.431 ' HG3' ' CD1' ' A' ' 346' ' ' LEU . 0.0 OUTLIER -73.24 -41.07 64.13 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.48 1.113 . . . . 0.0 110.282 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.13 -50.51 65.73 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.423 1.077 . . . . 0.0 109.305 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' THR . . . . . 0.403 ' CG2' ' HA ' ' A' ' 341' ' ' PHE . 7.4 t -64.97 -37.68 88.45 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.514 1.134 . . . . 0.0 110.429 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 341' ' ' PHE . . . -65.15 -43.32 92.24 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.504 1.127 . . . . 0.0 109.335 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.431 ' CD1' ' HG3' ' A' ' 342' ' ' ARG . 0.4 OUTLIER -64.9 -35.12 80.13 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 0.0 109.256 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -69.42 -37.77 77.58 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.543 1.152 . . . . 0.0 110.33 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -72.64 -43.87 62.63 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.464 1.102 . . . . 0.0 110.309 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.61 -34.68 77.48 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.549 1.156 . . . . 0.0 110.273 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -38.21 -48.56 2.13 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.501 1.126 . . . . 0.0 111.014 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -154.77 120.98 5.28 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.536 0.786 . . . . 0.0 109.296 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -61.48 171.15 1.55 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.469 1.106 . . . . 0.0 109.333 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -116.43 123.17 46.86 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.49 1.119 . . . . 0.0 109.308 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 89.9 p -129.04 160.6 32.26 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.514 1.134 . . . . 0.0 109.996 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.481 1.113 . . . . 0.0 109.338 179.961 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.002 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 2.0 m -139.63 162.72 34.43 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.509 0.77 . . . . 0.0 110.01 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -137.69 171.05 15.01 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.467 1.104 . . . . 0.0 110.345 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.64 153.71 44.98 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.522 1.139 . . . . 0.0 110.286 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.7 p -109.42 145.06 16.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.48 1.113 . . . . 0.0 109.317 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.5 165.31 8.1 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.483 1.114 . . . . 0.0 110.295 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.9 mmt85 -126.13 157.74 37.3 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.493 1.121 . . . . 0.0 110.278 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -116.04 -32.73 1.63 Allowed Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.496 1.122 . . . . 0.0 111.008 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 16.3 p30 -97.27 14.04 27.41 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.537 0.787 . . . . 0.0 109.318 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -53.61 -38.59 64.15 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.507 1.129 . . . . 0.0 110.966 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.74 -35.15 59.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.486 1.117 . . . . 0.0 109.283 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -36.61 81.2 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.509 1.131 . . . . 0.0 110.323 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . 0.439 ' HB3' ' CD1' ' A' ' 251' ' ' LEU . 1.6 m-20 -75.1 -30.19 60.83 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.478 1.111 . . . . 0.0 109.288 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' TRP . . . . . 0.455 ' HA ' ' CG2' ' A' ' 248' ' ' VAL . 1.6 t90 -67.63 -49.51 62.64 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.405 ' O ' ' N ' ' A' ' 232' ' ' ALA . 6.0 pt20 -67.22 -30.94 70.99 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.54 1.15 . . . . 0.0 110.312 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.54 -47.14 79.93 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.508 1.13 . . . . 0.0 109.3 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.477 ' CG2' ' CD1' ' A' ' 244' ' ' LEU . 34.9 m -70.11 -37.63 72.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.501 1.125 . . . . 0.0 109.304 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.469 ' N ' HG21 ' A' ' 230' ' ' VAL . . . -75.83 -14.97 60.3 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.479 1.112 . . . . 0.0 109.308 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 228' ' ' GLN . . . -82.27 -25.15 34.3 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.567 1.167 . . . . 0.0 109.337 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . 0.539 HG13 ' CD2' ' A' ' 236' ' ' PHE . 0.3 OUTLIER -86.94 133.51 39.11 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.483 1.114 . . . . 0.0 109.311 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 -4.35 15.27 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.498 1.789 . . . . 0.0 111.012 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.98 -24.07 33.08 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.492 1.12 . . . . 0.0 109.32 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . 0.539 ' CD2' HG13 ' A' ' 233' ' ' VAL . 17.4 m-30 -119.73 -1.26 10.59 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.467 1.105 . . . . 0.0 110.986 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -71.69 -23.39 61.65 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.513 1.133 . . . . 0.0 110.309 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.442 ' NZ ' ' HA ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -92.55 7.59 42.58 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.482 1.114 . . . . 0.0 109.316 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.484 HD11 ' CG1' ' A' ' 243' ' ' VAL . 86.4 mt -89.26 179.76 6.04 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.48 1.113 . . . . 0.0 109.265 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -98.21 -176.94 33.18 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.506 1.129 . . . . 0.0 111.036 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.504 ' O ' ' CG2' ' A' ' 245' ' ' VAL . 18.3 Cg_endo -75.0 -37.33 2.07 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.5 1.789 . . . . 0.0 110.985 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.84 -34.68 77.19 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.464 1.102 . . . . 0.0 109.3 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.484 ' CG1' HD11 ' A' ' 239' ' ' LEU . 14.1 t -75.4 -38.02 39.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.514 1.134 . . . . 0.0 109.317 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.477 ' CD1' ' CG2' ' A' ' 230' ' ' VAL . 1.4 mm? -66.79 -35.84 81.0 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.514 1.133 . . . . 0.0 109.305 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.504 ' CG2' ' O ' ' A' ' 241' ' ' PRO . 60.9 t -74.39 -38.88 47.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.485 1.116 . . . . 0.0 109.296 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -65.25 -48.39 73.43 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.519 1.137 . . . . 0.0 110.268 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 32.1 mt -63.15 -43.27 98.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.524 1.14 . . . . 0.0 109.316 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.455 ' CG2' ' HA ' ' A' ' 227' ' ' TRP . 41.2 t -65.29 -38.21 82.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.459 1.1 . . . . 0.0 109.269 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -72.49 -19.25 61.58 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.422 1.076 . . . . 0.0 110.292 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -91.82 -16.3 26.96 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.521 1.138 . . . . 0.0 109.303 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.439 ' CD1' ' HB3' ' A' ' 226' ' ' ASN . 2.2 mt -66.84 129.27 39.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.495 1.122 . . . . 0.0 109.313 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 3.2 tpt85 -110.15 118.08 35.41 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.492 1.12 . . . . 0.0 110.308 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.465 ' CB ' HD21 ' A' ' 320' ' ' LEU . . . -80.15 136.77 36.58 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.458 1.099 . . . . 0.0 109.311 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.06 139.67 30.6 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.547 1.155 . . . . 0.0 110.339 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.0 m -92.4 117.92 30.41 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.561 1.163 . . . . 0.0 110.373 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.481 HG22 ' CD2' ' A' ' 319' ' ' LEU . 37.1 t -107.33 112.77 62.57 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.499 1.124 . . . . 0.0 109.285 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.457 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.3 Cg_endo -74.99 173.33 14.7 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.485 1.782 . . . . 0.0 111.006 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.474 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -67.37 130.38 42.89 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.543 1.152 . . . . 0.0 109.301 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 95.48 -25.28 25.37 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.519 1.137 . . . . 0.0 111.01 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . 0.457 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -56.43 140.59 45.27 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.496 0.762 . . . . 0.0 109.326 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.7 t -92.28 127.17 44.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.491 1.119 . . . . 0.0 109.34 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 40.8 mt -85.03 -41.91 16.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.477 1.111 . . . . 0.0 109.325 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 11.9 p -155.81 148.87 24.43 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.536 1.147 . . . . 0.0 108.296 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 2.0 mmt85 -92.35 178.57 5.8 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.491 1.119 . . . . 0.0 110.329 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.523 ' N ' ' HG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -76.42 141.59 15.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.495 1.122 . . . . 0.0 109.304 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 46.23 46.83 16.08 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.52 1.138 . . . . 0.0 111.006 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.452 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.0 OUTLIER -70.19 164.91 48.8 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 124.451 0.736 . . . . 0.0 110.299 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 267' ' ' GLU . 18.4 Cg_endo -75.0 77.04 3.22 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.502 1.791 . . . . 0.0 111.03 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . 0.473 ' CA ' ' HB1' ' A' ' 300' ' ' ALA . . . -35.84 100.21 0.01 OUTLIER Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.452 1.095 . . . . 0.0 111.016 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -169.76 38.09 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.545 0.791 . . . . 0.0 109.315 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -171.33 147.14 2.42 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.129 . . . . 0.0 110.281 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.468 ' SD ' ' CD1' ' A' ' 301' ' ' LEU . 2.0 ttt -116.67 150.45 38.13 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.479 1.112 . . . . 0.0 111.003 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.577 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 14.8 m-85 -135.43 136.9 41.73 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.453 1.095 . . . . 0.0 110.973 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . 0.47 ' CD1' ' CB ' ' A' ' 295' ' ' PHE . 22.8 m-30 -125.66 124.38 41.02 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.494 1.121 . . . . 0.0 110.959 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 85.2 t -80.03 135.81 24.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.515 1.134 . . . . 0.0 109.255 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . 0.465 ' CG2' HD11 ' A' ' 320' ' ' LEU . 99.1 t -108.73 -56.01 4.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.461 1.101 . . . . 0.0 109.27 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -139.98 138.88 35.88 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.456 1.097 . . . . 0.0 110.314 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.01 -154.72 16.59 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.452 1.095 . . . . 0.0 111.03 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 3.7 m -150.76 135.92 17.67 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.511 0.771 . . . . 0.0 110.029 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.409 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 13.6 m -115.16 166.06 9.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.5 1.125 . . . . 0.0 109.321 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 28.8 t -131.33 149.44 52.55 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.457 1.098 . . . . 0.0 110.007 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.51 131.17 66.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.533 1.145 . . . . 0.0 109.304 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.4 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -79.7 101.87 8.65 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.52 1.137 . . . . 0.0 109.31 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' THR . . . . . 0.648 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.7 OUTLIER -148.27 -168.5 0.19 Allowed Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.458 1.099 . . . . 0.0 110.423 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.648 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.4 Cg_endo -74.95 4.89 4.31 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.533 1.807 . . . . 0.0 111.063 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -151.58 156.65 34.72 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.459 1.1 . . . . 0.0 109.293 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.91 95.37 0.97 Allowed 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.466 1.772 . . . . 0.0 111.032 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 24.1 t -99.53 118.9 46.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.105 . . . . 0.0 109.346 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -124.76 138.16 54.29 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.511 1.132 . . . . 0.0 110.321 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.417 HD21 ' N ' ' A' ' 290' ' ' LEU . 4.3 mm? -119.84 142.19 48.87 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.51 1.131 . . . . 0.0 109.275 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -96.28 -153.25 29.65 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.53 1.144 . . . . 0.0 110.981 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 151.88 39.98 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.491 1.785 . . . . 0.0 111.021 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 76.99 6.35 85.82 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.52 1.138 . . . . 0.0 110.956 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -87.4 113.72 23.36 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.528 0.781 . . . . 0.0 109.279 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . 0.47 ' CB ' ' CD1' ' A' ' 274' ' ' PHE . 15.1 p90 -107.15 152.98 23.33 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.488 1.117 . . . . 0.0 110.986 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 20.6 p90 -159.07 153.65 24.38 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.465 1.103 . . . . 0.0 110.98 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 123.17 -9.02 8.98 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.522 1.139 . . . . 0.0 111.041 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . 0.436 ' HG2' ' N ' ' A' ' 299' ' ' MET . 0.4 OUTLIER -52.37 -37.21 55.69 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.469 0.747 . . . . 0.0 110.273 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' MET . . . . . 0.436 ' N ' ' HG2' ' A' ' 298' ' ' GLU . 1.2 mmt -60.13 -32.09 70.68 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 0.0 110.976 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . 0.473 ' HB1' ' CA ' ' A' ' 269' ' ' GLY . . . -75.02 -37.27 61.83 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.446 1.091 . . . . 0.0 109.298 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.522 ' CD2' ' CG ' ' A' ' 327' ' ' PHE . 0.9 OUTLIER -78.11 -11.61 59.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.546 1.154 . . . . 0.0 109.321 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 35.0 mt -83.82 -52.87 12.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.495 1.122 . . . . 0.0 109.274 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.454 ' O ' ' C ' ' A' ' 304' ' ' GLY . 3.4 m -153.21 39.08 0.51 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.528 1.143 . . . . 0.0 110.02 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 33.07 43.76 0.21 Allowed Glycine 0 CA--C 1.529 0.966 0 O-C-N 124.493 1.121 . . . . 0.0 111.061 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.61 157.71 88.51 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.487 0.757 . . . . 0.0 110.287 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 129.95 12.83 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.503 1.791 . . . . 0.0 111.034 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -46.59 -34.98 5.4 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.506 1.129 . . . . 0.0 110.328 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 1.3 m 60.39 20.53 10.14 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.485 1.115 . . . . 0.0 109.962 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . -171.26 160.66 6.3 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 0.0 109.322 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.523 ' HG1' ' N ' ' A' ' 265' ' ' ILE . 0.9 OUTLIER -107.68 137.22 46.1 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.523 1.14 . . . . 0.0 110.372 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 86.5 t -114.79 127.51 72.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.459 1.1 . . . . 0.0 109.317 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 32.3 m -128.18 159.24 35.79 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.505 1.128 . . . . 0.0 109.96 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . 0.544 ' CB ' ' CG1' ' A' ' 317' ' ' VAL . . . -90.92 110.45 21.69 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.461 1.101 . . . . 0.0 109.275 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -53.19 -32.06 46.07 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.511 1.132 . . . . 0.0 109.287 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' THR . . . . . 0.474 ' HA ' ' CB ' ' A' ' 258' ' ' ALA . 12.7 t -156.68 -163.74 1.49 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.487 1.117 . . . . 0.0 110.407 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 96.6 m -63.07 76.78 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.48 1.112 . . . . 0.0 110.35 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.544 ' CG1' ' CB ' ' A' ' 313' ' ' ALA . 2.8 p -107.38 141.14 23.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.491 1.12 . . . . 0.0 109.353 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' SER . . . . . 0.515 ' C ' ' CD1' ' A' ' 319' ' ' LEU . 66.1 m -116.12 134.59 54.77 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.534 1.146 . . . . 0.0 110.04 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . 0.515 ' CD1' ' C ' ' A' ' 318' ' ' SER . 0.0 OUTLIER -132.54 177.98 7.19 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.49 1.119 . . . . 0.0 109.324 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.465 HD21 ' CB ' ' A' ' 253' ' ' ALA . 0.2 OUTLIER -124.5 128.62 49.24 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.502 1.126 . . . . 0.0 109.326 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 13.1 p -90.12 155.18 19.23 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.534 1.146 . . . . 0.0 110.036 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -149.02 90.86 1.79 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.517 1.136 . . . . 0.0 109.311 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . 0.534 ' CE1' ' HB2' ' A' ' 326' ' ' ASP . 7.9 p80 -49.98 136.54 18.49 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.538 1.149 . . . . 0.0 109.63 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 43.7 t -59.93 -25.56 65.25 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.545 1.153 . . . . 0.0 109.984 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -57.03 -34.06 67.83 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.496 1.123 . . . . 0.0 109.308 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . 0.534 ' HB2' ' CE1' ' A' ' 323' ' ' HIS . 31.6 t70 -68.83 -37.15 78.98 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.49 1.119 . . . . 0.0 109.337 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' PHE . . . . . 0.522 ' CG ' ' CD2' ' A' ' 301' ' ' LEU . 33.3 t80 -68.75 -40.38 79.83 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.499 1.124 . . . . 0.0 110.975 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -70.54 -31.92 69.15 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 0.0 110.327 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 17.6 tmm? -69.38 -44.7 70.98 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.467 1.105 . . . . 0.0 111.03 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 13.3 mt -70.6 -38.86 74.04 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.465 1.103 . . . . 0.0 109.31 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 1.8 m -64.43 -38.12 89.9 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.472 1.107 . . . . 0.0 108.279 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 7.6 t -77.24 -26.24 52.39 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.494 1.121 . . . . 0.0 109.98 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.18 -39.2 71.99 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.129 . . . . 0.0 110.057 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.19 129.94 23.36 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.529 1.143 . . . . 0.0 109.979 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -25.44 11.92 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.464 1.771 . . . . 0.0 111.023 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.26 -28.57 67.32 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.123 . . . . 0.0 110.299 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.459 ' CD1' HG22 ' A' ' 243' ' ' VAL . 59.9 mt -71.43 -42.47 73.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.514 1.134 . . . . 0.0 109.294 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.11 -30.49 67.7 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.492 1.12 . . . . 0.0 109.303 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -72.1 -43.51 64.67 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 0.0 110.316 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 68.2 mt -72.08 -40.06 66.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.537 1.148 . . . . 0.0 109.306 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.478 ' CD1' ' O ' ' A' ' 341' ' ' PHE . 0.4 OUTLIER -68.66 -39.33 80.69 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.534 1.146 . . . . 0.0 110.994 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -68.65 -39.08 80.85 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.465 1.103 . . . . 0.0 110.275 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.7 -48.07 70.43 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.526 1.141 . . . . 0.0 109.341 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.24 -41.77 94.04 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.47 1.106 . . . . 0.0 110.424 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -68.65 -34.4 75.65 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.528 1.143 . . . . 0.0 109.315 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 13.5 mt -69.9 -33.52 72.3 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.482 1.114 . . . . 0.0 109.262 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.4 -37.01 66.1 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.549 1.156 . . . . 0.0 110.334 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 4.4 mtt85 -69.67 -38.97 77.28 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.527 1.142 . . . . 0.0 110.249 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 350' ' ' GLY . 0.0 OUTLIER -72.21 -34.79 68.62 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.465 1.103 . . . . 0.0 110.321 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 349' ' ' ARG . . . -37.81 -46.68 1.71 Allowed Glycine 0 CA--C 1.529 0.966 0 O-C-N 124.476 1.11 . . . . 0.0 111.033 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -153.89 120.03 5.4 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.517 0.775 . . . . 0.0 109.284 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -61.92 164.4 6.53 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.527 1.142 . . . . 0.0 109.321 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -124.01 170.18 10.91 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.483 1.114 . . . . 0.0 109.296 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 3.1 m -70.51 148.0 48.72 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.502 1.126 . . . . 0.0 109.992 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.464 0 O-C-N 124.499 1.125 . . . . 0.0 109.304 179.995 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 16.5 t80 . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.481 0.181 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -71.52 -43.22 72.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.515 1.134 . . . . 0.0 109.319 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.716 ' CD ' HD23 ' A' ' 229' ' ' LEU . 0.0 OUTLIER -65.86 -29.05 69.45 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.5 1.125 . . . . 0.0 110.328 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.58 ' ND2' HD22 ' A' ' 320' ' ' LEU . 6.5 t-20 -79.76 -30.37 40.73 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.541 1.151 . . . . 0.0 109.271 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' TRP . . . . . 0.879 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 2.1 t90 -68.09 -43.96 77.33 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.13 . . . . 0.0 107.985 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.619 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 9.8 pt20 -70.63 -36.93 73.69 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.513 1.133 . . . . 0.0 110.315 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.716 HD23 ' CD ' ' A' ' 225' ' ' ARG . 0.6 OUTLIER -60.99 -47.6 85.68 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.488 1.118 . . . . 0.0 109.323 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.791 HG12 ' CD1' ' A' ' 244' ' ' LEU . 64.5 t -73.23 -44.09 56.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.504 1.128 . . . . 0.0 109.307 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -68.28 -13.91 62.61 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.493 1.121 . . . . 0.0 109.282 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.619 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -81.64 -24.89 36.06 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.51 1.131 . . . . 0.0 109.288 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' VAL . . . . . 0.421 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 91.0 t -64.73 135.03 96.22 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.505 1.128 . . . . 0.0 109.316 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 233' ' ' VAL . 18.3 Cg_endo -75.02 -40.43 0.89 Allowed 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.42 1.747 . . . . 0.0 110.967 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 1.1 tp -63.56 -14.11 48.09 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.445 1.091 . . . . 0.0 109.302 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' PHE . . . . . 0.474 ' CB ' HD12 ' A' ' 239' ' ' LEU . 16.8 m-30 -113.24 5.28 16.87 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.473 1.108 . . . . 0.0 110.973 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' GLN . . . . . 0.417 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -73.52 -29.43 62.47 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.492 1.12 . . . . 0.0 110.325 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.426 ' HB3' HG21 ' A' ' 340' ' ' ILE . 0.0 OUTLIER -89.31 7.09 37.42 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.517 1.136 . . . . 0.0 109.298 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.609 ' HB2' HD21 ' A' ' 244' ' ' LEU . 74.4 mt -85.58 176.64 8.09 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.504 1.128 . . . . 0.0 109.265 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' GLY . . . . . 0.68 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -101.03 176.19 26.78 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.509 1.131 . . . . 0.0 111.03 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.938 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.3 Cg_endo -74.99 -36.35 2.6 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.513 1.796 . . . . 0.0 110.993 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -69.54 -35.12 75.15 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.53 1.144 . . . . 0.0 109.271 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.808 HG21 HD11 ' A' ' 337' ' ' ILE . 57.0 t -73.25 -40.16 56.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.463 1.102 . . . . 0.0 109.297 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.791 ' CD1' HG12 ' A' ' 230' ' ' VAL . 3.5 mm? -67.61 -37.55 82.7 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 0.0 109.269 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.938 HG23 ' O ' ' A' ' 241' ' ' PRO . 74.3 t -65.84 -45.98 89.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.519 1.137 . . . . 0.0 109.328 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -64.89 -40.78 95.64 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.125 . . . . 0.0 110.251 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.758 ' O ' HD13 ' A' ' 251' ' ' LEU . 44.2 mt -62.27 -47.97 90.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.456 1.098 . . . . 0.0 109.306 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.496 HG21 ' HA ' ' A' ' 227' ' ' TRP . 27.3 t -61.98 -34.65 64.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.469 1.105 . . . . 0.0 109.296 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.02 -13.01 60.04 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.463 1.102 . . . . 0.0 110.291 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -99.6 -7.0 26.38 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.502 1.126 . . . . 0.0 109.312 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.758 HD13 ' O ' ' A' ' 247' ' ' ILE . 6.2 mp -75.31 146.51 40.93 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.533 1.146 . . . . 0.0 109.281 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 320' ' ' LEU . 6.1 tpt180 -116.33 113.6 23.17 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.502 1.127 . . . . 0.0 110.314 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.734 ' HB2' HD23 ' A' ' 320' ' ' LEU . . . -80.03 126.79 31.5 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.51 1.131 . . . . 0.0 109.258 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -139.09 137.74 36.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.464 1.102 . . . . 0.0 110.305 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 4.1 m -90.85 123.56 34.48 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.471 1.107 . . . . 0.0 110.385 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.769 ' CG2' HD21 ' A' ' 319' ' ' LEU . 4.7 t -106.8 112.76 63.32 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.467 1.104 . . . . 0.0 109.291 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.482 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.3 Cg_endo -75.03 169.27 22.98 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.524 1.802 . . . . 0.0 111.011 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.689 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -64.92 126.77 29.05 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.496 1.123 . . . . 0.0 109.334 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 100.63 -25.3 28.84 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.486 1.116 . . . . 0.0 111.006 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.499 ' HB3' HG13 ' A' ' 256' ' ' VAL . . . -67.65 131.07 44.9 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.504 0.767 . . . . 0.0 109.303 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 311' ' ' VAL . 2.9 p -87.72 135.43 25.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.529 1.143 . . . . 0.0 109.326 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.649 HD12 HG12 ' A' ' 311' ' ' VAL . 35.6 mt -82.38 -44.12 19.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.542 1.151 . . . . 0.0 109.294 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 10.5 p -152.12 147.07 26.02 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.538 1.149 . . . . 0.0 108.28 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -85.65 -179.9 6.96 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.485 1.115 . . . . 0.0 110.298 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.465 HG23 ' OG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -77.21 134.71 28.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.563 1.164 . . . . 0.0 109.289 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 56.32 51.48 55.85 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.458 1.099 . . . . 0.0 110.969 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.95 165.65 45.3 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.495 0.762 . . . . 0.0 110.298 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.3 Cg_endo -75.01 82.98 1.89 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.45 1.763 . . . . 0.0 111.002 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -38.0 93.31 0.01 OUTLIER Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.534 1.146 . . . . 0.0 110.997 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 268' ' ' PRO . 0.7 OUTLIER -171.61 37.51 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.482 0.754 . . . . 0.0 109.307 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ARG . . . . . 0.406 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 1.9 ttt180 -169.81 147.74 3.44 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.49 1.119 . . . . 0.0 110.276 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' MET . . . . . 0.878 ' HB2' HD11 ' A' ' 301' ' ' LEU . 2.1 ttm -118.04 156.26 28.9 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.534 1.147 . . . . 0.0 110.986 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.571 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 32.8 m-85 -146.02 136.61 24.15 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.519 1.137 . . . . 0.0 111.023 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' PHE . . . . . 0.494 ' CZ ' ' SD ' ' A' ' 272' ' ' MET . 19.6 m-85 -125.71 137.8 53.85 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.538 1.149 . . . . 0.0 111.007 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.605 HG22 HD12 ' A' ' 319' ' ' LEU . 4.3 t -94.24 135.34 28.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.473 1.108 . . . . 0.0 109.318 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.497 ' CG2' HD11 ' A' ' 320' ' ' LEU . 42.0 t -109.49 -49.16 7.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.481 1.113 . . . . 0.0 109.246 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -142.04 132.77 25.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.486 1.116 . . . . 0.0 110.281 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.693 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 120.96 -176.35 16.24 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.483 1.115 . . . . 0.0 111.023 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 5.2 t -131.2 118.8 20.95 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.498 0.764 . . . . 0.0 110.026 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.439 HG23 ' HB2' ' A' ' 290' ' ' LEU . 16.2 m -98.43 162.17 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.496 1.122 . . . . 0.0 109.313 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 31.1 t -127.71 153.76 46.13 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.493 1.12 . . . . 0.0 109.957 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 288' ' ' VAL . 0.2 OUTLIER -116.95 129.23 73.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.463 1.102 . . . . 0.0 109.327 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.716 ' HB3' ' H ' ' A' ' 310' ' ' THR . . . -77.97 101.62 6.97 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.469 1.106 . . . . 0.0 109.298 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' THR . . . . . 0.651 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.7 OUTLIER -148.62 -168.31 0.18 Allowed Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.568 1.168 . . . . 0.0 110.399 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.651 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -75.07 4.59 4.63 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.474 1.776 . . . . 0.0 110.956 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -151.5 156.67 34.85 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.521 1.138 . . . . 0.0 109.265 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.95 94.79 0.95 Allowed 'Trans proline' 0 C--N 1.36 1.184 0 O-C-N 124.509 1.794 . . . . 0.0 110.987 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 281' ' ' SER . 45.4 t -98.37 118.83 45.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.494 1.121 . . . . 0.0 109.327 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 15.0 mt-10 -125.22 136.96 54.08 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.475 1.109 . . . . 0.0 110.278 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.439 ' HB2' HG23 ' A' ' 280' ' ' VAL . 4.0 mm? -117.23 139.73 50.42 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.474 1.109 . . . . 0.0 109.312 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -90.6 -160.18 36.3 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.497 1.123 . . . . 0.0 111.005 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' PRO . . . . . 0.477 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.2 Cg_endo -75.01 148.21 34.91 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.546 1.814 . . . . 0.0 111.038 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.424 ' HA2' HD21 ' A' ' 229' ' ' LEU . . . 83.61 4.42 89.09 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.569 1.168 . . . . 0.0 110.99 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -86.03 130.67 34.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.472 0.748 . . . . 0.0 109.295 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.485 ' HB3' ' CD1' ' A' ' 274' ' ' PHE . 0.8 OUTLIER -116.16 153.02 32.56 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.504 1.127 . . . . 0.0 110.993 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.592 ' HZ ' HG21 ' A' ' 262' ' ' ILE . 40.4 p90 -159.64 146.17 16.32 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.527 1.142 . . . . 0.0 110.992 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 127.81 -7.07 6.93 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.472 1.107 . . . . 0.0 111.015 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -52.49 -48.76 65.75 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.511 0.771 . . . . 0.0 110.336 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' MET . . . . . 0.423 ' HA ' ' CE ' ' A' ' 299' ' ' MET . 3.1 mmt -48.91 -39.26 25.36 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.541 1.151 . . . . 0.0 111.002 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -67.79 -37.42 82.0 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.504 1.128 . . . . 0.0 109.252 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.878 HD11 ' HB2' ' A' ' 272' ' ' MET . 10.6 mt -79.02 -9.07 59.43 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.527 1.142 . . . . 0.0 109.267 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 3.1 mm -82.25 -54.17 10.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.478 1.111 . . . . 0.0 109.294 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 304' ' ' GLY . 1.0 OUTLIER -153.47 42.97 0.58 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 0.0 109.989 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 303' ' ' SER . . . 36.21 42.28 0.58 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.479 1.112 . . . . 0.0 111.042 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.19 157.13 83.43 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.441 0.73 . . . . 0.0 110.276 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.11 131.99 14.78 Favored 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.481 1.779 . . . . 0.0 110.976 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -44.38 -43.32 7.54 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.516 1.135 . . . . 0.0 110.34 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.545 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 25.3 m 67.74 39.41 2.69 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.454 1.096 . . . . 0.0 109.99 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 173.42 160.2 0.14 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.541 1.151 . . . . 0.0 109.307 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.716 ' H ' ' HB3' ' A' ' 283' ' ' ALA . 0.6 OUTLIER -105.19 122.3 45.62 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.505 1.128 . . . . 0.0 110.441 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.649 HG12 HD12 ' A' ' 262' ' ' ILE . 58.6 t -102.7 128.25 55.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.5 1.125 . . . . 0.0 109.3 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 9.7 p -141.24 156.66 45.87 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.557 1.161 . . . . 0.0 110.037 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' ALA . . . . . 0.543 ' CB ' HG12 ' A' ' 256' ' ' VAL . . . -90.31 124.37 34.84 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.543 1.152 . . . . 0.0 109.284 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -70.45 -26.33 63.59 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.468 1.105 . . . . 0.0 109.293 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' THR . . . . . 0.689 ' HA ' ' HB2' ' A' ' 258' ' ' ALA . 6.2 t -152.98 -169.79 3.44 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.51 1.131 . . . . 0.0 110.415 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 93.0 m -58.67 85.36 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 0.0 110.409 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.693 HG22 ' HA3' ' A' ' 278' ' ' GLY . 48.3 t -105.42 159.45 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.461 1.101 . . . . 0.0 109.246 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 318' ' ' SER . . . . . 0.646 ' C ' HD13 ' A' ' 319' ' ' LEU . 49.3 m -136.88 123.62 21.17 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.508 1.13 . . . . 0.0 109.984 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 319' ' ' LEU . . . . . 0.769 HD21 ' CG2' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -134.56 170.46 15.76 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.508 1.13 . . . . 0.0 109.278 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.734 HD23 ' HB2' ' A' ' 253' ' ' ALA . 0.0 OUTLIER -124.4 131.82 53.51 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.478 1.111 . . . . 0.0 109.295 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 63.5 p -90.15 158.88 17.05 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.552 1.157 . . . . 0.0 110.017 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.839 ' O ' HD13 ' A' ' 322' ' ' LEU . 0.9 OUTLIER -151.23 104.75 3.14 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.52 1.137 . . . . 0.0 109.338 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 323' ' ' HIS . . . . . 0.495 ' CE1' ' HB2' ' A' ' 326' ' ' ASP . 8.2 p80 -57.55 131.2 49.46 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.538 1.149 . . . . 0.0 109.609 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 23.0 t -58.96 -16.77 19.55 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.488 1.118 . . . . 0.0 109.993 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -66.71 -31.71 72.54 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.431 1.082 . . . . 0.0 109.305 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' ASP . . . . . 0.553 ' HB3' HD21 ' A' ' 322' ' ' LEU . 35.0 t70 -65.59 -47.52 75.44 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.543 1.152 . . . . 0.0 109.304 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 327' ' ' PHE . . . . . 0.469 ' CZ ' ' CE2' ' A' ' 341' ' ' PHE . 1.8 t80 -65.38 -35.74 81.88 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.431 1.082 . . . . 0.0 110.999 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -71.13 -32.29 68.8 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.505 1.128 . . . . 0.0 110.286 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 14.9 tmm? -68.29 -44.82 74.65 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.451 1.094 . . . . 0.0 110.991 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.62 HD13 HG13 ' A' ' 247' ' ' ILE . 2.4 mt -73.85 -31.57 63.25 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.504 1.128 . . . . 0.0 109.34 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 28.7 t -69.84 -38.14 76.41 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 0.0 108.322 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 11.3 t -76.86 -29.07 55.69 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.492 1.12 . . . . 0.0 109.984 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.9 -38.7 73.02 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.5 1.125 . . . . 0.0 109.974 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.8 124.07 32.51 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.483 1.114 . . . . 0.0 109.998 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 -27.87 9.64 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.417 1.746 . . . . 0.0 110.991 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.86 -32.61 72.4 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 0.0 110.315 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.808 HD11 HG21 ' A' ' 243' ' ' VAL . 71.2 mt -75.14 -32.88 27.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.506 1.129 . . . . 0.0 109.316 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.29 -34.97 66.04 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.447 1.092 . . . . 0.0 109.295 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -73.77 -43.42 59.04 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.531 1.144 . . . . 0.0 110.308 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.426 HG21 ' HB3' ' A' ' 238' ' ' LYS . 97.7 mt -71.64 -38.06 65.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 0.0 109.339 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.514 ' O ' HG22 ' A' ' 344' ' ' THR . 4.7 t80 -67.0 -39.22 87.07 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 0.0 111.042 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.06 -35.59 69.33 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.506 1.129 . . . . 0.0 110.311 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -46.17 83.66 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.45 1.094 . . . . 0.0 109.307 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 344' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 341' ' ' PHE . 6.6 t -71.23 -33.98 70.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.543 1.152 . . . . 0.0 110.399 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -70.21 -37.23 75.02 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.452 1.095 . . . . 0.0 109.366 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.472 ' HA ' HD23 ' A' ' 346' ' ' LEU . 12.4 mt -71.43 -37.02 71.49 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.523 1.139 . . . . 0.0 109.29 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -72.68 -37.34 67.91 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.487 1.117 . . . . 0.0 110.335 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 . . . . . 0 C--N 1.324 -0.504 0 O-C-N 124.559 1.162 . . . . 0.0 110.251 179.997 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 31.7 t80 . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 120.484 0.183 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.12 -40.05 50.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.494 1.121 . . . . 0.0 109.322 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.465 ' HD3' ' CD1' ' A' ' 229' ' ' LEU . 0.0 OUTLIER -66.22 -31.87 72.95 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.519 1.137 . . . . 0.0 110.339 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.641 ' ND2' HD22 ' A' ' 320' ' ' LEU . 12.4 t-20 -80.61 -30.84 36.78 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.538 1.149 . . . . 0.0 109.335 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' TRP . . . . . 0.928 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 2.8 t90 -67.24 -42.66 83.61 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.127 . . . . 0.0 107.994 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.406 ' HG3' ' N ' ' A' ' 229' ' ' LEU . 8.9 pt20 -71.02 -40.77 71.56 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.478 1.111 . . . . 0.0 110.333 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.465 ' CD1' ' HD3' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -61.87 -48.65 79.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.471 1.107 . . . . 0.0 109.304 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.516 HG13 ' CD1' ' A' ' 244' ' ' LEU . 5.7 p -68.09 -39.63 81.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.503 1.127 . . . . 0.0 109.309 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -72.11 -16.53 62.01 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.502 1.126 . . . . 0.0 109.264 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 228' ' ' GLN . . . -81.25 -10.45 59.59 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.473 1.108 . . . . 0.0 109.282 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 6.7 t -80.85 121.04 80.54 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.561 1.163 . . . . 0.0 109.29 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 -18.35 18.75 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.501 1.79 . . . . 0.0 111.018 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.538 HD21 HD11 ' A' ' 302' ' ' ILE . 5.7 tp -75.87 -20.96 57.67 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.511 1.132 . . . . 0.0 109.281 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' PHE . . . . . 0.488 ' CD2' HD12 ' A' ' 239' ' ' LEU . 3.3 m-85 -108.97 8.9 26.55 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.495 1.122 . . . . 0.0 110.998 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.26 -19.92 65.58 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.572 1.17 . . . . 0.0 110.311 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.526 ' CB ' HG21 ' A' ' 340' ' ' ILE . 69.5 mmtt -80.63 -17.95 49.64 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.523 1.139 . . . . 0.0 109.313 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.726 HD22 HG11 ' A' ' 243' ' ' VAL . 75.1 mt -70.49 172.81 7.82 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.457 1.098 . . . . 0.0 109.284 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' GLY . . . . . 0.54 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -107.42 -172.54 22.26 Favored Glycine 0 CA--C 1.529 0.952 0 O-C-N 124.509 1.131 . . . . 0.0 111.07 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.912 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.3 Cg_endo -75.05 -35.16 3.27 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.487 1.783 . . . . 0.0 110.986 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -69.56 -34.08 73.66 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.475 1.11 . . . . 0.0 109.301 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.726 HG11 HD22 ' A' ' 239' ' ' LEU . 3.6 t -74.93 -40.58 45.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.493 1.12 . . . . 0.0 109.298 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.784 ' O ' HG23 ' A' ' 248' ' ' VAL . 0.7 OUTLIER -64.83 -40.1 94.65 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.478 1.111 . . . . 0.0 109.262 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.928 HG22 ' CZ2' ' A' ' 227' ' ' TRP . 63.0 t -70.65 -42.13 77.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.459 1.099 . . . . 0.0 109.299 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -64.95 -35.65 81.86 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.492 1.12 . . . . 0.0 110.262 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.432 HD12 HG12 ' A' ' 243' ' ' VAL . 36.7 mt -71.75 -44.84 68.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.559 1.162 . . . . 0.0 109.321 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 244' ' ' LEU . 96.4 t -68.17 -32.15 54.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.454 1.096 . . . . 0.0 109.292 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.93 -21.97 46.48 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.493 1.121 . . . . 0.0 110.327 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.511 ' HB3' ' OD1' ' A' ' 326' ' ' ASP . . . -89.94 -21.26 22.55 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.473 1.108 . . . . 0.0 109.276 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.411 ' CD2' ' HB2' ' A' ' 322' ' ' LEU . 0.2 OUTLIER -67.3 149.77 49.92 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.469 1.106 . . . . 0.0 109.304 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -121.08 119.57 32.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.442 1.088 . . . . 0.0 110.334 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.563 ' HB2' HD23 ' A' ' 320' ' ' LEU . . . -80.99 122.83 27.77 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.495 1.122 . . . . 0.0 109.324 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.96 142.9 49.12 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.506 1.129 . . . . 0.0 110.293 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.3 m -94.18 125.36 38.77 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.496 1.123 . . . . 0.0 110.359 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.524 HG12 ' CB ' ' A' ' 313' ' ' ALA . 47.6 t -106.92 112.44 63.32 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.534 1.146 . . . . 0.0 109.334 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.3 Cg_endo -75.01 171.38 18.43 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.485 1.781 . . . . 0.0 110.993 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.589 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -66.25 130.21 42.44 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.487 1.117 . . . . 0.0 109.336 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 94.97 -25.09 25.52 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.478 1.111 . . . . 0.0 111.031 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.517 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -64.75 119.94 11.53 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.527 0.781 . . . . 0.0 109.297 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.17 136.03 24.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.539 1.15 . . . . 0.0 109.284 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.974 HD12 HG12 ' A' ' 311' ' ' VAL . 39.9 mt -82.12 -52.64 13.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.492 1.12 . . . . 0.0 109.334 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 17.1 p -147.43 146.26 29.51 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.512 1.133 . . . . 0.0 108.291 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -83.36 -177.8 6.86 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.115 . . . . 0.0 110.291 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.54 HG23 ' CB ' ' A' ' 310' ' ' THR . 0.0 OUTLIER -76.08 133.21 31.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.507 1.129 . . . . 0.0 109.301 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 55.5 53.9 38.14 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.486 1.116 . . . . 0.0 110.983 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.81 165.75 43.65 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.467 0.745 . . . . 0.0 110.313 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.486 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.3 Cg_endo -75.01 87.12 1.35 Allowed 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.498 1.788 . . . . 0.0 110.947 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -39.79 93.4 0.01 OUTLIER Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.506 1.129 . . . . 0.0 111.02 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 268' ' ' PRO . 17.9 p30 -170.82 38.48 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.513 0.773 . . . . 0.0 109.261 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ARG . . . . . 0.401 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 12.8 mtt180 -169.51 154.45 5.63 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.477 1.11 . . . . 0.0 110.309 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' MET . . . . . 0.41 ' SD ' ' CD1' ' A' ' 301' ' ' LEU . 1.2 ttt -126.09 149.66 48.75 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.506 1.129 . . . . 0.0 110.985 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 296' ' ' PHE . 12.1 m-85 -135.63 138.2 42.65 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.475 1.109 . . . . 0.0 110.98 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -128.36 126.15 40.12 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.552 1.158 . . . . 0.0 110.973 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 1.034 HG22 HD22 ' A' ' 319' ' ' LEU . 41.7 t -85.47 129.64 37.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.467 1.104 . . . . 0.0 109.298 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.809 ' CG2' HD11 ' A' ' 320' ' ' LEU . 46.3 t -104.94 -46.97 9.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.467 1.105 . . . . 0.0 109.322 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.814 ' O ' HG23 ' A' ' 317' ' ' VAL . 0.0 OUTLIER -148.52 140.51 23.9 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.482 1.114 . . . . 0.0 110.336 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 116.46 -154.1 17.02 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.554 1.159 . . . . 0.0 110.994 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 290' ' ' LEU . 4.5 m -147.83 131.4 16.79 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.466 0.745 . . . . 0.0 109.967 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 20.3 m -117.17 135.58 57.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.484 1.115 . . . . 0.0 109.332 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 29.3 t -102.5 149.6 24.23 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.519 1.137 . . . . 0.0 109.983 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.463 HG13 HG22 ' A' ' 311' ' ' VAL . 0.4 OUTLIER -113.35 130.42 67.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.502 1.127 . . . . 0.0 109.291 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.666 ' HB3' ' H ' ' A' ' 310' ' ' THR . . . -76.77 101.84 6.0 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.541 1.15 . . . . 0.0 109.31 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' THR . . . . . 0.648 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -149.07 -168.63 0.19 Allowed Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.47 1.106 . . . . 0.0 110.427 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.648 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -75.01 3.83 5.28 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.553 1.817 . . . . 0.0 110.975 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -151.91 157.68 34.22 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.533 1.146 . . . . 0.0 109.325 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 92.59 0.98 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.533 1.807 . . . . 0.0 111.0 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.443 ' O ' HG23 ' A' ' 282' ' ' VAL . 29.0 t -95.49 118.97 42.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.506 1.129 . . . . 0.0 109.311 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.54 ' C ' HD22 ' A' ' 290' ' ' LEU . 14.2 mt-10 -124.34 138.69 54.35 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.482 1.114 . . . . 0.0 110.313 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.54 HD22 ' C ' ' A' ' 289' ' ' GLU . 4.4 mm? -121.37 140.92 51.48 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.464 1.103 . . . . 0.0 109.311 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -97.55 -155.01 29.91 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.459 1.1 . . . . 0.0 110.985 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.94 147.04 33.65 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.498 1.789 . . . . 0.0 111.018 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 85.26 5.77 85.0 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.474 1.109 . . . . 0.0 111.011 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -90.44 121.42 32.39 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.495 0.762 . . . . 0.0 109.323 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -116.16 152.89 32.8 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.541 1.151 . . . . 0.0 110.994 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.558 ' CZ ' ' HB3' ' A' ' 273' ' ' PHE . 33.7 p90 -163.71 148.95 10.88 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.486 1.116 . . . . 0.0 111.018 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 132.98 -11.58 5.1 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.454 1.096 . . . . 0.0 110.976 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -52.82 -44.91 67.01 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.452 0.737 . . . . 0.0 110.3 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.67 -39.21 57.81 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.438 1.086 . . . . 0.0 110.965 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' ALA . . . . . 0.457 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -68.49 -39.03 81.48 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.516 1.135 . . . . 0.0 109.304 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.55 HD22 ' CB ' ' A' ' 327' ' ' PHE . 13.3 mt -76.76 -8.78 57.96 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.516 1.135 . . . . 0.0 109.334 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 302' ' ' ILE . . . . . 0.538 HD11 HD21 ' A' ' 235' ' ' LEU . 6.5 mm -85.01 -52.95 11.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.488 1.117 . . . . 0.0 109.341 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 304' ' ' GLY . 0.4 OUTLIER -153.51 41.13 0.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.5 1.125 . . . . 0.0 109.967 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 36.48 36.4 0.15 Allowed Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.494 1.121 . . . . 0.0 110.956 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.93 155.76 85.84 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.511 0.771 . . . . 0.0 110.266 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 130.87 13.63 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.539 1.81 . . . . 0.0 110.999 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -45.16 -31.32 1.4 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.528 1.143 . . . . 0.0 110.288 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 2.4 m 59.1 33.1 22.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 0.0 110.03 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 176.35 160.63 0.34 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.498 1.124 . . . . 0.0 109.317 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.666 ' H ' ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -109.98 127.2 54.65 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.471 1.107 . . . . 0.0 110.396 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.974 HG12 HD12 ' A' ' 262' ' ' ILE . 57.6 t -107.21 131.64 56.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.496 1.122 . . . . 0.0 109.301 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 1.9 p -137.03 150.55 48.16 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.473 1.108 . . . . 0.0 110.036 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' ALA . . . . . 0.842 ' HB1' HG12 ' A' ' 317' ' ' VAL . . . -80.04 111.09 16.05 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.518 1.137 . . . . 0.0 109.278 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -58.61 -26.69 63.96 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.461 1.101 . . . . 0.0 109.285 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 315' ' ' THR . . . . . 0.589 ' HA ' ' HB2' ' A' ' 258' ' ' ALA . 8.8 t -160.18 -164.01 1.21 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.514 1.133 . . . . 0.0 110.379 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 316' ' ' THR . . . . . 0.433 ' N ' ' OG1' ' A' ' 315' ' ' THR . 65.2 m -64.08 74.61 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.504 1.128 . . . . 0.0 110.417 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.859 HG22 ' CD2' ' A' ' 319' ' ' LEU . 2.7 p -104.14 137.81 31.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.125 . . . . 0.0 109.319 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' SER . . . . . 0.464 ' C ' HD23 ' A' ' 319' ' ' LEU . 71.1 m -106.19 134.83 48.7 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.542 1.151 . . . . 0.0 109.972 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 319' ' ' LEU . . . . . 1.034 HD22 HG22 ' A' ' 275' ' ' VAL . 0.0 OUTLIER -141.5 174.23 10.75 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.535 1.147 . . . . 0.0 109.319 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.809 HD11 ' CG2' ' A' ' 276' ' ' VAL . 0.6 OUTLIER -124.83 134.01 52.9 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.517 1.135 . . . . 0.0 109.262 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 29.5 t -98.03 146.82 25.15 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.529 1.143 . . . . 0.0 109.972 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.411 ' HB2' ' CD2' ' A' ' 251' ' ' LEU . 2.2 tm? -138.06 104.64 5.29 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.518 1.136 . . . . 0.0 109.318 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 323' ' ' HIS . . . . . 0.44 ' ND1' ' HB3' ' A' ' 325' ' ' ALA . 5.8 p80 -63.71 134.31 55.12 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.557 1.161 . . . . 0.0 109.631 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 86.4 p -55.56 -18.47 7.55 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.54 1.15 . . . . 0.0 109.978 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 0.44 ' HB3' ' ND1' ' A' ' 323' ' ' HIS . . . -58.12 -36.99 73.73 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.466 1.104 . . . . 0.0 109.291 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 326' ' ' ASP . . . . . 0.511 ' OD1' ' HB3' ' A' ' 250' ' ' ALA . 27.2 t0 -65.32 -38.87 91.5 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.499 1.125 . . . . 0.0 109.312 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 327' ' ' PHE . . . . . 0.55 ' CB ' HD22 ' A' ' 301' ' ' LEU . 17.7 t80 -68.63 -35.64 77.55 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.478 1.111 . . . . 0.0 110.991 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -69.33 -33.84 73.74 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.5 1.125 . . . . 0.0 110.326 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.418 ' O ' ' CB ' ' A' ' 333' ' ' SER . 32.2 ttp -70.59 -43.21 69.85 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.457 1.098 . . . . 0.0 110.987 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 2.6 mt -70.58 -34.7 72.47 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.435 1.085 . . . . 0.0 109.342 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 1.3 m -73.22 -44.12 60.14 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.473 1.108 . . . . 0.0 108.3 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 7.6 t -73.09 -27.86 61.96 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.529 1.143 . . . . 0.0 110.04 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 329' ' ' MET . 11.7 t -74.04 -38.38 64.03 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.537 1.148 . . . . 0.0 110.028 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 334' ' ' SER . . . . . 0.636 ' HB2' HD12 ' A' ' 337' ' ' ILE . 0.3 OUTLIER -126.92 120.52 22.72 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 0.0 109.977 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -23.62 13.57 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.503 1.791 . . . . 0.0 111.038 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -72.32 -33.66 67.52 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.481 1.113 . . . . 0.0 110.263 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.679 HG23 HD21 ' A' ' 239' ' ' LEU . 87.3 mt -71.07 -40.34 75.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.556 1.16 . . . . 0.0 109.337 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.98 -30.7 64.02 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.443 1.089 . . . . 0.0 109.286 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.89 -37.34 70.16 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.529 1.143 . . . . 0.0 110.294 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.526 HG21 ' CB ' ' A' ' 238' ' ' LYS . 30.6 mt -72.93 -45.64 54.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.526 1.141 . . . . 0.0 109.295 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -67.65 -30.9 70.57 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.463 1.102 . . . . 0.0 110.997 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -72.54 -44.58 61.95 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.133 . . . . 0.0 110.258 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -45.26 76.88 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.521 1.138 . . . . 0.0 109.371 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.53 -40.12 92.57 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 0.0 110.409 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -69.09 -32.96 72.75 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.135 . . . . 0.0 109.28 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.428 ' HA ' HD23 ' A' ' 346' ' ' LEU . 13.1 mt -73.64 -31.18 63.37 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.519 1.137 . . . . 0.0 109.308 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -72.72 -40.56 66.03 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.14 . . . . 0.0 110.353 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 . . . . . 0 C--N 1.325 -0.472 0 O-C-N 124.466 1.104 . . . . 0.0 110.273 179.995 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.564 ' CE1' ' HD3' ' A' ' 249' ' ' ARG . 68.3 t80 . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.516 0.198 . . . . 0.0 110.969 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.62 -39.29 81.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.474 1.109 . . . . 0.0 109.315 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.66 ' HD2' HD12 ' A' ' 229' ' ' LEU . 0.1 OUTLIER -67.66 -34.41 76.87 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.512 1.132 . . . . 0.0 110.281 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.995 ' O ' HG12 ' A' ' 230' ' ' VAL . 36.9 t30 -78.73 -30.49 45.89 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.506 1.129 . . . . 0.0 109.271 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' TRP . . . . . 0.632 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 5.5 t90 -66.99 -44.4 80.5 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.522 1.139 . . . . 0.0 108.011 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.537 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 19.4 pt20 -71.78 -33.99 69.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.444 1.09 . . . . 0.0 110.332 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.66 HD12 ' HD2' ' A' ' 225' ' ' ARG . 0.3 OUTLIER -65.63 -55.39 17.84 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.544 1.152 . . . . 0.0 109.308 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.995 HG12 ' O ' ' A' ' 226' ' ' ASN . 7.4 p -65.51 -35.01 74.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.509 1.131 . . . . 0.0 109.287 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.475 ' CB ' ' O ' ' A' ' 227' ' ' TRP . . . -75.29 -18.88 59.94 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.485 1.115 . . . . 0.0 109.297 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.537 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -80.72 -20.31 43.12 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.102 . . . . 0.0 109.264 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 229' ' ' LEU . 60.3 t -62.78 128.58 92.08 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.507 1.13 . . . . 0.0 109.308 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.426 ' HA ' ' HB2' ' A' ' 237' ' ' GLN . 18.4 Cg_endo -74.99 -35.97 2.83 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.485 1.782 . . . . 0.0 111.078 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.756 HD22 ' HG3' ' A' ' 298' ' ' GLU . 1.2 tp -63.91 -19.22 64.94 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.5 1.125 . . . . 0.0 109.323 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' PHE . . . . . 0.662 ' CG ' HD12 ' A' ' 239' ' ' LEU . 4.3 m-30 -114.28 8.5 16.77 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.468 1.105 . . . . 0.0 110.988 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' GLN . . . . . 0.426 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 1.5 mt-30 -71.18 -22.61 62.01 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.508 1.13 . . . . 0.0 110.304 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -83.41 -19.37 36.11 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.476 1.11 . . . . 0.0 109.265 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.751 HD22 HG11 ' A' ' 243' ' ' VAL . 67.7 mt -63.79 -179.98 0.44 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.549 1.155 . . . . 0.0 109.296 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' GLY . . . . . 0.651 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -103.95 178.2 24.66 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.487 1.117 . . . . 0.0 111.04 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.543 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.2 Cg_endo -75.02 -34.54 3.72 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.486 1.782 . . . . 0.0 111.006 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -71.8 -35.4 69.96 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.499 1.125 . . . . 0.0 109.337 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.751 HG11 HD22 ' A' ' 239' ' ' LEU . 71.6 t -72.73 -40.62 61.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.528 1.142 . . . . 0.0 109.291 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 240' ' ' GLY . 3.9 mm? -69.08 -40.51 78.39 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.515 1.134 . . . . 0.0 109.308 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.632 HG22 ' CZ2' ' A' ' 227' ' ' TRP . 20.5 t -66.17 -37.05 78.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.487 1.117 . . . . 0.0 109.296 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -74.3 -30.78 62.23 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.55 1.156 . . . . 0.0 110.298 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 44.2 mt -70.93 -48.59 55.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.542 1.151 . . . . 0.0 109.308 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.67 HG23 ' ND2' ' A' ' 226' ' ' ASN . 14.5 p -65.56 -36.14 76.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.525 1.14 . . . . 0.0 109.286 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.564 ' HD3' ' CE1' ' A' ' 223' ' ' PHE . 1.4 mmm180 -72.44 -25.2 61.37 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.495 1.122 . . . . 0.0 110.311 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -91.41 0.33 57.53 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.472 1.108 . . . . 0.0 109.261 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.402 HD22 ' HB2' ' A' ' 320' ' ' LEU . 0.1 OUTLIER -83.69 151.61 25.18 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 0.0 109.269 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.08 125.16 46.57 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.46 1.1 . . . . 0.0 110.291 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -82.97 122.72 28.66 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.523 1.139 . . . . 0.0 109.267 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.405 ' O ' ' O ' ' A' ' 319' ' ' LEU . 0.0 OUTLIER -127.72 139.35 52.74 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.436 1.085 . . . . 0.0 110.265 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 6.6 m -95.55 128.07 42.11 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.479 1.112 . . . . 0.0 110.405 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.588 HG21 HD11 ' A' ' 319' ' ' LEU . 22.0 t -106.54 115.78 60.13 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.458 1.099 . . . . 0.0 109.251 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.504 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.95 154.44 42.76 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.52 1.8 . . . . 0.0 111.036 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.489 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -57.51 126.27 26.59 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.475 1.11 . . . . 0.0 109.266 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 98.7 -25.19 29.01 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.511 1.132 . . . . 0.0 110.995 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.504 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -66.3 146.58 54.44 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.479 0.752 . . . . 0.0 109.254 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 311' ' ' VAL . 2.4 p -97.18 136.29 28.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.461 1.101 . . . . 0.0 109.319 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.687 HD12 HG12 ' A' ' 311' ' ' VAL . 7.4 mt -81.65 -45.42 20.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.489 1.118 . . . . 0.0 109.33 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' CYS . . . . . 0.643 ' SG ' HG23 ' A' ' 311' ' ' VAL . 14.1 p -147.4 153.53 39.73 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.479 1.112 . . . . 0.0 108.331 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.41 179.91 5.0 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.513 1.133 . . . . 0.0 110.304 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.67 135.95 25.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.471 1.107 . . . . 0.0 109.311 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 52.27 53.55 30.77 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.539 1.149 . . . . 0.0 111.027 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.417 ' CD ' ' CD ' ' A' ' 268' ' ' PRO . 5.7 mm-40 -71.57 166.1 42.73 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.512 0.772 . . . . 0.0 110.313 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.517 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.2 Cg_endo -74.96 82.52 1.98 Allowed 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.515 1.797 . . . . 0.0 111.024 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' GLY . . . . . 0.424 ' HA2' ' HB1' ' A' ' 300' ' ' ALA . . . -36.86 92.39 0.01 OUTLIER Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.471 1.107 . . . . 0.0 110.976 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 268' ' ' PRO . 36.6 m-20 -171.92 37.84 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.526 0.78 . . . . 0.0 109.322 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.8 148.57 2.93 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.476 1.11 . . . . 0.0 110.299 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 272' ' ' MET . . . . . 0.747 ' HB2' HD11 ' A' ' 301' ' ' LEU . 2.1 ttt -123.26 146.65 47.68 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.543 1.152 . . . . 0.0 110.971 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.568 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 92.4 m-85 -133.4 136.98 45.6 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.512 1.133 . . . . 0.0 110.982 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' PHE . . . . . 0.501 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 20.5 m-85 -124.72 135.06 52.69 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.451 1.094 . . . . 0.0 111.004 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.534 HG12 ' HA ' ' A' ' 292' ' ' PRO . 38.6 t -90.43 137.93 20.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.471 1.107 . . . . 0.0 109.321 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.661 ' CG2' HD11 ' A' ' 320' ' ' LEU . 3.4 t -115.86 -48.99 4.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.484 1.115 . . . . 0.0 109.329 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.419 ' O ' HG13 ' A' ' 317' ' ' VAL . 3.9 mm-40 -139.01 136.57 35.47 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.51 1.131 . . . . 0.0 110.306 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.942 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 110.87 -173.31 15.93 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.486 1.116 . . . . 0.0 110.957 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 290' ' ' LEU . 5.5 t -134.34 126.67 30.14 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.481 0.754 . . . . 0.0 109.992 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.437 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 17.4 m -104.18 166.32 3.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.485 1.116 . . . . 0.0 109.286 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 30.8 t -129.81 154.79 46.9 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.502 1.126 . . . . 0.0 110.022 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.449 ' CG2' ' HB ' ' A' ' 288' ' ' VAL . 0.5 OUTLIER -118.03 127.84 75.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.502 1.126 . . . . 0.0 109.301 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.413 ' HB3' ' H ' ' A' ' 310' ' ' THR . . . -77.0 101.37 5.99 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.44 1.088 . . . . 0.0 109.338 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' THR . . . . . 0.651 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.63 -168.35 0.18 Allowed Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.525 1.141 . . . . 0.0 110.392 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.651 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.3 Cg_endo -74.97 4.17 4.96 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.528 1.804 . . . . 0.0 111.017 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.443 ' O ' HG23 ' A' ' 288' ' ' VAL . 5.1 m120 -150.68 156.16 36.13 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.509 1.131 . . . . 0.0 109.299 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 94.19 0.96 Allowed 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.517 1.798 . . . . 0.0 111.032 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.449 ' HB ' ' CG2' ' A' ' 282' ' ' VAL . 2.1 t -98.13 119.26 45.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.54 1.15 . . . . 0.0 109.322 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 13.9 mt-10 -124.5 135.44 53.21 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.547 1.154 . . . . 0.0 110.337 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.437 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 3.9 mm? -115.3 142.61 46.45 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.52 1.137 . . . . 0.0 109.308 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -97.96 -162.56 30.98 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.434 1.084 . . . . 0.0 111.025 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' PRO . . . . . 0.534 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.2 Cg_endo -75.0 144.99 30.91 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.467 1.772 . . . . 0.0 110.999 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 90.21 -1.84 80.43 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.502 1.126 . . . . 0.0 111.022 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -83.76 139.31 32.8 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.51 0.77 . . . . 0.0 109.321 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.405 ' CB ' ' CD1' ' A' ' 274' ' ' PHE . 1.5 p90 -126.4 152.74 45.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.491 1.119 . . . . 0.0 110.998 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.568 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 33.4 p90 -160.85 149.71 16.6 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.446 1.091 . . . . 0.0 111.013 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 297' ' ' GLY . . . . . 0.657 ' O ' HD12 ' A' ' 301' ' ' LEU . . . 126.23 -8.55 7.5 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.479 1.112 . . . . 0.0 111.025 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' GLU . . . . . 0.756 ' HG3' HD22 ' A' ' 235' ' ' LEU . 27.0 tt0 -52.87 -44.19 66.66 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.525 0.779 . . . . 0.0 110.283 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 299' ' ' MET . . . . . 0.464 ' HB3' ' CG ' ' A' ' 305' ' ' GLU . 0.0 OUTLIER -56.34 -37.13 69.59 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.497 1.123 . . . . 0.0 111.037 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 300' ' ' ALA . . . . . 0.424 ' HB1' ' HA2' ' A' ' 269' ' ' GLY . . . -66.36 -38.38 87.46 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.503 1.127 . . . . 0.0 109.227 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.747 HD11 ' HB2' ' A' ' 272' ' ' MET . 1.8 mp -81.98 -10.22 59.32 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.124 . . . . 0.0 109.328 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 3.9 mm -76.9 -56.42 8.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.464 1.102 . . . . 0.0 109.33 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 305' ' ' GLU . 1.5 m -151.53 48.37 0.81 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.526 1.141 . . . . 0.0 109.992 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 303' ' ' SER . . . 36.57 31.66 0.05 OUTLIER Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.516 1.135 . . . . 0.0 110.99 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' GLU . . . . . 0.464 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 0.0 OUTLIER -65.24 151.67 93.41 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.517 0.775 . . . . 0.0 110.28 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 129.51 12.45 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.434 1.755 . . . . 0.0 111.022 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.88 -22.92 0.93 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.491 1.119 . . . . 0.0 110.288 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.695 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 27.4 m 41.79 57.24 3.18 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.566 1.166 . . . . 0.0 110.03 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' ALA . . . . . 0.695 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 162.68 159.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.463 1.102 . . . . 0.0 109.349 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.413 ' H ' ' HB3' ' A' ' 283' ' ' ALA . 0.3 OUTLIER -112.7 122.06 46.56 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.509 1.131 . . . . 0.0 110.408 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.687 HG12 HD12 ' A' ' 262' ' ' ILE . 23.0 t -102.79 131.51 50.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.524 1.14 . . . . 0.0 109.302 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 261' ' ' VAL . 33.8 p -138.37 154.07 48.93 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.494 1.121 . . . . 0.0 109.984 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -91.15 120.55 32.19 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.497 1.123 . . . . 0.0 109.297 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -61.94 -33.79 74.91 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.481 1.113 . . . . 0.0 109.316 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' THR . . . . . 0.605 ' O ' HG23 ' A' ' 317' ' ' VAL . 9.9 t -149.78 -176.22 5.34 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.517 1.136 . . . . 0.0 110.425 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 13.9 p -49.8 92.36 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.525 1.14 . . . . 0.0 110.361 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.942 HG22 ' HA3' ' A' ' 278' ' ' GLY . 43.0 t -108.56 158.49 8.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.509 1.131 . . . . 0.0 109.312 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 68.4 m -132.92 118.16 18.56 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.487 1.117 . . . . 0.0 110.014 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' LEU . . . . . 0.588 HD11 HG21 ' A' ' 256' ' ' VAL . 0.2 OUTLIER -131.65 172.94 11.65 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.49 1.119 . . . . 0.0 109.286 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.661 HD11 ' CG2' ' A' ' 276' ' ' VAL . 0.0 OUTLIER -125.1 137.14 54.19 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.451 1.095 . . . . 0.0 109.31 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 4.0 t -95.51 156.41 16.34 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.463 1.102 . . . . 0.0 110.021 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.94 103.51 3.22 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 0.0 109.289 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 323' ' ' HIS . . . . . 0.56 ' CE1' ' HB2' ' A' ' 326' ' ' ASP . 9.1 p80 -57.72 136.46 56.88 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.494 1.121 . . . . 0.0 109.584 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 42.0 t -62.12 -21.46 65.03 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.448 1.092 . . . . 0.0 109.984 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -62.97 -30.43 71.57 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.506 1.129 . . . . 0.0 109.307 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 326' ' ' ASP . . . . . 0.868 ' O ' HD12 ' A' ' 330' ' ' LEU . 27.7 t70 -65.98 -47.91 73.0 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.506 1.129 . . . . 0.0 109.339 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 327' ' ' PHE . . . . . 0.503 ' CZ ' ' CE2' ' A' ' 341' ' ' PHE . 2.5 t80 -64.95 -34.26 78.0 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.494 1.121 . . . . 0.0 110.996 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 328' ' ' GLN . . . . . 0.486 ' O ' ' CB ' ' A' ' 332' ' ' SER . 67.5 mt-30 -70.53 -33.37 71.1 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.509 1.13 . . . . 0.0 110.264 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 14.3 tmm? -68.98 -44.83 72.08 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.513 1.133 . . . . 0.0 110.989 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.868 HD12 ' O ' ' A' ' 326' ' ' ASP . 0.6 OUTLIER -73.47 -41.87 62.61 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.479 1.112 . . . . 0.0 109.275 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 331' ' ' CYS . . . . . 0.407 ' HG ' ' HD2' ' A' ' 341' ' ' PHE . 22.7 t -66.11 -38.57 88.52 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.479 1.112 . . . . 0.0 108.257 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 332' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 328' ' ' GLN . 38.7 t -76.72 -25.62 53.77 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.462 1.101 . . . . 0.0 109.953 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 17.7 t -71.73 -38.87 70.4 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.123 . . . . 0.0 110.034 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 334' ' ' SER . . . . . 0.442 ' CB ' HD12 ' A' ' 337' ' ' ILE . 0.2 OUTLIER -115.19 127.65 26.63 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.477 1.11 . . . . 0.0 109.965 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 335' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 334' ' ' SER . 18.2 Cg_endo -75.0 -28.8 8.86 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.525 1.803 . . . . 0.0 110.981 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -67.22 -29.82 69.58 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.502 1.126 . . . . 0.0 110.263 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.54 HD11 HG21 ' A' ' 243' ' ' VAL . 87.4 mt -75.0 -34.46 32.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.543 1.152 . . . . 0.0 109.257 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.73 -30.65 64.35 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.528 1.142 . . . . 0.0 109.3 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -74.93 -46.23 37.1 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.491 1.119 . . . . 0.0 110.317 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 87.4 mt -71.59 -36.45 59.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.459 1.099 . . . . 0.0 109.278 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.511 ' CB ' ' O ' ' A' ' 337' ' ' ILE . 6.0 t80 -67.39 -41.96 84.14 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.514 1.134 . . . . 0.0 110.991 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 342' ' ' ARG . . . . . 0.467 ' HG3' ' CD1' ' A' ' 346' ' ' LEU . 0.7 OUTLIER -70.63 -35.84 73.15 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.492 1.12 . . . . 0.0 110.26 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -50.86 65.36 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.492 1.12 . . . . 0.0 109.277 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 344' ' ' THR . . . . . 0.511 HG22 ' O ' ' A' ' 341' ' ' PHE . 10.2 t -65.04 -33.02 75.03 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.474 1.108 . . . . 0.0 110.389 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -66.09 -44.92 83.0 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.484 1.115 . . . . 0.0 109.283 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.467 ' CD1' ' HG3' ' A' ' 342' ' ' ARG . 1.0 OUTLIER -65.34 -36.46 84.1 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.502 1.126 . . . . 0.0 109.329 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -73.53 -35.4 65.55 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.499 1.124 . . . . 0.0 110.317 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.476 0 O-C-N 124.495 1.122 . . . . 0.0 110.255 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.492 ' O ' ' CB ' ' A' ' 227' ' ' TRP . 28.9 t80 . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.495 0.188 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -86.39 -21.06 7.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.519 1.137 . . . . 0.0 109.311 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.779 ' O ' HD12 ' A' ' 229' ' ' LEU . 0.0 OUTLIER -77.33 -44.15 30.5 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.527 1.142 . . . . 0.0 110.284 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.513 ' O ' HG13 ' A' ' 230' ' ' VAL . 18.4 p-10 -81.02 -30.73 34.85 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.52 1.137 . . . . 0.0 109.317 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' TRP . . . . . 1.027 ' CZ3' HG23 ' A' ' 245' ' ' VAL . 1.0 OUTLIER -68.86 -45.27 71.5 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 0.0 107.981 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.606 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 3.5 pt20 -71.98 -32.18 67.0 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.568 1.167 . . . . 0.0 110.282 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.779 HD12 ' O ' ' A' ' 225' ' ' ARG . 1.2 mt -63.4 -47.71 80.84 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.534 1.146 . . . . 0.0 109.306 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.822 ' O ' HG22 ' A' ' 233' ' ' VAL . 34.1 m -66.98 -41.24 87.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.483 1.115 . . . . 0.0 109.324 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -76.76 -11.4 59.83 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.535 1.147 . . . . 0.0 109.277 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -81.24 -26.01 36.18 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.479 1.112 . . . . 0.0 109.298 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' VAL . . . . . 0.822 HG22 ' O ' ' A' ' 230' ' ' VAL . 34.1 m -86.46 135.9 35.85 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.493 1.121 . . . . 0.0 109.279 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.41 ' HA ' ' HB2' ' A' ' 237' ' ' GLN . 18.4 Cg_endo -74.94 -13.48 21.54 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.497 1.788 . . . . 0.0 111.046 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.86 -28.65 66.9 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.485 1.116 . . . . 0.0 109.334 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' PHE . . . . . 0.498 ' HA ' ' CD1' ' A' ' 239' ' ' LEU . 11.6 m-30 -110.82 -17.01 13.44 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.518 1.136 . . . . 0.0 111.033 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' GLN . . . . . 0.41 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 0.3 OUTLIER -59.4 -26.65 65.31 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.467 1.104 . . . . 0.0 110.335 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -83.45 7.56 16.54 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.465 1.103 . . . . 0.0 109.291 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.5 HD13 HG11 ' A' ' 243' ' ' VAL . 34.0 mt -101.65 -179.48 4.03 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.538 1.149 . . . . 0.0 109.294 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -92.06 176.84 39.4 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.479 1.112 . . . . 0.0 110.992 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -30.34 7.24 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.457 1.767 . . . . 0.0 111.009 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.505 ' HA ' HG12 ' A' ' 245' ' ' VAL . . . -70.91 -31.49 68.13 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 0.0 109.322 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.746 ' CG2' HD11 ' A' ' 337' ' ' ILE . 2.7 t -76.89 -43.0 33.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.504 1.128 . . . . 0.0 109.327 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.589 ' O ' HG12 ' A' ' 248' ' ' VAL . 0.2 OUTLIER -67.3 -45.16 77.34 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.529 1.143 . . . . 0.0 109.321 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 1.027 HG23 ' CZ3' ' A' ' 227' ' ' TRP . 2.9 p -64.49 -44.83 96.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.529 1.143 . . . . 0.0 109.32 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.405 ' N ' ' CG1' ' A' ' 245' ' ' VAL . 19.7 tp10 -66.01 -34.66 78.61 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.45 1.094 . . . . 0.0 110.301 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.538 ' CG1' HD13 ' A' ' 330' ' ' LEU . 15.5 mt -68.81 -55.17 16.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.548 1.155 . . . . 0.0 109.31 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.946 ' HA ' HD12 ' A' ' 251' ' ' LEU . 13.7 p -64.81 -30.36 50.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.532 1.145 . . . . 0.0 109.318 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.484 ' CG ' ' O ' ' A' ' 245' ' ' VAL . 5.8 mmm180 -70.17 -28.76 65.58 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.526 1.141 . . . . 0.0 110.308 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.542 ' HB1' ' OD2' ' A' ' 326' ' ' ASP . . . -86.86 -21.06 26.61 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.475 1.109 . . . . 0.0 109.309 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.946 HD12 ' HA ' ' A' ' 248' ' ' VAL . 1.7 mt -54.72 144.85 20.88 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.527 1.142 . . . . 0.0 109.256 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.66 124.88 50.82 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.485 1.116 . . . . 0.0 110.302 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -81.94 124.25 29.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.486 1.116 . . . . 0.0 109.267 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.46 136.56 48.04 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.523 1.139 . . . . 0.0 110.295 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 55.7 m -94.16 125.04 38.55 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 0.0 110.384 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.489 HG21 HD11 ' A' ' 319' ' ' LEU . 42.1 t -106.8 113.95 62.23 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.47 1.106 . . . . 0.0 109.301 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.492 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.2 Cg_endo -75.03 158.11 42.27 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.49 1.784 . . . . 0.0 110.983 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.499 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -57.85 125.39 22.82 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.491 1.119 . . . . 0.0 109.314 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 101.52 -24.08 32.85 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.513 1.133 . . . . 0.0 110.99 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.492 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -61.35 147.44 44.75 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.554 0.796 . . . . 0.0 109.291 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.9 t -97.11 131.3 44.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.51 1.131 . . . . 0.0 109.298 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.744 HD12 HG12 ' A' ' 311' ' ' VAL . 86.2 mt -83.11 -47.96 17.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.457 1.098 . . . . 0.0 109.33 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 14.3 p -153.88 145.48 23.26 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.478 1.111 . . . . 0.0 108.289 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -89.25 178.96 6.22 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.542 1.151 . . . . 0.0 110.28 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.467 HG23 ' OG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -77.89 130.69 35.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.48 1.112 . . . . 0.0 109.261 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 59.9 49.4 78.94 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.497 1.123 . . . . 0.0 111.012 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.12 164.3 58.11 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.521 0.777 . . . . 0.0 110.325 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.5 Cg_endo -74.98 80.6 2.39 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.517 1.799 . . . . 0.0 111.043 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 268' ' ' PRO . . . -37.14 95.82 0.01 OUTLIER Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.488 1.117 . . . . 0.0 111.024 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 268' ' ' PRO . 1.0 OUTLIER -170.2 37.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.499 0.764 . . . . 0.0 109.311 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 6.5 ttt180 -171.57 146.33 2.17 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.506 1.129 . . . . 0.0 110.309 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' MET . . . . . 0.757 ' HB2' HD11 ' A' ' 301' ' ' LEU . 2.6 ttt -116.69 146.51 42.71 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.533 1.146 . . . . 0.0 111.023 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.561 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 44.5 m-85 -133.92 137.03 44.64 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.124 . . . . 0.0 111.023 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 274' ' ' PHE . . . . . 0.437 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 21.1 m-85 -126.38 133.48 51.3 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.519 1.137 . . . . 0.0 111.003 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.74 HG22 HD22 ' A' ' 319' ' ' LEU . 3.2 t -91.07 133.11 33.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.475 1.109 . . . . 0.0 109.294 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.672 ' CG2' HD11 ' A' ' 320' ' ' LEU . 40.2 t -110.27 -35.35 2.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.576 1.173 . . . . 0.0 109.268 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.767 ' O ' HG13 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -156.27 137.84 14.09 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.516 1.135 . . . . 0.0 110.309 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.869 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 117.15 -177.53 16.7 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.483 1.114 . . . . 0.0 110.987 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 2.7 m -126.35 113.49 16.98 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.478 0.752 . . . . 0.0 109.97 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 289' ' ' GLU . 32.7 m -99.26 135.1 35.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.493 1.121 . . . . 0.0 109.325 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 29.3 t -104.16 148.49 26.23 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.475 1.109 . . . . 0.0 109.997 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 288' ' ' VAL . 1.7 t -112.27 128.92 68.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.482 1.113 . . . . 0.0 109.319 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.415 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -77.34 100.96 6.11 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.538 1.149 . . . . 0.0 109.282 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' THR . . . . . 0.661 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.9 OUTLIER -149.37 -167.99 0.17 Allowed Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.455 1.097 . . . . 0.0 110.382 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.661 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.4 Cg_endo -75.0 3.93 5.19 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.51 1.794 . . . . 0.0 111.028 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.415 ' O ' HG23 ' A' ' 288' ' ' VAL . 26.4 m120 -152.21 154.82 32.76 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.448 1.093 . . . . 0.0 109.276 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 95.48 0.98 Allowed 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.515 1.797 . . . . 0.0 110.981 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 286' ' ' ASN . 1.3 t -100.03 118.53 46.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.491 1.119 . . . . 0.0 109.303 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 2.5 mm-40 -125.16 133.53 52.76 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.498 1.124 . . . . 0.0 110.312 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.427 HD13 ' HA ' ' A' ' 290' ' ' LEU . 4.4 mm? -115.41 139.66 49.82 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.506 1.129 . . . . 0.0 109.324 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -95.77 -155.96 31.31 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.502 1.126 . . . . 0.0 110.98 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' PRO . . . . . 0.419 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.2 Cg_endo -75.05 138.37 22.82 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.53 1.805 . . . . 0.0 110.972 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 95.23 6.19 60.2 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.481 1.113 . . . . 0.0 110.965 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -90.58 130.75 36.58 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.461 0.742 . . . . 0.0 109.238 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 295' ' ' PHE . 2.3 p90 -120.75 152.92 37.7 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.506 1.129 . . . . 0.0 111.018 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.561 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 36.9 p90 -164.72 148.27 8.92 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.13 . . . . 0.0 110.975 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 297' ' ' GLY . . . . . 0.592 ' O ' HD12 ' A' ' 301' ' ' LEU . . . 128.07 -8.45 6.74 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.457 1.098 . . . . 0.0 110.989 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -54.94 -53.35 56.76 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.474 0.749 . . . . 0.0 110.319 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -46.98 -35.03 6.12 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.512 1.133 . . . . 0.0 110.979 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 300' ' ' ALA . . . . . 0.458 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -68.74 -46.91 67.64 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.515 1.134 . . . . 0.0 109.324 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.757 HD11 ' HB2' ' A' ' 272' ' ' MET . 1.1 mp -75.21 -3.21 31.76 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.475 1.11 . . . . 0.0 109.312 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 302' ' ' ILE . . . . . 0.42 HD13 ' CZ ' ' A' ' 341' ' ' PHE . 8.8 mm -86.85 -54.35 8.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.509 1.131 . . . . 0.0 109.296 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 304' ' ' GLY . 0.9 OUTLIER -149.44 40.89 0.86 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.47 1.106 . . . . 0.0 110.036 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 37.03 34.04 0.1 OUTLIER Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.54 1.15 . . . . 0.0 110.989 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.72 155.23 89.88 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.502 0.766 . . . . 0.0 110.266 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 129.66 12.52 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.468 1.773 . . . . 0.0 111.013 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.98 -29.64 1.52 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.503 1.127 . . . . 0.0 110.273 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.506 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 0.1 OUTLIER 50.65 40.88 25.01 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.444 1.09 . . . . 0.0 109.957 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 309' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 175.26 160.82 0.24 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.497 1.123 . . . . 0.0 109.311 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.467 ' OG1' HG23 ' A' ' 265' ' ' ILE . 0.9 OUTLIER -117.78 123.43 45.97 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.539 1.149 . . . . 0.0 110.392 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.744 HG12 HD12 ' A' ' 262' ' ' ILE . 95.1 t -103.99 131.39 52.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.506 1.129 . . . . 0.0 109.279 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 65.2 p -131.54 151.27 51.72 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.475 1.109 . . . . 0.0 109.997 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.26 109.65 19.65 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.515 1.134 . . . . 0.0 109.282 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -56.41 -32.19 64.61 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.503 1.127 . . . . 0.0 109.304 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' THR . . . . . 0.843 ' O ' HG23 ' A' ' 317' ' ' VAL . 8.2 t -153.86 -171.76 3.99 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.526 1.141 . . . . 0.0 110.416 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 316' ' ' THR . . . . . 0.452 ' N ' ' OG1' ' A' ' 315' ' ' THR . 43.1 p -54.74 87.91 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.554 1.159 . . . . 0.0 110.39 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.869 HG22 ' HA3' ' A' ' 278' ' ' GLY . 44.9 t -107.71 144.25 16.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.482 1.113 . . . . 0.0 109.265 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 69.1 m -117.99 117.87 30.4 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.529 1.143 . . . . 0.0 109.958 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' LEU . . . . . 0.74 HD22 HG22 ' A' ' 275' ' ' VAL . 0.0 OUTLIER -128.48 173.33 10.32 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.49 1.119 . . . . 0.0 109.328 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.672 HD11 ' CG2' ' A' ' 276' ' ' VAL . 0.2 OUTLIER -124.49 136.3 53.9 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.471 1.107 . . . . 0.0 109.298 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 14.1 t -96.23 154.63 17.15 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.513 1.133 . . . . 0.0 110.01 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.468 ' HB2' ' CD2' ' A' ' 251' ' ' LEU . 1.2 tm? -145.28 87.66 1.82 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.506 1.129 . . . . 0.0 109.268 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 323' ' ' HIS . . . . . 0.414 ' ND1' ' HB3' ' A' ' 325' ' ' ALA . 10.4 p80 -49.69 139.1 13.34 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.557 1.16 . . . . 0.0 109.602 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 36.0 t -59.52 -23.87 63.17 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.466 1.104 . . . . 0.0 110.006 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 0.414 ' HB3' ' ND1' ' A' ' 323' ' ' HIS . . . -55.95 -31.03 62.58 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.474 1.108 . . . . 0.0 109.325 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' ASP . . . . . 0.542 ' OD2' ' HB1' ' A' ' 250' ' ' ALA . 2.6 t70 -70.11 -38.88 75.72 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.532 1.145 . . . . 0.0 109.357 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -67.5 -36.51 81.23 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.517 1.136 . . . . 0.0 110.965 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -70.32 -37.01 74.63 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.525 1.14 . . . . 0.0 110.297 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 5.1 ttp -68.86 -40.39 79.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 0.0 111.009 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.538 HD13 ' CG1' ' A' ' 247' ' ' ILE . 9.3 mt -72.14 -34.52 68.6 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.462 1.101 . . . . 0.0 109.299 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 16.0 m -74.18 -33.32 63.41 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.488 1.117 . . . . 0.0 108.318 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 8.6 t -75.91 -36.52 59.41 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.129 . . . . 0.0 110.004 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 10.0 t -74.51 -34.34 63.01 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.487 1.117 . . . . 0.0 110.03 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 334' ' ' SER . . . . . 0.798 ' CB ' HD12 ' A' ' 337' ' ' ILE . 0.3 OUTLIER -128.1 114.62 20.22 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.562 1.164 . . . . 0.0 110.036 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -18.95 18.29 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.499 1.789 . . . . 0.0 111.013 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -72.37 -28.92 63.33 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 0.0 110.329 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.798 HD12 ' CB ' ' A' ' 334' ' ' SER . 46.2 mt -72.69 -41.43 62.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.554 1.159 . . . . 0.0 109.257 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.97 -32.41 65.18 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.455 1.097 . . . . 0.0 109.27 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.53 -39.75 62.16 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.491 1.12 . . . . 0.0 110.293 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 48.6 mt -73.23 -42.69 57.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.551 1.157 . . . . 0.0 109.286 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.42 ' CZ ' HD13 ' A' ' 302' ' ' ILE . 46.7 t80 -69.24 -34.26 74.55 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.55 1.157 . . . . 0.0 111.009 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 342' ' ' ARG . . . . . 0.461 ' HG3' ' CD1' ' A' ' 346' ' ' LEU . 1.4 ttp-105 -72.78 -39.54 66.64 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.538 1.149 . . . . 0.0 110.276 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -50.59 65.93 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.509 1.13 . . . . 0.0 109.291 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 7.6 t -65.37 -32.98 74.9 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.47 1.106 . . . . 0.0 110.453 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -66.74 -44.99 80.05 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.521 1.138 . . . . 0.0 109.334 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.461 ' CD1' ' HG3' ' A' ' 342' ' ' ARG . 0.6 OUTLIER -65.14 -37.03 86.12 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.503 1.127 . . . . 0.0 109.289 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.08 -39.22 92.89 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.472 1.107 . . . . 0.0 110.31 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 49.6 mtt-85 . . . . . 0 C--N 1.325 -0.457 0 O-C-N 124.481 1.113 . . . . 0.0 110.296 -179.998 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 40.0 t80 . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 120.534 0.206 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.98 -33.29 58.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.471 1.107 . . . . 0.0 109.339 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.764 ' HD2' HG13 ' A' ' 276' ' ' VAL . 0.0 OUTLIER -67.91 -35.02 77.74 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.498 1.124 . . . . 0.0 110.308 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.681 ' OD1' HD13 ' A' ' 320' ' ' LEU . 3.7 m-20 -77.46 -30.44 53.23 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.487 1.117 . . . . 0.0 109.279 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' TRP . . . . . 0.79 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 1.9 t90 -67.58 -44.81 77.26 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.513 1.133 . . . . 0.0 108.04 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 5.7 pt20 -71.14 -35.75 71.81 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.493 1.12 . . . . 0.0 110.307 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.607 HD23 ' HD3' ' A' ' 225' ' ' ARG . 0.8 OUTLIER -61.45 -47.43 85.76 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.509 1.131 . . . . 0.0 109.323 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.621 HG12 HD13 ' A' ' 244' ' ' LEU . 99.7 t -71.76 -40.76 70.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.473 1.108 . . . . 0.0 109.274 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.58 -15.94 62.81 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.481 1.113 . . . . 0.0 109.251 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -81.34 -11.09 59.42 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.553 1.158 . . . . 0.0 109.31 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 229' ' ' LEU . 31.2 t -89.64 123.33 66.81 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.514 1.134 . . . . 0.0 109.308 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 -16.09 20.31 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.481 1.78 . . . . 0.0 110.997 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.759 HD12 ' CE2' ' A' ' 341' ' ' PHE . 0.0 OUTLIER -79.6 -24.66 41.85 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.498 1.124 . . . . 0.0 109.268 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 236' ' ' PHE . . . . . 0.4 ' CB ' HD12 ' A' ' 239' ' ' LEU . 3.4 m-30 -108.51 -11.88 15.08 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.537 1.148 . . . . 0.0 111.022 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.66 -24.65 66.87 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.488 1.118 . . . . 0.0 110.338 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -74.62 -4.45 37.21 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.516 1.135 . . . . 0.0 109.333 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.557 HD22 HG11 ' A' ' 243' ' ' VAL . 12.5 mt -85.0 -179.65 7.1 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.45 1.094 . . . . 0.0 109.321 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' GLY . . . . . 0.633 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -103.24 -172.66 26.15 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.489 1.118 . . . . 0.0 111.012 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.906 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.2 Cg_endo -75.02 -36.14 2.71 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.464 1.77 . . . . 0.0 111.02 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.04 -35.31 78.04 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.533 1.146 . . . . 0.0 109.299 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.636 HG21 HD11 ' A' ' 337' ' ' ILE . 13.0 t -75.33 -36.58 36.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.451 1.095 . . . . 0.0 109.258 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.633 HD23 ' O ' ' A' ' 240' ' ' GLY . 1.6 mm? -70.54 -35.48 73.16 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.499 1.125 . . . . 0.0 109.304 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.906 HG23 ' O ' ' A' ' 241' ' ' PRO . 96.4 t -72.85 -38.28 56.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.473 1.108 . . . . 0.0 109.334 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -69.06 -49.7 55.1 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.514 1.134 . . . . 0.0 110.235 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.513 HD12 HG12 ' A' ' 243' ' ' VAL . 14.1 mt -63.13 -35.63 72.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.502 1.127 . . . . 0.0 109.319 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 244' ' ' LEU . 4.6 t -67.51 -41.13 85.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.526 1.141 . . . . 0.0 109.309 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -77.23 -13.03 60.01 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.489 1.118 . . . . 0.0 110.298 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -89.18 -17.46 29.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.461 1.101 . . . . 0.0 109.311 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.59 HD23 ' HB2' ' A' ' 322' ' ' LEU . 3.2 mt -65.89 144.53 56.75 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.456 1.097 . . . . 0.0 109.294 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 320' ' ' LEU . 0.0 OUTLIER -119.75 133.15 55.72 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.535 1.147 . . . . 0.0 110.284 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.657 ' HA ' HD23 ' A' ' 320' ' ' LEU . . . -80.63 130.91 35.38 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.462 1.101 . . . . 0.0 109.284 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.22 125.03 19.63 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.489 1.118 . . . . 0.0 110.295 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 13.4 m -91.07 116.53 28.88 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.49 1.119 . . . . 0.0 110.381 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.626 HG12 ' CB ' ' A' ' 313' ' ' ALA . 24.4 t -107.05 111.63 63.5 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 124.533 1.145 . . . . 0.0 109.315 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.96 176.38 9.98 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.482 1.78 . . . . 0.0 111.039 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.521 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -67.8 134.14 50.44 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.505 1.128 . . . . 0.0 109.304 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 89.15 -25.53 10.13 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.501 1.126 . . . . 0.0 110.981 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.547 ' HB3' HG13 ' A' ' 256' ' ' VAL . . . -55.43 148.49 15.15 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.489 0.758 . . . . 0.0 109.285 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 2.7 t -96.93 129.7 46.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.536 1.148 . . . . 0.0 109.309 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.793 HD12 HG12 ' A' ' 311' ' ' VAL . 65.7 mt -84.81 -45.77 17.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.533 1.145 . . . . 0.0 109.303 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 13.5 p -154.97 149.71 26.58 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.486 1.116 . . . . 0.0 108.333 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -89.53 175.9 7.1 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.128 . . . . 0.0 110.308 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.503 HD13 ' H ' ' A' ' 265' ' ' ILE . 0.2 OUTLIER -76.97 141.16 16.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.503 1.127 . . . . 0.0 109.321 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 45.67 49.46 12.11 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.524 1.14 . . . . 0.0 110.974 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.472 ' HG3' ' N ' ' A' ' 268' ' ' PRO . 2.9 pt-20 -73.1 173.75 5.58 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.48 0.753 . . . . 0.0 110.275 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.472 ' N ' ' HG3' ' A' ' 267' ' ' GLU . 18.2 Cg_endo -75.01 97.1 1.05 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.493 1.786 . . . . 0.0 110.967 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -50.88 89.46 0.01 OUTLIER Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.465 1.103 . . . . 0.0 110.964 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 268' ' ' PRO . 40.6 m-20 -170.39 38.36 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.48 0.753 . . . . 0.0 109.3 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -171.23 149.21 2.78 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.504 1.128 . . . . 0.0 110.353 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' MET . . . . . 0.489 ' SD ' ' CD1' ' A' ' 301' ' ' LEU . 8.3 ptm -138.74 146.97 42.1 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.5 1.125 . . . . 0.0 110.97 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.575 ' HB2' ' CE1' ' A' ' 296' ' ' PHE . 34.0 m-85 -124.98 151.48 45.46 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.528 1.143 . . . . 0.0 110.943 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' PHE . . . . . 0.502 ' CD1' ' HB3' ' A' ' 295' ' ' PHE . 23.6 m-85 -129.48 124.89 35.14 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.497 1.123 . . . . 0.0 110.99 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 1.074 HG22 HD23 ' A' ' 319' ' ' LEU . 76.2 t -79.7 138.19 20.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.477 1.11 . . . . 0.0 109.278 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.764 HG13 ' HD2' ' A' ' 225' ' ' ARG . 2.9 t -116.14 -47.54 4.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.443 1.089 . . . . 0.0 109.304 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.479 ' O ' HG23 ' A' ' 317' ' ' VAL . 5.9 mt-10 -145.62 135.9 23.94 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.533 1.146 . . . . 0.0 110.318 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.404 ' HA3' ' HB ' ' A' ' 317' ' ' VAL . . . 115.63 -155.11 16.5 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.535 1.147 . . . . 0.0 110.99 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 3.1 m -151.32 138.62 19.36 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.461 0.742 . . . . 0.0 109.982 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.474 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 17.6 m -117.59 166.77 11.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.496 1.122 . . . . 0.0 109.287 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 29.4 t -131.9 155.47 47.83 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.475 1.109 . . . . 0.0 109.983 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.508 HG13 HG22 ' A' ' 311' ' ' VAL . 0.3 OUTLIER -119.12 129.37 75.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.474 1.109 . . . . 0.0 109.308 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.4 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -77.77 101.85 6.9 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.512 1.133 . . . . 0.0 109.271 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' THR . . . . . 0.649 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.39 -168.62 0.19 Allowed Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.509 1.13 . . . . 0.0 110.392 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.649 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -74.98 4.88 4.33 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.469 1.773 . . . . 0.0 110.965 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -151.83 157.12 34.53 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.455 1.097 . . . . 0.0 109.31 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.98 94.89 0.96 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.488 1.783 . . . . 0.0 110.981 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 281' ' ' SER . 31.2 t -99.04 119.45 47.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.498 1.123 . . . . 0.0 109.323 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 14.4 mt-10 -124.33 136.89 54.44 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.491 1.119 . . . . 0.0 110.296 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.474 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 3.9 mm? -114.76 142.83 45.99 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.533 1.145 . . . . 0.0 109.288 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -98.44 -164.97 30.78 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.497 1.123 . . . . 0.0 110.981 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' PRO . . . . . 0.642 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.3 Cg_endo -74.98 156.23 43.07 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.454 1.765 . . . . 0.0 110.974 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.433 ' HA2' HD21 ' A' ' 229' ' ' LEU . . . 77.37 2.17 78.44 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.508 1.13 . . . . 0.0 110.973 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' ALA . . . . . 0.406 ' HB1' HD12 ' A' ' 290' ' ' LEU . . . -87.79 136.05 33.12 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.518 0.775 . . . . 0.0 109.325 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.502 ' HB3' ' CD1' ' A' ' 274' ' ' PHE . 0.7 OUTLIER -123.76 153.05 41.47 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.508 1.13 . . . . 0.0 110.983 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.575 ' CE1' ' HB2' ' A' ' 273' ' ' PHE . 51.7 p90 -163.52 143.35 8.54 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.515 1.134 . . . . 0.0 110.962 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 297' ' ' GLY . . . . . 0.469 ' HA3' ' CB ' ' A' ' 272' ' ' MET . . . 137.57 -14.31 3.67 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.499 1.125 . . . . 0.0 110.943 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -52.84 -44.41 66.72 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.514 0.773 . . . . 0.0 110.311 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' MET . . . . . 0.487 ' CE ' HD12 ' A' ' 302' ' ' ILE . 0.1 OUTLIER -47.37 -39.11 14.41 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.487 1.117 . . . . 0.0 111.003 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 300' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -72.64 -37.16 68.08 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.489 1.118 . . . . 0.0 109.31 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.489 ' CD1' ' SD ' ' A' ' 272' ' ' MET . 4.5 mt -76.67 -5.47 48.06 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.485 1.116 . . . . 0.0 109.34 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 302' ' ' ILE . . . . . 0.674 HG23 ' HB1' ' A' ' 345' ' ' ALA . 22.0 mt -91.81 -51.43 11.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.475 1.109 . . . . 0.0 109.261 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.442 ' O ' ' C ' ' A' ' 304' ' ' GLY . 1.2 m -151.94 41.01 0.65 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.506 1.129 . . . . 0.0 109.954 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 34.7 39.97 0.18 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.498 1.123 . . . . 0.0 110.99 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' GLU . . . . . 0.425 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 0.5 OUTLIER -68.17 151.05 97.48 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.505 0.768 . . . . 0.0 110.292 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 132.36 15.37 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.532 1.806 . . . . 0.0 111.03 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' ARG . . . . . 0.425 ' NH2' ' HA2' ' A' ' 297' ' ' GLY . 10.5 mmp_? -44.39 -44.92 8.65 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.436 1.085 . . . . 0.0 110.309 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.57 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 0.3 OUTLIER 66.31 38.18 4.58 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.483 1.114 . . . . 0.0 109.991 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 309' ' ' ALA . . . . . 0.57 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 171.73 160.88 0.1 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.532 1.145 . . . . 0.0 109.308 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.89 125.48 52.85 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.529 1.143 . . . . 0.0 110.409 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.793 HG12 HD12 ' A' ' 262' ' ' ILE . 77.7 t -103.3 127.7 56.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 0.0 109.318 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 87.5 p -127.86 157.45 40.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.516 1.135 . . . . 0.0 109.994 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' ALA . . . . . 0.821 ' HB1' ' CG1' ' A' ' 317' ' ' VAL . . . -89.19 112.99 24.14 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.502 1.126 . . . . 0.0 109.319 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -54.3 -32.71 57.12 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.55 1.156 . . . . 0.0 109.35 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 315' ' ' THR . . . . . 0.68 ' O ' HG12 ' A' ' 317' ' ' VAL . 9.8 t -158.63 -159.05 0.75 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.462 1.101 . . . . 0.0 110.44 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 316' ' ' THR . . . . . 0.443 ' N ' ' OG1' ' A' ' 315' ' ' THR . 86.6 m -66.03 81.26 0.08 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.525 1.141 . . . . 0.0 110.38 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.821 ' CG1' ' HB1' ' A' ' 313' ' ' ALA . 1.3 p -108.26 140.98 24.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.491 1.12 . . . . 0.0 109.265 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 49.2 m -112.3 127.73 56.07 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.511 1.132 . . . . 0.0 110.003 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' LEU . . . . . 1.074 HD23 HG22 ' A' ' 275' ' ' VAL . 0.0 OUTLIER -134.81 174.71 10.28 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.555 1.159 . . . . 0.0 109.295 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.681 HD13 ' OD1' ' A' ' 226' ' ' ASN . 1.0 OUTLIER -124.18 135.27 53.35 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.499 1.124 . . . . 0.0 109.312 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 53.9 p -96.86 150.66 20.49 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.531 1.144 . . . . 0.0 109.994 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.59 ' HB2' HD23 ' A' ' 251' ' ' LEU . 2.6 tm? -146.17 104.02 3.77 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.529 1.143 . . . . 0.0 109.304 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -65.15 138.53 58.34 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.448 1.092 . . . . 0.0 109.578 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' SER . . . . . 0.426 ' HA ' HD21 ' A' ' 301' ' ' LEU . 89.2 p -59.81 -19.65 52.03 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.48 1.113 . . . . 0.0 109.985 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -51.22 -35.36 36.3 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.514 1.134 . . . . 0.0 109.261 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 326' ' ' ASP . . . . . 0.585 ' OD1' HD11 ' A' ' 322' ' ' LEU . 3.2 p-10 -65.84 -38.38 88.72 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.508 1.13 . . . . 0.0 109.295 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -67.85 -37.79 82.33 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.5 1.125 . . . . 0.0 110.981 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -68.81 -32.49 72.23 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.515 1.134 . . . . 0.0 110.31 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 15.6 tmm? -70.58 -43.2 69.9 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.519 1.137 . . . . 0.0 111.022 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.82 -31.2 61.63 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.124 . . . . 0.0 109.278 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 331' ' ' CYS . . . . . 0.422 ' CB ' ' HB2' ' A' ' 338' ' ' ALA . 1.8 m -75.0 -39.74 61.03 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.457 1.098 . . . . 0.0 108.297 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 26.3 t -70.8 -32.55 69.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.53 1.144 . . . . 0.0 110.013 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 31.9 t -79.16 -35.68 41.59 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.511 1.132 . . . . 0.0 109.988 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 1.5 m -128.96 109.16 18.3 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.522 1.139 . . . . 0.0 109.972 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 -20.26 17.04 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.504 1.792 . . . . 0.0 111.052 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.453 ' O ' ' CG1' ' A' ' 340' ' ' ILE . 1.2 tt0 -66.1 -37.26 85.31 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 0.0 110.347 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.636 HD11 HG21 ' A' ' 243' ' ' VAL . 88.1 mt -75.97 -42.8 39.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.44 1.088 . . . . 0.0 109.285 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 338' ' ' ALA . . . . . 0.422 ' HB2' ' CB ' ' A' ' 331' ' ' CYS . . . -64.83 -45.23 87.02 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.484 1.115 . . . . 0.0 109.315 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.52 -33.37 74.0 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.49 1.119 . . . . 0.0 110.314 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.453 ' CG1' ' O ' ' A' ' 336' ' ' GLU . 21.1 mt -70.17 -40.66 78.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.519 1.137 . . . . 0.0 109.341 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.759 ' CE2' HD12 ' A' ' 235' ' ' LEU . 2.7 t80 -69.08 -35.13 76.15 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.499 1.125 . . . . 0.0 111.036 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 27.7 ttt-85 -70.37 -38.94 74.85 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.494 1.121 . . . . 0.0 110.318 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -51.07 63.16 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.535 1.147 . . . . 0.0 109.328 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 344' ' ' THR . . . . . 0.46 HG22 ' HA ' ' A' ' 341' ' ' PHE . 13.1 t -68.64 -33.32 73.82 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.497 1.123 . . . . 0.0 110.43 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 345' ' ' ALA . . . . . 0.674 ' HB1' HG23 ' A' ' 302' ' ' ILE . . . -70.18 -36.44 74.66 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.445 1.091 . . . . 0.0 109.301 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 346' ' ' LEU . 11.7 mt -69.28 -40.94 77.47 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.471 1.107 . . . . 0.0 109.318 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -68.42 -34.05 75.31 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.486 1.116 . . . . 0.0 110.323 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 34.3 mtt-85 . . . . . 0 C--N 1.325 -0.48 0 O-C-N 124.474 1.109 . . . . 0.0 110.285 179.97 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 46.9 t80 . . . . . 0 N--CA 1.453 -0.284 0 CA-C-O 120.505 0.193 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.55 -39.64 40.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.124 . . . . 0.0 109.252 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.401 ' HG3' HD12 ' A' ' 229' ' ' LEU . 13.6 tpp85 -68.37 -30.64 69.63 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.115 . . . . 0.0 110.275 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.705 HD21 HD22 ' A' ' 320' ' ' LEU . 2.2 m-20 -79.3 -41.4 28.12 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.408 1.068 . . . . 0.0 109.302 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' TRP . . . . . 0.485 ' O ' HG22 ' A' ' 230' ' ' VAL . 4.5 t90 -66.68 -44.52 81.54 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.527 1.142 . . . . 0.0 107.977 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.611 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 9.7 pt20 -67.71 -31.63 71.71 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.478 1.111 . . . . 0.0 110.31 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.401 HD12 ' HG3' ' A' ' 225' ' ' ARG . 1.6 mt -63.54 -45.08 92.2 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.514 1.133 . . . . 0.0 109.316 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.87 HG23 HD12 ' A' ' 244' ' ' LEU . 35.2 m -74.55 -38.78 46.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.528 1.143 . . . . 0.0 109.33 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -75.42 -11.78 60.11 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.47 1.106 . . . . 0.0 109.336 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -81.32 -23.99 37.44 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.525 1.14 . . . . 0.0 109.247 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' VAL . . . . . 0.583 HG12 ' O ' ' A' ' 230' ' ' VAL . 0.4 OUTLIER -81.35 130.93 60.23 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.475 1.109 . . . . 0.0 109.263 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.42 ' HA ' ' HB2' ' A' ' 237' ' ' GLN . 18.2 Cg_endo -75.02 -16.75 19.98 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.513 1.796 . . . . 0.0 110.982 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.455 HD21 HD11 ' A' ' 302' ' ' ILE . 0.1 OUTLIER -63.34 -30.04 71.24 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.456 1.098 . . . . 0.0 109.33 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 236' ' ' PHE . . . . . 0.539 ' HB3' HD12 ' A' ' 239' ' ' LEU . 16.1 m-30 -112.95 17.08 19.18 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.538 1.149 . . . . 0.0 111.003 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' GLN . . . . . 0.42 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 2.1 mt-30 -70.01 -20.02 63.29 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.549 1.155 . . . . 0.0 110.282 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -92.58 -12.37 31.94 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.508 1.13 . . . . 0.0 109.302 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.744 HD22 HG11 ' A' ' 243' ' ' VAL . 46.0 mt -70.11 179.26 2.41 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.46 1.1 . . . . 0.0 109.276 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' GLY . . . . . 0.691 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -109.79 -174.89 20.94 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.509 1.131 . . . . 0.0 111.006 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 -32.84 5.13 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.485 1.782 . . . . 0.0 111.065 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.507 ' HA ' HG12 ' A' ' 245' ' ' VAL . . . -73.09 -33.2 65.47 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.457 1.098 . . . . 0.0 109.284 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.744 HG11 HD22 ' A' ' 239' ' ' LEU . 63.5 t -77.09 -36.59 24.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.474 1.109 . . . . 0.0 109.334 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.87 HD12 HG23 ' A' ' 230' ' ' VAL . 3.8 mm? -72.57 -42.65 64.4 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.497 1.123 . . . . 0.0 109.289 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.507 HG12 ' HA ' ' A' ' 242' ' ' ALA . 2.8 p -68.21 -39.51 81.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.465 1.103 . . . . 0.0 109.261 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -70.88 -40.99 71.91 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.52 1.138 . . . . 0.0 110.284 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.649 ' CG1' HD13 ' A' ' 330' ' ' LEU . 25.6 mt -66.56 -51.97 51.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.503 1.127 . . . . 0.0 109.278 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.706 ' HA ' HD12 ' A' ' 251' ' ' LEU . 10.0 p -62.87 -30.74 50.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.48 1.113 . . . . 0.0 109.315 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.454 ' CG ' ' O ' ' A' ' 245' ' ' VAL . 16.6 mmm-85 -73.55 -25.77 60.54 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.542 1.151 . . . . 0.0 110.283 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -85.2 -17.98 35.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 0.0 109.297 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.706 HD12 ' HA ' ' A' ' 248' ' ' VAL . 0.3 OUTLIER -59.41 144.24 47.43 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 0.0 109.339 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 252' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 320' ' ' LEU . 3.2 mmm180 -118.18 135.09 54.45 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.558 1.161 . . . . 0.0 110.331 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -80.68 123.18 27.96 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.532 1.145 . . . . 0.0 109.303 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.6 ttm-85 -125.05 123.49 39.9 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.462 1.101 . . . . 0.0 110.34 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 50.2 m -91.51 117.65 29.89 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.484 1.115 . . . . 0.0 110.428 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.506 ' CG2' HD21 ' A' ' 319' ' ' LEU . 2.6 t -109.41 113.46 58.36 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.524 1.14 . . . . 0.0 109.285 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -75.0 168.71 24.24 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.543 1.812 . . . . 0.0 111.011 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.555 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -65.93 126.34 28.24 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.524 1.14 . . . . 0.0 109.286 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 100.59 -25.32 28.75 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.489 1.118 . . . . 0.0 111.003 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.49 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -67.27 145.08 55.52 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.497 0.763 . . . . 0.0 109.301 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 5.8 t -94.82 135.02 30.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.504 1.128 . . . . 0.0 109.299 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.806 HD12 HG12 ' A' ' 311' ' ' VAL . 17.8 mt -82.95 -42.74 18.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.541 1.151 . . . . 0.0 109.29 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' CYS . . . . . 0.604 ' SG ' HG23 ' A' ' 311' ' ' VAL . 11.3 p -152.4 142.61 22.4 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.49 1.119 . . . . 0.0 108.289 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 3.4 mmt85 -84.87 178.58 7.56 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.5 1.125 . . . . 0.0 110.277 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.425 ' CG2' ' HB ' ' A' ' 310' ' ' THR . 0.1 OUTLIER -76.57 137.44 22.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.513 1.133 . . . . 0.0 109.327 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 52.95 50.81 49.34 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.46 1.1 . . . . 0.0 111.026 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -70.37 163.89 58.6 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.486 0.756 . . . . 0.0 110.302 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.507 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.3 Cg_endo -74.98 82.77 1.93 Allowed 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.532 1.806 . . . . 0.0 111.051 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' GLY . . . . . 0.44 ' CA ' ' HB1' ' A' ' 300' ' ' ALA . . . -36.07 93.16 0.01 OUTLIER Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.477 1.111 . . . . 0.0 110.994 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 268' ' ' PRO . 12.3 m-20 -171.63 37.93 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.528 0.781 . . . . 0.0 109.335 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ARG . . . . . 0.426 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 3.3 mtp180 -169.89 144.54 2.79 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.537 1.148 . . . . 0.0 110.359 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 272' ' ' MET . . . . . 0.857 ' HB2' HD11 ' A' ' 301' ' ' LEU . 2.2 ttt -118.34 147.63 43.3 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.505 1.128 . . . . 0.0 110.99 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.571 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 28.4 m-85 -135.8 136.65 40.86 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.506 1.128 . . . . 0.0 111.006 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 319' ' ' LEU . 22.1 m-85 -125.98 127.49 46.0 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.117 . . . . 0.0 110.998 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.611 HG22 HD12 ' A' ' 319' ' ' LEU . 13.7 t -83.96 135.03 25.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.481 1.113 . . . . 0.0 109.319 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.441 HG12 ' HG2' ' A' ' 277' ' ' GLU . 40.3 t -111.75 -49.42 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.492 1.12 . . . . 0.0 109.355 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.581 ' O ' HG13 ' A' ' 317' ' ' VAL . 7.8 mm-40 -139.67 137.96 35.65 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.52 1.137 . . . . 0.0 110.337 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.822 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 112.75 -175.47 16.82 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.491 1.12 . . . . 0.0 111.003 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 290' ' ' LEU . 3.6 m -131.17 120.26 23.05 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.497 0.763 . . . . 0.0 109.964 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.452 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 28.9 m -99.03 164.67 2.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.505 1.128 . . . . 0.0 109.293 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 281' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 31.6 t -131.97 148.13 52.5 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.476 1.11 . . . . 0.0 110.017 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -111.26 129.93 65.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.44 1.087 . . . . 0.0 109.295 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.502 ' HB2' HG22 ' A' ' 310' ' ' THR . . . -77.96 101.87 7.08 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.505 1.128 . . . . 0.0 109.306 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' THR . . . . . 0.647 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -147.76 -168.55 0.19 Allowed Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.466 1.104 . . . . 0.0 110.427 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.647 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.4 Cg_endo -74.99 4.89 4.33 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.57 1.826 . . . . 0.0 111.025 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.419 ' O ' HG23 ' A' ' 288' ' ' VAL . 10.9 m120 -151.37 157.29 35.01 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.496 1.123 . . . . 0.0 109.271 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.1 93.85 0.97 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.51 1.795 . . . . 0.0 110.98 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 281' ' ' SER . 4.1 t -97.94 119.37 45.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.115 . . . . 0.0 109.293 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.565 ' C ' HD22 ' A' ' 290' ' ' LEU . 15.4 mt-10 -124.7 140.25 53.11 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.557 1.161 . . . . 0.0 110.315 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.565 HD22 ' C ' ' A' ' 289' ' ' GLU . 4.5 mm? -121.81 141.71 50.95 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.505 1.128 . . . . 0.0 109.304 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -96.9 -160.06 31.69 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.498 1.124 . . . . 0.0 111.038 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' PRO . . . . . 0.481 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.2 Cg_endo -75.03 142.02 27.24 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.478 1.778 . . . . 0.0 110.982 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 91.46 4.39 68.19 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.508 1.13 . . . . 0.0 111.002 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -92.04 127.76 37.63 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.436 0.727 . . . . 0.0 109.293 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.454 ' CB ' ' CD1' ' A' ' 274' ' ' PHE . 2.4 p90 -114.36 152.8 30.9 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.468 1.105 . . . . 0.0 110.979 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.681 ' HZ ' HG21 ' A' ' 262' ' ' ILE . 33.7 p90 -158.07 148.75 20.67 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.534 1.146 . . . . 0.0 111.018 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 123.54 -5.64 9.25 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.474 1.109 . . . . 0.0 110.955 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -55.83 -46.31 78.14 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.504 0.767 . . . . 0.0 110.305 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 36.9 mmt -51.89 -37.14 51.21 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 0.0 110.984 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' ALA . . . . . 0.44 ' HB1' ' CA ' ' A' ' 269' ' ' GLY . . . -67.42 -41.27 85.11 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.489 1.118 . . . . 0.0 109.278 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.857 HD11 ' HB2' ' A' ' 272' ' ' MET . 1.5 mt -77.32 -11.32 59.82 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.563 1.164 . . . . 0.0 109.331 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 302' ' ' ILE . . . . . 0.5 HD13 ' HA ' ' A' ' 302' ' ' ILE . 7.0 mm -77.17 -56.09 8.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.483 1.114 . . . . 0.0 109.272 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.46 ' O ' ' N ' ' A' ' 305' ' ' GLU . 53.2 p -151.32 48.37 0.83 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.458 1.099 . . . . 0.0 110.026 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 303' ' ' SER . . . 35.08 34.22 0.05 OUTLIER Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.574 1.172 . . . . 0.0 110.991 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 305' ' ' GLU . . . . . 0.46 ' N ' ' O ' ' A' ' 303' ' ' SER . 0.0 OUTLIER -70.24 151.52 95.84 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.522 0.778 . . . . 0.0 110.297 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 134.15 17.46 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.477 1.777 . . . . 0.0 110.991 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -44.39 -42.47 6.94 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.468 1.105 . . . . 0.0 110.322 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 2.2 t 67.35 28.56 7.84 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 0.0 110.009 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . -176.61 160.55 2.01 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.447 1.092 . . . . 0.0 109.282 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.502 HG22 ' HB2' ' A' ' 283' ' ' ALA . 0.3 OUTLIER -108.59 123.64 49.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.512 1.132 . . . . 0.0 110.392 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.806 HG12 HD12 ' A' ' 262' ' ' ILE . 43.5 t -103.17 130.31 53.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.52 1.138 . . . . 0.0 109.298 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 56.9 p -134.94 157.42 46.94 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.463 1.102 . . . . 0.0 109.993 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' ALA . . . . . 0.505 ' CB ' HG12 ' A' ' 256' ' ' VAL . . . -95.52 116.13 28.39 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.457 1.098 . . . . 0.0 109.299 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -60.22 -33.42 72.23 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.496 1.123 . . . . 0.0 109.276 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' THR . . . . . 0.831 ' O ' HG23 ' A' ' 317' ' ' VAL . 10.2 t -149.77 -173.49 4.43 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.436 1.085 . . . . 0.0 110.403 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 316' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 316' ' ' THR . 43.8 p -53.76 88.18 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.513 1.133 . . . . 0.0 110.417 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.834 HG12 ' CD1' ' A' ' 319' ' ' LEU . 57.8 t -107.56 145.82 14.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.533 1.145 . . . . 0.0 109.257 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 318' ' ' SER . . . . . 0.741 ' C ' HD13 ' A' ' 319' ' ' LEU . 50.3 m -122.95 118.31 27.53 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.492 1.12 . . . . 0.0 109.982 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 319' ' ' LEU . . . . . 0.834 ' CD1' HG12 ' A' ' 317' ' ' VAL . 0.0 OUTLIER -126.22 175.09 8.04 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.125 . . . . 0.0 109.309 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.705 HD22 HD21 ' A' ' 226' ' ' ASN . 0.5 OUTLIER -124.55 130.95 53.4 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.441 1.088 . . . . 0.0 109.314 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 73.6 p -92.23 157.06 16.89 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 0.0 109.997 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -148.55 92.03 1.96 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.458 1.099 . . . . 0.0 109.293 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' HIS . . . . . 0.461 ' ND1' ' HB3' ' A' ' 325' ' ' ALA . 5.8 p80 -54.61 135.18 46.77 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.534 1.146 . . . . 0.0 109.615 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 3.4 t -53.66 -26.45 22.52 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.505 1.128 . . . . 0.0 109.984 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 0.461 ' HB3' ' ND1' ' A' ' 323' ' ' HIS . . . -50.66 -35.48 30.99 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.546 1.154 . . . . 0.0 109.285 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -64.73 -41.5 95.9 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.517 1.136 . . . . 0.0 109.318 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 327' ' ' PHE . . . . . 0.465 ' CE1' ' CE2' ' A' ' 341' ' ' PHE . 80.3 t80 -67.38 -32.77 73.91 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.467 1.105 . . . . 0.0 111.046 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -70.49 -37.71 74.24 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.469 1.106 . . . . 0.0 110.343 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 16.5 tmm? -67.98 -41.34 82.48 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.467 1.104 . . . . 0.0 111.032 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.649 HD13 ' CG1' ' A' ' 247' ' ' ILE . 6.4 mt -73.23 -35.03 66.22 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.492 1.12 . . . . 0.0 109.284 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 331' ' ' CYS . . . . . 0.812 ' SG ' ' HB2' ' A' ' 338' ' ' ALA . 41.4 t -68.84 -35.19 76.64 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.499 1.125 . . . . 0.0 108.296 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.8 t -72.97 -39.2 66.33 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.127 . . . . 0.0 109.979 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.2 t -73.49 -28.43 61.91 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.503 1.127 . . . . 0.0 109.979 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 334' ' ' SER . . . . . 0.466 ' CB ' HD12 ' A' ' 337' ' ' ILE . 0.5 OUTLIER -128.92 103.78 18.71 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 124.51 1.131 . . . . 0.0 110.016 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -21.64 15.61 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.469 1.773 . . . . 0.0 111.01 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.87 -28.78 60.79 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.539 1.149 . . . . 0.0 110.312 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.638 HD11 HG21 ' A' ' 243' ' ' VAL . 34.4 mt -68.69 -30.84 48.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.126 . . . . 0.0 109.302 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 338' ' ' ALA . . . . . 0.812 ' HB2' ' SG ' ' A' ' 331' ' ' CYS . . . -69.81 -37.54 76.29 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.476 1.11 . . . . 0.0 109.34 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -72.87 -36.73 67.45 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.458 1.099 . . . . 0.0 110.326 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 31.1 mt -71.68 -42.71 71.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.445 1.091 . . . . 0.0 109.305 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.465 ' CE2' ' CE1' ' A' ' 327' ' ' PHE . 40.2 t80 -66.95 -36.88 83.22 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.45 1.094 . . . . 0.0 111.04 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -72.94 -34.79 66.77 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.489 1.118 . . . . 0.0 110.269 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -50.75 65.3 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.511 1.132 . . . . 0.0 109.344 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 344' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 341' ' ' PHE . 8.8 t -65.13 -38.0 89.22 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.498 1.124 . . . . 0.0 110.372 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -67.17 -35.74 80.31 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.536 1.147 . . . . 0.0 109.301 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.508 ' HA ' HD23 ' A' ' 346' ' ' LEU . 9.3 mt -71.48 -33.87 69.66 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.492 1.12 . . . . 0.0 109.317 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.6 -34.73 70.13 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.531 1.145 . . . . 0.0 110.285 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 39.0 mtt-85 . . . . . 0 C--N 1.325 -0.467 0 O-C-N 124.48 1.112 . . . . 0.0 110.328 179.975 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 35.0 t80 . . . . . 0 N--CA 1.453 -0.307 0 CA-C-O 120.474 0.178 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.86 -36.56 52.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.532 1.145 . . . . 0.0 109.309 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.659 ' HD2' HG13 ' A' ' 276' ' ' VAL . 0.0 OUTLIER -67.48 -37.05 82.3 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.511 1.132 . . . . 0.0 110.296 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.823 ' O ' HG23 ' A' ' 230' ' ' VAL . 0.1 OUTLIER -76.37 -30.64 57.63 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.551 1.157 . . . . 0.0 109.29 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 227' ' ' TRP . . . . . 0.866 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 3.0 t90 -66.31 -45.59 79.84 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.485 1.116 . . . . 0.0 108.019 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.628 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 6.4 pt20 -71.27 -34.82 71.06 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.517 1.135 . . . . 0.0 110.35 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.547 HD21 ' HA2' ' A' ' 293' ' ' GLY . 0.3 OUTLIER -63.56 -48.49 77.24 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.482 1.114 . . . . 0.0 109.267 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 226' ' ' ASN . 38.3 t -69.89 -43.08 79.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.432 1.082 . . . . 0.0 109.271 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.34 -16.63 63.01 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.476 1.11 . . . . 0.0 109.309 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.628 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -80.67 -19.32 45.5 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.448 1.092 . . . . 0.0 109.332 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 229' ' ' LEU . 84.4 t -81.25 137.02 49.17 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.485 1.116 . . . . 0.0 109.276 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.468 ' HD2' HG13 ' A' ' 233' ' ' VAL . 18.3 Cg_endo -75.01 -40.32 0.93 Allowed 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.59 1.837 . . . . 0.0 111.001 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.659 HD12 ' HB2' ' A' ' 298' ' ' GLU . 11.0 mt -60.81 -15.48 30.42 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.444 1.09 . . . . 0.0 109.333 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' PHE . . . . . 0.649 ' CE1' HD13 ' A' ' 247' ' ' ILE . 1.4 m-85 -106.56 -22.94 12.61 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.51 1.131 . . . . 0.0 110.959 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' GLN . . . . . 0.404 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 0.4 OUTLIER -64.1 -18.73 64.69 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.483 1.115 . . . . 0.0 110.362 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -75.15 -9.67 58.76 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.498 1.124 . . . . 0.0 109.252 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.71 HD13 HG11 ' A' ' 243' ' ' VAL . 12.0 mt -96.66 -179.19 4.51 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.493 1.12 . . . . 0.0 109.325 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' GLY . . . . . 0.419 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -100.99 -173.56 29.0 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.487 1.117 . . . . 0.0 110.976 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.849 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.3 Cg_endo -74.97 -34.47 3.83 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.474 1.776 . . . . 0.0 110.98 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.96 -36.41 80.03 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.502 1.126 . . . . 0.0 109.311 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.71 HG11 HD13 ' A' ' 239' ' ' LEU . 3.0 t -72.64 -42.83 62.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.53 1.144 . . . . 0.0 109.296 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.76 ' CD1' HG12 ' A' ' 230' ' ' VAL . 0.9 OUTLIER -66.37 -37.68 85.83 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.502 1.126 . . . . 0.0 109.287 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.866 HG22 ' CZ2' ' A' ' 227' ' ' TRP . 53.6 t -66.11 -42.94 92.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.497 1.123 . . . . 0.0 109.287 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.59 -45.24 87.81 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.507 1.129 . . . . 0.0 110.302 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.649 HD13 ' CE1' ' A' ' 236' ' ' PHE . 38.3 mt -62.93 -45.41 98.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.439 1.087 . . . . 0.0 109.259 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 244' ' ' LEU . 45.6 t -62.8 -33.39 59.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 0.0 109.297 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -77.34 -19.48 56.26 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.514 1.134 . . . . 0.0 110.277 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -95.91 2.86 53.86 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.469 1.106 . . . . 0.0 109.308 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.17 148.31 25.23 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.524 1.14 . . . . 0.0 109.328 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.34 126.82 50.39 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.512 1.132 . . . . 0.0 110.265 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.481 ' HB2' HD23 ' A' ' 320' ' ' LEU . . . -83.26 122.75 28.83 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.509 1.131 . . . . 0.0 109.318 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.57 134.79 47.93 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.49 1.119 . . . . 0.0 110.289 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 52.3 m -93.46 121.05 34.46 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.505 1.128 . . . . 0.0 110.414 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.871 HG21 HD11 ' A' ' 319' ' ' LEU . 92.2 t -106.79 113.72 62.49 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.513 1.133 . . . . 0.0 109.329 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.497 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.98 173.48 14.43 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.44 1.758 . . . . 0.0 110.976 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.584 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -66.06 131.04 45.27 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.506 1.128 . . . . 0.0 109.322 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 94.24 -25.52 21.93 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.537 1.148 . . . . 0.0 110.969 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.497 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -57.92 146.28 32.75 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.518 0.775 . . . . 0.0 109.302 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.433 HG21 HH21 ' A' ' 264' ' ' ARG . 3.7 t -97.33 131.58 43.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.486 1.116 . . . . 0.0 109.301 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.775 HD12 HG12 ' A' ' 311' ' ' VAL . 67.9 mt -84.44 -42.27 16.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.5 1.125 . . . . 0.0 109.281 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' CYS . . . . . 0.491 ' SG ' HG23 ' A' ' 311' ' ' VAL . 14.0 p -157.5 148.91 21.82 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.492 1.12 . . . . 0.0 108.311 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 264' ' ' ARG . . . . . 0.433 HH21 HG21 ' A' ' 261' ' ' VAL . 3.3 mmt85 -88.16 179.85 6.3 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.484 1.115 . . . . 0.0 110.315 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.507 HG23 ' CB ' ' A' ' 310' ' ' THR . 0.0 OUTLIER -77.96 140.07 17.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.447 1.092 . . . . 0.0 109.301 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 47.78 50.1 20.89 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.498 1.123 . . . . 0.0 111.012 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.448 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.0 OUTLIER -70.75 164.06 58.8 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.451 0.736 . . . . 0.0 110.301 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.448 ' HD2' ' HB2' ' A' ' 267' ' ' GLU . 18.1 Cg_endo -75.01 91.78 1.01 Allowed 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.474 1.776 . . . . 0.0 110.942 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -43.93 94.4 0.01 OUTLIER Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.489 1.118 . . . . 0.0 110.945 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 268' ' ' PRO . 0.5 OUTLIER -170.2 38.28 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.471 0.748 . . . . 0.0 109.286 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ARG . . . . . 0.402 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 6.0 mtt180 -170.34 145.17 2.64 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.483 1.115 . . . . 0.0 110.313 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 272' ' ' MET . . . . . 0.739 ' HB2' HD11 ' A' ' 301' ' ' LEU . 12.1 ttt -117.96 147.28 43.31 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.527 1.142 . . . . 0.0 110.964 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.569 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 56.9 m-85 -136.28 136.52 39.87 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.531 1.145 . . . . 0.0 110.998 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 274' ' ' PHE . . . . . 0.472 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 20.5 m-85 -125.71 134.3 51.84 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.495 1.122 . . . . 0.0 111.009 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.586 HG22 HD23 ' A' ' 319' ' ' LEU . 4.5 t -91.94 129.76 42.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.517 1.135 . . . . 0.0 109.323 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.659 HG13 ' HD2' ' A' ' 225' ' ' ARG . 13.9 t -105.63 -44.02 7.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.515 1.134 . . . . 0.0 109.307 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.64 ' O ' HG13 ' A' ' 317' ' ' VAL . 0.0 OUTLIER -148.84 134.33 18.6 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.139 . . . . 0.0 110.308 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.849 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 121.06 178.65 15.95 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.44 1.087 . . . . 0.0 111.042 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 314' ' ' ALA . 3.3 m -124.15 114.96 20.35 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.532 0.783 . . . . 0.0 109.974 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.472 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 25.5 m -96.73 163.33 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.492 1.12 . . . . 0.0 109.35 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 281' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 30.5 t -129.25 154.64 46.62 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.453 1.096 . . . . 0.0 110.032 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.24 130.04 73.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.519 1.137 . . . . 0.0 109.271 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.61 ' HB3' ' H ' ' A' ' 310' ' ' THR . . . -77.46 102.15 6.75 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.475 1.11 . . . . 0.0 109.269 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' THR . . . . . 0.644 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.51 -168.67 0.19 Allowed Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.492 1.12 . . . . 0.0 110.413 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.644 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.3 Cg_endo -74.96 4.33 4.82 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.527 1.804 . . . . 0.0 110.993 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -151.84 157.75 34.27 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.526 1.141 . . . . 0.0 109.282 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 94.26 0.96 Allowed 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.464 1.771 . . . . 0.0 110.995 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 281' ' ' SER . 21.2 t -98.34 119.42 46.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.517 1.136 . . . . 0.0 109.334 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.562 ' C ' HD22 ' A' ' 290' ' ' LEU . 14.7 mt-10 -124.1 140.83 52.59 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 0.0 110.306 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.562 HD22 ' C ' ' A' ' 289' ' ' GLU . 4.5 mm? -121.38 141.02 51.37 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.498 1.124 . . . . 0.0 109.3 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -93.97 -157.25 32.94 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.521 1.138 . . . . 0.0 110.95 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' PRO . . . . . 0.469 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.1 Cg_endo -75.02 148.8 35.68 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.511 1.795 . . . . 0.0 111.01 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.547 ' HA2' HD21 ' A' ' 229' ' ' LEU . . . 83.0 5.9 88.86 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.498 1.124 . . . . 0.0 111.018 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -86.68 122.76 31.03 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.511 0.771 . . . . 0.0 109.328 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -114.86 153.18 30.92 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 0.0 110.954 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.569 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 32.7 p90 -163.29 149.65 12.1 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.535 1.147 . . . . 0.0 111.004 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 129.57 -9.74 6.13 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.539 1.149 . . . . 0.0 110.986 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' GLU . . . . . 0.659 ' HB2' HD12 ' A' ' 235' ' ' LEU . 12.1 pt-20 -52.36 -45.26 65.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.548 0.793 . . . . 0.0 110.29 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 299' ' ' MET . . . . . 0.418 ' N ' ' HG3' ' A' ' 298' ' ' GLU . 0.1 OUTLIER -52.4 -38.3 58.64 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.546 1.154 . . . . 0.0 111.039 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 300' ' ' ALA . . . . . 0.441 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -67.64 -38.16 83.46 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.498 1.123 . . . . 0.0 109.284 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.739 HD11 ' HB2' ' A' ' 272' ' ' MET . 0.8 OUTLIER -76.57 -14.39 60.01 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.485 1.116 . . . . 0.0 109.333 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 302' ' ' ILE . . . . . 0.417 ' HA ' ' CE2' ' A' ' 341' ' ' PHE . 11.0 mm -76.79 -55.5 10.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.49 1.119 . . . . 0.0 109.332 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 304' ' ' GLY . 0.5 OUTLIER -153.78 42.16 0.54 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.422 1.076 . . . . 0.0 110.011 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 35.82 43.09 0.58 Allowed Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.48 1.113 . . . . 0.0 111.012 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.17 157.61 88.1 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.549 0.793 . . . . 0.0 110.306 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 129.61 12.45 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.547 1.814 . . . . 0.0 110.968 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -43.92 -36.7 2.53 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.457 1.098 . . . . 0.0 110.272 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 8.0 t 66.75 23.16 10.19 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.49 1.119 . . . . 0.0 109.996 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 309' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . -179.11 160.93 1.09 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 0.0 109.318 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.61 ' H ' ' HB3' ' A' ' 283' ' ' ALA . 0.8 OUTLIER -108.55 137.33 46.67 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.5 1.125 . . . . 0.0 110.395 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.775 HG12 HD12 ' A' ' 262' ' ' ILE . 57.5 t -110.87 131.05 63.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.525 1.14 . . . . 0.0 109.31 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 96.5 p -130.19 153.95 48.04 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.524 1.14 . . . . 0.0 109.992 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -94.46 107.26 19.24 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.521 1.138 . . . . 0.0 109.312 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 279' ' ' SER . . . -50.75 -33.4 22.95 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.48 1.112 . . . . 0.0 109.305 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 315' ' ' THR . . . . . 0.633 ' O ' HG23 ' A' ' 317' ' ' VAL . 9.8 t -148.28 -170.03 3.49 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.486 1.116 . . . . 0.0 110.388 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 316' ' ' THR . . . . . 0.448 ' N ' ' OG1' ' A' ' 315' ' ' THR . 0.0 OUTLIER -61.37 78.08 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.532 1.145 . . . . 0.0 110.373 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.849 HG22 ' HA3' ' A' ' 278' ' ' GLY . 44.5 t -94.65 140.18 17.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.481 1.113 . . . . 0.0 109.275 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 49.3 m -111.16 117.57 33.59 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.502 1.126 . . . . 0.0 110.0 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' LEU . . . . . 0.871 HD11 HG21 ' A' ' 256' ' ' VAL . 0.1 OUTLIER -128.67 173.18 10.53 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.486 1.116 . . . . 0.0 109.302 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.811 HD13 ' ND2' ' A' ' 226' ' ' ASN . 0.7 OUTLIER -124.46 133.85 53.23 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.554 1.159 . . . . 0.0 109.269 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 19.9 t -96.09 157.57 15.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.527 1.142 . . . . 0.0 110.001 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.789 HD21 ' CB ' ' A' ' 326' ' ' ASP . 1.4 tm? -150.01 103.67 3.22 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.436 1.085 . . . . 0.0 109.34 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 323' ' ' HIS . . . . . 0.687 ' CD2' ' HB3' ' A' ' 325' ' ' ALA . 0.0 OUTLIER -62.15 138.35 58.39 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.478 1.111 . . . . 0.0 109.587 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 22.8 t -54.21 -22.36 11.33 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.549 1.156 . . . . 0.0 109.973 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 0.687 ' HB3' ' CD2' ' A' ' 323' ' ' HIS . . . -52.59 -36.61 56.53 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.457 1.098 . . . . 0.0 109.28 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 326' ' ' ASP . . . . . 0.789 ' CB ' HD21 ' A' ' 322' ' ' LEU . 8.0 t70 -63.77 -46.15 86.55 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.475 1.109 . . . . 0.0 109.299 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 327' ' ' PHE . . . . . 0.578 ' CG ' HD23 ' A' ' 301' ' ' LEU . 20.1 t80 -65.41 -31.17 72.13 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.503 1.127 . . . . 0.0 111.049 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -70.71 -32.36 69.53 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.523 1.14 . . . . 0.0 110.334 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.494 ' O ' ' CB ' ' A' ' 333' ' ' SER . 37.1 ttp -74.5 -37.49 63.1 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.536 1.147 . . . . 0.0 110.998 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.633 HD12 HG13 ' A' ' 243' ' ' VAL . 0.1 OUTLIER -72.5 -42.52 64.75 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 0.0 109.273 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 331' ' ' CYS . . . . . 0.803 ' SG ' ' HB2' ' A' ' 338' ' ' ALA . 26.1 t -66.04 -45.13 82.51 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 0.0 108.318 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 44.4 t -73.3 -22.84 60.26 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.509 1.131 . . . . 0.0 110.031 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 329' ' ' MET . 9.1 t -78.43 -39.44 38.78 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.438 1.086 . . . . 0.0 109.977 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.24 121.6 20.62 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.13 . . . . 0.0 110.05 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 -26.15 11.25 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.535 1.808 . . . . 0.0 111.028 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.74 -29.18 69.66 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.484 1.115 . . . . 0.0 110.274 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.67 HD11 HG21 ' A' ' 243' ' ' VAL . 96.9 mt -74.59 -35.89 39.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.534 1.146 . . . . 0.0 109.294 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 338' ' ' ALA . . . . . 0.803 ' HB2' ' SG ' ' A' ' 331' ' ' CYS . . . -68.0 -43.54 78.63 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.51 1.131 . . . . 0.0 109.311 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -69.21 -35.33 76.09 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.475 1.109 . . . . 0.0 110.322 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 17.3 mt -70.94 -41.51 77.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.515 1.134 . . . . 0.0 109.27 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.475 ' CE2' ' O ' ' A' ' 301' ' ' LEU . 27.8 t80 -67.73 -34.7 77.36 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.472 1.107 . . . . 0.0 111.02 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -72.48 -37.02 68.57 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.538 1.149 . . . . 0.0 110.294 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.59 -51.81 60.79 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.505 1.128 . . . . 0.0 109.316 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 9.9 t -65.91 -38.86 89.8 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.475 1.109 . . . . 0.0 110.362 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -68.52 -34.83 76.55 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.527 1.142 . . . . 0.0 109.283 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' A' ' 346' ' ' LEU . 12.0 mt -68.64 -36.85 79.15 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.489 1.118 . . . . 0.0 109.328 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.05 -35.67 69.39 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.462 1.101 . . . . 0.0 110.262 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.474 1.109 . . . . 0.0 110.265 -179.971 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 50.7 t80 . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 120.499 0.19 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.16 -40.98 78.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.522 1.139 . . . . 0.0 109.27 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.823 ' HG2' HG13 ' A' ' 276' ' ' VAL . 0.0 OUTLIER -67.13 -29.39 69.1 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.529 1.143 . . . . 0.0 110.303 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.754 ' OD1' HD13 ' A' ' 320' ' ' LEU . 4.9 t30 -79.24 -30.88 43.39 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.496 1.123 . . . . 0.0 109.322 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' TRP . . . . . 0.546 ' HA ' HG21 ' A' ' 248' ' ' VAL . 2.6 t90 -70.64 -46.65 62.91 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 4.5 pt20 -68.12 -31.87 71.77 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 0.0 110.263 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 3.5 mt -64.36 -45.59 87.11 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 0.0 109.257 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.568 HG23 ' CD1' ' A' ' 244' ' ' LEU . 33.1 m -73.55 -36.63 48.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.464 1.103 . . . . 0.0 109.328 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -74.98 -15.55 60.66 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.522 1.139 . . . . 0.0 109.245 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -80.83 -1.87 44.94 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.511 1.132 . . . . 0.0 109.322 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 4.9 t -101.03 118.85 59.58 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.501 1.126 . . . . 0.0 109.276 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 -17.92 19.04 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.494 1.787 . . . . 0.0 110.989 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.684 HD23 ' CZ ' ' A' ' 348' ' ' ARG . 0.1 OUTLIER -65.06 -29.46 70.35 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.574 1.171 . . . . 0.0 109.302 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 236' ' ' PHE . . . . . 0.415 ' HB3' HD12 ' A' ' 239' ' ' LEU . 15.4 m-85 -113.74 19.76 16.44 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.44 1.087 . . . . 0.0 111.0 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.22 -23.43 62.01 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.515 1.134 . . . . 0.0 110.345 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 50.0 mmtt -80.2 0.7 31.35 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.456 1.097 . . . . 0.0 109.295 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.776 HD13 HG11 ' A' ' 243' ' ' VAL . 15.1 mt -82.13 175.18 10.53 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.542 1.151 . . . . 0.0 109.29 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -107.73 -173.8 22.17 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.478 1.111 . . . . 0.0 110.981 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.94 -33.66 4.5 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.46 1.769 . . . . 0.0 111.051 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.5 ' HA ' HG12 ' A' ' 245' ' ' VAL . . . -71.22 -31.97 68.23 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.482 1.114 . . . . 0.0 109.318 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.776 HG11 HD13 ' A' ' 239' ' ' LEU . 4.8 t -75.9 -42.17 39.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.486 1.116 . . . . 0.0 109.272 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.568 ' CD1' HG23 ' A' ' 230' ' ' VAL . 0.6 OUTLIER -67.24 -46.22 74.42 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.476 1.11 . . . . 0.0 109.289 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' A' ' 242' ' ' ALA . 2.8 p -65.05 -45.14 95.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.497 1.123 . . . . 0.0 109.273 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.405 ' N ' ' CG1' ' A' ' 245' ' ' VAL . 4.9 tp10 -64.87 -36.12 83.33 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.114 . . . . 0.0 110.325 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.502 HD12 HG12 ' A' ' 243' ' ' VAL . 26.4 mt -67.85 -48.0 77.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.514 1.134 . . . . 0.0 109.329 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.546 HG21 ' HA ' ' A' ' 227' ' ' TRP . 55.2 t -63.26 -33.07 58.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.123 . . . . 0.0 109.323 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.1 mmm180 -74.61 -25.13 59.04 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.434 1.084 . . . . 0.0 110.294 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.458 ' HB3' ' OD1' ' A' ' 326' ' ' ASP . . . -87.15 -18.54 30.18 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.481 1.113 . . . . 0.0 109.344 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.82 146.16 54.72 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.575 1.172 . . . . 0.0 109.321 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -120.54 135.08 55.19 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 0.0 110.368 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -80.57 122.4 27.0 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.459 1.099 . . . . 0.0 109.262 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.7 ttm-85 -124.25 121.95 36.43 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.543 1.152 . . . . 0.0 110.276 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.6 m -91.28 117.81 29.96 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 0.0 110.373 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.576 HG21 HD11 ' A' ' 319' ' ' LEU . 69.3 t -106.69 112.02 63.71 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.461 1.101 . . . . 0.0 109.329 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.516 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.97 173.65 14.14 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.472 1.775 . . . . 0.0 111.023 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.524 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -67.51 131.33 45.44 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.488 1.117 . . . . 0.0 109.263 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 93.27 -25.39 20.59 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 124.556 1.16 . . . . 0.0 110.984 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.516 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -61.07 149.04 38.31 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.52 0.776 . . . . 0.0 109.332 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.2 t -97.47 131.35 44.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.483 1.114 . . . . 0.0 109.324 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.774 HD12 HG12 ' A' ' 311' ' ' VAL . 43.3 mt -83.9 -40.09 15.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.53 1.144 . . . . 0.0 109.308 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' CYS . . . . . 0.405 ' SG ' HG23 ' A' ' 311' ' ' VAL . 13.8 p -156.12 150.71 25.89 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.503 1.127 . . . . 0.0 108.276 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 264' ' ' ARG . . . . . 0.402 ' HA ' ' OG1' ' A' ' 310' ' ' THR . 16.6 mmt180 -94.42 179.67 5.21 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.566 1.166 . . . . 0.0 110.339 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.51 HG23 ' OG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -77.49 140.34 17.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.467 1.104 . . . . 0.0 109.326 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 46.54 52.71 10.64 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.5 1.125 . . . . 0.0 111.045 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.458 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.2 OUTLIER -71.03 168.08 23.86 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.548 0.793 . . . . 0.0 110.357 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 267' ' ' GLU . 18.4 Cg_endo -74.98 88.49 1.23 Allowed 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.458 1.767 . . . . 0.0 111.005 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 269' ' ' GLY . . . . . 0.401 ' O ' ' CA ' ' A' ' 304' ' ' GLY . . . -45.23 93.5 0.01 OUTLIER Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.553 1.158 . . . . 0.0 110.988 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 268' ' ' PRO . 0.6 OUTLIER -170.47 36.68 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.51 0.771 . . . . 0.0 109.345 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -173.35 162.27 4.32 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.566 1.166 . . . . 0.0 110.295 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' MET . . . . . 0.471 ' CE ' ' CZ ' ' A' ' 274' ' ' PHE . 9.3 ptm -145.84 146.66 31.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.538 1.149 . . . . 0.0 110.996 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.566 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 33.2 m-85 -128.37 154.08 46.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.484 1.115 . . . . 0.0 111.017 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 274' ' ' PHE . . . . . 0.505 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 23.6 m-85 -129.87 137.37 50.39 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.481 1.113 . . . . 0.0 111.017 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.58 HG12 ' HA ' ' A' ' 292' ' ' PRO . 42.7 t -90.71 136.72 23.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.52 1.137 . . . . 0.0 109.295 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.823 HG13 ' HG2' ' A' ' 225' ' ' ARG . 39.8 t -116.03 -43.78 3.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.535 1.147 . . . . 0.0 109.326 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -146.61 136.74 23.55 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.517 1.136 . . . . 0.0 110.272 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.95 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 114.46 -173.22 14.72 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.502 1.126 . . . . 0.0 111.004 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 3.2 m -134.9 119.92 18.65 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.539 0.788 . . . . 0.0 109.989 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.421 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 16.5 m -99.0 165.82 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.499 1.125 . . . . 0.0 109.323 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 30.5 t -131.52 154.97 48.23 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.504 1.128 . . . . 0.0 110.009 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.429 HG13 HG22 ' A' ' 311' ' ' VAL . 0.7 OUTLIER -118.92 131.21 72.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.503 1.127 . . . . 0.0 109.306 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -79.41 102.03 8.48 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 0.0 109.325 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' THR . . . . . 0.655 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.18 -168.25 0.18 Allowed Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.525 1.14 . . . . 0.0 110.391 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.655 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -75.04 4.48 4.72 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.566 1.824 . . . . 0.0 110.964 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.411 ' O ' HG23 ' A' ' 288' ' ' VAL . 35.2 m120 -151.75 157.2 34.59 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.548 1.155 . . . . 0.0 109.263 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.06 95.36 0.98 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.472 1.775 . . . . 0.0 110.937 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 281' ' ' SER . 4.6 t -99.39 119.23 47.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.47 1.106 . . . . 0.0 109.263 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 15.8 mt-10 -124.44 135.85 53.58 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.426 1.079 . . . . 0.0 110.29 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.506 HD12 ' CB ' ' A' ' 294' ' ' ALA . 3.9 mm? -115.11 142.11 47.1 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.451 1.095 . . . . 0.0 109.307 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -98.79 -161.24 29.82 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.494 1.121 . . . . 0.0 110.983 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' PRO . . . . . 0.58 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.2 Cg_endo -75.0 145.88 31.98 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.491 1.785 . . . . 0.0 110.999 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 88.09 4.63 77.9 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.459 1.099 . . . . 0.0 110.95 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' ALA . . . . . 0.506 ' CB ' HD12 ' A' ' 290' ' ' LEU . . . -91.25 127.77 36.81 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.501 0.765 . . . . 0.0 109.315 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.451 ' HB3' ' CD1' ' A' ' 274' ' ' PHE . 1.2 p90 -116.34 153.38 32.09 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.52 1.138 . . . . 0.0 110.987 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 48.1 p90 -161.63 146.38 13.19 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.452 1.095 . . . . 0.0 110.977 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 297' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 300' ' ' ALA . . . 129.66 -9.99 6.09 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 124.527 1.142 . . . . 0.0 111.001 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -52.77 -51.21 61.54 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.457 0.74 . . . . 0.0 110.295 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.2 mmt -50.48 -32.89 19.37 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.523 1.139 . . . . 0.0 111.008 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 297' ' ' GLY . . . -68.85 -42.64 76.84 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.535 1.147 . . . . 0.0 109.337 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.458 HD11 ' SD ' ' A' ' 272' ' ' MET . 6.0 mt -75.01 -11.68 60.16 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.475 1.109 . . . . 0.0 109.283 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 302' ' ' ILE . . . . . 0.482 HD13 ' CZ ' ' A' ' 341' ' ' PHE . 14.5 mm -77.83 -56.63 7.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.484 1.115 . . . . 0.0 109.291 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 304' ' ' GLY . 2.4 m -151.46 42.57 0.74 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.445 1.091 . . . . 0.0 110.0 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 34.93 51.21 0.82 Allowed Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.462 1.101 . . . . 0.0 110.969 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.58 151.34 80.15 Favored Pre-proline 0 C--N 1.326 -0.436 0 O-C-N 124.524 0.779 . . . . 0.0 110.33 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 130.29 13.11 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.461 1.769 . . . . 0.0 110.955 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -44.04 -33.09 1.34 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.536 1.147 . . . . 0.0 110.301 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 59.38 15.9 4.73 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.525 1.14 . . . . 0.0 109.989 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . -170.15 160.75 8.17 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.544 1.153 . . . . 0.0 109.333 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.51 ' OG1' HG23 ' A' ' 265' ' ' ILE . 0.9 OUTLIER -110.29 139.68 45.23 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.469 1.106 . . . . 0.0 110.42 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.774 HG12 HD12 ' A' ' 262' ' ' ILE . 91.1 t -115.57 131.62 67.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.493 1.121 . . . . 0.0 109.269 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 56.3 p -128.6 153.75 46.92 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.491 1.119 . . . . 0.0 110.018 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' ALA . . . . . 0.418 ' CB ' HG12 ' A' ' 256' ' ' VAL . . . -90.95 114.3 26.75 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.556 1.16 . . . . 0.0 109.286 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -57.73 -35.19 70.34 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.521 1.138 . . . . 0.0 109.304 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' THR . . . . . 0.589 ' O ' HG23 ' A' ' 317' ' ' VAL . 8.7 t -153.96 -173.91 4.76 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.559 1.162 . . . . 0.0 110.424 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 29.0 m -49.9 91.36 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 0.0 110.378 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.95 HG22 ' HA3' ' A' ' 278' ' ' GLY . 41.6 t -106.75 154.54 7.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.53 1.144 . . . . 0.0 109.31 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 69.3 m -129.79 114.93 16.55 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.534 1.146 . . . . 0.0 109.965 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' LEU . . . . . 0.576 HD11 HG21 ' A' ' 256' ' ' VAL . 0.2 OUTLIER -130.43 173.17 11.09 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.484 1.115 . . . . 0.0 109.289 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.754 HD13 ' OD1' ' A' ' 226' ' ' ASN . 0.8 OUTLIER -124.29 136.41 54.11 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.532 1.145 . . . . 0.0 109.29 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.477 ' HB2' ' CE2' ' A' ' 273' ' ' PHE . 36.7 t -96.07 148.53 22.58 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.466 1.104 . . . . 0.0 110.02 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.483 ' O ' HD13 ' A' ' 322' ' ' LEU . 3.0 tm? -146.49 98.54 3.09 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.5 1.125 . . . . 0.0 109.302 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -60.02 146.9 41.02 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.485 1.116 . . . . 0.0 109.582 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 37.8 t -63.68 -13.71 45.39 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.504 1.127 . . . . 0.0 110.02 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -61.67 -27.8 68.94 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.486 1.116 . . . . 0.0 109.331 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 326' ' ' ASP . . . . . 0.458 ' OD1' ' HB3' ' A' ' 250' ' ' ALA . 0.6 OUTLIER -74.66 -39.52 61.99 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.504 1.127 . . . . 0.0 109.277 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 327' ' ' PHE . . . . . 0.483 ' C ' ' CD1' ' A' ' 327' ' ' PHE . 0.8 OUTLIER -70.47 -42.68 71.11 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.504 1.127 . . . . 0.0 110.995 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -67.15 -35.61 80.07 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.512 1.133 . . . . 0.0 110.266 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 17.9 tmm? -66.8 -42.12 86.48 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.515 1.135 . . . . 0.0 110.985 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.443 HD13 ' CG1' ' A' ' 247' ' ' ILE . 5.2 mt -72.51 -37.42 68.38 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.456 1.097 . . . . 0.0 109.307 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 331' ' ' CYS . . . . . 0.642 ' HB3' ' HB2' ' A' ' 338' ' ' ALA . 6.2 m -72.57 -31.64 65.4 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.478 1.111 . . . . 0.0 108.329 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 47.1 t -71.83 -37.91 70.25 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 0.0 109.981 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 42.6 t -72.17 -36.0 69.16 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.464 1.103 . . . . 0.0 109.981 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -123.02 114.32 29.53 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.51 1.131 . . . . 0.0 110.005 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -19.04 18.2 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.537 1.809 . . . . 0.0 111.005 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -72.57 -32.13 65.8 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.548 1.155 . . . . 0.0 110.31 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.474 HG23 ' CD2' ' A' ' 239' ' ' LEU . 77.6 mt -74.87 -44.95 44.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.485 1.116 . . . . 0.0 109.286 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 338' ' ' ALA . . . . . 0.642 ' HB2' ' HB3' ' A' ' 331' ' ' CYS . . . -66.6 -35.33 79.94 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.131 . . . . 0.0 109.338 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 339' ' ' GLU . . . . . 0.478 ' O ' ' CG ' ' A' ' 343' ' ' LYS . 50.2 mm-40 -72.3 -42.78 65.09 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.516 1.135 . . . . 0.0 110.279 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 58.5 mt -68.35 -36.52 75.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.523 1.14 . . . . 0.0 109.256 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.666 ' CE1' HD12 ' A' ' 235' ' ' LEU . 49.7 t80 -69.55 -37.2 76.94 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.101 . . . . 0.0 110.982 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -69.76 -37.99 76.6 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.474 1.109 . . . . 0.0 110.335 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 343' ' ' LYS . . . . . 0.478 ' CG ' ' O ' ' A' ' 339' ' ' GLU . 0.5 OUTLIER -65.0 -50.65 65.45 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.496 1.123 . . . . 0.0 109.344 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 344' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 341' ' ' PHE . 4.5 t -64.83 -32.86 74.76 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.51 1.131 . . . . 0.0 110.4 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -70.07 -39.05 75.85 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.466 1.104 . . . . 0.0 109.29 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.43 ' HA ' HD23 ' A' ' 346' ' ' LEU . 12.6 mt -68.93 -34.04 74.71 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.434 1.084 . . . . 0.0 109.312 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.75 -31.68 61.87 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.467 1.105 . . . . 0.0 110.299 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 348' ' ' ARG . . . . . 0.684 ' CZ ' HD23 ' A' ' 235' ' ' LEU . 7.0 mtt180 . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.535 1.147 . . . . 0.0 110.304 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 14.6 t80 . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 120.498 0.19 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.81 -35.89 44.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.543 1.152 . . . . 0.0 109.289 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.648 ' CD ' HD23 ' A' ' 229' ' ' LEU . 0.0 OUTLIER -69.32 -32.12 71.02 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.559 1.162 . . . . 0.0 110.333 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.677 ' O ' HG23 ' A' ' 230' ' ' VAL . 46.6 t30 -79.89 -30.63 40.19 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.471 1.107 . . . . 0.0 109.256 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' TRP . . . . . 0.866 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 2.5 t90 -67.8 -43.65 79.19 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.538 1.149 . . . . 0.0 107.974 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -71.03 -38.38 72.58 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.585 1.178 . . . . 0.0 110.339 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.651 HD21 ' HA2' ' A' ' 293' ' ' GLY . 1.2 mm? -62.43 -46.25 89.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.146 . . . . 0.0 109.3 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.737 HG12 HD13 ' A' ' 244' ' ' LEU . 59.1 t -72.69 -37.01 54.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.466 1.104 . . . . 0.0 109.316 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -73.5 -15.86 61.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.487 1.117 . . . . 0.0 109.328 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -81.86 -12.74 58.33 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.511 1.132 . . . . 0.0 109.318 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 38.2 t -70.9 132.3 86.86 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.122 . . . . 0.0 109.298 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.407 ' HA ' ' HB2' ' A' ' 237' ' ' GLN . 18.2 Cg_endo -74.98 -30.4 7.23 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.482 1.78 . . . . 0.0 110.979 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 1.059 HD11 HD11 ' A' ' 302' ' ' ILE . 0.7 OUTLIER -68.87 -28.21 66.5 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.447 1.092 . . . . 0.0 109.29 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 236' ' ' PHE . . . . . 0.713 ' CG ' HD12 ' A' ' 239' ' ' LEU . 13.8 m-30 -104.63 14.32 30.04 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.497 1.123 . . . . 0.0 111.016 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' GLN . . . . . 0.407 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 1.4 tt0 -72.17 -26.15 61.97 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.492 1.12 . . . . 0.0 110.286 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.468 ' HB2' ' CG2' ' A' ' 340' ' ' ILE . 6.6 mmpt? -100.47 7.62 44.06 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.528 1.143 . . . . 0.0 109.314 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.713 HD12 ' CG ' ' A' ' 236' ' ' PHE . 16.9 mt -81.51 171.24 14.92 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 0.0 109.258 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' GLY . . . . . 0.583 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -95.16 173.68 31.82 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.51 1.131 . . . . 0.0 110.981 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.928 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.2 Cg_endo -75.05 -35.29 3.19 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.494 1.786 . . . . 0.0 111.015 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.4 -34.66 76.41 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.474 1.109 . . . . 0.0 109.3 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.805 HG21 HD11 ' A' ' 337' ' ' ILE . 25.6 t -74.17 -42.07 51.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.44 1.087 . . . . 0.0 109.301 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.737 HD13 HG12 ' A' ' 230' ' ' VAL . 2.1 mm? -64.81 -34.58 78.68 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.511 1.132 . . . . 0.0 109.293 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.928 HG23 ' O ' ' A' ' 241' ' ' PRO . 70.4 t -70.72 -44.56 76.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.547 1.155 . . . . 0.0 109.311 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -65.3 -31.18 72.18 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.478 1.111 . . . . 0.0 110.293 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 56.0 mt -75.14 -40.54 44.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.451 1.095 . . . . 0.0 109.317 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 244' ' ' LEU . 55.8 t -70.96 -33.32 51.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.503 1.127 . . . . 0.0 109.309 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.427 ' NH1' ' HB3' ' A' ' 249' ' ' ARG . 5.6 mmm180 -78.94 -25.84 43.63 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.471 1.107 . . . . 0.0 110.275 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.446 ' HB1' ' OD2' ' A' ' 326' ' ' ASP . . . -86.87 -21.68 26.21 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.523 1.139 . . . . 0.0 109.332 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.49 152.35 30.31 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.46 1.1 . . . . 0.0 109.339 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -121.13 119.1 31.41 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.495 1.122 . . . . 0.0 110.299 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.755 ' HB2' HD23 ' A' ' 320' ' ' LEU . . . -81.17 122.43 27.37 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.502 1.126 . . . . 0.0 109.298 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.96 142.75 50.38 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.453 1.096 . . . . 0.0 110.299 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 4.5 m -96.64 125.83 41.39 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.517 1.136 . . . . 0.0 110.386 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.517 HG12 ' CB ' ' A' ' 313' ' ' ALA . 86.7 t -106.58 115.73 60.17 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.473 1.108 . . . . 0.0 109.3 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.507 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.5 Cg_endo -74.96 168.41 24.89 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.535 1.808 . . . . 0.0 111.038 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.523 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -66.81 128.5 36.53 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.511 1.132 . . . . 0.0 109.302 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 96.06 -25.57 24.85 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.486 1.116 . . . . 0.0 110.989 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.507 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -64.35 134.1 53.96 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.505 0.767 . . . . 0.0 109.313 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 312' ' ' SER . 2.5 p -90.21 134.98 27.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.485 1.116 . . . . 0.0 109.295 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.822 HD12 HG12 ' A' ' 311' ' ' VAL . 11.3 mt -82.47 -52.6 13.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.121 . . . . 0.0 109.377 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' CYS . . . . . 0.653 ' SG ' HG23 ' A' ' 311' ' ' VAL . 14.0 p -137.48 157.68 46.03 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.511 1.132 . . . . 0.0 108.31 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 1.8 mmt85 -100.98 178.43 4.67 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.58 1.175 . . . . 0.0 110.302 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.559 HD13 ' H ' ' A' ' 265' ' ' ILE . 0.2 OUTLIER -77.74 130.73 35.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.56 1.162 . . . . 0.0 109.308 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 59.9 47.51 90.64 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.533 1.146 . . . . 0.0 111.028 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.417 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.2 OUTLIER -71.53 164.37 58.38 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.473 0.749 . . . . 0.0 110.302 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.449 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.3 Cg_endo -74.96 81.52 2.18 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.469 1.773 . . . . 0.0 111.05 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 269' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 268' ' ' PRO . . . -37.08 95.86 0.01 OUTLIER Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.537 1.148 . . . . 0.0 111.039 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 268' ' ' PRO . 51.5 m-20 -170.45 38.67 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.507 0.769 . . . . 0.0 109.288 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ARG . . . . . 0.471 ' HD3' ' CE1' ' A' ' 273' ' ' PHE . 3.8 ttm180 -170.78 151.83 3.55 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.505 1.128 . . . . 0.0 110.298 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' MET . . . . . 0.522 ' SD ' HD11 ' A' ' 301' ' ' LEU . 3.4 ttt -121.5 155.33 35.17 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.505 1.128 . . . . 0.0 111.031 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.568 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 25.8 m-85 -140.42 136.74 33.37 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.49 1.119 . . . . 0.0 111.006 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 274' ' ' PHE . . . . . 0.402 ' CE2' HG22 ' A' ' 230' ' ' VAL . 20.0 m-85 -128.47 126.84 41.32 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.476 1.11 . . . . 0.0 111.018 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 1.061 HG22 HD22 ' A' ' 319' ' ' LEU . 53.9 t -85.58 132.71 31.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.459 1.1 . . . . 0.0 109.32 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.556 HG21 HD11 ' A' ' 320' ' ' LEU . 48.3 t -107.15 -52.84 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.485 1.116 . . . . 0.0 109.302 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.647 ' O ' HG23 ' A' ' 317' ' ' VAL . 11.0 mt-10 -139.81 137.9 35.37 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.51 1.131 . . . . 0.0 110.254 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.402 ' HA3' ' HB ' ' A' ' 317' ' ' VAL . . . 116.27 -158.0 14.7 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.458 1.099 . . . . 0.0 110.952 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 8.7 t -148.3 134.07 18.95 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.54 0.788 . . . . 0.0 109.998 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 11.3 m -114.02 165.41 9.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.516 1.135 . . . . 0.0 109.283 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 29.3 t -131.59 148.54 52.62 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.529 1.143 . . . . 0.0 109.991 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.468 HG23 HG12 ' A' ' 288' ' ' VAL . 0.6 OUTLIER -110.91 129.79 65.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.461 1.101 . . . . 0.0 109.262 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.546 ' HB2' HG22 ' A' ' 310' ' ' THR . . . -78.52 101.46 7.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.479 1.112 . . . . 0.0 109.32 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' THR . . . . . 0.659 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.9 OUTLIER -147.14 -168.05 0.17 Allowed Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.505 1.128 . . . . 0.0 110.38 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.659 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.6 Cg_endo -74.96 3.98 5.12 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.502 1.791 . . . . 0.0 111.022 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -150.37 157.2 37.03 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.482 1.114 . . . . 0.0 109.302 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.91 94.1 0.95 Allowed 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.493 1.786 . . . . 0.0 110.989 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.468 HG12 HG23 ' A' ' 282' ' ' VAL . 72.1 t -98.09 118.94 45.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.544 1.152 . . . . 0.0 109.29 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.501 ' C ' HD22 ' A' ' 290' ' ' LEU . 13.0 mt-10 -125.11 134.49 52.44 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.443 1.089 . . . . 0.0 110.291 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.501 HD22 ' C ' ' A' ' 289' ' ' GLU . 2.6 mm? -116.73 141.48 48.15 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.536 1.148 . . . . 0.0 109.308 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -95.72 -158.47 32.36 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.518 1.136 . . . . 0.0 110.974 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' PRO . . . . . 0.461 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.3 Cg_endo -75.02 152.63 40.88 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.466 1.772 . . . . 0.0 110.994 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.651 ' HA2' HD21 ' A' ' 229' ' ' LEU . . . 79.66 6.78 88.91 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.501 1.125 . . . . 0.0 110.971 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -88.98 128.71 35.7 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.489 0.758 . . . . 0.0 109.278 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -117.45 153.01 33.84 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.471 1.107 . . . . 0.0 111.005 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.568 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 45.5 p90 -166.28 145.7 5.94 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.512 1.133 . . . . 0.0 111.024 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 297' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 300' ' ' ALA . . . 133.21 -10.53 5.06 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.514 1.133 . . . . 0.0 111.004 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 298' ' ' GLU . . . . . 0.504 ' CD ' HD13 ' A' ' 235' ' ' LEU . 32.8 tt0 -52.75 -53.22 51.05 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.493 0.761 . . . . 0.0 110.242 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -47.58 -35.56 9.32 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.467 1.104 . . . . 0.0 110.99 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 300' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 297' ' ' GLY . . . -68.4 -43.21 77.75 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.513 1.133 . . . . 0.0 109.327 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.522 HD11 ' SD ' ' A' ' 272' ' ' MET . 1.2 mt -77.26 -5.98 51.41 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.498 1.124 . . . . 0.0 109.285 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 302' ' ' ILE . . . . . 1.059 HD11 HD11 ' A' ' 235' ' ' LEU . 8.1 mm -83.37 -53.92 10.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 0.0 109.282 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 304' ' ' GLY . 78.5 p -151.89 43.2 0.72 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.511 1.132 . . . . 0.0 109.968 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 303' ' ' SER . . . 36.16 35.0 0.09 OUTLIER Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.474 1.109 . . . . 0.0 111.009 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 305' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 303' ' ' SER . 0.1 OUTLIER -62.4 151.55 82.36 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.498 0.763 . . . . 0.0 110.318 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 127.57 10.79 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.435 1.755 . . . . 0.0 110.974 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' ARG . . . . . 0.402 ' NE ' ' HG2' ' A' ' 267' ' ' GLU . 0.0 OUTLIER -46.16 -24.9 0.51 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 0.0 110.295 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 43.18 36.85 1.07 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.475 1.11 . . . . 0.0 110.012 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . -177.99 161.07 1.5 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.474 1.108 . . . . 0.0 109.283 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.546 HG22 ' HB2' ' A' ' 283' ' ' ALA . 0.3 OUTLIER -113.89 121.4 43.87 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.472 1.107 . . . . 0.0 110.355 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.822 HG12 HD12 ' A' ' 262' ' ' ILE . 31.5 t -102.69 131.79 50.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.116 . . . . 0.0 109.267 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 312' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 261' ' ' VAL . 6.0 p -136.11 158.29 44.76 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.538 1.149 . . . . 0.0 110.007 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 313' ' ' ALA . . . . . 0.877 ' HB1' HG12 ' A' ' 317' ' ' VAL . . . -88.29 111.86 22.17 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.471 1.107 . . . . 0.0 109.259 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -55.55 -26.34 42.87 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.507 1.129 . . . . 0.0 109.286 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 315' ' ' THR . . . . . 0.694 ' O ' HG12 ' A' ' 317' ' ' VAL . 10.0 t -164.43 -165.08 0.9 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.49 1.119 . . . . 0.0 110.41 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 316' ' ' THR . . . . . 0.418 ' N ' ' OG1' ' A' ' 315' ' ' THR . 31.5 p -60.26 80.7 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.516 1.135 . . . . 0.0 110.426 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.877 HG12 ' HB1' ' A' ' 313' ' ' ALA . 2.5 p -113.0 138.5 42.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.129 . . . . 0.0 109.266 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 318' ' ' SER . . . . . 0.62 ' C ' HD23 ' A' ' 319' ' ' LEU . 49.7 m -107.26 139.05 42.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.556 1.16 . . . . 0.0 109.998 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 319' ' ' LEU . . . . . 1.061 HD22 HG22 ' A' ' 275' ' ' VAL . 0.0 OUTLIER -143.73 173.51 11.61 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.498 1.124 . . . . 0.0 109.306 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.755 HD23 ' HB2' ' A' ' 253' ' ' ALA . 1.2 mp -124.37 133.99 53.26 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.448 1.092 . . . . 0.0 109.308 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 20.9 t -97.99 151.34 20.41 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.469 1.106 . . . . 0.0 109.985 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.457 HD13 ' C ' ' A' ' 322' ' ' LEU . 3.2 tm? -144.8 106.87 4.32 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.494 1.121 . . . . 0.0 109.34 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 323' ' ' HIS . . . . . 0.421 ' CE1' ' HB2' ' A' ' 326' ' ' ASP . 10.2 p80 -66.4 132.99 49.55 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.502 1.126 . . . . 0.0 109.615 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 96.1 p -56.64 -21.95 30.91 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.469 1.106 . . . . 0.0 110.004 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -58.84 -35.47 72.98 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.5 1.125 . . . . 0.0 109.29 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 326' ' ' ASP . . . . . 0.446 ' OD2' ' HB1' ' A' ' 250' ' ' ALA . 23.8 t70 -66.1 -41.05 91.13 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.502 1.126 . . . . 0.0 109.34 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 327' ' ' PHE . . . . . 0.482 ' CD1' ' O ' ' A' ' 327' ' ' PHE . 2.6 t80 -70.53 -29.77 66.34 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.47 1.106 . . . . 0.0 110.998 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -70.92 -45.73 63.74 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.523 1.139 . . . . 0.0 110.319 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.454 ' HG3' ' N ' ' A' ' 330' ' ' LEU . 3.9 ptm -66.47 -34.6 78.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.49 1.119 . . . . 0.0 110.978 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.454 ' N ' ' HG3' ' A' ' 329' ' ' MET . 16.5 mt -72.77 -37.74 67.54 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.486 1.116 . . . . 0.0 109.275 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 331' ' ' CYS . . . . . 0.402 ' O ' ' O ' ' A' ' 334' ' ' SER . 14.2 t -66.26 -41.47 89.85 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.549 1.156 . . . . 0.0 108.336 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.28 -23.36 51.15 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.486 1.116 . . . . 0.0 109.992 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 19.9 t -71.65 -39.33 70.42 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.532 1.145 . . . . 0.0 110.032 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 334' ' ' SER . . . . . 0.402 ' O ' ' O ' ' A' ' 331' ' ' CYS . 0.1 OUTLIER -121.98 131.9 24.34 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.491 1.12 . . . . 0.0 109.957 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -28.5 9.14 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.495 1.787 . . . . 0.0 110.999 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.78 -28.57 67.72 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.477 1.111 . . . . 0.0 110.259 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.805 HD11 HG21 ' A' ' 243' ' ' VAL . 95.7 mt -72.28 -35.77 53.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.486 1.116 . . . . 0.0 109.254 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.22 -33.98 65.64 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.536 1.147 . . . . 0.0 109.309 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -74.54 -42.35 59.0 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.511 1.132 . . . . 0.0 110.272 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.468 ' CG2' ' HB2' ' A' ' 238' ' ' LYS . 43.2 mt -71.7 -40.24 70.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.524 1.14 . . . . 0.0 109.27 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.481 ' CE2' ' CZ ' ' A' ' 327' ' ' PHE . 10.2 t80 -70.04 -34.94 73.89 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.547 1.154 . . . . 0.0 111.009 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.18 -41.47 73.7 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.484 1.115 . . . . 0.0 110.257 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.05 -40.57 71.58 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.498 1.124 . . . . 0.0 109.295 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.1 m -67.46 -42.39 83.12 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.457 1.098 . . . . 0.0 110.403 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -70.87 -35.08 72.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.557 1.161 . . . . 0.0 109.293 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 346' ' ' LEU . 15.8 mt -71.46 -31.99 67.79 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.546 1.154 . . . . 0.0 109.277 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -73.71 -39.02 64.64 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.539 1.149 . . . . 0.0 110.281 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 16.0 mtt-85 . . . . . 0 C--N 1.325 -0.489 0 O-C-N 124.477 1.111 . . . . 0.0 110.349 179.976 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.7 t80 . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.494 0.187 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -71.16 -37.76 67.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.525 1.14 . . . . 0.0 109.27 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.475 ' O ' HD12 ' A' ' 229' ' ' LEU . 0.0 OUTLIER -66.57 -33.14 75.02 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.536 1.147 . . . . 0.0 110.334 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.736 ' O ' HG23 ' A' ' 230' ' ' VAL . 0.3 OUTLIER -79.21 -30.3 43.24 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.471 1.107 . . . . 0.0 109.321 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 227' ' ' TRP . . . . . 0.871 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 3.1 t90 -66.45 -44.44 82.77 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.52 1.137 . . . . 0.0 108.01 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.44 ' HG3' ' N ' ' A' ' 229' ' ' LEU . 7.7 pt20 -71.67 -44.95 63.37 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.533 1.146 . . . . 0.0 110.359 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.678 HD21 ' HA2' ' A' ' 293' ' ' GLY . 0.3 OUTLIER -57.75 -44.76 86.34 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.468 1.105 . . . . 0.0 109.3 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 226' ' ' ASN . 95.7 t -70.34 -38.99 76.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.48 1.113 . . . . 0.0 109.244 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -75.29 -10.18 59.23 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.48 1.113 . . . . 0.0 109.254 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 228' ' ' GLN . . . -80.06 -25.07 40.27 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.451 1.094 . . . . 0.0 109.223 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' VAL . . . . . 0.463 HG13 ' HD2' ' A' ' 234' ' ' PRO . 61.9 t -70.05 138.14 87.32 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.469 1.106 . . . . 0.0 109.298 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.463 ' HD2' HG13 ' A' ' 233' ' ' VAL . 18.3 Cg_endo -75.02 -50.24 0.13 Allowed 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.478 1.778 . . . . 0.0 110.998 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.66 HD11 HD11 ' A' ' 302' ' ' ILE . 18.2 mt -50.84 -37.13 41.28 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.489 1.118 . . . . 0.0 109.275 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -78.88 -21.99 46.64 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.465 1.103 . . . . 0.0 110.979 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' GLN . . . . . 0.444 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -59.12 -22.72 61.31 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.514 1.134 . . . . 0.0 110.282 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -75.11 -23.27 57.91 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.495 1.122 . . . . 0.0 109.275 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.538 HD21 HG23 ' A' ' 337' ' ' ILE . 16.3 mt -74.51 -179.83 4.26 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.483 1.114 . . . . 0.0 109.275 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' GLY . . . . . 0.622 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -107.72 -172.6 22.04 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.517 1.136 . . . . 0.0 111.005 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.877 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.1 Cg_endo -75.0 -36.96 2.24 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.5 1.789 . . . . 0.0 111.015 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.09 -34.83 78.48 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.493 1.121 . . . . 0.0 109.327 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.519 HG12 HD12 ' A' ' 247' ' ' ILE . 13.6 t -75.38 -39.21 41.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.531 1.144 . . . . 0.0 109.329 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.622 HD23 ' O ' ' A' ' 240' ' ' GLY . 1.4 mm? -66.28 -37.94 86.62 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.498 1.124 . . . . 0.0 109.253 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 241' ' ' PRO . 94.1 t -68.95 -44.67 81.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.478 1.111 . . . . 0.0 109.274 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -64.74 -36.94 85.93 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.468 1.105 . . . . 0.0 110.301 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.519 HD12 HG12 ' A' ' 243' ' ' VAL . 41.7 mt -69.09 -49.07 65.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.47 1.106 . . . . 0.0 109.285 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 244' ' ' LEU . 63.9 t -62.58 -31.09 50.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 0.0 109.308 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -78.92 -22.67 45.5 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.549 1.155 . . . . 0.0 110.282 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -91.86 -12.59 33.21 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.48 1.113 . . . . 0.0 109.25 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.61 148.89 47.63 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.535 1.147 . . . . 0.0 109.318 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 2.4 tpt85 -120.64 116.11 24.68 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.471 1.107 . . . . 0.0 110.288 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.754 ' HB2' HD23 ' A' ' 320' ' ' LEU . . . -80.7 122.28 26.93 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.414 1.072 . . . . 0.0 109.355 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.4 ' O ' ' O ' ' A' ' 319' ' ' LEU . 13.5 ptp180 -130.27 142.97 50.52 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.486 1.116 . . . . 0.0 110.303 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 10.5 m -95.36 129.19 42.59 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.51 1.131 . . . . 0.0 110.383 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.442 HG21 HD11 ' A' ' 319' ' ' LEU . 51.5 t -106.46 117.67 56.52 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.521 1.138 . . . . 0.0 109.276 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.2 Cg_endo -75.03 164.6 32.98 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.473 1.775 . . . . 0.0 110.988 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.501 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -66.85 125.21 25.18 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.495 1.122 . . . . 0.0 109.287 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 99.03 -24.91 30.32 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 124.5 1.125 . . . . 0.0 111.002 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.514 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -63.64 144.74 56.77 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.49 0.759 . . . . 0.0 109.299 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 311' ' ' VAL . 2.7 p -97.54 135.82 30.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 0.0 109.288 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.617 HD12 HG12 ' A' ' 311' ' ' VAL . 12.2 mt -82.3 -49.17 17.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.541 1.15 . . . . 0.0 109.328 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' CYS . . . . . 0.605 ' SG ' HG23 ' A' ' 311' ' ' VAL . 12.8 p -142.96 163.63 32.27 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.522 1.139 . . . . 0.0 108.28 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 1.1 mmt-85 -103.81 178.34 4.59 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.515 1.135 . . . . 0.0 110.313 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.79 142.02 14.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.458 1.099 . . . . 0.0 109.317 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 46.82 43.92 17.12 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.536 1.148 . . . . 0.0 111.009 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.434 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.2 OUTLIER -71.38 166.93 34.32 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.485 0.756 . . . . 0.0 110.311 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.434 ' HD2' ' HB2' ' A' ' 267' ' ' GLU . 18.1 Cg_endo -75.01 86.91 1.37 Allowed 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.487 1.783 . . . . 0.0 111.0 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -45.54 97.9 0.01 OUTLIER Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.499 1.124 . . . . 0.0 110.979 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -170.19 38.11 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.539 0.788 . . . . 0.0 109.284 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.46 144.55 6.42 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.139 . . . . 0.0 110.299 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 272' ' ' MET . . . . . 0.504 ' HB2' HD11 ' A' ' 301' ' ' LEU . 2.1 ttt -113.94 146.65 39.78 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.501 1.125 . . . . 0.0 111.008 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.565 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 86.6 m-85 -138.07 136.63 37.0 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.488 1.117 . . . . 0.0 110.984 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 274' ' ' PHE . . . . . 0.469 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 23.0 m-85 -126.65 133.67 50.92 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.123 . . . . 0.0 110.986 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 36.9 t -89.67 135.2 26.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.495 1.122 . . . . 0.0 109.311 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.566 ' CG2' HD11 ' A' ' 320' ' ' LEU . 9.8 t -110.4 -49.1 6.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.535 1.147 . . . . 0.0 109.334 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -143.59 132.74 23.05 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.483 1.115 . . . . 0.0 110.253 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.99 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 121.95 -169.25 14.72 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.492 1.12 . . . . 0.0 111.023 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 7.6 t -138.33 117.0 12.2 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.555 0.797 . . . . 0.0 110.007 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.469 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 30.0 m -98.76 161.47 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.504 1.127 . . . . 0.0 109.28 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 28.9 t -127.97 151.18 49.44 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.414 1.071 . . . . 0.0 110.018 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 1.4 t -114.81 130.75 68.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.468 1.105 . . . . 0.0 109.328 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.769 ' HB3' ' H ' ' A' ' 310' ' ' THR . . . -77.99 102.14 7.24 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.469 1.106 . . . . 0.0 109.298 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 284' ' ' THR . . . . . 0.655 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.29 -168.46 0.19 Allowed Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.502 1.126 . . . . 0.0 110.403 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.655 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -75.0 3.77 5.33 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.483 1.781 . . . . 0.0 110.936 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -151.45 157.48 34.82 Favored Pre-proline 0 C--N 1.324 -0.529 0 O-C-N 124.501 1.126 . . . . 0.0 109.302 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 94.73 0.96 Allowed 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.493 1.786 . . . . 0.0 110.95 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 281' ' ' SER . 61.5 t -98.94 118.92 46.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 0.0 109.3 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 14.2 mt-10 -124.28 139.11 54.22 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.433 1.083 . . . . 0.0 110.275 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.469 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 3.7 mm? -117.15 140.34 49.64 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.465 1.103 . . . . 0.0 109.299 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -96.5 -162.58 32.75 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.527 1.142 . . . . 0.0 111.061 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 141.47 26.68 Favored 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.567 1.825 . . . . 0.0 110.999 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.678 ' HA2' HD21 ' A' ' 229' ' ' LEU . . . 90.23 6.56 68.7 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.55 1.156 . . . . 0.0 110.971 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -91.69 131.8 36.82 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.484 0.756 . . . . 0.0 109.287 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -119.3 152.71 36.24 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.489 1.118 . . . . 0.0 110.995 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.565 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 45.2 p90 -163.57 145.63 9.58 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.483 1.114 . . . . 0.0 111.02 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 297' ' ' GLY . . . . . 0.464 ' O ' HD12 ' A' ' 301' ' ' LEU . . . 132.26 -3.53 5.17 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.513 1.133 . . . . 0.0 110.99 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 298' ' ' GLU . . . . . 0.493 ' HG2' ' CE ' ' A' ' 272' ' ' MET . 1.7 mt-10 -59.41 -46.06 89.76 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.497 0.763 . . . . 0.0 110.294 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 299' ' ' MET . . . . . 0.408 ' HB3' ' CG ' ' A' ' 305' ' ' GLU . 0.0 OUTLIER -52.03 -34.36 42.73 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.486 1.116 . . . . 0.0 110.997 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 300' ' ' ALA . . . . . 0.65 ' HB2' ' NH2' ' A' ' 307' ' ' ARG . . . -69.08 -45.06 71.23 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 0.0 109.289 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.504 HD11 ' HB2' ' A' ' 272' ' ' MET . 1.0 OUTLIER -75.37 -6.96 52.64 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.506 1.128 . . . . 0.0 109.251 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 302' ' ' ILE . . . . . 0.66 HD11 HD11 ' A' ' 235' ' ' LEU . 3.0 mm -82.25 -55.6 7.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.538 1.149 . . . . 0.0 109.337 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 304' ' ' GLY . 1.6 m -151.57 38.16 0.61 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.468 1.105 . . . . 0.0 110.011 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 36.68 53.14 1.44 Allowed Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.527 1.142 . . . . 0.0 111.005 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 305' ' ' GLU . . . . . 0.408 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 1.3 pt-20 -82.48 157.17 67.95 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.534 0.785 . . . . 0.0 110.312 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.07 133.82 16.95 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.467 1.772 . . . . 0.0 110.982 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' ARG . . . . . 0.65 ' NH2' ' HB2' ' A' ' 300' ' ' ALA . 0.0 OUTLIER -50.59 -26.0 4.82 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.45 1.094 . . . . 0.0 110.239 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.535 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 0.2 OUTLIER 46.73 39.14 6.71 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.486 1.116 . . . . 0.0 110.025 -180.0 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 309' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 173.91 161.05 0.16 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.514 1.134 . . . . 0.0 109.344 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.769 ' H ' ' HB3' ' A' ' 283' ' ' ALA . 0.6 OUTLIER -109.14 132.87 53.71 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.539 1.149 . . . . 0.0 110.388 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.617 HG12 HD12 ' A' ' 262' ' ' ILE . 44.5 t -111.7 131.56 62.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.483 1.115 . . . . 0.0 109.296 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 6.2 p -141.62 151.64 43.29 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.461 1.101 . . . . 0.0 109.991 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.42 118.48 26.89 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.526 1.141 . . . . 0.0 109.318 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -59.92 -32.24 70.58 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.505 1.128 . . . . 0.0 109.267 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 315' ' ' THR . . . . . 0.665 ' O ' HG23 ' A' ' 317' ' ' VAL . 13.1 t -153.97 -175.58 5.45 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.515 1.135 . . . . 0.0 110.362 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 41.7 p -49.29 92.46 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.531 1.144 . . . . 0.0 110.394 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.99 HG22 ' HA3' ' A' ' 278' ' ' GLY . 53.5 t -109.33 162.41 7.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.472 1.108 . . . . 0.0 109.273 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 318' ' ' SER . . . . . 0.433 ' N ' ' CG1' ' A' ' 317' ' ' VAL . 64.0 m -136.29 116.64 13.63 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.514 1.134 . . . . 0.0 109.989 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 319' ' ' LEU . . . . . 0.469 ' CB ' ' O ' ' A' ' 274' ' ' PHE . 0.2 OUTLIER -132.0 172.25 12.59 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.472 1.107 . . . . 0.0 109.341 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.754 HD23 ' HB2' ' A' ' 253' ' ' ALA . 0.2 OUTLIER -124.66 135.74 53.32 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.495 1.122 . . . . 0.0 109.341 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 45.5 t -93.36 158.25 15.83 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.525 1.141 . . . . 0.0 110.01 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -151.77 94.6 2.0 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.483 1.115 . . . . 0.0 109.329 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' HIS . . . . . 0.413 ' CD2' ' H ' ' A' ' 323' ' ' HIS . 5.0 p80 -55.39 135.32 50.36 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 0.0 109.624 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 8.1 t -57.78 -17.07 13.53 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.499 1.124 . . . . 0.0 110.0 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -58.31 -36.74 73.82 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.533 1.145 . . . . 0.0 109.297 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -42.61 95.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.491 1.119 . . . . 0.0 109.285 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 327' ' ' PHE . . . . . 0.462 ' HB2' ' CD2' ' A' ' 301' ' ' LEU . 83.7 t80 -65.19 -36.14 83.28 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.46 1.1 . . . . 0.0 110.981 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -69.65 -31.75 70.0 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.464 1.102 . . . . 0.0 110.328 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -69.86 -45.12 68.42 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.538 1.149 . . . . 0.0 110.995 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 1.2 mt -71.27 -30.89 66.84 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.492 1.12 . . . . 0.0 109.274 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 331' ' ' CYS . . . . . 0.412 ' CB ' ' HB2' ' A' ' 338' ' ' ALA . 1.6 m -72.29 -37.52 68.99 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.535 1.147 . . . . 0.0 108.303 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.87 -36.28 64.81 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.44 1.088 . . . . 0.0 110.005 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.77 -33.56 70.9 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.517 1.135 . . . . 0.0 109.98 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 334' ' ' SER . . . . . 0.596 ' CB ' HD12 ' A' ' 337' ' ' ILE . 0.6 OUTLIER -128.68 113.22 19.16 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.531 1.145 . . . . 0.0 109.985 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -22.27 14.97 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.429 1.752 . . . . 0.0 110.988 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -73.53 -31.57 63.75 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.467 1.105 . . . . 0.0 110.337 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.596 HD12 ' CB ' ' A' ' 334' ' ' SER . 60.5 mt -73.69 -45.53 50.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.542 1.151 . . . . 0.0 109.331 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 338' ' ' ALA . . . . . 0.412 ' HB2' ' CB ' ' A' ' 331' ' ' CYS . . . -69.26 -32.17 71.18 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 0.0 109.298 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -71.4 -38.38 71.46 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.469 1.105 . . . . 0.0 110.334 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.442 ' O ' HG22 ' A' ' 344' ' ' THR . 78.5 mt -73.1 -42.67 58.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.467 1.105 . . . . 0.0 109.341 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.578 ' CZ ' HD13 ' A' ' 235' ' ' LEU . 2.5 t80 -72.39 -30.72 64.93 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.513 1.133 . . . . 0.0 110.997 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 342' ' ' ARG . . . . . 0.47 ' HG3' ' CD1' ' A' ' 346' ' ' LEU . 0.0 OUTLIER -72.58 -43.21 63.67 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.511 1.132 . . . . 0.0 110.264 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -51.07 63.43 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.461 1.101 . . . . 0.0 109.323 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 344' ' ' THR . . . . . 0.545 HG22 ' HA ' ' A' ' 341' ' ' PHE . 9.0 t -65.02 -34.06 77.54 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.513 1.133 . . . . 0.0 110.355 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 345' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 341' ' ' PHE . . . -65.22 -43.4 91.62 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.542 1.151 . . . . 0.0 109.291 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.47 ' CD1' ' HG3' ' A' ' 342' ' ' ARG . 0.5 OUTLIER -65.03 -38.87 92.3 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.482 1.114 . . . . 0.0 109.286 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -68.88 -37.95 79.37 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.46 1.1 . . . . 0.0 110.32 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 348' ' ' ARG . . . . . 0.513 ' HE ' HD21 ' A' ' 235' ' ' LEU . 40.0 mtt-85 . . . . . 0 C--N 1.326 -0.431 0 O-C-N 124.472 1.107 . . . . 0.0 110.345 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 25.3 t80 . . . . . 0 N--CA 1.454 -0.264 0 CA-C-O 120.524 0.202 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.26 -32.58 58.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.485 1.115 . . . . 0.0 109.258 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.34 -35.39 71.17 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.532 1.145 . . . . 0.0 110.291 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.749 ' ND2' HD22 ' A' ' 320' ' ' LEU . 5.3 t-20 -78.95 -30.43 44.6 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.498 1.123 . . . . 0.0 109.25 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' TRP . . . . . 0.893 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 2.5 t90 -67.79 -45.52 74.59 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.502 1.126 . . . . 0.0 107.982 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.658 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 6.1 pt20 -71.54 -34.41 69.99 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.535 1.147 . . . . 0.0 110.339 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 6.2 mt -60.55 -43.83 96.8 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.479 1.112 . . . . 0.0 109.318 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.504 ' O ' HG12 ' A' ' 233' ' ' VAL . 82.7 t -75.5 -45.86 38.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.498 1.124 . . . . 0.0 109.324 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -69.16 -10.26 56.81 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.544 1.152 . . . . 0.0 109.299 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.658 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -80.42 -20.52 43.71 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.459 1.099 . . . . 0.0 109.268 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 230' ' ' VAL . 0.3 OUTLIER -91.74 126.92 52.15 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.491 1.12 . . . . 0.0 109.299 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.405 ' HA ' ' HB2' ' A' ' 237' ' ' GLN . 18.2 Cg_endo -75.01 -0.34 9.85 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.551 1.816 . . . . 0.0 111.029 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -24.12 32.06 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.508 1.13 . . . . 0.0 109.311 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' PHE . . . . . 0.553 ' CE2' HD13 ' A' ' 247' ' ' ILE . 1.4 m-30 -120.4 -8.49 9.6 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.528 1.143 . . . . 0.0 111.029 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' GLN . . . . . 0.405 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -61.66 -26.71 68.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.464 1.102 . . . . 0.0 110.258 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -74.71 -3.69 32.96 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.539 1.149 . . . . 0.0 109.342 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.594 HD13 HG11 ' A' ' 243' ' ' VAL . 66.5 mt -81.84 -179.32 7.34 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.509 1.131 . . . . 0.0 109.327 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 240' ' ' GLY . . . . . 0.567 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -100.73 -176.76 29.62 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.5 1.125 . . . . 0.0 111.016 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.942 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.1 Cg_endo -75.05 -38.84 1.39 Allowed 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.469 1.773 . . . . 0.0 110.991 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -66.37 -33.13 75.04 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 0.0 109.286 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.868 HG21 HD11 ' A' ' 337' ' ' ILE . 4.5 t -75.13 -42.02 44.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.503 1.127 . . . . 0.0 109.286 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.567 HD23 ' O ' ' A' ' 240' ' ' GLY . 1.3 mm? -65.34 -37.91 88.52 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.487 1.117 . . . . 0.0 109.271 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.942 HG23 ' O ' ' A' ' 241' ' ' PRO . 58.4 t -71.82 -38.33 65.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.504 1.128 . . . . 0.0 109.247 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -67.64 -40.1 84.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.502 1.126 . . . . 0.0 110.289 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.553 HD13 ' CE2' ' A' ' 236' ' ' PHE . 31.6 mt -68.48 -48.9 70.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.461 1.1 . . . . 0.0 109.312 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.537 ' HA ' HD12 ' A' ' 251' ' ' LEU . 68.6 t -64.32 -33.15 60.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.132 . . . . 0.0 109.286 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.496 ' CG ' ' O ' ' A' ' 245' ' ' VAL . 0.9 OUTLIER -75.84 -22.85 55.84 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.489 1.118 . . . . 0.0 110.332 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.636 ' HB1' ' OD1' ' A' ' 326' ' ' ASP . . . -90.53 -18.08 25.91 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.446 1.091 . . . . 0.0 109.282 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.537 HD12 ' HA ' ' A' ' 248' ' ' VAL . 0.3 OUTLIER -63.4 147.82 50.18 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.475 1.109 . . . . 0.0 109.288 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.97 134.26 55.29 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.541 1.15 . . . . 0.0 110.322 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -80.75 122.46 27.18 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.543 1.152 . . . . 0.0 109.323 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -123.73 123.3 40.21 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.482 1.113 . . . . 0.0 110.301 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 9.3 m -92.13 116.94 29.37 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.533 1.146 . . . . 0.0 110.41 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.489 HG21 HD11 ' A' ' 319' ' ' LEU . 77.4 t -106.67 112.22 63.65 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.548 1.155 . . . . 0.0 109.324 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.529 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.2 Cg_endo -75.0 175.37 11.33 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.501 1.79 . . . . 0.0 110.997 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.574 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -66.97 133.27 49.63 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.499 1.124 . . . . 0.0 109.359 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 90.42 -25.14 13.61 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.456 1.097 . . . . 0.0 110.99 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.529 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -57.66 147.24 28.07 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.53 0.783 . . . . 0.0 109.301 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.7 t -97.25 128.96 48.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.113 . . . . 0.0 109.307 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.795 HD12 HG12 ' A' ' 311' ' ' VAL . 38.7 mt -82.96 -39.17 15.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.467 1.105 . . . . 0.0 109.291 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 263' ' ' CYS . . . . . 0.466 ' SG ' HG23 ' A' ' 311' ' ' VAL . 14.2 p -159.47 151.27 20.46 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.507 1.129 . . . . 0.0 108.27 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 -95.16 -179.46 4.81 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.512 1.133 . . . . 0.0 110.303 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.493 HG23 ' OG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -75.95 139.26 19.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.526 1.141 . . . . 0.0 109.354 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 47.82 51.46 18.15 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.519 1.137 . . . . 0.0 110.999 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.413 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.2 OUTLIER -71.47 164.42 57.83 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.491 0.76 . . . . 0.0 110.306 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.43 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.3 Cg_endo -74.94 78.5 2.86 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.488 1.783 . . . . 0.0 111.045 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 269' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 268' ' ' PRO . . . -36.58 96.54 0.01 OUTLIER Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.514 1.134 . . . . 0.0 111.009 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 268' ' ' PRO . 0.3 OUTLIER -170.26 37.6 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.506 0.768 . . . . 0.0 109.283 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 271' ' ' ARG . . . . . 0.415 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 0.2 OUTLIER -168.09 144.93 4.07 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.484 1.115 . . . . 0.0 110.291 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 272' ' ' MET . . . . . 0.487 ' SD ' ' CD1' ' A' ' 301' ' ' LEU . 0.1 OUTLIER -114.85 146.47 41.03 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 0.0 110.948 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.572 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 66.9 m-85 -133.46 136.7 45.31 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.474 1.109 . . . . 0.0 111.037 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 274' ' ' PHE . . . . . 0.449 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 22.0 m-85 -127.13 131.02 50.88 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.53 1.144 . . . . 0.0 111.046 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.575 HG12 ' HA ' ' A' ' 292' ' ' PRO . 45.7 t -87.07 137.7 20.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.501 1.126 . . . . 0.0 109.295 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.634 ' CG2' HD11 ' A' ' 320' ' ' LEU . 4.2 t -118.56 -40.54 2.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.533 1.145 . . . . 0.0 109.301 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -147.52 136.16 21.87 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.511 1.132 . . . . 0.0 110.339 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.954 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 112.31 -167.33 12.35 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.513 1.133 . . . . 0.0 110.999 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 279' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 290' ' ' LEU . 11.2 t -140.97 122.12 14.72 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.569 0.805 . . . . 0.0 109.997 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.467 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 21.1 m -99.27 163.56 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.511 1.132 . . . . 0.0 109.308 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 281' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 31.6 t -130.25 151.85 50.32 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.492 1.12 . . . . 0.0 110.03 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.418 ' CG2' ' HB ' ' A' ' 288' ' ' VAL . 0.8 OUTLIER -114.77 129.01 71.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.463 1.102 . . . . 0.0 109.316 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.42 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -80.06 101.06 8.49 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.517 1.135 . . . . 0.0 109.318 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 284' ' ' THR . . . . . 0.661 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -149.04 -168.13 0.18 Allowed Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.554 1.159 . . . . 0.0 110.409 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.661 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.3 Cg_endo -74.98 5.49 3.94 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.448 1.762 . . . . 0.0 111.011 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.443 ' O ' HG23 ' A' ' 288' ' ' VAL . 11.9 m120 -151.59 153.37 31.98 Favored Pre-proline 0 C--N 1.324 -0.529 0 O-C-N 124.511 1.132 . . . . 0.0 109.348 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.95 97.48 1.08 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.509 1.794 . . . . 0.0 111.044 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 286' ' ' ASN . 2.3 t -102.78 119.24 50.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.469 1.106 . . . . 0.0 109.324 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 12.9 mt-10 -124.46 134.8 52.94 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.477 1.11 . . . . 0.0 110.271 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.467 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 3.9 mm? -112.97 141.59 46.62 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.488 1.118 . . . . 0.0 109.336 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -98.12 -164.72 31.13 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.466 1.104 . . . . 0.0 110.953 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 292' ' ' PRO . . . . . 0.575 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.1 Cg_endo -75.0 139.68 24.57 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.541 1.811 . . . . 0.0 111.007 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 96.6 1.93 60.19 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.509 1.131 . . . . 0.0 111.016 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 294' ' ' ALA . . . . . 0.41 ' CB ' HD12 ' A' ' 290' ' ' LEU . . . -87.64 144.68 26.54 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.529 0.782 . . . . 0.0 109.301 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -134.83 153.11 52.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.468 1.105 . . . . 0.0 110.958 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.572 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 45.9 p90 -163.89 146.25 9.38 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.508 1.13 . . . . 0.0 110.992 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 297' ' ' GLY . . . . . 0.474 ' O ' HD12 ' A' ' 301' ' ' LEU . . . 137.34 -10.33 3.8 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.455 1.097 . . . . 0.0 111.026 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 298' ' ' GLU . . . . . 0.44 ' HG2' ' N ' ' A' ' 299' ' ' MET . 0.9 OUTLIER -52.46 -34.85 50.81 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.482 0.754 . . . . 0.0 110.282 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 299' ' ' MET . . . . . 0.447 ' HB3' ' CG ' ' A' ' 305' ' ' GLU . 0.5 OUTLIER -64.27 -41.5 96.89 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.458 1.099 . . . . 0.0 111.032 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -63.67 -29.9 71.07 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.473 1.108 . . . . 0.0 109.296 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.487 ' CD1' ' SD ' ' A' ' 272' ' ' MET . 1.2 mt -86.34 -19.04 30.39 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.548 1.155 . . . . 0.0 109.286 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 302' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 298' ' ' GLU . 3.9 mm -68.56 -57.4 9.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.426 1.079 . . . . 0.0 109.33 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 304' ' ' GLY . 2.7 m -155.02 44.99 0.5 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.484 1.115 . . . . 0.0 110.021 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 303' ' ' SER . . . 35.4 51.15 0.98 Allowed Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.481 1.113 . . . . 0.0 111.005 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 305' ' ' GLU . . . . . 0.447 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 0.1 OUTLIER -78.76 155.02 78.37 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.504 0.767 . . . . 0.0 110.295 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 130.2 13.08 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.496 1.788 . . . . 0.0 111.003 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 307' ' ' ARG . . . . . 0.41 ' NE ' ' HG2' ' A' ' 267' ' ' GLU . 0.2 OUTLIER -44.61 -36.37 3.02 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.495 1.122 . . . . 0.0 110.321 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.679 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 0.8 OUTLIER 59.9 42.49 16.21 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.459 1.1 . . . . 0.0 109.967 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 309' ' ' ALA . . . . . 0.679 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 164.59 160.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.517 1.135 . . . . 0.0 109.315 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.493 ' OG1' HG23 ' A' ' 265' ' ' ILE . 0.9 OUTLIER -108.36 137.38 46.43 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.484 1.115 . . . . 0.0 110.387 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.795 HG12 HD12 ' A' ' 262' ' ' ILE . 61.6 t -116.92 131.38 69.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.459 1.1 . . . . 0.0 109.303 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 61.9 p -132.16 159.11 39.92 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.534 1.146 . . . . 0.0 110.008 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -93.6 118.3 31.2 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.547 1.155 . . . . 0.0 109.302 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -58.59 -35.26 72.13 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.499 1.124 . . . . 0.0 109.311 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 315' ' ' THR . . . . . 0.574 ' HA ' ' HB2' ' A' ' 258' ' ' ALA . 9.8 t -155.62 -172.5 4.17 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.491 1.119 . . . . 0.0 110.373 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 316' ' ' THR . . . . . 0.426 ' N ' ' OG1' ' A' ' 315' ' ' THR . 32.0 m -49.49 91.33 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.508 1.13 . . . . 0.0 110.396 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.954 HG22 ' HA3' ' A' ' 278' ' ' GLY . 38.6 t -107.79 155.98 8.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.444 1.09 . . . . 0.0 109.281 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 31.0 m -132.56 114.25 14.03 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.491 1.119 . . . . 0.0 110.045 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 319' ' ' LEU . . . . . 0.489 HD11 HG21 ' A' ' 256' ' ' VAL . 0.2 OUTLIER -129.28 173.29 10.64 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 0.0 109.261 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.749 HD22 ' ND2' ' A' ' 226' ' ' ASN . 0.3 OUTLIER -124.2 138.18 54.44 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.434 1.084 . . . . 0.0 109.303 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 30.9 t -97.59 155.29 17.04 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.501 1.126 . . . . 0.0 109.976 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.739 ' O ' HD13 ' A' ' 322' ' ' LEU . 1.4 tm? -145.69 92.99 2.29 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.441 1.088 . . . . 0.0 109.282 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 323' ' ' HIS . . . . . 0.509 ' CE1' ' OD1' ' A' ' 326' ' ' ASP . 13.8 p80 -54.99 126.77 25.95 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.464 1.103 . . . . 0.0 109.638 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 324' ' ' SER . . . . . 0.407 ' OG ' ' CG ' ' A' ' 270' ' ' ASP . 2.1 p -49.38 -26.92 3.55 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.476 1.11 . . . . 0.0 109.974 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -52.0 -30.46 25.25 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.492 1.12 . . . . 0.0 109.324 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 326' ' ' ASP . . . . . 0.636 ' OD1' ' HB1' ' A' ' 250' ' ' ALA . 0.2 OUTLIER -70.41 -41.85 72.41 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.448 1.092 . . . . 0.0 109.288 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 327' ' ' PHE . . . . . 0.672 ' CZ ' ' CE2' ' A' ' 341' ' ' PHE . 2.5 t80 -64.82 -38.82 92.28 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.486 1.116 . . . . 0.0 110.994 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -69.53 -34.13 73.8 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.424 1.077 . . . . 0.0 110.252 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 28.7 ttp -71.22 -32.24 68.56 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.465 1.103 . . . . 0.0 111.013 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.518 HD12 HG13 ' A' ' 243' ' ' VAL . 0.2 OUTLIER -72.78 -46.2 54.55 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.546 1.154 . . . . 0.0 109.278 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 331' ' ' CYS . . . . . 0.887 ' SG ' HG22 ' A' ' 337' ' ' ILE . 1.5 m -65.92 -32.38 73.85 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.527 1.142 . . . . 0.0 108.259 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 4.7 t -76.27 -29.8 57.57 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.486 1.116 . . . . 0.0 110.04 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 12.8 t -72.38 -38.19 68.54 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 0.0 109.983 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 334' ' ' SER . . . . . 0.407 ' HA ' ' HD3' ' A' ' 335' ' ' PRO . 0.3 OUTLIER -127.86 130.15 23.66 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.461 1.101 . . . . 0.0 109.97 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 335' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 334' ' ' SER . 18.3 Cg_endo -75.0 -23.79 13.45 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.514 1.797 . . . . 0.0 111.035 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.55 -30.27 68.04 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.495 1.122 . . . . 0.0 110.351 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.887 HG22 ' SG ' ' A' ' 331' ' ' CYS . 49.4 mt -73.36 -36.86 50.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.498 1.124 . . . . 0.0 109.317 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -71.53 -34.63 70.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.502 1.126 . . . . 0.0 109.291 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -74.05 -45.13 51.48 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.512 1.132 . . . . 0.0 110.273 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 94.5 mt -69.82 -35.55 65.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.517 1.136 . . . . 0.0 109.316 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.672 ' CE2' ' CZ ' ' A' ' 327' ' ' PHE . 1.6 t80 -69.14 -39.46 78.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.523 1.14 . . . . 0.0 110.996 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.46 -38.05 77.57 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.479 1.112 . . . . 0.0 110.336 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -43.52 78.29 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.516 1.135 . . . . 0.0 109.311 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.91 -40.78 83.36 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.517 1.136 . . . . 0.0 110.414 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -66.37 -38.02 86.62 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.511 1.132 . . . . 0.0 109.282 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 346' ' ' LEU . 9.6 mt -68.59 -35.1 76.9 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.538 1.149 . . . . 0.0 109.344 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -69.69 -40.1 76.53 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.124 . . . . 0.0 110.286 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 13.9 mtt180 . . . . . 0 C--N 1.325 -0.498 0 O-C-N 124.506 1.129 . . . . 0.0 110.314 -179.966 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 43.0 t80 . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.514 0.197 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.78 -37.94 43.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.439 1.087 . . . . 0.0 109.271 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.495 ' O ' HD12 ' A' ' 229' ' ' LEU . 0.0 OUTLIER -68.3 -31.1 70.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.144 . . . . 0.0 110.335 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.967 ' O ' HG12 ' A' ' 230' ' ' VAL . 6.4 t-20 -80.3 -31.55 38.19 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.532 1.145 . . . . 0.0 109.286 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' TRP . . . . . 0.712 ' CZ3' HG23 ' A' ' 245' ' ' VAL . 2.0 t90 -68.68 -43.98 75.0 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.674 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 4.1 pt20 -72.02 -33.82 68.34 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.454 1.096 . . . . 0.0 110.308 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.637 HD21 ' HA2' ' A' ' 293' ' ' GLY . 2.4 mt -64.94 -55.37 19.6 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 0.0 109.269 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.967 HG12 ' O ' ' A' ' 226' ' ' ASN . 5.7 p -65.09 -37.66 80.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.523 1.139 . . . . 0.0 109.34 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 227' ' ' TRP . . . -76.03 -15.1 60.19 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.478 1.111 . . . . 0.0 109.235 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.674 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -80.71 -11.33 59.64 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.503 1.127 . . . . 0.0 109.307 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' VAL . . . . . 0.729 HG12 ' O ' ' A' ' 230' ' ' VAL . 0.6 OUTLIER -89.02 132.61 37.46 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.547 1.155 . . . . 0.0 109.32 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.432 ' HA ' ' HB2' ' A' ' 237' ' ' GLN . 18.4 Cg_endo -74.97 -0.08 9.51 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.457 1.767 . . . . 0.0 111.028 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.25 -24.4 22.1 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 0.0 109.32 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' PHE . . . . . 0.61 ' H ' HG13 ' A' ' 233' ' ' VAL . 21.2 m-30 -122.92 8.14 9.32 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.478 1.111 . . . . 0.0 110.987 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 237' ' ' GLN . . . . . 0.432 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 3.0 tt0 -73.16 -19.53 61.1 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.483 1.114 . . . . 0.0 110.286 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.438 ' NZ ' ' HA ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -97.57 4.99 50.14 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.527 1.142 . . . . 0.0 109.326 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.814 HD13 ' CG1' ' A' ' 243' ' ' VAL . 19.3 mt -80.28 -179.42 7.09 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.465 1.103 . . . . 0.0 109.316 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' GLY . . . . . 0.601 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -103.23 -178.48 26.3 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.499 1.124 . . . . 0.0 110.991 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 -32.9 5.04 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.53 1.805 . . . . 0.0 110.98 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.521 ' HA ' HG12 ' A' ' 245' ' ' VAL . . . -73.62 -32.81 64.26 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.445 1.09 . . . . 0.0 109.297 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.814 ' CG1' HD13 ' A' ' 239' ' ' LEU . 63.0 t -76.6 -38.39 31.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.126 . . . . 0.0 109.271 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.643 ' O ' HG23 ' A' ' 248' ' ' VAL . 3.6 mm? -71.31 -45.47 62.96 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.488 1.118 . . . . 0.0 109.289 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.712 HG23 ' CZ3' ' A' ' 227' ' ' TRP . 3.3 p -64.65 -45.09 96.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.528 1.142 . . . . 0.0 109.317 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.402 ' N ' ' CG1' ' A' ' 245' ' ' VAL . 15.3 tp10 -65.0 -40.89 95.62 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.509 1.13 . . . . 0.0 110.262 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.591 ' CG1' HD13 ' A' ' 330' ' ' LEU . 26.5 mt -65.16 -43.83 95.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.493 1.121 . . . . 0.0 109.303 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 244' ' ' LEU . 75.7 t -69.51 -30.99 47.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.504 1.128 . . . . 0.0 109.277 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -76.87 -19.6 57.27 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.55 1.156 . . . . 0.0 110.324 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.611 ' HB1' ' OD2' ' A' ' 326' ' ' ASP . . . -93.82 -14.84 25.71 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.539 1.149 . . . . 0.0 109.302 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.464 HD22 ' HB2' ' A' ' 320' ' ' LEU . 0.2 OUTLIER -66.12 146.35 54.76 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.541 1.151 . . . . 0.0 109.293 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 252' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 320' ' ' LEU . 1.0 OUTLIER -117.82 117.96 30.73 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.555 1.159 . . . . 0.0 110.288 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.737 ' HB2' HD23 ' A' ' 320' ' ' LEU . . . -80.79 125.03 29.56 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.436 1.085 . . . . 0.0 109.289 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -132.56 143.89 50.02 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.491 1.119 . . . . 0.0 110.275 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 20.1 m -96.64 125.93 41.45 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 0.0 110.413 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.792 HG21 HD11 ' A' ' 319' ' ' LEU . 93.4 t -106.39 116.14 59.7 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.537 1.148 . . . . 0.0 109.345 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.483 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.9 162.12 37.86 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.513 1.796 . . . . 0.0 111.026 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.502 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -63.71 125.19 23.52 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.475 1.109 . . . . 0.0 109.317 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 100.7 -25.27 28.96 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.489 1.118 . . . . 0.0 110.988 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.483 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -64.02 139.15 58.74 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.459 0.74 . . . . 0.0 109.295 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 311' ' ' VAL . 2.7 p -93.25 135.64 27.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.466 1.104 . . . . 0.0 109.282 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.785 HD12 HG12 ' A' ' 311' ' ' VAL . 11.2 mt -82.49 -49.35 17.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.531 1.144 . . . . 0.0 109.284 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' CYS . . . . . 0.655 ' SG ' HG23 ' A' ' 311' ' ' VAL . 12.4 p -141.7 162.43 35.5 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.531 1.144 . . . . 0.0 108.255 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -103.93 -179.01 3.83 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.449 1.093 . . . . 0.0 110.28 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.32 137.41 22.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 0.0 109.299 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 47.01 48.91 18.87 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.504 1.128 . . . . 0.0 111.028 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.416 ' OE1' ' C ' ' A' ' 268' ' ' PRO . 0.0 OUTLIER -71.26 162.6 71.71 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.455 0.738 . . . . 0.0 110.333 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 269' ' ' GLY . 18.5 Cg_endo -74.98 78.07 2.98 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.521 1.801 . . . . 0.0 111.041 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 269' ' ' GLY . . . . . 0.464 ' O ' ' CA ' ' A' ' 304' ' ' GLY . . . -35.23 102.73 0.01 OUTLIER Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.527 1.142 . . . . 0.0 110.973 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -170.33 38.31 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 0.765 . . . . 0.0 109.293 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.45 144.86 2.01 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.131 . . . . 0.0 110.293 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 272' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.97 146.56 37.62 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.511 1.132 . . . . 0.0 111.057 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.562 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 20.1 m-85 -137.55 136.78 37.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.486 1.117 . . . . 0.0 111.021 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 274' ' ' PHE . . . . . 0.484 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 21.4 m-85 -127.25 135.95 51.32 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.537 1.148 . . . . 0.0 111.005 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.531 HG12 ' HA ' ' A' ' 292' ' ' PRO . 25.4 t -93.57 138.65 19.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.46 1.1 . . . . 0.0 109.305 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 2.7 t -115.99 -48.49 4.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.469 1.106 . . . . 0.0 109.274 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -140.2 132.99 29.07 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.528 1.143 . . . . 0.0 110.304 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.933 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 118.34 -173.35 14.83 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.531 1.144 . . . . 0.0 110.997 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 279' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 290' ' ' LEU . 8.4 t -134.73 122.29 21.95 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.52 0.776 . . . . 0.0 110.012 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.456 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 26.1 m -100.08 163.86 2.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.492 1.12 . . . . 0.0 109.302 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 281' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 31.1 t -129.24 152.51 48.74 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 0.0 109.993 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 1.5 t -115.96 128.87 73.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.467 1.105 . . . . 0.0 109.3 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.619 ' HB3' ' H ' ' A' ' 310' ' ' THR . . . -78.43 101.66 7.4 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.48 1.113 . . . . 0.0 109.319 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 284' ' ' THR . . . . . 0.664 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.9 OUTLIER -148.54 -167.96 0.17 Allowed Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.485 1.116 . . . . 0.0 110.366 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.664 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.5 Cg_endo -74.96 4.77 4.42 Favored 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.524 1.802 . . . . 0.0 111.057 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.444 ' O ' HG23 ' A' ' 288' ' ' VAL . 17.4 m120 -152.0 155.25 33.45 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.477 1.11 . . . . 0.0 109.31 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 96.52 1.02 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.545 1.813 . . . . 0.0 111.032 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 286' ' ' ASN . 2.1 t -101.52 119.54 49.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.536 1.148 . . . . 0.0 109.281 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 14.3 mt-10 -124.29 136.09 53.87 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.484 1.115 . . . . 0.0 110.321 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.456 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 3.8 mm? -115.44 141.77 47.6 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.483 1.115 . . . . 0.0 109.341 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -94.11 -160.21 34.51 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.505 1.128 . . . . 0.0 110.982 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 292' ' ' PRO . . . . . 0.531 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.2 Cg_endo -75.01 148.27 35.01 Favored 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.513 1.796 . . . . 0.0 111.009 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.637 ' HA2' HD21 ' A' ' 229' ' ' LEU . . . 86.46 -0.62 87.06 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.499 1.125 . . . . 0.0 110.984 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -83.49 123.43 29.71 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.478 0.752 . . . . 0.0 109.279 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.481 ' HD2' HD23 ' A' ' 229' ' ' LEU . 3.8 p90 -114.82 152.92 31.33 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.482 1.114 . . . . 0.0 111.006 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.562 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 37.5 p90 -160.57 147.99 15.91 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.518 1.136 . . . . 0.0 111.046 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 134.72 -8.35 4.56 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.548 1.155 . . . . 0.0 111.007 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -52.58 -41.9 64.02 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.458 0.74 . . . . 0.0 110.284 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 299' ' ' MET . . . . . 0.466 ' HB3' ' CG ' ' A' ' 305' ' ' GLU . 0.1 OUTLIER -54.92 -41.08 70.54 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.494 1.121 . . . . 0.0 111.006 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 300' ' ' ALA . . . . . 0.434 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -66.92 -35.7 80.6 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.509 1.131 . . . . 0.0 109.258 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.45 ' O ' ' CZ ' ' A' ' 341' ' ' PHE . 6.5 mt -75.01 -20.31 59.68 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.511 1.132 . . . . 0.0 109.261 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 3.3 mm -73.06 -54.97 14.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.129 . . . . 0.0 109.329 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.85 40.39 0.23 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.456 1.098 . . . . 0.0 110.015 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.464 ' CA ' ' O ' ' A' ' 269' ' ' GLY . . . 39.6 40.65 1.52 Allowed Glycine 0 CA--C 1.531 1.052 0 O-C-N 124.497 1.123 . . . . 0.0 110.989 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 305' ' ' GLU . . . . . 0.466 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 0.0 OUTLIER -66.11 158.65 75.67 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.509 0.77 . . . . 0.0 110.292 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.403 ' O ' ' OE2' ' A' ' 305' ' ' GLU . 18.5 Cg_endo -74.95 130.69 13.56 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.528 1.804 . . . . 0.0 111.02 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.9 -40.89 14.95 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.516 1.135 . . . . 0.0 110.318 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.555 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 0.5 OUTLIER 68.19 34.43 3.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.493 1.121 . . . . 0.0 110.044 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 309' ' ' ALA . . . . . 0.555 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 172.78 161.98 0.12 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.521 1.138 . . . . 0.0 109.282 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.619 ' H ' ' HB3' ' A' ' 283' ' ' ALA . 0.5 OUTLIER -107.71 130.99 54.89 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.538 1.149 . . . . 0.0 110.416 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.785 HG12 HD12 ' A' ' 262' ' ' ILE . 41.6 t -109.75 131.48 60.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.472 1.108 . . . . 0.0 109.343 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 3.2 p -139.2 152.33 47.28 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.11 . . . . 0.0 109.993 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.94 117.17 26.61 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.474 1.109 . . . . 0.0 109.297 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -59.62 -31.48 69.53 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.547 1.154 . . . . 0.0 109.317 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 315' ' ' THR . . . . . 0.739 ' O ' HG23 ' A' ' 317' ' ' VAL . 8.1 t -154.59 -175.36 5.37 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.472 1.108 . . . . 0.0 110.405 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 316' ' ' THR . . . . . 0.401 ' H ' HG23 ' A' ' 316' ' ' THR . 65.1 p -49.73 92.81 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.514 1.134 . . . . 0.0 110.392 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.933 HG22 ' HA3' ' A' ' 278' ' ' GLY . 75.8 t -110.23 152.07 12.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.498 1.124 . . . . 0.0 109.31 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 70.3 m -123.96 117.42 24.73 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.548 1.155 . . . . 0.0 109.988 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 319' ' ' LEU . . . . . 0.792 HD11 HG21 ' A' ' 256' ' ' VAL . 0.2 OUTLIER -134.06 169.38 17.22 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.481 1.113 . . . . 0.0 109.293 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.737 HD23 ' HB2' ' A' ' 253' ' ' ALA . 0.0 OUTLIER -124.35 139.05 54.27 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.473 1.108 . . . . 0.0 109.314 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 3.2 p -95.04 158.17 15.58 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.534 1.146 . . . . 0.0 110.002 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.46 ' O ' HD13 ' A' ' 322' ' ' LEU . 1.5 tm? -151.0 77.69 1.28 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.471 1.107 . . . . 0.0 109.305 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -42.54 141.46 1.01 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.416 1.072 . . . . 0.0 109.577 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -24.82 63.57 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.447 1.092 . . . . 0.0 109.963 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -52.21 -35.87 50.53 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.521 1.138 . . . . 0.0 109.292 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 326' ' ' ASP . . . . . 0.611 ' OD2' ' HB1' ' A' ' 250' ' ' ALA . 0.4 OUTLIER -71.6 -37.33 70.97 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.542 1.151 . . . . 0.0 109.329 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 327' ' ' PHE . . . . . 0.417 ' CE2' ' CE2' ' A' ' 341' ' ' PHE . 38.4 t80 -66.51 -41.18 89.23 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.484 1.115 . . . . 0.0 111.031 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -71.29 -31.52 67.55 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.503 1.127 . . . . 0.0 110.297 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.403 ' SD ' ' C ' ' A' ' 329' ' ' MET . 15.6 tmm? -68.54 -43.74 76.03 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.548 1.155 . . . . 0.0 111.014 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.591 HD13 ' CG1' ' A' ' 247' ' ' ILE . 5.0 mt -71.39 -37.78 71.53 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.521 1.138 . . . . 0.0 109.265 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 331' ' ' CYS . . . . . 0.422 ' SG ' HG22 ' A' ' 337' ' ' ILE . 73.6 m -65.88 -41.68 91.25 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.531 1.144 . . . . 0.0 108.29 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.4 t -77.55 -24.42 49.86 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.471 1.107 . . . . 0.0 110.01 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 47.6 t -72.21 -39.02 68.87 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.533 1.145 . . . . 0.0 110.034 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 334' ' ' SER . . . . . 0.706 ' CB ' HD12 ' A' ' 337' ' ' ILE . 0.1 OUTLIER -129.03 133.83 25.64 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.482 1.114 . . . . 0.0 109.978 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 335' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 334' ' ' SER . 18.4 Cg_endo -74.98 -23.75 13.53 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.54 1.81 . . . . 0.0 110.974 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -72.26 -29.32 63.79 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.5 1.125 . . . . 0.0 110.328 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.706 HD12 ' CB ' ' A' ' 334' ' ' SER . 30.9 mt -72.98 -42.71 59.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.483 1.114 . . . . 0.0 109.281 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.74 -30.72 67.32 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.55 1.157 . . . . 0.0 109.297 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -73.61 -43.76 58.79 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.564 1.165 . . . . 0.0 110.36 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 76.1 mt -70.76 -39.42 75.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.513 1.133 . . . . 0.0 109.298 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.491 ' CD1' ' C ' ' A' ' 341' ' ' PHE . 0.5 OUTLIER -66.95 -41.46 86.91 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.488 1.118 . . . . 0.0 111.005 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 -70.48 -33.41 71.22 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.504 1.128 . . . . 0.0 110.303 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -50.54 66.53 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.504 1.127 . . . . 0.0 109.323 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 344' ' ' THR . . . . . 0.455 HG22 ' O ' ' A' ' 341' ' ' PHE . 6.0 t -65.11 -39.12 92.68 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.541 1.151 . . . . 0.0 110.433 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -66.77 -33.78 76.37 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.471 1.107 . . . . 0.0 109.282 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.504 ' HA ' HD23 ' A' ' 346' ' ' LEU . 10.2 mt -71.83 -36.9 70.34 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.514 1.134 . . . . 0.0 109.314 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -76.26 -30.8 57.98 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.535 1.147 . . . . 0.0 110.3 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 7.0 mtt-85 . . . . . 0 C--N 1.325 -0.499 0 O-C-N 124.472 1.107 . . . . 0.0 110.335 179.964 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 46.4 t80 . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 120.515 0.198 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.65 -39.45 60.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.467 1.104 . . . . 0.0 109.321 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.654 ' HG2' HG13 ' A' ' 276' ' ' VAL . 0.1 OUTLIER -69.21 -29.78 67.81 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.493 1.121 . . . . 0.0 110.322 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.448 ' CG ' HG23 ' A' ' 248' ' ' VAL . 39.6 t-20 -78.12 -32.66 50.55 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.452 1.095 . . . . 0.0 109.299 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' TRP . . . . . 0.726 ' CH2' HG23 ' A' ' 245' ' ' VAL . 2.8 t90 -73.99 -42.94 59.66 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.519 1.137 . . . . 0.0 108.026 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.411 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 6.8 pt20 -70.38 -28.79 65.37 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.505 1.128 . . . . 0.0 110.314 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.623 HD12 ' HG3' ' A' ' 225' ' ' ARG . 3.3 mt -69.14 -54.96 12.21 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.515 1.134 . . . . 0.0 109.316 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.608 HG21 ' HB ' ' A' ' 248' ' ' VAL . 33.0 m -65.02 -32.04 56.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.497 1.123 . . . . 0.0 109.323 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -76.13 -24.63 54.91 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.111 . . . . 0.0 109.271 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -80.54 1.21 30.49 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.488 1.117 . . . . 0.0 109.289 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 229' ' ' LEU . 96.7 t -92.07 118.75 68.34 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.518 1.136 . . . . 0.0 109.311 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.417 ' HA ' ' HB2' ' A' ' 237' ' ' GLN . 18.2 Cg_endo -75.0 -21.96 15.3 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.536 1.808 . . . . 0.0 110.989 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.98 -30.56 71.63 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.496 1.123 . . . . 0.0 109.325 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' PHE . . . . . 0.861 ' HB3' HD12 ' A' ' 239' ' ' LEU . 24.4 m-85 -112.42 20.31 16.81 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.482 1.114 . . . . 0.0 110.985 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' GLN . . . . . 0.417 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 1.0 OUTLIER -68.12 -18.57 64.67 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.485 1.116 . . . . 0.0 110.316 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -86.99 -14.16 42.46 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.465 1.103 . . . . 0.0 109.322 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.861 HD12 ' HB3' ' A' ' 236' ' ' PHE . 55.6 mt -68.5 176.29 2.97 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.507 1.129 . . . . 0.0 109.277 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' GLY . . . . . 0.604 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -109.63 -171.97 20.53 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.445 1.09 . . . . 0.0 110.974 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -32.39 5.43 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.463 1.77 . . . . 0.0 111.004 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.522 ' HA ' HG12 ' A' ' 245' ' ' VAL . . . -72.9 -32.92 65.69 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.48 1.112 . . . . 0.0 109.309 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.827 ' CG1' HD13 ' A' ' 239' ' ' LEU . 54.5 t -76.82 -38.64 29.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.491 1.119 . . . . 0.0 109.295 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.604 HD23 ' O ' ' A' ' 240' ' ' GLY . 2.9 mm? -71.0 -44.41 65.95 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.521 1.138 . . . . 0.0 109.239 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.726 HG23 ' CH2' ' A' ' 227' ' ' TRP . 3.0 p -66.27 -39.77 85.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.448 1.093 . . . . 0.0 109.271 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -69.87 -40.29 75.8 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.543 1.152 . . . . 0.0 110.319 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.75 ' O ' HD13 ' A' ' 251' ' ' LEU . 46.0 mt -65.63 -55.16 21.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.497 1.123 . . . . 0.0 109.271 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.608 ' HB ' HG21 ' A' ' 230' ' ' VAL . 4.2 p -60.81 -30.63 47.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.54 1.15 . . . . 0.0 109.363 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.517 ' CG ' ' O ' ' A' ' 245' ' ' VAL . 14.3 mmt180 -79.21 -16.84 55.93 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.527 1.142 . . . . 0.0 110.287 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -95.56 -16.05 22.41 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.513 1.133 . . . . 0.0 109.286 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 1.019 HD12 HD23 ' A' ' 322' ' ' LEU . 7.9 mp -65.28 151.76 45.4 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.563 1.164 . . . . 0.0 109.316 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 6.0 tpt85 -121.12 116.18 24.5 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.496 1.123 . . . . 0.0 110.283 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.693 ' HB2' HD23 ' A' ' 320' ' ' LEU . . . -80.59 122.73 27.42 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.493 1.12 . . . . 0.0 109.266 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.45 141.07 52.26 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.48 1.112 . . . . 0.0 110.297 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.2 m -91.51 118.24 30.41 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.494 1.121 . . . . 0.0 110.349 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.664 ' CG1' ' HB2' ' A' ' 313' ' ' ALA . 4.0 t -106.36 114.19 62.47 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.536 1.148 . . . . 0.0 109.329 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.505 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.93 171.64 17.9 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.493 1.786 . . . . 0.0 110.978 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.519 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -67.73 129.13 38.95 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.535 1.147 . . . . 0.0 109.316 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 96.07 -25.55 24.95 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.55 1.156 . . . . 0.0 110.994 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.533 ' HB3' HG13 ' A' ' 256' ' ' VAL . . . -58.95 138.3 57.51 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.516 0.774 . . . . 0.0 109.262 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 9.3 t -83.34 126.65 40.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.496 1.123 . . . . 0.0 109.334 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.61 HD12 HG12 ' A' ' 311' ' ' VAL . 94.9 mt -82.92 -45.49 19.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.476 1.11 . . . . 0.0 109.307 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 263' ' ' CYS . . . . . 0.609 ' SG ' HG23 ' A' ' 311' ' ' VAL . 7.9 p -152.72 143.87 23.13 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.493 1.12 . . . . 0.0 108.321 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -86.81 176.67 7.6 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.513 1.133 . . . . 0.0 110.281 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.444 HG23 ' OG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -78.25 148.56 6.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.492 1.12 . . . . 0.0 109.286 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 37.08 47.44 1.36 Allowed Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.469 1.106 . . . . 0.0 110.981 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.445 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.0 OUTLIER -70.25 165.21 46.19 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.516 0.774 . . . . 0.0 110.3 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 267' ' ' GLU . 18.2 Cg_endo -75.06 76.39 3.44 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.525 1.803 . . . . 0.0 110.983 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 269' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 268' ' ' PRO . . . -36.71 105.95 0.04 OUTLIER Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.576 1.173 . . . . 0.0 110.994 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -170.51 37.37 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.481 0.754 . . . . 0.0 109.29 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -172.31 156.83 3.94 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.476 1.11 . . . . 0.0 110.301 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 272' ' ' MET . . . . . 0.686 ' HG3' HD12 ' A' ' 301' ' ' LEU . 0.0 OUTLIER -122.6 146.47 47.41 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.467 1.105 . . . . 0.0 111.022 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.591 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 13.6 m-85 -133.21 143.37 49.11 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.471 1.107 . . . . 0.0 111.033 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -133.15 125.2 28.95 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.515 1.134 . . . . 0.0 110.987 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.547 HG22 HD12 ' A' ' 319' ' ' LEU . 56.4 t -78.22 129.32 37.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.431 1.082 . . . . 0.0 109.319 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.838 ' CG2' HD11 ' A' ' 320' ' ' LEU . 59.3 t -101.55 -54.05 7.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.506 1.129 . . . . 0.0 109.323 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.714 ' O ' HG23 ' A' ' 317' ' ' VAL . 15.6 mt-10 -141.83 140.71 33.02 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.542 1.151 . . . . 0.0 110.274 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 113.15 -155.87 16.01 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.526 1.142 . . . . 0.0 111.01 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 290' ' ' LEU . 1.8 m -145.96 139.36 26.13 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.487 0.757 . . . . 0.0 110.001 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.579 HG12 HD11 ' A' ' 262' ' ' ILE . 27.1 m -120.76 135.57 60.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.555 1.159 . . . . 0.0 109.266 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 281' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 29.9 t -104.27 139.77 38.81 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.429 1.08 . . . . 0.0 109.968 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 1.3 t -103.88 129.66 55.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.471 1.107 . . . . 0.0 109.322 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.413 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -78.05 101.36 6.92 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.543 1.152 . . . . 0.0 109.358 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 284' ' ' THR . . . . . 0.662 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -149.0 -168.0 0.17 Allowed Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.5 1.125 . . . . 0.0 110.427 -179.974 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.662 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -75.01 4.43 4.75 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.502 1.79 . . . . 0.0 111.007 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -152.27 154.59 32.37 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.529 1.143 . . . . 0.0 109.309 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 95.12 0.96 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.46 1.769 . . . . 0.0 110.983 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 281' ' ' SER . 19.3 t -100.15 118.39 46.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.56 1.163 . . . . 0.0 109.331 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.407 ' C ' HD22 ' A' ' 290' ' ' LEU . 3.4 mm-40 -125.38 133.74 52.42 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.489 1.118 . . . . 0.0 110.324 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.407 HD22 ' C ' ' A' ' 289' ' ' GLU . 4.6 mm? -114.51 139.71 49.34 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.52 1.138 . . . . 0.0 109.289 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -93.72 -157.43 33.17 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.564 1.165 . . . . 0.0 111.007 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 147.86 34.49 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.509 1.794 . . . . 0.0 111.005 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 85.95 5.85 83.02 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.532 1.145 . . . . 0.0 111.034 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -85.61 146.27 26.95 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.539 0.788 . . . . 0.0 109.332 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 295' ' ' PHE . 1.0 OUTLIER -132.95 152.81 51.87 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.549 1.156 . . . . 0.0 110.99 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.591 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 46.3 p90 -165.77 143.88 5.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.553 1.158 . . . . 0.0 110.958 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 129.59 -6.73 6.22 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.48 1.113 . . . . 0.0 110.994 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -52.09 -48.43 64.71 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.503 0.767 . . . . 0.0 110.275 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 299' ' ' MET . . . . . 0.442 ' HB3' ' CG ' ' A' ' 305' ' ' GLU . 0.0 OUTLIER -50.21 -37.45 35.28 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.502 1.126 . . . . 0.0 111.047 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 300' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -66.13 -40.34 90.58 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.466 1.104 . . . . 0.0 109.298 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.686 HD12 ' HG3' ' A' ' 272' ' ' MET . 27.7 mt -74.84 -21.64 59.15 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 0.0 109.306 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 15.0 mm -67.16 -57.64 9.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.458 1.099 . . . . 0.0 109.303 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 304' ' ' GLY . 7.4 m -155.96 44.85 0.44 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.532 1.145 . . . . 0.0 109.98 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 35.69 49.9 1.04 Allowed Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.531 1.144 . . . . 0.0 111.041 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 305' ' ' GLU . . . . . 0.442 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 0.0 OUTLIER -80.26 158.8 71.45 Favored Pre-proline 0 C--N 1.326 -0.443 0 O-C-N 124.497 0.763 . . . . 0.0 110.271 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.01 130.25 13.09 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.525 1.802 . . . . 0.0 111.032 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -47.07 -39.34 12.82 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.5 1.125 . . . . 0.0 110.275 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.503 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 15.0 m 67.77 30.34 6.4 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.478 1.111 . . . . 0.0 109.995 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 309' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 175.67 162.26 0.3 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.532 1.145 . . . . 0.0 109.299 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.444 ' OG1' HG23 ' A' ' 265' ' ' ILE . 0.9 OUTLIER -113.04 137.6 51.17 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.515 1.135 . . . . 0.0 110.398 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.61 HG12 HD12 ' A' ' 262' ' ' ILE . 95.1 t -109.43 127.62 66.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.504 1.128 . . . . 0.0 109.318 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 48.3 p -121.94 145.28 48.26 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.501 1.126 . . . . 0.0 110.026 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 313' ' ' ALA . . . . . 0.758 ' HB1' HG12 ' A' ' 317' ' ' VAL . . . -79.53 106.23 11.41 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.536 1.148 . . . . 0.0 109.28 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -52.99 -24.64 9.89 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.473 1.108 . . . . 0.0 109.325 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 315' ' ' THR . . . . . 0.636 ' O ' HG12 ' A' ' 317' ' ' VAL . 8.8 t -168.09 -164.64 0.55 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.495 1.122 . . . . 0.0 110.38 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 316' ' ' THR . . . . . 0.438 ' N ' ' OG1' ' A' ' 315' ' ' THR . 29.2 p -61.35 79.11 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.508 1.13 . . . . 0.0 110.443 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.819 HG22 ' CD1' ' A' ' 319' ' ' LEU . 2.7 p -110.74 141.88 24.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.5 1.125 . . . . 0.0 109.277 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 318' ' ' SER . . . . . 1.019 ' C ' HD13 ' A' ' 319' ' ' LEU . 53.4 m -117.57 136.51 53.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.454 1.096 . . . . 0.0 109.949 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 319' ' ' LEU . . . . . 1.019 HD13 ' C ' ' A' ' 318' ' ' SER . 0.0 OUTLIER -135.86 173.77 11.35 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.479 1.112 . . . . 0.0 109.309 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.838 HD11 ' CG2' ' A' ' 276' ' ' VAL . 0.1 OUTLIER -124.22 125.19 44.0 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.528 1.143 . . . . 0.0 109.292 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 272' ' ' MET . 25.8 p -86.97 158.67 19.22 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.518 1.136 . . . . 0.0 110.036 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 1.019 HD23 HD12 ' A' ' 251' ' ' LEU . 3.1 tm? -145.44 86.71 1.76 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.491 1.119 . . . . 0.0 109.311 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 323' ' ' HIS . . . . . 0.536 ' CE1' ' OD1' ' A' ' 326' ' ' ASP . 6.0 p80 -50.7 137.31 20.26 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.535 1.147 . . . . 0.0 109.605 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.19 -26.11 62.39 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.473 1.108 . . . . 0.0 110.004 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -53.6 -36.76 62.31 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.459 1.1 . . . . 0.0 109.311 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 326' ' ' ASP . . . . . 0.536 ' OD1' ' CE1' ' A' ' 323' ' ' HIS . 0.6 OUTLIER -64.99 -41.45 95.4 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.485 1.116 . . . . 0.0 109.317 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 327' ' ' PHE . . . . . 0.49 ' CE1' ' CE2' ' A' ' 341' ' ' PHE . 71.9 t80 -66.84 -34.96 78.95 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.439 1.087 . . . . 0.0 110.965 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -69.86 -33.99 73.0 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.482 1.113 . . . . 0.0 110.288 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 30.4 ttp -70.19 -43.88 69.84 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.441 1.088 . . . . 0.0 111.014 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 2.7 mt -71.66 -35.38 70.31 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.505 1.128 . . . . 0.0 109.286 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 41.6 m -72.31 -30.63 64.95 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.52 1.137 . . . . 0.0 108.278 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 33.0 t -75.78 -34.49 60.23 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.518 1.136 . . . . 0.0 110.021 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.48 -36.3 65.79 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.528 1.142 . . . . 0.0 109.97 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.5 114.32 27.25 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 0.0 109.975 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -22.51 14.81 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.448 1.762 . . . . 0.0 111.007 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -71.91 -29.34 64.21 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.562 1.164 . . . . 0.0 110.286 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.671 HD11 HG21 ' A' ' 243' ' ' VAL . 44.5 mt -71.95 -40.14 67.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.134 . . . . 0.0 109.26 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.55 -31.84 65.59 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 0.0 109.278 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -74.95 -42.15 58.2 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.562 1.164 . . . . 0.0 110.288 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 86.3 mt -70.96 -42.81 77.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.486 1.116 . . . . 0.0 109.287 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.49 ' CE2' ' CE1' ' A' ' 327' ' ' PHE . 24.8 t80 -67.46 -39.61 85.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.521 1.138 . . . . 0.0 111.039 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -68.12 -37.32 80.99 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.526 1.141 . . . . 0.0 110.303 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -44.09 84.16 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.52 1.137 . . . . 0.0 109.281 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 344' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 341' ' ' PHE . 0.6 OUTLIER -67.99 -32.62 73.15 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.465 1.103 . . . . 0.0 110.377 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -69.91 -41.15 75.07 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.45 1.094 . . . . 0.0 109.333 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' A' ' 346' ' ' LEU . 14.5 mt -65.2 -41.42 94.55 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 0.0 109.283 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -65.81 -37.64 86.81 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.112 . . . . 0.0 110.3 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 28.3 mtt-85 . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.512 1.133 . . . . 0.0 110.325 -179.999 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.4 ' CE1' HG11 ' A' ' 248' ' ' VAL . 1.6 t80 . . . . . 0 N--CA 1.452 -0.332 0 CA-C-O 120.541 0.21 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.57 -35.44 56.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.466 1.104 . . . . 0.0 109.276 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.767 ' O ' HD23 ' A' ' 229' ' ' LEU . 0.5 OUTLIER -70.72 -31.56 68.44 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.478 1.111 . . . . 0.0 110.311 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.455 ' ND2' ' CD1' ' A' ' 320' ' ' LEU . 4.1 m-20 -81.23 -31.57 33.77 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.532 1.145 . . . . 0.0 109.276 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' TRP . . . . . 0.89 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 2.0 t90 -70.61 -43.75 68.67 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.455 ' O ' ' N ' ' A' ' 232' ' ' ALA . 1.5 pt20 -70.89 -37.28 73.0 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.494 1.121 . . . . 0.0 110.278 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.909 HD12 ' HB3' ' A' ' 274' ' ' PHE . 1.6 mm? -60.18 -42.75 95.69 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.51 1.131 . . . . 0.0 109.314 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.688 HG13 ' CD1' ' A' ' 244' ' ' LEU . 12.7 p -74.23 -38.74 48.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.515 1.135 . . . . 0.0 109.284 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -75.15 -11.51 60.1 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.472 1.107 . . . . 0.0 109.33 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 228' ' ' GLN . . . -81.15 -7.83 59.64 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.496 1.123 . . . . 0.0 109.297 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 1.5 t -98.64 130.06 28.74 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.522 1.139 . . . . 0.0 109.298 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 -16.0 20.33 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.472 1.775 . . . . 0.0 110.971 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.677 HD12 ' CE2' ' A' ' 341' ' ' PHE . 0.0 OUTLIER -81.08 -23.84 38.18 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.519 1.137 . . . . 0.0 109.314 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 236' ' ' PHE . . . . . 0.719 ' CE1' HD13 ' A' ' 247' ' ' ILE . 30.7 m-85 -102.95 -19.22 14.69 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.454 1.096 . . . . 0.0 111.018 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.51 -22.91 67.1 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.463 1.102 . . . . 0.0 110.28 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -76.77 -1.59 28.85 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.502 1.126 . . . . 0.0 109.294 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.586 ' HB3' HG11 ' A' ' 243' ' ' VAL . 8.4 mt -94.38 -179.78 5.03 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.437 1.086 . . . . 0.0 109.278 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -98.45 -174.42 32.61 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.518 1.136 . . . . 0.0 110.969 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.9 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.4 Cg_endo -75.01 -35.48 3.1 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.451 1.764 . . . . 0.0 110.97 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.1 -33.37 75.32 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.461 1.101 . . . . 0.0 109.299 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.795 HG21 HD11 ' A' ' 337' ' ' ILE . 2.7 t -75.18 -42.4 44.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.535 1.147 . . . . 0.0 109.327 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.688 ' CD1' HG13 ' A' ' 230' ' ' VAL . 0.3 OUTLIER -65.63 -36.82 84.8 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.524 1.14 . . . . 0.0 109.289 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 241' ' ' PRO . 87.8 t -69.15 -43.18 81.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.449 1.093 . . . . 0.0 109.278 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -44.17 91.68 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 0.0 110.312 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.719 HD13 ' CE1' ' A' ' 236' ' ' PHE . 90.0 mt -65.6 -37.16 79.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.495 1.122 . . . . 0.0 109.3 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 244' ' ' LEU . 14.4 t -67.54 -34.97 71.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.506 1.128 . . . . 0.0 109.31 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -24.84 59.92 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.49 1.118 . . . . 0.0 110.274 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.472 ' CB ' ' OD1' ' A' ' 326' ' ' ASP . . . -87.22 -21.59 25.75 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.477 1.111 . . . . 0.0 109.291 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.471 HD22 ' HB2' ' A' ' 320' ' ' LEU . 3.0 mt -55.9 136.48 51.56 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.484 1.115 . . . . 0.0 109.283 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.42 134.76 55.06 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.494 1.121 . . . . 0.0 110.265 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.554 ' HA ' HD22 ' A' ' 320' ' ' LEU . . . -80.15 129.6 34.62 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.525 1.141 . . . . 0.0 109.323 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 319' ' ' LEU . 6.7 ttm-85 -133.62 121.28 21.8 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.513 1.133 . . . . 0.0 110.333 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 20.0 m -91.79 116.57 29.0 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.532 1.145 . . . . 0.0 110.436 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.689 HG21 HD11 ' A' ' 319' ' ' LEU . 97.3 t -106.68 113.14 63.22 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.473 1.108 . . . . 0.0 109.263 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.51 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -75.0 171.45 18.31 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.5 1.789 . . . . 0.0 111.04 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.519 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -67.33 128.58 36.93 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.465 1.103 . . . . 0.0 109.325 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 96.85 -25.11 28.11 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.489 1.118 . . . . 0.0 110.992 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.51 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -60.64 149.14 36.04 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.532 0.784 . . . . 0.0 109.306 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.3 t -97.28 131.61 43.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 124.494 1.121 . . . . 0.0 109.331 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.768 HD12 HG12 ' A' ' 311' ' ' VAL . 45.8 mt -83.41 -41.65 17.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.468 1.105 . . . . 0.0 109.309 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' CYS . . . . . 0.423 ' SG ' HG23 ' A' ' 311' ' ' VAL . 14.9 p -158.34 151.09 22.35 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.452 1.095 . . . . 0.0 108.273 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -94.32 -178.81 4.71 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.472 1.108 . . . . 0.0 110.305 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.457 HG23 ' OG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -74.64 143.99 12.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.101 . . . . 0.0 109.321 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 41.47 53.95 4.13 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.537 1.148 . . . . 0.0 110.987 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.409 ' OE1' ' C ' ' A' ' 268' ' ' PRO . 0.3 OUTLIER -70.61 163.5 63.13 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.498 0.764 . . . . 0.0 110.295 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.452 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.1 Cg_endo -75.01 81.43 2.22 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.476 1.777 . . . . 0.0 110.965 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -36.65 95.76 0.01 OUTLIER Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.559 1.162 . . . . 0.0 111.037 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 268' ' ' PRO . 6.8 m-20 -170.83 38.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.519 0.776 . . . . 0.0 109.305 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 271' ' ' ARG . . . . . 0.411 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 0.0 OUTLIER -170.01 144.62 2.74 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.508 1.13 . . . . 0.0 110.233 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 272' ' ' MET . . . . . 0.593 ' SD ' ' CZ ' ' A' ' 274' ' ' PHE . 0.0 OUTLIER -114.4 147.38 39.29 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.126 . . . . 0.0 111.003 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.583 ' HD2' HD13 ' A' ' 319' ' ' LEU . 50.3 m-85 -135.91 137.64 41.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.452 1.095 . . . . 0.0 111.026 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 274' ' ' PHE . . . . . 0.909 ' HB3' HD12 ' A' ' 229' ' ' LEU . 17.8 m-85 -129.11 130.29 46.27 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.548 1.155 . . . . 0.0 111.014 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 292' ' ' PRO . 29.1 t -86.28 130.48 36.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.488 1.117 . . . . 0.0 109.33 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.636 HG13 ' HD2' ' A' ' 225' ' ' ARG . 2.6 t -110.87 -44.39 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.479 1.112 . . . . 0.0 109.274 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.406 ' O ' HG13 ' A' ' 317' ' ' VAL . 2.9 mt-10 -145.85 132.79 20.2 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 0.0 110.299 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.902 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 117.06 -177.68 16.79 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.545 1.153 . . . . 0.0 111.003 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 279' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 290' ' ' LEU . 5.4 t -128.94 121.79 28.81 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.497 0.763 . . . . 0.0 110.014 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.464 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 24.1 m -99.87 161.18 3.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.474 1.109 . . . . 0.0 109.286 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 281' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 29.4 t -129.41 149.6 51.12 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.537 1.148 . . . . 0.0 110.006 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 1.4 t -112.45 131.44 63.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.493 1.121 . . . . 0.0 109.331 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.403 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -79.85 101.92 8.81 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.46 1.1 . . . . 0.0 109.268 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 284' ' ' THR . . . . . 0.654 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.41 -168.32 0.18 Allowed Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.508 1.13 . . . . 0.0 110.396 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.654 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.4 Cg_endo -75.0 4.8 4.42 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.491 1.785 . . . . 0.0 111.038 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -151.59 155.69 34.27 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.481 1.113 . . . . 0.0 109.286 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.07 95.85 1.0 Allowed 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.517 1.798 . . . . 0.0 111.029 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 281' ' ' SER . 6.0 t -100.42 119.3 48.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.455 1.097 . . . . 0.0 109.33 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.503 ' C ' HD22 ' A' ' 290' ' ' LEU . 15.1 mt-10 -124.9 141.68 51.96 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.493 1.121 . . . . 0.0 110.332 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.503 HD22 ' C ' ' A' ' 289' ' ' GLU . 4.4 mm? -120.69 142.5 49.43 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.546 1.154 . . . . 0.0 109.276 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -93.79 -163.43 36.34 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.529 1.143 . . . . 0.0 111.023 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 292' ' ' PRO . . . . . 0.537 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.4 Cg_endo -74.94 149.63 37.28 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.502 1.791 . . . . 0.0 110.995 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 86.95 -0.07 85.99 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.481 1.113 . . . . 0.0 110.974 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -79.65 146.21 32.6 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.488 0.757 . . . . 0.0 109.362 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -132.84 152.69 51.78 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.516 1.135 . . . . 0.0 111.012 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.552 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 40.7 p90 -166.57 147.65 6.23 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.496 1.123 . . . . 0.0 110.959 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 297' ' ' GLY . . . . . 0.467 ' CA ' ' HE3' ' A' ' 272' ' ' MET . . . 129.8 -10.38 6.03 Favored Glycine 0 CA--C 1.531 1.053 0 O-C-N 124.544 1.153 . . . . 0.0 110.995 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -52.57 -41.78 63.89 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.532 0.784 . . . . 0.0 110.316 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 299' ' ' MET . . . . . 0.583 ' HA ' HD12 ' A' ' 302' ' ' ILE . 0.8 OUTLIER -54.83 -37.28 65.97 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.503 1.127 . . . . 0.0 111.015 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 300' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -67.72 -39.21 84.31 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.496 1.123 . . . . 0.0 109.284 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.467 ' CD1' ' HG3' ' A' ' 272' ' ' MET . 5.7 mt -76.44 -13.67 60.1 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.503 1.127 . . . . 0.0 109.265 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 302' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' A' ' 299' ' ' MET . 32.2 mt -77.3 -54.5 12.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.514 1.134 . . . . 0.0 109.295 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.441 ' O ' ' N ' ' A' ' 305' ' ' GLU . 46.4 p -155.07 42.05 0.45 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.506 1.129 . . . . 0.0 109.986 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 37.07 31.56 0.06 OUTLIER Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.501 1.126 . . . . 0.0 110.998 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 305' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 303' ' ' SER . 0.1 OUTLIER -61.71 157.12 50.8 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.52 0.777 . . . . 0.0 110.322 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 128.99 11.91 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.51 1.795 . . . . 0.0 111.044 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 307' ' ' ARG . . . . . 0.423 HH11 ' HB2' ' A' ' 300' ' ' ALA . 0.0 OUTLIER -44.52 -40.29 5.53 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.506 1.129 . . . . 0.0 110.294 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.66 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 22.8 t 64.87 43.31 4.0 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.486 1.117 . . . . 0.0 110.02 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 309' ' ' ALA . . . . . 0.66 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 165.86 159.76 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.48 1.113 . . . . 0.0 109.291 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.457 ' OG1' HG23 ' A' ' 265' ' ' ILE . 1.0 OUTLIER -110.38 133.92 52.8 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.465 1.103 . . . . 0.0 110.416 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.768 HG12 HD12 ' A' ' 262' ' ' ILE . 55.3 t -113.06 129.39 68.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.525 1.14 . . . . 0.0 109.294 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 60.3 p -129.59 156.71 43.76 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.542 1.151 . . . . 0.0 110.02 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -92.53 115.57 28.22 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.515 1.135 . . . . 0.0 109.312 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -59.5 -32.65 70.48 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.481 1.113 . . . . 0.0 109.287 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 315' ' ' THR . . . . . 0.653 ' O ' HG23 ' A' ' 317' ' ' VAL . 11.0 t -154.6 -173.14 4.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.506 1.129 . . . . 0.0 110.385 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 316' ' ' THR . . . . . 0.413 HG23 ' H ' ' A' ' 316' ' ' THR . 65.4 p -52.2 88.54 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.503 1.127 . . . . 0.0 110.391 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.902 HG22 ' HA3' ' A' ' 278' ' ' GLY . 68.9 t -103.57 154.35 5.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 O-C-N 124.539 1.149 . . . . 0.0 109.308 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 49.1 m -129.07 113.89 15.69 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.482 1.114 . . . . 0.0 109.998 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 319' ' ' LEU . . . . . 1.03 ' C ' HD23 ' A' ' 320' ' ' LEU . 0.2 OUTLIER -129.0 170.44 13.46 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.136 . . . . 0.0 109.266 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 1.03 HD23 ' C ' ' A' ' 319' ' ' LEU . 0.6 OUTLIER -121.79 139.87 53.06 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.518 1.136 . . . . 0.0 109.327 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 64.8 p -95.6 158.79 15.3 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.122 . . . . 0.0 109.982 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.503 ' O ' HD13 ' A' ' 322' ' ' LEU . 3.3 tm? -148.64 82.36 1.46 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.496 1.122 . . . . 0.0 109.312 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 323' ' ' HIS . . . . . 0.572 ' ND1' ' HB3' ' A' ' 325' ' ' ALA . 8.5 p80 -47.63 136.99 9.7 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.504 1.127 . . . . 0.0 109.599 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.95 -20.93 6.89 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.504 1.128 . . . . 0.0 109.981 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 325' ' ' ALA . . . . . 0.572 ' HB3' ' ND1' ' A' ' 323' ' ' HIS . . . -51.9 -38.24 55.48 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.522 1.139 . . . . 0.0 109.291 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 326' ' ' ASP . . . . . 0.472 ' OD1' ' CB ' ' A' ' 250' ' ' ALA . 36.0 t70 -63.94 -37.08 86.09 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.541 1.151 . . . . 0.0 109.257 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 327' ' ' PHE . . . . . 0.472 ' CZ ' ' CE2' ' A' ' 341' ' ' PHE . 6.1 t80 -66.96 -40.02 87.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.48 1.112 . . . . 0.0 110.96 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -66.0 -33.24 75.35 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.527 1.142 . . . . 0.0 110.301 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 50.9 ttp -70.91 -39.33 72.79 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.549 1.155 . . . . 0.0 111.004 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.683 HD11 HG13 ' A' ' 247' ' ' ILE . 0.1 OUTLIER -68.7 -39.23 80.58 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.487 1.117 . . . . 0.0 109.293 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 331' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 338' ' ' ALA . 19.8 t -70.97 -32.97 69.99 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.45 1.093 . . . . 0.0 108.268 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 19.1 t -72.87 -31.08 64.47 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.482 1.114 . . . . 0.0 110.039 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.9 t -83.3 -37.86 22.88 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.447 1.092 . . . . 0.0 110.022 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.12 107.94 17.94 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.539 1.149 . . . . 0.0 110.009 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -21.01 16.33 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.466 1.772 . . . . 0.0 110.978 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -72.58 -28.52 62.85 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.519 1.137 . . . . 0.0 110.319 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.795 HD11 HG21 ' A' ' 243' ' ' VAL . 46.2 mt -65.46 -32.88 60.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 0.0 109.308 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 338' ' ' ALA . . . . . 0.589 ' HB2' ' SG ' ' A' ' 331' ' ' CYS . . . -70.74 -35.06 72.5 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.536 1.147 . . . . 0.0 109.31 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -71.42 -34.79 70.63 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.518 1.136 . . . . 0.0 110.338 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.486 ' O ' HG22 ' A' ' 344' ' ' THR . 66.1 mt -73.06 -42.53 59.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.124 . . . . 0.0 109.303 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.677 ' CE2' HD12 ' A' ' 235' ' ' LEU . 1.0 OUTLIER -70.98 -31.2 67.68 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 0.0 111.02 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 342' ' ' ARG . . . . . 0.491 ' O ' HD12 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -73.24 -41.07 64.13 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.48 1.113 . . . . 0.0 110.282 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.13 -50.51 65.73 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.423 1.077 . . . . 0.0 109.305 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 344' ' ' THR . . . . . 0.5 HG22 ' HA ' ' A' ' 341' ' ' PHE . 7.4 t -64.97 -37.68 88.45 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.514 1.134 . . . . 0.0 110.429 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 345' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 341' ' ' PHE . . . -65.15 -43.32 92.24 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.504 1.127 . . . . 0.0 109.335 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 342' ' ' ARG . 0.4 OUTLIER -64.9 -35.12 80.13 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 0.0 109.256 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -69.42 -37.77 77.58 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.543 1.152 . . . . 0.0 110.33 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 . . . . . 0 C--N 1.326 -0.442 0 O-C-N 124.464 1.102 . . . . 0.0 110.309 179.967 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 35.3 t80 . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 120.503 0.192 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.74 -35.15 59.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.486 1.117 . . . . 0.0 109.283 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.534 ' HD3' HD23 ' A' ' 229' ' ' LEU . 0.0 OUTLIER -67.6 -36.61 81.2 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.509 1.131 . . . . 0.0 110.323 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.792 ' HB3' HD13 ' A' ' 251' ' ' LEU . 1.6 m-20 -75.1 -30.19 60.83 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.478 1.111 . . . . 0.0 109.288 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' TRP . . . . . 0.679 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 1.6 t90 -67.63 -49.51 62.64 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.505 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 6.0 pt20 -67.22 -30.94 70.99 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.54 1.15 . . . . 0.0 110.312 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.534 HD23 ' HD3' ' A' ' 225' ' ' ARG . 0.6 OUTLIER -64.54 -47.14 79.93 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.508 1.13 . . . . 0.0 109.3 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.778 HG23 ' CD1' ' A' ' 244' ' ' LEU . 34.9 m -70.11 -37.63 72.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.501 1.125 . . . . 0.0 109.304 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -75.83 -14.97 60.3 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.479 1.112 . . . . 0.0 109.308 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -82.27 -25.15 34.3 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.567 1.167 . . . . 0.0 109.337 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 230' ' ' VAL . 0.3 OUTLIER -86.94 133.51 39.11 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.483 1.114 . . . . 0.0 109.311 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 -4.35 15.27 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.498 1.789 . . . . 0.0 111.012 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.98 -24.07 33.08 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.492 1.12 . . . . 0.0 109.32 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' PHE . . . . . 0.516 ' O ' HD21 ' A' ' 244' ' ' LEU . 17.4 m-30 -119.73 -1.26 10.59 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.467 1.105 . . . . 0.0 110.986 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -71.69 -23.39 61.65 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.513 1.133 . . . . 0.0 110.309 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.442 ' NZ ' ' HA ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -92.55 7.59 42.58 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.482 1.114 . . . . 0.0 109.316 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.566 HD22 HG11 ' A' ' 243' ' ' VAL . 86.4 mt -89.26 179.76 6.04 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.48 1.113 . . . . 0.0 109.265 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' GLY . . . . . 0.669 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -98.21 -176.94 33.18 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.506 1.129 . . . . 0.0 111.036 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.981 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.3 Cg_endo -75.0 -37.33 2.07 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.5 1.789 . . . . 0.0 110.985 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.84 -34.68 77.19 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.464 1.102 . . . . 0.0 109.3 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.566 HG11 HD22 ' A' ' 239' ' ' LEU . 14.1 t -75.4 -38.02 39.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.514 1.134 . . . . 0.0 109.317 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.778 ' CD1' HG23 ' A' ' 230' ' ' VAL . 1.4 mm? -66.79 -35.84 81.0 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.514 1.133 . . . . 0.0 109.305 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.981 HG23 ' O ' ' A' ' 241' ' ' PRO . 60.9 t -74.39 -38.88 47.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.485 1.116 . . . . 0.0 109.296 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -65.25 -48.39 73.43 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.519 1.137 . . . . 0.0 110.268 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.552 HG13 HD13 ' A' ' 330' ' ' LEU . 32.1 mt -63.15 -43.27 98.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.524 1.14 . . . . 0.0 109.316 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 244' ' ' LEU . 41.2 t -65.29 -38.21 82.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.459 1.1 . . . . 0.0 109.269 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -72.49 -19.25 61.58 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.422 1.076 . . . . 0.0 110.292 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -91.82 -16.3 26.96 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.521 1.138 . . . . 0.0 109.303 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.792 HD13 ' HB3' ' A' ' 226' ' ' ASN . 2.2 mt -66.84 129.27 39.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.495 1.122 . . . . 0.0 109.313 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 252' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 320' ' ' LEU . 3.2 tpt85 -110.15 118.08 35.41 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.492 1.12 . . . . 0.0 110.308 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.536 ' HB2' HD23 ' A' ' 320' ' ' LEU . . . -80.15 136.77 36.58 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.458 1.099 . . . . 0.0 109.311 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.47 ' HD2' HD23 ' A' ' 319' ' ' LEU . 0.0 OUTLIER -143.06 139.67 30.6 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.547 1.155 . . . . 0.0 110.339 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.0 m -92.4 117.92 30.41 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.561 1.163 . . . . 0.0 110.373 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.631 HG12 ' CB ' ' A' ' 313' ' ' ALA . 37.1 t -107.33 112.77 62.57 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.499 1.124 . . . . 0.0 109.285 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.457 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.3 Cg_endo -74.99 173.33 14.7 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.485 1.782 . . . . 0.0 111.006 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.633 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -67.37 130.38 42.89 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.543 1.152 . . . . 0.0 109.301 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 95.48 -25.28 25.37 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.519 1.137 . . . . 0.0 111.01 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.608 ' HB3' HG13 ' A' ' 256' ' ' VAL . . . -56.43 140.59 45.27 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.496 0.762 . . . . 0.0 109.326 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.648 HG21 HH21 ' A' ' 264' ' ' ARG . 3.7 t -92.28 127.17 44.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.491 1.119 . . . . 0.0 109.34 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.842 HD12 HG12 ' A' ' 311' ' ' VAL . 40.8 mt -85.03 -41.91 16.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.477 1.111 . . . . 0.0 109.325 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 11.9 p -155.81 148.87 24.43 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.536 1.147 . . . . 0.0 108.296 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' ARG . . . . . 0.648 HH21 HG21 ' A' ' 261' ' ' VAL . 2.0 mmt85 -92.35 178.57 5.8 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.491 1.119 . . . . 0.0 110.329 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.574 HG23 ' OG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -76.42 141.59 15.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.495 1.122 . . . . 0.0 109.304 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 46.23 46.83 16.08 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.52 1.138 . . . . 0.0 111.006 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.453 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.0 OUTLIER -70.19 164.91 48.8 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 124.451 0.736 . . . . 0.0 110.299 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 267' ' ' GLU . 18.4 Cg_endo -75.0 77.04 3.22 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.502 1.791 . . . . 0.0 111.03 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 269' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 268' ' ' PRO . . . -35.84 100.21 0.01 OUTLIER Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.452 1.095 . . . . 0.0 111.016 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -169.76 38.09 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.545 0.791 . . . . 0.0 109.315 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -171.33 147.14 2.42 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.129 . . . . 0.0 110.281 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 272' ' ' MET . . . . . 0.872 ' HB2' HD11 ' A' ' 301' ' ' LEU . 2.0 ttt -116.67 150.45 38.13 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.479 1.112 . . . . 0.0 111.003 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.577 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 14.8 m-85 -135.43 136.9 41.73 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.453 1.095 . . . . 0.0 110.973 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 274' ' ' PHE . . . . . 0.47 ' CD1' ' CB ' ' A' ' 295' ' ' PHE . 22.8 m-30 -125.66 124.38 41.02 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.494 1.121 . . . . 0.0 110.959 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.441 HG22 HD12 ' A' ' 319' ' ' LEU . 85.2 t -80.03 135.81 24.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.515 1.134 . . . . 0.0 109.255 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.656 HG12 ' HG3' ' A' ' 277' ' ' GLU . 99.1 t -108.73 -56.01 4.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.461 1.101 . . . . 0.0 109.27 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.656 ' HG3' HG12 ' A' ' 276' ' ' VAL . 16.8 mt-10 -139.98 138.88 35.88 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.456 1.097 . . . . 0.0 110.314 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.01 -154.72 16.59 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.452 1.095 . . . . 0.0 111.03 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 290' ' ' LEU . 3.7 m -150.76 135.92 17.67 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.511 0.771 . . . . 0.0 110.029 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 289' ' ' GLU . 13.6 m -115.16 166.06 9.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.5 1.125 . . . . 0.0 109.321 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 281' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 28.8 t -131.33 149.44 52.55 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.457 1.098 . . . . 0.0 110.007 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.51 131.17 66.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.533 1.145 . . . . 0.0 109.304 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.478 ' HB3' ' H ' ' A' ' 310' ' ' THR . . . -79.7 101.87 8.65 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.52 1.137 . . . . 0.0 109.31 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 284' ' ' THR . . . . . 0.648 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.7 OUTLIER -148.27 -168.5 0.19 Allowed Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.458 1.099 . . . . 0.0 110.423 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.648 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.4 Cg_endo -74.95 4.89 4.31 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.533 1.807 . . . . 0.0 111.063 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -151.58 156.65 34.72 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.459 1.1 . . . . 0.0 109.293 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.91 95.37 0.97 Allowed 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.466 1.772 . . . . 0.0 111.032 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 281' ' ' SER . 24.1 t -99.53 118.9 46.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.105 . . . . 0.0 109.346 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.444 ' C ' HD22 ' A' ' 290' ' ' LEU . 14.4 mt-10 -124.76 138.16 54.29 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.511 1.132 . . . . 0.0 110.321 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.444 HD22 ' C ' ' A' ' 289' ' ' GLU . 4.3 mm? -119.84 142.19 48.87 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.51 1.131 . . . . 0.0 109.275 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -96.28 -153.25 29.65 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.53 1.144 . . . . 0.0 110.981 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 151.88 39.98 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.491 1.785 . . . . 0.0 111.021 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 76.99 6.35 85.82 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.52 1.138 . . . . 0.0 110.956 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -87.4 113.72 23.36 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.528 0.781 . . . . 0.0 109.279 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.47 ' CB ' ' CD1' ' A' ' 274' ' ' PHE . 15.1 p90 -107.15 152.98 23.33 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.488 1.117 . . . . 0.0 110.986 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 20.6 p90 -159.07 153.65 24.38 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.465 1.103 . . . . 0.0 110.98 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 123.17 -9.02 8.98 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.522 1.139 . . . . 0.0 111.041 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 298' ' ' GLU . . . . . 0.438 ' HG2' ' N ' ' A' ' 299' ' ' MET . 0.4 OUTLIER -52.37 -37.21 55.69 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.469 0.747 . . . . 0.0 110.273 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 299' ' ' MET . . . . . 0.438 ' N ' ' HG2' ' A' ' 298' ' ' GLU . 1.2 mmt -60.13 -32.09 70.68 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 0.0 110.976 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 300' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -75.02 -37.27 61.83 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.446 1.091 . . . . 0.0 109.298 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.872 HD11 ' HB2' ' A' ' 272' ' ' MET . 0.9 OUTLIER -78.11 -11.61 59.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.546 1.154 . . . . 0.0 109.321 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 302' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 299' ' ' MET . 35.0 mt -83.82 -52.87 12.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.495 1.122 . . . . 0.0 109.274 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.454 ' O ' ' C ' ' A' ' 304' ' ' GLY . 3.4 m -153.21 39.08 0.51 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.528 1.143 . . . . 0.0 110.02 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 33.07 43.76 0.21 Allowed Glycine 0 CA--C 1.529 0.966 0 O-C-N 124.493 1.121 . . . . 0.0 111.061 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.61 157.71 88.51 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.487 0.757 . . . . 0.0 110.287 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 129.95 12.83 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.503 1.791 . . . . 0.0 111.034 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -46.59 -34.98 5.4 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.506 1.129 . . . . 0.0 110.328 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 1.3 m 60.39 20.53 10.14 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.485 1.115 . . . . 0.0 109.962 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . -171.26 160.66 6.3 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 0.0 109.322 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.574 ' OG1' HG23 ' A' ' 265' ' ' ILE . 0.9 OUTLIER -107.68 137.22 46.1 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.523 1.14 . . . . 0.0 110.372 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.842 HG12 HD12 ' A' ' 262' ' ' ILE . 86.5 t -114.79 127.51 72.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.459 1.1 . . . . 0.0 109.317 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 32.3 m -128.18 159.24 35.79 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.505 1.128 . . . . 0.0 109.96 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 313' ' ' ALA . . . . . 0.927 ' HB1' HG12 ' A' ' 317' ' ' VAL . . . -90.92 110.45 21.69 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.461 1.101 . . . . 0.0 109.275 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -53.19 -32.06 46.07 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.511 1.132 . . . . 0.0 109.287 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 315' ' ' THR . . . . . 0.633 ' HA ' ' HB2' ' A' ' 258' ' ' ALA . 12.7 t -156.68 -163.74 1.49 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.487 1.117 . . . . 0.0 110.407 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 96.6 m -63.07 76.78 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.48 1.112 . . . . 0.0 110.35 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.927 HG12 ' HB1' ' A' ' 313' ' ' ALA . 2.8 p -107.38 141.14 23.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.491 1.12 . . . . 0.0 109.353 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 318' ' ' SER . . . . . 1.015 ' C ' HD13 ' A' ' 319' ' ' LEU . 66.1 m -116.12 134.59 54.77 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.534 1.146 . . . . 0.0 110.04 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 319' ' ' LEU . . . . . 1.015 HD13 ' C ' ' A' ' 318' ' ' SER . 0.0 OUTLIER -132.54 177.98 7.19 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.49 1.119 . . . . 0.0 109.324 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.728 ' HB2' HD22 ' A' ' 251' ' ' LEU . 0.2 OUTLIER -124.5 128.62 49.24 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.502 1.126 . . . . 0.0 109.326 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 13.1 p -90.12 155.18 19.23 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.534 1.146 . . . . 0.0 110.036 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 322' ' ' LEU . 1.5 tm? -149.02 90.86 1.79 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.517 1.136 . . . . 0.0 109.311 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 323' ' ' HIS . . . . . 0.534 ' CE1' ' HB2' ' A' ' 326' ' ' ASP . 7.9 p80 -49.98 136.54 18.49 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.538 1.149 . . . . 0.0 109.63 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 43.7 t -59.93 -25.56 65.25 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.545 1.153 . . . . 0.0 109.984 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -57.03 -34.06 67.83 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.496 1.123 . . . . 0.0 109.308 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 326' ' ' ASP . . . . . 0.534 ' HB2' ' CE1' ' A' ' 323' ' ' HIS . 31.6 t70 -68.83 -37.15 78.98 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.49 1.119 . . . . 0.0 109.337 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 327' ' ' PHE . . . . . 0.572 ' CG ' HD23 ' A' ' 301' ' ' LEU . 33.3 t80 -68.75 -40.38 79.83 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.499 1.124 . . . . 0.0 110.975 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -70.54 -31.92 69.15 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 0.0 110.327 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 17.6 tmm? -69.38 -44.7 70.98 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.467 1.105 . . . . 0.0 111.03 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.552 HD13 HG13 ' A' ' 247' ' ' ILE . 13.3 mt -70.6 -38.86 74.04 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.465 1.103 . . . . 0.0 109.31 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 331' ' ' CYS . . . . . 0.549 ' SG ' HG22 ' A' ' 337' ' ' ILE . 1.8 m -64.43 -38.12 89.9 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.472 1.107 . . . . 0.0 108.279 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 7.6 t -77.24 -26.24 52.39 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.494 1.121 . . . . 0.0 109.98 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.18 -39.2 71.99 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.129 . . . . 0.0 110.057 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.19 129.94 23.36 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.529 1.143 . . . . 0.0 109.979 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -25.44 11.92 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.464 1.771 . . . . 0.0 111.023 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.26 -28.57 67.32 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.123 . . . . 0.0 110.299 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.549 HG22 ' SG ' ' A' ' 331' ' ' CYS . 59.9 mt -71.43 -42.47 73.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.514 1.134 . . . . 0.0 109.294 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.11 -30.49 67.7 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.492 1.12 . . . . 0.0 109.303 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -72.1 -43.51 64.67 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 0.0 110.316 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.404 HG21 ' HB2' ' A' ' 238' ' ' LYS . 68.2 mt -72.08 -40.06 66.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.537 1.148 . . . . 0.0 109.306 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.478 ' CD1' ' O ' ' A' ' 341' ' ' PHE . 0.4 OUTLIER -68.66 -39.33 80.69 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.534 1.146 . . . . 0.0 110.994 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -68.65 -39.08 80.85 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.465 1.103 . . . . 0.0 110.275 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.7 -48.07 70.43 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.526 1.141 . . . . 0.0 109.341 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.24 -41.77 94.04 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.47 1.106 . . . . 0.0 110.424 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -68.65 -34.4 75.65 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.528 1.143 . . . . 0.0 109.315 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 346' ' ' LEU . 13.5 mt -69.9 -33.52 72.3 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.482 1.114 . . . . 0.0 109.262 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.4 -37.01 66.1 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.549 1.156 . . . . 0.0 110.334 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 4.4 mtt85 . . . . . 0 C--N 1.325 -0.457 0 O-C-N 124.527 1.142 . . . . 0.0 110.249 -179.984 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.992 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.13 160.87 14.99 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.499 0.764 . . . . 0.0 109.979 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -151.89 171.61 17.51 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.519 1.137 . . . . 0.0 110.317 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -118.43 168.45 10.63 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.51 1.131 . . . . 0.0 110.294 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 1.1 p -138.24 137.83 43.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.523 1.139 . . . . 0.0 109.31 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -63.84 175.35 1.17 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.492 1.12 . . . . 0.0 110.312 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.86 128.91 16.55 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.504 1.127 . . . . 0.0 110.288 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -112.1 -31.36 2.68 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.492 1.12 . . . . 0.0 110.978 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -91.22 19.27 6.04 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.545 0.791 . . . . 0.0 109.305 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -53.26 -39.29 63.76 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.526 1.141 . . . . 0.0 110.997 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -71.52 -43.22 72.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.515 1.134 . . . . 0.0 109.319 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.716 ' CD ' HD23 ' A' ' 229' ' ' LEU . 0.0 OUTLIER -65.86 -29.05 69.45 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.5 1.125 . . . . 0.0 110.328 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.58 ' ND2' HD22 ' A' ' 320' ' ' LEU . 6.5 t-20 -79.76 -30.37 40.73 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.541 1.151 . . . . 0.0 109.271 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' TRP . . . . . 0.879 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 2.1 t90 -68.09 -43.96 77.33 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.13 . . . . 0.0 107.985 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.619 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 9.8 pt20 -70.63 -36.93 73.69 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.513 1.133 . . . . 0.0 110.315 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.716 HD23 ' CD ' ' A' ' 225' ' ' ARG . 0.6 OUTLIER -60.99 -47.6 85.68 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.488 1.118 . . . . 0.0 109.323 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.791 HG12 ' CD1' ' A' ' 244' ' ' LEU . 64.5 t -73.23 -44.09 56.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.504 1.128 . . . . 0.0 109.307 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -68.28 -13.91 62.61 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.493 1.121 . . . . 0.0 109.282 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.619 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -81.64 -24.89 36.06 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.51 1.131 . . . . 0.0 109.288 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' VAL . . . . . 0.421 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 91.0 t -64.73 135.03 96.22 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.505 1.128 . . . . 0.0 109.316 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 233' ' ' VAL . 18.3 Cg_endo -75.02 -40.43 0.89 Allowed 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.42 1.747 . . . . 0.0 110.967 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 1.1 tp -63.56 -14.11 48.09 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.445 1.091 . . . . 0.0 109.302 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.474 ' CB ' HD12 ' A' ' 239' ' ' LEU . 16.8 m-30 -113.24 5.28 16.87 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.473 1.108 . . . . 0.0 110.973 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLN . . . . . 0.417 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -73.52 -29.43 62.47 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.492 1.12 . . . . 0.0 110.325 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.426 ' HB3' HG21 ' A' ' 340' ' ' ILE . 0.0 OUTLIER -89.31 7.09 37.42 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.517 1.136 . . . . 0.0 109.298 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.609 ' HB2' HD21 ' A' ' 244' ' ' LEU . 74.4 mt -85.58 176.64 8.09 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.504 1.128 . . . . 0.0 109.265 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' GLY . . . . . 0.68 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -101.03 176.19 26.78 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.509 1.131 . . . . 0.0 111.03 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.938 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.3 Cg_endo -74.99 -36.35 2.6 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.513 1.796 . . . . 0.0 110.993 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -69.54 -35.12 75.15 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.53 1.144 . . . . 0.0 109.271 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.808 HG21 HD11 ' A' ' 337' ' ' ILE . 57.0 t -73.25 -40.16 56.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.463 1.102 . . . . 0.0 109.297 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.791 ' CD1' HG12 ' A' ' 230' ' ' VAL . 3.5 mm? -67.61 -37.55 82.7 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 0.0 109.269 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.938 HG23 ' O ' ' A' ' 241' ' ' PRO . 74.3 t -65.84 -45.98 89.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.519 1.137 . . . . 0.0 109.328 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -64.89 -40.78 95.64 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.125 . . . . 0.0 110.251 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.758 ' O ' HD13 ' A' ' 251' ' ' LEU . 44.2 mt -62.27 -47.97 90.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.456 1.098 . . . . 0.0 109.306 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.496 HG21 ' HA ' ' A' ' 227' ' ' TRP . 27.3 t -61.98 -34.65 64.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.469 1.105 . . . . 0.0 109.296 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.02 -13.01 60.04 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.463 1.102 . . . . 0.0 110.291 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -99.6 -7.0 26.38 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.502 1.126 . . . . 0.0 109.312 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.758 HD13 ' O ' ' A' ' 247' ' ' ILE . 6.2 mp -75.31 146.51 40.93 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.533 1.146 . . . . 0.0 109.281 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 320' ' ' LEU . 6.1 tpt180 -116.33 113.6 23.17 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.502 1.127 . . . . 0.0 110.314 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.734 ' HB2' HD23 ' A' ' 320' ' ' LEU . . . -80.03 126.79 31.5 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.51 1.131 . . . . 0.0 109.258 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -139.09 137.74 36.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.464 1.102 . . . . 0.0 110.305 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 4.1 m -90.85 123.56 34.48 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.471 1.107 . . . . 0.0 110.385 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.769 ' CG2' HD21 ' A' ' 319' ' ' LEU . 4.7 t -106.8 112.76 63.32 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.467 1.104 . . . . 0.0 109.291 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.482 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.3 Cg_endo -75.03 169.27 22.98 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.524 1.802 . . . . 0.0 111.011 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.689 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -64.92 126.77 29.05 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.496 1.123 . . . . 0.0 109.334 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 100.63 -25.3 28.84 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.486 1.116 . . . . 0.0 111.006 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.499 ' HB3' HG13 ' A' ' 256' ' ' VAL . . . -67.65 131.07 44.9 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.504 0.767 . . . . 0.0 109.303 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 311' ' ' VAL . 2.9 p -87.72 135.43 25.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.529 1.143 . . . . 0.0 109.326 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.649 HD12 HG12 ' A' ' 311' ' ' VAL . 35.6 mt -82.38 -44.12 19.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.542 1.151 . . . . 0.0 109.294 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 10.5 p -152.12 147.07 26.02 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.538 1.149 . . . . 0.0 108.28 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -85.65 -179.9 6.96 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.485 1.115 . . . . 0.0 110.298 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.465 HG23 ' OG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -77.21 134.71 28.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.563 1.164 . . . . 0.0 109.289 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 56.32 51.48 55.85 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.458 1.099 . . . . 0.0 110.969 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.95 165.65 45.3 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.495 0.762 . . . . 0.0 110.298 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.3 Cg_endo -75.01 82.98 1.89 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.45 1.763 . . . . 0.0 111.002 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -38.0 93.31 0.01 OUTLIER Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.534 1.146 . . . . 0.0 110.997 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 268' ' ' PRO . 0.7 OUTLIER -171.61 37.51 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.482 0.754 . . . . 0.0 109.307 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.406 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 1.9 ttt180 -169.81 147.74 3.44 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.49 1.119 . . . . 0.0 110.276 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' MET . . . . . 0.878 ' HB2' HD11 ' A' ' 301' ' ' LEU . 2.1 ttm -118.04 156.26 28.9 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.534 1.147 . . . . 0.0 110.986 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.571 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 32.8 m-85 -146.02 136.61 24.15 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.519 1.137 . . . . 0.0 111.023 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' PHE . . . . . 0.494 ' CZ ' ' SD ' ' A' ' 272' ' ' MET . 19.6 m-85 -125.71 137.8 53.85 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.538 1.149 . . . . 0.0 111.007 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.605 HG22 HD12 ' A' ' 319' ' ' LEU . 4.3 t -94.24 135.34 28.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.473 1.108 . . . . 0.0 109.318 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.497 ' CG2' HD11 ' A' ' 320' ' ' LEU . 42.0 t -109.49 -49.16 7.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.481 1.113 . . . . 0.0 109.246 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -142.04 132.77 25.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.486 1.116 . . . . 0.0 110.281 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.693 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 120.96 -176.35 16.24 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.483 1.115 . . . . 0.0 111.023 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 5.2 t -131.2 118.8 20.95 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.498 0.764 . . . . 0.0 110.026 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.439 HG23 ' HB2' ' A' ' 290' ' ' LEU . 16.2 m -98.43 162.17 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.496 1.122 . . . . 0.0 109.313 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 31.1 t -127.71 153.76 46.13 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.493 1.12 . . . . 0.0 109.957 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 288' ' ' VAL . 0.2 OUTLIER -116.95 129.23 73.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.463 1.102 . . . . 0.0 109.327 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.716 ' HB3' ' H ' ' A' ' 310' ' ' THR . . . -77.97 101.62 6.97 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.469 1.106 . . . . 0.0 109.298 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' THR . . . . . 0.651 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.7 OUTLIER -148.62 -168.31 0.18 Allowed Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.568 1.168 . . . . 0.0 110.399 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.651 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -75.07 4.59 4.63 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.474 1.776 . . . . 0.0 110.956 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -151.5 156.67 34.85 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.521 1.138 . . . . 0.0 109.265 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.95 94.79 0.95 Allowed 'Trans proline' 0 C--N 1.36 1.184 0 O-C-N 124.509 1.794 . . . . 0.0 110.987 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 281' ' ' SER . 45.4 t -98.37 118.83 45.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.494 1.121 . . . . 0.0 109.327 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 15.0 mt-10 -125.22 136.96 54.08 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.475 1.109 . . . . 0.0 110.278 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.439 ' HB2' HG23 ' A' ' 280' ' ' VAL . 4.0 mm? -117.23 139.73 50.42 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.474 1.109 . . . . 0.0 109.312 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -90.6 -160.18 36.3 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.497 1.123 . . . . 0.0 111.005 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' PRO . . . . . 0.477 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.2 Cg_endo -75.01 148.21 34.91 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.546 1.814 . . . . 0.0 111.038 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.424 ' HA2' HD21 ' A' ' 229' ' ' LEU . . . 83.61 4.42 89.09 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.569 1.168 . . . . 0.0 110.99 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -86.03 130.67 34.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.472 0.748 . . . . 0.0 109.295 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.485 ' HB3' ' CD1' ' A' ' 274' ' ' PHE . 0.8 OUTLIER -116.16 153.02 32.56 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.504 1.127 . . . . 0.0 110.993 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.592 ' HZ ' HG21 ' A' ' 262' ' ' ILE . 40.4 p90 -159.64 146.17 16.32 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.527 1.142 . . . . 0.0 110.992 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 127.81 -7.07 6.93 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.472 1.107 . . . . 0.0 111.015 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -52.49 -48.76 65.75 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.511 0.771 . . . . 0.0 110.336 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' MET . . . . . 0.423 ' HA ' ' CE ' ' A' ' 299' ' ' MET . 3.1 mmt -48.91 -39.26 25.36 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.541 1.151 . . . . 0.0 111.002 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -67.79 -37.42 82.0 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.504 1.128 . . . . 0.0 109.252 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.878 HD11 ' HB2' ' A' ' 272' ' ' MET . 10.6 mt -79.02 -9.07 59.43 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.527 1.142 . . . . 0.0 109.267 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 3.1 mm -82.25 -54.17 10.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.478 1.111 . . . . 0.0 109.294 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 304' ' ' GLY . 1.0 OUTLIER -153.47 42.97 0.58 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 0.0 109.989 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 303' ' ' SER . . . 36.21 42.28 0.58 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.479 1.112 . . . . 0.0 111.042 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.19 157.13 83.43 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.441 0.73 . . . . 0.0 110.276 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.11 131.99 14.78 Favored 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.481 1.779 . . . . 0.0 110.976 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -44.38 -43.32 7.54 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.516 1.135 . . . . 0.0 110.34 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.545 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 25.3 m 67.74 39.41 2.69 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.454 1.096 . . . . 0.0 109.99 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 173.42 160.2 0.14 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.541 1.151 . . . . 0.0 109.307 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.716 ' H ' ' HB3' ' A' ' 283' ' ' ALA . 0.6 OUTLIER -105.19 122.3 45.62 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.505 1.128 . . . . 0.0 110.441 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.649 HG12 HD12 ' A' ' 262' ' ' ILE . 58.6 t -102.7 128.25 55.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.5 1.125 . . . . 0.0 109.3 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 9.7 p -141.24 156.66 45.87 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.557 1.161 . . . . 0.0 110.037 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' ALA . . . . . 0.543 ' CB ' HG12 ' A' ' 256' ' ' VAL . . . -90.31 124.37 34.84 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.543 1.152 . . . . 0.0 109.284 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -70.45 -26.33 63.59 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.468 1.105 . . . . 0.0 109.293 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' THR . . . . . 0.689 ' HA ' ' HB2' ' A' ' 258' ' ' ALA . 6.2 t -152.98 -169.79 3.44 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.51 1.131 . . . . 0.0 110.415 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 93.0 m -58.67 85.36 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 0.0 110.409 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.693 HG22 ' HA3' ' A' ' 278' ' ' GLY . 48.3 t -105.42 159.45 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.461 1.101 . . . . 0.0 109.246 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' SER . . . . . 0.646 ' C ' HD13 ' A' ' 319' ' ' LEU . 49.3 m -136.88 123.62 21.17 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.508 1.13 . . . . 0.0 109.984 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' LEU . . . . . 0.769 HD21 ' CG2' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -134.56 170.46 15.76 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.508 1.13 . . . . 0.0 109.278 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.734 HD23 ' HB2' ' A' ' 253' ' ' ALA . 0.0 OUTLIER -124.4 131.82 53.51 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.478 1.111 . . . . 0.0 109.295 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 63.5 p -90.15 158.88 17.05 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.552 1.157 . . . . 0.0 110.017 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.839 ' O ' HD13 ' A' ' 322' ' ' LEU . 0.9 OUTLIER -151.23 104.75 3.14 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.52 1.137 . . . . 0.0 109.338 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 323' ' ' HIS . . . . . 0.495 ' CE1' ' HB2' ' A' ' 326' ' ' ASP . 8.2 p80 -57.55 131.2 49.46 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.538 1.149 . . . . 0.0 109.609 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 23.0 t -58.96 -16.77 19.55 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.488 1.118 . . . . 0.0 109.993 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -66.71 -31.71 72.54 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.431 1.082 . . . . 0.0 109.305 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' ASP . . . . . 0.553 ' HB3' HD21 ' A' ' 322' ' ' LEU . 35.0 t70 -65.59 -47.52 75.44 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.543 1.152 . . . . 0.0 109.304 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' PHE . . . . . 0.469 ' CZ ' ' CE2' ' A' ' 341' ' ' PHE . 1.8 t80 -65.38 -35.74 81.88 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.431 1.082 . . . . 0.0 110.999 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -71.13 -32.29 68.8 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.505 1.128 . . . . 0.0 110.286 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 14.9 tmm? -68.29 -44.82 74.65 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.451 1.094 . . . . 0.0 110.991 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.62 HD13 HG13 ' A' ' 247' ' ' ILE . 2.4 mt -73.85 -31.57 63.25 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.504 1.128 . . . . 0.0 109.34 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 28.7 t -69.84 -38.14 76.41 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 0.0 108.322 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 11.3 t -76.86 -29.07 55.69 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.492 1.12 . . . . 0.0 109.984 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.9 -38.7 73.02 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.5 1.125 . . . . 0.0 109.974 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.8 124.07 32.51 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.483 1.114 . . . . 0.0 109.998 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 -27.87 9.64 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.417 1.746 . . . . 0.0 110.991 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.86 -32.61 72.4 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 0.0 110.315 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.808 HD11 HG21 ' A' ' 243' ' ' VAL . 71.2 mt -75.14 -32.88 27.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.506 1.129 . . . . 0.0 109.316 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.29 -34.97 66.04 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.447 1.092 . . . . 0.0 109.295 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -73.77 -43.42 59.04 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.531 1.144 . . . . 0.0 110.308 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.426 HG21 ' HB3' ' A' ' 238' ' ' LYS . 97.7 mt -71.64 -38.06 65.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 0.0 109.339 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.514 ' O ' HG22 ' A' ' 344' ' ' THR . 4.7 t80 -67.0 -39.22 87.07 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 0.0 111.042 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.06 -35.59 69.33 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.506 1.129 . . . . 0.0 110.311 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -46.17 83.66 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.45 1.094 . . . . 0.0 109.307 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 341' ' ' PHE . 6.6 t -71.23 -33.98 70.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.543 1.152 . . . . 0.0 110.399 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -70.21 -37.23 75.02 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.452 1.095 . . . . 0.0 109.366 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.472 ' HA ' HD23 ' A' ' 346' ' ' LEU . 12.4 mt -71.43 -37.02 71.49 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.523 1.139 . . . . 0.0 109.29 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -72.68 -37.34 67.91 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.487 1.117 . . . . 0.0 110.335 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -72.46 -40.16 67.21 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.559 1.162 . . . . 0.0 110.251 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.5 -34.73 70.37 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.498 1.124 . . . . 0.0 110.314 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -43.65 -46.33 7.25 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 124.495 1.122 . . . . 0.0 110.96 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -154.81 121.19 5.33 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.546 0.792 . . . . 0.0 109.276 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -65.51 173.31 2.76 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.504 1.127 . . . . 0.0 109.308 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -120.18 120.13 35.27 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.116 . . . . 0.0 109.326 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 49.9 m -154.91 172.38 18.14 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.508 1.13 . . . . 0.0 110.007 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.457 0 O-C-N 124.48 1.113 . . . . 0.0 109.321 179.971 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.028 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.17 165.05 11.3 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.487 0.757 . . . . 0.0 109.977 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -128.75 170.43 13.34 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.527 1.142 . . . . 0.0 110.296 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -88.23 154.03 20.75 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.487 1.117 . . . . 0.0 110.323 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 61.8 t -138.32 134.43 43.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.539 1.149 . . . . 0.0 109.277 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -89.35 162.7 15.67 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.489 1.118 . . . . 0.0 110.3 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.11 120.08 5.76 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.523 1.14 . . . . 0.0 110.235 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -113.86 -32.47 2.06 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.468 1.105 . . . . 0.0 110.965 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -91.09 17.17 8.4 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.499 0.764 . . . . 0.0 109.326 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -52.78 -39.03 61.93 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.566 1.166 . . . . 0.0 110.997 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.12 -40.05 50.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.494 1.121 . . . . 0.0 109.322 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.465 ' HD3' ' CD1' ' A' ' 229' ' ' LEU . 0.0 OUTLIER -66.22 -31.87 72.95 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.519 1.137 . . . . 0.0 110.339 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.641 ' ND2' HD22 ' A' ' 320' ' ' LEU . 12.4 t-20 -80.61 -30.84 36.78 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.538 1.149 . . . . 0.0 109.335 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' TRP . . . . . 0.928 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 2.8 t90 -67.24 -42.66 83.61 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.127 . . . . 0.0 107.994 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.406 ' HG3' ' N ' ' A' ' 229' ' ' LEU . 8.9 pt20 -71.02 -40.77 71.56 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.478 1.111 . . . . 0.0 110.333 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.465 ' CD1' ' HD3' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -61.87 -48.65 79.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.471 1.107 . . . . 0.0 109.304 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.516 HG13 ' CD1' ' A' ' 244' ' ' LEU . 5.7 p -68.09 -39.63 81.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.503 1.127 . . . . 0.0 109.309 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -72.11 -16.53 62.01 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.502 1.126 . . . . 0.0 109.264 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 228' ' ' GLN . . . -81.25 -10.45 59.59 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.473 1.108 . . . . 0.0 109.282 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 6.7 t -80.85 121.04 80.54 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.561 1.163 . . . . 0.0 109.29 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 -18.35 18.75 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.501 1.79 . . . . 0.0 111.018 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.538 HD21 HD11 ' A' ' 302' ' ' ILE . 5.7 tp -75.87 -20.96 57.67 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.511 1.132 . . . . 0.0 109.281 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.488 ' CD2' HD12 ' A' ' 239' ' ' LEU . 3.3 m-85 -108.97 8.9 26.55 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.495 1.122 . . . . 0.0 110.998 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.26 -19.92 65.58 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.572 1.17 . . . . 0.0 110.311 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.526 ' CB ' HG21 ' A' ' 340' ' ' ILE . 69.5 mmtt -80.63 -17.95 49.64 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.523 1.139 . . . . 0.0 109.313 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.726 HD22 HG11 ' A' ' 243' ' ' VAL . 75.1 mt -70.49 172.81 7.82 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.457 1.098 . . . . 0.0 109.284 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' GLY . . . . . 0.54 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -107.42 -172.54 22.26 Favored Glycine 0 CA--C 1.529 0.952 0 O-C-N 124.509 1.131 . . . . 0.0 111.07 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.912 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.3 Cg_endo -75.05 -35.16 3.27 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.487 1.783 . . . . 0.0 110.986 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -69.56 -34.08 73.66 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.475 1.11 . . . . 0.0 109.301 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.726 HG11 HD22 ' A' ' 239' ' ' LEU . 3.6 t -74.93 -40.58 45.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.493 1.12 . . . . 0.0 109.298 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.784 ' O ' HG23 ' A' ' 248' ' ' VAL . 0.7 OUTLIER -64.83 -40.1 94.65 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.478 1.111 . . . . 0.0 109.262 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.928 HG22 ' CZ2' ' A' ' 227' ' ' TRP . 63.0 t -70.65 -42.13 77.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.459 1.099 . . . . 0.0 109.299 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -64.95 -35.65 81.86 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.492 1.12 . . . . 0.0 110.262 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.432 HD12 HG12 ' A' ' 243' ' ' VAL . 36.7 mt -71.75 -44.84 68.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.559 1.162 . . . . 0.0 109.321 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 244' ' ' LEU . 96.4 t -68.17 -32.15 54.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.454 1.096 . . . . 0.0 109.292 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.93 -21.97 46.48 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.493 1.121 . . . . 0.0 110.327 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.511 ' HB3' ' OD1' ' A' ' 326' ' ' ASP . . . -89.94 -21.26 22.55 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.473 1.108 . . . . 0.0 109.276 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.411 ' CD2' ' HB2' ' A' ' 322' ' ' LEU . 0.2 OUTLIER -67.3 149.77 49.92 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.469 1.106 . . . . 0.0 109.304 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -121.08 119.57 32.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.442 1.088 . . . . 0.0 110.334 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.563 ' HB2' HD23 ' A' ' 320' ' ' LEU . . . -80.99 122.83 27.77 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.495 1.122 . . . . 0.0 109.324 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.96 142.9 49.12 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.506 1.129 . . . . 0.0 110.293 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.3 m -94.18 125.36 38.77 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.496 1.123 . . . . 0.0 110.359 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.524 HG12 ' CB ' ' A' ' 313' ' ' ALA . 47.6 t -106.92 112.44 63.32 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.534 1.146 . . . . 0.0 109.334 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.3 Cg_endo -75.01 171.38 18.43 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.485 1.781 . . . . 0.0 110.993 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.589 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -66.25 130.21 42.44 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.487 1.117 . . . . 0.0 109.336 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 94.97 -25.09 25.52 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.478 1.111 . . . . 0.0 111.031 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.517 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -64.75 119.94 11.53 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.527 0.781 . . . . 0.0 109.297 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.17 136.03 24.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.539 1.15 . . . . 0.0 109.284 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.974 HD12 HG12 ' A' ' 311' ' ' VAL . 39.9 mt -82.12 -52.64 13.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.492 1.12 . . . . 0.0 109.334 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 17.1 p -147.43 146.26 29.51 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.512 1.133 . . . . 0.0 108.291 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -83.36 -177.8 6.86 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.115 . . . . 0.0 110.291 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.54 HG23 ' CB ' ' A' ' 310' ' ' THR . 0.0 OUTLIER -76.08 133.21 31.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.507 1.129 . . . . 0.0 109.301 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 55.5 53.9 38.14 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.486 1.116 . . . . 0.0 110.983 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.81 165.75 43.65 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.467 0.745 . . . . 0.0 110.313 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.486 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.3 Cg_endo -75.01 87.12 1.35 Allowed 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.498 1.788 . . . . 0.0 110.947 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -39.79 93.4 0.01 OUTLIER Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.506 1.129 . . . . 0.0 111.02 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 268' ' ' PRO . 17.9 p30 -170.82 38.48 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.513 0.773 . . . . 0.0 109.261 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.401 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 12.8 mtt180 -169.51 154.45 5.63 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.477 1.11 . . . . 0.0 110.309 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' MET . . . . . 0.41 ' SD ' ' CD1' ' A' ' 301' ' ' LEU . 1.2 ttt -126.09 149.66 48.75 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.506 1.129 . . . . 0.0 110.985 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 296' ' ' PHE . 12.1 m-85 -135.63 138.2 42.65 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.475 1.109 . . . . 0.0 110.98 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -128.36 126.15 40.12 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.552 1.158 . . . . 0.0 110.973 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 1.034 HG22 HD22 ' A' ' 319' ' ' LEU . 41.7 t -85.47 129.64 37.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.467 1.104 . . . . 0.0 109.298 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.809 ' CG2' HD11 ' A' ' 320' ' ' LEU . 46.3 t -104.94 -46.97 9.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.467 1.105 . . . . 0.0 109.322 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.814 ' O ' HG23 ' A' ' 317' ' ' VAL . 0.0 OUTLIER -148.52 140.51 23.9 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.482 1.114 . . . . 0.0 110.336 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 116.46 -154.1 17.02 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.554 1.159 . . . . 0.0 110.994 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 290' ' ' LEU . 4.5 m -147.83 131.4 16.79 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.466 0.745 . . . . 0.0 109.967 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 20.3 m -117.17 135.58 57.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.484 1.115 . . . . 0.0 109.332 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 29.3 t -102.5 149.6 24.23 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.519 1.137 . . . . 0.0 109.983 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.463 HG13 HG22 ' A' ' 311' ' ' VAL . 0.4 OUTLIER -113.35 130.42 67.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.502 1.127 . . . . 0.0 109.291 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.666 ' HB3' ' H ' ' A' ' 310' ' ' THR . . . -76.77 101.84 6.0 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.541 1.15 . . . . 0.0 109.31 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' THR . . . . . 0.648 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -149.07 -168.63 0.19 Allowed Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.47 1.106 . . . . 0.0 110.427 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.648 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -75.01 3.83 5.28 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.553 1.817 . . . . 0.0 110.975 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -151.91 157.68 34.22 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.533 1.146 . . . . 0.0 109.325 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 92.59 0.98 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.533 1.807 . . . . 0.0 111.0 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.443 ' O ' HG23 ' A' ' 282' ' ' VAL . 29.0 t -95.49 118.97 42.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.506 1.129 . . . . 0.0 109.311 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.54 ' C ' HD22 ' A' ' 290' ' ' LEU . 14.2 mt-10 -124.34 138.69 54.35 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.482 1.114 . . . . 0.0 110.313 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.54 HD22 ' C ' ' A' ' 289' ' ' GLU . 4.4 mm? -121.37 140.92 51.48 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.464 1.103 . . . . 0.0 109.311 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -97.55 -155.01 29.91 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.459 1.1 . . . . 0.0 110.985 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.94 147.04 33.65 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.498 1.789 . . . . 0.0 111.018 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 85.26 5.77 85.0 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.474 1.109 . . . . 0.0 111.011 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -90.44 121.42 32.39 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.495 0.762 . . . . 0.0 109.323 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -116.16 152.89 32.8 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.541 1.151 . . . . 0.0 110.994 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.558 ' CZ ' ' HB3' ' A' ' 273' ' ' PHE . 33.7 p90 -163.71 148.95 10.88 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.486 1.116 . . . . 0.0 111.018 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 132.98 -11.58 5.1 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.454 1.096 . . . . 0.0 110.976 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -52.82 -44.91 67.01 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.452 0.737 . . . . 0.0 110.3 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.67 -39.21 57.81 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.438 1.086 . . . . 0.0 110.965 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' ALA . . . . . 0.457 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -68.49 -39.03 81.48 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.516 1.135 . . . . 0.0 109.304 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.55 HD22 ' CB ' ' A' ' 327' ' ' PHE . 13.3 mt -76.76 -8.78 57.96 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.516 1.135 . . . . 0.0 109.334 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 302' ' ' ILE . . . . . 0.538 HD11 HD21 ' A' ' 235' ' ' LEU . 6.5 mm -85.01 -52.95 11.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.488 1.117 . . . . 0.0 109.341 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 304' ' ' GLY . 0.4 OUTLIER -153.51 41.13 0.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.5 1.125 . . . . 0.0 109.967 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 36.48 36.4 0.15 Allowed Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.494 1.121 . . . . 0.0 110.956 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.93 155.76 85.84 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.511 0.771 . . . . 0.0 110.266 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 130.87 13.63 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.539 1.81 . . . . 0.0 110.999 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -45.16 -31.32 1.4 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.528 1.143 . . . . 0.0 110.288 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 2.4 m 59.1 33.1 22.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 0.0 110.03 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 176.35 160.63 0.34 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.498 1.124 . . . . 0.0 109.317 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.666 ' H ' ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -109.98 127.2 54.65 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.471 1.107 . . . . 0.0 110.396 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.974 HG12 HD12 ' A' ' 262' ' ' ILE . 57.6 t -107.21 131.64 56.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.496 1.122 . . . . 0.0 109.301 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 1.9 p -137.03 150.55 48.16 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.473 1.108 . . . . 0.0 110.036 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' ALA . . . . . 0.842 ' HB1' HG12 ' A' ' 317' ' ' VAL . . . -80.04 111.09 16.05 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.518 1.137 . . . . 0.0 109.278 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -58.61 -26.69 63.96 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.461 1.101 . . . . 0.0 109.285 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' THR . . . . . 0.589 ' HA ' ' HB2' ' A' ' 258' ' ' ALA . 8.8 t -160.18 -164.01 1.21 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.514 1.133 . . . . 0.0 110.379 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' THR . . . . . 0.433 ' N ' ' OG1' ' A' ' 315' ' ' THR . 65.2 m -64.08 74.61 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.504 1.128 . . . . 0.0 110.417 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.859 HG22 ' CD2' ' A' ' 319' ' ' LEU . 2.7 p -104.14 137.81 31.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.125 . . . . 0.0 109.319 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' SER . . . . . 0.464 ' C ' HD23 ' A' ' 319' ' ' LEU . 71.1 m -106.19 134.83 48.7 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.542 1.151 . . . . 0.0 109.972 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 319' ' ' LEU . . . . . 1.034 HD22 HG22 ' A' ' 275' ' ' VAL . 0.0 OUTLIER -141.5 174.23 10.75 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.535 1.147 . . . . 0.0 109.319 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.809 HD11 ' CG2' ' A' ' 276' ' ' VAL . 0.6 OUTLIER -124.83 134.01 52.9 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.517 1.135 . . . . 0.0 109.262 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 29.5 t -98.03 146.82 25.15 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.529 1.143 . . . . 0.0 109.972 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.411 ' HB2' ' CD2' ' A' ' 251' ' ' LEU . 2.2 tm? -138.06 104.64 5.29 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.518 1.136 . . . . 0.0 109.318 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 323' ' ' HIS . . . . . 0.44 ' ND1' ' HB3' ' A' ' 325' ' ' ALA . 5.8 p80 -63.71 134.31 55.12 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.557 1.161 . . . . 0.0 109.631 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 86.4 p -55.56 -18.47 7.55 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.54 1.15 . . . . 0.0 109.978 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 0.44 ' HB3' ' ND1' ' A' ' 323' ' ' HIS . . . -58.12 -36.99 73.73 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.466 1.104 . . . . 0.0 109.291 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' ASP . . . . . 0.511 ' OD1' ' HB3' ' A' ' 250' ' ' ALA . 27.2 t0 -65.32 -38.87 91.5 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.499 1.125 . . . . 0.0 109.312 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 327' ' ' PHE . . . . . 0.55 ' CB ' HD22 ' A' ' 301' ' ' LEU . 17.7 t80 -68.63 -35.64 77.55 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.478 1.111 . . . . 0.0 110.991 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -69.33 -33.84 73.74 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.5 1.125 . . . . 0.0 110.326 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.418 ' O ' ' CB ' ' A' ' 333' ' ' SER . 32.2 ttp -70.59 -43.21 69.85 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.457 1.098 . . . . 0.0 110.987 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 2.6 mt -70.58 -34.7 72.47 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.435 1.085 . . . . 0.0 109.342 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 1.3 m -73.22 -44.12 60.14 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.473 1.108 . . . . 0.0 108.3 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 7.6 t -73.09 -27.86 61.96 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.529 1.143 . . . . 0.0 110.04 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 329' ' ' MET . 11.7 t -74.04 -38.38 64.03 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.537 1.148 . . . . 0.0 110.028 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 334' ' ' SER . . . . . 0.636 ' HB2' HD12 ' A' ' 337' ' ' ILE . 0.3 OUTLIER -126.92 120.52 22.72 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 0.0 109.977 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -23.62 13.57 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.503 1.791 . . . . 0.0 111.038 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -72.32 -33.66 67.52 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.481 1.113 . . . . 0.0 110.263 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.679 HG23 HD21 ' A' ' 239' ' ' LEU . 87.3 mt -71.07 -40.34 75.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.556 1.16 . . . . 0.0 109.337 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.98 -30.7 64.02 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.443 1.089 . . . . 0.0 109.286 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.89 -37.34 70.16 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.529 1.143 . . . . 0.0 110.294 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.526 HG21 ' CB ' ' A' ' 238' ' ' LYS . 30.6 mt -72.93 -45.64 54.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.526 1.141 . . . . 0.0 109.295 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -67.65 -30.9 70.57 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.463 1.102 . . . . 0.0 110.997 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -72.54 -44.58 61.95 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.133 . . . . 0.0 110.258 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -45.26 76.88 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.521 1.138 . . . . 0.0 109.371 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.53 -40.12 92.57 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 0.0 110.409 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -69.09 -32.96 72.75 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.135 . . . . 0.0 109.28 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.428 ' HA ' HD23 ' A' ' 346' ' ' LEU . 13.1 mt -73.64 -31.18 63.37 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.519 1.137 . . . . 0.0 109.308 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -72.72 -40.56 66.03 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.14 . . . . 0.0 110.353 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -69.83 -40.9 75.6 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.466 1.104 . . . . 0.0 110.273 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 350' ' ' GLY . 0.0 OUTLIER -73.11 -34.7 66.32 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.479 1.112 . . . . 0.0 110.316 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 350' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 349' ' ' ARG . . . -37.04 -46.97 1.3 Allowed Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.536 1.147 . . . . 0.0 111.0 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -154.61 121.6 5.56 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.48 0.753 . . . . 0.0 109.341 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -62.9 166.91 5.14 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.498 1.123 . . . . 0.0 109.345 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -102.63 120.72 41.04 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.538 1.149 . . . . 0.0 109.309 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 10.7 m -64.12 138.62 58.54 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.47 1.106 . . . . 0.0 109.973 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.446 0 O-C-N 124.46 1.1 . . . . 0.0 109.287 179.963 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.048 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 25.5 p -60.56 140.58 57.29 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.528 0.781 . . . . 0.0 109.994 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.82 173.1 7.24 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.54 1.15 . . . . 0.0 110.278 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -110.57 170.42 8.1 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.485 1.116 . . . . 0.0 110.29 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 32.9 m -131.67 166.98 27.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.464 1.103 . . . . 0.0 109.303 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 15.2 mtt180 -107.66 170.85 7.73 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.506 1.129 . . . . 0.0 110.264 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.27 137.4 35.85 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.532 1.145 . . . . 0.0 110.341 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -110.32 -26.05 5.03 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.517 1.135 . . . . 0.0 110.987 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -99.12 17.23 20.35 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.505 0.768 . . . . 0.0 109.294 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.564 ' CE1' ' HD3' ' A' ' 249' ' ' ARG . 68.3 t80 -53.78 -39.89 65.8 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.481 1.113 . . . . 0.0 110.969 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.62 -39.29 81.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.474 1.109 . . . . 0.0 109.315 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.66 ' HD2' HD12 ' A' ' 229' ' ' LEU . 0.1 OUTLIER -67.66 -34.41 76.87 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.512 1.132 . . . . 0.0 110.281 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.995 ' O ' HG12 ' A' ' 230' ' ' VAL . 36.9 t30 -78.73 -30.49 45.89 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.506 1.129 . . . . 0.0 109.271 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' TRP . . . . . 0.632 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 5.5 t90 -66.99 -44.4 80.5 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.522 1.139 . . . . 0.0 108.011 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.537 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 19.4 pt20 -71.78 -33.99 69.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.444 1.09 . . . . 0.0 110.332 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.66 HD12 ' HD2' ' A' ' 225' ' ' ARG . 0.3 OUTLIER -65.63 -55.39 17.84 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.544 1.152 . . . . 0.0 109.308 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.995 HG12 ' O ' ' A' ' 226' ' ' ASN . 7.4 p -65.51 -35.01 74.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.509 1.131 . . . . 0.0 109.287 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.475 ' CB ' ' O ' ' A' ' 227' ' ' TRP . . . -75.29 -18.88 59.94 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.485 1.115 . . . . 0.0 109.297 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.537 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -80.72 -20.31 43.12 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.102 . . . . 0.0 109.264 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 229' ' ' LEU . 60.3 t -62.78 128.58 92.08 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.507 1.13 . . . . 0.0 109.308 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.426 ' HA ' ' HB2' ' A' ' 237' ' ' GLN . 18.4 Cg_endo -74.99 -35.97 2.83 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.485 1.782 . . . . 0.0 111.078 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.756 HD22 ' HG3' ' A' ' 298' ' ' GLU . 1.2 tp -63.91 -19.22 64.94 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.5 1.125 . . . . 0.0 109.323 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.662 ' CG ' HD12 ' A' ' 239' ' ' LEU . 4.3 m-30 -114.28 8.5 16.77 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.468 1.105 . . . . 0.0 110.988 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' GLN . . . . . 0.426 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 1.5 mt-30 -71.18 -22.61 62.01 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.508 1.13 . . . . 0.0 110.304 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -83.41 -19.37 36.11 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.476 1.11 . . . . 0.0 109.265 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.751 HD22 HG11 ' A' ' 243' ' ' VAL . 67.7 mt -63.79 -179.98 0.44 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.549 1.155 . . . . 0.0 109.296 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' GLY . . . . . 0.651 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -103.95 178.2 24.66 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.487 1.117 . . . . 0.0 111.04 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.543 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.2 Cg_endo -75.02 -34.54 3.72 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.486 1.782 . . . . 0.0 111.006 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -71.8 -35.4 69.96 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.499 1.125 . . . . 0.0 109.337 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.751 HG11 HD22 ' A' ' 239' ' ' LEU . 71.6 t -72.73 -40.62 61.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.528 1.142 . . . . 0.0 109.291 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 240' ' ' GLY . 3.9 mm? -69.08 -40.51 78.39 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.515 1.134 . . . . 0.0 109.308 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.632 HG22 ' CZ2' ' A' ' 227' ' ' TRP . 20.5 t -66.17 -37.05 78.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.487 1.117 . . . . 0.0 109.296 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -74.3 -30.78 62.23 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.55 1.156 . . . . 0.0 110.298 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 44.2 mt -70.93 -48.59 55.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.542 1.151 . . . . 0.0 109.308 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.67 HG23 ' ND2' ' A' ' 226' ' ' ASN . 14.5 p -65.56 -36.14 76.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.525 1.14 . . . . 0.0 109.286 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.564 ' HD3' ' CE1' ' A' ' 223' ' ' PHE . 1.4 mmm180 -72.44 -25.2 61.37 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.495 1.122 . . . . 0.0 110.311 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -91.41 0.33 57.53 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.472 1.108 . . . . 0.0 109.261 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.402 HD22 ' HB2' ' A' ' 320' ' ' LEU . 0.1 OUTLIER -83.69 151.61 25.18 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 0.0 109.269 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.08 125.16 46.57 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.46 1.1 . . . . 0.0 110.291 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -82.97 122.72 28.66 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.523 1.139 . . . . 0.0 109.267 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.405 ' O ' ' O ' ' A' ' 319' ' ' LEU . 0.0 OUTLIER -127.72 139.35 52.74 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.436 1.085 . . . . 0.0 110.265 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 6.6 m -95.55 128.07 42.11 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.479 1.112 . . . . 0.0 110.405 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.588 HG21 HD11 ' A' ' 319' ' ' LEU . 22.0 t -106.54 115.78 60.13 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.458 1.099 . . . . 0.0 109.251 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.504 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.95 154.44 42.76 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.52 1.8 . . . . 0.0 111.036 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.489 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -57.51 126.27 26.59 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.475 1.11 . . . . 0.0 109.266 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 98.7 -25.19 29.01 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.511 1.132 . . . . 0.0 110.995 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.504 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -66.3 146.58 54.44 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.479 0.752 . . . . 0.0 109.254 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 311' ' ' VAL . 2.4 p -97.18 136.29 28.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.461 1.101 . . . . 0.0 109.319 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.687 HD12 HG12 ' A' ' 311' ' ' VAL . 7.4 mt -81.65 -45.42 20.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.489 1.118 . . . . 0.0 109.33 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' CYS . . . . . 0.643 ' SG ' HG23 ' A' ' 311' ' ' VAL . 14.1 p -147.4 153.53 39.73 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.479 1.112 . . . . 0.0 108.331 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.41 179.91 5.0 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.513 1.133 . . . . 0.0 110.304 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.67 135.95 25.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.471 1.107 . . . . 0.0 109.311 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 52.27 53.55 30.77 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.539 1.149 . . . . 0.0 111.027 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.417 ' CD ' ' CD ' ' A' ' 268' ' ' PRO . 5.7 mm-40 -71.57 166.1 42.73 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.512 0.772 . . . . 0.0 110.313 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.517 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.2 Cg_endo -74.96 82.52 1.98 Allowed 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.515 1.797 . . . . 0.0 111.024 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' GLY . . . . . 0.424 ' HA2' ' HB1' ' A' ' 300' ' ' ALA . . . -36.86 92.39 0.01 OUTLIER Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.471 1.107 . . . . 0.0 110.976 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 268' ' ' PRO . 36.6 m-20 -171.92 37.84 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.526 0.78 . . . . 0.0 109.322 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.8 148.57 2.93 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.476 1.11 . . . . 0.0 110.299 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' MET . . . . . 0.747 ' HB2' HD11 ' A' ' 301' ' ' LEU . 2.1 ttt -123.26 146.65 47.68 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.543 1.152 . . . . 0.0 110.971 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.568 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 92.4 m-85 -133.4 136.98 45.6 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.512 1.133 . . . . 0.0 110.982 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' PHE . . . . . 0.501 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 20.5 m-85 -124.72 135.06 52.69 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.451 1.094 . . . . 0.0 111.004 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.534 HG12 ' HA ' ' A' ' 292' ' ' PRO . 38.6 t -90.43 137.93 20.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.471 1.107 . . . . 0.0 109.321 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.661 ' CG2' HD11 ' A' ' 320' ' ' LEU . 3.4 t -115.86 -48.99 4.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.484 1.115 . . . . 0.0 109.329 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.419 ' O ' HG13 ' A' ' 317' ' ' VAL . 3.9 mm-40 -139.01 136.57 35.47 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.51 1.131 . . . . 0.0 110.306 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.942 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 110.87 -173.31 15.93 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.486 1.116 . . . . 0.0 110.957 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 290' ' ' LEU . 5.5 t -134.34 126.67 30.14 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.481 0.754 . . . . 0.0 109.992 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.437 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 17.4 m -104.18 166.32 3.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.485 1.116 . . . . 0.0 109.286 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 30.8 t -129.81 154.79 46.9 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.502 1.126 . . . . 0.0 110.022 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.449 ' CG2' ' HB ' ' A' ' 288' ' ' VAL . 0.5 OUTLIER -118.03 127.84 75.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.502 1.126 . . . . 0.0 109.301 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.413 ' HB3' ' H ' ' A' ' 310' ' ' THR . . . -77.0 101.37 5.99 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.44 1.088 . . . . 0.0 109.338 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' THR . . . . . 0.651 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.63 -168.35 0.18 Allowed Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.525 1.141 . . . . 0.0 110.392 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.651 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.3 Cg_endo -74.97 4.17 4.96 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.528 1.804 . . . . 0.0 111.017 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.443 ' O ' HG23 ' A' ' 288' ' ' VAL . 5.1 m120 -150.68 156.16 36.13 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.509 1.131 . . . . 0.0 109.299 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 94.19 0.96 Allowed 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.517 1.798 . . . . 0.0 111.032 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.449 ' HB ' ' CG2' ' A' ' 282' ' ' VAL . 2.1 t -98.13 119.26 45.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.54 1.15 . . . . 0.0 109.322 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 13.9 mt-10 -124.5 135.44 53.21 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.547 1.154 . . . . 0.0 110.337 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.437 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 3.9 mm? -115.3 142.61 46.45 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.52 1.137 . . . . 0.0 109.308 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -97.96 -162.56 30.98 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.434 1.084 . . . . 0.0 111.025 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' PRO . . . . . 0.534 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.2 Cg_endo -75.0 144.99 30.91 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.467 1.772 . . . . 0.0 110.999 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 90.21 -1.84 80.43 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.502 1.126 . . . . 0.0 111.022 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -83.76 139.31 32.8 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.51 0.77 . . . . 0.0 109.321 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.405 ' CB ' ' CD1' ' A' ' 274' ' ' PHE . 1.5 p90 -126.4 152.74 45.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.491 1.119 . . . . 0.0 110.998 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.568 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 33.4 p90 -160.85 149.71 16.6 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.446 1.091 . . . . 0.0 111.013 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 297' ' ' GLY . . . . . 0.657 ' O ' HD12 ' A' ' 301' ' ' LEU . . . 126.23 -8.55 7.5 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.479 1.112 . . . . 0.0 111.025 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.756 ' HG3' HD22 ' A' ' 235' ' ' LEU . 27.0 tt0 -52.87 -44.19 66.66 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.525 0.779 . . . . 0.0 110.283 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 299' ' ' MET . . . . . 0.464 ' HB3' ' CG ' ' A' ' 305' ' ' GLU . 0.0 OUTLIER -56.34 -37.13 69.59 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.497 1.123 . . . . 0.0 111.037 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 300' ' ' ALA . . . . . 0.424 ' HB1' ' HA2' ' A' ' 269' ' ' GLY . . . -66.36 -38.38 87.46 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.503 1.127 . . . . 0.0 109.227 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.747 HD11 ' HB2' ' A' ' 272' ' ' MET . 1.8 mp -81.98 -10.22 59.32 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.124 . . . . 0.0 109.328 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 3.9 mm -76.9 -56.42 8.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.464 1.102 . . . . 0.0 109.33 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 305' ' ' GLU . 1.5 m -151.53 48.37 0.81 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.526 1.141 . . . . 0.0 109.992 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 303' ' ' SER . . . 36.57 31.66 0.05 OUTLIER Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.516 1.135 . . . . 0.0 110.99 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' GLU . . . . . 0.464 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 0.0 OUTLIER -65.24 151.67 93.41 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.517 0.775 . . . . 0.0 110.28 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 129.51 12.45 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.434 1.755 . . . . 0.0 111.022 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.88 -22.92 0.93 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.491 1.119 . . . . 0.0 110.288 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.695 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 27.4 m 41.79 57.24 3.18 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.566 1.166 . . . . 0.0 110.03 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' ALA . . . . . 0.695 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 162.68 159.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.463 1.102 . . . . 0.0 109.349 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.413 ' H ' ' HB3' ' A' ' 283' ' ' ALA . 0.3 OUTLIER -112.7 122.06 46.56 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.509 1.131 . . . . 0.0 110.408 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.687 HG12 HD12 ' A' ' 262' ' ' ILE . 23.0 t -102.79 131.51 50.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.524 1.14 . . . . 0.0 109.302 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 261' ' ' VAL . 33.8 p -138.37 154.07 48.93 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.494 1.121 . . . . 0.0 109.984 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -91.15 120.55 32.19 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.497 1.123 . . . . 0.0 109.297 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -61.94 -33.79 74.91 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.481 1.113 . . . . 0.0 109.316 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' THR . . . . . 0.605 ' O ' HG23 ' A' ' 317' ' ' VAL . 9.9 t -149.78 -176.22 5.34 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.517 1.136 . . . . 0.0 110.425 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 13.9 p -49.8 92.36 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.525 1.14 . . . . 0.0 110.361 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.942 HG22 ' HA3' ' A' ' 278' ' ' GLY . 43.0 t -108.56 158.49 8.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.509 1.131 . . . . 0.0 109.312 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 68.4 m -132.92 118.16 18.56 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.487 1.117 . . . . 0.0 110.014 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' LEU . . . . . 0.588 HD11 HG21 ' A' ' 256' ' ' VAL . 0.2 OUTLIER -131.65 172.94 11.65 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.49 1.119 . . . . 0.0 109.286 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.661 HD11 ' CG2' ' A' ' 276' ' ' VAL . 0.0 OUTLIER -125.1 137.14 54.19 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.451 1.095 . . . . 0.0 109.31 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 4.0 t -95.51 156.41 16.34 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.463 1.102 . . . . 0.0 110.021 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.94 103.51 3.22 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 0.0 109.289 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 323' ' ' HIS . . . . . 0.56 ' CE1' ' HB2' ' A' ' 326' ' ' ASP . 9.1 p80 -57.72 136.46 56.88 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.494 1.121 . . . . 0.0 109.584 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 42.0 t -62.12 -21.46 65.03 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.448 1.092 . . . . 0.0 109.984 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -62.97 -30.43 71.57 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.506 1.129 . . . . 0.0 109.307 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' ASP . . . . . 0.868 ' O ' HD12 ' A' ' 330' ' ' LEU . 27.7 t70 -65.98 -47.91 73.0 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.506 1.129 . . . . 0.0 109.339 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 327' ' ' PHE . . . . . 0.503 ' CZ ' ' CE2' ' A' ' 341' ' ' PHE . 2.5 t80 -64.95 -34.26 78.0 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.494 1.121 . . . . 0.0 110.996 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.486 ' O ' ' CB ' ' A' ' 332' ' ' SER . 67.5 mt-30 -70.53 -33.37 71.1 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.509 1.13 . . . . 0.0 110.264 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 14.3 tmm? -68.98 -44.83 72.08 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.513 1.133 . . . . 0.0 110.989 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.868 HD12 ' O ' ' A' ' 326' ' ' ASP . 0.6 OUTLIER -73.47 -41.87 62.61 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.479 1.112 . . . . 0.0 109.275 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 331' ' ' CYS . . . . . 0.407 ' HG ' ' HD2' ' A' ' 341' ' ' PHE . 22.7 t -66.11 -38.57 88.52 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.479 1.112 . . . . 0.0 108.257 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 328' ' ' GLN . 38.7 t -76.72 -25.62 53.77 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.462 1.101 . . . . 0.0 109.953 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 17.7 t -71.73 -38.87 70.4 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.123 . . . . 0.0 110.034 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' SER . . . . . 0.442 ' CB ' HD12 ' A' ' 337' ' ' ILE . 0.2 OUTLIER -115.19 127.65 26.63 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.477 1.11 . . . . 0.0 109.965 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 335' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 334' ' ' SER . 18.2 Cg_endo -75.0 -28.8 8.86 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.525 1.803 . . . . 0.0 110.981 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -67.22 -29.82 69.58 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.502 1.126 . . . . 0.0 110.263 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.54 HD11 HG21 ' A' ' 243' ' ' VAL . 87.4 mt -75.0 -34.46 32.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.543 1.152 . . . . 0.0 109.257 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.73 -30.65 64.35 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.528 1.142 . . . . 0.0 109.3 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -74.93 -46.23 37.1 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.491 1.119 . . . . 0.0 110.317 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 87.4 mt -71.59 -36.45 59.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.459 1.099 . . . . 0.0 109.278 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.511 ' CB ' ' O ' ' A' ' 337' ' ' ILE . 6.0 t80 -67.39 -41.96 84.14 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.514 1.134 . . . . 0.0 110.991 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 342' ' ' ARG . . . . . 0.467 ' HG3' ' CD1' ' A' ' 346' ' ' LEU . 0.7 OUTLIER -70.63 -35.84 73.15 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.492 1.12 . . . . 0.0 110.26 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -50.86 65.36 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.492 1.12 . . . . 0.0 109.277 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.511 HG22 ' O ' ' A' ' 341' ' ' PHE . 10.2 t -65.04 -33.02 75.03 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.474 1.108 . . . . 0.0 110.389 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -66.09 -44.92 83.0 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.484 1.115 . . . . 0.0 109.283 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.467 ' CD1' ' HG3' ' A' ' 342' ' ' ARG . 1.0 OUTLIER -65.34 -36.46 84.1 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.502 1.126 . . . . 0.0 109.329 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -73.53 -35.4 65.55 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.499 1.124 . . . . 0.0 110.317 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.95 -44.69 60.84 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.495 1.122 . . . . 0.0 110.255 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -34.82 78.21 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.453 1.096 . . . . 0.0 110.312 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -38.18 -46.65 1.91 Allowed Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.529 1.143 . . . . 0.0 110.989 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -154.31 121.9 5.82 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.499 0.764 . . . . 0.0 109.31 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -64.12 169.07 4.72 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.509 1.131 . . . . 0.0 109.329 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -106.42 120.7 42.58 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.473 1.108 . . . . 0.0 109.316 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.64 121.32 15.13 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.471 1.107 . . . . 0.0 110.021 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.493 0 O-C-N 124.468 1.105 . . . . 0.0 109.317 -179.925 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.985 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 18.1 p -129.53 171.48 12.54 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.473 0.749 . . . . 0.0 109.964 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -114.64 146.48 40.8 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.464 1.103 . . . . 0.0 110.309 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -115.27 157.29 23.97 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.447 1.092 . . . . 0.0 110.326 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 34.8 m -112.12 171.67 3.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.504 1.127 . . . . 0.0 109.286 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.57 164.9 11.68 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.532 1.145 . . . . 0.0 110.327 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 3.2 mtt-85 -140.99 143.64 34.58 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.484 1.115 . . . . 0.0 110.341 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -110.32 -17.72 9.18 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.51 1.131 . . . . 0.0 111.005 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.413 ' O ' ' OD1' ' A' ' 226' ' ' ASN . 0.7 OUTLIER -102.2 16.85 24.91 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.427 0.722 . . . . 0.0 109.315 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.492 ' O ' ' CB ' ' A' ' 227' ' ' TRP . 28.9 t80 -53.12 -32.4 47.19 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.488 1.117 . . . . 0.0 111.007 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -86.39 -21.06 7.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.519 1.137 . . . . 0.0 109.311 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.779 ' O ' HD12 ' A' ' 229' ' ' LEU . 0.0 OUTLIER -77.33 -44.15 30.5 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.527 1.142 . . . . 0.0 110.284 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.513 ' O ' HG13 ' A' ' 230' ' ' VAL . 18.4 p-10 -81.02 -30.73 34.85 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.52 1.137 . . . . 0.0 109.317 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' TRP . . . . . 1.027 ' CZ3' HG23 ' A' ' 245' ' ' VAL . 1.0 OUTLIER -68.86 -45.27 71.5 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 0.0 107.981 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.606 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 3.5 pt20 -71.98 -32.18 67.0 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.568 1.167 . . . . 0.0 110.282 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.779 HD12 ' O ' ' A' ' 225' ' ' ARG . 1.2 mt -63.4 -47.71 80.84 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.534 1.146 . . . . 0.0 109.306 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.822 ' O ' HG22 ' A' ' 233' ' ' VAL . 34.1 m -66.98 -41.24 87.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.483 1.115 . . . . 0.0 109.324 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -76.76 -11.4 59.83 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.535 1.147 . . . . 0.0 109.277 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -81.24 -26.01 36.18 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.479 1.112 . . . . 0.0 109.298 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' VAL . . . . . 0.822 HG22 ' O ' ' A' ' 230' ' ' VAL . 34.1 m -86.46 135.9 35.85 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.493 1.121 . . . . 0.0 109.279 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.41 ' HA ' ' HB2' ' A' ' 237' ' ' GLN . 18.4 Cg_endo -74.94 -13.48 21.54 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.497 1.788 . . . . 0.0 111.046 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.86 -28.65 66.9 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.485 1.116 . . . . 0.0 109.334 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.498 ' HA ' ' CD1' ' A' ' 239' ' ' LEU . 11.6 m-30 -110.82 -17.01 13.44 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.518 1.136 . . . . 0.0 111.033 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' GLN . . . . . 0.41 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 0.3 OUTLIER -59.4 -26.65 65.31 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.467 1.104 . . . . 0.0 110.335 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -83.45 7.56 16.54 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.465 1.103 . . . . 0.0 109.291 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.5 HD13 HG11 ' A' ' 243' ' ' VAL . 34.0 mt -101.65 -179.48 4.03 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.538 1.149 . . . . 0.0 109.294 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -92.06 176.84 39.4 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.479 1.112 . . . . 0.0 110.992 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -30.34 7.24 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.457 1.767 . . . . 0.0 111.009 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.505 ' HA ' HG12 ' A' ' 245' ' ' VAL . . . -70.91 -31.49 68.13 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 0.0 109.322 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.746 ' CG2' HD11 ' A' ' 337' ' ' ILE . 2.7 t -76.89 -43.0 33.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.504 1.128 . . . . 0.0 109.327 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.589 ' O ' HG12 ' A' ' 248' ' ' VAL . 0.2 OUTLIER -67.3 -45.16 77.34 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.529 1.143 . . . . 0.0 109.321 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 1.027 HG23 ' CZ3' ' A' ' 227' ' ' TRP . 2.9 p -64.49 -44.83 96.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.529 1.143 . . . . 0.0 109.32 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.405 ' N ' ' CG1' ' A' ' 245' ' ' VAL . 19.7 tp10 -66.01 -34.66 78.61 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.45 1.094 . . . . 0.0 110.301 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.538 ' CG1' HD13 ' A' ' 330' ' ' LEU . 15.5 mt -68.81 -55.17 16.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.548 1.155 . . . . 0.0 109.31 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.946 ' HA ' HD12 ' A' ' 251' ' ' LEU . 13.7 p -64.81 -30.36 50.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.532 1.145 . . . . 0.0 109.318 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.484 ' CG ' ' O ' ' A' ' 245' ' ' VAL . 5.8 mmm180 -70.17 -28.76 65.58 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.526 1.141 . . . . 0.0 110.308 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.542 ' HB1' ' OD2' ' A' ' 326' ' ' ASP . . . -86.86 -21.06 26.61 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.475 1.109 . . . . 0.0 109.309 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.946 HD12 ' HA ' ' A' ' 248' ' ' VAL . 1.7 mt -54.72 144.85 20.88 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.527 1.142 . . . . 0.0 109.256 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.66 124.88 50.82 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.485 1.116 . . . . 0.0 110.302 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -81.94 124.25 29.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.486 1.116 . . . . 0.0 109.267 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.46 136.56 48.04 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.523 1.139 . . . . 0.0 110.295 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 55.7 m -94.16 125.04 38.55 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 0.0 110.384 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.489 HG21 HD11 ' A' ' 319' ' ' LEU . 42.1 t -106.8 113.95 62.23 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.47 1.106 . . . . 0.0 109.301 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.492 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.2 Cg_endo -75.03 158.11 42.27 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.49 1.784 . . . . 0.0 110.983 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.499 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -57.85 125.39 22.82 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.491 1.119 . . . . 0.0 109.314 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 101.52 -24.08 32.85 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.513 1.133 . . . . 0.0 110.99 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.492 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -61.35 147.44 44.75 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.554 0.796 . . . . 0.0 109.291 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.9 t -97.11 131.3 44.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.51 1.131 . . . . 0.0 109.298 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.744 HD12 HG12 ' A' ' 311' ' ' VAL . 86.2 mt -83.11 -47.96 17.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.457 1.098 . . . . 0.0 109.33 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 14.3 p -153.88 145.48 23.26 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.478 1.111 . . . . 0.0 108.289 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -89.25 178.96 6.22 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.542 1.151 . . . . 0.0 110.28 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.467 HG23 ' OG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -77.89 130.69 35.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.48 1.112 . . . . 0.0 109.261 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 59.9 49.4 78.94 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.497 1.123 . . . . 0.0 111.012 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.12 164.3 58.11 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.521 0.777 . . . . 0.0 110.325 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.5 Cg_endo -74.98 80.6 2.39 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.517 1.799 . . . . 0.0 111.043 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 268' ' ' PRO . . . -37.14 95.82 0.01 OUTLIER Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.488 1.117 . . . . 0.0 111.024 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 268' ' ' PRO . 1.0 OUTLIER -170.2 37.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.499 0.764 . . . . 0.0 109.311 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 6.5 ttt180 -171.57 146.33 2.17 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.506 1.129 . . . . 0.0 110.309 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' MET . . . . . 0.757 ' HB2' HD11 ' A' ' 301' ' ' LEU . 2.6 ttt -116.69 146.51 42.71 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.533 1.146 . . . . 0.0 111.023 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.561 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 44.5 m-85 -133.92 137.03 44.64 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.124 . . . . 0.0 111.023 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' PHE . . . . . 0.437 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 21.1 m-85 -126.38 133.48 51.3 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.519 1.137 . . . . 0.0 111.003 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.74 HG22 HD22 ' A' ' 319' ' ' LEU . 3.2 t -91.07 133.11 33.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.475 1.109 . . . . 0.0 109.294 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.672 ' CG2' HD11 ' A' ' 320' ' ' LEU . 40.2 t -110.27 -35.35 2.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.576 1.173 . . . . 0.0 109.268 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.767 ' O ' HG13 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -156.27 137.84 14.09 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.516 1.135 . . . . 0.0 110.309 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.869 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 117.15 -177.53 16.7 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.483 1.114 . . . . 0.0 110.987 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 2.7 m -126.35 113.49 16.98 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.478 0.752 . . . . 0.0 109.97 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 289' ' ' GLU . 32.7 m -99.26 135.1 35.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.493 1.121 . . . . 0.0 109.325 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 29.3 t -104.16 148.49 26.23 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.475 1.109 . . . . 0.0 109.997 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 288' ' ' VAL . 1.7 t -112.27 128.92 68.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.482 1.113 . . . . 0.0 109.319 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.415 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -77.34 100.96 6.11 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.538 1.149 . . . . 0.0 109.282 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' THR . . . . . 0.661 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.9 OUTLIER -149.37 -167.99 0.17 Allowed Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.455 1.097 . . . . 0.0 110.382 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.661 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.4 Cg_endo -75.0 3.93 5.19 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.51 1.794 . . . . 0.0 111.028 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.415 ' O ' HG23 ' A' ' 288' ' ' VAL . 26.4 m120 -152.21 154.82 32.76 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.448 1.093 . . . . 0.0 109.276 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 95.48 0.98 Allowed 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.515 1.797 . . . . 0.0 110.981 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 286' ' ' ASN . 1.3 t -100.03 118.53 46.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.491 1.119 . . . . 0.0 109.303 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 2.5 mm-40 -125.16 133.53 52.76 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.498 1.124 . . . . 0.0 110.312 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.427 HD13 ' HA ' ' A' ' 290' ' ' LEU . 4.4 mm? -115.41 139.66 49.82 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.506 1.129 . . . . 0.0 109.324 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -95.77 -155.96 31.31 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.502 1.126 . . . . 0.0 110.98 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' PRO . . . . . 0.419 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.2 Cg_endo -75.05 138.37 22.82 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.53 1.805 . . . . 0.0 110.972 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 95.23 6.19 60.2 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.481 1.113 . . . . 0.0 110.965 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -90.58 130.75 36.58 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.461 0.742 . . . . 0.0 109.238 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 295' ' ' PHE . 2.3 p90 -120.75 152.92 37.7 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.506 1.129 . . . . 0.0 111.018 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.561 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 36.9 p90 -164.72 148.27 8.92 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.13 . . . . 0.0 110.975 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' GLY . . . . . 0.592 ' O ' HD12 ' A' ' 301' ' ' LEU . . . 128.07 -8.45 6.74 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.457 1.098 . . . . 0.0 110.989 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -54.94 -53.35 56.76 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.474 0.749 . . . . 0.0 110.319 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -46.98 -35.03 6.12 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.512 1.133 . . . . 0.0 110.979 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 300' ' ' ALA . . . . . 0.458 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -68.74 -46.91 67.64 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.515 1.134 . . . . 0.0 109.324 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.757 HD11 ' HB2' ' A' ' 272' ' ' MET . 1.1 mp -75.21 -3.21 31.76 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.475 1.11 . . . . 0.0 109.312 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' ILE . . . . . 0.42 HD13 ' CZ ' ' A' ' 341' ' ' PHE . 8.8 mm -86.85 -54.35 8.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.509 1.131 . . . . 0.0 109.296 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 304' ' ' GLY . 0.9 OUTLIER -149.44 40.89 0.86 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.47 1.106 . . . . 0.0 110.036 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 37.03 34.04 0.1 OUTLIER Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.54 1.15 . . . . 0.0 110.989 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.72 155.23 89.88 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.502 0.766 . . . . 0.0 110.266 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 129.66 12.52 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.468 1.773 . . . . 0.0 111.013 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.98 -29.64 1.52 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.503 1.127 . . . . 0.0 110.273 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.506 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 0.1 OUTLIER 50.65 40.88 25.01 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.444 1.09 . . . . 0.0 109.957 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 309' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 175.26 160.82 0.24 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.497 1.123 . . . . 0.0 109.311 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.467 ' OG1' HG23 ' A' ' 265' ' ' ILE . 0.9 OUTLIER -117.78 123.43 45.97 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.539 1.149 . . . . 0.0 110.392 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.744 HG12 HD12 ' A' ' 262' ' ' ILE . 95.1 t -103.99 131.39 52.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.506 1.129 . . . . 0.0 109.279 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 65.2 p -131.54 151.27 51.72 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.475 1.109 . . . . 0.0 109.997 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.26 109.65 19.65 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.515 1.134 . . . . 0.0 109.282 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -56.41 -32.19 64.61 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.503 1.127 . . . . 0.0 109.304 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' THR . . . . . 0.843 ' O ' HG23 ' A' ' 317' ' ' VAL . 8.2 t -153.86 -171.76 3.99 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.526 1.141 . . . . 0.0 110.416 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 316' ' ' THR . . . . . 0.452 ' N ' ' OG1' ' A' ' 315' ' ' THR . 43.1 p -54.74 87.91 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.554 1.159 . . . . 0.0 110.39 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.869 HG22 ' HA3' ' A' ' 278' ' ' GLY . 44.9 t -107.71 144.25 16.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.482 1.113 . . . . 0.0 109.265 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 69.1 m -117.99 117.87 30.4 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.529 1.143 . . . . 0.0 109.958 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' LEU . . . . . 0.74 HD22 HG22 ' A' ' 275' ' ' VAL . 0.0 OUTLIER -128.48 173.33 10.32 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.49 1.119 . . . . 0.0 109.328 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.672 HD11 ' CG2' ' A' ' 276' ' ' VAL . 0.2 OUTLIER -124.49 136.3 53.9 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.471 1.107 . . . . 0.0 109.298 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 14.1 t -96.23 154.63 17.15 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.513 1.133 . . . . 0.0 110.01 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.468 ' HB2' ' CD2' ' A' ' 251' ' ' LEU . 1.2 tm? -145.28 87.66 1.82 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.506 1.129 . . . . 0.0 109.268 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 323' ' ' HIS . . . . . 0.414 ' ND1' ' HB3' ' A' ' 325' ' ' ALA . 10.4 p80 -49.69 139.1 13.34 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.557 1.16 . . . . 0.0 109.602 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 36.0 t -59.52 -23.87 63.17 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.466 1.104 . . . . 0.0 110.006 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 0.414 ' HB3' ' ND1' ' A' ' 323' ' ' HIS . . . -55.95 -31.03 62.58 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.474 1.108 . . . . 0.0 109.325 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' ASP . . . . . 0.542 ' OD2' ' HB1' ' A' ' 250' ' ' ALA . 2.6 t70 -70.11 -38.88 75.72 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.532 1.145 . . . . 0.0 109.357 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -67.5 -36.51 81.23 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.517 1.136 . . . . 0.0 110.965 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -70.32 -37.01 74.63 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.525 1.14 . . . . 0.0 110.297 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 5.1 ttp -68.86 -40.39 79.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 0.0 111.009 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.538 HD13 ' CG1' ' A' ' 247' ' ' ILE . 9.3 mt -72.14 -34.52 68.6 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.462 1.101 . . . . 0.0 109.299 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 16.0 m -74.18 -33.32 63.41 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.488 1.117 . . . . 0.0 108.318 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 8.6 t -75.91 -36.52 59.41 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.129 . . . . 0.0 110.004 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 10.0 t -74.51 -34.34 63.01 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.487 1.117 . . . . 0.0 110.03 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 334' ' ' SER . . . . . 0.798 ' CB ' HD12 ' A' ' 337' ' ' ILE . 0.3 OUTLIER -128.1 114.62 20.22 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.562 1.164 . . . . 0.0 110.036 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -18.95 18.29 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.499 1.789 . . . . 0.0 111.013 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -72.37 -28.92 63.33 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 0.0 110.329 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.798 HD12 ' CB ' ' A' ' 334' ' ' SER . 46.2 mt -72.69 -41.43 62.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.554 1.159 . . . . 0.0 109.257 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.97 -32.41 65.18 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.455 1.097 . . . . 0.0 109.27 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.53 -39.75 62.16 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.491 1.12 . . . . 0.0 110.293 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 48.6 mt -73.23 -42.69 57.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.551 1.157 . . . . 0.0 109.286 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.42 ' CZ ' HD13 ' A' ' 302' ' ' ILE . 46.7 t80 -69.24 -34.26 74.55 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.55 1.157 . . . . 0.0 111.009 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 342' ' ' ARG . . . . . 0.461 ' HG3' ' CD1' ' A' ' 346' ' ' LEU . 1.4 ttp-105 -72.78 -39.54 66.64 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.538 1.149 . . . . 0.0 110.276 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -50.59 65.93 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.509 1.13 . . . . 0.0 109.291 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 7.6 t -65.37 -32.98 74.9 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.47 1.106 . . . . 0.0 110.453 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -66.74 -44.99 80.05 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.521 1.138 . . . . 0.0 109.334 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.461 ' CD1' ' HG3' ' A' ' 342' ' ' ARG . 0.6 OUTLIER -65.14 -37.03 86.12 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.503 1.127 . . . . 0.0 109.289 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.08 -39.22 92.89 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.472 1.107 . . . . 0.0 110.31 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 49.6 mtt-85 -72.8 -43.3 62.92 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.481 1.113 . . . . 0.0 110.296 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 350' ' ' GLY . 0.0 OUTLIER -71.46 -34.52 70.29 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 0.0 110.311 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 350' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 349' ' ' ARG . . . -36.08 -46.99 1.0 Allowed Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.547 1.155 . . . . 0.0 110.966 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -155.19 120.64 4.99 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.482 0.754 . . . . 0.0 109.325 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -60.46 170.05 1.51 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.469 1.105 . . . . 0.0 109.258 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -115.79 132.25 56.7 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.492 1.12 . . . . 0.0 109.33 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 48.3 m -77.95 125.93 30.09 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.545 1.153 . . . . 0.0 110.014 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.47 0 O-C-N 124.472 1.108 . . . . 0.0 109.303 -179.973 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.999 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 5.4 m -97.11 149.99 21.35 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.501 0.765 . . . . 0.0 110.012 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -154.94 146.56 23.23 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.51 1.131 . . . . 0.0 110.279 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.6 157.52 18.42 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.451 1.095 . . . . 0.0 110.299 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.1 m -107.24 166.38 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.488 1.118 . . . . 0.0 109.309 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 7.9 mtt85 -103.66 168.59 9.05 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.497 1.123 . . . . 0.0 110.329 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.55 154.36 39.33 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.504 1.127 . . . . 0.0 110.319 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -110.73 19.05 26.36 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.516 1.135 . . . . 0.0 111.002 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.2 19.64 6.76 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.496 0.762 . . . . 0.0 109.283 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -52.98 -36.61 60.45 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.48 1.113 . . . . 0.0 111.046 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.98 -33.29 58.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.471 1.107 . . . . 0.0 109.339 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.764 ' HD2' HG13 ' A' ' 276' ' ' VAL . 0.0 OUTLIER -67.91 -35.02 77.74 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.498 1.124 . . . . 0.0 110.308 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.681 ' OD1' HD13 ' A' ' 320' ' ' LEU . 3.7 m-20 -77.46 -30.44 53.23 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.487 1.117 . . . . 0.0 109.279 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' TRP . . . . . 0.79 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 1.9 t90 -67.58 -44.81 77.26 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.513 1.133 . . . . 0.0 108.04 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 5.7 pt20 -71.14 -35.75 71.81 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.493 1.12 . . . . 0.0 110.307 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.607 HD23 ' HD3' ' A' ' 225' ' ' ARG . 0.8 OUTLIER -61.45 -47.43 85.76 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.509 1.131 . . . . 0.0 109.323 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.621 HG12 HD13 ' A' ' 244' ' ' LEU . 99.7 t -71.76 -40.76 70.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.473 1.108 . . . . 0.0 109.274 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.58 -15.94 62.81 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.481 1.113 . . . . 0.0 109.251 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -81.34 -11.09 59.42 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.553 1.158 . . . . 0.0 109.31 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 229' ' ' LEU . 31.2 t -89.64 123.33 66.81 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.514 1.134 . . . . 0.0 109.308 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 -16.09 20.31 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.481 1.78 . . . . 0.0 110.997 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.759 HD12 ' CE2' ' A' ' 341' ' ' PHE . 0.0 OUTLIER -79.6 -24.66 41.85 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.498 1.124 . . . . 0.0 109.268 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.4 ' CB ' HD12 ' A' ' 239' ' ' LEU . 3.4 m-30 -108.51 -11.88 15.08 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.537 1.148 . . . . 0.0 111.022 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.66 -24.65 66.87 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.488 1.118 . . . . 0.0 110.338 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -74.62 -4.45 37.21 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.516 1.135 . . . . 0.0 109.333 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.557 HD22 HG11 ' A' ' 243' ' ' VAL . 12.5 mt -85.0 -179.65 7.1 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.45 1.094 . . . . 0.0 109.321 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' GLY . . . . . 0.633 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -103.24 -172.66 26.15 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.489 1.118 . . . . 0.0 111.012 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.906 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.2 Cg_endo -75.02 -36.14 2.71 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.464 1.77 . . . . 0.0 111.02 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.04 -35.31 78.04 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.533 1.146 . . . . 0.0 109.299 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.636 HG21 HD11 ' A' ' 337' ' ' ILE . 13.0 t -75.33 -36.58 36.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.451 1.095 . . . . 0.0 109.258 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.633 HD23 ' O ' ' A' ' 240' ' ' GLY . 1.6 mm? -70.54 -35.48 73.16 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.499 1.125 . . . . 0.0 109.304 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.906 HG23 ' O ' ' A' ' 241' ' ' PRO . 96.4 t -72.85 -38.28 56.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.473 1.108 . . . . 0.0 109.334 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -69.06 -49.7 55.1 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.514 1.134 . . . . 0.0 110.235 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.513 HD12 HG12 ' A' ' 243' ' ' VAL . 14.1 mt -63.13 -35.63 72.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.502 1.127 . . . . 0.0 109.319 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 244' ' ' LEU . 4.6 t -67.51 -41.13 85.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.526 1.141 . . . . 0.0 109.309 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -77.23 -13.03 60.01 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.489 1.118 . . . . 0.0 110.298 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -89.18 -17.46 29.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.461 1.101 . . . . 0.0 109.311 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.59 HD23 ' HB2' ' A' ' 322' ' ' LEU . 3.2 mt -65.89 144.53 56.75 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.456 1.097 . . . . 0.0 109.294 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 320' ' ' LEU . 0.0 OUTLIER -119.75 133.15 55.72 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.535 1.147 . . . . 0.0 110.284 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.657 ' HA ' HD23 ' A' ' 320' ' ' LEU . . . -80.63 130.91 35.38 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.462 1.101 . . . . 0.0 109.284 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.22 125.03 19.63 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.489 1.118 . . . . 0.0 110.295 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 13.4 m -91.07 116.53 28.88 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.49 1.119 . . . . 0.0 110.381 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.626 HG12 ' CB ' ' A' ' 313' ' ' ALA . 24.4 t -107.05 111.63 63.5 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 124.533 1.145 . . . . 0.0 109.315 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.96 176.38 9.98 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.482 1.78 . . . . 0.0 111.039 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.521 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -67.8 134.14 50.44 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.505 1.128 . . . . 0.0 109.304 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 89.15 -25.53 10.13 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.501 1.126 . . . . 0.0 110.981 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.547 ' HB3' HG13 ' A' ' 256' ' ' VAL . . . -55.43 148.49 15.15 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.489 0.758 . . . . 0.0 109.285 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 2.7 t -96.93 129.7 46.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.536 1.148 . . . . 0.0 109.309 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.793 HD12 HG12 ' A' ' 311' ' ' VAL . 65.7 mt -84.81 -45.77 17.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.533 1.145 . . . . 0.0 109.303 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 13.5 p -154.97 149.71 26.58 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.486 1.116 . . . . 0.0 108.333 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -89.53 175.9 7.1 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.128 . . . . 0.0 110.308 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.503 HD13 ' H ' ' A' ' 265' ' ' ILE . 0.2 OUTLIER -76.97 141.16 16.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.503 1.127 . . . . 0.0 109.321 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 45.67 49.46 12.11 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.524 1.14 . . . . 0.0 110.974 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.472 ' HG3' ' N ' ' A' ' 268' ' ' PRO . 2.9 pt-20 -73.1 173.75 5.58 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.48 0.753 . . . . 0.0 110.275 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.472 ' N ' ' HG3' ' A' ' 267' ' ' GLU . 18.2 Cg_endo -75.01 97.1 1.05 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.493 1.786 . . . . 0.0 110.967 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -50.88 89.46 0.01 OUTLIER Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.465 1.103 . . . . 0.0 110.964 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 268' ' ' PRO . 40.6 m-20 -170.39 38.36 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.48 0.753 . . . . 0.0 109.3 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -171.23 149.21 2.78 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.504 1.128 . . . . 0.0 110.353 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' MET . . . . . 0.489 ' SD ' ' CD1' ' A' ' 301' ' ' LEU . 8.3 ptm -138.74 146.97 42.1 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.5 1.125 . . . . 0.0 110.97 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.575 ' HB2' ' CE1' ' A' ' 296' ' ' PHE . 34.0 m-85 -124.98 151.48 45.46 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.528 1.143 . . . . 0.0 110.943 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' PHE . . . . . 0.502 ' CD1' ' HB3' ' A' ' 295' ' ' PHE . 23.6 m-85 -129.48 124.89 35.14 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.497 1.123 . . . . 0.0 110.99 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 1.074 HG22 HD23 ' A' ' 319' ' ' LEU . 76.2 t -79.7 138.19 20.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.477 1.11 . . . . 0.0 109.278 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.764 HG13 ' HD2' ' A' ' 225' ' ' ARG . 2.9 t -116.14 -47.54 4.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.443 1.089 . . . . 0.0 109.304 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.479 ' O ' HG23 ' A' ' 317' ' ' VAL . 5.9 mt-10 -145.62 135.9 23.94 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.533 1.146 . . . . 0.0 110.318 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.404 ' HA3' ' HB ' ' A' ' 317' ' ' VAL . . . 115.63 -155.11 16.5 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.535 1.147 . . . . 0.0 110.99 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 3.1 m -151.32 138.62 19.36 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.461 0.742 . . . . 0.0 109.982 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.474 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 17.6 m -117.59 166.77 11.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.496 1.122 . . . . 0.0 109.287 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 29.4 t -131.9 155.47 47.83 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.475 1.109 . . . . 0.0 109.983 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.508 HG13 HG22 ' A' ' 311' ' ' VAL . 0.3 OUTLIER -119.12 129.37 75.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.474 1.109 . . . . 0.0 109.308 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.4 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -77.77 101.85 6.9 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.512 1.133 . . . . 0.0 109.271 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' THR . . . . . 0.649 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.39 -168.62 0.19 Allowed Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.509 1.13 . . . . 0.0 110.392 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.649 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -74.98 4.88 4.33 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.469 1.773 . . . . 0.0 110.965 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -151.83 157.12 34.53 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.455 1.097 . . . . 0.0 109.31 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.98 94.89 0.96 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.488 1.783 . . . . 0.0 110.981 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 281' ' ' SER . 31.2 t -99.04 119.45 47.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.498 1.123 . . . . 0.0 109.323 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 14.4 mt-10 -124.33 136.89 54.44 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.491 1.119 . . . . 0.0 110.296 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.474 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 3.9 mm? -114.76 142.83 45.99 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.533 1.145 . . . . 0.0 109.288 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -98.44 -164.97 30.78 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.497 1.123 . . . . 0.0 110.981 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' PRO . . . . . 0.642 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.3 Cg_endo -74.98 156.23 43.07 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.454 1.765 . . . . 0.0 110.974 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.433 ' HA2' HD21 ' A' ' 229' ' ' LEU . . . 77.37 2.17 78.44 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.508 1.13 . . . . 0.0 110.973 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' ALA . . . . . 0.406 ' HB1' HD12 ' A' ' 290' ' ' LEU . . . -87.79 136.05 33.12 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.518 0.775 . . . . 0.0 109.325 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.502 ' HB3' ' CD1' ' A' ' 274' ' ' PHE . 0.7 OUTLIER -123.76 153.05 41.47 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.508 1.13 . . . . 0.0 110.983 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.575 ' CE1' ' HB2' ' A' ' 273' ' ' PHE . 51.7 p90 -163.52 143.35 8.54 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.515 1.134 . . . . 0.0 110.962 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' GLY . . . . . 0.469 ' HA3' ' CB ' ' A' ' 272' ' ' MET . . . 137.57 -14.31 3.67 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.499 1.125 . . . . 0.0 110.943 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -52.84 -44.41 66.72 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.514 0.773 . . . . 0.0 110.311 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' MET . . . . . 0.487 ' CE ' HD12 ' A' ' 302' ' ' ILE . 0.1 OUTLIER -47.37 -39.11 14.41 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.487 1.117 . . . . 0.0 111.003 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 300' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -72.64 -37.16 68.08 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.489 1.118 . . . . 0.0 109.31 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.489 ' CD1' ' SD ' ' A' ' 272' ' ' MET . 4.5 mt -76.67 -5.47 48.06 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.485 1.116 . . . . 0.0 109.34 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 302' ' ' ILE . . . . . 0.674 HG23 ' HB1' ' A' ' 345' ' ' ALA . 22.0 mt -91.81 -51.43 11.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.475 1.109 . . . . 0.0 109.261 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.442 ' O ' ' C ' ' A' ' 304' ' ' GLY . 1.2 m -151.94 41.01 0.65 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.506 1.129 . . . . 0.0 109.954 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 34.7 39.97 0.18 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.498 1.123 . . . . 0.0 110.99 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' GLU . . . . . 0.425 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 0.5 OUTLIER -68.17 151.05 97.48 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.505 0.768 . . . . 0.0 110.292 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 132.36 15.37 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.532 1.806 . . . . 0.0 111.03 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' ARG . . . . . 0.425 ' NH2' ' HA2' ' A' ' 297' ' ' GLY . 10.5 mmp_? -44.39 -44.92 8.65 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.436 1.085 . . . . 0.0 110.309 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.57 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 0.3 OUTLIER 66.31 38.18 4.58 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.483 1.114 . . . . 0.0 109.991 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 309' ' ' ALA . . . . . 0.57 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 171.73 160.88 0.1 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.532 1.145 . . . . 0.0 109.308 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.89 125.48 52.85 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.529 1.143 . . . . 0.0 110.409 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.793 HG12 HD12 ' A' ' 262' ' ' ILE . 77.7 t -103.3 127.7 56.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 0.0 109.318 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 87.5 p -127.86 157.45 40.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.516 1.135 . . . . 0.0 109.994 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' ALA . . . . . 0.821 ' HB1' ' CG1' ' A' ' 317' ' ' VAL . . . -89.19 112.99 24.14 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.502 1.126 . . . . 0.0 109.319 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -54.3 -32.71 57.12 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.55 1.156 . . . . 0.0 109.35 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' THR . . . . . 0.68 ' O ' HG12 ' A' ' 317' ' ' VAL . 9.8 t -158.63 -159.05 0.75 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.462 1.101 . . . . 0.0 110.44 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 316' ' ' THR . . . . . 0.443 ' N ' ' OG1' ' A' ' 315' ' ' THR . 86.6 m -66.03 81.26 0.08 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.525 1.141 . . . . 0.0 110.38 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.821 ' CG1' ' HB1' ' A' ' 313' ' ' ALA . 1.3 p -108.26 140.98 24.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.491 1.12 . . . . 0.0 109.265 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 49.2 m -112.3 127.73 56.07 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.511 1.132 . . . . 0.0 110.003 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' LEU . . . . . 1.074 HD23 HG22 ' A' ' 275' ' ' VAL . 0.0 OUTLIER -134.81 174.71 10.28 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.555 1.159 . . . . 0.0 109.295 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.681 HD13 ' OD1' ' A' ' 226' ' ' ASN . 1.0 OUTLIER -124.18 135.27 53.35 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.499 1.124 . . . . 0.0 109.312 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 53.9 p -96.86 150.66 20.49 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.531 1.144 . . . . 0.0 109.994 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.59 ' HB2' HD23 ' A' ' 251' ' ' LEU . 2.6 tm? -146.17 104.02 3.77 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.529 1.143 . . . . 0.0 109.304 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -65.15 138.53 58.34 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.448 1.092 . . . . 0.0 109.578 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' SER . . . . . 0.426 ' HA ' HD21 ' A' ' 301' ' ' LEU . 89.2 p -59.81 -19.65 52.03 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.48 1.113 . . . . 0.0 109.985 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -51.22 -35.36 36.3 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.514 1.134 . . . . 0.0 109.261 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' ASP . . . . . 0.585 ' OD1' HD11 ' A' ' 322' ' ' LEU . 3.2 p-10 -65.84 -38.38 88.72 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.508 1.13 . . . . 0.0 109.295 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -67.85 -37.79 82.33 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.5 1.125 . . . . 0.0 110.981 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -68.81 -32.49 72.23 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.515 1.134 . . . . 0.0 110.31 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 15.6 tmm? -70.58 -43.2 69.9 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.519 1.137 . . . . 0.0 111.022 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.82 -31.2 61.63 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.124 . . . . 0.0 109.278 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' CYS . . . . . 0.422 ' CB ' ' HB2' ' A' ' 338' ' ' ALA . 1.8 m -75.0 -39.74 61.03 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.457 1.098 . . . . 0.0 108.297 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 26.3 t -70.8 -32.55 69.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.53 1.144 . . . . 0.0 110.013 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 31.9 t -79.16 -35.68 41.59 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.511 1.132 . . . . 0.0 109.988 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 1.5 m -128.96 109.16 18.3 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.522 1.139 . . . . 0.0 109.972 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 -20.26 17.04 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.504 1.792 . . . . 0.0 111.052 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.453 ' O ' ' CG1' ' A' ' 340' ' ' ILE . 1.2 tt0 -66.1 -37.26 85.31 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 0.0 110.347 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.636 HD11 HG21 ' A' ' 243' ' ' VAL . 88.1 mt -75.97 -42.8 39.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.44 1.088 . . . . 0.0 109.285 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 338' ' ' ALA . . . . . 0.422 ' HB2' ' CB ' ' A' ' 331' ' ' CYS . . . -64.83 -45.23 87.02 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.484 1.115 . . . . 0.0 109.315 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.52 -33.37 74.0 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.49 1.119 . . . . 0.0 110.314 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.453 ' CG1' ' O ' ' A' ' 336' ' ' GLU . 21.1 mt -70.17 -40.66 78.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.519 1.137 . . . . 0.0 109.341 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.759 ' CE2' HD12 ' A' ' 235' ' ' LEU . 2.7 t80 -69.08 -35.13 76.15 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.499 1.125 . . . . 0.0 111.036 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 27.7 ttt-85 -70.37 -38.94 74.85 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.494 1.121 . . . . 0.0 110.318 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -51.07 63.16 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.535 1.147 . . . . 0.0 109.328 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.46 HG22 ' HA ' ' A' ' 341' ' ' PHE . 13.1 t -68.64 -33.32 73.82 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.497 1.123 . . . . 0.0 110.43 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 345' ' ' ALA . . . . . 0.674 ' HB1' HG23 ' A' ' 302' ' ' ILE . . . -70.18 -36.44 74.66 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.445 1.091 . . . . 0.0 109.301 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 346' ' ' LEU . 11.7 mt -69.28 -40.94 77.47 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.471 1.107 . . . . 0.0 109.318 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -68.42 -34.05 75.31 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.486 1.116 . . . . 0.0 110.323 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 34.3 mtt-85 -73.05 -42.83 62.67 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.474 1.109 . . . . 0.0 110.285 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 4.9 tpt85 -68.54 -39.13 81.23 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.513 1.133 . . . . 0.0 110.266 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -39.84 -46.65 3.1 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.509 1.131 . . . . 0.0 110.979 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -155.0 120.67 5.08 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.477 0.751 . . . . 0.0 109.264 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -60.04 166.74 2.63 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.475 1.109 . . . . 0.0 109.303 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -102.8 135.45 44.44 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.509 1.131 . . . . 0.0 109.268 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 58.1 m -135.08 168.21 19.54 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.535 1.147 . . . . 0.0 109.984 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.463 0 O-C-N 124.469 1.106 . . . . 0.0 109.297 -179.992 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.993 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.91 159.29 37.87 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.51 0.771 . . . . 0.0 110.019 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -135.63 170.09 16.5 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.549 1.156 . . . . 0.0 110.275 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -124.09 134.43 53.38 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.473 1.108 . . . . 0.0 110.307 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 1.4 p -137.87 157.59 32.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.511 1.132 . . . . 0.0 109.309 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 37.2 mtp180 -81.65 144.67 31.04 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.444 1.09 . . . . 0.0 110.28 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.83 172.67 6.76 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 0.0 110.302 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.78 -11.89 84.26 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.48 1.112 . . . . 0.0 110.984 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -109.47 13.15 24.19 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.499 0.764 . . . . 0.0 109.306 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -52.76 -34.5 53.35 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.483 1.114 . . . . 0.0 110.954 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.55 -39.64 40.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.124 . . . . 0.0 109.252 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.401 ' HG3' HD12 ' A' ' 229' ' ' LEU . 13.6 tpp85 -68.37 -30.64 69.63 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.115 . . . . 0.0 110.275 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.705 HD21 HD22 ' A' ' 320' ' ' LEU . 2.2 m-20 -79.3 -41.4 28.12 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.408 1.068 . . . . 0.0 109.302 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' TRP . . . . . 0.485 ' O ' HG22 ' A' ' 230' ' ' VAL . 4.5 t90 -66.68 -44.52 81.54 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.527 1.142 . . . . 0.0 107.977 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.611 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 9.7 pt20 -67.71 -31.63 71.71 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.478 1.111 . . . . 0.0 110.31 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.401 HD12 ' HG3' ' A' ' 225' ' ' ARG . 1.6 mt -63.54 -45.08 92.2 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.514 1.133 . . . . 0.0 109.316 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.87 HG23 HD12 ' A' ' 244' ' ' LEU . 35.2 m -74.55 -38.78 46.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.528 1.143 . . . . 0.0 109.33 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -75.42 -11.78 60.11 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.47 1.106 . . . . 0.0 109.336 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -81.32 -23.99 37.44 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.525 1.14 . . . . 0.0 109.247 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' VAL . . . . . 0.583 HG12 ' O ' ' A' ' 230' ' ' VAL . 0.4 OUTLIER -81.35 130.93 60.23 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.475 1.109 . . . . 0.0 109.263 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.42 ' HA ' ' HB2' ' A' ' 237' ' ' GLN . 18.2 Cg_endo -75.02 -16.75 19.98 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.513 1.796 . . . . 0.0 110.982 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.455 HD21 HD11 ' A' ' 302' ' ' ILE . 0.1 OUTLIER -63.34 -30.04 71.24 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.456 1.098 . . . . 0.0 109.33 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.539 ' HB3' HD12 ' A' ' 239' ' ' LEU . 16.1 m-30 -112.95 17.08 19.18 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.538 1.149 . . . . 0.0 111.003 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' GLN . . . . . 0.42 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 2.1 mt-30 -70.01 -20.02 63.29 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.549 1.155 . . . . 0.0 110.282 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -92.58 -12.37 31.94 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.508 1.13 . . . . 0.0 109.302 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.744 HD22 HG11 ' A' ' 243' ' ' VAL . 46.0 mt -70.11 179.26 2.41 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.46 1.1 . . . . 0.0 109.276 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' GLY . . . . . 0.691 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -109.79 -174.89 20.94 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.509 1.131 . . . . 0.0 111.006 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 -32.84 5.13 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.485 1.782 . . . . 0.0 111.065 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.507 ' HA ' HG12 ' A' ' 245' ' ' VAL . . . -73.09 -33.2 65.47 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.457 1.098 . . . . 0.0 109.284 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.744 HG11 HD22 ' A' ' 239' ' ' LEU . 63.5 t -77.09 -36.59 24.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.474 1.109 . . . . 0.0 109.334 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.87 HD12 HG23 ' A' ' 230' ' ' VAL . 3.8 mm? -72.57 -42.65 64.4 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.497 1.123 . . . . 0.0 109.289 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.507 HG12 ' HA ' ' A' ' 242' ' ' ALA . 2.8 p -68.21 -39.51 81.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.465 1.103 . . . . 0.0 109.261 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -70.88 -40.99 71.91 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.52 1.138 . . . . 0.0 110.284 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.649 ' CG1' HD13 ' A' ' 330' ' ' LEU . 25.6 mt -66.56 -51.97 51.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.503 1.127 . . . . 0.0 109.278 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.706 ' HA ' HD12 ' A' ' 251' ' ' LEU . 10.0 p -62.87 -30.74 50.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.48 1.113 . . . . 0.0 109.315 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.454 ' CG ' ' O ' ' A' ' 245' ' ' VAL . 16.6 mmm-85 -73.55 -25.77 60.54 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.542 1.151 . . . . 0.0 110.283 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -85.2 -17.98 35.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 0.0 109.297 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.706 HD12 ' HA ' ' A' ' 248' ' ' VAL . 0.3 OUTLIER -59.41 144.24 47.43 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 0.0 109.339 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 320' ' ' LEU . 3.2 mmm180 -118.18 135.09 54.45 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.558 1.161 . . . . 0.0 110.331 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -80.68 123.18 27.96 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.532 1.145 . . . . 0.0 109.303 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.6 ttm-85 -125.05 123.49 39.9 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.462 1.101 . . . . 0.0 110.34 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 50.2 m -91.51 117.65 29.89 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.484 1.115 . . . . 0.0 110.428 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.506 ' CG2' HD21 ' A' ' 319' ' ' LEU . 2.6 t -109.41 113.46 58.36 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.524 1.14 . . . . 0.0 109.285 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -75.0 168.71 24.24 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.543 1.812 . . . . 0.0 111.011 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.555 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -65.93 126.34 28.24 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.524 1.14 . . . . 0.0 109.286 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 100.59 -25.32 28.75 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.489 1.118 . . . . 0.0 111.003 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.49 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -67.27 145.08 55.52 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.497 0.763 . . . . 0.0 109.301 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 5.8 t -94.82 135.02 30.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.504 1.128 . . . . 0.0 109.299 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.806 HD12 HG12 ' A' ' 311' ' ' VAL . 17.8 mt -82.95 -42.74 18.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.541 1.151 . . . . 0.0 109.29 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' CYS . . . . . 0.604 ' SG ' HG23 ' A' ' 311' ' ' VAL . 11.3 p -152.4 142.61 22.4 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.49 1.119 . . . . 0.0 108.289 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 3.4 mmt85 -84.87 178.58 7.56 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.5 1.125 . . . . 0.0 110.277 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.425 ' CG2' ' HB ' ' A' ' 310' ' ' THR . 0.1 OUTLIER -76.57 137.44 22.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.513 1.133 . . . . 0.0 109.327 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 52.95 50.81 49.34 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.46 1.1 . . . . 0.0 111.026 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -70.37 163.89 58.6 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.486 0.756 . . . . 0.0 110.302 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.507 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.3 Cg_endo -74.98 82.77 1.93 Allowed 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.532 1.806 . . . . 0.0 111.051 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' GLY . . . . . 0.44 ' CA ' ' HB1' ' A' ' 300' ' ' ALA . . . -36.07 93.16 0.01 OUTLIER Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.477 1.111 . . . . 0.0 110.994 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 268' ' ' PRO . 12.3 m-20 -171.63 37.93 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.528 0.781 . . . . 0.0 109.335 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.426 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 3.3 mtp180 -169.89 144.54 2.79 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.537 1.148 . . . . 0.0 110.359 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' MET . . . . . 0.857 ' HB2' HD11 ' A' ' 301' ' ' LEU . 2.2 ttt -118.34 147.63 43.3 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.505 1.128 . . . . 0.0 110.99 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.571 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 28.4 m-85 -135.8 136.65 40.86 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.506 1.128 . . . . 0.0 111.006 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 319' ' ' LEU . 22.1 m-85 -125.98 127.49 46.0 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.117 . . . . 0.0 110.998 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.611 HG22 HD12 ' A' ' 319' ' ' LEU . 13.7 t -83.96 135.03 25.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.481 1.113 . . . . 0.0 109.319 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.441 HG12 ' HG2' ' A' ' 277' ' ' GLU . 40.3 t -111.75 -49.42 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.492 1.12 . . . . 0.0 109.355 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.581 ' O ' HG13 ' A' ' 317' ' ' VAL . 7.8 mm-40 -139.67 137.96 35.65 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.52 1.137 . . . . 0.0 110.337 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.822 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 112.75 -175.47 16.82 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.491 1.12 . . . . 0.0 111.003 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 290' ' ' LEU . 3.6 m -131.17 120.26 23.05 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.497 0.763 . . . . 0.0 109.964 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.452 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 28.9 m -99.03 164.67 2.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.505 1.128 . . . . 0.0 109.293 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 31.6 t -131.97 148.13 52.5 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.476 1.11 . . . . 0.0 110.017 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -111.26 129.93 65.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.44 1.087 . . . . 0.0 109.295 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.502 ' HB2' HG22 ' A' ' 310' ' ' THR . . . -77.96 101.87 7.08 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.505 1.128 . . . . 0.0 109.306 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' THR . . . . . 0.647 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -147.76 -168.55 0.19 Allowed Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.466 1.104 . . . . 0.0 110.427 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.647 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.4 Cg_endo -74.99 4.89 4.33 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.57 1.826 . . . . 0.0 111.025 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.419 ' O ' HG23 ' A' ' 288' ' ' VAL . 10.9 m120 -151.37 157.29 35.01 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.496 1.123 . . . . 0.0 109.271 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.1 93.85 0.97 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.51 1.795 . . . . 0.0 110.98 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 281' ' ' SER . 4.1 t -97.94 119.37 45.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.115 . . . . 0.0 109.293 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.565 ' C ' HD22 ' A' ' 290' ' ' LEU . 15.4 mt-10 -124.7 140.25 53.11 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.557 1.161 . . . . 0.0 110.315 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.565 HD22 ' C ' ' A' ' 289' ' ' GLU . 4.5 mm? -121.81 141.71 50.95 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.505 1.128 . . . . 0.0 109.304 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -96.9 -160.06 31.69 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.498 1.124 . . . . 0.0 111.038 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' PRO . . . . . 0.481 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.2 Cg_endo -75.03 142.02 27.24 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.478 1.778 . . . . 0.0 110.982 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 91.46 4.39 68.19 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.508 1.13 . . . . 0.0 111.002 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -92.04 127.76 37.63 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.436 0.727 . . . . 0.0 109.293 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.454 ' CB ' ' CD1' ' A' ' 274' ' ' PHE . 2.4 p90 -114.36 152.8 30.9 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.468 1.105 . . . . 0.0 110.979 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.681 ' HZ ' HG21 ' A' ' 262' ' ' ILE . 33.7 p90 -158.07 148.75 20.67 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.534 1.146 . . . . 0.0 111.018 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 123.54 -5.64 9.25 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.474 1.109 . . . . 0.0 110.955 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -55.83 -46.31 78.14 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.504 0.767 . . . . 0.0 110.305 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 36.9 mmt -51.89 -37.14 51.21 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 0.0 110.984 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' ALA . . . . . 0.44 ' HB1' ' CA ' ' A' ' 269' ' ' GLY . . . -67.42 -41.27 85.11 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.489 1.118 . . . . 0.0 109.278 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.857 HD11 ' HB2' ' A' ' 272' ' ' MET . 1.5 mt -77.32 -11.32 59.82 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.563 1.164 . . . . 0.0 109.331 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' ILE . . . . . 0.5 HD13 ' HA ' ' A' ' 302' ' ' ILE . 7.0 mm -77.17 -56.09 8.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.483 1.114 . . . . 0.0 109.272 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.46 ' O ' ' N ' ' A' ' 305' ' ' GLU . 53.2 p -151.32 48.37 0.83 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.458 1.099 . . . . 0.0 110.026 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 303' ' ' SER . . . 35.08 34.22 0.05 OUTLIER Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.574 1.172 . . . . 0.0 110.991 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 305' ' ' GLU . . . . . 0.46 ' N ' ' O ' ' A' ' 303' ' ' SER . 0.0 OUTLIER -70.24 151.52 95.84 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.522 0.778 . . . . 0.0 110.297 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 134.15 17.46 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.477 1.777 . . . . 0.0 110.991 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -44.39 -42.47 6.94 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.468 1.105 . . . . 0.0 110.322 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 2.2 t 67.35 28.56 7.84 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 0.0 110.009 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . -176.61 160.55 2.01 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.447 1.092 . . . . 0.0 109.282 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.502 HG22 ' HB2' ' A' ' 283' ' ' ALA . 0.3 OUTLIER -108.59 123.64 49.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.512 1.132 . . . . 0.0 110.392 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.806 HG12 HD12 ' A' ' 262' ' ' ILE . 43.5 t -103.17 130.31 53.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.52 1.138 . . . . 0.0 109.298 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 56.9 p -134.94 157.42 46.94 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.463 1.102 . . . . 0.0 109.993 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' ALA . . . . . 0.505 ' CB ' HG12 ' A' ' 256' ' ' VAL . . . -95.52 116.13 28.39 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.457 1.098 . . . . 0.0 109.299 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -60.22 -33.42 72.23 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.496 1.123 . . . . 0.0 109.276 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' THR . . . . . 0.831 ' O ' HG23 ' A' ' 317' ' ' VAL . 10.2 t -149.77 -173.49 4.43 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.436 1.085 . . . . 0.0 110.403 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 316' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 316' ' ' THR . 43.8 p -53.76 88.18 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.513 1.133 . . . . 0.0 110.417 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.834 HG12 ' CD1' ' A' ' 319' ' ' LEU . 57.8 t -107.56 145.82 14.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.533 1.145 . . . . 0.0 109.257 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 318' ' ' SER . . . . . 0.741 ' C ' HD13 ' A' ' 319' ' ' LEU . 50.3 m -122.95 118.31 27.53 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.492 1.12 . . . . 0.0 109.982 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 319' ' ' LEU . . . . . 0.834 ' CD1' HG12 ' A' ' 317' ' ' VAL . 0.0 OUTLIER -126.22 175.09 8.04 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.125 . . . . 0.0 109.309 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.705 HD22 HD21 ' A' ' 226' ' ' ASN . 0.5 OUTLIER -124.55 130.95 53.4 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.441 1.088 . . . . 0.0 109.314 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 73.6 p -92.23 157.06 16.89 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 0.0 109.997 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -148.55 92.03 1.96 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.458 1.099 . . . . 0.0 109.293 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' HIS . . . . . 0.461 ' ND1' ' HB3' ' A' ' 325' ' ' ALA . 5.8 p80 -54.61 135.18 46.77 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.534 1.146 . . . . 0.0 109.615 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 3.4 t -53.66 -26.45 22.52 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.505 1.128 . . . . 0.0 109.984 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 0.461 ' HB3' ' ND1' ' A' ' 323' ' ' HIS . . . -50.66 -35.48 30.99 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.546 1.154 . . . . 0.0 109.285 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -64.73 -41.5 95.9 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.517 1.136 . . . . 0.0 109.318 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' PHE . . . . . 0.465 ' CE1' ' CE2' ' A' ' 341' ' ' PHE . 80.3 t80 -67.38 -32.77 73.91 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.467 1.105 . . . . 0.0 111.046 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -70.49 -37.71 74.24 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.469 1.106 . . . . 0.0 110.343 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 16.5 tmm? -67.98 -41.34 82.48 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.467 1.104 . . . . 0.0 111.032 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.649 HD13 ' CG1' ' A' ' 247' ' ' ILE . 6.4 mt -73.23 -35.03 66.22 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.492 1.12 . . . . 0.0 109.284 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 331' ' ' CYS . . . . . 0.812 ' SG ' ' HB2' ' A' ' 338' ' ' ALA . 41.4 t -68.84 -35.19 76.64 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.499 1.125 . . . . 0.0 108.296 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.8 t -72.97 -39.2 66.33 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.127 . . . . 0.0 109.979 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.2 t -73.49 -28.43 61.91 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.503 1.127 . . . . 0.0 109.979 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' SER . . . . . 0.466 ' CB ' HD12 ' A' ' 337' ' ' ILE . 0.5 OUTLIER -128.92 103.78 18.71 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 124.51 1.131 . . . . 0.0 110.016 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -21.64 15.61 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.469 1.773 . . . . 0.0 111.01 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.87 -28.78 60.79 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.539 1.149 . . . . 0.0 110.312 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.638 HD11 HG21 ' A' ' 243' ' ' VAL . 34.4 mt -68.69 -30.84 48.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.126 . . . . 0.0 109.302 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 338' ' ' ALA . . . . . 0.812 ' HB2' ' SG ' ' A' ' 331' ' ' CYS . . . -69.81 -37.54 76.29 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.476 1.11 . . . . 0.0 109.34 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -72.87 -36.73 67.45 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.458 1.099 . . . . 0.0 110.326 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 31.1 mt -71.68 -42.71 71.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.445 1.091 . . . . 0.0 109.305 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.465 ' CE2' ' CE1' ' A' ' 327' ' ' PHE . 40.2 t80 -66.95 -36.88 83.22 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.45 1.094 . . . . 0.0 111.04 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -72.94 -34.79 66.77 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.489 1.118 . . . . 0.0 110.269 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -50.75 65.3 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.511 1.132 . . . . 0.0 109.344 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 341' ' ' PHE . 8.8 t -65.13 -38.0 89.22 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.498 1.124 . . . . 0.0 110.372 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -67.17 -35.74 80.31 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.536 1.147 . . . . 0.0 109.301 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.508 ' HA ' HD23 ' A' ' 346' ' ' LEU . 9.3 mt -71.48 -33.87 69.66 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.492 1.12 . . . . 0.0 109.317 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.6 -34.73 70.13 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.531 1.145 . . . . 0.0 110.285 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 39.0 mtt-85 -71.8 -44.04 64.63 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.48 1.112 . . . . 0.0 110.328 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.01 -34.67 76.95 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.453 1.096 . . . . 0.0 110.288 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -37.31 -44.01 1.09 Allowed Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.556 1.16 . . . . 0.0 111.003 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -154.59 123.16 6.12 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.452 0.736 . . . . 0.0 109.329 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -61.01 164.3 5.11 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.51 1.132 . . . . 0.0 109.281 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -111.17 122.98 49.27 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.516 1.135 . . . . 0.0 109.302 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 15.7 m -151.41 167.77 26.93 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.532 1.145 . . . . 0.0 109.994 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.457 0 O-C-N 124.539 1.149 . . . . 0.0 109.292 179.988 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.988 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 1.4 t -142.35 157.75 44.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.509 0.77 . . . . 0.0 110.004 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -117.11 174.04 6.33 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.494 1.121 . . . . 0.0 110.309 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -150.86 154.55 37.43 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.511 1.132 . . . . 0.0 110.291 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 9.7 p -146.62 166.2 7.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.452 1.095 . . . . 0.0 109.308 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.96 173.41 11.82 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.521 1.138 . . . . 0.0 110.331 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 61.3 mtt-85 -140.54 179.42 6.68 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.545 1.153 . . . . 0.0 110.313 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -110.32 -42.37 1.17 Allowed Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.51 1.131 . . . . 0.0 111.012 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -93.11 19.91 7.43 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.45 0.735 . . . . 0.0 109.322 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -58.17 -34.35 70.23 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.499 1.125 . . . . 0.0 110.989 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.86 -36.56 52.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.532 1.145 . . . . 0.0 109.309 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.659 ' HD2' HG13 ' A' ' 276' ' ' VAL . 0.0 OUTLIER -67.48 -37.05 82.3 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.511 1.132 . . . . 0.0 110.296 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.823 ' O ' HG23 ' A' ' 230' ' ' VAL . 0.1 OUTLIER -76.37 -30.64 57.63 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.551 1.157 . . . . 0.0 109.29 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 227' ' ' TRP . . . . . 0.866 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 3.0 t90 -66.31 -45.59 79.84 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.485 1.116 . . . . 0.0 108.019 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.628 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 6.4 pt20 -71.27 -34.82 71.06 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.517 1.135 . . . . 0.0 110.35 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.547 HD21 ' HA2' ' A' ' 293' ' ' GLY . 0.3 OUTLIER -63.56 -48.49 77.24 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.482 1.114 . . . . 0.0 109.267 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 226' ' ' ASN . 38.3 t -69.89 -43.08 79.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.432 1.082 . . . . 0.0 109.271 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.34 -16.63 63.01 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.476 1.11 . . . . 0.0 109.309 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.628 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -80.67 -19.32 45.5 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.448 1.092 . . . . 0.0 109.332 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 229' ' ' LEU . 84.4 t -81.25 137.02 49.17 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.485 1.116 . . . . 0.0 109.276 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.468 ' HD2' HG13 ' A' ' 233' ' ' VAL . 18.3 Cg_endo -75.01 -40.32 0.93 Allowed 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.59 1.837 . . . . 0.0 111.001 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.659 HD12 ' HB2' ' A' ' 298' ' ' GLU . 11.0 mt -60.81 -15.48 30.42 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.444 1.09 . . . . 0.0 109.333 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.649 ' CE1' HD13 ' A' ' 247' ' ' ILE . 1.4 m-85 -106.56 -22.94 12.61 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.51 1.131 . . . . 0.0 110.959 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' GLN . . . . . 0.404 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 0.4 OUTLIER -64.1 -18.73 64.69 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.483 1.115 . . . . 0.0 110.362 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -75.15 -9.67 58.76 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.498 1.124 . . . . 0.0 109.252 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.71 HD13 HG11 ' A' ' 243' ' ' VAL . 12.0 mt -96.66 -179.19 4.51 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.493 1.12 . . . . 0.0 109.325 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' GLY . . . . . 0.419 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -100.99 -173.56 29.0 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.487 1.117 . . . . 0.0 110.976 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.849 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.3 Cg_endo -74.97 -34.47 3.83 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.474 1.776 . . . . 0.0 110.98 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.96 -36.41 80.03 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.502 1.126 . . . . 0.0 109.311 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.71 HG11 HD13 ' A' ' 239' ' ' LEU . 3.0 t -72.64 -42.83 62.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.53 1.144 . . . . 0.0 109.296 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.76 ' CD1' HG12 ' A' ' 230' ' ' VAL . 0.9 OUTLIER -66.37 -37.68 85.83 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.502 1.126 . . . . 0.0 109.287 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.866 HG22 ' CZ2' ' A' ' 227' ' ' TRP . 53.6 t -66.11 -42.94 92.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.497 1.123 . . . . 0.0 109.287 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.59 -45.24 87.81 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.507 1.129 . . . . 0.0 110.302 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.649 HD13 ' CE1' ' A' ' 236' ' ' PHE . 38.3 mt -62.93 -45.41 98.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.439 1.087 . . . . 0.0 109.259 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 244' ' ' LEU . 45.6 t -62.8 -33.39 59.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 0.0 109.297 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -77.34 -19.48 56.26 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.514 1.134 . . . . 0.0 110.277 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -95.91 2.86 53.86 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.469 1.106 . . . . 0.0 109.308 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.17 148.31 25.23 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.524 1.14 . . . . 0.0 109.328 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.34 126.82 50.39 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.512 1.132 . . . . 0.0 110.265 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.481 ' HB2' HD23 ' A' ' 320' ' ' LEU . . . -83.26 122.75 28.83 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.509 1.131 . . . . 0.0 109.318 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.57 134.79 47.93 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.49 1.119 . . . . 0.0 110.289 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 52.3 m -93.46 121.05 34.46 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.505 1.128 . . . . 0.0 110.414 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.871 HG21 HD11 ' A' ' 319' ' ' LEU . 92.2 t -106.79 113.72 62.49 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.513 1.133 . . . . 0.0 109.329 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.497 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.98 173.48 14.43 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.44 1.758 . . . . 0.0 110.976 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.584 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -66.06 131.04 45.27 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.506 1.128 . . . . 0.0 109.322 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 94.24 -25.52 21.93 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.537 1.148 . . . . 0.0 110.969 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.497 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -57.92 146.28 32.75 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.518 0.775 . . . . 0.0 109.302 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.433 HG21 HH21 ' A' ' 264' ' ' ARG . 3.7 t -97.33 131.58 43.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.486 1.116 . . . . 0.0 109.301 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.775 HD12 HG12 ' A' ' 311' ' ' VAL . 67.9 mt -84.44 -42.27 16.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.5 1.125 . . . . 0.0 109.281 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' CYS . . . . . 0.491 ' SG ' HG23 ' A' ' 311' ' ' VAL . 14.0 p -157.5 148.91 21.82 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.492 1.12 . . . . 0.0 108.311 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ARG . . . . . 0.433 HH21 HG21 ' A' ' 261' ' ' VAL . 3.3 mmt85 -88.16 179.85 6.3 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.484 1.115 . . . . 0.0 110.315 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.507 HG23 ' CB ' ' A' ' 310' ' ' THR . 0.0 OUTLIER -77.96 140.07 17.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.447 1.092 . . . . 0.0 109.301 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 47.78 50.1 20.89 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.498 1.123 . . . . 0.0 111.012 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.448 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.0 OUTLIER -70.75 164.06 58.8 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.451 0.736 . . . . 0.0 110.301 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.448 ' HD2' ' HB2' ' A' ' 267' ' ' GLU . 18.1 Cg_endo -75.01 91.78 1.01 Allowed 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.474 1.776 . . . . 0.0 110.942 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -43.93 94.4 0.01 OUTLIER Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.489 1.118 . . . . 0.0 110.945 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 268' ' ' PRO . 0.5 OUTLIER -170.2 38.28 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.471 0.748 . . . . 0.0 109.286 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.402 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 6.0 mtt180 -170.34 145.17 2.64 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.483 1.115 . . . . 0.0 110.313 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' MET . . . . . 0.739 ' HB2' HD11 ' A' ' 301' ' ' LEU . 12.1 ttt -117.96 147.28 43.31 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.527 1.142 . . . . 0.0 110.964 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.569 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 56.9 m-85 -136.28 136.52 39.87 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.531 1.145 . . . . 0.0 110.998 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' PHE . . . . . 0.472 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 20.5 m-85 -125.71 134.3 51.84 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.495 1.122 . . . . 0.0 111.009 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.586 HG22 HD23 ' A' ' 319' ' ' LEU . 4.5 t -91.94 129.76 42.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.517 1.135 . . . . 0.0 109.323 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.659 HG13 ' HD2' ' A' ' 225' ' ' ARG . 13.9 t -105.63 -44.02 7.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.515 1.134 . . . . 0.0 109.307 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.64 ' O ' HG13 ' A' ' 317' ' ' VAL . 0.0 OUTLIER -148.84 134.33 18.6 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.139 . . . . 0.0 110.308 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.849 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 121.06 178.65 15.95 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.44 1.087 . . . . 0.0 111.042 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 314' ' ' ALA . 3.3 m -124.15 114.96 20.35 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.532 0.783 . . . . 0.0 109.974 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.472 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 25.5 m -96.73 163.33 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.492 1.12 . . . . 0.0 109.35 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 30.5 t -129.25 154.64 46.62 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.453 1.096 . . . . 0.0 110.032 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.24 130.04 73.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.519 1.137 . . . . 0.0 109.271 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.61 ' HB3' ' H ' ' A' ' 310' ' ' THR . . . -77.46 102.15 6.75 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.475 1.11 . . . . 0.0 109.269 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' THR . . . . . 0.644 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.51 -168.67 0.19 Allowed Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.492 1.12 . . . . 0.0 110.413 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.644 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.3 Cg_endo -74.96 4.33 4.82 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.527 1.804 . . . . 0.0 110.993 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -151.84 157.75 34.27 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.526 1.141 . . . . 0.0 109.282 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 94.26 0.96 Allowed 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.464 1.771 . . . . 0.0 110.995 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 281' ' ' SER . 21.2 t -98.34 119.42 46.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.517 1.136 . . . . 0.0 109.334 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.562 ' C ' HD22 ' A' ' 290' ' ' LEU . 14.7 mt-10 -124.1 140.83 52.59 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 0.0 110.306 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.562 HD22 ' C ' ' A' ' 289' ' ' GLU . 4.5 mm? -121.38 141.02 51.37 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.498 1.124 . . . . 0.0 109.3 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -93.97 -157.25 32.94 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.521 1.138 . . . . 0.0 110.95 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' PRO . . . . . 0.469 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.1 Cg_endo -75.02 148.8 35.68 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.511 1.795 . . . . 0.0 111.01 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.547 ' HA2' HD21 ' A' ' 229' ' ' LEU . . . 83.0 5.9 88.86 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.498 1.124 . . . . 0.0 111.018 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -86.68 122.76 31.03 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.511 0.771 . . . . 0.0 109.328 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -114.86 153.18 30.92 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 0.0 110.954 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.569 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 32.7 p90 -163.29 149.65 12.1 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.535 1.147 . . . . 0.0 111.004 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 129.57 -9.74 6.13 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.539 1.149 . . . . 0.0 110.986 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.659 ' HB2' HD12 ' A' ' 235' ' ' LEU . 12.1 pt-20 -52.36 -45.26 65.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.548 0.793 . . . . 0.0 110.29 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 299' ' ' MET . . . . . 0.418 ' N ' ' HG3' ' A' ' 298' ' ' GLU . 0.1 OUTLIER -52.4 -38.3 58.64 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.546 1.154 . . . . 0.0 111.039 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 300' ' ' ALA . . . . . 0.441 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -67.64 -38.16 83.46 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.498 1.123 . . . . 0.0 109.284 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.739 HD11 ' HB2' ' A' ' 272' ' ' MET . 0.8 OUTLIER -76.57 -14.39 60.01 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.485 1.116 . . . . 0.0 109.333 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 302' ' ' ILE . . . . . 0.417 ' HA ' ' CE2' ' A' ' 341' ' ' PHE . 11.0 mm -76.79 -55.5 10.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.49 1.119 . . . . 0.0 109.332 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 304' ' ' GLY . 0.5 OUTLIER -153.78 42.16 0.54 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.422 1.076 . . . . 0.0 110.011 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 35.82 43.09 0.58 Allowed Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.48 1.113 . . . . 0.0 111.012 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.17 157.61 88.1 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.549 0.793 . . . . 0.0 110.306 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 129.61 12.45 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.547 1.814 . . . . 0.0 110.968 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -43.92 -36.7 2.53 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.457 1.098 . . . . 0.0 110.272 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 8.0 t 66.75 23.16 10.19 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.49 1.119 . . . . 0.0 109.996 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 309' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . -179.11 160.93 1.09 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 0.0 109.318 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.61 ' H ' ' HB3' ' A' ' 283' ' ' ALA . 0.8 OUTLIER -108.55 137.33 46.67 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.5 1.125 . . . . 0.0 110.395 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.775 HG12 HD12 ' A' ' 262' ' ' ILE . 57.5 t -110.87 131.05 63.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.525 1.14 . . . . 0.0 109.31 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 96.5 p -130.19 153.95 48.04 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.524 1.14 . . . . 0.0 109.992 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -94.46 107.26 19.24 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.521 1.138 . . . . 0.0 109.312 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 279' ' ' SER . . . -50.75 -33.4 22.95 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.48 1.112 . . . . 0.0 109.305 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 315' ' ' THR . . . . . 0.633 ' O ' HG23 ' A' ' 317' ' ' VAL . 9.8 t -148.28 -170.03 3.49 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.486 1.116 . . . . 0.0 110.388 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 316' ' ' THR . . . . . 0.448 ' N ' ' OG1' ' A' ' 315' ' ' THR . 0.0 OUTLIER -61.37 78.08 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.532 1.145 . . . . 0.0 110.373 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.849 HG22 ' HA3' ' A' ' 278' ' ' GLY . 44.5 t -94.65 140.18 17.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.481 1.113 . . . . 0.0 109.275 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 49.3 m -111.16 117.57 33.59 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.502 1.126 . . . . 0.0 110.0 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' LEU . . . . . 0.871 HD11 HG21 ' A' ' 256' ' ' VAL . 0.1 OUTLIER -128.67 173.18 10.53 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.486 1.116 . . . . 0.0 109.302 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.811 HD13 ' ND2' ' A' ' 226' ' ' ASN . 0.7 OUTLIER -124.46 133.85 53.23 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.554 1.159 . . . . 0.0 109.269 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 19.9 t -96.09 157.57 15.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.527 1.142 . . . . 0.0 110.001 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.789 HD21 ' CB ' ' A' ' 326' ' ' ASP . 1.4 tm? -150.01 103.67 3.22 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.436 1.085 . . . . 0.0 109.34 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 323' ' ' HIS . . . . . 0.687 ' CD2' ' HB3' ' A' ' 325' ' ' ALA . 0.0 OUTLIER -62.15 138.35 58.39 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.478 1.111 . . . . 0.0 109.587 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 22.8 t -54.21 -22.36 11.33 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.549 1.156 . . . . 0.0 109.973 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 0.687 ' HB3' ' CD2' ' A' ' 323' ' ' HIS . . . -52.59 -36.61 56.53 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.457 1.098 . . . . 0.0 109.28 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' ASP . . . . . 0.789 ' CB ' HD21 ' A' ' 322' ' ' LEU . 8.0 t70 -63.77 -46.15 86.55 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.475 1.109 . . . . 0.0 109.299 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 327' ' ' PHE . . . . . 0.578 ' CG ' HD23 ' A' ' 301' ' ' LEU . 20.1 t80 -65.41 -31.17 72.13 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.503 1.127 . . . . 0.0 111.049 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -70.71 -32.36 69.53 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.523 1.14 . . . . 0.0 110.334 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.494 ' O ' ' CB ' ' A' ' 333' ' ' SER . 37.1 ttp -74.5 -37.49 63.1 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.536 1.147 . . . . 0.0 110.998 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.633 HD12 HG13 ' A' ' 243' ' ' VAL . 0.1 OUTLIER -72.5 -42.52 64.75 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 0.0 109.273 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 331' ' ' CYS . . . . . 0.803 ' SG ' ' HB2' ' A' ' 338' ' ' ALA . 26.1 t -66.04 -45.13 82.51 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 0.0 108.318 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 44.4 t -73.3 -22.84 60.26 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.509 1.131 . . . . 0.0 110.031 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 329' ' ' MET . 9.1 t -78.43 -39.44 38.78 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.438 1.086 . . . . 0.0 109.977 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.24 121.6 20.62 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.13 . . . . 0.0 110.05 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 -26.15 11.25 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.535 1.808 . . . . 0.0 111.028 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.74 -29.18 69.66 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.484 1.115 . . . . 0.0 110.274 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.67 HD11 HG21 ' A' ' 243' ' ' VAL . 96.9 mt -74.59 -35.89 39.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.534 1.146 . . . . 0.0 109.294 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 338' ' ' ALA . . . . . 0.803 ' HB2' ' SG ' ' A' ' 331' ' ' CYS . . . -68.0 -43.54 78.63 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.51 1.131 . . . . 0.0 109.311 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -69.21 -35.33 76.09 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.475 1.109 . . . . 0.0 110.322 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 17.3 mt -70.94 -41.51 77.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.515 1.134 . . . . 0.0 109.27 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.475 ' CE2' ' O ' ' A' ' 301' ' ' LEU . 27.8 t80 -67.73 -34.7 77.36 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.472 1.107 . . . . 0.0 111.02 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -72.48 -37.02 68.57 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.538 1.149 . . . . 0.0 110.294 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.59 -51.81 60.79 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.505 1.128 . . . . 0.0 109.316 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 9.9 t -65.91 -38.86 89.8 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.475 1.109 . . . . 0.0 110.362 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -68.52 -34.83 76.55 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.527 1.142 . . . . 0.0 109.283 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' A' ' 346' ' ' LEU . 12.0 mt -68.64 -36.85 79.15 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.489 1.118 . . . . 0.0 109.328 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.05 -35.67 69.39 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.462 1.101 . . . . 0.0 110.262 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -73.15 -45.0 59.24 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.474 1.109 . . . . 0.0 110.265 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 349' ' ' ARG . . . . . 0.474 ' O ' ' C ' ' A' ' 350' ' ' GLY . 0.1 OUTLIER -72.63 -33.34 66.56 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.482 1.114 . . . . 0.0 110.283 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 350' ' ' GLY . . . . . 0.474 ' C ' ' O ' ' A' ' 349' ' ' ARG . . . -31.75 -39.06 0.05 OUTLIER Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.459 1.1 . . . . 0.0 110.961 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 351' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 349' ' ' ARG . . . -127.61 119.93 27.01 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.519 0.776 . . . . 0.0 109.262 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -59.94 157.72 12.09 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.5 1.125 . . . . 0.0 109.315 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -150.6 130.83 13.6 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.499 1.125 . . . . 0.0 109.292 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.15 139.11 35.28 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.466 1.104 . . . . 0.0 110.049 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.476 1.11 . . . . 0.0 109.287 -179.965 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.032 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 11.8 p -154.69 145.09 22.1 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.52 0.776 . . . . 0.0 110.027 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -138.85 170.47 15.93 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.122 . . . . 0.0 110.337 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.98 131.19 12.76 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.501 1.126 . . . . 0.0 110.278 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 15.8 m -107.2 137.41 38.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.525 1.141 . . . . 0.0 109.294 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -115.77 126.18 53.7 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.512 1.133 . . . . 0.0 110.292 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.47 175.67 5.4 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.477 1.111 . . . . 0.0 110.313 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -104.89 8.31 45.96 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.478 1.111 . . . . 0.0 111.015 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -91.97 20.12 6.07 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.488 0.758 . . . . 0.0 109.284 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -52.72 -37.8 59.77 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.525 1.141 . . . . 0.0 111.022 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.16 -40.98 78.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.522 1.139 . . . . 0.0 109.27 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.823 ' HG2' HG13 ' A' ' 276' ' ' VAL . 0.0 OUTLIER -67.13 -29.39 69.1 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.529 1.143 . . . . 0.0 110.303 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.754 ' OD1' HD13 ' A' ' 320' ' ' LEU . 4.9 t30 -79.24 -30.88 43.39 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.496 1.123 . . . . 0.0 109.322 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' TRP . . . . . 0.546 ' HA ' HG21 ' A' ' 248' ' ' VAL . 2.6 t90 -70.64 -46.65 62.91 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 4.5 pt20 -68.12 -31.87 71.77 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 0.0 110.263 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 3.5 mt -64.36 -45.59 87.11 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 0.0 109.257 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.568 HG23 ' CD1' ' A' ' 244' ' ' LEU . 33.1 m -73.55 -36.63 48.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.464 1.103 . . . . 0.0 109.328 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -74.98 -15.55 60.66 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.522 1.139 . . . . 0.0 109.245 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -80.83 -1.87 44.94 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.511 1.132 . . . . 0.0 109.322 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 4.9 t -101.03 118.85 59.58 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.501 1.126 . . . . 0.0 109.276 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 -17.92 19.04 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.494 1.787 . . . . 0.0 110.989 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.684 HD23 ' CZ ' ' A' ' 348' ' ' ARG . 0.1 OUTLIER -65.06 -29.46 70.35 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.574 1.171 . . . . 0.0 109.302 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.415 ' HB3' HD12 ' A' ' 239' ' ' LEU . 15.4 m-85 -113.74 19.76 16.44 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.44 1.087 . . . . 0.0 111.0 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.22 -23.43 62.01 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.515 1.134 . . . . 0.0 110.345 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 50.0 mmtt -80.2 0.7 31.35 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.456 1.097 . . . . 0.0 109.295 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.776 HD13 HG11 ' A' ' 243' ' ' VAL . 15.1 mt -82.13 175.18 10.53 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.542 1.151 . . . . 0.0 109.29 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -107.73 -173.8 22.17 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.478 1.111 . . . . 0.0 110.981 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.94 -33.66 4.5 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.46 1.769 . . . . 0.0 111.051 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.5 ' HA ' HG12 ' A' ' 245' ' ' VAL . . . -71.22 -31.97 68.23 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.482 1.114 . . . . 0.0 109.318 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.776 HG11 HD13 ' A' ' 239' ' ' LEU . 4.8 t -75.9 -42.17 39.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.486 1.116 . . . . 0.0 109.272 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.568 ' CD1' HG23 ' A' ' 230' ' ' VAL . 0.6 OUTLIER -67.24 -46.22 74.42 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.476 1.11 . . . . 0.0 109.289 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' A' ' 242' ' ' ALA . 2.8 p -65.05 -45.14 95.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.497 1.123 . . . . 0.0 109.273 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.405 ' N ' ' CG1' ' A' ' 245' ' ' VAL . 4.9 tp10 -64.87 -36.12 83.33 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.114 . . . . 0.0 110.325 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.502 HD12 HG12 ' A' ' 243' ' ' VAL . 26.4 mt -67.85 -48.0 77.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.514 1.134 . . . . 0.0 109.329 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.546 HG21 ' HA ' ' A' ' 227' ' ' TRP . 55.2 t -63.26 -33.07 58.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.123 . . . . 0.0 109.323 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.1 mmm180 -74.61 -25.13 59.04 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.434 1.084 . . . . 0.0 110.294 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.458 ' HB3' ' OD1' ' A' ' 326' ' ' ASP . . . -87.15 -18.54 30.18 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.481 1.113 . . . . 0.0 109.344 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.82 146.16 54.72 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.575 1.172 . . . . 0.0 109.321 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -120.54 135.08 55.19 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 0.0 110.368 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -80.57 122.4 27.0 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.459 1.099 . . . . 0.0 109.262 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.7 ttm-85 -124.25 121.95 36.43 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.543 1.152 . . . . 0.0 110.276 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.6 m -91.28 117.81 29.96 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 0.0 110.373 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.576 HG21 HD11 ' A' ' 319' ' ' LEU . 69.3 t -106.69 112.02 63.71 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.461 1.101 . . . . 0.0 109.329 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.516 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.97 173.65 14.14 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.472 1.775 . . . . 0.0 111.023 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.524 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -67.51 131.33 45.44 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.488 1.117 . . . . 0.0 109.263 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 93.27 -25.39 20.59 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 124.556 1.16 . . . . 0.0 110.984 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.516 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -61.07 149.04 38.31 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.52 0.776 . . . . 0.0 109.332 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.2 t -97.47 131.35 44.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.483 1.114 . . . . 0.0 109.324 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.774 HD12 HG12 ' A' ' 311' ' ' VAL . 43.3 mt -83.9 -40.09 15.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.53 1.144 . . . . 0.0 109.308 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' CYS . . . . . 0.405 ' SG ' HG23 ' A' ' 311' ' ' VAL . 13.8 p -156.12 150.71 25.89 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.503 1.127 . . . . 0.0 108.276 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ARG . . . . . 0.402 ' HA ' ' OG1' ' A' ' 310' ' ' THR . 16.6 mmt180 -94.42 179.67 5.21 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.566 1.166 . . . . 0.0 110.339 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.51 HG23 ' OG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -77.49 140.34 17.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.467 1.104 . . . . 0.0 109.326 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 46.54 52.71 10.64 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.5 1.125 . . . . 0.0 111.045 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.458 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.2 OUTLIER -71.03 168.08 23.86 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.548 0.793 . . . . 0.0 110.357 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 267' ' ' GLU . 18.4 Cg_endo -74.98 88.49 1.23 Allowed 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.458 1.767 . . . . 0.0 111.005 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' GLY . . . . . 0.401 ' O ' ' CA ' ' A' ' 304' ' ' GLY . . . -45.23 93.5 0.01 OUTLIER Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.553 1.158 . . . . 0.0 110.988 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 268' ' ' PRO . 0.6 OUTLIER -170.47 36.68 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.51 0.771 . . . . 0.0 109.345 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -173.35 162.27 4.32 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.566 1.166 . . . . 0.0 110.295 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' MET . . . . . 0.471 ' CE ' ' CZ ' ' A' ' 274' ' ' PHE . 9.3 ptm -145.84 146.66 31.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.538 1.149 . . . . 0.0 110.996 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.566 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 33.2 m-85 -128.37 154.08 46.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.484 1.115 . . . . 0.0 111.017 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 274' ' ' PHE . . . . . 0.505 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 23.6 m-85 -129.87 137.37 50.39 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.481 1.113 . . . . 0.0 111.017 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.58 HG12 ' HA ' ' A' ' 292' ' ' PRO . 42.7 t -90.71 136.72 23.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.52 1.137 . . . . 0.0 109.295 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.823 HG13 ' HG2' ' A' ' 225' ' ' ARG . 39.8 t -116.03 -43.78 3.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.535 1.147 . . . . 0.0 109.326 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -146.61 136.74 23.55 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.517 1.136 . . . . 0.0 110.272 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.95 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 114.46 -173.22 14.72 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.502 1.126 . . . . 0.0 111.004 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 3.2 m -134.9 119.92 18.65 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.539 0.788 . . . . 0.0 109.989 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.421 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 16.5 m -99.0 165.82 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.499 1.125 . . . . 0.0 109.323 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 30.5 t -131.52 154.97 48.23 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.504 1.128 . . . . 0.0 110.009 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.429 HG13 HG22 ' A' ' 311' ' ' VAL . 0.7 OUTLIER -118.92 131.21 72.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.503 1.127 . . . . 0.0 109.306 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -79.41 102.03 8.48 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 0.0 109.325 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' THR . . . . . 0.655 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.18 -168.25 0.18 Allowed Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.525 1.14 . . . . 0.0 110.391 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.655 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -75.04 4.48 4.72 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.566 1.824 . . . . 0.0 110.964 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.411 ' O ' HG23 ' A' ' 288' ' ' VAL . 35.2 m120 -151.75 157.2 34.59 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.548 1.155 . . . . 0.0 109.263 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.06 95.36 0.98 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.472 1.775 . . . . 0.0 110.937 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 281' ' ' SER . 4.6 t -99.39 119.23 47.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.47 1.106 . . . . 0.0 109.263 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 15.8 mt-10 -124.44 135.85 53.58 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.426 1.079 . . . . 0.0 110.29 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.506 HD12 ' CB ' ' A' ' 294' ' ' ALA . 3.9 mm? -115.11 142.11 47.1 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.451 1.095 . . . . 0.0 109.307 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -98.79 -161.24 29.82 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.494 1.121 . . . . 0.0 110.983 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' PRO . . . . . 0.58 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.2 Cg_endo -75.0 145.88 31.98 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.491 1.785 . . . . 0.0 110.999 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 88.09 4.63 77.9 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.459 1.099 . . . . 0.0 110.95 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' ALA . . . . . 0.506 ' CB ' HD12 ' A' ' 290' ' ' LEU . . . -91.25 127.77 36.81 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.501 0.765 . . . . 0.0 109.315 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.451 ' HB3' ' CD1' ' A' ' 274' ' ' PHE . 1.2 p90 -116.34 153.38 32.09 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.52 1.138 . . . . 0.0 110.987 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 48.1 p90 -161.63 146.38 13.19 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.452 1.095 . . . . 0.0 110.977 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 297' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 300' ' ' ALA . . . 129.66 -9.99 6.09 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 124.527 1.142 . . . . 0.0 111.001 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -52.77 -51.21 61.54 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.457 0.74 . . . . 0.0 110.295 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.2 mmt -50.48 -32.89 19.37 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.523 1.139 . . . . 0.0 111.008 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 297' ' ' GLY . . . -68.85 -42.64 76.84 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.535 1.147 . . . . 0.0 109.337 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.458 HD11 ' SD ' ' A' ' 272' ' ' MET . 6.0 mt -75.01 -11.68 60.16 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.475 1.109 . . . . 0.0 109.283 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 302' ' ' ILE . . . . . 0.482 HD13 ' CZ ' ' A' ' 341' ' ' PHE . 14.5 mm -77.83 -56.63 7.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.484 1.115 . . . . 0.0 109.291 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 304' ' ' GLY . 2.4 m -151.46 42.57 0.74 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.445 1.091 . . . . 0.0 110.0 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 34.93 51.21 0.82 Allowed Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.462 1.101 . . . . 0.0 110.969 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.58 151.34 80.15 Favored Pre-proline 0 C--N 1.326 -0.436 0 O-C-N 124.524 0.779 . . . . 0.0 110.33 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 130.29 13.11 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.461 1.769 . . . . 0.0 110.955 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -44.04 -33.09 1.34 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.536 1.147 . . . . 0.0 110.301 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 59.38 15.9 4.73 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.525 1.14 . . . . 0.0 109.989 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . -170.15 160.75 8.17 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.544 1.153 . . . . 0.0 109.333 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.51 ' OG1' HG23 ' A' ' 265' ' ' ILE . 0.9 OUTLIER -110.29 139.68 45.23 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.469 1.106 . . . . 0.0 110.42 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.774 HG12 HD12 ' A' ' 262' ' ' ILE . 91.1 t -115.57 131.62 67.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.493 1.121 . . . . 0.0 109.269 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 56.3 p -128.6 153.75 46.92 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.491 1.119 . . . . 0.0 110.018 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' ALA . . . . . 0.418 ' CB ' HG12 ' A' ' 256' ' ' VAL . . . -90.95 114.3 26.75 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.556 1.16 . . . . 0.0 109.286 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -57.73 -35.19 70.34 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.521 1.138 . . . . 0.0 109.304 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' THR . . . . . 0.589 ' O ' HG23 ' A' ' 317' ' ' VAL . 8.7 t -153.96 -173.91 4.76 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.559 1.162 . . . . 0.0 110.424 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 29.0 m -49.9 91.36 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 0.0 110.378 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.95 HG22 ' HA3' ' A' ' 278' ' ' GLY . 41.6 t -106.75 154.54 7.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.53 1.144 . . . . 0.0 109.31 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 69.3 m -129.79 114.93 16.55 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.534 1.146 . . . . 0.0 109.965 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' LEU . . . . . 0.576 HD11 HG21 ' A' ' 256' ' ' VAL . 0.2 OUTLIER -130.43 173.17 11.09 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.484 1.115 . . . . 0.0 109.289 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.754 HD13 ' OD1' ' A' ' 226' ' ' ASN . 0.8 OUTLIER -124.29 136.41 54.11 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.532 1.145 . . . . 0.0 109.29 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.477 ' HB2' ' CE2' ' A' ' 273' ' ' PHE . 36.7 t -96.07 148.53 22.58 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.466 1.104 . . . . 0.0 110.02 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.483 ' O ' HD13 ' A' ' 322' ' ' LEU . 3.0 tm? -146.49 98.54 3.09 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.5 1.125 . . . . 0.0 109.302 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -60.02 146.9 41.02 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.485 1.116 . . . . 0.0 109.582 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 37.8 t -63.68 -13.71 45.39 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.504 1.127 . . . . 0.0 110.02 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -61.67 -27.8 68.94 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.486 1.116 . . . . 0.0 109.331 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' ASP . . . . . 0.458 ' OD1' ' HB3' ' A' ' 250' ' ' ALA . 0.6 OUTLIER -74.66 -39.52 61.99 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.504 1.127 . . . . 0.0 109.277 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 327' ' ' PHE . . . . . 0.483 ' C ' ' CD1' ' A' ' 327' ' ' PHE . 0.8 OUTLIER -70.47 -42.68 71.11 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.504 1.127 . . . . 0.0 110.995 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -67.15 -35.61 80.07 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.512 1.133 . . . . 0.0 110.266 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 17.9 tmm? -66.8 -42.12 86.48 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.515 1.135 . . . . 0.0 110.985 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.443 HD13 ' CG1' ' A' ' 247' ' ' ILE . 5.2 mt -72.51 -37.42 68.38 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.456 1.097 . . . . 0.0 109.307 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 331' ' ' CYS . . . . . 0.642 ' HB3' ' HB2' ' A' ' 338' ' ' ALA . 6.2 m -72.57 -31.64 65.4 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.478 1.111 . . . . 0.0 108.329 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 47.1 t -71.83 -37.91 70.25 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 0.0 109.981 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 42.6 t -72.17 -36.0 69.16 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.464 1.103 . . . . 0.0 109.981 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -123.02 114.32 29.53 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.51 1.131 . . . . 0.0 110.005 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -19.04 18.2 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.537 1.809 . . . . 0.0 111.005 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -72.57 -32.13 65.8 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.548 1.155 . . . . 0.0 110.31 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.474 HG23 ' CD2' ' A' ' 239' ' ' LEU . 77.6 mt -74.87 -44.95 44.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.485 1.116 . . . . 0.0 109.286 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 338' ' ' ALA . . . . . 0.642 ' HB2' ' HB3' ' A' ' 331' ' ' CYS . . . -66.6 -35.33 79.94 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.131 . . . . 0.0 109.338 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.478 ' O ' ' CG ' ' A' ' 343' ' ' LYS . 50.2 mm-40 -72.3 -42.78 65.09 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.516 1.135 . . . . 0.0 110.279 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 58.5 mt -68.35 -36.52 75.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.523 1.14 . . . . 0.0 109.256 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.666 ' CE1' HD12 ' A' ' 235' ' ' LEU . 49.7 t80 -69.55 -37.2 76.94 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.101 . . . . 0.0 110.982 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -69.76 -37.99 76.6 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.474 1.109 . . . . 0.0 110.335 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' LYS . . . . . 0.478 ' CG ' ' O ' ' A' ' 339' ' ' GLU . 0.5 OUTLIER -65.0 -50.65 65.45 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.496 1.123 . . . . 0.0 109.344 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 341' ' ' PHE . 4.5 t -64.83 -32.86 74.76 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.51 1.131 . . . . 0.0 110.4 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -70.07 -39.05 75.85 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.466 1.104 . . . . 0.0 109.29 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.43 ' HA ' HD23 ' A' ' 346' ' ' LEU . 12.6 mt -68.93 -34.04 74.71 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.434 1.084 . . . . 0.0 109.312 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.75 -31.68 61.87 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.467 1.105 . . . . 0.0 110.299 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 348' ' ' ARG . . . . . 0.684 ' CZ ' HD23 ' A' ' 235' ' ' LEU . 7.0 mtt180 -72.31 -43.94 63.44 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.535 1.147 . . . . 0.0 110.304 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 349' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 350' ' ' GLY . 0.0 OUTLIER -72.44 -34.76 68.03 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.479 1.112 . . . . 0.0 110.302 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 350' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 349' ' ' ARG . . . -37.4 -45.12 1.28 Allowed Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.512 1.132 . . . . 0.0 110.987 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -155.01 121.9 5.46 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.51 0.77 . . . . 0.0 109.283 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -63.51 168.53 4.56 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.484 1.115 . . . . 0.0 109.336 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -113.51 120.9 42.57 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.498 1.124 . . . . 0.0 109.282 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 67.3 m -73.2 145.09 46.51 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.447 1.092 . . . . 0.0 109.969 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.529 1.143 . . . . 0.0 109.294 -179.987 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.974 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 1.1 t -80.22 134.45 36.12 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.47 0.747 . . . . 0.0 109.997 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -105.09 170.89 7.61 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.471 1.107 . . . . 0.0 110.27 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.72 167.05 11.9 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.492 1.12 . . . . 0.0 110.319 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 58.4 t -120.4 155.02 23.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.527 1.142 . . . . 0.0 109.309 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.6 153.99 17.54 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.491 1.119 . . . . 0.0 110.318 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.83 141.65 50.34 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.502 1.126 . . . . 0.0 110.289 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -99.36 -19.53 20.56 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.498 1.124 . . . . 0.0 110.988 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 10.4 p30 -97.15 19.36 13.1 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.495 0.762 . . . . 0.0 109.316 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -53.91 -41.98 68.24 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.14 . . . . 0.0 110.967 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.81 -35.89 44.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.543 1.152 . . . . 0.0 109.289 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.648 ' CD ' HD23 ' A' ' 229' ' ' LEU . 0.0 OUTLIER -69.32 -32.12 71.02 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.559 1.162 . . . . 0.0 110.333 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.677 ' O ' HG23 ' A' ' 230' ' ' VAL . 46.6 t30 -79.89 -30.63 40.19 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.471 1.107 . . . . 0.0 109.256 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' TRP . . . . . 0.866 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 2.5 t90 -67.8 -43.65 79.19 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.538 1.149 . . . . 0.0 107.974 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -71.03 -38.38 72.58 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.585 1.178 . . . . 0.0 110.339 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.651 HD21 ' HA2' ' A' ' 293' ' ' GLY . 1.2 mm? -62.43 -46.25 89.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.146 . . . . 0.0 109.3 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.737 HG12 HD13 ' A' ' 244' ' ' LEU . 59.1 t -72.69 -37.01 54.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.466 1.104 . . . . 0.0 109.316 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -73.5 -15.86 61.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.487 1.117 . . . . 0.0 109.328 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -81.86 -12.74 58.33 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.511 1.132 . . . . 0.0 109.318 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 38.2 t -70.9 132.3 86.86 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.122 . . . . 0.0 109.298 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.407 ' HA ' ' HB2' ' A' ' 237' ' ' GLN . 18.2 Cg_endo -74.98 -30.4 7.23 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.482 1.78 . . . . 0.0 110.979 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 1.059 HD11 HD11 ' A' ' 302' ' ' ILE . 0.7 OUTLIER -68.87 -28.21 66.5 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.447 1.092 . . . . 0.0 109.29 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.713 ' CG ' HD12 ' A' ' 239' ' ' LEU . 13.8 m-30 -104.63 14.32 30.04 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.497 1.123 . . . . 0.0 111.016 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' GLN . . . . . 0.407 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 1.4 tt0 -72.17 -26.15 61.97 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.492 1.12 . . . . 0.0 110.286 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.468 ' HB2' ' CG2' ' A' ' 340' ' ' ILE . 6.6 mmpt? -100.47 7.62 44.06 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.528 1.143 . . . . 0.0 109.314 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.713 HD12 ' CG ' ' A' ' 236' ' ' PHE . 16.9 mt -81.51 171.24 14.92 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 0.0 109.258 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' GLY . . . . . 0.583 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -95.16 173.68 31.82 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.51 1.131 . . . . 0.0 110.981 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.928 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.2 Cg_endo -75.05 -35.29 3.19 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.494 1.786 . . . . 0.0 111.015 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.4 -34.66 76.41 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.474 1.109 . . . . 0.0 109.3 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.805 HG21 HD11 ' A' ' 337' ' ' ILE . 25.6 t -74.17 -42.07 51.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.44 1.087 . . . . 0.0 109.301 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.737 HD13 HG12 ' A' ' 230' ' ' VAL . 2.1 mm? -64.81 -34.58 78.68 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.511 1.132 . . . . 0.0 109.293 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.928 HG23 ' O ' ' A' ' 241' ' ' PRO . 70.4 t -70.72 -44.56 76.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.547 1.155 . . . . 0.0 109.311 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -65.3 -31.18 72.18 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.478 1.111 . . . . 0.0 110.293 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 56.0 mt -75.14 -40.54 44.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.451 1.095 . . . . 0.0 109.317 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 244' ' ' LEU . 55.8 t -70.96 -33.32 51.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.503 1.127 . . . . 0.0 109.309 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.427 ' NH1' ' HB3' ' A' ' 249' ' ' ARG . 5.6 mmm180 -78.94 -25.84 43.63 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.471 1.107 . . . . 0.0 110.275 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.446 ' HB1' ' OD2' ' A' ' 326' ' ' ASP . . . -86.87 -21.68 26.21 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.523 1.139 . . . . 0.0 109.332 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.49 152.35 30.31 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.46 1.1 . . . . 0.0 109.339 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -121.13 119.1 31.41 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.495 1.122 . . . . 0.0 110.299 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.755 ' HB2' HD23 ' A' ' 320' ' ' LEU . . . -81.17 122.43 27.37 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.502 1.126 . . . . 0.0 109.298 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.96 142.75 50.38 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.453 1.096 . . . . 0.0 110.299 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 4.5 m -96.64 125.83 41.39 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.517 1.136 . . . . 0.0 110.386 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.517 HG12 ' CB ' ' A' ' 313' ' ' ALA . 86.7 t -106.58 115.73 60.17 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.473 1.108 . . . . 0.0 109.3 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.507 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.5 Cg_endo -74.96 168.41 24.89 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.535 1.808 . . . . 0.0 111.038 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.523 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -66.81 128.5 36.53 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.511 1.132 . . . . 0.0 109.302 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 96.06 -25.57 24.85 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.486 1.116 . . . . 0.0 110.989 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.507 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -64.35 134.1 53.96 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.505 0.767 . . . . 0.0 109.313 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 312' ' ' SER . 2.5 p -90.21 134.98 27.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.485 1.116 . . . . 0.0 109.295 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.822 HD12 HG12 ' A' ' 311' ' ' VAL . 11.3 mt -82.47 -52.6 13.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.121 . . . . 0.0 109.377 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' CYS . . . . . 0.653 ' SG ' HG23 ' A' ' 311' ' ' VAL . 14.0 p -137.48 157.68 46.03 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.511 1.132 . . . . 0.0 108.31 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 1.8 mmt85 -100.98 178.43 4.67 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.58 1.175 . . . . 0.0 110.302 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.559 HD13 ' H ' ' A' ' 265' ' ' ILE . 0.2 OUTLIER -77.74 130.73 35.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.56 1.162 . . . . 0.0 109.308 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 59.9 47.51 90.64 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.533 1.146 . . . . 0.0 111.028 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.417 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.2 OUTLIER -71.53 164.37 58.38 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.473 0.749 . . . . 0.0 110.302 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.449 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.3 Cg_endo -74.96 81.52 2.18 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.469 1.773 . . . . 0.0 111.05 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 269' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 268' ' ' PRO . . . -37.08 95.86 0.01 OUTLIER Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.537 1.148 . . . . 0.0 111.039 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 268' ' ' PRO . 51.5 m-20 -170.45 38.67 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.507 0.769 . . . . 0.0 109.288 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.471 ' HD3' ' CE1' ' A' ' 273' ' ' PHE . 3.8 ttm180 -170.78 151.83 3.55 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.505 1.128 . . . . 0.0 110.298 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' MET . . . . . 0.522 ' SD ' HD11 ' A' ' 301' ' ' LEU . 3.4 ttt -121.5 155.33 35.17 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.505 1.128 . . . . 0.0 111.031 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.568 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 25.8 m-85 -140.42 136.74 33.37 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.49 1.119 . . . . 0.0 111.006 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' PHE . . . . . 0.402 ' CE2' HG22 ' A' ' 230' ' ' VAL . 20.0 m-85 -128.47 126.84 41.32 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.476 1.11 . . . . 0.0 111.018 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 1.061 HG22 HD22 ' A' ' 319' ' ' LEU . 53.9 t -85.58 132.71 31.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.459 1.1 . . . . 0.0 109.32 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.556 HG21 HD11 ' A' ' 320' ' ' LEU . 48.3 t -107.15 -52.84 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.485 1.116 . . . . 0.0 109.302 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.647 ' O ' HG23 ' A' ' 317' ' ' VAL . 11.0 mt-10 -139.81 137.9 35.37 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.51 1.131 . . . . 0.0 110.254 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.402 ' HA3' ' HB ' ' A' ' 317' ' ' VAL . . . 116.27 -158.0 14.7 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.458 1.099 . . . . 0.0 110.952 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 8.7 t -148.3 134.07 18.95 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.54 0.788 . . . . 0.0 109.998 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 11.3 m -114.02 165.41 9.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.516 1.135 . . . . 0.0 109.283 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 29.3 t -131.59 148.54 52.62 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.529 1.143 . . . . 0.0 109.991 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.468 HG23 HG12 ' A' ' 288' ' ' VAL . 0.6 OUTLIER -110.91 129.79 65.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.461 1.101 . . . . 0.0 109.262 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.546 ' HB2' HG22 ' A' ' 310' ' ' THR . . . -78.52 101.46 7.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.479 1.112 . . . . 0.0 109.32 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' THR . . . . . 0.659 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.9 OUTLIER -147.14 -168.05 0.17 Allowed Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.505 1.128 . . . . 0.0 110.38 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.659 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.6 Cg_endo -74.96 3.98 5.12 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.502 1.791 . . . . 0.0 111.022 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -150.37 157.2 37.03 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.482 1.114 . . . . 0.0 109.302 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.91 94.1 0.95 Allowed 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.493 1.786 . . . . 0.0 110.989 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.468 HG12 HG23 ' A' ' 282' ' ' VAL . 72.1 t -98.09 118.94 45.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.544 1.152 . . . . 0.0 109.29 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.501 ' C ' HD22 ' A' ' 290' ' ' LEU . 13.0 mt-10 -125.11 134.49 52.44 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.443 1.089 . . . . 0.0 110.291 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.501 HD22 ' C ' ' A' ' 289' ' ' GLU . 2.6 mm? -116.73 141.48 48.15 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.536 1.148 . . . . 0.0 109.308 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -95.72 -158.47 32.36 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.518 1.136 . . . . 0.0 110.974 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' PRO . . . . . 0.461 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.3 Cg_endo -75.02 152.63 40.88 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.466 1.772 . . . . 0.0 110.994 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.651 ' HA2' HD21 ' A' ' 229' ' ' LEU . . . 79.66 6.78 88.91 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.501 1.125 . . . . 0.0 110.971 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -88.98 128.71 35.7 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.489 0.758 . . . . 0.0 109.278 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -117.45 153.01 33.84 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.471 1.107 . . . . 0.0 111.005 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.568 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 45.5 p90 -166.28 145.7 5.94 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.512 1.133 . . . . 0.0 111.024 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 300' ' ' ALA . . . 133.21 -10.53 5.06 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.514 1.133 . . . . 0.0 111.004 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.504 ' CD ' HD13 ' A' ' 235' ' ' LEU . 32.8 tt0 -52.75 -53.22 51.05 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.493 0.761 . . . . 0.0 110.242 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -47.58 -35.56 9.32 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.467 1.104 . . . . 0.0 110.99 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 300' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 297' ' ' GLY . . . -68.4 -43.21 77.75 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.513 1.133 . . . . 0.0 109.327 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.522 HD11 ' SD ' ' A' ' 272' ' ' MET . 1.2 mt -77.26 -5.98 51.41 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.498 1.124 . . . . 0.0 109.285 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 302' ' ' ILE . . . . . 1.059 HD11 HD11 ' A' ' 235' ' ' LEU . 8.1 mm -83.37 -53.92 10.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 0.0 109.282 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 304' ' ' GLY . 78.5 p -151.89 43.2 0.72 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.511 1.132 . . . . 0.0 109.968 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 303' ' ' SER . . . 36.16 35.0 0.09 OUTLIER Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.474 1.109 . . . . 0.0 111.009 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 303' ' ' SER . 0.1 OUTLIER -62.4 151.55 82.36 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.498 0.763 . . . . 0.0 110.318 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 127.57 10.79 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.435 1.755 . . . . 0.0 110.974 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' ARG . . . . . 0.402 ' NE ' ' HG2' ' A' ' 267' ' ' GLU . 0.0 OUTLIER -46.16 -24.9 0.51 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 0.0 110.295 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 43.18 36.85 1.07 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.475 1.11 . . . . 0.0 110.012 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . -177.99 161.07 1.5 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.474 1.108 . . . . 0.0 109.283 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.546 HG22 ' HB2' ' A' ' 283' ' ' ALA . 0.3 OUTLIER -113.89 121.4 43.87 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.472 1.107 . . . . 0.0 110.355 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.822 HG12 HD12 ' A' ' 262' ' ' ILE . 31.5 t -102.69 131.79 50.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.116 . . . . 0.0 109.267 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 312' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 261' ' ' VAL . 6.0 p -136.11 158.29 44.76 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.538 1.149 . . . . 0.0 110.007 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 313' ' ' ALA . . . . . 0.877 ' HB1' HG12 ' A' ' 317' ' ' VAL . . . -88.29 111.86 22.17 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.471 1.107 . . . . 0.0 109.259 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -55.55 -26.34 42.87 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.507 1.129 . . . . 0.0 109.286 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' THR . . . . . 0.694 ' O ' HG12 ' A' ' 317' ' ' VAL . 10.0 t -164.43 -165.08 0.9 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.49 1.119 . . . . 0.0 110.41 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 316' ' ' THR . . . . . 0.418 ' N ' ' OG1' ' A' ' 315' ' ' THR . 31.5 p -60.26 80.7 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.516 1.135 . . . . 0.0 110.426 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.877 HG12 ' HB1' ' A' ' 313' ' ' ALA . 2.5 p -113.0 138.5 42.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.129 . . . . 0.0 109.266 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 318' ' ' SER . . . . . 0.62 ' C ' HD23 ' A' ' 319' ' ' LEU . 49.7 m -107.26 139.05 42.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.556 1.16 . . . . 0.0 109.998 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 319' ' ' LEU . . . . . 1.061 HD22 HG22 ' A' ' 275' ' ' VAL . 0.0 OUTLIER -143.73 173.51 11.61 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.498 1.124 . . . . 0.0 109.306 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.755 HD23 ' HB2' ' A' ' 253' ' ' ALA . 1.2 mp -124.37 133.99 53.26 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.448 1.092 . . . . 0.0 109.308 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 20.9 t -97.99 151.34 20.41 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.469 1.106 . . . . 0.0 109.985 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.457 HD13 ' C ' ' A' ' 322' ' ' LEU . 3.2 tm? -144.8 106.87 4.32 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.494 1.121 . . . . 0.0 109.34 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 323' ' ' HIS . . . . . 0.421 ' CE1' ' HB2' ' A' ' 326' ' ' ASP . 10.2 p80 -66.4 132.99 49.55 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.502 1.126 . . . . 0.0 109.615 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 96.1 p -56.64 -21.95 30.91 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.469 1.106 . . . . 0.0 110.004 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -58.84 -35.47 72.98 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.5 1.125 . . . . 0.0 109.29 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 326' ' ' ASP . . . . . 0.446 ' OD2' ' HB1' ' A' ' 250' ' ' ALA . 23.8 t70 -66.1 -41.05 91.13 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.502 1.126 . . . . 0.0 109.34 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 327' ' ' PHE . . . . . 0.482 ' CD1' ' O ' ' A' ' 327' ' ' PHE . 2.6 t80 -70.53 -29.77 66.34 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.47 1.106 . . . . 0.0 110.998 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -70.92 -45.73 63.74 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.523 1.139 . . . . 0.0 110.319 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.454 ' HG3' ' N ' ' A' ' 330' ' ' LEU . 3.9 ptm -66.47 -34.6 78.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.49 1.119 . . . . 0.0 110.978 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.454 ' N ' ' HG3' ' A' ' 329' ' ' MET . 16.5 mt -72.77 -37.74 67.54 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.486 1.116 . . . . 0.0 109.275 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 331' ' ' CYS . . . . . 0.402 ' O ' ' O ' ' A' ' 334' ' ' SER . 14.2 t -66.26 -41.47 89.85 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.549 1.156 . . . . 0.0 108.336 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.28 -23.36 51.15 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.486 1.116 . . . . 0.0 109.992 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 19.9 t -71.65 -39.33 70.42 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.532 1.145 . . . . 0.0 110.032 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' SER . . . . . 0.402 ' O ' ' O ' ' A' ' 331' ' ' CYS . 0.1 OUTLIER -121.98 131.9 24.34 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.491 1.12 . . . . 0.0 109.957 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -28.5 9.14 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.495 1.787 . . . . 0.0 110.999 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.78 -28.57 67.72 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.477 1.111 . . . . 0.0 110.259 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.805 HD11 HG21 ' A' ' 243' ' ' VAL . 95.7 mt -72.28 -35.77 53.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.486 1.116 . . . . 0.0 109.254 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.22 -33.98 65.64 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.536 1.147 . . . . 0.0 109.309 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -74.54 -42.35 59.0 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.511 1.132 . . . . 0.0 110.272 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.468 ' CG2' ' HB2' ' A' ' 238' ' ' LYS . 43.2 mt -71.7 -40.24 70.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.524 1.14 . . . . 0.0 109.27 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.481 ' CE2' ' CZ ' ' A' ' 327' ' ' PHE . 10.2 t80 -70.04 -34.94 73.89 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.547 1.154 . . . . 0.0 111.009 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.18 -41.47 73.7 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.484 1.115 . . . . 0.0 110.257 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.05 -40.57 71.58 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.498 1.124 . . . . 0.0 109.295 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.1 m -67.46 -42.39 83.12 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.457 1.098 . . . . 0.0 110.403 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -70.87 -35.08 72.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.557 1.161 . . . . 0.0 109.293 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 346' ' ' LEU . 15.8 mt -71.46 -31.99 67.79 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.546 1.154 . . . . 0.0 109.277 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -73.71 -39.02 64.64 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.539 1.149 . . . . 0.0 110.281 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 16.0 mtt-85 -70.24 -39.68 74.9 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.477 1.111 . . . . 0.0 110.349 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 349' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 350' ' ' GLY . 0.0 OUTLIER -72.79 -36.79 67.68 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.495 1.122 . . . . 0.0 110.271 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 350' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 349' ' ' ARG . . . -35.69 -46.53 0.85 Allowed Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.513 1.133 . . . . 0.0 111.005 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -155.3 122.57 5.53 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.5 0.765 . . . . 0.0 109.312 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -64.34 163.69 12.59 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.481 1.113 . . . . 0.0 109.319 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -110.24 121.48 45.37 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.519 1.137 . . . . 0.0 109.295 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 3.6 m -62.01 136.8 58.11 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.537 1.148 . . . . 0.0 109.997 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.465 0 O-C-N 124.562 1.164 . . . . 0.0 109.301 -179.981 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.976 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 74.1 m -122.14 165.98 15.27 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.484 0.755 . . . . 0.0 110.039 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -111.55 160.35 17.26 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.529 1.143 . . . . 0.0 110.317 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -93.8 170.6 9.44 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.505 1.128 . . . . 0.0 110.291 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 9.7 p -120.5 162.95 18.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.515 1.135 . . . . 0.0 109.314 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.32 161.88 25.96 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.473 1.108 . . . . 0.0 110.309 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.93 165.0 16.63 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.486 1.116 . . . . 0.0 110.322 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -80.04 -39.58 16.07 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.498 1.124 . . . . 0.0 110.998 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -98.5 14.8 26.99 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.458 0.74 . . . . 0.0 109.307 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -53.91 -37.39 63.75 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.542 1.151 . . . . 0.0 110.982 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -71.16 -37.76 67.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.525 1.14 . . . . 0.0 109.27 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.475 ' O ' HD12 ' A' ' 229' ' ' LEU . 0.0 OUTLIER -66.57 -33.14 75.02 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.536 1.147 . . . . 0.0 110.334 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.736 ' O ' HG23 ' A' ' 230' ' ' VAL . 0.3 OUTLIER -79.21 -30.3 43.24 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.471 1.107 . . . . 0.0 109.321 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 227' ' ' TRP . . . . . 0.871 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 3.1 t90 -66.45 -44.44 82.77 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.52 1.137 . . . . 0.0 108.01 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.44 ' HG3' ' N ' ' A' ' 229' ' ' LEU . 7.7 pt20 -71.67 -44.95 63.37 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.533 1.146 . . . . 0.0 110.359 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.678 HD21 ' HA2' ' A' ' 293' ' ' GLY . 0.3 OUTLIER -57.75 -44.76 86.34 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.468 1.105 . . . . 0.0 109.3 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 226' ' ' ASN . 95.7 t -70.34 -38.99 76.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.48 1.113 . . . . 0.0 109.244 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -75.29 -10.18 59.23 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.48 1.113 . . . . 0.0 109.254 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 228' ' ' GLN . . . -80.06 -25.07 40.27 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.451 1.094 . . . . 0.0 109.223 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' VAL . . . . . 0.463 HG13 ' HD2' ' A' ' 234' ' ' PRO . 61.9 t -70.05 138.14 87.32 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.469 1.106 . . . . 0.0 109.298 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.463 ' HD2' HG13 ' A' ' 233' ' ' VAL . 18.3 Cg_endo -75.02 -50.24 0.13 Allowed 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.478 1.778 . . . . 0.0 110.998 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.66 HD11 HD11 ' A' ' 302' ' ' ILE . 18.2 mt -50.84 -37.13 41.28 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.489 1.118 . . . . 0.0 109.275 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -78.88 -21.99 46.64 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.465 1.103 . . . . 0.0 110.979 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' GLN . . . . . 0.444 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -59.12 -22.72 61.31 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.514 1.134 . . . . 0.0 110.282 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -75.11 -23.27 57.91 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.495 1.122 . . . . 0.0 109.275 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.538 HD21 HG23 ' A' ' 337' ' ' ILE . 16.3 mt -74.51 -179.83 4.26 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.483 1.114 . . . . 0.0 109.275 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' GLY . . . . . 0.622 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -107.72 -172.6 22.04 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.517 1.136 . . . . 0.0 111.005 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.877 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.1 Cg_endo -75.0 -36.96 2.24 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.5 1.789 . . . . 0.0 111.015 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.09 -34.83 78.48 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.493 1.121 . . . . 0.0 109.327 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.519 HG12 HD12 ' A' ' 247' ' ' ILE . 13.6 t -75.38 -39.21 41.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.531 1.144 . . . . 0.0 109.329 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.622 HD23 ' O ' ' A' ' 240' ' ' GLY . 1.4 mm? -66.28 -37.94 86.62 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.498 1.124 . . . . 0.0 109.253 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 241' ' ' PRO . 94.1 t -68.95 -44.67 81.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.478 1.111 . . . . 0.0 109.274 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -64.74 -36.94 85.93 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.468 1.105 . . . . 0.0 110.301 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.519 HD12 HG12 ' A' ' 243' ' ' VAL . 41.7 mt -69.09 -49.07 65.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.47 1.106 . . . . 0.0 109.285 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 244' ' ' LEU . 63.9 t -62.58 -31.09 50.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 0.0 109.308 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -78.92 -22.67 45.5 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.549 1.155 . . . . 0.0 110.282 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -91.86 -12.59 33.21 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.48 1.113 . . . . 0.0 109.25 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.61 148.89 47.63 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.535 1.147 . . . . 0.0 109.318 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 2.4 tpt85 -120.64 116.11 24.68 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.471 1.107 . . . . 0.0 110.288 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.754 ' HB2' HD23 ' A' ' 320' ' ' LEU . . . -80.7 122.28 26.93 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.414 1.072 . . . . 0.0 109.355 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.4 ' O ' ' O ' ' A' ' 319' ' ' LEU . 13.5 ptp180 -130.27 142.97 50.52 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.486 1.116 . . . . 0.0 110.303 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 10.5 m -95.36 129.19 42.59 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.51 1.131 . . . . 0.0 110.383 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.442 HG21 HD11 ' A' ' 319' ' ' LEU . 51.5 t -106.46 117.67 56.52 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.521 1.138 . . . . 0.0 109.276 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.2 Cg_endo -75.03 164.6 32.98 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.473 1.775 . . . . 0.0 110.988 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.501 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -66.85 125.21 25.18 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.495 1.122 . . . . 0.0 109.287 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 99.03 -24.91 30.32 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 124.5 1.125 . . . . 0.0 111.002 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.514 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -63.64 144.74 56.77 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.49 0.759 . . . . 0.0 109.299 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 311' ' ' VAL . 2.7 p -97.54 135.82 30.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 0.0 109.288 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.617 HD12 HG12 ' A' ' 311' ' ' VAL . 12.2 mt -82.3 -49.17 17.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.541 1.15 . . . . 0.0 109.328 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' CYS . . . . . 0.605 ' SG ' HG23 ' A' ' 311' ' ' VAL . 12.8 p -142.96 163.63 32.27 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.522 1.139 . . . . 0.0 108.28 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 1.1 mmt-85 -103.81 178.34 4.59 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.515 1.135 . . . . 0.0 110.313 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.79 142.02 14.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.458 1.099 . . . . 0.0 109.317 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 46.82 43.92 17.12 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.536 1.148 . . . . 0.0 111.009 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.434 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.2 OUTLIER -71.38 166.93 34.32 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.485 0.756 . . . . 0.0 110.311 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.434 ' HD2' ' HB2' ' A' ' 267' ' ' GLU . 18.1 Cg_endo -75.01 86.91 1.37 Allowed 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.487 1.783 . . . . 0.0 111.0 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -45.54 97.9 0.01 OUTLIER Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.499 1.124 . . . . 0.0 110.979 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -170.19 38.11 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.539 0.788 . . . . 0.0 109.284 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.46 144.55 6.42 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.139 . . . . 0.0 110.299 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 272' ' ' MET . . . . . 0.504 ' HB2' HD11 ' A' ' 301' ' ' LEU . 2.1 ttt -113.94 146.65 39.78 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.501 1.125 . . . . 0.0 111.008 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.565 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 86.6 m-85 -138.07 136.63 37.0 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.488 1.117 . . . . 0.0 110.984 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 274' ' ' PHE . . . . . 0.469 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 23.0 m-85 -126.65 133.67 50.92 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.123 . . . . 0.0 110.986 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 36.9 t -89.67 135.2 26.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.495 1.122 . . . . 0.0 109.311 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.566 ' CG2' HD11 ' A' ' 320' ' ' LEU . 9.8 t -110.4 -49.1 6.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.535 1.147 . . . . 0.0 109.334 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -143.59 132.74 23.05 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.483 1.115 . . . . 0.0 110.253 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.99 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 121.95 -169.25 14.72 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.492 1.12 . . . . 0.0 111.023 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 7.6 t -138.33 117.0 12.2 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.555 0.797 . . . . 0.0 110.007 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.469 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 30.0 m -98.76 161.47 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.504 1.127 . . . . 0.0 109.28 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 28.9 t -127.97 151.18 49.44 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.414 1.071 . . . . 0.0 110.018 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 1.4 t -114.81 130.75 68.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.468 1.105 . . . . 0.0 109.328 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.769 ' HB3' ' H ' ' A' ' 310' ' ' THR . . . -77.99 102.14 7.24 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.469 1.106 . . . . 0.0 109.298 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' THR . . . . . 0.655 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.29 -168.46 0.19 Allowed Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.502 1.126 . . . . 0.0 110.403 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.655 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -75.0 3.77 5.33 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.483 1.781 . . . . 0.0 110.936 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -151.45 157.48 34.82 Favored Pre-proline 0 C--N 1.324 -0.529 0 O-C-N 124.501 1.126 . . . . 0.0 109.302 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 94.73 0.96 Allowed 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.493 1.786 . . . . 0.0 110.95 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 281' ' ' SER . 61.5 t -98.94 118.92 46.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 0.0 109.3 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 14.2 mt-10 -124.28 139.11 54.22 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.433 1.083 . . . . 0.0 110.275 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.469 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 3.7 mm? -117.15 140.34 49.64 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.465 1.103 . . . . 0.0 109.299 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -96.5 -162.58 32.75 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.527 1.142 . . . . 0.0 111.061 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 141.47 26.68 Favored 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.567 1.825 . . . . 0.0 110.999 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.678 ' HA2' HD21 ' A' ' 229' ' ' LEU . . . 90.23 6.56 68.7 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.55 1.156 . . . . 0.0 110.971 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -91.69 131.8 36.82 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.484 0.756 . . . . 0.0 109.287 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -119.3 152.71 36.24 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.489 1.118 . . . . 0.0 110.995 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.565 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 45.2 p90 -163.57 145.63 9.58 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.483 1.114 . . . . 0.0 111.02 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' GLY . . . . . 0.464 ' O ' HD12 ' A' ' 301' ' ' LEU . . . 132.26 -3.53 5.17 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.513 1.133 . . . . 0.0 110.99 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.493 ' HG2' ' CE ' ' A' ' 272' ' ' MET . 1.7 mt-10 -59.41 -46.06 89.76 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.497 0.763 . . . . 0.0 110.294 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' MET . . . . . 0.408 ' HB3' ' CG ' ' A' ' 305' ' ' GLU . 0.0 OUTLIER -52.03 -34.36 42.73 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.486 1.116 . . . . 0.0 110.997 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 300' ' ' ALA . . . . . 0.65 ' HB2' ' NH2' ' A' ' 307' ' ' ARG . . . -69.08 -45.06 71.23 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 0.0 109.289 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.504 HD11 ' HB2' ' A' ' 272' ' ' MET . 1.0 OUTLIER -75.37 -6.96 52.64 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.506 1.128 . . . . 0.0 109.251 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 302' ' ' ILE . . . . . 0.66 HD11 HD11 ' A' ' 235' ' ' LEU . 3.0 mm -82.25 -55.6 7.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.538 1.149 . . . . 0.0 109.337 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 304' ' ' GLY . 1.6 m -151.57 38.16 0.61 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.468 1.105 . . . . 0.0 110.011 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 36.68 53.14 1.44 Allowed Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.527 1.142 . . . . 0.0 111.005 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 305' ' ' GLU . . . . . 0.408 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 1.3 pt-20 -82.48 157.17 67.95 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.534 0.785 . . . . 0.0 110.312 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.07 133.82 16.95 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.467 1.772 . . . . 0.0 110.982 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' ARG . . . . . 0.65 ' NH2' ' HB2' ' A' ' 300' ' ' ALA . 0.0 OUTLIER -50.59 -26.0 4.82 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.45 1.094 . . . . 0.0 110.239 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.535 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 0.2 OUTLIER 46.73 39.14 6.71 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.486 1.116 . . . . 0.0 110.025 -180.0 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 309' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 173.91 161.05 0.16 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.514 1.134 . . . . 0.0 109.344 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.769 ' H ' ' HB3' ' A' ' 283' ' ' ALA . 0.6 OUTLIER -109.14 132.87 53.71 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.539 1.149 . . . . 0.0 110.388 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.617 HG12 HD12 ' A' ' 262' ' ' ILE . 44.5 t -111.7 131.56 62.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.483 1.115 . . . . 0.0 109.296 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 6.2 p -141.62 151.64 43.29 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.461 1.101 . . . . 0.0 109.991 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.42 118.48 26.89 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.526 1.141 . . . . 0.0 109.318 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -59.92 -32.24 70.58 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.505 1.128 . . . . 0.0 109.267 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' THR . . . . . 0.665 ' O ' HG23 ' A' ' 317' ' ' VAL . 13.1 t -153.97 -175.58 5.45 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.515 1.135 . . . . 0.0 110.362 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 41.7 p -49.29 92.46 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.531 1.144 . . . . 0.0 110.394 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.99 HG22 ' HA3' ' A' ' 278' ' ' GLY . 53.5 t -109.33 162.41 7.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.472 1.108 . . . . 0.0 109.273 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 318' ' ' SER . . . . . 0.433 ' N ' ' CG1' ' A' ' 317' ' ' VAL . 64.0 m -136.29 116.64 13.63 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.514 1.134 . . . . 0.0 109.989 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 319' ' ' LEU . . . . . 0.469 ' CB ' ' O ' ' A' ' 274' ' ' PHE . 0.2 OUTLIER -132.0 172.25 12.59 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.472 1.107 . . . . 0.0 109.341 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.754 HD23 ' HB2' ' A' ' 253' ' ' ALA . 0.2 OUTLIER -124.66 135.74 53.32 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.495 1.122 . . . . 0.0 109.341 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 45.5 t -93.36 158.25 15.83 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.525 1.141 . . . . 0.0 110.01 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -151.77 94.6 2.0 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.483 1.115 . . . . 0.0 109.329 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' HIS . . . . . 0.413 ' CD2' ' H ' ' A' ' 323' ' ' HIS . 5.0 p80 -55.39 135.32 50.36 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 0.0 109.624 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 8.1 t -57.78 -17.07 13.53 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.499 1.124 . . . . 0.0 110.0 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -58.31 -36.74 73.82 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.533 1.145 . . . . 0.0 109.297 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -42.61 95.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.491 1.119 . . . . 0.0 109.285 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 327' ' ' PHE . . . . . 0.462 ' HB2' ' CD2' ' A' ' 301' ' ' LEU . 83.7 t80 -65.19 -36.14 83.28 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.46 1.1 . . . . 0.0 110.981 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -69.65 -31.75 70.0 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.464 1.102 . . . . 0.0 110.328 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -69.86 -45.12 68.42 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.538 1.149 . . . . 0.0 110.995 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 1.2 mt -71.27 -30.89 66.84 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.492 1.12 . . . . 0.0 109.274 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' CYS . . . . . 0.412 ' CB ' ' HB2' ' A' ' 338' ' ' ALA . 1.6 m -72.29 -37.52 68.99 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.535 1.147 . . . . 0.0 108.303 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.87 -36.28 64.81 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.44 1.088 . . . . 0.0 110.005 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.77 -33.56 70.9 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.517 1.135 . . . . 0.0 109.98 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 334' ' ' SER . . . . . 0.596 ' CB ' HD12 ' A' ' 337' ' ' ILE . 0.6 OUTLIER -128.68 113.22 19.16 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.531 1.145 . . . . 0.0 109.985 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -22.27 14.97 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.429 1.752 . . . . 0.0 110.988 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -73.53 -31.57 63.75 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.467 1.105 . . . . 0.0 110.337 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.596 HD12 ' CB ' ' A' ' 334' ' ' SER . 60.5 mt -73.69 -45.53 50.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.542 1.151 . . . . 0.0 109.331 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 338' ' ' ALA . . . . . 0.412 ' HB2' ' CB ' ' A' ' 331' ' ' CYS . . . -69.26 -32.17 71.18 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 0.0 109.298 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -71.4 -38.38 71.46 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.469 1.105 . . . . 0.0 110.334 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.442 ' O ' HG22 ' A' ' 344' ' ' THR . 78.5 mt -73.1 -42.67 58.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.467 1.105 . . . . 0.0 109.341 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.578 ' CZ ' HD13 ' A' ' 235' ' ' LEU . 2.5 t80 -72.39 -30.72 64.93 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.513 1.133 . . . . 0.0 110.997 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 342' ' ' ARG . . . . . 0.47 ' HG3' ' CD1' ' A' ' 346' ' ' LEU . 0.0 OUTLIER -72.58 -43.21 63.67 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.511 1.132 . . . . 0.0 110.264 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -51.07 63.43 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.461 1.101 . . . . 0.0 109.323 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.545 HG22 ' HA ' ' A' ' 341' ' ' PHE . 9.0 t -65.02 -34.06 77.54 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.513 1.133 . . . . 0.0 110.355 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 345' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 341' ' ' PHE . . . -65.22 -43.4 91.62 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.542 1.151 . . . . 0.0 109.291 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.47 ' CD1' ' HG3' ' A' ' 342' ' ' ARG . 0.5 OUTLIER -65.03 -38.87 92.3 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.482 1.114 . . . . 0.0 109.286 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -68.88 -37.95 79.37 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.46 1.1 . . . . 0.0 110.32 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 348' ' ' ARG . . . . . 0.513 ' HE ' HD21 ' A' ' 235' ' ' LEU . 40.0 mtt-85 -72.43 -42.97 64.46 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.472 1.107 . . . . 0.0 110.345 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 349' ' ' ARG . . . . . 0.405 ' O ' ' C ' ' A' ' 350' ' ' GLY . 0.0 OUTLIER -72.56 -34.77 67.72 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.464 1.103 . . . . 0.0 110.31 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 350' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 349' ' ' ARG . . . -37.35 -47.95 1.57 Allowed Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.514 1.133 . . . . 0.0 110.99 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -154.95 120.07 4.94 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.555 0.797 . . . . 0.0 109.263 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -61.16 171.67 1.26 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.473 1.108 . . . . 0.0 109.297 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -134.16 123.28 24.12 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.439 1.087 . . . . 0.0 109.322 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 68.7 m -152.69 162.7 40.9 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.472 1.107 . . . . 0.0 109.991 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.53 0 O-C-N 124.572 1.17 . . . . 0.0 109.362 179.977 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.009 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 24.1 p -86.7 158.12 19.5 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.51 0.771 . . . . 0.0 109.997 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -141.34 147.47 38.16 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.53 1.144 . . . . 0.0 110.323 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.61 171.81 16.06 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.512 1.132 . . . . 0.0 110.315 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.57 178.98 3.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.509 1.13 . . . . 0.0 109.344 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -78.37 160.55 27.74 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.502 1.126 . . . . 0.0 110.268 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.27 157.2 45.01 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.521 1.138 . . . . 0.0 110.33 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -119.92 -37.67 0.75 Allowed Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.543 1.152 . . . . 0.0 110.983 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 35.0 p30 -92.09 19.38 6.89 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.459 0.741 . . . . 0.0 109.287 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -56.09 -40.5 73.76 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.518 1.137 . . . . 0.0 111.034 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.26 -32.58 58.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.485 1.115 . . . . 0.0 109.258 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.34 -35.39 71.17 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.532 1.145 . . . . 0.0 110.291 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.749 ' ND2' HD22 ' A' ' 320' ' ' LEU . 5.3 t-20 -78.95 -30.43 44.6 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.498 1.123 . . . . 0.0 109.25 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' TRP . . . . . 0.893 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 2.5 t90 -67.79 -45.52 74.59 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.502 1.126 . . . . 0.0 107.982 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.658 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 6.1 pt20 -71.54 -34.41 69.99 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.535 1.147 . . . . 0.0 110.339 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 6.2 mt -60.55 -43.83 96.8 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.479 1.112 . . . . 0.0 109.318 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.504 ' O ' HG12 ' A' ' 233' ' ' VAL . 82.7 t -75.5 -45.86 38.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.498 1.124 . . . . 0.0 109.324 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -69.16 -10.26 56.81 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.544 1.152 . . . . 0.0 109.299 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.658 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -80.42 -20.52 43.71 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.459 1.099 . . . . 0.0 109.268 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 230' ' ' VAL . 0.3 OUTLIER -91.74 126.92 52.15 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.491 1.12 . . . . 0.0 109.299 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.405 ' HA ' ' HB2' ' A' ' 237' ' ' GLN . 18.2 Cg_endo -75.01 -0.34 9.85 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.551 1.816 . . . . 0.0 111.029 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -24.12 32.06 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.508 1.13 . . . . 0.0 109.311 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.553 ' CE2' HD13 ' A' ' 247' ' ' ILE . 1.4 m-30 -120.4 -8.49 9.6 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.528 1.143 . . . . 0.0 111.029 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' GLN . . . . . 0.405 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -61.66 -26.71 68.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.464 1.102 . . . . 0.0 110.258 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -74.71 -3.69 32.96 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.539 1.149 . . . . 0.0 109.342 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.594 HD13 HG11 ' A' ' 243' ' ' VAL . 66.5 mt -81.84 -179.32 7.34 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.509 1.131 . . . . 0.0 109.327 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' GLY . . . . . 0.567 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -100.73 -176.76 29.62 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.5 1.125 . . . . 0.0 111.016 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.942 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.1 Cg_endo -75.05 -38.84 1.39 Allowed 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.469 1.773 . . . . 0.0 110.991 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -66.37 -33.13 75.04 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 0.0 109.286 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.868 HG21 HD11 ' A' ' 337' ' ' ILE . 4.5 t -75.13 -42.02 44.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.503 1.127 . . . . 0.0 109.286 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.567 HD23 ' O ' ' A' ' 240' ' ' GLY . 1.3 mm? -65.34 -37.91 88.52 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.487 1.117 . . . . 0.0 109.271 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.942 HG23 ' O ' ' A' ' 241' ' ' PRO . 58.4 t -71.82 -38.33 65.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.504 1.128 . . . . 0.0 109.247 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -67.64 -40.1 84.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.502 1.126 . . . . 0.0 110.289 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.553 HD13 ' CE2' ' A' ' 236' ' ' PHE . 31.6 mt -68.48 -48.9 70.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.461 1.1 . . . . 0.0 109.312 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.537 ' HA ' HD12 ' A' ' 251' ' ' LEU . 68.6 t -64.32 -33.15 60.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.132 . . . . 0.0 109.286 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.496 ' CG ' ' O ' ' A' ' 245' ' ' VAL . 0.9 OUTLIER -75.84 -22.85 55.84 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.489 1.118 . . . . 0.0 110.332 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.636 ' HB1' ' OD1' ' A' ' 326' ' ' ASP . . . -90.53 -18.08 25.91 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.446 1.091 . . . . 0.0 109.282 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.537 HD12 ' HA ' ' A' ' 248' ' ' VAL . 0.3 OUTLIER -63.4 147.82 50.18 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.475 1.109 . . . . 0.0 109.288 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.97 134.26 55.29 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.541 1.15 . . . . 0.0 110.322 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -80.75 122.46 27.18 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.543 1.152 . . . . 0.0 109.323 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -123.73 123.3 40.21 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.482 1.113 . . . . 0.0 110.301 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 9.3 m -92.13 116.94 29.37 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.533 1.146 . . . . 0.0 110.41 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.489 HG21 HD11 ' A' ' 319' ' ' LEU . 77.4 t -106.67 112.22 63.65 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.548 1.155 . . . . 0.0 109.324 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.529 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.2 Cg_endo -75.0 175.37 11.33 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.501 1.79 . . . . 0.0 110.997 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.574 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -66.97 133.27 49.63 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.499 1.124 . . . . 0.0 109.359 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 90.42 -25.14 13.61 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.456 1.097 . . . . 0.0 110.99 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.529 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -57.66 147.24 28.07 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.53 0.783 . . . . 0.0 109.301 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.7 t -97.25 128.96 48.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.113 . . . . 0.0 109.307 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.795 HD12 HG12 ' A' ' 311' ' ' VAL . 38.7 mt -82.96 -39.17 15.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.467 1.105 . . . . 0.0 109.291 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' CYS . . . . . 0.466 ' SG ' HG23 ' A' ' 311' ' ' VAL . 14.2 p -159.47 151.27 20.46 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.507 1.129 . . . . 0.0 108.27 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 -95.16 -179.46 4.81 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.512 1.133 . . . . 0.0 110.303 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.493 HG23 ' OG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -75.95 139.26 19.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.526 1.141 . . . . 0.0 109.354 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 47.82 51.46 18.15 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.519 1.137 . . . . 0.0 110.999 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.413 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.2 OUTLIER -71.47 164.42 57.83 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.491 0.76 . . . . 0.0 110.306 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.43 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.3 Cg_endo -74.94 78.5 2.86 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.488 1.783 . . . . 0.0 111.045 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 269' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 268' ' ' PRO . . . -36.58 96.54 0.01 OUTLIER Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.514 1.134 . . . . 0.0 111.009 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 268' ' ' PRO . 0.3 OUTLIER -170.26 37.6 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.506 0.768 . . . . 0.0 109.283 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.415 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 0.2 OUTLIER -168.09 144.93 4.07 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.484 1.115 . . . . 0.0 110.291 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 272' ' ' MET . . . . . 0.487 ' SD ' ' CD1' ' A' ' 301' ' ' LEU . 0.1 OUTLIER -114.85 146.47 41.03 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 0.0 110.948 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.572 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 66.9 m-85 -133.46 136.7 45.31 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.474 1.109 . . . . 0.0 111.037 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 274' ' ' PHE . . . . . 0.449 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 22.0 m-85 -127.13 131.02 50.88 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.53 1.144 . . . . 0.0 111.046 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.575 HG12 ' HA ' ' A' ' 292' ' ' PRO . 45.7 t -87.07 137.7 20.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.501 1.126 . . . . 0.0 109.295 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.634 ' CG2' HD11 ' A' ' 320' ' ' LEU . 4.2 t -118.56 -40.54 2.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.533 1.145 . . . . 0.0 109.301 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -147.52 136.16 21.87 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.511 1.132 . . . . 0.0 110.339 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.954 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 112.31 -167.33 12.35 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.513 1.133 . . . . 0.0 110.999 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 279' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 290' ' ' LEU . 11.2 t -140.97 122.12 14.72 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.569 0.805 . . . . 0.0 109.997 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.467 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 21.1 m -99.27 163.56 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.511 1.132 . . . . 0.0 109.308 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 31.6 t -130.25 151.85 50.32 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.492 1.12 . . . . 0.0 110.03 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.418 ' CG2' ' HB ' ' A' ' 288' ' ' VAL . 0.8 OUTLIER -114.77 129.01 71.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.463 1.102 . . . . 0.0 109.316 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.42 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -80.06 101.06 8.49 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.517 1.135 . . . . 0.0 109.318 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' THR . . . . . 0.661 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -149.04 -168.13 0.18 Allowed Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.554 1.159 . . . . 0.0 110.409 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.661 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.3 Cg_endo -74.98 5.49 3.94 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.448 1.762 . . . . 0.0 111.011 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.443 ' O ' HG23 ' A' ' 288' ' ' VAL . 11.9 m120 -151.59 153.37 31.98 Favored Pre-proline 0 C--N 1.324 -0.529 0 O-C-N 124.511 1.132 . . . . 0.0 109.348 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.95 97.48 1.08 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.509 1.794 . . . . 0.0 111.044 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 286' ' ' ASN . 2.3 t -102.78 119.24 50.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.469 1.106 . . . . 0.0 109.324 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 12.9 mt-10 -124.46 134.8 52.94 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.477 1.11 . . . . 0.0 110.271 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.467 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 3.9 mm? -112.97 141.59 46.62 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.488 1.118 . . . . 0.0 109.336 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -98.12 -164.72 31.13 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.466 1.104 . . . . 0.0 110.953 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' PRO . . . . . 0.575 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.1 Cg_endo -75.0 139.68 24.57 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.541 1.811 . . . . 0.0 111.007 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 96.6 1.93 60.19 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.509 1.131 . . . . 0.0 111.016 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' ALA . . . . . 0.41 ' CB ' HD12 ' A' ' 290' ' ' LEU . . . -87.64 144.68 26.54 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.529 0.782 . . . . 0.0 109.301 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -134.83 153.11 52.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.468 1.105 . . . . 0.0 110.958 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.572 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 45.9 p90 -163.89 146.25 9.38 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.508 1.13 . . . . 0.0 110.992 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 297' ' ' GLY . . . . . 0.474 ' O ' HD12 ' A' ' 301' ' ' LEU . . . 137.34 -10.33 3.8 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.455 1.097 . . . . 0.0 111.026 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.44 ' HG2' ' N ' ' A' ' 299' ' ' MET . 0.9 OUTLIER -52.46 -34.85 50.81 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.482 0.754 . . . . 0.0 110.282 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 299' ' ' MET . . . . . 0.447 ' HB3' ' CG ' ' A' ' 305' ' ' GLU . 0.5 OUTLIER -64.27 -41.5 96.89 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.458 1.099 . . . . 0.0 111.032 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -63.67 -29.9 71.07 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.473 1.108 . . . . 0.0 109.296 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.487 ' CD1' ' SD ' ' A' ' 272' ' ' MET . 1.2 mt -86.34 -19.04 30.39 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.548 1.155 . . . . 0.0 109.286 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 302' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 298' ' ' GLU . 3.9 mm -68.56 -57.4 9.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.426 1.079 . . . . 0.0 109.33 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 304' ' ' GLY . 2.7 m -155.02 44.99 0.5 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.484 1.115 . . . . 0.0 110.021 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 303' ' ' SER . . . 35.4 51.15 0.98 Allowed Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.481 1.113 . . . . 0.0 111.005 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 305' ' ' GLU . . . . . 0.447 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 0.1 OUTLIER -78.76 155.02 78.37 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.504 0.767 . . . . 0.0 110.295 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 130.2 13.08 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.496 1.788 . . . . 0.0 111.003 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 307' ' ' ARG . . . . . 0.41 ' NE ' ' HG2' ' A' ' 267' ' ' GLU . 0.2 OUTLIER -44.61 -36.37 3.02 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.495 1.122 . . . . 0.0 110.321 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.679 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 0.8 OUTLIER 59.9 42.49 16.21 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.459 1.1 . . . . 0.0 109.967 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 309' ' ' ALA . . . . . 0.679 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 164.59 160.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.517 1.135 . . . . 0.0 109.315 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.493 ' OG1' HG23 ' A' ' 265' ' ' ILE . 0.9 OUTLIER -108.36 137.38 46.43 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.484 1.115 . . . . 0.0 110.387 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.795 HG12 HD12 ' A' ' 262' ' ' ILE . 61.6 t -116.92 131.38 69.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.459 1.1 . . . . 0.0 109.303 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 61.9 p -132.16 159.11 39.92 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.534 1.146 . . . . 0.0 110.008 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -93.6 118.3 31.2 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.547 1.155 . . . . 0.0 109.302 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -58.59 -35.26 72.13 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.499 1.124 . . . . 0.0 109.311 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 315' ' ' THR . . . . . 0.574 ' HA ' ' HB2' ' A' ' 258' ' ' ALA . 9.8 t -155.62 -172.5 4.17 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.491 1.119 . . . . 0.0 110.373 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 316' ' ' THR . . . . . 0.426 ' N ' ' OG1' ' A' ' 315' ' ' THR . 32.0 m -49.49 91.33 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.508 1.13 . . . . 0.0 110.396 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.954 HG22 ' HA3' ' A' ' 278' ' ' GLY . 38.6 t -107.79 155.98 8.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.444 1.09 . . . . 0.0 109.281 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 31.0 m -132.56 114.25 14.03 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.491 1.119 . . . . 0.0 110.045 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 319' ' ' LEU . . . . . 0.489 HD11 HG21 ' A' ' 256' ' ' VAL . 0.2 OUTLIER -129.28 173.29 10.64 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 0.0 109.261 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.749 HD22 ' ND2' ' A' ' 226' ' ' ASN . 0.3 OUTLIER -124.2 138.18 54.44 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.434 1.084 . . . . 0.0 109.303 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 30.9 t -97.59 155.29 17.04 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.501 1.126 . . . . 0.0 109.976 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.739 ' O ' HD13 ' A' ' 322' ' ' LEU . 1.4 tm? -145.69 92.99 2.29 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.441 1.088 . . . . 0.0 109.282 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 323' ' ' HIS . . . . . 0.509 ' CE1' ' OD1' ' A' ' 326' ' ' ASP . 13.8 p80 -54.99 126.77 25.95 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.464 1.103 . . . . 0.0 109.638 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 324' ' ' SER . . . . . 0.407 ' OG ' ' CG ' ' A' ' 270' ' ' ASP . 2.1 p -49.38 -26.92 3.55 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.476 1.11 . . . . 0.0 109.974 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -52.0 -30.46 25.25 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.492 1.12 . . . . 0.0 109.324 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 326' ' ' ASP . . . . . 0.636 ' OD1' ' HB1' ' A' ' 250' ' ' ALA . 0.2 OUTLIER -70.41 -41.85 72.41 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.448 1.092 . . . . 0.0 109.288 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 327' ' ' PHE . . . . . 0.672 ' CZ ' ' CE2' ' A' ' 341' ' ' PHE . 2.5 t80 -64.82 -38.82 92.28 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.486 1.116 . . . . 0.0 110.994 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -69.53 -34.13 73.8 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.424 1.077 . . . . 0.0 110.252 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 28.7 ttp -71.22 -32.24 68.56 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.465 1.103 . . . . 0.0 111.013 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.518 HD12 HG13 ' A' ' 243' ' ' VAL . 0.2 OUTLIER -72.78 -46.2 54.55 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.546 1.154 . . . . 0.0 109.278 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 331' ' ' CYS . . . . . 0.887 ' SG ' HG22 ' A' ' 337' ' ' ILE . 1.5 m -65.92 -32.38 73.85 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.527 1.142 . . . . 0.0 108.259 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 4.7 t -76.27 -29.8 57.57 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.486 1.116 . . . . 0.0 110.04 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 12.8 t -72.38 -38.19 68.54 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 0.0 109.983 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 334' ' ' SER . . . . . 0.407 ' HA ' ' HD3' ' A' ' 335' ' ' PRO . 0.3 OUTLIER -127.86 130.15 23.66 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.461 1.101 . . . . 0.0 109.97 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 335' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 334' ' ' SER . 18.3 Cg_endo -75.0 -23.79 13.45 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.514 1.797 . . . . 0.0 111.035 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.55 -30.27 68.04 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.495 1.122 . . . . 0.0 110.351 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.887 HG22 ' SG ' ' A' ' 331' ' ' CYS . 49.4 mt -73.36 -36.86 50.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.498 1.124 . . . . 0.0 109.317 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -71.53 -34.63 70.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.502 1.126 . . . . 0.0 109.291 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -74.05 -45.13 51.48 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.512 1.132 . . . . 0.0 110.273 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 94.5 mt -69.82 -35.55 65.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.517 1.136 . . . . 0.0 109.316 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.672 ' CE2' ' CZ ' ' A' ' 327' ' ' PHE . 1.6 t80 -69.14 -39.46 78.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.523 1.14 . . . . 0.0 110.996 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.46 -38.05 77.57 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.479 1.112 . . . . 0.0 110.336 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -43.52 78.29 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.516 1.135 . . . . 0.0 109.311 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.91 -40.78 83.36 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.517 1.136 . . . . 0.0 110.414 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -66.37 -38.02 86.62 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.511 1.132 . . . . 0.0 109.282 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 346' ' ' LEU . 9.6 mt -68.59 -35.1 76.9 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.538 1.149 . . . . 0.0 109.344 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -69.69 -40.1 76.53 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.124 . . . . 0.0 110.286 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 13.9 mtt180 -70.19 -40.22 74.74 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.506 1.129 . . . . 0.0 110.314 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.72 -34.74 67.31 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.509 1.131 . . . . 0.0 110.327 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -38.37 -50.29 2.3 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.532 1.145 . . . . 0.0 110.986 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -153.67 121.1 5.85 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.471 0.748 . . . . 0.0 109.31 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -61.11 166.28 3.74 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.496 1.122 . . . . 0.0 109.287 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -119.3 120.15 36.12 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.491 1.119 . . . . 0.0 109.319 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 1.5 t -132.64 169.83 16.08 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.461 1.101 . . . . 0.0 110.027 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.537 1.148 . . . . 0.0 109.289 179.994 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.023 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 18.6 m -128.34 171.97 11.52 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.55 0.794 . . . . 0.0 110.029 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -100.78 172.65 6.93 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.581 1.176 . . . . 0.0 110.267 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -116.06 163.05 16.5 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.524 1.14 . . . . 0.0 110.324 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.619 HG13 ' HE ' ' A' ' 220' ' ' ARG . 11.2 p -151.61 159.73 3.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.498 1.124 . . . . 0.0 109.269 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.37 162.87 14.08 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.445 1.091 . . . . 0.0 110.339 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.619 ' HE ' HG13 ' A' ' 218' ' ' VAL . 2.6 mpt_? -136.75 158.63 44.01 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.446 1.091 . . . . 0.0 110.334 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -108.99 -34.4 2.57 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.509 1.13 . . . . 0.0 110.983 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.527 ' OD2' HG11 ' A' ' 276' ' ' VAL . 25.2 m-20 -92.07 19.39 6.86 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.457 0.739 . . . . 0.0 109.263 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -54.52 -40.05 68.22 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.455 1.097 . . . . 0.0 111.018 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.78 -37.94 43.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.439 1.087 . . . . 0.0 109.271 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.495 ' O ' HD12 ' A' ' 229' ' ' LEU . 0.0 OUTLIER -68.3 -31.1 70.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.144 . . . . 0.0 110.335 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.967 ' O ' HG12 ' A' ' 230' ' ' VAL . 6.4 t-20 -80.3 -31.55 38.19 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.532 1.145 . . . . 0.0 109.286 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' TRP . . . . . 0.712 ' CZ3' HG23 ' A' ' 245' ' ' VAL . 2.0 t90 -68.68 -43.98 75.0 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.674 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 4.1 pt20 -72.02 -33.82 68.34 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.454 1.096 . . . . 0.0 110.308 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.637 HD21 ' HA2' ' A' ' 293' ' ' GLY . 2.4 mt -64.94 -55.37 19.6 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 0.0 109.269 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.967 HG12 ' O ' ' A' ' 226' ' ' ASN . 5.7 p -65.09 -37.66 80.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.523 1.139 . . . . 0.0 109.34 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 227' ' ' TRP . . . -76.03 -15.1 60.19 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.478 1.111 . . . . 0.0 109.235 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.674 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -80.71 -11.33 59.64 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.503 1.127 . . . . 0.0 109.307 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' VAL . . . . . 0.729 HG12 ' O ' ' A' ' 230' ' ' VAL . 0.6 OUTLIER -89.02 132.61 37.46 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.547 1.155 . . . . 0.0 109.32 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.432 ' HA ' ' HB2' ' A' ' 237' ' ' GLN . 18.4 Cg_endo -74.97 -0.08 9.51 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.457 1.767 . . . . 0.0 111.028 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.25 -24.4 22.1 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 0.0 109.32 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.61 ' H ' HG13 ' A' ' 233' ' ' VAL . 21.2 m-30 -122.92 8.14 9.32 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.478 1.111 . . . . 0.0 110.987 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 237' ' ' GLN . . . . . 0.432 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 3.0 tt0 -73.16 -19.53 61.1 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.483 1.114 . . . . 0.0 110.286 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.438 ' NZ ' ' HA ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -97.57 4.99 50.14 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.527 1.142 . . . . 0.0 109.326 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.814 HD13 ' CG1' ' A' ' 243' ' ' VAL . 19.3 mt -80.28 -179.42 7.09 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.465 1.103 . . . . 0.0 109.316 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' GLY . . . . . 0.601 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -103.23 -178.48 26.3 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.499 1.124 . . . . 0.0 110.991 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 -32.9 5.04 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.53 1.805 . . . . 0.0 110.98 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.521 ' HA ' HG12 ' A' ' 245' ' ' VAL . . . -73.62 -32.81 64.26 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.445 1.09 . . . . 0.0 109.297 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.814 ' CG1' HD13 ' A' ' 239' ' ' LEU . 63.0 t -76.6 -38.39 31.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.126 . . . . 0.0 109.271 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.643 ' O ' HG23 ' A' ' 248' ' ' VAL . 3.6 mm? -71.31 -45.47 62.96 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.488 1.118 . . . . 0.0 109.289 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.712 HG23 ' CZ3' ' A' ' 227' ' ' TRP . 3.3 p -64.65 -45.09 96.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.528 1.142 . . . . 0.0 109.317 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.402 ' N ' ' CG1' ' A' ' 245' ' ' VAL . 15.3 tp10 -65.0 -40.89 95.62 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.509 1.13 . . . . 0.0 110.262 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.591 ' CG1' HD13 ' A' ' 330' ' ' LEU . 26.5 mt -65.16 -43.83 95.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.493 1.121 . . . . 0.0 109.303 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 244' ' ' LEU . 75.7 t -69.51 -30.99 47.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.504 1.128 . . . . 0.0 109.277 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -76.87 -19.6 57.27 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.55 1.156 . . . . 0.0 110.324 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.611 ' HB1' ' OD2' ' A' ' 326' ' ' ASP . . . -93.82 -14.84 25.71 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.539 1.149 . . . . 0.0 109.302 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.464 HD22 ' HB2' ' A' ' 320' ' ' LEU . 0.2 OUTLIER -66.12 146.35 54.76 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.541 1.151 . . . . 0.0 109.293 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 320' ' ' LEU . 1.0 OUTLIER -117.82 117.96 30.73 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.555 1.159 . . . . 0.0 110.288 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.737 ' HB2' HD23 ' A' ' 320' ' ' LEU . . . -80.79 125.03 29.56 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.436 1.085 . . . . 0.0 109.289 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -132.56 143.89 50.02 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.491 1.119 . . . . 0.0 110.275 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 20.1 m -96.64 125.93 41.45 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 0.0 110.413 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.792 HG21 HD11 ' A' ' 319' ' ' LEU . 93.4 t -106.39 116.14 59.7 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.537 1.148 . . . . 0.0 109.345 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.483 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.9 162.12 37.86 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.513 1.796 . . . . 0.0 111.026 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.502 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -63.71 125.19 23.52 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.475 1.109 . . . . 0.0 109.317 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 100.7 -25.27 28.96 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.489 1.118 . . . . 0.0 110.988 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.483 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -64.02 139.15 58.74 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.459 0.74 . . . . 0.0 109.295 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 311' ' ' VAL . 2.7 p -93.25 135.64 27.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.466 1.104 . . . . 0.0 109.282 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.785 HD12 HG12 ' A' ' 311' ' ' VAL . 11.2 mt -82.49 -49.35 17.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.531 1.144 . . . . 0.0 109.284 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' CYS . . . . . 0.655 ' SG ' HG23 ' A' ' 311' ' ' VAL . 12.4 p -141.7 162.43 35.5 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.531 1.144 . . . . 0.0 108.255 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -103.93 -179.01 3.83 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.449 1.093 . . . . 0.0 110.28 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.32 137.41 22.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 0.0 109.299 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 47.01 48.91 18.87 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.504 1.128 . . . . 0.0 111.028 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.416 ' OE1' ' C ' ' A' ' 268' ' ' PRO . 0.0 OUTLIER -71.26 162.6 71.71 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.455 0.738 . . . . 0.0 110.333 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 269' ' ' GLY . 18.5 Cg_endo -74.98 78.07 2.98 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.521 1.801 . . . . 0.0 111.041 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 269' ' ' GLY . . . . . 0.464 ' O ' ' CA ' ' A' ' 304' ' ' GLY . . . -35.23 102.73 0.01 OUTLIER Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.527 1.142 . . . . 0.0 110.973 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -170.33 38.31 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 0.765 . . . . 0.0 109.293 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.45 144.86 2.01 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.131 . . . . 0.0 110.293 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 272' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.97 146.56 37.62 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.511 1.132 . . . . 0.0 111.057 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.562 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 20.1 m-85 -137.55 136.78 37.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.486 1.117 . . . . 0.0 111.021 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 274' ' ' PHE . . . . . 0.484 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 21.4 m-85 -127.25 135.95 51.32 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.537 1.148 . . . . 0.0 111.005 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.531 HG12 ' HA ' ' A' ' 292' ' ' PRO . 25.4 t -93.57 138.65 19.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.46 1.1 . . . . 0.0 109.305 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.527 HG11 ' OD2' ' A' ' 222' ' ' ASP . 2.7 t -115.99 -48.49 4.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.469 1.106 . . . . 0.0 109.274 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -140.2 132.99 29.07 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.528 1.143 . . . . 0.0 110.304 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.933 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 118.34 -173.35 14.83 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.531 1.144 . . . . 0.0 110.997 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 279' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 290' ' ' LEU . 8.4 t -134.73 122.29 21.95 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.52 0.776 . . . . 0.0 110.012 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.456 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 26.1 m -100.08 163.86 2.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.492 1.12 . . . . 0.0 109.302 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 31.1 t -129.24 152.51 48.74 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 0.0 109.993 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 1.5 t -115.96 128.87 73.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.467 1.105 . . . . 0.0 109.3 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.619 ' HB3' ' H ' ' A' ' 310' ' ' THR . . . -78.43 101.66 7.4 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.48 1.113 . . . . 0.0 109.319 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 284' ' ' THR . . . . . 0.664 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.9 OUTLIER -148.54 -167.96 0.17 Allowed Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.485 1.116 . . . . 0.0 110.366 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.664 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.5 Cg_endo -74.96 4.77 4.42 Favored 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.524 1.802 . . . . 0.0 111.057 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.444 ' O ' HG23 ' A' ' 288' ' ' VAL . 17.4 m120 -152.0 155.25 33.45 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.477 1.11 . . . . 0.0 109.31 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 96.52 1.02 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.545 1.813 . . . . 0.0 111.032 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 286' ' ' ASN . 2.1 t -101.52 119.54 49.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.536 1.148 . . . . 0.0 109.281 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 14.3 mt-10 -124.29 136.09 53.87 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.484 1.115 . . . . 0.0 110.321 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.456 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 3.8 mm? -115.44 141.77 47.6 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.483 1.115 . . . . 0.0 109.341 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -94.11 -160.21 34.51 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.505 1.128 . . . . 0.0 110.982 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' PRO . . . . . 0.531 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.2 Cg_endo -75.01 148.27 35.01 Favored 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.513 1.796 . . . . 0.0 111.009 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.637 ' HA2' HD21 ' A' ' 229' ' ' LEU . . . 86.46 -0.62 87.06 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.499 1.125 . . . . 0.0 110.984 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -83.49 123.43 29.71 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.478 0.752 . . . . 0.0 109.279 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.481 ' HD2' HD23 ' A' ' 229' ' ' LEU . 3.8 p90 -114.82 152.92 31.33 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.482 1.114 . . . . 0.0 111.006 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.562 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 37.5 p90 -160.57 147.99 15.91 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.518 1.136 . . . . 0.0 111.046 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 134.72 -8.35 4.56 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.548 1.155 . . . . 0.0 111.007 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -52.58 -41.9 64.02 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.458 0.74 . . . . 0.0 110.284 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' MET . . . . . 0.466 ' HB3' ' CG ' ' A' ' 305' ' ' GLU . 0.1 OUTLIER -54.92 -41.08 70.54 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.494 1.121 . . . . 0.0 111.006 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 300' ' ' ALA . . . . . 0.434 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -66.92 -35.7 80.6 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.509 1.131 . . . . 0.0 109.258 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.45 ' O ' ' CZ ' ' A' ' 341' ' ' PHE . 6.5 mt -75.01 -20.31 59.68 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.511 1.132 . . . . 0.0 109.261 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 3.3 mm -73.06 -54.97 14.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.129 . . . . 0.0 109.329 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.85 40.39 0.23 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.456 1.098 . . . . 0.0 110.015 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.464 ' CA ' ' O ' ' A' ' 269' ' ' GLY . . . 39.6 40.65 1.52 Allowed Glycine 0 CA--C 1.531 1.052 0 O-C-N 124.497 1.123 . . . . 0.0 110.989 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 305' ' ' GLU . . . . . 0.466 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 0.0 OUTLIER -66.11 158.65 75.67 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.509 0.77 . . . . 0.0 110.292 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.403 ' O ' ' OE2' ' A' ' 305' ' ' GLU . 18.5 Cg_endo -74.95 130.69 13.56 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.528 1.804 . . . . 0.0 111.02 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.9 -40.89 14.95 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.516 1.135 . . . . 0.0 110.318 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.555 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 0.5 OUTLIER 68.19 34.43 3.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.493 1.121 . . . . 0.0 110.044 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 309' ' ' ALA . . . . . 0.555 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 172.78 161.98 0.12 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.521 1.138 . . . . 0.0 109.282 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.619 ' H ' ' HB3' ' A' ' 283' ' ' ALA . 0.5 OUTLIER -107.71 130.99 54.89 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.538 1.149 . . . . 0.0 110.416 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.785 HG12 HD12 ' A' ' 262' ' ' ILE . 41.6 t -109.75 131.48 60.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.472 1.108 . . . . 0.0 109.343 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 3.2 p -139.2 152.33 47.28 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.11 . . . . 0.0 109.993 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.94 117.17 26.61 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.474 1.109 . . . . 0.0 109.297 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -59.62 -31.48 69.53 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.547 1.154 . . . . 0.0 109.317 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 315' ' ' THR . . . . . 0.739 ' O ' HG23 ' A' ' 317' ' ' VAL . 8.1 t -154.59 -175.36 5.37 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.472 1.108 . . . . 0.0 110.405 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 316' ' ' THR . . . . . 0.401 ' H ' HG23 ' A' ' 316' ' ' THR . 65.1 p -49.73 92.81 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.514 1.134 . . . . 0.0 110.392 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.933 HG22 ' HA3' ' A' ' 278' ' ' GLY . 75.8 t -110.23 152.07 12.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.498 1.124 . . . . 0.0 109.31 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 70.3 m -123.96 117.42 24.73 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.548 1.155 . . . . 0.0 109.988 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' LEU . . . . . 0.792 HD11 HG21 ' A' ' 256' ' ' VAL . 0.2 OUTLIER -134.06 169.38 17.22 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.481 1.113 . . . . 0.0 109.293 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.737 HD23 ' HB2' ' A' ' 253' ' ' ALA . 0.0 OUTLIER -124.35 139.05 54.27 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.473 1.108 . . . . 0.0 109.314 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 3.2 p -95.04 158.17 15.58 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.534 1.146 . . . . 0.0 110.002 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.46 ' O ' HD13 ' A' ' 322' ' ' LEU . 1.5 tm? -151.0 77.69 1.28 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.471 1.107 . . . . 0.0 109.305 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -42.54 141.46 1.01 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.416 1.072 . . . . 0.0 109.577 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -24.82 63.57 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.447 1.092 . . . . 0.0 109.963 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -52.21 -35.87 50.53 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.521 1.138 . . . . 0.0 109.292 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 326' ' ' ASP . . . . . 0.611 ' OD2' ' HB1' ' A' ' 250' ' ' ALA . 0.4 OUTLIER -71.6 -37.33 70.97 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.542 1.151 . . . . 0.0 109.329 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 327' ' ' PHE . . . . . 0.417 ' CE2' ' CE2' ' A' ' 341' ' ' PHE . 38.4 t80 -66.51 -41.18 89.23 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.484 1.115 . . . . 0.0 111.031 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -71.29 -31.52 67.55 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.503 1.127 . . . . 0.0 110.297 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.403 ' SD ' ' C ' ' A' ' 329' ' ' MET . 15.6 tmm? -68.54 -43.74 76.03 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.548 1.155 . . . . 0.0 111.014 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.591 HD13 ' CG1' ' A' ' 247' ' ' ILE . 5.0 mt -71.39 -37.78 71.53 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.521 1.138 . . . . 0.0 109.265 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 331' ' ' CYS . . . . . 0.422 ' SG ' HG22 ' A' ' 337' ' ' ILE . 73.6 m -65.88 -41.68 91.25 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.531 1.144 . . . . 0.0 108.29 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.4 t -77.55 -24.42 49.86 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.471 1.107 . . . . 0.0 110.01 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 47.6 t -72.21 -39.02 68.87 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.533 1.145 . . . . 0.0 110.034 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 334' ' ' SER . . . . . 0.706 ' CB ' HD12 ' A' ' 337' ' ' ILE . 0.1 OUTLIER -129.03 133.83 25.64 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.482 1.114 . . . . 0.0 109.978 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 335' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 334' ' ' SER . 18.4 Cg_endo -74.98 -23.75 13.53 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.54 1.81 . . . . 0.0 110.974 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -72.26 -29.32 63.79 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.5 1.125 . . . . 0.0 110.328 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.706 HD12 ' CB ' ' A' ' 334' ' ' SER . 30.9 mt -72.98 -42.71 59.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.483 1.114 . . . . 0.0 109.281 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.74 -30.72 67.32 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.55 1.157 . . . . 0.0 109.297 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -73.61 -43.76 58.79 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.564 1.165 . . . . 0.0 110.36 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 76.1 mt -70.76 -39.42 75.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.513 1.133 . . . . 0.0 109.298 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.491 ' CD1' ' C ' ' A' ' 341' ' ' PHE . 0.5 OUTLIER -66.95 -41.46 86.91 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.488 1.118 . . . . 0.0 111.005 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 -70.48 -33.41 71.22 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.504 1.128 . . . . 0.0 110.303 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -50.54 66.53 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.504 1.127 . . . . 0.0 109.323 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.455 HG22 ' O ' ' A' ' 341' ' ' PHE . 6.0 t -65.11 -39.12 92.68 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.541 1.151 . . . . 0.0 110.433 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -66.77 -33.78 76.37 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.471 1.107 . . . . 0.0 109.282 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.504 ' HA ' HD23 ' A' ' 346' ' ' LEU . 10.2 mt -71.83 -36.9 70.34 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.514 1.134 . . . . 0.0 109.314 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -76.26 -30.8 57.98 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.535 1.147 . . . . 0.0 110.3 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 7.0 mtt-85 -72.05 -41.12 67.83 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.472 1.107 . . . . 0.0 110.335 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.81 -34.86 67.14 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.519 1.137 . . . . 0.0 110.272 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -38.58 -48.87 2.38 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.515 1.135 . . . . 0.0 110.976 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -154.92 121.97 5.53 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.514 0.773 . . . . 0.0 109.246 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -64.68 175.95 1.29 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.484 1.115 . . . . 0.0 109.29 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -143.1 120.03 11.31 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.502 1.126 . . . . 0.0 109.347 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 3.6 m -155.0 170.2 22.31 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.526 1.141 . . . . 0.0 109.985 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.45 1.094 . . . . 0.0 109.334 179.982 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.988 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.66 172.72 6.67 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.534 0.785 . . . . 0.0 110.013 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.89 168.74 11.81 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.495 1.122 . . . . 0.0 110.291 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -128.78 155.63 44.83 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.547 1.155 . . . . 0.0 110.303 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 14.7 p -151.77 145.72 15.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.477 1.111 . . . . 0.0 109.293 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.35 158.45 41.54 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.483 1.114 . . . . 0.0 110.31 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -121.98 159.4 27.04 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.563 1.164 . . . . 0.0 110.278 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -96.6 -37.81 4.65 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.552 1.157 . . . . 0.0 111.045 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 226' ' ' ASN . 41.2 p30 -91.59 18.44 7.43 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.542 0.79 . . . . 0.0 109.293 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -53.58 -40.87 65.99 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.521 1.138 . . . . 0.0 110.98 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.65 -39.45 60.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.467 1.104 . . . . 0.0 109.321 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.654 ' HG2' HG13 ' A' ' 276' ' ' VAL . 0.1 OUTLIER -69.21 -29.78 67.81 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.493 1.121 . . . . 0.0 110.322 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.448 ' CG ' HG23 ' A' ' 248' ' ' VAL . 39.6 t-20 -78.12 -32.66 50.55 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.452 1.095 . . . . 0.0 109.299 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' TRP . . . . . 0.726 ' CH2' HG23 ' A' ' 245' ' ' VAL . 2.8 t90 -73.99 -42.94 59.66 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.519 1.137 . . . . 0.0 108.026 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.411 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 6.8 pt20 -70.38 -28.79 65.37 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.505 1.128 . . . . 0.0 110.314 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.623 HD12 ' HG3' ' A' ' 225' ' ' ARG . 3.3 mt -69.14 -54.96 12.21 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.515 1.134 . . . . 0.0 109.316 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.608 HG21 ' HB ' ' A' ' 248' ' ' VAL . 33.0 m -65.02 -32.04 56.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.497 1.123 . . . . 0.0 109.323 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -76.13 -24.63 54.91 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.111 . . . . 0.0 109.271 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -80.54 1.21 30.49 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.488 1.117 . . . . 0.0 109.289 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 229' ' ' LEU . 96.7 t -92.07 118.75 68.34 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.518 1.136 . . . . 0.0 109.311 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.417 ' HA ' ' HB2' ' A' ' 237' ' ' GLN . 18.2 Cg_endo -75.0 -21.96 15.3 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.536 1.808 . . . . 0.0 110.989 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.98 -30.56 71.63 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.496 1.123 . . . . 0.0 109.325 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.861 ' HB3' HD12 ' A' ' 239' ' ' LEU . 24.4 m-85 -112.42 20.31 16.81 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.482 1.114 . . . . 0.0 110.985 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' GLN . . . . . 0.417 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 1.0 OUTLIER -68.12 -18.57 64.67 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.485 1.116 . . . . 0.0 110.316 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -86.99 -14.16 42.46 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.465 1.103 . . . . 0.0 109.322 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.861 HD12 ' HB3' ' A' ' 236' ' ' PHE . 55.6 mt -68.5 176.29 2.97 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.507 1.129 . . . . 0.0 109.277 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' GLY . . . . . 0.604 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -109.63 -171.97 20.53 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.445 1.09 . . . . 0.0 110.974 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -32.39 5.43 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.463 1.77 . . . . 0.0 111.004 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.522 ' HA ' HG12 ' A' ' 245' ' ' VAL . . . -72.9 -32.92 65.69 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.48 1.112 . . . . 0.0 109.309 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.827 ' CG1' HD13 ' A' ' 239' ' ' LEU . 54.5 t -76.82 -38.64 29.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.491 1.119 . . . . 0.0 109.295 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.604 HD23 ' O ' ' A' ' 240' ' ' GLY . 2.9 mm? -71.0 -44.41 65.95 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.521 1.138 . . . . 0.0 109.239 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.726 HG23 ' CH2' ' A' ' 227' ' ' TRP . 3.0 p -66.27 -39.77 85.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.448 1.093 . . . . 0.0 109.271 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -69.87 -40.29 75.8 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.543 1.152 . . . . 0.0 110.319 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.75 ' O ' HD13 ' A' ' 251' ' ' LEU . 46.0 mt -65.63 -55.16 21.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.497 1.123 . . . . 0.0 109.271 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.608 ' HB ' HG21 ' A' ' 230' ' ' VAL . 4.2 p -60.81 -30.63 47.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.54 1.15 . . . . 0.0 109.363 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.517 ' CG ' ' O ' ' A' ' 245' ' ' VAL . 14.3 mmt180 -79.21 -16.84 55.93 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.527 1.142 . . . . 0.0 110.287 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -95.56 -16.05 22.41 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.513 1.133 . . . . 0.0 109.286 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 1.019 HD12 HD23 ' A' ' 322' ' ' LEU . 7.9 mp -65.28 151.76 45.4 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.563 1.164 . . . . 0.0 109.316 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 6.0 tpt85 -121.12 116.18 24.5 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.496 1.123 . . . . 0.0 110.283 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.693 ' HB2' HD23 ' A' ' 320' ' ' LEU . . . -80.59 122.73 27.42 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.493 1.12 . . . . 0.0 109.266 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.45 141.07 52.26 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.48 1.112 . . . . 0.0 110.297 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.2 m -91.51 118.24 30.41 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.494 1.121 . . . . 0.0 110.349 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.664 ' CG1' ' HB2' ' A' ' 313' ' ' ALA . 4.0 t -106.36 114.19 62.47 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.536 1.148 . . . . 0.0 109.329 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.505 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.93 171.64 17.9 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.493 1.786 . . . . 0.0 110.978 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.519 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -67.73 129.13 38.95 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.535 1.147 . . . . 0.0 109.316 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 96.07 -25.55 24.95 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.55 1.156 . . . . 0.0 110.994 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.533 ' HB3' HG13 ' A' ' 256' ' ' VAL . . . -58.95 138.3 57.51 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.516 0.774 . . . . 0.0 109.262 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 9.3 t -83.34 126.65 40.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.496 1.123 . . . . 0.0 109.334 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.61 HD12 HG12 ' A' ' 311' ' ' VAL . 94.9 mt -82.92 -45.49 19.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.476 1.11 . . . . 0.0 109.307 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 263' ' ' CYS . . . . . 0.609 ' SG ' HG23 ' A' ' 311' ' ' VAL . 7.9 p -152.72 143.87 23.13 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.493 1.12 . . . . 0.0 108.321 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -86.81 176.67 7.6 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.513 1.133 . . . . 0.0 110.281 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.444 HG23 ' OG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -78.25 148.56 6.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.492 1.12 . . . . 0.0 109.286 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 37.08 47.44 1.36 Allowed Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.469 1.106 . . . . 0.0 110.981 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.445 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.0 OUTLIER -70.25 165.21 46.19 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.516 0.774 . . . . 0.0 110.3 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 267' ' ' GLU . 18.2 Cg_endo -75.06 76.39 3.44 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.525 1.803 . . . . 0.0 110.983 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 269' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 268' ' ' PRO . . . -36.71 105.95 0.04 OUTLIER Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.576 1.173 . . . . 0.0 110.994 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -170.51 37.37 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.481 0.754 . . . . 0.0 109.29 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -172.31 156.83 3.94 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.476 1.11 . . . . 0.0 110.301 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 272' ' ' MET . . . . . 0.686 ' HG3' HD12 ' A' ' 301' ' ' LEU . 0.0 OUTLIER -122.6 146.47 47.41 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.467 1.105 . . . . 0.0 111.022 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.591 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 13.6 m-85 -133.21 143.37 49.11 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.471 1.107 . . . . 0.0 111.033 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -133.15 125.2 28.95 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.515 1.134 . . . . 0.0 110.987 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.547 HG22 HD12 ' A' ' 319' ' ' LEU . 56.4 t -78.22 129.32 37.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.431 1.082 . . . . 0.0 109.319 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.838 ' CG2' HD11 ' A' ' 320' ' ' LEU . 59.3 t -101.55 -54.05 7.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.506 1.129 . . . . 0.0 109.323 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.714 ' O ' HG23 ' A' ' 317' ' ' VAL . 15.6 mt-10 -141.83 140.71 33.02 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.542 1.151 . . . . 0.0 110.274 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 113.15 -155.87 16.01 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.526 1.142 . . . . 0.0 111.01 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 290' ' ' LEU . 1.8 m -145.96 139.36 26.13 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.487 0.757 . . . . 0.0 110.001 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.579 HG12 HD11 ' A' ' 262' ' ' ILE . 27.1 m -120.76 135.57 60.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.555 1.159 . . . . 0.0 109.266 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 29.9 t -104.27 139.77 38.81 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.429 1.08 . . . . 0.0 109.968 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 1.3 t -103.88 129.66 55.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.471 1.107 . . . . 0.0 109.322 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.413 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -78.05 101.36 6.92 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.543 1.152 . . . . 0.0 109.358 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 284' ' ' THR . . . . . 0.662 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -149.0 -168.0 0.17 Allowed Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.5 1.125 . . . . 0.0 110.427 -179.974 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.662 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -75.01 4.43 4.75 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.502 1.79 . . . . 0.0 111.007 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -152.27 154.59 32.37 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.529 1.143 . . . . 0.0 109.309 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 95.12 0.96 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.46 1.769 . . . . 0.0 110.983 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 281' ' ' SER . 19.3 t -100.15 118.39 46.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.56 1.163 . . . . 0.0 109.331 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.407 ' C ' HD22 ' A' ' 290' ' ' LEU . 3.4 mm-40 -125.38 133.74 52.42 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.489 1.118 . . . . 0.0 110.324 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.407 HD22 ' C ' ' A' ' 289' ' ' GLU . 4.6 mm? -114.51 139.71 49.34 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.52 1.138 . . . . 0.0 109.289 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -93.72 -157.43 33.17 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.564 1.165 . . . . 0.0 111.007 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 147.86 34.49 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.509 1.794 . . . . 0.0 111.005 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 85.95 5.85 83.02 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.532 1.145 . . . . 0.0 111.034 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -85.61 146.27 26.95 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.539 0.788 . . . . 0.0 109.332 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 295' ' ' PHE . 1.0 OUTLIER -132.95 152.81 51.87 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.549 1.156 . . . . 0.0 110.99 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.591 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 46.3 p90 -165.77 143.88 5.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.553 1.158 . . . . 0.0 110.958 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 129.59 -6.73 6.22 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.48 1.113 . . . . 0.0 110.994 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -52.09 -48.43 64.71 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.503 0.767 . . . . 0.0 110.275 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' MET . . . . . 0.442 ' HB3' ' CG ' ' A' ' 305' ' ' GLU . 0.0 OUTLIER -50.21 -37.45 35.28 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.502 1.126 . . . . 0.0 111.047 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 300' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -66.13 -40.34 90.58 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.466 1.104 . . . . 0.0 109.298 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.686 HD12 ' HG3' ' A' ' 272' ' ' MET . 27.7 mt -74.84 -21.64 59.15 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 0.0 109.306 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 15.0 mm -67.16 -57.64 9.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.458 1.099 . . . . 0.0 109.303 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 304' ' ' GLY . 7.4 m -155.96 44.85 0.44 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.532 1.145 . . . . 0.0 109.98 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 35.69 49.9 1.04 Allowed Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.531 1.144 . . . . 0.0 111.041 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 305' ' ' GLU . . . . . 0.442 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 0.0 OUTLIER -80.26 158.8 71.45 Favored Pre-proline 0 C--N 1.326 -0.443 0 O-C-N 124.497 0.763 . . . . 0.0 110.271 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.01 130.25 13.09 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.525 1.802 . . . . 0.0 111.032 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -47.07 -39.34 12.82 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.5 1.125 . . . . 0.0 110.275 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.503 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 15.0 m 67.77 30.34 6.4 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.478 1.111 . . . . 0.0 109.995 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 309' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 175.67 162.26 0.3 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.532 1.145 . . . . 0.0 109.299 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.444 ' OG1' HG23 ' A' ' 265' ' ' ILE . 0.9 OUTLIER -113.04 137.6 51.17 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.515 1.135 . . . . 0.0 110.398 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.61 HG12 HD12 ' A' ' 262' ' ' ILE . 95.1 t -109.43 127.62 66.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.504 1.128 . . . . 0.0 109.318 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 48.3 p -121.94 145.28 48.26 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.501 1.126 . . . . 0.0 110.026 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 313' ' ' ALA . . . . . 0.758 ' HB1' HG12 ' A' ' 317' ' ' VAL . . . -79.53 106.23 11.41 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.536 1.148 . . . . 0.0 109.28 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -52.99 -24.64 9.89 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.473 1.108 . . . . 0.0 109.325 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 315' ' ' THR . . . . . 0.636 ' O ' HG12 ' A' ' 317' ' ' VAL . 8.8 t -168.09 -164.64 0.55 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.495 1.122 . . . . 0.0 110.38 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 316' ' ' THR . . . . . 0.438 ' N ' ' OG1' ' A' ' 315' ' ' THR . 29.2 p -61.35 79.11 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.508 1.13 . . . . 0.0 110.443 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.819 HG22 ' CD1' ' A' ' 319' ' ' LEU . 2.7 p -110.74 141.88 24.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.5 1.125 . . . . 0.0 109.277 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 318' ' ' SER . . . . . 1.019 ' C ' HD13 ' A' ' 319' ' ' LEU . 53.4 m -117.57 136.51 53.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.454 1.096 . . . . 0.0 109.949 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 319' ' ' LEU . . . . . 1.019 HD13 ' C ' ' A' ' 318' ' ' SER . 0.0 OUTLIER -135.86 173.77 11.35 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.479 1.112 . . . . 0.0 109.309 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.838 HD11 ' CG2' ' A' ' 276' ' ' VAL . 0.1 OUTLIER -124.22 125.19 44.0 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.528 1.143 . . . . 0.0 109.292 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 272' ' ' MET . 25.8 p -86.97 158.67 19.22 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.518 1.136 . . . . 0.0 110.036 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 1.019 HD23 HD12 ' A' ' 251' ' ' LEU . 3.1 tm? -145.44 86.71 1.76 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.491 1.119 . . . . 0.0 109.311 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 323' ' ' HIS . . . . . 0.536 ' CE1' ' OD1' ' A' ' 326' ' ' ASP . 6.0 p80 -50.7 137.31 20.26 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.535 1.147 . . . . 0.0 109.605 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.19 -26.11 62.39 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.473 1.108 . . . . 0.0 110.004 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -53.6 -36.76 62.31 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.459 1.1 . . . . 0.0 109.311 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 326' ' ' ASP . . . . . 0.536 ' OD1' ' CE1' ' A' ' 323' ' ' HIS . 0.6 OUTLIER -64.99 -41.45 95.4 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.485 1.116 . . . . 0.0 109.317 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 327' ' ' PHE . . . . . 0.49 ' CE1' ' CE2' ' A' ' 341' ' ' PHE . 71.9 t80 -66.84 -34.96 78.95 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.439 1.087 . . . . 0.0 110.965 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -69.86 -33.99 73.0 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.482 1.113 . . . . 0.0 110.288 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 30.4 ttp -70.19 -43.88 69.84 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.441 1.088 . . . . 0.0 111.014 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 2.7 mt -71.66 -35.38 70.31 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.505 1.128 . . . . 0.0 109.286 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 41.6 m -72.31 -30.63 64.95 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.52 1.137 . . . . 0.0 108.278 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 33.0 t -75.78 -34.49 60.23 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.518 1.136 . . . . 0.0 110.021 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.48 -36.3 65.79 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.528 1.142 . . . . 0.0 109.97 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.5 114.32 27.25 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 0.0 109.975 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -22.51 14.81 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.448 1.762 . . . . 0.0 111.007 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -71.91 -29.34 64.21 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.562 1.164 . . . . 0.0 110.286 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.671 HD11 HG21 ' A' ' 243' ' ' VAL . 44.5 mt -71.95 -40.14 67.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.134 . . . . 0.0 109.26 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.55 -31.84 65.59 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 0.0 109.278 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -74.95 -42.15 58.2 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.562 1.164 . . . . 0.0 110.288 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 86.3 mt -70.96 -42.81 77.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.486 1.116 . . . . 0.0 109.287 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.49 ' CE2' ' CE1' ' A' ' 327' ' ' PHE . 24.8 t80 -67.46 -39.61 85.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.521 1.138 . . . . 0.0 111.039 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -68.12 -37.32 80.99 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.526 1.141 . . . . 0.0 110.303 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -44.09 84.16 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.52 1.137 . . . . 0.0 109.281 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 341' ' ' PHE . 0.6 OUTLIER -67.99 -32.62 73.15 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.465 1.103 . . . . 0.0 110.377 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -69.91 -41.15 75.07 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.45 1.094 . . . . 0.0 109.333 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' A' ' 346' ' ' LEU . 14.5 mt -65.2 -41.42 94.55 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 0.0 109.283 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -65.81 -37.64 86.81 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.112 . . . . 0.0 110.3 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 28.3 mtt-85 -72.76 -44.72 61.26 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.512 1.133 . . . . 0.0 110.325 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -34.77 77.56 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.515 1.134 . . . . 0.0 110.302 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -37.52 -46.22 1.48 Allowed Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.53 1.144 . . . . 0.0 111.046 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -155.01 120.03 4.9 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.575 0.809 . . . . 0.0 109.3 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -60.61 172.24 0.95 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.501 1.125 . . . . 0.0 109.313 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -130.13 125.15 34.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.503 1.127 . . . . 0.0 109.317 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 29.7 p -129.65 154.76 46.8 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.496 1.123 . . . . 0.0 110.01 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.499 0 O-C-N 124.521 1.138 . . . . 0.0 109.278 -179.982 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.986 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 13.1 m -139.5 167.72 21.45 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.44 0.729 . . . . 0.0 110.025 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.72 170.9 12.74 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.529 1.143 . . . . 0.0 110.314 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -121.86 162.71 20.48 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.502 1.126 . . . . 0.0 110.301 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 76.0 t -145.65 150.22 15.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.555 1.159 . . . . 0.0 109.3 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -68.1 174.52 3.79 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.528 1.142 . . . . 0.0 110.299 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 10.9 mtt180 -140.9 157.45 45.35 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.456 1.097 . . . . 0.0 110.233 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -111.08 -33.15 2.42 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.478 1.111 . . . . 0.0 110.985 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 41.8 p30 -94.68 19.62 9.71 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.519 0.776 . . . . 0.0 109.293 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.4 ' CE1' HG11 ' A' ' 248' ' ' VAL . 1.6 t80 -56.36 -38.63 71.69 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.499 1.124 . . . . 0.0 111.024 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.57 -35.44 56.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.466 1.104 . . . . 0.0 109.276 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.767 ' O ' HD23 ' A' ' 229' ' ' LEU . 0.5 OUTLIER -70.72 -31.56 68.44 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.478 1.111 . . . . 0.0 110.311 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.455 ' ND2' ' CD1' ' A' ' 320' ' ' LEU . 4.1 m-20 -81.23 -31.57 33.77 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.532 1.145 . . . . 0.0 109.276 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' TRP . . . . . 0.89 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 2.0 t90 -70.61 -43.75 68.67 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.455 ' O ' ' N ' ' A' ' 232' ' ' ALA . 1.5 pt20 -70.89 -37.28 73.0 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.494 1.121 . . . . 0.0 110.278 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.909 HD12 ' HB3' ' A' ' 274' ' ' PHE . 1.6 mm? -60.18 -42.75 95.69 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.51 1.131 . . . . 0.0 109.314 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.688 HG13 ' CD1' ' A' ' 244' ' ' LEU . 12.7 p -74.23 -38.74 48.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.515 1.135 . . . . 0.0 109.284 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -75.15 -11.51 60.1 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.472 1.107 . . . . 0.0 109.33 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 228' ' ' GLN . . . -81.15 -7.83 59.64 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.496 1.123 . . . . 0.0 109.297 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 1.5 t -98.64 130.06 28.74 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.522 1.139 . . . . 0.0 109.298 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 -16.0 20.33 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.472 1.775 . . . . 0.0 110.971 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.677 HD12 ' CE2' ' A' ' 341' ' ' PHE . 0.0 OUTLIER -81.08 -23.84 38.18 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.519 1.137 . . . . 0.0 109.314 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.719 ' CE1' HD13 ' A' ' 247' ' ' ILE . 30.7 m-85 -102.95 -19.22 14.69 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.454 1.096 . . . . 0.0 111.018 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.51 -22.91 67.1 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.463 1.102 . . . . 0.0 110.28 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -76.77 -1.59 28.85 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.502 1.126 . . . . 0.0 109.294 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.586 ' HB3' HG11 ' A' ' 243' ' ' VAL . 8.4 mt -94.38 -179.78 5.03 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.437 1.086 . . . . 0.0 109.278 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -98.45 -174.42 32.61 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.518 1.136 . . . . 0.0 110.969 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.9 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.4 Cg_endo -75.01 -35.48 3.1 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.451 1.764 . . . . 0.0 110.97 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.1 -33.37 75.32 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.461 1.101 . . . . 0.0 109.299 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.795 HG21 HD11 ' A' ' 337' ' ' ILE . 2.7 t -75.18 -42.4 44.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.535 1.147 . . . . 0.0 109.327 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.688 ' CD1' HG13 ' A' ' 230' ' ' VAL . 0.3 OUTLIER -65.63 -36.82 84.8 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.524 1.14 . . . . 0.0 109.289 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 241' ' ' PRO . 87.8 t -69.15 -43.18 81.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.449 1.093 . . . . 0.0 109.278 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -44.17 91.68 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 0.0 110.312 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.719 HD13 ' CE1' ' A' ' 236' ' ' PHE . 90.0 mt -65.6 -37.16 79.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.495 1.122 . . . . 0.0 109.3 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 244' ' ' LEU . 14.4 t -67.54 -34.97 71.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.506 1.128 . . . . 0.0 109.31 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -24.84 59.92 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.49 1.118 . . . . 0.0 110.274 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.472 ' CB ' ' OD1' ' A' ' 326' ' ' ASP . . . -87.22 -21.59 25.75 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.477 1.111 . . . . 0.0 109.291 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.471 HD22 ' HB2' ' A' ' 320' ' ' LEU . 3.0 mt -55.9 136.48 51.56 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.484 1.115 . . . . 0.0 109.283 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.42 134.76 55.06 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.494 1.121 . . . . 0.0 110.265 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.554 ' HA ' HD22 ' A' ' 320' ' ' LEU . . . -80.15 129.6 34.62 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.525 1.141 . . . . 0.0 109.323 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 319' ' ' LEU . 6.7 ttm-85 -133.62 121.28 21.8 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.513 1.133 . . . . 0.0 110.333 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 20.0 m -91.79 116.57 29.0 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.532 1.145 . . . . 0.0 110.436 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.689 HG21 HD11 ' A' ' 319' ' ' LEU . 97.3 t -106.68 113.14 63.22 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.473 1.108 . . . . 0.0 109.263 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.51 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -75.0 171.45 18.31 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.5 1.789 . . . . 0.0 111.04 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.519 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -67.33 128.58 36.93 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.465 1.103 . . . . 0.0 109.325 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 96.85 -25.11 28.11 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.489 1.118 . . . . 0.0 110.992 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.51 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -60.64 149.14 36.04 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.532 0.784 . . . . 0.0 109.306 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.3 t -97.28 131.61 43.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 124.494 1.121 . . . . 0.0 109.331 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.768 HD12 HG12 ' A' ' 311' ' ' VAL . 45.8 mt -83.41 -41.65 17.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.468 1.105 . . . . 0.0 109.309 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' CYS . . . . . 0.423 ' SG ' HG23 ' A' ' 311' ' ' VAL . 14.9 p -158.34 151.09 22.35 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.452 1.095 . . . . 0.0 108.273 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -94.32 -178.81 4.71 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.472 1.108 . . . . 0.0 110.305 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.457 HG23 ' OG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -74.64 143.99 12.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.101 . . . . 0.0 109.321 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 41.47 53.95 4.13 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.537 1.148 . . . . 0.0 110.987 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.409 ' OE1' ' C ' ' A' ' 268' ' ' PRO . 0.3 OUTLIER -70.61 163.5 63.13 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.498 0.764 . . . . 0.0 110.295 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.452 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.1 Cg_endo -75.01 81.43 2.22 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.476 1.777 . . . . 0.0 110.965 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -36.65 95.76 0.01 OUTLIER Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.559 1.162 . . . . 0.0 111.037 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 268' ' ' PRO . 6.8 m-20 -170.83 38.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.519 0.776 . . . . 0.0 109.305 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.411 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 0.0 OUTLIER -170.01 144.62 2.74 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.508 1.13 . . . . 0.0 110.233 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 272' ' ' MET . . . . . 0.593 ' SD ' ' CZ ' ' A' ' 274' ' ' PHE . 0.0 OUTLIER -114.4 147.38 39.29 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.126 . . . . 0.0 111.003 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.583 ' HD2' HD13 ' A' ' 319' ' ' LEU . 50.3 m-85 -135.91 137.64 41.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.452 1.095 . . . . 0.0 111.026 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 274' ' ' PHE . . . . . 0.909 ' HB3' HD12 ' A' ' 229' ' ' LEU . 17.8 m-85 -129.11 130.29 46.27 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.548 1.155 . . . . 0.0 111.014 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 292' ' ' PRO . 29.1 t -86.28 130.48 36.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.488 1.117 . . . . 0.0 109.33 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.636 HG13 ' HD2' ' A' ' 225' ' ' ARG . 2.6 t -110.87 -44.39 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.479 1.112 . . . . 0.0 109.274 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.406 ' O ' HG13 ' A' ' 317' ' ' VAL . 2.9 mt-10 -145.85 132.79 20.2 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 0.0 110.299 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.902 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 117.06 -177.68 16.79 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.545 1.153 . . . . 0.0 111.003 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 279' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 290' ' ' LEU . 5.4 t -128.94 121.79 28.81 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.497 0.763 . . . . 0.0 110.014 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.464 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 24.1 m -99.87 161.18 3.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.474 1.109 . . . . 0.0 109.286 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 29.4 t -129.41 149.6 51.12 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.537 1.148 . . . . 0.0 110.006 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 1.4 t -112.45 131.44 63.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.493 1.121 . . . . 0.0 109.331 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.403 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -79.85 101.92 8.81 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.46 1.1 . . . . 0.0 109.268 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 284' ' ' THR . . . . . 0.654 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.41 -168.32 0.18 Allowed Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.508 1.13 . . . . 0.0 110.396 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.654 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.4 Cg_endo -75.0 4.8 4.42 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.491 1.785 . . . . 0.0 111.038 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -151.59 155.69 34.27 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.481 1.113 . . . . 0.0 109.286 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.07 95.85 1.0 Allowed 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.517 1.798 . . . . 0.0 111.029 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 281' ' ' SER . 6.0 t -100.42 119.3 48.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.455 1.097 . . . . 0.0 109.33 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.503 ' C ' HD22 ' A' ' 290' ' ' LEU . 15.1 mt-10 -124.9 141.68 51.96 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.493 1.121 . . . . 0.0 110.332 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.503 HD22 ' C ' ' A' ' 289' ' ' GLU . 4.4 mm? -120.69 142.5 49.43 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.546 1.154 . . . . 0.0 109.276 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -93.79 -163.43 36.34 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.529 1.143 . . . . 0.0 111.023 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' PRO . . . . . 0.537 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.4 Cg_endo -74.94 149.63 37.28 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.502 1.791 . . . . 0.0 110.995 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 86.95 -0.07 85.99 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.481 1.113 . . . . 0.0 110.974 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -79.65 146.21 32.6 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.488 0.757 . . . . 0.0 109.362 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -132.84 152.69 51.78 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.516 1.135 . . . . 0.0 111.012 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.552 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 40.7 p90 -166.57 147.65 6.23 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.496 1.123 . . . . 0.0 110.959 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' GLY . . . . . 0.467 ' CA ' ' HE3' ' A' ' 272' ' ' MET . . . 129.8 -10.38 6.03 Favored Glycine 0 CA--C 1.531 1.053 0 O-C-N 124.544 1.153 . . . . 0.0 110.995 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -52.57 -41.78 63.89 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.532 0.784 . . . . 0.0 110.316 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 299' ' ' MET . . . . . 0.583 ' HA ' HD12 ' A' ' 302' ' ' ILE . 0.8 OUTLIER -54.83 -37.28 65.97 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.503 1.127 . . . . 0.0 111.015 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 300' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -67.72 -39.21 84.31 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.496 1.123 . . . . 0.0 109.284 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.467 ' CD1' ' HG3' ' A' ' 272' ' ' MET . 5.7 mt -76.44 -13.67 60.1 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.503 1.127 . . . . 0.0 109.265 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 302' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' A' ' 299' ' ' MET . 32.2 mt -77.3 -54.5 12.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.514 1.134 . . . . 0.0 109.295 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.441 ' O ' ' N ' ' A' ' 305' ' ' GLU . 46.4 p -155.07 42.05 0.45 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.506 1.129 . . . . 0.0 109.986 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 37.07 31.56 0.06 OUTLIER Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.501 1.126 . . . . 0.0 110.998 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 305' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 303' ' ' SER . 0.1 OUTLIER -61.71 157.12 50.8 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.52 0.777 . . . . 0.0 110.322 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 128.99 11.91 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.51 1.795 . . . . 0.0 111.044 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 307' ' ' ARG . . . . . 0.423 HH11 ' HB2' ' A' ' 300' ' ' ALA . 0.0 OUTLIER -44.52 -40.29 5.53 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.506 1.129 . . . . 0.0 110.294 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.66 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 22.8 t 64.87 43.31 4.0 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.486 1.117 . . . . 0.0 110.02 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 309' ' ' ALA . . . . . 0.66 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 165.86 159.76 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.48 1.113 . . . . 0.0 109.291 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.457 ' OG1' HG23 ' A' ' 265' ' ' ILE . 1.0 OUTLIER -110.38 133.92 52.8 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.465 1.103 . . . . 0.0 110.416 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.768 HG12 HD12 ' A' ' 262' ' ' ILE . 55.3 t -113.06 129.39 68.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.525 1.14 . . . . 0.0 109.294 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 60.3 p -129.59 156.71 43.76 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.542 1.151 . . . . 0.0 110.02 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -92.53 115.57 28.22 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.515 1.135 . . . . 0.0 109.312 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -59.5 -32.65 70.48 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.481 1.113 . . . . 0.0 109.287 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 315' ' ' THR . . . . . 0.653 ' O ' HG23 ' A' ' 317' ' ' VAL . 11.0 t -154.6 -173.14 4.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.506 1.129 . . . . 0.0 110.385 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 316' ' ' THR . . . . . 0.413 HG23 ' H ' ' A' ' 316' ' ' THR . 65.4 p -52.2 88.54 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.503 1.127 . . . . 0.0 110.391 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.902 HG22 ' HA3' ' A' ' 278' ' ' GLY . 68.9 t -103.57 154.35 5.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 O-C-N 124.539 1.149 . . . . 0.0 109.308 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 49.1 m -129.07 113.89 15.69 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.482 1.114 . . . . 0.0 109.998 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' LEU . . . . . 1.03 ' C ' HD23 ' A' ' 320' ' ' LEU . 0.2 OUTLIER -129.0 170.44 13.46 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.136 . . . . 0.0 109.266 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 1.03 HD23 ' C ' ' A' ' 319' ' ' LEU . 0.6 OUTLIER -121.79 139.87 53.06 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.518 1.136 . . . . 0.0 109.327 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 64.8 p -95.6 158.79 15.3 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.122 . . . . 0.0 109.982 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.503 ' O ' HD13 ' A' ' 322' ' ' LEU . 3.3 tm? -148.64 82.36 1.46 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.496 1.122 . . . . 0.0 109.312 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 323' ' ' HIS . . . . . 0.572 ' ND1' ' HB3' ' A' ' 325' ' ' ALA . 8.5 p80 -47.63 136.99 9.7 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.504 1.127 . . . . 0.0 109.599 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.95 -20.93 6.89 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.504 1.128 . . . . 0.0 109.981 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 0.572 ' HB3' ' ND1' ' A' ' 323' ' ' HIS . . . -51.9 -38.24 55.48 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.522 1.139 . . . . 0.0 109.291 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 326' ' ' ASP . . . . . 0.472 ' OD1' ' CB ' ' A' ' 250' ' ' ALA . 36.0 t70 -63.94 -37.08 86.09 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.541 1.151 . . . . 0.0 109.257 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 327' ' ' PHE . . . . . 0.472 ' CZ ' ' CE2' ' A' ' 341' ' ' PHE . 6.1 t80 -66.96 -40.02 87.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.48 1.112 . . . . 0.0 110.96 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -66.0 -33.24 75.35 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.527 1.142 . . . . 0.0 110.301 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 50.9 ttp -70.91 -39.33 72.79 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.549 1.155 . . . . 0.0 111.004 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.683 HD11 HG13 ' A' ' 247' ' ' ILE . 0.1 OUTLIER -68.7 -39.23 80.58 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.487 1.117 . . . . 0.0 109.293 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 331' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 338' ' ' ALA . 19.8 t -70.97 -32.97 69.99 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.45 1.093 . . . . 0.0 108.268 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 19.1 t -72.87 -31.08 64.47 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.482 1.114 . . . . 0.0 110.039 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.9 t -83.3 -37.86 22.88 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.447 1.092 . . . . 0.0 110.022 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.12 107.94 17.94 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.539 1.149 . . . . 0.0 110.009 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -21.01 16.33 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.466 1.772 . . . . 0.0 110.978 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -72.58 -28.52 62.85 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.519 1.137 . . . . 0.0 110.319 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.795 HD11 HG21 ' A' ' 243' ' ' VAL . 46.2 mt -65.46 -32.88 60.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 0.0 109.308 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 338' ' ' ALA . . . . . 0.589 ' HB2' ' SG ' ' A' ' 331' ' ' CYS . . . -70.74 -35.06 72.5 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.536 1.147 . . . . 0.0 109.31 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -71.42 -34.79 70.63 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.518 1.136 . . . . 0.0 110.338 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.486 ' O ' HG22 ' A' ' 344' ' ' THR . 66.1 mt -73.06 -42.53 59.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.124 . . . . 0.0 109.303 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.677 ' CE2' HD12 ' A' ' 235' ' ' LEU . 1.0 OUTLIER -70.98 -31.2 67.68 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 0.0 111.02 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 342' ' ' ARG . . . . . 0.491 ' O ' HD12 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -73.24 -41.07 64.13 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.48 1.113 . . . . 0.0 110.282 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.13 -50.51 65.73 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.423 1.077 . . . . 0.0 109.305 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.5 HG22 ' HA ' ' A' ' 341' ' ' PHE . 7.4 t -64.97 -37.68 88.45 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.514 1.134 . . . . 0.0 110.429 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 345' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 341' ' ' PHE . . . -65.15 -43.32 92.24 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.504 1.127 . . . . 0.0 109.335 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 342' ' ' ARG . 0.4 OUTLIER -64.9 -35.12 80.13 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 0.0 109.256 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -69.42 -37.77 77.58 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.543 1.152 . . . . 0.0 110.33 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -72.64 -43.87 62.63 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.464 1.102 . . . . 0.0 110.309 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.61 -34.68 77.48 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.549 1.156 . . . . 0.0 110.273 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -38.21 -48.56 2.13 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.501 1.126 . . . . 0.0 111.014 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -154.77 120.98 5.28 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.536 0.786 . . . . 0.0 109.296 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -61.48 171.15 1.55 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.469 1.106 . . . . 0.0 109.333 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -116.43 123.17 46.86 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.49 1.119 . . . . 0.0 109.308 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 89.9 p -129.04 160.6 32.26 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.514 1.134 . . . . 0.0 109.996 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.481 1.113 . . . . 0.0 109.338 179.961 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.002 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 2.0 m -139.63 162.72 34.43 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.509 0.77 . . . . 0.0 110.01 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -137.69 171.05 15.01 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.467 1.104 . . . . 0.0 110.345 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.64 153.71 44.98 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.522 1.139 . . . . 0.0 110.286 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.7 p -109.42 145.06 16.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.48 1.113 . . . . 0.0 109.317 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.5 165.31 8.1 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.483 1.114 . . . . 0.0 110.295 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.9 mmt85 -126.13 157.74 37.3 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.493 1.121 . . . . 0.0 110.278 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -116.04 -32.73 1.63 Allowed Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.496 1.122 . . . . 0.0 111.008 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 16.3 p30 -97.27 14.04 27.41 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.537 0.787 . . . . 0.0 109.318 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -53.61 -38.59 64.15 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.507 1.129 . . . . 0.0 110.966 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.74 -35.15 59.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.486 1.117 . . . . 0.0 109.283 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.534 ' HD3' HD23 ' A' ' 229' ' ' LEU . 0.0 OUTLIER -67.6 -36.61 81.2 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.509 1.131 . . . . 0.0 110.323 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.792 ' HB3' HD13 ' A' ' 251' ' ' LEU . 1.6 m-20 -75.1 -30.19 60.83 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.478 1.111 . . . . 0.0 109.288 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' TRP . . . . . 0.679 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 1.6 t90 -67.63 -49.51 62.64 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.505 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 6.0 pt20 -67.22 -30.94 70.99 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.54 1.15 . . . . 0.0 110.312 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.534 HD23 ' HD3' ' A' ' 225' ' ' ARG . 0.6 OUTLIER -64.54 -47.14 79.93 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.508 1.13 . . . . 0.0 109.3 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.778 HG23 ' CD1' ' A' ' 244' ' ' LEU . 34.9 m -70.11 -37.63 72.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.501 1.125 . . . . 0.0 109.304 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -75.83 -14.97 60.3 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.479 1.112 . . . . 0.0 109.308 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -82.27 -25.15 34.3 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.567 1.167 . . . . 0.0 109.337 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 230' ' ' VAL . 0.3 OUTLIER -86.94 133.51 39.11 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.483 1.114 . . . . 0.0 109.311 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 -4.35 15.27 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.498 1.789 . . . . 0.0 111.012 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.98 -24.07 33.08 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.492 1.12 . . . . 0.0 109.32 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.516 ' O ' HD21 ' A' ' 244' ' ' LEU . 17.4 m-30 -119.73 -1.26 10.59 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.467 1.105 . . . . 0.0 110.986 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -71.69 -23.39 61.65 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.513 1.133 . . . . 0.0 110.309 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.442 ' NZ ' ' HA ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -92.55 7.59 42.58 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.482 1.114 . . . . 0.0 109.316 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.566 HD22 HG11 ' A' ' 243' ' ' VAL . 86.4 mt -89.26 179.76 6.04 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.48 1.113 . . . . 0.0 109.265 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' GLY . . . . . 0.669 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -98.21 -176.94 33.18 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.506 1.129 . . . . 0.0 111.036 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.981 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.3 Cg_endo -75.0 -37.33 2.07 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.5 1.789 . . . . 0.0 110.985 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.84 -34.68 77.19 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.464 1.102 . . . . 0.0 109.3 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.566 HG11 HD22 ' A' ' 239' ' ' LEU . 14.1 t -75.4 -38.02 39.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.514 1.134 . . . . 0.0 109.317 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.778 ' CD1' HG23 ' A' ' 230' ' ' VAL . 1.4 mm? -66.79 -35.84 81.0 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.514 1.133 . . . . 0.0 109.305 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.981 HG23 ' O ' ' A' ' 241' ' ' PRO . 60.9 t -74.39 -38.88 47.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.485 1.116 . . . . 0.0 109.296 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -65.25 -48.39 73.43 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.519 1.137 . . . . 0.0 110.268 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.552 HG13 HD13 ' A' ' 330' ' ' LEU . 32.1 mt -63.15 -43.27 98.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.524 1.14 . . . . 0.0 109.316 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 244' ' ' LEU . 41.2 t -65.29 -38.21 82.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.459 1.1 . . . . 0.0 109.269 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -72.49 -19.25 61.58 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.422 1.076 . . . . 0.0 110.292 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -91.82 -16.3 26.96 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.521 1.138 . . . . 0.0 109.303 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.792 HD13 ' HB3' ' A' ' 226' ' ' ASN . 2.2 mt -66.84 129.27 39.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.495 1.122 . . . . 0.0 109.313 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 320' ' ' LEU . 3.2 tpt85 -110.15 118.08 35.41 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.492 1.12 . . . . 0.0 110.308 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.536 ' HB2' HD23 ' A' ' 320' ' ' LEU . . . -80.15 136.77 36.58 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.458 1.099 . . . . 0.0 109.311 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.47 ' HD2' HD23 ' A' ' 319' ' ' LEU . 0.0 OUTLIER -143.06 139.67 30.6 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.547 1.155 . . . . 0.0 110.339 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.0 m -92.4 117.92 30.41 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.561 1.163 . . . . 0.0 110.373 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.631 HG12 ' CB ' ' A' ' 313' ' ' ALA . 37.1 t -107.33 112.77 62.57 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.499 1.124 . . . . 0.0 109.285 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.457 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.3 Cg_endo -74.99 173.33 14.7 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.485 1.782 . . . . 0.0 111.006 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.633 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -67.37 130.38 42.89 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.543 1.152 . . . . 0.0 109.301 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 95.48 -25.28 25.37 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.519 1.137 . . . . 0.0 111.01 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.608 ' HB3' HG13 ' A' ' 256' ' ' VAL . . . -56.43 140.59 45.27 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.496 0.762 . . . . 0.0 109.326 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.648 HG21 HH21 ' A' ' 264' ' ' ARG . 3.7 t -92.28 127.17 44.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.491 1.119 . . . . 0.0 109.34 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.842 HD12 HG12 ' A' ' 311' ' ' VAL . 40.8 mt -85.03 -41.91 16.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.477 1.111 . . . . 0.0 109.325 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 11.9 p -155.81 148.87 24.43 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.536 1.147 . . . . 0.0 108.296 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' ARG . . . . . 0.648 HH21 HG21 ' A' ' 261' ' ' VAL . 2.0 mmt85 -92.35 178.57 5.8 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.491 1.119 . . . . 0.0 110.329 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.574 HG23 ' OG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -76.42 141.59 15.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.495 1.122 . . . . 0.0 109.304 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 46.23 46.83 16.08 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.52 1.138 . . . . 0.0 111.006 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.453 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.0 OUTLIER -70.19 164.91 48.8 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 124.451 0.736 . . . . 0.0 110.299 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 267' ' ' GLU . 18.4 Cg_endo -75.0 77.04 3.22 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.502 1.791 . . . . 0.0 111.03 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 269' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 268' ' ' PRO . . . -35.84 100.21 0.01 OUTLIER Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.452 1.095 . . . . 0.0 111.016 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -169.76 38.09 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.545 0.791 . . . . 0.0 109.315 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -171.33 147.14 2.42 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.129 . . . . 0.0 110.281 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' MET . . . . . 0.872 ' HB2' HD11 ' A' ' 301' ' ' LEU . 2.0 ttt -116.67 150.45 38.13 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.479 1.112 . . . . 0.0 111.003 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.577 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 14.8 m-85 -135.43 136.9 41.73 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.453 1.095 . . . . 0.0 110.973 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 274' ' ' PHE . . . . . 0.47 ' CD1' ' CB ' ' A' ' 295' ' ' PHE . 22.8 m-30 -125.66 124.38 41.02 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.494 1.121 . . . . 0.0 110.959 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.441 HG22 HD12 ' A' ' 319' ' ' LEU . 85.2 t -80.03 135.81 24.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.515 1.134 . . . . 0.0 109.255 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.656 HG12 ' HG3' ' A' ' 277' ' ' GLU . 99.1 t -108.73 -56.01 4.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.461 1.101 . . . . 0.0 109.27 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.656 ' HG3' HG12 ' A' ' 276' ' ' VAL . 16.8 mt-10 -139.98 138.88 35.88 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.456 1.097 . . . . 0.0 110.314 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.01 -154.72 16.59 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.452 1.095 . . . . 0.0 111.03 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 290' ' ' LEU . 3.7 m -150.76 135.92 17.67 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.511 0.771 . . . . 0.0 110.029 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 289' ' ' GLU . 13.6 m -115.16 166.06 9.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.5 1.125 . . . . 0.0 109.321 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 28.8 t -131.33 149.44 52.55 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.457 1.098 . . . . 0.0 110.007 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.51 131.17 66.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.533 1.145 . . . . 0.0 109.304 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.478 ' HB3' ' H ' ' A' ' 310' ' ' THR . . . -79.7 101.87 8.65 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.52 1.137 . . . . 0.0 109.31 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 284' ' ' THR . . . . . 0.648 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.7 OUTLIER -148.27 -168.5 0.19 Allowed Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.458 1.099 . . . . 0.0 110.423 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.648 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.4 Cg_endo -74.95 4.89 4.31 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.533 1.807 . . . . 0.0 111.063 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -151.58 156.65 34.72 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.459 1.1 . . . . 0.0 109.293 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.91 95.37 0.97 Allowed 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.466 1.772 . . . . 0.0 111.032 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 281' ' ' SER . 24.1 t -99.53 118.9 46.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.105 . . . . 0.0 109.346 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.444 ' C ' HD22 ' A' ' 290' ' ' LEU . 14.4 mt-10 -124.76 138.16 54.29 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.511 1.132 . . . . 0.0 110.321 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.444 HD22 ' C ' ' A' ' 289' ' ' GLU . 4.3 mm? -119.84 142.19 48.87 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.51 1.131 . . . . 0.0 109.275 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -96.28 -153.25 29.65 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.53 1.144 . . . . 0.0 110.981 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 151.88 39.98 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.491 1.785 . . . . 0.0 111.021 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 76.99 6.35 85.82 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.52 1.138 . . . . 0.0 110.956 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -87.4 113.72 23.36 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.528 0.781 . . . . 0.0 109.279 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.47 ' CB ' ' CD1' ' A' ' 274' ' ' PHE . 15.1 p90 -107.15 152.98 23.33 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.488 1.117 . . . . 0.0 110.986 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 20.6 p90 -159.07 153.65 24.38 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.465 1.103 . . . . 0.0 110.98 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 123.17 -9.02 8.98 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.522 1.139 . . . . 0.0 111.041 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.438 ' HG2' ' N ' ' A' ' 299' ' ' MET . 0.4 OUTLIER -52.37 -37.21 55.69 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.469 0.747 . . . . 0.0 110.273 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 299' ' ' MET . . . . . 0.438 ' N ' ' HG2' ' A' ' 298' ' ' GLU . 1.2 mmt -60.13 -32.09 70.68 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 0.0 110.976 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 300' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -75.02 -37.27 61.83 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.446 1.091 . . . . 0.0 109.298 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.872 HD11 ' HB2' ' A' ' 272' ' ' MET . 0.9 OUTLIER -78.11 -11.61 59.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.546 1.154 . . . . 0.0 109.321 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 302' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 299' ' ' MET . 35.0 mt -83.82 -52.87 12.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.495 1.122 . . . . 0.0 109.274 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.454 ' O ' ' C ' ' A' ' 304' ' ' GLY . 3.4 m -153.21 39.08 0.51 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.528 1.143 . . . . 0.0 110.02 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 33.07 43.76 0.21 Allowed Glycine 0 CA--C 1.529 0.966 0 O-C-N 124.493 1.121 . . . . 0.0 111.061 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.61 157.71 88.51 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.487 0.757 . . . . 0.0 110.287 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 129.95 12.83 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.503 1.791 . . . . 0.0 111.034 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -46.59 -34.98 5.4 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.506 1.129 . . . . 0.0 110.328 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 1.3 m 60.39 20.53 10.14 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.485 1.115 . . . . 0.0 109.962 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . -171.26 160.66 6.3 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 0.0 109.322 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.574 ' OG1' HG23 ' A' ' 265' ' ' ILE . 0.9 OUTLIER -107.68 137.22 46.1 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.523 1.14 . . . . 0.0 110.372 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.842 HG12 HD12 ' A' ' 262' ' ' ILE . 86.5 t -114.79 127.51 72.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.459 1.1 . . . . 0.0 109.317 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 32.3 m -128.18 159.24 35.79 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.505 1.128 . . . . 0.0 109.96 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 313' ' ' ALA . . . . . 0.927 ' HB1' HG12 ' A' ' 317' ' ' VAL . . . -90.92 110.45 21.69 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.461 1.101 . . . . 0.0 109.275 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -53.19 -32.06 46.07 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.511 1.132 . . . . 0.0 109.287 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 315' ' ' THR . . . . . 0.633 ' HA ' ' HB2' ' A' ' 258' ' ' ALA . 12.7 t -156.68 -163.74 1.49 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.487 1.117 . . . . 0.0 110.407 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 96.6 m -63.07 76.78 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.48 1.112 . . . . 0.0 110.35 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.927 HG12 ' HB1' ' A' ' 313' ' ' ALA . 2.8 p -107.38 141.14 23.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.491 1.12 . . . . 0.0 109.353 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 318' ' ' SER . . . . . 1.015 ' C ' HD13 ' A' ' 319' ' ' LEU . 66.1 m -116.12 134.59 54.77 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.534 1.146 . . . . 0.0 110.04 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 319' ' ' LEU . . . . . 1.015 HD13 ' C ' ' A' ' 318' ' ' SER . 0.0 OUTLIER -132.54 177.98 7.19 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.49 1.119 . . . . 0.0 109.324 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.728 ' HB2' HD22 ' A' ' 251' ' ' LEU . 0.2 OUTLIER -124.5 128.62 49.24 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.502 1.126 . . . . 0.0 109.326 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 13.1 p -90.12 155.18 19.23 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.534 1.146 . . . . 0.0 110.036 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 322' ' ' LEU . 1.5 tm? -149.02 90.86 1.79 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.517 1.136 . . . . 0.0 109.311 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 323' ' ' HIS . . . . . 0.534 ' CE1' ' HB2' ' A' ' 326' ' ' ASP . 7.9 p80 -49.98 136.54 18.49 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.538 1.149 . . . . 0.0 109.63 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 43.7 t -59.93 -25.56 65.25 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.545 1.153 . . . . 0.0 109.984 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -57.03 -34.06 67.83 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.496 1.123 . . . . 0.0 109.308 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 326' ' ' ASP . . . . . 0.534 ' HB2' ' CE1' ' A' ' 323' ' ' HIS . 31.6 t70 -68.83 -37.15 78.98 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.49 1.119 . . . . 0.0 109.337 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 327' ' ' PHE . . . . . 0.572 ' CG ' HD23 ' A' ' 301' ' ' LEU . 33.3 t80 -68.75 -40.38 79.83 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.499 1.124 . . . . 0.0 110.975 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -70.54 -31.92 69.15 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 0.0 110.327 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 17.6 tmm? -69.38 -44.7 70.98 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.467 1.105 . . . . 0.0 111.03 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.552 HD13 HG13 ' A' ' 247' ' ' ILE . 13.3 mt -70.6 -38.86 74.04 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.465 1.103 . . . . 0.0 109.31 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 331' ' ' CYS . . . . . 0.549 ' SG ' HG22 ' A' ' 337' ' ' ILE . 1.8 m -64.43 -38.12 89.9 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.472 1.107 . . . . 0.0 108.279 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 7.6 t -77.24 -26.24 52.39 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.494 1.121 . . . . 0.0 109.98 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.18 -39.2 71.99 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.129 . . . . 0.0 110.057 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.19 129.94 23.36 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.529 1.143 . . . . 0.0 109.979 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -25.44 11.92 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.464 1.771 . . . . 0.0 111.023 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.26 -28.57 67.32 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.123 . . . . 0.0 110.299 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.549 HG22 ' SG ' ' A' ' 331' ' ' CYS . 59.9 mt -71.43 -42.47 73.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.514 1.134 . . . . 0.0 109.294 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.11 -30.49 67.7 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.492 1.12 . . . . 0.0 109.303 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -72.1 -43.51 64.67 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 0.0 110.316 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.404 HG21 ' HB2' ' A' ' 238' ' ' LYS . 68.2 mt -72.08 -40.06 66.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.537 1.148 . . . . 0.0 109.306 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.478 ' CD1' ' O ' ' A' ' 341' ' ' PHE . 0.4 OUTLIER -68.66 -39.33 80.69 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.534 1.146 . . . . 0.0 110.994 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -68.65 -39.08 80.85 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.465 1.103 . . . . 0.0 110.275 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.7 -48.07 70.43 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.526 1.141 . . . . 0.0 109.341 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.24 -41.77 94.04 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.47 1.106 . . . . 0.0 110.424 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -68.65 -34.4 75.65 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.528 1.143 . . . . 0.0 109.315 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 346' ' ' LEU . 13.5 mt -69.9 -33.52 72.3 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.482 1.114 . . . . 0.0 109.262 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.4 -37.01 66.1 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.549 1.156 . . . . 0.0 110.334 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 4.4 mtt85 -69.67 -38.97 77.28 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.527 1.142 . . . . 0.0 110.249 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 349' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 350' ' ' GLY . 0.0 OUTLIER -72.21 -34.79 68.62 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.465 1.103 . . . . 0.0 110.321 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 350' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 349' ' ' ARG . . . -37.81 -46.68 1.71 Allowed Glycine 0 CA--C 1.529 0.966 0 O-C-N 124.476 1.11 . . . . 0.0 111.033 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -153.89 120.03 5.4 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.517 0.775 . . . . 0.0 109.284 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -61.92 164.4 6.53 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.527 1.142 . . . . 0.0 109.321 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -124.01 170.18 10.91 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.483 1.114 . . . . 0.0 109.296 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 3.1 m -70.51 148.0 48.72 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.502 1.126 . . . . 0.0 109.992 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.464 0 O-C-N 124.499 1.125 . . . . 0.0 109.304 179.995 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 16.5 t80 . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.481 0.181 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -71.52 -43.22 72.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.515 1.134 . . . . 0.0 109.319 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.716 ' CD ' HD23 ' A' ' 229' ' ' LEU . 0.0 OUTLIER -65.86 -29.05 69.45 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.5 1.125 . . . . 0.0 110.328 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.58 ' ND2' HD22 ' A' ' 320' ' ' LEU . 6.5 t-20 -79.76 -30.37 40.73 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.541 1.151 . . . . 0.0 109.271 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' TRP . . . . . 0.879 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 2.1 t90 -68.09 -43.96 77.33 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.13 . . . . 0.0 107.985 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.619 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 9.8 pt20 -70.63 -36.93 73.69 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.513 1.133 . . . . 0.0 110.315 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.716 HD23 ' CD ' ' A' ' 225' ' ' ARG . 0.6 OUTLIER -60.99 -47.6 85.68 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.488 1.118 . . . . 0.0 109.323 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.791 HG12 ' CD1' ' A' ' 244' ' ' LEU . 64.5 t -73.23 -44.09 56.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.504 1.128 . . . . 0.0 109.307 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -68.28 -13.91 62.61 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.493 1.121 . . . . 0.0 109.282 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.619 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -81.64 -24.89 36.06 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.51 1.131 . . . . 0.0 109.288 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . 0.421 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 91.0 t -64.73 135.03 96.22 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.505 1.128 . . . . 0.0 109.316 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 233' ' ' VAL . 18.3 Cg_endo -75.02 -40.43 0.89 Allowed 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.42 1.747 . . . . 0.0 110.967 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 1.1 tp -63.56 -14.11 48.09 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.445 1.091 . . . . 0.0 109.302 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . 0.474 ' CB ' HD12 ' A' ' 239' ' ' LEU . 16.8 m-30 -113.24 5.28 16.87 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.473 1.108 . . . . 0.0 110.973 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' GLN . . . . . 0.417 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -73.52 -29.43 62.47 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.492 1.12 . . . . 0.0 110.325 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.426 ' HB3' HG21 ' A' ' 340' ' ' ILE . 0.0 OUTLIER -89.31 7.09 37.42 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.517 1.136 . . . . 0.0 109.298 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.609 ' HB2' HD21 ' A' ' 244' ' ' LEU . 74.4 mt -85.58 176.64 8.09 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.504 1.128 . . . . 0.0 109.265 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . 0.68 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -101.03 176.19 26.78 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.509 1.131 . . . . 0.0 111.03 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.938 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.3 Cg_endo -74.99 -36.35 2.6 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.513 1.796 . . . . 0.0 110.993 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -69.54 -35.12 75.15 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.53 1.144 . . . . 0.0 109.271 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.808 HG21 HD11 ' A' ' 337' ' ' ILE . 57.0 t -73.25 -40.16 56.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.463 1.102 . . . . 0.0 109.297 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.791 ' CD1' HG12 ' A' ' 230' ' ' VAL . 3.5 mm? -67.61 -37.55 82.7 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 0.0 109.269 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.938 HG23 ' O ' ' A' ' 241' ' ' PRO . 74.3 t -65.84 -45.98 89.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.519 1.137 . . . . 0.0 109.328 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -64.89 -40.78 95.64 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.125 . . . . 0.0 110.251 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.758 ' O ' HD13 ' A' ' 251' ' ' LEU . 44.2 mt -62.27 -47.97 90.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.456 1.098 . . . . 0.0 109.306 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.496 HG21 ' HA ' ' A' ' 227' ' ' TRP . 27.3 t -61.98 -34.65 64.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.469 1.105 . . . . 0.0 109.296 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.02 -13.01 60.04 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.463 1.102 . . . . 0.0 110.291 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -99.6 -7.0 26.38 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.502 1.126 . . . . 0.0 109.312 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.758 HD13 ' O ' ' A' ' 247' ' ' ILE . 6.2 mp -75.31 146.51 40.93 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.533 1.146 . . . . 0.0 109.281 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 320' ' ' LEU . 6.1 tpt180 -116.33 113.6 23.17 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.502 1.127 . . . . 0.0 110.314 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.734 ' HB2' HD23 ' A' ' 320' ' ' LEU . . . -80.03 126.79 31.5 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.51 1.131 . . . . 0.0 109.258 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -139.09 137.74 36.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.464 1.102 . . . . 0.0 110.305 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 4.1 m -90.85 123.56 34.48 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.471 1.107 . . . . 0.0 110.385 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.769 ' CG2' HD21 ' A' ' 319' ' ' LEU . 4.7 t -106.8 112.76 63.32 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.467 1.104 . . . . 0.0 109.291 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.482 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.3 Cg_endo -75.03 169.27 22.98 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.524 1.802 . . . . 0.0 111.011 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.689 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -64.92 126.77 29.05 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.496 1.123 . . . . 0.0 109.334 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 100.63 -25.3 28.84 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.486 1.116 . . . . 0.0 111.006 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.499 ' HB3' HG13 ' A' ' 256' ' ' VAL . . . -67.65 131.07 44.9 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.504 0.767 . . . . 0.0 109.303 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 311' ' ' VAL . 2.9 p -87.72 135.43 25.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.529 1.143 . . . . 0.0 109.326 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.649 HD12 HG12 ' A' ' 311' ' ' VAL . 35.6 mt -82.38 -44.12 19.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.542 1.151 . . . . 0.0 109.294 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 10.5 p -152.12 147.07 26.02 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.538 1.149 . . . . 0.0 108.28 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -85.65 -179.9 6.96 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.485 1.115 . . . . 0.0 110.298 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.465 HG23 ' OG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -77.21 134.71 28.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.563 1.164 . . . . 0.0 109.289 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 56.32 51.48 55.85 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.458 1.099 . . . . 0.0 110.969 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.95 165.65 45.3 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.495 0.762 . . . . 0.0 110.298 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.3 Cg_endo -75.01 82.98 1.89 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.45 1.763 . . . . 0.0 111.002 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -38.0 93.31 0.01 OUTLIER Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.534 1.146 . . . . 0.0 110.997 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 268' ' ' PRO . 0.7 OUTLIER -171.61 37.51 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.482 0.754 . . . . 0.0 109.307 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . 0.406 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 1.9 ttt180 -169.81 147.74 3.44 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.49 1.119 . . . . 0.0 110.276 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.878 ' HB2' HD11 ' A' ' 301' ' ' LEU . 2.1 ttm -118.04 156.26 28.9 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.534 1.147 . . . . 0.0 110.986 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.571 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 32.8 m-85 -146.02 136.61 24.15 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.519 1.137 . . . . 0.0 111.023 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . 0.494 ' CZ ' ' SD ' ' A' ' 272' ' ' MET . 19.6 m-85 -125.71 137.8 53.85 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.538 1.149 . . . . 0.0 111.007 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.605 HG22 HD12 ' A' ' 319' ' ' LEU . 4.3 t -94.24 135.34 28.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.473 1.108 . . . . 0.0 109.318 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.497 ' CG2' HD11 ' A' ' 320' ' ' LEU . 42.0 t -109.49 -49.16 7.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.481 1.113 . . . . 0.0 109.246 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -142.04 132.77 25.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.486 1.116 . . . . 0.0 110.281 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.693 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 120.96 -176.35 16.24 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.483 1.115 . . . . 0.0 111.023 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 5.2 t -131.2 118.8 20.95 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.498 0.764 . . . . 0.0 110.026 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.439 HG23 ' HB2' ' A' ' 290' ' ' LEU . 16.2 m -98.43 162.17 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.496 1.122 . . . . 0.0 109.313 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 31.1 t -127.71 153.76 46.13 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.493 1.12 . . . . 0.0 109.957 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 288' ' ' VAL . 0.2 OUTLIER -116.95 129.23 73.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.463 1.102 . . . . 0.0 109.327 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.716 ' HB3' ' H ' ' A' ' 310' ' ' THR . . . -77.97 101.62 6.97 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.469 1.106 . . . . 0.0 109.298 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' THR . . . . . 0.651 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.7 OUTLIER -148.62 -168.31 0.18 Allowed Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.568 1.168 . . . . 0.0 110.399 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.651 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -75.07 4.59 4.63 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.474 1.776 . . . . 0.0 110.956 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -151.5 156.67 34.85 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.521 1.138 . . . . 0.0 109.265 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.95 94.79 0.95 Allowed 'Trans proline' 0 C--N 1.36 1.184 0 O-C-N 124.509 1.794 . . . . 0.0 110.987 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 281' ' ' SER . 45.4 t -98.37 118.83 45.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.494 1.121 . . . . 0.0 109.327 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 15.0 mt-10 -125.22 136.96 54.08 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.475 1.109 . . . . 0.0 110.278 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.439 ' HB2' HG23 ' A' ' 280' ' ' VAL . 4.0 mm? -117.23 139.73 50.42 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.474 1.109 . . . . 0.0 109.312 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -90.6 -160.18 36.3 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.497 1.123 . . . . 0.0 111.005 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' PRO . . . . . 0.477 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.2 Cg_endo -75.01 148.21 34.91 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.546 1.814 . . . . 0.0 111.038 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.424 ' HA2' HD21 ' A' ' 229' ' ' LEU . . . 83.61 4.42 89.09 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.569 1.168 . . . . 0.0 110.99 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -86.03 130.67 34.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.472 0.748 . . . . 0.0 109.295 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.485 ' HB3' ' CD1' ' A' ' 274' ' ' PHE . 0.8 OUTLIER -116.16 153.02 32.56 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.504 1.127 . . . . 0.0 110.993 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.592 ' HZ ' HG21 ' A' ' 262' ' ' ILE . 40.4 p90 -159.64 146.17 16.32 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.527 1.142 . . . . 0.0 110.992 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 127.81 -7.07 6.93 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.472 1.107 . . . . 0.0 111.015 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -52.49 -48.76 65.75 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.511 0.771 . . . . 0.0 110.336 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . 0.423 ' HA ' ' CE ' ' A' ' 299' ' ' MET . 3.1 mmt -48.91 -39.26 25.36 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.541 1.151 . . . . 0.0 111.002 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -67.79 -37.42 82.0 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.504 1.128 . . . . 0.0 109.252 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.878 HD11 ' HB2' ' A' ' 272' ' ' MET . 10.6 mt -79.02 -9.07 59.43 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.527 1.142 . . . . 0.0 109.267 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 3.1 mm -82.25 -54.17 10.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.478 1.111 . . . . 0.0 109.294 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 304' ' ' GLY . 1.0 OUTLIER -153.47 42.97 0.58 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 0.0 109.989 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 303' ' ' SER . . . 36.21 42.28 0.58 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.479 1.112 . . . . 0.0 111.042 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.19 157.13 83.43 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.441 0.73 . . . . 0.0 110.276 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.11 131.99 14.78 Favored 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.481 1.779 . . . . 0.0 110.976 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -44.38 -43.32 7.54 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.516 1.135 . . . . 0.0 110.34 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.545 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 25.3 m 67.74 39.41 2.69 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.454 1.096 . . . . 0.0 109.99 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 173.42 160.2 0.14 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.541 1.151 . . . . 0.0 109.307 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.716 ' H ' ' HB3' ' A' ' 283' ' ' ALA . 0.6 OUTLIER -105.19 122.3 45.62 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.505 1.128 . . . . 0.0 110.441 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.649 HG12 HD12 ' A' ' 262' ' ' ILE . 58.6 t -102.7 128.25 55.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.5 1.125 . . . . 0.0 109.3 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 9.7 p -141.24 156.66 45.87 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.557 1.161 . . . . 0.0 110.037 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . 0.543 ' CB ' HG12 ' A' ' 256' ' ' VAL . . . -90.31 124.37 34.84 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.543 1.152 . . . . 0.0 109.284 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -70.45 -26.33 63.59 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.468 1.105 . . . . 0.0 109.293 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' THR . . . . . 0.689 ' HA ' ' HB2' ' A' ' 258' ' ' ALA . 6.2 t -152.98 -169.79 3.44 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.51 1.131 . . . . 0.0 110.415 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 93.0 m -58.67 85.36 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 0.0 110.409 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.693 HG22 ' HA3' ' A' ' 278' ' ' GLY . 48.3 t -105.42 159.45 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.461 1.101 . . . . 0.0 109.246 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . 0.646 ' C ' HD13 ' A' ' 319' ' ' LEU . 49.3 m -136.88 123.62 21.17 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.508 1.13 . . . . 0.0 109.984 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . 0.769 HD21 ' CG2' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -134.56 170.46 15.76 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.508 1.13 . . . . 0.0 109.278 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.734 HD23 ' HB2' ' A' ' 253' ' ' ALA . 0.0 OUTLIER -124.4 131.82 53.51 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.478 1.111 . . . . 0.0 109.295 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 63.5 p -90.15 158.88 17.05 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.552 1.157 . . . . 0.0 110.017 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.839 ' O ' HD13 ' A' ' 322' ' ' LEU . 0.9 OUTLIER -151.23 104.75 3.14 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.52 1.137 . . . . 0.0 109.338 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . 0.495 ' CE1' ' HB2' ' A' ' 326' ' ' ASP . 8.2 p80 -57.55 131.2 49.46 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.538 1.149 . . . . 0.0 109.609 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 23.0 t -58.96 -16.77 19.55 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.488 1.118 . . . . 0.0 109.993 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -66.71 -31.71 72.54 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.431 1.082 . . . . 0.0 109.305 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . 0.553 ' HB3' HD21 ' A' ' 322' ' ' LEU . 35.0 t70 -65.59 -47.52 75.44 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.543 1.152 . . . . 0.0 109.304 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' PHE . . . . . 0.469 ' CZ ' ' CE2' ' A' ' 341' ' ' PHE . 1.8 t80 -65.38 -35.74 81.88 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.431 1.082 . . . . 0.0 110.999 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -71.13 -32.29 68.8 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.505 1.128 . . . . 0.0 110.286 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 14.9 tmm? -68.29 -44.82 74.65 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.451 1.094 . . . . 0.0 110.991 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.62 HD13 HG13 ' A' ' 247' ' ' ILE . 2.4 mt -73.85 -31.57 63.25 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.504 1.128 . . . . 0.0 109.34 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 28.7 t -69.84 -38.14 76.41 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 0.0 108.322 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 11.3 t -76.86 -29.07 55.69 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.492 1.12 . . . . 0.0 109.984 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.9 -38.7 73.02 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.5 1.125 . . . . 0.0 109.974 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.8 124.07 32.51 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.483 1.114 . . . . 0.0 109.998 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 -27.87 9.64 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.417 1.746 . . . . 0.0 110.991 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.86 -32.61 72.4 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 0.0 110.315 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.808 HD11 HG21 ' A' ' 243' ' ' VAL . 71.2 mt -75.14 -32.88 27.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.506 1.129 . . . . 0.0 109.316 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.29 -34.97 66.04 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.447 1.092 . . . . 0.0 109.295 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -73.77 -43.42 59.04 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.531 1.144 . . . . 0.0 110.308 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.426 HG21 ' HB3' ' A' ' 238' ' ' LYS . 97.7 mt -71.64 -38.06 65.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 0.0 109.339 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.514 ' O ' HG22 ' A' ' 344' ' ' THR . 4.7 t80 -67.0 -39.22 87.07 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 0.0 111.042 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.06 -35.59 69.33 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.506 1.129 . . . . 0.0 110.311 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -46.17 83.66 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.45 1.094 . . . . 0.0 109.307 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 341' ' ' PHE . 6.6 t -71.23 -33.98 70.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.543 1.152 . . . . 0.0 110.399 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -70.21 -37.23 75.02 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.452 1.095 . . . . 0.0 109.366 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.472 ' HA ' HD23 ' A' ' 346' ' ' LEU . 12.4 mt -71.43 -37.02 71.49 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.523 1.139 . . . . 0.0 109.29 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -72.68 -37.34 67.91 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.487 1.117 . . . . 0.0 110.335 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 . . . . . 0 C--N 1.324 -0.504 0 O-C-N 124.559 1.162 . . . . 0.0 110.251 179.997 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 31.7 t80 . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 120.484 0.183 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.12 -40.05 50.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.494 1.121 . . . . 0.0 109.322 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.465 ' HD3' ' CD1' ' A' ' 229' ' ' LEU . 0.0 OUTLIER -66.22 -31.87 72.95 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.519 1.137 . . . . 0.0 110.339 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.641 ' ND2' HD22 ' A' ' 320' ' ' LEU . 12.4 t-20 -80.61 -30.84 36.78 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.538 1.149 . . . . 0.0 109.335 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' TRP . . . . . 0.928 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 2.8 t90 -67.24 -42.66 83.61 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.127 . . . . 0.0 107.994 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.406 ' HG3' ' N ' ' A' ' 229' ' ' LEU . 8.9 pt20 -71.02 -40.77 71.56 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.478 1.111 . . . . 0.0 110.333 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.465 ' CD1' ' HD3' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -61.87 -48.65 79.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.471 1.107 . . . . 0.0 109.304 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.516 HG13 ' CD1' ' A' ' 244' ' ' LEU . 5.7 p -68.09 -39.63 81.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.503 1.127 . . . . 0.0 109.309 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -72.11 -16.53 62.01 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.502 1.126 . . . . 0.0 109.264 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 228' ' ' GLN . . . -81.25 -10.45 59.59 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.473 1.108 . . . . 0.0 109.282 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 6.7 t -80.85 121.04 80.54 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.561 1.163 . . . . 0.0 109.29 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 -18.35 18.75 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.501 1.79 . . . . 0.0 111.018 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.538 HD21 HD11 ' A' ' 302' ' ' ILE . 5.7 tp -75.87 -20.96 57.67 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.511 1.132 . . . . 0.0 109.281 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . 0.488 ' CD2' HD12 ' A' ' 239' ' ' LEU . 3.3 m-85 -108.97 8.9 26.55 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.495 1.122 . . . . 0.0 110.998 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.26 -19.92 65.58 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.572 1.17 . . . . 0.0 110.311 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.526 ' CB ' HG21 ' A' ' 340' ' ' ILE . 69.5 mmtt -80.63 -17.95 49.64 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.523 1.139 . . . . 0.0 109.313 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.726 HD22 HG11 ' A' ' 243' ' ' VAL . 75.1 mt -70.49 172.81 7.82 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.457 1.098 . . . . 0.0 109.284 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . 0.54 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -107.42 -172.54 22.26 Favored Glycine 0 CA--C 1.529 0.952 0 O-C-N 124.509 1.131 . . . . 0.0 111.07 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.912 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.3 Cg_endo -75.05 -35.16 3.27 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.487 1.783 . . . . 0.0 110.986 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -69.56 -34.08 73.66 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.475 1.11 . . . . 0.0 109.301 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.726 HG11 HD22 ' A' ' 239' ' ' LEU . 3.6 t -74.93 -40.58 45.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.493 1.12 . . . . 0.0 109.298 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.784 ' O ' HG23 ' A' ' 248' ' ' VAL . 0.7 OUTLIER -64.83 -40.1 94.65 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.478 1.111 . . . . 0.0 109.262 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.928 HG22 ' CZ2' ' A' ' 227' ' ' TRP . 63.0 t -70.65 -42.13 77.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.459 1.099 . . . . 0.0 109.299 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -64.95 -35.65 81.86 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.492 1.12 . . . . 0.0 110.262 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.432 HD12 HG12 ' A' ' 243' ' ' VAL . 36.7 mt -71.75 -44.84 68.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.559 1.162 . . . . 0.0 109.321 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 244' ' ' LEU . 96.4 t -68.17 -32.15 54.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.454 1.096 . . . . 0.0 109.292 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.93 -21.97 46.48 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.493 1.121 . . . . 0.0 110.327 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.511 ' HB3' ' OD1' ' A' ' 326' ' ' ASP . . . -89.94 -21.26 22.55 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.473 1.108 . . . . 0.0 109.276 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.411 ' CD2' ' HB2' ' A' ' 322' ' ' LEU . 0.2 OUTLIER -67.3 149.77 49.92 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.469 1.106 . . . . 0.0 109.304 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -121.08 119.57 32.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.442 1.088 . . . . 0.0 110.334 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.563 ' HB2' HD23 ' A' ' 320' ' ' LEU . . . -80.99 122.83 27.77 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.495 1.122 . . . . 0.0 109.324 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.96 142.9 49.12 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.506 1.129 . . . . 0.0 110.293 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.3 m -94.18 125.36 38.77 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.496 1.123 . . . . 0.0 110.359 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.524 HG12 ' CB ' ' A' ' 313' ' ' ALA . 47.6 t -106.92 112.44 63.32 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.534 1.146 . . . . 0.0 109.334 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.3 Cg_endo -75.01 171.38 18.43 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.485 1.781 . . . . 0.0 110.993 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.589 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -66.25 130.21 42.44 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.487 1.117 . . . . 0.0 109.336 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 94.97 -25.09 25.52 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.478 1.111 . . . . 0.0 111.031 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.517 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -64.75 119.94 11.53 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.527 0.781 . . . . 0.0 109.297 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.17 136.03 24.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.539 1.15 . . . . 0.0 109.284 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.974 HD12 HG12 ' A' ' 311' ' ' VAL . 39.9 mt -82.12 -52.64 13.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.492 1.12 . . . . 0.0 109.334 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 17.1 p -147.43 146.26 29.51 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.512 1.133 . . . . 0.0 108.291 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -83.36 -177.8 6.86 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.115 . . . . 0.0 110.291 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.54 HG23 ' CB ' ' A' ' 310' ' ' THR . 0.0 OUTLIER -76.08 133.21 31.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.507 1.129 . . . . 0.0 109.301 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 55.5 53.9 38.14 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.486 1.116 . . . . 0.0 110.983 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.81 165.75 43.65 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.467 0.745 . . . . 0.0 110.313 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.486 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.3 Cg_endo -75.01 87.12 1.35 Allowed 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.498 1.788 . . . . 0.0 110.947 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -39.79 93.4 0.01 OUTLIER Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.506 1.129 . . . . 0.0 111.02 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 268' ' ' PRO . 17.9 p30 -170.82 38.48 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.513 0.773 . . . . 0.0 109.261 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . 0.401 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 12.8 mtt180 -169.51 154.45 5.63 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.477 1.11 . . . . 0.0 110.309 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.41 ' SD ' ' CD1' ' A' ' 301' ' ' LEU . 1.2 ttt -126.09 149.66 48.75 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.506 1.129 . . . . 0.0 110.985 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 296' ' ' PHE . 12.1 m-85 -135.63 138.2 42.65 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.475 1.109 . . . . 0.0 110.98 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -128.36 126.15 40.12 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.552 1.158 . . . . 0.0 110.973 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 1.034 HG22 HD22 ' A' ' 319' ' ' LEU . 41.7 t -85.47 129.64 37.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.467 1.104 . . . . 0.0 109.298 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.809 ' CG2' HD11 ' A' ' 320' ' ' LEU . 46.3 t -104.94 -46.97 9.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.467 1.105 . . . . 0.0 109.322 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.814 ' O ' HG23 ' A' ' 317' ' ' VAL . 0.0 OUTLIER -148.52 140.51 23.9 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.482 1.114 . . . . 0.0 110.336 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 116.46 -154.1 17.02 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.554 1.159 . . . . 0.0 110.994 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 290' ' ' LEU . 4.5 m -147.83 131.4 16.79 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.466 0.745 . . . . 0.0 109.967 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 20.3 m -117.17 135.58 57.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.484 1.115 . . . . 0.0 109.332 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 29.3 t -102.5 149.6 24.23 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.519 1.137 . . . . 0.0 109.983 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.463 HG13 HG22 ' A' ' 311' ' ' VAL . 0.4 OUTLIER -113.35 130.42 67.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.502 1.127 . . . . 0.0 109.291 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.666 ' HB3' ' H ' ' A' ' 310' ' ' THR . . . -76.77 101.84 6.0 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.541 1.15 . . . . 0.0 109.31 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' THR . . . . . 0.648 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -149.07 -168.63 0.19 Allowed Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.47 1.106 . . . . 0.0 110.427 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.648 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -75.01 3.83 5.28 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.553 1.817 . . . . 0.0 110.975 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -151.91 157.68 34.22 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.533 1.146 . . . . 0.0 109.325 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 92.59 0.98 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.533 1.807 . . . . 0.0 111.0 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.443 ' O ' HG23 ' A' ' 282' ' ' VAL . 29.0 t -95.49 118.97 42.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.506 1.129 . . . . 0.0 109.311 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.54 ' C ' HD22 ' A' ' 290' ' ' LEU . 14.2 mt-10 -124.34 138.69 54.35 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.482 1.114 . . . . 0.0 110.313 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.54 HD22 ' C ' ' A' ' 289' ' ' GLU . 4.4 mm? -121.37 140.92 51.48 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.464 1.103 . . . . 0.0 109.311 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -97.55 -155.01 29.91 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.459 1.1 . . . . 0.0 110.985 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.94 147.04 33.65 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.498 1.789 . . . . 0.0 111.018 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 85.26 5.77 85.0 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.474 1.109 . . . . 0.0 111.011 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -90.44 121.42 32.39 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.495 0.762 . . . . 0.0 109.323 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -116.16 152.89 32.8 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.541 1.151 . . . . 0.0 110.994 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.558 ' CZ ' ' HB3' ' A' ' 273' ' ' PHE . 33.7 p90 -163.71 148.95 10.88 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.486 1.116 . . . . 0.0 111.018 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 132.98 -11.58 5.1 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.454 1.096 . . . . 0.0 110.976 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -52.82 -44.91 67.01 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.452 0.737 . . . . 0.0 110.3 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.67 -39.21 57.81 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.438 1.086 . . . . 0.0 110.965 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . 0.457 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -68.49 -39.03 81.48 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.516 1.135 . . . . 0.0 109.304 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.55 HD22 ' CB ' ' A' ' 327' ' ' PHE . 13.3 mt -76.76 -8.78 57.96 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.516 1.135 . . . . 0.0 109.334 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . 0.538 HD11 HD21 ' A' ' 235' ' ' LEU . 6.5 mm -85.01 -52.95 11.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.488 1.117 . . . . 0.0 109.341 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 304' ' ' GLY . 0.4 OUTLIER -153.51 41.13 0.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.5 1.125 . . . . 0.0 109.967 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 36.48 36.4 0.15 Allowed Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.494 1.121 . . . . 0.0 110.956 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.93 155.76 85.84 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.511 0.771 . . . . 0.0 110.266 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 130.87 13.63 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.539 1.81 . . . . 0.0 110.999 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -45.16 -31.32 1.4 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.528 1.143 . . . . 0.0 110.288 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 2.4 m 59.1 33.1 22.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 0.0 110.03 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 176.35 160.63 0.34 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.498 1.124 . . . . 0.0 109.317 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.666 ' H ' ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -109.98 127.2 54.65 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.471 1.107 . . . . 0.0 110.396 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.974 HG12 HD12 ' A' ' 262' ' ' ILE . 57.6 t -107.21 131.64 56.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.496 1.122 . . . . 0.0 109.301 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 1.9 p -137.03 150.55 48.16 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.473 1.108 . . . . 0.0 110.036 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . 0.842 ' HB1' HG12 ' A' ' 317' ' ' VAL . . . -80.04 111.09 16.05 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.518 1.137 . . . . 0.0 109.278 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -58.61 -26.69 63.96 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.461 1.101 . . . . 0.0 109.285 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' THR . . . . . 0.589 ' HA ' ' HB2' ' A' ' 258' ' ' ALA . 8.8 t -160.18 -164.01 1.21 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.514 1.133 . . . . 0.0 110.379 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . 0.433 ' N ' ' OG1' ' A' ' 315' ' ' THR . 65.2 m -64.08 74.61 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.504 1.128 . . . . 0.0 110.417 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.859 HG22 ' CD2' ' A' ' 319' ' ' LEU . 2.7 p -104.14 137.81 31.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.125 . . . . 0.0 109.319 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . 0.464 ' C ' HD23 ' A' ' 319' ' ' LEU . 71.1 m -106.19 134.83 48.7 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.542 1.151 . . . . 0.0 109.972 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . 1.034 HD22 HG22 ' A' ' 275' ' ' VAL . 0.0 OUTLIER -141.5 174.23 10.75 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.535 1.147 . . . . 0.0 109.319 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.809 HD11 ' CG2' ' A' ' 276' ' ' VAL . 0.6 OUTLIER -124.83 134.01 52.9 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.517 1.135 . . . . 0.0 109.262 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 29.5 t -98.03 146.82 25.15 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.529 1.143 . . . . 0.0 109.972 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.411 ' HB2' ' CD2' ' A' ' 251' ' ' LEU . 2.2 tm? -138.06 104.64 5.29 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.518 1.136 . . . . 0.0 109.318 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . 0.44 ' ND1' ' HB3' ' A' ' 325' ' ' ALA . 5.8 p80 -63.71 134.31 55.12 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.557 1.161 . . . . 0.0 109.631 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 86.4 p -55.56 -18.47 7.55 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.54 1.15 . . . . 0.0 109.978 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 0.44 ' HB3' ' ND1' ' A' ' 323' ' ' HIS . . . -58.12 -36.99 73.73 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.466 1.104 . . . . 0.0 109.291 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . 0.511 ' OD1' ' HB3' ' A' ' 250' ' ' ALA . 27.2 t0 -65.32 -38.87 91.5 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.499 1.125 . . . . 0.0 109.312 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' PHE . . . . . 0.55 ' CB ' HD22 ' A' ' 301' ' ' LEU . 17.7 t80 -68.63 -35.64 77.55 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.478 1.111 . . . . 0.0 110.991 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -69.33 -33.84 73.74 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.5 1.125 . . . . 0.0 110.326 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.418 ' O ' ' CB ' ' A' ' 333' ' ' SER . 32.2 ttp -70.59 -43.21 69.85 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.457 1.098 . . . . 0.0 110.987 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 2.6 mt -70.58 -34.7 72.47 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.435 1.085 . . . . 0.0 109.342 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 1.3 m -73.22 -44.12 60.14 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.473 1.108 . . . . 0.0 108.3 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 7.6 t -73.09 -27.86 61.96 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.529 1.143 . . . . 0.0 110.04 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 329' ' ' MET . 11.7 t -74.04 -38.38 64.03 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.537 1.148 . . . . 0.0 110.028 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' SER . . . . . 0.636 ' HB2' HD12 ' A' ' 337' ' ' ILE . 0.3 OUTLIER -126.92 120.52 22.72 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 0.0 109.977 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -23.62 13.57 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.503 1.791 . . . . 0.0 111.038 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -72.32 -33.66 67.52 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.481 1.113 . . . . 0.0 110.263 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.679 HG23 HD21 ' A' ' 239' ' ' LEU . 87.3 mt -71.07 -40.34 75.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.556 1.16 . . . . 0.0 109.337 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.98 -30.7 64.02 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.443 1.089 . . . . 0.0 109.286 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.89 -37.34 70.16 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.529 1.143 . . . . 0.0 110.294 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.526 HG21 ' CB ' ' A' ' 238' ' ' LYS . 30.6 mt -72.93 -45.64 54.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.526 1.141 . . . . 0.0 109.295 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -67.65 -30.9 70.57 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.463 1.102 . . . . 0.0 110.997 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -72.54 -44.58 61.95 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.133 . . . . 0.0 110.258 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -45.26 76.88 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.521 1.138 . . . . 0.0 109.371 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.53 -40.12 92.57 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 0.0 110.409 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -69.09 -32.96 72.75 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.135 . . . . 0.0 109.28 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.428 ' HA ' HD23 ' A' ' 346' ' ' LEU . 13.1 mt -73.64 -31.18 63.37 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.519 1.137 . . . . 0.0 109.308 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -72.72 -40.56 66.03 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.14 . . . . 0.0 110.353 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 . . . . . 0 C--N 1.325 -0.472 0 O-C-N 124.466 1.104 . . . . 0.0 110.273 179.995 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.564 ' CE1' ' HD3' ' A' ' 249' ' ' ARG . 68.3 t80 . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.516 0.198 . . . . 0.0 110.969 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.62 -39.29 81.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.474 1.109 . . . . 0.0 109.315 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.66 ' HD2' HD12 ' A' ' 229' ' ' LEU . 0.1 OUTLIER -67.66 -34.41 76.87 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.512 1.132 . . . . 0.0 110.281 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.995 ' O ' HG12 ' A' ' 230' ' ' VAL . 36.9 t30 -78.73 -30.49 45.89 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.506 1.129 . . . . 0.0 109.271 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' TRP . . . . . 0.632 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 5.5 t90 -66.99 -44.4 80.5 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.522 1.139 . . . . 0.0 108.011 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.537 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 11.1 pt20 -71.78 -33.99 69.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.444 1.09 . . . . 0.0 110.332 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.66 HD12 ' HD2' ' A' ' 225' ' ' ARG . 0.3 OUTLIER -65.63 -55.39 17.84 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.544 1.152 . . . . 0.0 109.308 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.995 HG12 ' O ' ' A' ' 226' ' ' ASN . 7.4 p -65.51 -35.01 74.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.509 1.131 . . . . 0.0 109.287 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.475 ' CB ' ' O ' ' A' ' 227' ' ' TRP . . . -75.29 -18.88 59.94 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.485 1.115 . . . . 0.0 109.297 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.537 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -80.72 -20.31 43.12 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.102 . . . . 0.0 109.264 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 229' ' ' LEU . 60.3 t -62.78 128.58 92.08 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.507 1.13 . . . . 0.0 109.308 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.426 ' HA ' ' HB2' ' A' ' 237' ' ' GLN . 18.4 Cg_endo -74.99 -35.97 2.83 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.485 1.782 . . . . 0.0 111.078 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.756 HD22 ' HG3' ' A' ' 298' ' ' GLU . 1.2 tp -63.91 -19.22 64.94 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.5 1.125 . . . . 0.0 109.323 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . 0.662 ' CG ' HD12 ' A' ' 239' ' ' LEU . 4.3 m-30 -114.28 8.5 16.77 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.468 1.105 . . . . 0.0 110.988 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' GLN . . . . . 0.426 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 1.5 mt-30 -71.18 -22.61 62.01 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.508 1.13 . . . . 0.0 110.304 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -83.41 -19.37 36.11 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.476 1.11 . . . . 0.0 109.265 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.751 HD22 HG11 ' A' ' 243' ' ' VAL . 67.7 mt -63.79 -179.98 0.44 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.549 1.155 . . . . 0.0 109.296 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . 0.651 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -103.95 178.2 24.66 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.487 1.117 . . . . 0.0 111.04 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.543 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.2 Cg_endo -75.02 -34.54 3.72 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.486 1.782 . . . . 0.0 111.006 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -71.8 -35.4 69.96 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.499 1.125 . . . . 0.0 109.337 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.751 HG11 HD22 ' A' ' 239' ' ' LEU . 71.6 t -72.73 -40.62 61.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.528 1.142 . . . . 0.0 109.291 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 240' ' ' GLY . 3.9 mm? -69.08 -40.51 78.39 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.515 1.134 . . . . 0.0 109.308 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.632 HG22 ' CZ2' ' A' ' 227' ' ' TRP . 20.5 t -66.17 -37.05 78.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.487 1.117 . . . . 0.0 109.296 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -74.3 -30.78 62.23 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.55 1.156 . . . . 0.0 110.298 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 44.2 mt -70.93 -48.59 55.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.542 1.151 . . . . 0.0 109.308 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.67 HG23 ' ND2' ' A' ' 226' ' ' ASN . 14.5 p -65.56 -36.14 76.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.525 1.14 . . . . 0.0 109.286 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.564 ' HD3' ' CE1' ' A' ' 223' ' ' PHE . 1.4 mmm180 -72.44 -25.2 61.37 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.495 1.122 . . . . 0.0 110.311 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -91.41 0.33 57.53 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.472 1.108 . . . . 0.0 109.261 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.402 HD22 ' HB2' ' A' ' 320' ' ' LEU . 0.1 OUTLIER -83.69 151.61 25.18 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 0.0 109.269 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.08 125.16 46.57 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.46 1.1 . . . . 0.0 110.291 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -82.97 122.72 28.66 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.523 1.139 . . . . 0.0 109.267 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.405 ' O ' ' O ' ' A' ' 319' ' ' LEU . 0.0 OUTLIER -127.72 139.35 52.74 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.436 1.085 . . . . 0.0 110.265 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 6.6 m -95.55 128.07 42.11 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.479 1.112 . . . . 0.0 110.405 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.588 HG21 HD11 ' A' ' 319' ' ' LEU . 22.0 t -106.54 115.78 60.13 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.458 1.099 . . . . 0.0 109.251 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.504 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.95 154.44 42.76 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.52 1.8 . . . . 0.0 111.036 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.489 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -57.51 126.27 26.59 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.475 1.11 . . . . 0.0 109.266 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 98.7 -25.19 29.01 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.511 1.132 . . . . 0.0 110.995 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.504 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -66.3 146.58 54.44 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.479 0.752 . . . . 0.0 109.254 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 311' ' ' VAL . 2.4 p -97.18 136.29 28.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.461 1.101 . . . . 0.0 109.319 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.687 HD12 HG12 ' A' ' 311' ' ' VAL . 7.4 mt -81.65 -45.42 20.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.489 1.118 . . . . 0.0 109.33 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' CYS . . . . . 0.643 ' SG ' HG23 ' A' ' 311' ' ' VAL . 14.1 p -147.4 153.53 39.73 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.479 1.112 . . . . 0.0 108.331 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.41 179.91 5.0 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.513 1.133 . . . . 0.0 110.304 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.67 135.95 25.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.471 1.107 . . . . 0.0 109.311 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 52.27 53.55 30.77 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.539 1.149 . . . . 0.0 111.027 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.417 ' CD ' ' CD ' ' A' ' 268' ' ' PRO . 5.7 mm-40 -71.57 166.1 42.73 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.512 0.772 . . . . 0.0 110.313 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.517 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.2 Cg_endo -74.96 82.52 1.98 Allowed 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.515 1.797 . . . . 0.0 111.024 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . 0.424 ' HA2' ' HB1' ' A' ' 300' ' ' ALA . . . -36.86 92.39 0.01 OUTLIER Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.471 1.107 . . . . 0.0 110.976 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 268' ' ' PRO . 36.6 m-20 -171.92 37.84 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.526 0.78 . . . . 0.0 109.322 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.8 148.57 2.93 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.476 1.11 . . . . 0.0 110.299 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.747 ' HB2' HD11 ' A' ' 301' ' ' LEU . 2.1 ttt -123.26 146.65 47.68 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.543 1.152 . . . . 0.0 110.971 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.568 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 92.4 m-85 -133.4 136.98 45.6 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.512 1.133 . . . . 0.0 110.982 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . 0.501 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 20.5 m-85 -124.72 135.06 52.69 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.451 1.094 . . . . 0.0 111.004 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.534 HG12 ' HA ' ' A' ' 292' ' ' PRO . 38.6 t -90.43 137.93 20.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.471 1.107 . . . . 0.0 109.321 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.661 ' CG2' HD11 ' A' ' 320' ' ' LEU . 3.4 t -115.86 -48.99 4.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.484 1.115 . . . . 0.0 109.329 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.419 ' O ' HG13 ' A' ' 317' ' ' VAL . 3.9 mm-40 -139.01 136.57 35.47 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.51 1.131 . . . . 0.0 110.306 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.942 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 110.87 -173.31 15.93 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.486 1.116 . . . . 0.0 110.957 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 290' ' ' LEU . 5.5 t -134.34 126.67 30.14 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.481 0.754 . . . . 0.0 109.992 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.437 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 17.4 m -104.18 166.32 3.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.485 1.116 . . . . 0.0 109.286 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 30.8 t -129.81 154.79 46.9 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.502 1.126 . . . . 0.0 110.022 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.449 ' CG2' ' HB ' ' A' ' 288' ' ' VAL . 0.5 OUTLIER -118.03 127.84 75.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.502 1.126 . . . . 0.0 109.301 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.413 ' HB3' ' H ' ' A' ' 310' ' ' THR . . . -77.0 101.37 5.99 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.44 1.088 . . . . 0.0 109.338 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' THR . . . . . 0.651 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.63 -168.35 0.18 Allowed Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.525 1.141 . . . . 0.0 110.392 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.651 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.3 Cg_endo -74.97 4.17 4.96 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.528 1.804 . . . . 0.0 111.017 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.443 ' O ' HG23 ' A' ' 288' ' ' VAL . 5.1 m120 -150.68 156.16 36.13 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.509 1.131 . . . . 0.0 109.299 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 94.19 0.96 Allowed 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.517 1.798 . . . . 0.0 111.032 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.449 ' HB ' ' CG2' ' A' ' 282' ' ' VAL . 2.1 t -98.13 119.26 45.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.54 1.15 . . . . 0.0 109.322 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 13.9 mt-10 -124.5 135.44 53.21 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.547 1.154 . . . . 0.0 110.337 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.437 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 3.9 mm? -115.3 142.61 46.45 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.52 1.137 . . . . 0.0 109.308 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -97.96 -162.56 30.98 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.434 1.084 . . . . 0.0 111.025 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' PRO . . . . . 0.534 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.2 Cg_endo -75.0 144.99 30.91 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.467 1.772 . . . . 0.0 110.999 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 90.21 -1.84 80.43 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.502 1.126 . . . . 0.0 111.022 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -83.76 139.31 32.8 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.51 0.77 . . . . 0.0 109.321 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.405 ' CB ' ' CD1' ' A' ' 274' ' ' PHE . 1.5 p90 -126.4 152.74 45.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.491 1.119 . . . . 0.0 110.998 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.568 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 33.4 p90 -160.85 149.71 16.6 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.446 1.091 . . . . 0.0 111.013 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . 0.657 ' O ' HD12 ' A' ' 301' ' ' LEU . . . 126.23 -8.55 7.5 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.479 1.112 . . . . 0.0 111.025 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . 0.756 ' HG3' HD22 ' A' ' 235' ' ' LEU . 27.0 tt0 -52.87 -44.19 66.66 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.525 0.779 . . . . 0.0 110.283 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . 0.464 ' HB3' ' CG ' ' A' ' 305' ' ' GLU . 0.0 OUTLIER -56.34 -37.13 69.59 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.497 1.123 . . . . 0.0 111.037 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . 0.424 ' HB1' ' HA2' ' A' ' 269' ' ' GLY . . . -66.36 -38.38 87.46 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.503 1.127 . . . . 0.0 109.227 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.747 HD11 ' HB2' ' A' ' 272' ' ' MET . 1.8 mp -81.98 -10.22 59.32 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.124 . . . . 0.0 109.328 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 3.9 mm -76.9 -56.42 8.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.464 1.102 . . . . 0.0 109.33 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 305' ' ' GLU . 1.5 m -151.53 48.37 0.81 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.526 1.141 . . . . 0.0 109.992 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 303' ' ' SER . . . 36.57 31.66 0.05 OUTLIER Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.516 1.135 . . . . 0.0 110.99 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' GLU . . . . . 0.464 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 0.0 OUTLIER -65.24 151.67 93.41 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.517 0.775 . . . . 0.0 110.28 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 129.51 12.45 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.434 1.755 . . . . 0.0 111.022 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.88 -22.92 0.93 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.491 1.119 . . . . 0.0 110.288 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.695 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 27.4 m 41.79 57.24 3.18 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.566 1.166 . . . . 0.0 110.03 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' ALA . . . . . 0.695 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 162.68 159.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.463 1.102 . . . . 0.0 109.349 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.413 ' H ' ' HB3' ' A' ' 283' ' ' ALA . 0.3 OUTLIER -112.7 122.06 46.56 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.509 1.131 . . . . 0.0 110.408 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.687 HG12 HD12 ' A' ' 262' ' ' ILE . 23.0 t -102.79 131.51 50.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.524 1.14 . . . . 0.0 109.302 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 261' ' ' VAL . 33.8 p -138.37 154.07 48.93 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.494 1.121 . . . . 0.0 109.984 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -91.15 120.55 32.19 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.497 1.123 . . . . 0.0 109.297 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -61.94 -33.79 74.91 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.481 1.113 . . . . 0.0 109.316 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' THR . . . . . 0.605 ' O ' HG23 ' A' ' 317' ' ' VAL . 9.9 t -149.78 -176.22 5.34 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.517 1.136 . . . . 0.0 110.425 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 13.9 p -49.8 92.36 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.525 1.14 . . . . 0.0 110.361 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.942 HG22 ' HA3' ' A' ' 278' ' ' GLY . 43.0 t -108.56 158.49 8.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.509 1.131 . . . . 0.0 109.312 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 68.4 m -132.92 118.16 18.56 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.487 1.117 . . . . 0.0 110.014 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . 0.588 HD11 HG21 ' A' ' 256' ' ' VAL . 0.2 OUTLIER -131.65 172.94 11.65 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.49 1.119 . . . . 0.0 109.286 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.661 HD11 ' CG2' ' A' ' 276' ' ' VAL . 0.0 OUTLIER -125.1 137.14 54.19 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.451 1.095 . . . . 0.0 109.31 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 4.0 t -95.51 156.41 16.34 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.463 1.102 . . . . 0.0 110.021 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.94 103.51 3.22 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 0.0 109.289 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . 0.56 ' CE1' ' HB2' ' A' ' 326' ' ' ASP . 9.1 p80 -57.72 136.46 56.88 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.494 1.121 . . . . 0.0 109.584 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 42.0 t -62.12 -21.46 65.03 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.448 1.092 . . . . 0.0 109.984 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -62.97 -30.43 71.57 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.506 1.129 . . . . 0.0 109.307 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . 0.868 ' O ' HD12 ' A' ' 330' ' ' LEU . 27.7 t70 -65.98 -47.91 73.0 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.506 1.129 . . . . 0.0 109.339 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' PHE . . . . . 0.503 ' CZ ' ' CE2' ' A' ' 341' ' ' PHE . 2.5 t80 -64.95 -34.26 78.0 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.494 1.121 . . . . 0.0 110.996 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . 0.486 ' O ' ' CB ' ' A' ' 332' ' ' SER . 67.5 mt-30 -70.53 -33.37 71.1 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.509 1.13 . . . . 0.0 110.264 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 14.3 tmm? -68.98 -44.83 72.08 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.513 1.133 . . . . 0.0 110.989 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.868 HD12 ' O ' ' A' ' 326' ' ' ASP . 0.6 OUTLIER -73.47 -41.87 62.61 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.479 1.112 . . . . 0.0 109.275 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' CYS . . . . . 0.407 ' HG ' ' HD2' ' A' ' 341' ' ' PHE . 22.7 t -66.11 -38.57 88.52 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.479 1.112 . . . . 0.0 108.257 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 328' ' ' GLN . 38.7 t -76.72 -25.62 53.77 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.462 1.101 . . . . 0.0 109.953 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 17.7 t -71.73 -38.87 70.4 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.123 . . . . 0.0 110.034 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' SER . . . . . 0.442 ' CB ' HD12 ' A' ' 337' ' ' ILE . 0.2 OUTLIER -115.19 127.65 26.63 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.477 1.11 . . . . 0.0 109.965 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 334' ' ' SER . 18.2 Cg_endo -75.0 -28.8 8.86 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.525 1.803 . . . . 0.0 110.981 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -67.22 -29.82 69.58 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.502 1.126 . . . . 0.0 110.263 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.54 HD11 HG21 ' A' ' 243' ' ' VAL . 87.4 mt -75.0 -34.46 32.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.543 1.152 . . . . 0.0 109.257 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.73 -30.65 64.35 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.528 1.142 . . . . 0.0 109.3 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -74.93 -46.23 37.1 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.491 1.119 . . . . 0.0 110.317 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 87.4 mt -71.59 -36.45 59.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.459 1.099 . . . . 0.0 109.278 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.511 ' CB ' ' O ' ' A' ' 337' ' ' ILE . 6.0 t80 -67.39 -41.96 84.14 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.514 1.134 . . . . 0.0 110.991 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . 0.467 ' HG3' ' CD1' ' A' ' 346' ' ' LEU . 0.7 OUTLIER -70.63 -35.84 73.15 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.492 1.12 . . . . 0.0 110.26 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -50.86 65.36 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.492 1.12 . . . . 0.0 109.277 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . 0.511 HG22 ' O ' ' A' ' 341' ' ' PHE . 10.2 t -65.04 -33.02 75.03 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.474 1.108 . . . . 0.0 110.389 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -66.09 -44.92 83.0 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.484 1.115 . . . . 0.0 109.283 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.467 ' CD1' ' HG3' ' A' ' 342' ' ' ARG . 1.0 OUTLIER -65.34 -36.46 84.1 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.502 1.126 . . . . 0.0 109.329 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -73.53 -35.4 65.55 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.499 1.124 . . . . 0.0 110.317 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.476 0 O-C-N 124.495 1.122 . . . . 0.0 110.255 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.492 ' O ' ' CB ' ' A' ' 227' ' ' TRP . 28.9 t80 . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.495 0.188 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -86.39 -21.06 7.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.519 1.137 . . . . 0.0 109.311 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.779 ' O ' HD12 ' A' ' 229' ' ' LEU . 0.0 OUTLIER -77.33 -44.15 30.5 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.527 1.142 . . . . 0.0 110.284 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.513 ' O ' HG13 ' A' ' 230' ' ' VAL . 18.4 p-10 -81.02 -30.73 34.85 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.52 1.137 . . . . 0.0 109.317 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' TRP . . . . . 1.027 ' CZ3' HG23 ' A' ' 245' ' ' VAL . 1.0 OUTLIER -68.86 -45.27 71.5 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 0.0 107.981 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.606 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 3.5 pt20 -71.98 -32.18 67.0 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.568 1.167 . . . . 0.0 110.282 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.779 HD12 ' O ' ' A' ' 225' ' ' ARG . 1.2 mt -63.4 -47.71 80.84 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.534 1.146 . . . . 0.0 109.306 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.822 ' O ' HG22 ' A' ' 233' ' ' VAL . 34.1 m -66.98 -41.24 87.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.483 1.115 . . . . 0.0 109.324 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -76.76 -11.4 59.83 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.535 1.147 . . . . 0.0 109.277 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -81.24 -26.01 36.18 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.479 1.112 . . . . 0.0 109.298 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . 0.822 HG22 ' O ' ' A' ' 230' ' ' VAL . 34.1 m -86.46 135.9 35.85 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.493 1.121 . . . . 0.0 109.279 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.41 ' HA ' ' HB2' ' A' ' 237' ' ' GLN . 18.4 Cg_endo -74.94 -13.48 21.54 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.497 1.788 . . . . 0.0 111.046 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.86 -28.65 66.9 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.485 1.116 . . . . 0.0 109.334 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . 0.498 ' HA ' ' CD1' ' A' ' 239' ' ' LEU . 11.6 m-30 -110.82 -17.01 13.44 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.518 1.136 . . . . 0.0 111.033 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' GLN . . . . . 0.41 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 0.3 OUTLIER -59.4 -26.65 65.31 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.467 1.104 . . . . 0.0 110.335 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -83.45 7.56 16.54 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.465 1.103 . . . . 0.0 109.291 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.5 HD13 HG11 ' A' ' 243' ' ' VAL . 34.0 mt -101.65 -179.48 4.03 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.538 1.149 . . . . 0.0 109.294 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -92.06 176.84 39.4 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.479 1.112 . . . . 0.0 110.992 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -30.34 7.24 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.457 1.767 . . . . 0.0 111.009 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.505 ' HA ' HG12 ' A' ' 245' ' ' VAL . . . -70.91 -31.49 68.13 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 0.0 109.322 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.746 ' CG2' HD11 ' A' ' 337' ' ' ILE . 2.7 t -76.89 -43.0 33.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.504 1.128 . . . . 0.0 109.327 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.589 ' O ' HG12 ' A' ' 248' ' ' VAL . 0.2 OUTLIER -67.3 -45.16 77.34 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.529 1.143 . . . . 0.0 109.321 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 1.027 HG23 ' CZ3' ' A' ' 227' ' ' TRP . 2.9 p -64.49 -44.83 96.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.529 1.143 . . . . 0.0 109.32 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.405 ' N ' ' CG1' ' A' ' 245' ' ' VAL . 19.7 tp10 -66.01 -34.66 78.61 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.45 1.094 . . . . 0.0 110.301 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.538 ' CG1' HD13 ' A' ' 330' ' ' LEU . 15.5 mt -68.81 -55.17 16.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.548 1.155 . . . . 0.0 109.31 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.946 ' HA ' HD12 ' A' ' 251' ' ' LEU . 13.7 p -64.81 -30.36 50.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.532 1.145 . . . . 0.0 109.318 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.484 ' CG ' ' O ' ' A' ' 245' ' ' VAL . 5.8 mmm180 -70.17 -28.76 65.58 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.526 1.141 . . . . 0.0 110.308 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.542 ' HB1' ' OD2' ' A' ' 326' ' ' ASP . . . -86.86 -21.06 26.61 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.475 1.109 . . . . 0.0 109.309 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.946 HD12 ' HA ' ' A' ' 248' ' ' VAL . 1.7 mt -54.72 144.85 20.88 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.527 1.142 . . . . 0.0 109.256 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.66 124.88 50.82 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.485 1.116 . . . . 0.0 110.302 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -81.94 124.25 29.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.486 1.116 . . . . 0.0 109.267 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.46 136.56 48.04 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.523 1.139 . . . . 0.0 110.295 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 55.7 m -94.16 125.04 38.55 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 0.0 110.384 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.489 HG21 HD11 ' A' ' 319' ' ' LEU . 42.1 t -106.8 113.95 62.23 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.47 1.106 . . . . 0.0 109.301 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.492 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.2 Cg_endo -75.03 158.11 42.27 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.49 1.784 . . . . 0.0 110.983 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.499 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -57.85 125.39 22.82 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.491 1.119 . . . . 0.0 109.314 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 101.52 -24.08 32.85 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.513 1.133 . . . . 0.0 110.99 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.492 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -61.35 147.44 44.75 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.554 0.796 . . . . 0.0 109.291 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.9 t -97.11 131.3 44.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.51 1.131 . . . . 0.0 109.298 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.744 HD12 HG12 ' A' ' 311' ' ' VAL . 86.2 mt -83.11 -47.96 17.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.457 1.098 . . . . 0.0 109.33 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 14.3 p -153.88 145.48 23.26 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.478 1.111 . . . . 0.0 108.289 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -89.25 178.96 6.22 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.542 1.151 . . . . 0.0 110.28 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.467 HG23 ' OG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -77.89 130.69 35.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.48 1.112 . . . . 0.0 109.261 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 59.9 49.4 78.94 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.497 1.123 . . . . 0.0 111.012 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.12 164.3 58.11 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.521 0.777 . . . . 0.0 110.325 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.5 Cg_endo -74.98 80.6 2.39 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.517 1.799 . . . . 0.0 111.043 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 268' ' ' PRO . . . -37.14 95.82 0.01 OUTLIER Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.488 1.117 . . . . 0.0 111.024 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 268' ' ' PRO . 1.0 OUTLIER -170.2 37.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.499 0.764 . . . . 0.0 109.311 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 6.5 ttt180 -171.57 146.33 2.17 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.506 1.129 . . . . 0.0 110.309 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.757 ' HB2' HD11 ' A' ' 301' ' ' LEU . 2.6 ttt -116.69 146.51 42.71 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.533 1.146 . . . . 0.0 111.023 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.561 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 44.5 m-85 -133.92 137.03 44.64 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.124 . . . . 0.0 111.023 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . 0.437 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 21.1 m-85 -126.38 133.48 51.3 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.519 1.137 . . . . 0.0 111.003 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.74 HG22 HD22 ' A' ' 319' ' ' LEU . 3.2 t -91.07 133.11 33.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.475 1.109 . . . . 0.0 109.294 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.672 ' CG2' HD11 ' A' ' 320' ' ' LEU . 40.2 t -110.27 -35.35 2.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.576 1.173 . . . . 0.0 109.268 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.767 ' O ' HG13 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -156.27 137.84 14.09 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.516 1.135 . . . . 0.0 110.309 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.869 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 117.15 -177.53 16.7 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.483 1.114 . . . . 0.0 110.987 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 2.7 m -126.35 113.49 16.98 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.478 0.752 . . . . 0.0 109.97 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 289' ' ' GLU . 32.7 m -99.26 135.1 35.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.493 1.121 . . . . 0.0 109.325 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 29.3 t -104.16 148.49 26.23 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.475 1.109 . . . . 0.0 109.997 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 288' ' ' VAL . 1.7 t -112.27 128.92 68.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.482 1.113 . . . . 0.0 109.319 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.415 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -77.34 100.96 6.11 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.538 1.149 . . . . 0.0 109.282 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' THR . . . . . 0.661 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.9 OUTLIER -149.37 -167.99 0.17 Allowed Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.455 1.097 . . . . 0.0 110.382 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.661 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.4 Cg_endo -75.0 3.93 5.19 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.51 1.794 . . . . 0.0 111.028 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.415 ' O ' HG23 ' A' ' 288' ' ' VAL . 26.4 m120 -152.21 154.82 32.76 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.448 1.093 . . . . 0.0 109.276 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 95.48 0.98 Allowed 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.515 1.797 . . . . 0.0 110.981 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 286' ' ' ASN . 1.3 t -100.03 118.53 46.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.491 1.119 . . . . 0.0 109.303 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 2.5 mm-40 -125.16 133.53 52.76 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.498 1.124 . . . . 0.0 110.312 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.427 HD13 ' HA ' ' A' ' 290' ' ' LEU . 4.4 mm? -115.41 139.66 49.82 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.506 1.129 . . . . 0.0 109.324 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -95.77 -155.96 31.31 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.502 1.126 . . . . 0.0 110.98 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' PRO . . . . . 0.419 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.2 Cg_endo -75.05 138.37 22.82 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.53 1.805 . . . . 0.0 110.972 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 95.23 6.19 60.2 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.481 1.113 . . . . 0.0 110.965 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -90.58 130.75 36.58 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.461 0.742 . . . . 0.0 109.238 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 295' ' ' PHE . 2.3 p90 -120.75 152.92 37.7 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.506 1.129 . . . . 0.0 111.018 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.561 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 36.9 p90 -164.72 148.27 8.92 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.13 . . . . 0.0 110.975 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . 0.592 ' O ' HD12 ' A' ' 301' ' ' LEU . . . 128.07 -8.45 6.74 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.457 1.098 . . . . 0.0 110.989 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -54.94 -53.35 56.76 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.474 0.749 . . . . 0.0 110.319 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -46.98 -35.03 6.12 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.512 1.133 . . . . 0.0 110.979 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . 0.458 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -68.74 -46.91 67.64 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.515 1.134 . . . . 0.0 109.324 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.757 HD11 ' HB2' ' A' ' 272' ' ' MET . 1.1 mp -75.21 -3.21 31.76 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.475 1.11 . . . . 0.0 109.312 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . 0.42 HD13 ' CZ ' ' A' ' 341' ' ' PHE . 8.8 mm -86.85 -54.35 8.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.509 1.131 . . . . 0.0 109.296 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 304' ' ' GLY . 0.9 OUTLIER -149.44 40.89 0.86 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.47 1.106 . . . . 0.0 110.036 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 37.03 34.04 0.1 OUTLIER Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.54 1.15 . . . . 0.0 110.989 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.72 155.23 89.88 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.502 0.766 . . . . 0.0 110.266 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 129.66 12.52 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.468 1.773 . . . . 0.0 111.013 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.98 -29.64 1.52 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.503 1.127 . . . . 0.0 110.273 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.506 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 0.1 OUTLIER 50.65 40.88 25.01 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.444 1.09 . . . . 0.0 109.957 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 175.26 160.82 0.24 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.497 1.123 . . . . 0.0 109.311 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.467 ' OG1' HG23 ' A' ' 265' ' ' ILE . 0.9 OUTLIER -117.78 123.43 45.97 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.539 1.149 . . . . 0.0 110.392 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.744 HG12 HD12 ' A' ' 262' ' ' ILE . 95.1 t -103.99 131.39 52.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.506 1.129 . . . . 0.0 109.279 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 65.2 p -131.54 151.27 51.72 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.475 1.109 . . . . 0.0 109.997 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.26 109.65 19.65 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.515 1.134 . . . . 0.0 109.282 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -56.41 -32.19 64.61 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.503 1.127 . . . . 0.0 109.304 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' THR . . . . . 0.843 ' O ' HG23 ' A' ' 317' ' ' VAL . 8.2 t -153.86 -171.76 3.99 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.526 1.141 . . . . 0.0 110.416 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . 0.452 ' N ' ' OG1' ' A' ' 315' ' ' THR . 43.1 p -54.74 87.91 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.554 1.159 . . . . 0.0 110.39 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.869 HG22 ' HA3' ' A' ' 278' ' ' GLY . 44.9 t -107.71 144.25 16.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.482 1.113 . . . . 0.0 109.265 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 69.1 m -117.99 117.87 30.4 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.529 1.143 . . . . 0.0 109.958 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . 0.74 HD22 HG22 ' A' ' 275' ' ' VAL . 0.0 OUTLIER -128.48 173.33 10.32 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.49 1.119 . . . . 0.0 109.328 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.672 HD11 ' CG2' ' A' ' 276' ' ' VAL . 0.2 OUTLIER -124.49 136.3 53.9 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.471 1.107 . . . . 0.0 109.298 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 14.1 t -96.23 154.63 17.15 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.513 1.133 . . . . 0.0 110.01 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.468 ' HB2' ' CD2' ' A' ' 251' ' ' LEU . 1.2 tm? -145.28 87.66 1.82 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.506 1.129 . . . . 0.0 109.268 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . 0.414 ' ND1' ' HB3' ' A' ' 325' ' ' ALA . 10.4 p80 -49.69 139.1 13.34 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.557 1.16 . . . . 0.0 109.602 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 36.0 t -59.52 -23.87 63.17 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.466 1.104 . . . . 0.0 110.006 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 0.414 ' HB3' ' ND1' ' A' ' 323' ' ' HIS . . . -55.95 -31.03 62.58 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.474 1.108 . . . . 0.0 109.325 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . 0.542 ' OD2' ' HB1' ' A' ' 250' ' ' ALA . 2.6 t70 -70.11 -38.88 75.72 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.532 1.145 . . . . 0.0 109.357 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -67.5 -36.51 81.23 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.517 1.136 . . . . 0.0 110.965 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -70.32 -37.01 74.63 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.525 1.14 . . . . 0.0 110.297 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 5.1 ttp -68.86 -40.39 79.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 0.0 111.009 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.538 HD13 ' CG1' ' A' ' 247' ' ' ILE . 9.3 mt -72.14 -34.52 68.6 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.462 1.101 . . . . 0.0 109.299 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 16.0 m -74.18 -33.32 63.41 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.488 1.117 . . . . 0.0 108.318 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 8.6 t -75.91 -36.52 59.41 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.129 . . . . 0.0 110.004 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 10.0 t -74.51 -34.34 63.01 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.487 1.117 . . . . 0.0 110.03 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' SER . . . . . 0.798 ' CB ' HD12 ' A' ' 337' ' ' ILE . 0.3 OUTLIER -128.1 114.62 20.22 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.562 1.164 . . . . 0.0 110.036 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -18.95 18.29 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.499 1.789 . . . . 0.0 111.013 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -72.37 -28.92 63.33 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 0.0 110.329 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.798 HD12 ' CB ' ' A' ' 334' ' ' SER . 46.2 mt -72.69 -41.43 62.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.554 1.159 . . . . 0.0 109.257 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.97 -32.41 65.18 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.455 1.097 . . . . 0.0 109.27 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.53 -39.75 62.16 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.491 1.12 . . . . 0.0 110.293 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 48.6 mt -73.23 -42.69 57.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.551 1.157 . . . . 0.0 109.286 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.42 ' CZ ' HD13 ' A' ' 302' ' ' ILE . 46.7 t80 -69.24 -34.26 74.55 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.55 1.157 . . . . 0.0 111.009 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . 0.461 ' HG3' ' CD1' ' A' ' 346' ' ' LEU . 1.4 ttp-105 -72.78 -39.54 66.64 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.538 1.149 . . . . 0.0 110.276 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -50.59 65.93 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.509 1.13 . . . . 0.0 109.291 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 7.6 t -65.37 -32.98 74.9 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.47 1.106 . . . . 0.0 110.453 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -66.74 -44.99 80.05 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.521 1.138 . . . . 0.0 109.334 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.461 ' CD1' ' HG3' ' A' ' 342' ' ' ARG . 0.6 OUTLIER -65.14 -37.03 86.12 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.503 1.127 . . . . 0.0 109.289 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.08 -39.22 92.89 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.472 1.107 . . . . 0.0 110.31 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 49.6 mtt-85 . . . . . 0 C--N 1.325 -0.457 0 O-C-N 124.481 1.113 . . . . 0.0 110.296 -179.998 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 40.0 t80 . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 120.534 0.206 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.98 -33.29 58.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.471 1.107 . . . . 0.0 109.339 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.764 ' HD2' HG13 ' A' ' 276' ' ' VAL . 0.0 OUTLIER -67.91 -35.02 77.74 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.498 1.124 . . . . 0.0 110.308 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.681 ' OD1' HD13 ' A' ' 320' ' ' LEU . 3.7 m-20 -77.46 -30.44 53.23 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.487 1.117 . . . . 0.0 109.279 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' TRP . . . . . 0.79 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 1.9 t90 -67.58 -44.81 77.26 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.513 1.133 . . . . 0.0 108.04 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 5.7 pt20 -71.14 -35.75 71.81 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.493 1.12 . . . . 0.0 110.307 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.607 HD23 ' HD3' ' A' ' 225' ' ' ARG . 0.8 OUTLIER -61.45 -47.43 85.76 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.509 1.131 . . . . 0.0 109.323 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.621 HG12 HD13 ' A' ' 244' ' ' LEU . 99.7 t -71.76 -40.76 70.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.473 1.108 . . . . 0.0 109.274 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.58 -15.94 62.81 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.481 1.113 . . . . 0.0 109.251 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -81.34 -11.09 59.42 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.553 1.158 . . . . 0.0 109.31 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 229' ' ' LEU . 31.2 t -89.64 123.33 66.81 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.514 1.134 . . . . 0.0 109.308 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 -16.09 20.31 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.481 1.78 . . . . 0.0 110.997 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.759 HD12 ' CE2' ' A' ' 341' ' ' PHE . 0.0 OUTLIER -79.6 -24.66 41.85 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.498 1.124 . . . . 0.0 109.268 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . 0.4 ' CB ' HD12 ' A' ' 239' ' ' LEU . 3.4 m-30 -108.51 -11.88 15.08 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.537 1.148 . . . . 0.0 111.022 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.66 -24.65 66.87 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.488 1.118 . . . . 0.0 110.338 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -74.62 -4.45 37.21 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.516 1.135 . . . . 0.0 109.333 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.557 HD22 HG11 ' A' ' 243' ' ' VAL . 12.5 mt -85.0 -179.65 7.1 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.45 1.094 . . . . 0.0 109.321 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . 0.633 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -103.24 -172.66 26.15 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.489 1.118 . . . . 0.0 111.012 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.906 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.2 Cg_endo -75.02 -36.14 2.71 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.464 1.77 . . . . 0.0 111.02 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.04 -35.31 78.04 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.533 1.146 . . . . 0.0 109.299 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.636 HG21 HD11 ' A' ' 337' ' ' ILE . 13.0 t -75.33 -36.58 36.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.451 1.095 . . . . 0.0 109.258 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.633 HD23 ' O ' ' A' ' 240' ' ' GLY . 1.6 mm? -70.54 -35.48 73.16 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.499 1.125 . . . . 0.0 109.304 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.906 HG23 ' O ' ' A' ' 241' ' ' PRO . 96.4 t -72.85 -38.28 56.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.473 1.108 . . . . 0.0 109.334 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -69.06 -49.7 55.1 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.514 1.134 . . . . 0.0 110.235 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.513 HD12 HG12 ' A' ' 243' ' ' VAL . 14.1 mt -63.13 -35.63 72.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.502 1.127 . . . . 0.0 109.319 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 244' ' ' LEU . 4.6 t -67.51 -41.13 85.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.526 1.141 . . . . 0.0 109.309 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -77.23 -13.03 60.01 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.489 1.118 . . . . 0.0 110.298 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -89.18 -17.46 29.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.461 1.101 . . . . 0.0 109.311 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.59 HD23 ' HB2' ' A' ' 322' ' ' LEU . 3.2 mt -65.89 144.53 56.75 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.456 1.097 . . . . 0.0 109.294 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 320' ' ' LEU . 0.0 OUTLIER -119.75 133.15 55.72 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.535 1.147 . . . . 0.0 110.284 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.657 ' HA ' HD23 ' A' ' 320' ' ' LEU . . . -80.63 130.91 35.38 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.462 1.101 . . . . 0.0 109.284 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.22 125.03 19.63 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.489 1.118 . . . . 0.0 110.295 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 13.4 m -91.07 116.53 28.88 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.49 1.119 . . . . 0.0 110.381 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.626 HG12 ' CB ' ' A' ' 313' ' ' ALA . 24.4 t -107.05 111.63 63.5 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 124.533 1.145 . . . . 0.0 109.315 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.96 176.38 9.98 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.482 1.78 . . . . 0.0 111.039 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.521 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -67.8 134.14 50.44 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.505 1.128 . . . . 0.0 109.304 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 89.15 -25.53 10.13 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.501 1.126 . . . . 0.0 110.981 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.547 ' HB3' HG13 ' A' ' 256' ' ' VAL . . . -55.43 148.49 15.15 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.489 0.758 . . . . 0.0 109.285 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 2.7 t -96.93 129.7 46.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.536 1.148 . . . . 0.0 109.309 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.793 HD12 HG12 ' A' ' 311' ' ' VAL . 65.7 mt -84.81 -45.77 17.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.533 1.145 . . . . 0.0 109.303 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 13.5 p -154.97 149.71 26.58 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.486 1.116 . . . . 0.0 108.333 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -89.53 175.9 7.1 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.128 . . . . 0.0 110.308 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.503 HD13 ' H ' ' A' ' 265' ' ' ILE . 0.2 OUTLIER -76.97 141.16 16.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.503 1.127 . . . . 0.0 109.321 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 45.67 49.46 12.11 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.524 1.14 . . . . 0.0 110.974 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.472 ' HG3' ' N ' ' A' ' 268' ' ' PRO . 2.9 pt-20 -73.1 173.75 5.58 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.48 0.753 . . . . 0.0 110.275 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.472 ' N ' ' HG3' ' A' ' 267' ' ' GLU . 18.2 Cg_endo -75.01 97.1 1.05 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.493 1.786 . . . . 0.0 110.967 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -50.88 89.46 0.01 OUTLIER Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.465 1.103 . . . . 0.0 110.964 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 268' ' ' PRO . 40.6 m-20 -170.39 38.36 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.48 0.753 . . . . 0.0 109.3 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -171.23 149.21 2.78 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.504 1.128 . . . . 0.0 110.353 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.489 ' SD ' ' CD1' ' A' ' 301' ' ' LEU . 8.3 ptm -138.74 146.97 42.1 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.5 1.125 . . . . 0.0 110.97 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.575 ' HB2' ' CE1' ' A' ' 296' ' ' PHE . 34.0 m-85 -124.98 151.48 45.46 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.528 1.143 . . . . 0.0 110.943 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . 0.502 ' CD1' ' HB3' ' A' ' 295' ' ' PHE . 23.6 m-85 -129.48 124.89 35.14 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.497 1.123 . . . . 0.0 110.99 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 1.074 HG22 HD23 ' A' ' 319' ' ' LEU . 76.2 t -79.7 138.19 20.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.477 1.11 . . . . 0.0 109.278 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.764 HG13 ' HD2' ' A' ' 225' ' ' ARG . 2.9 t -116.14 -47.54 4.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.443 1.089 . . . . 0.0 109.304 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.479 ' O ' HG23 ' A' ' 317' ' ' VAL . 5.9 mt-10 -145.62 135.9 23.94 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.533 1.146 . . . . 0.0 110.318 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.404 ' HA3' ' HB ' ' A' ' 317' ' ' VAL . . . 115.63 -155.11 16.5 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.535 1.147 . . . . 0.0 110.99 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 3.1 m -151.32 138.62 19.36 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.461 0.742 . . . . 0.0 109.982 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.474 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 17.6 m -117.59 166.77 11.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.496 1.122 . . . . 0.0 109.287 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 29.4 t -131.9 155.47 47.83 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.475 1.109 . . . . 0.0 109.983 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.508 HG13 HG22 ' A' ' 311' ' ' VAL . 0.3 OUTLIER -119.12 129.37 75.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.474 1.109 . . . . 0.0 109.308 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.4 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -77.77 101.85 6.9 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.512 1.133 . . . . 0.0 109.271 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' THR . . . . . 0.649 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.39 -168.62 0.19 Allowed Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.509 1.13 . . . . 0.0 110.392 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.649 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -74.98 4.88 4.33 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.469 1.773 . . . . 0.0 110.965 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -151.83 157.12 34.53 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.455 1.097 . . . . 0.0 109.31 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.98 94.89 0.96 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.488 1.783 . . . . 0.0 110.981 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 281' ' ' SER . 31.2 t -99.04 119.45 47.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.498 1.123 . . . . 0.0 109.323 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 14.4 mt-10 -124.33 136.89 54.44 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.491 1.119 . . . . 0.0 110.296 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.474 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 3.9 mm? -114.76 142.83 45.99 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.533 1.145 . . . . 0.0 109.288 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -98.44 -164.97 30.78 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.497 1.123 . . . . 0.0 110.981 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' PRO . . . . . 0.642 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.3 Cg_endo -74.98 156.23 43.07 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.454 1.765 . . . . 0.0 110.974 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.433 ' HA2' HD21 ' A' ' 229' ' ' LEU . . . 77.37 2.17 78.44 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.508 1.13 . . . . 0.0 110.973 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . 0.406 ' HB1' HD12 ' A' ' 290' ' ' LEU . . . -87.79 136.05 33.12 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.518 0.775 . . . . 0.0 109.325 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.502 ' HB3' ' CD1' ' A' ' 274' ' ' PHE . 0.7 OUTLIER -123.76 153.05 41.47 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.508 1.13 . . . . 0.0 110.983 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.575 ' CE1' ' HB2' ' A' ' 273' ' ' PHE . 51.7 p90 -163.52 143.35 8.54 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.515 1.134 . . . . 0.0 110.962 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . 0.469 ' HA3' ' CB ' ' A' ' 272' ' ' MET . . . 137.57 -14.31 3.67 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.499 1.125 . . . . 0.0 110.943 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -52.84 -44.41 66.72 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.514 0.773 . . . . 0.0 110.311 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . 0.487 ' CE ' HD12 ' A' ' 302' ' ' ILE . 0.1 OUTLIER -47.37 -39.11 14.41 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.487 1.117 . . . . 0.0 111.003 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -72.64 -37.16 68.08 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.489 1.118 . . . . 0.0 109.31 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.489 ' CD1' ' SD ' ' A' ' 272' ' ' MET . 4.5 mt -76.67 -5.47 48.06 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.485 1.116 . . . . 0.0 109.34 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . 0.674 HG23 ' HB1' ' A' ' 345' ' ' ALA . 22.0 mt -91.81 -51.43 11.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.475 1.109 . . . . 0.0 109.261 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.442 ' O ' ' C ' ' A' ' 304' ' ' GLY . 1.2 m -151.94 41.01 0.65 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.506 1.129 . . . . 0.0 109.954 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 34.7 39.97 0.18 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.498 1.123 . . . . 0.0 110.99 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' GLU . . . . . 0.425 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 0.5 OUTLIER -68.17 151.05 97.48 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.505 0.768 . . . . 0.0 110.292 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 132.36 15.37 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.532 1.806 . . . . 0.0 111.03 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . 0.425 ' NH2' ' HA2' ' A' ' 297' ' ' GLY . 10.5 mmp_? -44.39 -44.92 8.65 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.436 1.085 . . . . 0.0 110.309 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.57 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 0.3 OUTLIER 66.31 38.18 4.58 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.483 1.114 . . . . 0.0 109.991 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' ALA . . . . . 0.57 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 171.73 160.88 0.1 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.532 1.145 . . . . 0.0 109.308 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.89 125.48 52.85 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.529 1.143 . . . . 0.0 110.409 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.793 HG12 HD12 ' A' ' 262' ' ' ILE . 77.7 t -103.3 127.7 56.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 0.0 109.318 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 87.5 p -127.86 157.45 40.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.516 1.135 . . . . 0.0 109.994 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . 0.821 ' HB1' ' CG1' ' A' ' 317' ' ' VAL . . . -89.19 112.99 24.14 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.502 1.126 . . . . 0.0 109.319 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -54.3 -32.71 57.12 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.55 1.156 . . . . 0.0 109.35 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' THR . . . . . 0.68 ' O ' HG12 ' A' ' 317' ' ' VAL . 9.8 t -158.63 -159.05 0.75 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.462 1.101 . . . . 0.0 110.44 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . 0.443 ' N ' ' OG1' ' A' ' 315' ' ' THR . 86.6 m -66.03 81.26 0.08 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.525 1.141 . . . . 0.0 110.38 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.821 ' CG1' ' HB1' ' A' ' 313' ' ' ALA . 1.3 p -108.26 140.98 24.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.491 1.12 . . . . 0.0 109.265 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 49.2 m -112.3 127.73 56.07 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.511 1.132 . . . . 0.0 110.003 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . 1.074 HD23 HG22 ' A' ' 275' ' ' VAL . 0.0 OUTLIER -134.81 174.71 10.28 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.555 1.159 . . . . 0.0 109.295 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.681 HD13 ' OD1' ' A' ' 226' ' ' ASN . 1.0 OUTLIER -124.18 135.27 53.35 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.499 1.124 . . . . 0.0 109.312 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 53.9 p -96.86 150.66 20.49 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.531 1.144 . . . . 0.0 109.994 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.59 ' HB2' HD23 ' A' ' 251' ' ' LEU . 2.6 tm? -146.17 104.02 3.77 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.529 1.143 . . . . 0.0 109.304 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -65.15 138.53 58.34 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.448 1.092 . . . . 0.0 109.578 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . 0.426 ' HA ' HD21 ' A' ' 301' ' ' LEU . 89.2 p -59.81 -19.65 52.03 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.48 1.113 . . . . 0.0 109.985 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -51.22 -35.36 36.3 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.514 1.134 . . . . 0.0 109.261 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . 0.585 ' OD1' HD11 ' A' ' 322' ' ' LEU . 3.2 p-10 -65.84 -38.38 88.72 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.508 1.13 . . . . 0.0 109.295 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -67.85 -37.79 82.33 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.5 1.125 . . . . 0.0 110.981 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -68.81 -32.49 72.23 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.515 1.134 . . . . 0.0 110.31 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 15.6 tmm? -70.58 -43.2 69.9 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.519 1.137 . . . . 0.0 111.022 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.82 -31.2 61.63 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.124 . . . . 0.0 109.278 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' CYS . . . . . 0.422 ' CB ' ' HB2' ' A' ' 338' ' ' ALA . 1.8 m -75.0 -39.74 61.03 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.457 1.098 . . . . 0.0 108.297 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 26.3 t -70.8 -32.55 69.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.53 1.144 . . . . 0.0 110.013 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 31.9 t -79.16 -35.68 41.59 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.511 1.132 . . . . 0.0 109.988 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 1.5 m -128.96 109.16 18.3 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.522 1.139 . . . . 0.0 109.972 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 -20.26 17.04 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.504 1.792 . . . . 0.0 111.052 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.453 ' O ' ' CG1' ' A' ' 340' ' ' ILE . 1.2 tt0 -66.1 -37.26 85.31 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 0.0 110.347 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.636 HD11 HG21 ' A' ' 243' ' ' VAL . 88.1 mt -75.97 -42.8 39.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.44 1.088 . . . . 0.0 109.285 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . 0.422 ' HB2' ' CB ' ' A' ' 331' ' ' CYS . . . -64.83 -45.23 87.02 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.484 1.115 . . . . 0.0 109.315 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.52 -33.37 74.0 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.49 1.119 . . . . 0.0 110.314 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.453 ' CG1' ' O ' ' A' ' 336' ' ' GLU . 21.1 mt -70.17 -40.66 78.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.519 1.137 . . . . 0.0 109.341 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.759 ' CE2' HD12 ' A' ' 235' ' ' LEU . 2.7 t80 -69.08 -35.13 76.15 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.499 1.125 . . . . 0.0 111.036 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 27.7 ttt-85 -70.37 -38.94 74.85 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.494 1.121 . . . . 0.0 110.318 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -51.07 63.16 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.535 1.147 . . . . 0.0 109.328 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . 0.46 HG22 ' HA ' ' A' ' 341' ' ' PHE . 13.1 t -68.64 -33.32 73.82 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.497 1.123 . . . . 0.0 110.43 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . 0.674 ' HB1' HG23 ' A' ' 302' ' ' ILE . . . -70.18 -36.44 74.66 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.445 1.091 . . . . 0.0 109.301 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 346' ' ' LEU . 11.7 mt -69.28 -40.94 77.47 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.471 1.107 . . . . 0.0 109.318 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -68.42 -34.05 75.31 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.486 1.116 . . . . 0.0 110.323 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 34.3 mtt-85 . . . . . 0 C--N 1.325 -0.48 0 O-C-N 124.474 1.109 . . . . 0.0 110.285 179.97 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 46.9 t80 . . . . . 0 N--CA 1.453 -0.284 0 CA-C-O 120.505 0.193 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.55 -39.64 40.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.124 . . . . 0.0 109.252 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.401 ' HG3' HD12 ' A' ' 229' ' ' LEU . 13.6 tpp85 -68.37 -30.64 69.63 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.115 . . . . 0.0 110.275 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.705 HD21 HD22 ' A' ' 320' ' ' LEU . 2.2 m-20 -79.3 -41.4 28.12 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.408 1.068 . . . . 0.0 109.302 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' TRP . . . . . 0.485 ' O ' HG22 ' A' ' 230' ' ' VAL . 4.5 t90 -66.68 -44.52 81.54 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.527 1.142 . . . . 0.0 107.977 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.611 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 2.6 pt20 -67.71 -31.63 71.71 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.478 1.111 . . . . 0.0 110.31 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.401 HD12 ' HG3' ' A' ' 225' ' ' ARG . 1.6 mt -63.54 -45.08 92.2 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.514 1.133 . . . . 0.0 109.316 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.87 HG23 HD12 ' A' ' 244' ' ' LEU . 35.2 m -74.55 -38.78 46.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.528 1.143 . . . . 0.0 109.33 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -75.42 -11.78 60.11 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.47 1.106 . . . . 0.0 109.336 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -81.32 -23.99 37.44 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.525 1.14 . . . . 0.0 109.247 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . 0.583 HG12 ' O ' ' A' ' 230' ' ' VAL . 0.4 OUTLIER -81.35 130.93 60.23 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.475 1.109 . . . . 0.0 109.263 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.42 ' HA ' ' HB2' ' A' ' 237' ' ' GLN . 18.2 Cg_endo -75.02 -16.75 19.98 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.513 1.796 . . . . 0.0 110.982 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.455 HD21 HD11 ' A' ' 302' ' ' ILE . 0.1 OUTLIER -63.34 -30.04 71.24 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.456 1.098 . . . . 0.0 109.33 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . 0.539 ' HB3' HD12 ' A' ' 239' ' ' LEU . 16.1 m-30 -112.95 17.08 19.18 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.538 1.149 . . . . 0.0 111.003 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' GLN . . . . . 0.42 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 2.1 mt-30 -70.01 -20.02 63.29 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.549 1.155 . . . . 0.0 110.282 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -92.58 -12.37 31.94 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.508 1.13 . . . . 0.0 109.302 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.744 HD22 HG11 ' A' ' 243' ' ' VAL . 46.0 mt -70.11 179.26 2.41 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.46 1.1 . . . . 0.0 109.276 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . 0.691 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -109.79 -174.89 20.94 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.509 1.131 . . . . 0.0 111.006 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 -32.84 5.13 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.485 1.782 . . . . 0.0 111.065 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.507 ' HA ' HG12 ' A' ' 245' ' ' VAL . . . -73.09 -33.2 65.47 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.457 1.098 . . . . 0.0 109.284 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.744 HG11 HD22 ' A' ' 239' ' ' LEU . 63.5 t -77.09 -36.59 24.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.474 1.109 . . . . 0.0 109.334 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.87 HD12 HG23 ' A' ' 230' ' ' VAL . 3.8 mm? -72.57 -42.65 64.4 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.497 1.123 . . . . 0.0 109.289 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.507 HG12 ' HA ' ' A' ' 242' ' ' ALA . 2.8 p -68.21 -39.51 81.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.465 1.103 . . . . 0.0 109.261 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -70.88 -40.99 71.91 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.52 1.138 . . . . 0.0 110.284 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.649 ' CG1' HD13 ' A' ' 330' ' ' LEU . 25.6 mt -66.56 -51.97 51.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.503 1.127 . . . . 0.0 109.278 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.706 ' HA ' HD12 ' A' ' 251' ' ' LEU . 10.0 p -62.87 -30.74 50.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.48 1.113 . . . . 0.0 109.315 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.454 ' CG ' ' O ' ' A' ' 245' ' ' VAL . 16.6 mmm-85 -73.55 -25.77 60.54 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.542 1.151 . . . . 0.0 110.283 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -85.2 -17.98 35.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 0.0 109.297 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.706 HD12 ' HA ' ' A' ' 248' ' ' VAL . 0.3 OUTLIER -59.41 144.24 47.43 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 0.0 109.339 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 320' ' ' LEU . 3.2 mmm180 -118.18 135.09 54.45 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.558 1.161 . . . . 0.0 110.331 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -80.68 123.18 27.96 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.532 1.145 . . . . 0.0 109.303 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.6 ttm-85 -125.05 123.49 39.9 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.462 1.101 . . . . 0.0 110.34 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 50.2 m -91.51 117.65 29.89 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.484 1.115 . . . . 0.0 110.428 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.506 ' CG2' HD21 ' A' ' 319' ' ' LEU . 2.6 t -109.41 113.46 58.36 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.524 1.14 . . . . 0.0 109.285 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -75.0 168.71 24.24 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.543 1.812 . . . . 0.0 111.011 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.555 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -65.93 126.34 28.24 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.524 1.14 . . . . 0.0 109.286 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 100.59 -25.32 28.75 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.489 1.118 . . . . 0.0 111.003 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.49 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -67.27 145.08 55.52 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.497 0.763 . . . . 0.0 109.301 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 5.8 t -94.82 135.02 30.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.504 1.128 . . . . 0.0 109.299 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.806 HD12 HG12 ' A' ' 311' ' ' VAL . 17.8 mt -82.95 -42.74 18.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.541 1.151 . . . . 0.0 109.29 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' CYS . . . . . 0.604 ' SG ' HG23 ' A' ' 311' ' ' VAL . 11.3 p -152.4 142.61 22.4 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.49 1.119 . . . . 0.0 108.289 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 3.4 mmt85 -84.87 178.58 7.56 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.5 1.125 . . . . 0.0 110.277 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.425 ' CG2' ' HB ' ' A' ' 310' ' ' THR . 0.1 OUTLIER -76.57 137.44 22.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.513 1.133 . . . . 0.0 109.327 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 52.95 50.81 49.34 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.46 1.1 . . . . 0.0 111.026 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -70.37 163.89 58.6 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.486 0.756 . . . . 0.0 110.302 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.507 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.3 Cg_endo -74.98 82.77 1.93 Allowed 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.532 1.806 . . . . 0.0 111.051 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . 0.44 ' CA ' ' HB1' ' A' ' 300' ' ' ALA . . . -36.07 93.16 0.01 OUTLIER Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.477 1.111 . . . . 0.0 110.994 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 268' ' ' PRO . 12.3 m-20 -171.63 37.93 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.528 0.781 . . . . 0.0 109.335 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . 0.426 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 3.3 mtp180 -169.89 144.54 2.79 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.537 1.148 . . . . 0.0 110.359 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.857 ' HB2' HD11 ' A' ' 301' ' ' LEU . 2.2 ttt -118.34 147.63 43.3 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.505 1.128 . . . . 0.0 110.99 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.571 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 28.4 m-85 -135.8 136.65 40.86 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.506 1.128 . . . . 0.0 111.006 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 319' ' ' LEU . 22.1 m-85 -125.98 127.49 46.0 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.117 . . . . 0.0 110.998 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.611 HG22 HD12 ' A' ' 319' ' ' LEU . 13.7 t -83.96 135.03 25.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.481 1.113 . . . . 0.0 109.319 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.441 HG12 ' HG2' ' A' ' 277' ' ' GLU . 40.3 t -111.75 -49.42 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.492 1.12 . . . . 0.0 109.355 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.581 ' O ' HG13 ' A' ' 317' ' ' VAL . 7.8 mm-40 -139.67 137.96 35.65 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.52 1.137 . . . . 0.0 110.337 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.822 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 112.75 -175.47 16.82 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.491 1.12 . . . . 0.0 111.003 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 290' ' ' LEU . 3.6 m -131.17 120.26 23.05 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.497 0.763 . . . . 0.0 109.964 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.452 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 28.9 m -99.03 164.67 2.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.505 1.128 . . . . 0.0 109.293 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 31.6 t -131.97 148.13 52.5 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.476 1.11 . . . . 0.0 110.017 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -111.26 129.93 65.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.44 1.087 . . . . 0.0 109.295 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.502 ' HB2' HG22 ' A' ' 310' ' ' THR . . . -77.96 101.87 7.08 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.505 1.128 . . . . 0.0 109.306 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' THR . . . . . 0.647 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -147.76 -168.55 0.19 Allowed Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.466 1.104 . . . . 0.0 110.427 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.647 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.4 Cg_endo -74.99 4.89 4.33 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.57 1.826 . . . . 0.0 111.025 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.419 ' O ' HG23 ' A' ' 288' ' ' VAL . 10.9 m120 -151.37 157.29 35.01 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.496 1.123 . . . . 0.0 109.271 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.1 93.85 0.97 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.51 1.795 . . . . 0.0 110.98 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 281' ' ' SER . 4.1 t -97.94 119.37 45.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.115 . . . . 0.0 109.293 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.565 ' C ' HD22 ' A' ' 290' ' ' LEU . 15.4 mt-10 -124.7 140.25 53.11 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.557 1.161 . . . . 0.0 110.315 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.565 HD22 ' C ' ' A' ' 289' ' ' GLU . 4.5 mm? -121.81 141.71 50.95 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.505 1.128 . . . . 0.0 109.304 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -96.9 -160.06 31.69 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.498 1.124 . . . . 0.0 111.038 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' PRO . . . . . 0.481 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.2 Cg_endo -75.03 142.02 27.24 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.478 1.778 . . . . 0.0 110.982 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 91.46 4.39 68.19 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.508 1.13 . . . . 0.0 111.002 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -92.04 127.76 37.63 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.436 0.727 . . . . 0.0 109.293 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.454 ' CB ' ' CD1' ' A' ' 274' ' ' PHE . 2.4 p90 -114.36 152.8 30.9 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.468 1.105 . . . . 0.0 110.979 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.681 ' HZ ' HG21 ' A' ' 262' ' ' ILE . 33.7 p90 -158.07 148.75 20.67 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.534 1.146 . . . . 0.0 111.018 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 123.54 -5.64 9.25 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.474 1.109 . . . . 0.0 110.955 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -55.83 -46.31 78.14 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.504 0.767 . . . . 0.0 110.305 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 36.9 mmt -51.89 -37.14 51.21 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 0.0 110.984 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . 0.44 ' HB1' ' CA ' ' A' ' 269' ' ' GLY . . . -67.42 -41.27 85.11 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.489 1.118 . . . . 0.0 109.278 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.857 HD11 ' HB2' ' A' ' 272' ' ' MET . 1.5 mt -77.32 -11.32 59.82 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.563 1.164 . . . . 0.0 109.331 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . 0.5 HD13 ' HA ' ' A' ' 302' ' ' ILE . 7.0 mm -77.17 -56.09 8.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.483 1.114 . . . . 0.0 109.272 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.46 ' O ' ' N ' ' A' ' 305' ' ' GLU . 53.2 p -151.32 48.37 0.83 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.458 1.099 . . . . 0.0 110.026 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 303' ' ' SER . . . 35.08 34.22 0.05 OUTLIER Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.574 1.172 . . . . 0.0 110.991 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' GLU . . . . . 0.46 ' N ' ' O ' ' A' ' 303' ' ' SER . 0.0 OUTLIER -70.24 151.52 95.84 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.522 0.778 . . . . 0.0 110.297 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 134.15 17.46 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.477 1.777 . . . . 0.0 110.991 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -44.39 -42.47 6.94 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.468 1.105 . . . . 0.0 110.322 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 2.2 t 67.35 28.56 7.84 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 0.0 110.009 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . -176.61 160.55 2.01 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.447 1.092 . . . . 0.0 109.282 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.502 HG22 ' HB2' ' A' ' 283' ' ' ALA . 0.3 OUTLIER -108.59 123.64 49.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.512 1.132 . . . . 0.0 110.392 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.806 HG12 HD12 ' A' ' 262' ' ' ILE . 43.5 t -103.17 130.31 53.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.52 1.138 . . . . 0.0 109.298 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 56.9 p -134.94 157.42 46.94 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.463 1.102 . . . . 0.0 109.993 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . 0.505 ' CB ' HG12 ' A' ' 256' ' ' VAL . . . -95.52 116.13 28.39 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.457 1.098 . . . . 0.0 109.299 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -60.22 -33.42 72.23 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.496 1.123 . . . . 0.0 109.276 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' THR . . . . . 0.831 ' O ' HG23 ' A' ' 317' ' ' VAL . 10.2 t -149.77 -173.49 4.43 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.436 1.085 . . . . 0.0 110.403 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 316' ' ' THR . 43.8 p -53.76 88.18 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.513 1.133 . . . . 0.0 110.417 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.834 HG12 ' CD1' ' A' ' 319' ' ' LEU . 57.8 t -107.56 145.82 14.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.533 1.145 . . . . 0.0 109.257 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . 0.741 ' C ' HD13 ' A' ' 319' ' ' LEU . 50.3 m -122.95 118.31 27.53 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.492 1.12 . . . . 0.0 109.982 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . 0.834 ' CD1' HG12 ' A' ' 317' ' ' VAL . 0.0 OUTLIER -126.22 175.09 8.04 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.125 . . . . 0.0 109.309 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.705 HD22 HD21 ' A' ' 226' ' ' ASN . 0.5 OUTLIER -124.55 130.95 53.4 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.441 1.088 . . . . 0.0 109.314 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 73.6 p -92.23 157.06 16.89 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 0.0 109.997 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -148.55 92.03 1.96 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.458 1.099 . . . . 0.0 109.293 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . 0.461 ' ND1' ' HB3' ' A' ' 325' ' ' ALA . 5.8 p80 -54.61 135.18 46.77 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.534 1.146 . . . . 0.0 109.615 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 3.4 t -53.66 -26.45 22.52 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.505 1.128 . . . . 0.0 109.984 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 0.461 ' HB3' ' ND1' ' A' ' 323' ' ' HIS . . . -50.66 -35.48 30.99 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.546 1.154 . . . . 0.0 109.285 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -64.73 -41.5 95.9 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.517 1.136 . . . . 0.0 109.318 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' PHE . . . . . 0.465 ' CE1' ' CE2' ' A' ' 341' ' ' PHE . 80.3 t80 -67.38 -32.77 73.91 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.467 1.105 . . . . 0.0 111.046 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -70.49 -37.71 74.24 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.469 1.106 . . . . 0.0 110.343 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 16.5 tmm? -67.98 -41.34 82.48 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.467 1.104 . . . . 0.0 111.032 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.649 HD13 ' CG1' ' A' ' 247' ' ' ILE . 6.4 mt -73.23 -35.03 66.22 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.492 1.12 . . . . 0.0 109.284 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' CYS . . . . . 0.812 ' SG ' ' HB2' ' A' ' 338' ' ' ALA . 41.4 t -68.84 -35.19 76.64 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.499 1.125 . . . . 0.0 108.296 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.8 t -72.97 -39.2 66.33 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.127 . . . . 0.0 109.979 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.2 t -73.49 -28.43 61.91 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.503 1.127 . . . . 0.0 109.979 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' SER . . . . . 0.466 ' CB ' HD12 ' A' ' 337' ' ' ILE . 0.5 OUTLIER -128.92 103.78 18.71 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 124.51 1.131 . . . . 0.0 110.016 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -21.64 15.61 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.469 1.773 . . . . 0.0 111.01 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.87 -28.78 60.79 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.539 1.149 . . . . 0.0 110.312 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.638 HD11 HG21 ' A' ' 243' ' ' VAL . 34.4 mt -68.69 -30.84 48.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.126 . . . . 0.0 109.302 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . 0.812 ' HB2' ' SG ' ' A' ' 331' ' ' CYS . . . -69.81 -37.54 76.29 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.476 1.11 . . . . 0.0 109.34 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -72.87 -36.73 67.45 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.458 1.099 . . . . 0.0 110.326 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 31.1 mt -71.68 -42.71 71.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.445 1.091 . . . . 0.0 109.305 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.465 ' CE2' ' CE1' ' A' ' 327' ' ' PHE . 40.2 t80 -66.95 -36.88 83.22 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.45 1.094 . . . . 0.0 111.04 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -72.94 -34.79 66.77 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.489 1.118 . . . . 0.0 110.269 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -50.75 65.3 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.511 1.132 . . . . 0.0 109.344 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 341' ' ' PHE . 8.8 t -65.13 -38.0 89.22 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.498 1.124 . . . . 0.0 110.372 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -67.17 -35.74 80.31 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.536 1.147 . . . . 0.0 109.301 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.508 ' HA ' HD23 ' A' ' 346' ' ' LEU . 9.3 mt -71.48 -33.87 69.66 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.492 1.12 . . . . 0.0 109.317 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.6 -34.73 70.13 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.531 1.145 . . . . 0.0 110.285 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 39.0 mtt-85 . . . . . 0 C--N 1.325 -0.467 0 O-C-N 124.48 1.112 . . . . 0.0 110.328 179.975 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 35.0 t80 . . . . . 0 N--CA 1.453 -0.307 0 CA-C-O 120.474 0.178 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.86 -36.56 52.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.532 1.145 . . . . 0.0 109.309 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.659 ' HD2' HG13 ' A' ' 276' ' ' VAL . 0.0 OUTLIER -67.48 -37.05 82.3 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.511 1.132 . . . . 0.0 110.296 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.823 ' O ' HG23 ' A' ' 230' ' ' VAL . 4.0 t30 -76.37 -30.64 57.63 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.551 1.157 . . . . 0.0 109.29 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' TRP . . . . . 0.866 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 3.0 t90 -66.31 -45.59 79.84 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.485 1.116 . . . . 0.0 108.019 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.628 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 6.4 pt20 -71.27 -34.82 71.06 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.517 1.135 . . . . 0.0 110.35 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.547 HD21 ' HA2' ' A' ' 293' ' ' GLY . 0.3 OUTLIER -63.56 -48.49 77.24 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.482 1.114 . . . . 0.0 109.267 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 226' ' ' ASN . 38.3 t -69.89 -43.08 79.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.432 1.082 . . . . 0.0 109.271 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.34 -16.63 63.01 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.476 1.11 . . . . 0.0 109.309 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.628 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -80.67 -19.32 45.5 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.448 1.092 . . . . 0.0 109.332 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 229' ' ' LEU . 84.4 t -81.25 137.02 49.17 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.485 1.116 . . . . 0.0 109.276 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.468 ' HD2' HG13 ' A' ' 233' ' ' VAL . 18.3 Cg_endo -75.01 -40.32 0.93 Allowed 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.59 1.837 . . . . 0.0 111.001 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.659 HD12 ' HB2' ' A' ' 298' ' ' GLU . 11.0 mt -60.81 -15.48 30.42 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.444 1.09 . . . . 0.0 109.333 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . 0.649 ' CE1' HD13 ' A' ' 247' ' ' ILE . 1.4 m-85 -106.56 -22.94 12.61 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.51 1.131 . . . . 0.0 110.959 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' GLN . . . . . 0.404 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 0.4 OUTLIER -64.1 -18.73 64.69 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.483 1.115 . . . . 0.0 110.362 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -75.15 -9.67 58.76 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.498 1.124 . . . . 0.0 109.252 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.71 HD13 HG11 ' A' ' 243' ' ' VAL . 12.0 mt -96.66 -179.19 4.51 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.493 1.12 . . . . 0.0 109.325 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . 0.419 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -100.99 -173.56 29.0 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.487 1.117 . . . . 0.0 110.976 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.849 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.3 Cg_endo -74.97 -34.47 3.83 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.474 1.776 . . . . 0.0 110.98 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.96 -36.41 80.03 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.502 1.126 . . . . 0.0 109.311 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.71 HG11 HD13 ' A' ' 239' ' ' LEU . 3.0 t -72.64 -42.83 62.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.53 1.144 . . . . 0.0 109.296 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.76 ' CD1' HG12 ' A' ' 230' ' ' VAL . 0.9 OUTLIER -66.37 -37.68 85.83 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.502 1.126 . . . . 0.0 109.287 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.866 HG22 ' CZ2' ' A' ' 227' ' ' TRP . 53.6 t -66.11 -42.94 92.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.497 1.123 . . . . 0.0 109.287 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.59 -45.24 87.81 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.507 1.129 . . . . 0.0 110.302 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.649 HD13 ' CE1' ' A' ' 236' ' ' PHE . 38.3 mt -62.93 -45.41 98.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.439 1.087 . . . . 0.0 109.259 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 244' ' ' LEU . 45.6 t -62.8 -33.39 59.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 0.0 109.297 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -77.34 -19.48 56.26 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.514 1.134 . . . . 0.0 110.277 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -95.91 2.86 53.86 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.469 1.106 . . . . 0.0 109.308 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.612 HD22 HD21 ' A' ' 226' ' ' ASN . 0.2 OUTLIER -87.17 148.31 25.23 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.524 1.14 . . . . 0.0 109.328 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.34 126.82 50.39 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.512 1.132 . . . . 0.0 110.265 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.481 ' HB2' HD23 ' A' ' 320' ' ' LEU . . . -83.26 122.75 28.83 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.509 1.131 . . . . 0.0 109.318 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.57 134.79 47.93 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.49 1.119 . . . . 0.0 110.289 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 52.3 m -93.46 121.05 34.46 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.505 1.128 . . . . 0.0 110.414 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.871 HG21 HD11 ' A' ' 319' ' ' LEU . 92.2 t -106.79 113.72 62.49 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.513 1.133 . . . . 0.0 109.329 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.497 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.98 173.48 14.43 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.44 1.758 . . . . 0.0 110.976 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.584 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -66.06 131.04 45.27 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.506 1.128 . . . . 0.0 109.322 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 94.24 -25.52 21.93 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.537 1.148 . . . . 0.0 110.969 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.497 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -57.92 146.28 32.75 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.518 0.775 . . . . 0.0 109.302 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.433 HG21 HH21 ' A' ' 264' ' ' ARG . 3.7 t -97.33 131.58 43.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.486 1.116 . . . . 0.0 109.301 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.775 HD12 HG12 ' A' ' 311' ' ' VAL . 67.9 mt -84.44 -42.27 16.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.5 1.125 . . . . 0.0 109.281 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' CYS . . . . . 0.491 ' SG ' HG23 ' A' ' 311' ' ' VAL . 14.0 p -157.5 148.91 21.82 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.492 1.12 . . . . 0.0 108.311 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' ARG . . . . . 0.433 HH21 HG21 ' A' ' 261' ' ' VAL . 3.3 mmt85 -88.16 179.85 6.3 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.484 1.115 . . . . 0.0 110.315 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.507 HG23 ' CB ' ' A' ' 310' ' ' THR . 0.0 OUTLIER -77.96 140.07 17.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.447 1.092 . . . . 0.0 109.301 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 47.78 50.1 20.89 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.498 1.123 . . . . 0.0 111.012 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.448 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.0 OUTLIER -70.75 164.06 58.8 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.451 0.736 . . . . 0.0 110.301 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.448 ' HD2' ' HB2' ' A' ' 267' ' ' GLU . 18.1 Cg_endo -75.01 91.78 1.01 Allowed 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.474 1.776 . . . . 0.0 110.942 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -43.93 94.4 0.01 OUTLIER Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.489 1.118 . . . . 0.0 110.945 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 268' ' ' PRO . 0.5 OUTLIER -170.2 38.28 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.471 0.748 . . . . 0.0 109.286 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . 0.402 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 6.0 mtt180 -170.34 145.17 2.64 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.483 1.115 . . . . 0.0 110.313 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.739 ' HB2' HD11 ' A' ' 301' ' ' LEU . 12.1 ttt -117.96 147.28 43.31 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.527 1.142 . . . . 0.0 110.964 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.569 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 56.9 m-85 -136.28 136.52 39.87 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.531 1.145 . . . . 0.0 110.998 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . 0.472 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 20.5 m-85 -125.71 134.3 51.84 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.495 1.122 . . . . 0.0 111.009 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.586 HG22 HD23 ' A' ' 319' ' ' LEU . 4.5 t -91.94 129.76 42.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.517 1.135 . . . . 0.0 109.323 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.659 HG13 ' HD2' ' A' ' 225' ' ' ARG . 13.9 t -105.63 -44.02 7.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.515 1.134 . . . . 0.0 109.307 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.64 ' O ' HG13 ' A' ' 317' ' ' VAL . 0.0 OUTLIER -148.84 134.33 18.6 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.139 . . . . 0.0 110.308 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.849 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 121.06 178.65 15.95 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.44 1.087 . . . . 0.0 111.042 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 314' ' ' ALA . 3.3 m -124.15 114.96 20.35 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.532 0.783 . . . . 0.0 109.974 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.472 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 25.5 m -96.73 163.33 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.492 1.12 . . . . 0.0 109.35 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 30.5 t -129.25 154.64 46.62 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.453 1.096 . . . . 0.0 110.032 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.24 130.04 73.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.519 1.137 . . . . 0.0 109.271 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.61 ' HB3' ' H ' ' A' ' 310' ' ' THR . . . -77.46 102.15 6.75 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.475 1.11 . . . . 0.0 109.269 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' THR . . . . . 0.644 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.51 -168.67 0.19 Allowed Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.492 1.12 . . . . 0.0 110.413 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.644 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.3 Cg_endo -74.96 4.33 4.82 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.527 1.804 . . . . 0.0 110.993 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -151.84 157.75 34.27 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.526 1.141 . . . . 0.0 109.282 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 94.26 0.96 Allowed 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.464 1.771 . . . . 0.0 110.995 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 281' ' ' SER . 21.2 t -98.34 119.42 46.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.517 1.136 . . . . 0.0 109.334 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.562 ' C ' HD22 ' A' ' 290' ' ' LEU . 14.7 mt-10 -124.1 140.83 52.59 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 0.0 110.306 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.562 HD22 ' C ' ' A' ' 289' ' ' GLU . 4.5 mm? -121.38 141.02 51.37 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.498 1.124 . . . . 0.0 109.3 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -93.97 -157.25 32.94 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.521 1.138 . . . . 0.0 110.95 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' PRO . . . . . 0.469 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.1 Cg_endo -75.02 148.8 35.68 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.511 1.795 . . . . 0.0 111.01 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.547 ' HA2' HD21 ' A' ' 229' ' ' LEU . . . 83.0 5.9 88.86 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.498 1.124 . . . . 0.0 111.018 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -86.68 122.76 31.03 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.511 0.771 . . . . 0.0 109.328 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -114.86 153.18 30.92 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 0.0 110.954 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.569 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 32.7 p90 -163.29 149.65 12.1 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.535 1.147 . . . . 0.0 111.004 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 129.57 -9.74 6.13 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.539 1.149 . . . . 0.0 110.986 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . 0.659 ' HB2' HD12 ' A' ' 235' ' ' LEU . 12.1 pt-20 -52.36 -45.26 65.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.548 0.793 . . . . 0.0 110.29 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . 0.418 ' N ' ' HG3' ' A' ' 298' ' ' GLU . 0.1 OUTLIER -52.4 -38.3 58.64 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.546 1.154 . . . . 0.0 111.039 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . 0.441 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -67.64 -38.16 83.46 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.498 1.123 . . . . 0.0 109.284 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.739 HD11 ' HB2' ' A' ' 272' ' ' MET . 0.8 OUTLIER -76.57 -14.39 60.01 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.485 1.116 . . . . 0.0 109.333 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . 0.417 ' HA ' ' CE2' ' A' ' 341' ' ' PHE . 11.0 mm -76.79 -55.5 10.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.49 1.119 . . . . 0.0 109.332 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 304' ' ' GLY . 0.5 OUTLIER -153.78 42.16 0.54 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.422 1.076 . . . . 0.0 110.011 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 35.82 43.09 0.58 Allowed Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.48 1.113 . . . . 0.0 111.012 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.17 157.61 88.1 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.549 0.793 . . . . 0.0 110.306 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 129.61 12.45 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.547 1.814 . . . . 0.0 110.968 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -43.92 -36.7 2.53 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.457 1.098 . . . . 0.0 110.272 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 8.0 t 66.75 23.16 10.19 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.49 1.119 . . . . 0.0 109.996 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . -179.11 160.93 1.09 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 0.0 109.318 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.61 ' H ' ' HB3' ' A' ' 283' ' ' ALA . 0.8 OUTLIER -108.55 137.33 46.67 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.5 1.125 . . . . 0.0 110.395 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.775 HG12 HD12 ' A' ' 262' ' ' ILE . 57.5 t -110.87 131.05 63.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.525 1.14 . . . . 0.0 109.31 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 96.5 p -130.19 153.95 48.04 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.524 1.14 . . . . 0.0 109.992 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -94.46 107.26 19.24 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.521 1.138 . . . . 0.0 109.312 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 279' ' ' SER . . . -50.75 -33.4 22.95 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.48 1.112 . . . . 0.0 109.305 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' THR . . . . . 0.633 ' O ' HG23 ' A' ' 317' ' ' VAL . 9.8 t -148.28 -170.03 3.49 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.486 1.116 . . . . 0.0 110.388 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . 0.448 ' N ' ' OG1' ' A' ' 315' ' ' THR . 0.0 OUTLIER -61.37 78.08 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.532 1.145 . . . . 0.0 110.373 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.849 HG22 ' HA3' ' A' ' 278' ' ' GLY . 44.5 t -94.65 140.18 17.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.481 1.113 . . . . 0.0 109.275 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 49.3 m -111.16 117.57 33.59 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.502 1.126 . . . . 0.0 110.0 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . 0.871 HD11 HG21 ' A' ' 256' ' ' VAL . 0.1 OUTLIER -128.67 173.18 10.53 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.486 1.116 . . . . 0.0 109.302 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.665 HD13 ' OD1' ' A' ' 226' ' ' ASN . 0.7 OUTLIER -124.46 133.85 53.23 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.554 1.159 . . . . 0.0 109.269 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 19.9 t -96.09 157.57 15.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.527 1.142 . . . . 0.0 110.001 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.789 HD21 ' CB ' ' A' ' 326' ' ' ASP . 1.4 tm? -150.01 103.67 3.22 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.436 1.085 . . . . 0.0 109.34 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . 0.487 ' ND1' ' HB3' ' A' ' 325' ' ' ALA . 0.3 OUTLIER -62.15 138.35 58.39 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.478 1.111 . . . . 0.0 109.587 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 22.8 t -54.21 -22.36 11.33 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.549 1.156 . . . . 0.0 109.973 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 0.487 ' HB3' ' ND1' ' A' ' 323' ' ' HIS . . . -52.59 -36.61 56.53 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.457 1.098 . . . . 0.0 109.28 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . 0.789 ' CB ' HD21 ' A' ' 322' ' ' LEU . 8.0 t70 -63.77 -46.15 86.55 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.475 1.109 . . . . 0.0 109.299 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' PHE . . . . . 0.578 ' CG ' HD23 ' A' ' 301' ' ' LEU . 20.1 t80 -65.41 -31.17 72.13 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.503 1.127 . . . . 0.0 111.049 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -70.71 -32.36 69.53 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.523 1.14 . . . . 0.0 110.334 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.494 ' O ' ' CB ' ' A' ' 333' ' ' SER . 37.1 ttp -74.5 -37.49 63.1 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.536 1.147 . . . . 0.0 110.998 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.633 HD12 HG13 ' A' ' 243' ' ' VAL . 0.1 OUTLIER -72.5 -42.52 64.75 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 0.0 109.273 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' CYS . . . . . 0.803 ' SG ' ' HB2' ' A' ' 338' ' ' ALA . 26.1 t -66.04 -45.13 82.51 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 0.0 108.318 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 44.4 t -73.3 -22.84 60.26 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.509 1.131 . . . . 0.0 110.031 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 329' ' ' MET . 9.1 t -78.43 -39.44 38.78 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.438 1.086 . . . . 0.0 109.977 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.24 121.6 20.62 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.13 . . . . 0.0 110.05 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 -26.15 11.25 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.535 1.808 . . . . 0.0 111.028 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.74 -29.18 69.66 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.484 1.115 . . . . 0.0 110.274 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.67 HD11 HG21 ' A' ' 243' ' ' VAL . 96.9 mt -74.59 -35.89 39.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.534 1.146 . . . . 0.0 109.294 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . 0.803 ' HB2' ' SG ' ' A' ' 331' ' ' CYS . . . -68.0 -43.54 78.63 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.51 1.131 . . . . 0.0 109.311 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -69.21 -35.33 76.09 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.475 1.109 . . . . 0.0 110.322 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 17.3 mt -70.94 -41.51 77.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.515 1.134 . . . . 0.0 109.27 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.475 ' CE2' ' O ' ' A' ' 301' ' ' LEU . 27.8 t80 -67.73 -34.7 77.36 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.472 1.107 . . . . 0.0 111.02 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -72.48 -37.02 68.57 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.538 1.149 . . . . 0.0 110.294 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.59 -51.81 60.79 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.505 1.128 . . . . 0.0 109.316 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 9.9 t -65.91 -38.86 89.8 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.475 1.109 . . . . 0.0 110.362 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -68.52 -34.83 76.55 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.527 1.142 . . . . 0.0 109.283 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' A' ' 346' ' ' LEU . 12.0 mt -68.64 -36.85 79.15 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.489 1.118 . . . . 0.0 109.328 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.05 -35.67 69.39 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.462 1.101 . . . . 0.0 110.262 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.474 1.109 . . . . 0.0 110.265 -179.971 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 50.7 t80 . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 120.499 0.19 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.16 -40.98 78.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.522 1.139 . . . . 0.0 109.27 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.823 ' HG2' HG13 ' A' ' 276' ' ' VAL . 0.0 OUTLIER -67.13 -29.39 69.1 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.529 1.143 . . . . 0.0 110.303 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.754 ' OD1' HD13 ' A' ' 320' ' ' LEU . 4.9 t30 -79.24 -30.88 43.39 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.496 1.123 . . . . 0.0 109.322 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' TRP . . . . . 0.546 ' HA ' HG21 ' A' ' 248' ' ' VAL . 2.6 t90 -70.64 -46.65 62.91 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 4.5 pt20 -68.12 -31.87 71.77 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 0.0 110.263 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 3.5 mt -64.36 -45.59 87.11 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 0.0 109.257 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.568 HG23 ' CD1' ' A' ' 244' ' ' LEU . 33.1 m -73.55 -36.63 48.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.464 1.103 . . . . 0.0 109.328 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -74.98 -15.55 60.66 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.522 1.139 . . . . 0.0 109.245 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -80.83 -1.87 44.94 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.511 1.132 . . . . 0.0 109.322 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 4.9 t -101.03 118.85 59.58 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.501 1.126 . . . . 0.0 109.276 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 -17.92 19.04 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.494 1.787 . . . . 0.0 110.989 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.684 HD23 ' CZ ' ' A' ' 348' ' ' ARG . 0.1 OUTLIER -65.06 -29.46 70.35 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.574 1.171 . . . . 0.0 109.302 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . 0.415 ' HB3' HD12 ' A' ' 239' ' ' LEU . 15.4 m-85 -113.74 19.76 16.44 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.44 1.087 . . . . 0.0 111.0 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.22 -23.43 62.01 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.515 1.134 . . . . 0.0 110.345 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 50.0 mmtt -80.2 0.7 31.35 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.456 1.097 . . . . 0.0 109.295 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.776 HD13 HG11 ' A' ' 243' ' ' VAL . 15.1 mt -82.13 175.18 10.53 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.542 1.151 . . . . 0.0 109.29 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -107.73 -173.8 22.17 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.478 1.111 . . . . 0.0 110.981 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.94 -33.66 4.5 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.46 1.769 . . . . 0.0 111.051 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.5 ' HA ' HG12 ' A' ' 245' ' ' VAL . . . -71.22 -31.97 68.23 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.482 1.114 . . . . 0.0 109.318 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.776 HG11 HD13 ' A' ' 239' ' ' LEU . 4.8 t -75.9 -42.17 39.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.486 1.116 . . . . 0.0 109.272 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.568 ' CD1' HG23 ' A' ' 230' ' ' VAL . 0.6 OUTLIER -67.24 -46.22 74.42 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.476 1.11 . . . . 0.0 109.289 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' A' ' 242' ' ' ALA . 2.8 p -65.05 -45.14 95.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.497 1.123 . . . . 0.0 109.273 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.405 ' N ' ' CG1' ' A' ' 245' ' ' VAL . 4.9 tp10 -64.87 -36.12 83.33 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.114 . . . . 0.0 110.325 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.502 HD12 HG12 ' A' ' 243' ' ' VAL . 26.4 mt -67.85 -48.0 77.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.514 1.134 . . . . 0.0 109.329 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.546 HG21 ' HA ' ' A' ' 227' ' ' TRP . 55.2 t -63.26 -33.07 58.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.123 . . . . 0.0 109.323 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.1 mmm180 -74.61 -25.13 59.04 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.434 1.084 . . . . 0.0 110.294 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.458 ' HB3' ' OD1' ' A' ' 326' ' ' ASP . . . -87.15 -18.54 30.18 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.481 1.113 . . . . 0.0 109.344 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.82 146.16 54.72 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.575 1.172 . . . . 0.0 109.321 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -120.54 135.08 55.19 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 0.0 110.368 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -80.57 122.4 27.0 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.459 1.099 . . . . 0.0 109.262 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.7 ttm-85 -124.25 121.95 36.43 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.543 1.152 . . . . 0.0 110.276 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.6 m -91.28 117.81 29.96 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 0.0 110.373 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.576 HG21 HD11 ' A' ' 319' ' ' LEU . 69.3 t -106.69 112.02 63.71 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.461 1.101 . . . . 0.0 109.329 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.516 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.97 173.65 14.14 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.472 1.775 . . . . 0.0 111.023 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.524 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -67.51 131.33 45.44 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.488 1.117 . . . . 0.0 109.263 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 93.27 -25.39 20.59 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 124.556 1.16 . . . . 0.0 110.984 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.516 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -61.07 149.04 38.31 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.52 0.776 . . . . 0.0 109.332 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.2 t -97.47 131.35 44.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.483 1.114 . . . . 0.0 109.324 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.774 HD12 HG12 ' A' ' 311' ' ' VAL . 43.3 mt -83.9 -40.09 15.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.53 1.144 . . . . 0.0 109.308 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' CYS . . . . . 0.405 ' SG ' HG23 ' A' ' 311' ' ' VAL . 13.8 p -156.12 150.71 25.89 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.503 1.127 . . . . 0.0 108.276 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' ARG . . . . . 0.402 ' HA ' ' OG1' ' A' ' 310' ' ' THR . 16.6 mmt180 -94.42 179.67 5.21 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.566 1.166 . . . . 0.0 110.339 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.51 HG23 ' OG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -77.49 140.34 17.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.467 1.104 . . . . 0.0 109.326 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 46.54 52.71 10.64 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.5 1.125 . . . . 0.0 111.045 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.458 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.2 OUTLIER -71.03 168.08 23.86 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.548 0.793 . . . . 0.0 110.357 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 267' ' ' GLU . 18.4 Cg_endo -74.98 88.49 1.23 Allowed 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.458 1.767 . . . . 0.0 111.005 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . 0.401 ' O ' ' CA ' ' A' ' 304' ' ' GLY . . . -45.23 93.5 0.01 OUTLIER Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.553 1.158 . . . . 0.0 110.988 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 268' ' ' PRO . 0.6 OUTLIER -170.47 36.68 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.51 0.771 . . . . 0.0 109.345 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -173.35 162.27 4.32 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.566 1.166 . . . . 0.0 110.295 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.471 ' CE ' ' CZ ' ' A' ' 274' ' ' PHE . 9.3 ptm -145.84 146.66 31.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.538 1.149 . . . . 0.0 110.996 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.566 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 33.2 m-85 -128.37 154.08 46.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.484 1.115 . . . . 0.0 111.017 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . 0.505 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 23.6 m-85 -129.87 137.37 50.39 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.481 1.113 . . . . 0.0 111.017 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.58 HG12 ' HA ' ' A' ' 292' ' ' PRO . 42.7 t -90.71 136.72 23.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.52 1.137 . . . . 0.0 109.295 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.823 HG13 ' HG2' ' A' ' 225' ' ' ARG . 39.8 t -116.03 -43.78 3.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.535 1.147 . . . . 0.0 109.326 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -146.61 136.74 23.55 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.517 1.136 . . . . 0.0 110.272 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.95 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 114.46 -173.22 14.72 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.502 1.126 . . . . 0.0 111.004 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 3.2 m -134.9 119.92 18.65 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.539 0.788 . . . . 0.0 109.989 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.421 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 16.5 m -99.0 165.82 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.499 1.125 . . . . 0.0 109.323 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 30.5 t -131.52 154.97 48.23 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.504 1.128 . . . . 0.0 110.009 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.429 HG13 HG22 ' A' ' 311' ' ' VAL . 0.7 OUTLIER -118.92 131.21 72.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.503 1.127 . . . . 0.0 109.306 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -79.41 102.03 8.48 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 0.0 109.325 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' THR . . . . . 0.655 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.18 -168.25 0.18 Allowed Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.525 1.14 . . . . 0.0 110.391 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.655 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -75.04 4.48 4.72 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.566 1.824 . . . . 0.0 110.964 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.411 ' O ' HG23 ' A' ' 288' ' ' VAL . 35.2 m120 -151.75 157.2 34.59 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.548 1.155 . . . . 0.0 109.263 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.06 95.36 0.98 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.472 1.775 . . . . 0.0 110.937 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 281' ' ' SER . 4.6 t -99.39 119.23 47.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.47 1.106 . . . . 0.0 109.263 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 15.8 mt-10 -124.44 135.85 53.58 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.426 1.079 . . . . 0.0 110.29 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.506 HD12 ' CB ' ' A' ' 294' ' ' ALA . 3.9 mm? -115.11 142.11 47.1 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.451 1.095 . . . . 0.0 109.307 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -98.79 -161.24 29.82 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.494 1.121 . . . . 0.0 110.983 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' PRO . . . . . 0.58 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.2 Cg_endo -75.0 145.88 31.98 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.491 1.785 . . . . 0.0 110.999 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 88.09 4.63 77.9 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.459 1.099 . . . . 0.0 110.95 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . 0.506 ' CB ' HD12 ' A' ' 290' ' ' LEU . . . -91.25 127.77 36.81 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.501 0.765 . . . . 0.0 109.315 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.451 ' HB3' ' CD1' ' A' ' 274' ' ' PHE . 1.2 p90 -116.34 153.38 32.09 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.52 1.138 . . . . 0.0 110.987 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 48.1 p90 -161.63 146.38 13.19 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.452 1.095 . . . . 0.0 110.977 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 300' ' ' ALA . . . 129.66 -9.99 6.09 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 124.527 1.142 . . . . 0.0 111.001 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -52.77 -51.21 61.54 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.457 0.74 . . . . 0.0 110.295 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.2 mmt -50.48 -32.89 19.37 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.523 1.139 . . . . 0.0 111.008 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 297' ' ' GLY . . . -68.85 -42.64 76.84 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.535 1.147 . . . . 0.0 109.337 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.458 HD11 ' SD ' ' A' ' 272' ' ' MET . 6.0 mt -75.01 -11.68 60.16 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.475 1.109 . . . . 0.0 109.283 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . 0.482 HD13 ' CZ ' ' A' ' 341' ' ' PHE . 14.5 mm -77.83 -56.63 7.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.484 1.115 . . . . 0.0 109.291 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 304' ' ' GLY . 2.4 m -151.46 42.57 0.74 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.445 1.091 . . . . 0.0 110.0 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 34.93 51.21 0.82 Allowed Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.462 1.101 . . . . 0.0 110.969 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.58 151.34 80.15 Favored Pre-proline 0 C--N 1.326 -0.436 0 O-C-N 124.524 0.779 . . . . 0.0 110.33 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 130.29 13.11 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.461 1.769 . . . . 0.0 110.955 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -44.04 -33.09 1.34 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.536 1.147 . . . . 0.0 110.301 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 59.38 15.9 4.73 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.525 1.14 . . . . 0.0 109.989 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . -170.15 160.75 8.17 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.544 1.153 . . . . 0.0 109.333 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.51 ' OG1' HG23 ' A' ' 265' ' ' ILE . 0.9 OUTLIER -110.29 139.68 45.23 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.469 1.106 . . . . 0.0 110.42 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.774 HG12 HD12 ' A' ' 262' ' ' ILE . 91.1 t -115.57 131.62 67.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.493 1.121 . . . . 0.0 109.269 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 56.3 p -128.6 153.75 46.92 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.491 1.119 . . . . 0.0 110.018 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . 0.418 ' CB ' HG12 ' A' ' 256' ' ' VAL . . . -90.95 114.3 26.75 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.556 1.16 . . . . 0.0 109.286 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -57.73 -35.19 70.34 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.521 1.138 . . . . 0.0 109.304 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' THR . . . . . 0.589 ' O ' HG23 ' A' ' 317' ' ' VAL . 8.7 t -153.96 -173.91 4.76 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.559 1.162 . . . . 0.0 110.424 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 29.0 m -49.9 91.36 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 0.0 110.378 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.95 HG22 ' HA3' ' A' ' 278' ' ' GLY . 41.6 t -106.75 154.54 7.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.53 1.144 . . . . 0.0 109.31 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 69.3 m -129.79 114.93 16.55 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.534 1.146 . . . . 0.0 109.965 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . 0.576 HD11 HG21 ' A' ' 256' ' ' VAL . 0.2 OUTLIER -130.43 173.17 11.09 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.484 1.115 . . . . 0.0 109.289 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.754 HD13 ' OD1' ' A' ' 226' ' ' ASN . 0.8 OUTLIER -124.29 136.41 54.11 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.532 1.145 . . . . 0.0 109.29 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.477 ' HB2' ' CE2' ' A' ' 273' ' ' PHE . 36.7 t -96.07 148.53 22.58 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.466 1.104 . . . . 0.0 110.02 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.483 ' O ' HD13 ' A' ' 322' ' ' LEU . 3.0 tm? -146.49 98.54 3.09 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.5 1.125 . . . . 0.0 109.302 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -60.02 146.9 41.02 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.485 1.116 . . . . 0.0 109.582 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 37.8 t -63.68 -13.71 45.39 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.504 1.127 . . . . 0.0 110.02 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 0.4 ' HA ' ' NE2' ' A' ' 328' ' ' GLN . . . -61.67 -27.8 68.94 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.486 1.116 . . . . 0.0 109.331 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . 0.458 ' OD1' ' HB3' ' A' ' 250' ' ' ALA . 0.6 OUTLIER -74.66 -39.52 61.99 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.504 1.127 . . . . 0.0 109.277 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' PHE . . . . . 0.483 ' C ' ' CD1' ' A' ' 327' ' ' PHE . 0.8 OUTLIER -70.47 -42.68 71.11 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.504 1.127 . . . . 0.0 110.995 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . 0.4 ' NE2' ' HA ' ' A' ' 325' ' ' ALA . 1.8 pt20 -67.15 -35.61 80.07 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.512 1.133 . . . . 0.0 110.266 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 17.9 tmm? -66.8 -42.12 86.48 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.515 1.135 . . . . 0.0 110.985 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.443 HD13 ' CG1' ' A' ' 247' ' ' ILE . 5.2 mt -72.51 -37.42 68.38 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.456 1.097 . . . . 0.0 109.307 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' CYS . . . . . 0.642 ' HB3' ' HB2' ' A' ' 338' ' ' ALA . 6.2 m -72.57 -31.64 65.4 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.478 1.111 . . . . 0.0 108.329 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 47.1 t -71.83 -37.91 70.25 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 0.0 109.981 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 42.6 t -72.17 -36.0 69.16 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.464 1.103 . . . . 0.0 109.981 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -123.02 114.32 29.53 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.51 1.131 . . . . 0.0 110.005 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -19.04 18.2 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.537 1.809 . . . . 0.0 111.005 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -72.57 -32.13 65.8 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.548 1.155 . . . . 0.0 110.31 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.474 HG23 ' CD2' ' A' ' 239' ' ' LEU . 77.6 mt -74.87 -44.95 44.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.485 1.116 . . . . 0.0 109.286 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . 0.642 ' HB2' ' HB3' ' A' ' 331' ' ' CYS . . . -66.6 -35.33 79.94 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.131 . . . . 0.0 109.338 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . 0.478 ' O ' ' CG ' ' A' ' 343' ' ' LYS . 50.2 mm-40 -72.3 -42.78 65.09 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.516 1.135 . . . . 0.0 110.279 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 58.5 mt -68.35 -36.52 75.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.523 1.14 . . . . 0.0 109.256 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.666 ' CE1' HD12 ' A' ' 235' ' ' LEU . 49.7 t80 -69.55 -37.2 76.94 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.101 . . . . 0.0 110.982 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -69.76 -37.99 76.6 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.474 1.109 . . . . 0.0 110.335 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' LYS . . . . . 0.478 ' CG ' ' O ' ' A' ' 339' ' ' GLU . 0.5 OUTLIER -65.0 -50.65 65.45 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.496 1.123 . . . . 0.0 109.344 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 341' ' ' PHE . 4.5 t -64.83 -32.86 74.76 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.51 1.131 . . . . 0.0 110.4 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -70.07 -39.05 75.85 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.466 1.104 . . . . 0.0 109.29 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.43 ' HA ' HD23 ' A' ' 346' ' ' LEU . 12.6 mt -68.93 -34.04 74.71 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.434 1.084 . . . . 0.0 109.312 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.75 -31.68 61.87 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.467 1.105 . . . . 0.0 110.299 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . 0.684 ' CZ ' HD23 ' A' ' 235' ' ' LEU . 7.0 mtt180 . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.535 1.147 . . . . 0.0 110.304 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 14.6 t80 . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 120.498 0.19 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.81 -35.89 44.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.543 1.152 . . . . 0.0 109.289 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.648 ' CD ' HD23 ' A' ' 229' ' ' LEU . 0.0 OUTLIER -69.32 -32.12 71.02 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.559 1.162 . . . . 0.0 110.333 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.677 ' O ' HG23 ' A' ' 230' ' ' VAL . 46.6 t30 -79.89 -30.63 40.19 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.471 1.107 . . . . 0.0 109.256 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' TRP . . . . . 0.866 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 2.5 t90 -67.8 -43.65 79.19 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.538 1.149 . . . . 0.0 107.974 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -71.03 -38.38 72.58 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.585 1.178 . . . . 0.0 110.339 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.651 HD21 ' HA2' ' A' ' 293' ' ' GLY . 1.2 mm? -62.43 -46.25 89.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.146 . . . . 0.0 109.3 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.737 HG12 HD13 ' A' ' 244' ' ' LEU . 59.1 t -72.69 -37.01 54.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.466 1.104 . . . . 0.0 109.316 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -73.5 -15.86 61.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.487 1.117 . . . . 0.0 109.328 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -81.86 -12.74 58.33 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.511 1.132 . . . . 0.0 109.318 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 38.2 t -70.9 132.3 86.86 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.122 . . . . 0.0 109.298 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.407 ' HA ' ' HB2' ' A' ' 237' ' ' GLN . 18.2 Cg_endo -74.98 -30.4 7.23 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.482 1.78 . . . . 0.0 110.979 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 1.059 HD11 HD11 ' A' ' 302' ' ' ILE . 0.7 OUTLIER -68.87 -28.21 66.5 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.447 1.092 . . . . 0.0 109.29 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . 0.713 ' CG ' HD12 ' A' ' 239' ' ' LEU . 13.8 m-30 -104.63 14.32 30.04 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.497 1.123 . . . . 0.0 111.016 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' GLN . . . . . 0.407 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 1.4 tt0 -72.17 -26.15 61.97 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.492 1.12 . . . . 0.0 110.286 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.468 ' HB2' ' CG2' ' A' ' 340' ' ' ILE . 6.6 mmpt? -100.47 7.62 44.06 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.528 1.143 . . . . 0.0 109.314 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.713 HD12 ' CG ' ' A' ' 236' ' ' PHE . 16.9 mt -81.51 171.24 14.92 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 0.0 109.258 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . 0.583 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -95.16 173.68 31.82 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.51 1.131 . . . . 0.0 110.981 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.928 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.2 Cg_endo -75.05 -35.29 3.19 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.494 1.786 . . . . 0.0 111.015 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.4 -34.66 76.41 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.474 1.109 . . . . 0.0 109.3 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.805 HG21 HD11 ' A' ' 337' ' ' ILE . 25.6 t -74.17 -42.07 51.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.44 1.087 . . . . 0.0 109.301 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.737 HD13 HG12 ' A' ' 230' ' ' VAL . 2.1 mm? -64.81 -34.58 78.68 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.511 1.132 . . . . 0.0 109.293 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.928 HG23 ' O ' ' A' ' 241' ' ' PRO . 70.4 t -70.72 -44.56 76.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.547 1.155 . . . . 0.0 109.311 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -65.3 -31.18 72.18 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.478 1.111 . . . . 0.0 110.293 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 56.0 mt -75.14 -40.54 44.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.451 1.095 . . . . 0.0 109.317 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 244' ' ' LEU . 55.8 t -70.96 -33.32 51.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.503 1.127 . . . . 0.0 109.309 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.427 ' NH1' ' HB3' ' A' ' 249' ' ' ARG . 5.6 mmm180 -78.94 -25.84 43.63 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.471 1.107 . . . . 0.0 110.275 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.446 ' HB1' ' OD2' ' A' ' 326' ' ' ASP . . . -86.87 -21.68 26.21 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.523 1.139 . . . . 0.0 109.332 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.49 152.35 30.31 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.46 1.1 . . . . 0.0 109.339 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -121.13 119.1 31.41 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.495 1.122 . . . . 0.0 110.299 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.755 ' HB2' HD23 ' A' ' 320' ' ' LEU . . . -81.17 122.43 27.37 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.502 1.126 . . . . 0.0 109.298 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.96 142.75 50.38 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.453 1.096 . . . . 0.0 110.299 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 4.5 m -96.64 125.83 41.39 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.517 1.136 . . . . 0.0 110.386 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.517 HG12 ' CB ' ' A' ' 313' ' ' ALA . 86.7 t -106.58 115.73 60.17 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.473 1.108 . . . . 0.0 109.3 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.507 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.5 Cg_endo -74.96 168.41 24.89 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.535 1.808 . . . . 0.0 111.038 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.523 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -66.81 128.5 36.53 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.511 1.132 . . . . 0.0 109.302 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 96.06 -25.57 24.85 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.486 1.116 . . . . 0.0 110.989 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.507 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -64.35 134.1 53.96 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.505 0.767 . . . . 0.0 109.313 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 312' ' ' SER . 2.5 p -90.21 134.98 27.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.485 1.116 . . . . 0.0 109.295 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.822 HD12 HG12 ' A' ' 311' ' ' VAL . 11.3 mt -82.47 -52.6 13.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.121 . . . . 0.0 109.377 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' CYS . . . . . 0.653 ' SG ' HG23 ' A' ' 311' ' ' VAL . 14.0 p -137.48 157.68 46.03 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.511 1.132 . . . . 0.0 108.31 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 1.8 mmt85 -100.98 178.43 4.67 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.58 1.175 . . . . 0.0 110.302 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.559 HD13 ' H ' ' A' ' 265' ' ' ILE . 0.2 OUTLIER -77.74 130.73 35.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.56 1.162 . . . . 0.0 109.308 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 59.9 47.51 90.64 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.533 1.146 . . . . 0.0 111.028 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.417 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.2 OUTLIER -71.53 164.37 58.38 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.473 0.749 . . . . 0.0 110.302 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.449 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.3 Cg_endo -74.96 81.52 2.18 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.469 1.773 . . . . 0.0 111.05 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 268' ' ' PRO . . . -37.08 95.86 0.01 OUTLIER Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.537 1.148 . . . . 0.0 111.039 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 268' ' ' PRO . 51.5 m-20 -170.45 38.67 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.507 0.769 . . . . 0.0 109.288 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . 0.471 ' HD3' ' CE1' ' A' ' 273' ' ' PHE . 3.8 ttm180 -170.78 151.83 3.55 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.505 1.128 . . . . 0.0 110.298 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.522 ' SD ' HD11 ' A' ' 301' ' ' LEU . 3.4 ttt -121.5 155.33 35.17 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.505 1.128 . . . . 0.0 111.031 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.568 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 25.8 m-85 -140.42 136.74 33.37 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.49 1.119 . . . . 0.0 111.006 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . 0.402 ' CE2' HG22 ' A' ' 230' ' ' VAL . 20.0 m-85 -128.47 126.84 41.32 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.476 1.11 . . . . 0.0 111.018 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 1.061 HG22 HD22 ' A' ' 319' ' ' LEU . 53.9 t -85.58 132.71 31.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.459 1.1 . . . . 0.0 109.32 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.556 HG21 HD11 ' A' ' 320' ' ' LEU . 48.3 t -107.15 -52.84 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.485 1.116 . . . . 0.0 109.302 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.647 ' O ' HG23 ' A' ' 317' ' ' VAL . 11.0 mt-10 -139.81 137.9 35.37 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.51 1.131 . . . . 0.0 110.254 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.402 ' HA3' ' HB ' ' A' ' 317' ' ' VAL . . . 116.27 -158.0 14.7 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.458 1.099 . . . . 0.0 110.952 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 8.7 t -148.3 134.07 18.95 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.54 0.788 . . . . 0.0 109.998 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 11.3 m -114.02 165.41 9.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.516 1.135 . . . . 0.0 109.283 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 29.3 t -131.59 148.54 52.62 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.529 1.143 . . . . 0.0 109.991 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.468 HG23 HG12 ' A' ' 288' ' ' VAL . 0.6 OUTLIER -110.91 129.79 65.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.461 1.101 . . . . 0.0 109.262 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.546 ' HB2' HG22 ' A' ' 310' ' ' THR . . . -78.52 101.46 7.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.479 1.112 . . . . 0.0 109.32 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' THR . . . . . 0.659 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.9 OUTLIER -147.14 -168.05 0.17 Allowed Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.505 1.128 . . . . 0.0 110.38 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.659 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.6 Cg_endo -74.96 3.98 5.12 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.502 1.791 . . . . 0.0 111.022 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -150.37 157.2 37.03 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.482 1.114 . . . . 0.0 109.302 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.91 94.1 0.95 Allowed 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.493 1.786 . . . . 0.0 110.989 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.468 HG12 HG23 ' A' ' 282' ' ' VAL . 72.1 t -98.09 118.94 45.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.544 1.152 . . . . 0.0 109.29 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.501 ' C ' HD22 ' A' ' 290' ' ' LEU . 13.0 mt-10 -125.11 134.49 52.44 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.443 1.089 . . . . 0.0 110.291 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.501 HD22 ' C ' ' A' ' 289' ' ' GLU . 2.6 mm? -116.73 141.48 48.15 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.536 1.148 . . . . 0.0 109.308 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -95.72 -158.47 32.36 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.518 1.136 . . . . 0.0 110.974 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' PRO . . . . . 0.461 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.3 Cg_endo -75.02 152.63 40.88 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.466 1.772 . . . . 0.0 110.994 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.651 ' HA2' HD21 ' A' ' 229' ' ' LEU . . . 79.66 6.78 88.91 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.501 1.125 . . . . 0.0 110.971 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -88.98 128.71 35.7 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.489 0.758 . . . . 0.0 109.278 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -117.45 153.01 33.84 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.471 1.107 . . . . 0.0 111.005 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.568 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 45.5 p90 -166.28 145.7 5.94 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.512 1.133 . . . . 0.0 111.024 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 300' ' ' ALA . . . 133.21 -10.53 5.06 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.514 1.133 . . . . 0.0 111.004 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . 0.504 ' CD ' HD13 ' A' ' 235' ' ' LEU . 32.8 tt0 -52.75 -53.22 51.05 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.493 0.761 . . . . 0.0 110.242 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -47.58 -35.56 9.32 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.467 1.104 . . . . 0.0 110.99 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 297' ' ' GLY . . . -68.4 -43.21 77.75 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.513 1.133 . . . . 0.0 109.327 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.522 HD11 ' SD ' ' A' ' 272' ' ' MET . 1.2 mt -77.26 -5.98 51.41 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.498 1.124 . . . . 0.0 109.285 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . 1.059 HD11 HD11 ' A' ' 235' ' ' LEU . 8.1 mm -83.37 -53.92 10.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 0.0 109.282 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 304' ' ' GLY . 78.5 p -151.89 43.2 0.72 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.511 1.132 . . . . 0.0 109.968 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 303' ' ' SER . . . 36.16 35.0 0.09 OUTLIER Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.474 1.109 . . . . 0.0 111.009 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 303' ' ' SER . 0.1 OUTLIER -62.4 151.55 82.36 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.498 0.763 . . . . 0.0 110.318 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 127.57 10.79 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.435 1.755 . . . . 0.0 110.974 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . 0.402 ' NE ' ' HG2' ' A' ' 267' ' ' GLU . 0.0 OUTLIER -46.16 -24.9 0.51 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 0.0 110.295 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 43.18 36.85 1.07 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.475 1.11 . . . . 0.0 110.012 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . -177.99 161.07 1.5 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.474 1.108 . . . . 0.0 109.283 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.546 HG22 ' HB2' ' A' ' 283' ' ' ALA . 0.3 OUTLIER -113.89 121.4 43.87 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.472 1.107 . . . . 0.0 110.355 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.822 HG12 HD12 ' A' ' 262' ' ' ILE . 31.5 t -102.69 131.79 50.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.116 . . . . 0.0 109.267 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 261' ' ' VAL . 6.0 p -136.11 158.29 44.76 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.538 1.149 . . . . 0.0 110.007 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . 0.877 ' HB1' HG12 ' A' ' 317' ' ' VAL . . . -88.29 111.86 22.17 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.471 1.107 . . . . 0.0 109.259 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -55.55 -26.34 42.87 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.507 1.129 . . . . 0.0 109.286 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' THR . . . . . 0.694 ' O ' HG12 ' A' ' 317' ' ' VAL . 10.0 t -164.43 -165.08 0.9 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.49 1.119 . . . . 0.0 110.41 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . 0.418 ' N ' ' OG1' ' A' ' 315' ' ' THR . 31.5 p -60.26 80.7 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.516 1.135 . . . . 0.0 110.426 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.877 HG12 ' HB1' ' A' ' 313' ' ' ALA . 2.5 p -113.0 138.5 42.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.129 . . . . 0.0 109.266 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . 0.62 ' C ' HD23 ' A' ' 319' ' ' LEU . 49.7 m -107.26 139.05 42.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.556 1.16 . . . . 0.0 109.998 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . 1.061 HD22 HG22 ' A' ' 275' ' ' VAL . 0.0 OUTLIER -143.73 173.51 11.61 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.498 1.124 . . . . 0.0 109.306 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.755 HD23 ' HB2' ' A' ' 253' ' ' ALA . 1.2 mp -124.37 133.99 53.26 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.448 1.092 . . . . 0.0 109.308 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 20.9 t -97.99 151.34 20.41 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.469 1.106 . . . . 0.0 109.985 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.457 HD13 ' C ' ' A' ' 322' ' ' LEU . 3.2 tm? -144.8 106.87 4.32 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.494 1.121 . . . . 0.0 109.34 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . 0.421 ' CE1' ' HB2' ' A' ' 326' ' ' ASP . 10.2 p80 -66.4 132.99 49.55 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.502 1.126 . . . . 0.0 109.615 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 96.1 p -56.64 -21.95 30.91 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.469 1.106 . . . . 0.0 110.004 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -58.84 -35.47 72.98 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.5 1.125 . . . . 0.0 109.29 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . 0.446 ' OD2' ' HB1' ' A' ' 250' ' ' ALA . 23.8 t70 -66.1 -41.05 91.13 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.502 1.126 . . . . 0.0 109.34 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' PHE . . . . . 0.482 ' CD1' ' O ' ' A' ' 327' ' ' PHE . 2.6 t80 -70.53 -29.77 66.34 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.47 1.106 . . . . 0.0 110.998 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -70.92 -45.73 63.74 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.523 1.139 . . . . 0.0 110.319 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.454 ' HG3' ' N ' ' A' ' 330' ' ' LEU . 3.9 ptm -66.47 -34.6 78.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.49 1.119 . . . . 0.0 110.978 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.454 ' N ' ' HG3' ' A' ' 329' ' ' MET . 16.5 mt -72.77 -37.74 67.54 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.486 1.116 . . . . 0.0 109.275 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' CYS . . . . . 0.402 ' O ' ' O ' ' A' ' 334' ' ' SER . 14.2 t -66.26 -41.47 89.85 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.549 1.156 . . . . 0.0 108.336 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.28 -23.36 51.15 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.486 1.116 . . . . 0.0 109.992 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 19.9 t -71.65 -39.33 70.42 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.532 1.145 . . . . 0.0 110.032 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' SER . . . . . 0.402 ' O ' ' O ' ' A' ' 331' ' ' CYS . 0.1 OUTLIER -121.98 131.9 24.34 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.491 1.12 . . . . 0.0 109.957 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -28.5 9.14 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.495 1.787 . . . . 0.0 110.999 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.78 -28.57 67.72 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.477 1.111 . . . . 0.0 110.259 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.805 HD11 HG21 ' A' ' 243' ' ' VAL . 95.7 mt -72.28 -35.77 53.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.486 1.116 . . . . 0.0 109.254 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.22 -33.98 65.64 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.536 1.147 . . . . 0.0 109.309 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -74.54 -42.35 59.0 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.511 1.132 . . . . 0.0 110.272 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.468 ' CG2' ' HB2' ' A' ' 238' ' ' LYS . 43.2 mt -71.7 -40.24 70.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.524 1.14 . . . . 0.0 109.27 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.481 ' CE2' ' CZ ' ' A' ' 327' ' ' PHE . 10.2 t80 -70.04 -34.94 73.89 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.547 1.154 . . . . 0.0 111.009 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.18 -41.47 73.7 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.484 1.115 . . . . 0.0 110.257 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.05 -40.57 71.58 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.498 1.124 . . . . 0.0 109.295 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.1 m -67.46 -42.39 83.12 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.457 1.098 . . . . 0.0 110.403 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -70.87 -35.08 72.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.557 1.161 . . . . 0.0 109.293 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 346' ' ' LEU . 15.8 mt -71.46 -31.99 67.79 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.546 1.154 . . . . 0.0 109.277 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -73.71 -39.02 64.64 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.539 1.149 . . . . 0.0 110.281 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 16.0 mtt-85 . . . . . 0 C--N 1.325 -0.489 0 O-C-N 124.477 1.111 . . . . 0.0 110.349 179.976 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.7 t80 . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.494 0.187 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -71.16 -37.76 67.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.525 1.14 . . . . 0.0 109.27 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.475 ' O ' HD12 ' A' ' 229' ' ' LEU . 0.0 OUTLIER -66.57 -33.14 75.02 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.536 1.147 . . . . 0.0 110.334 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.877 ' ND2' HD22 ' A' ' 320' ' ' LEU . 10.4 t-20 -79.21 -30.3 43.24 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.471 1.107 . . . . 0.0 109.321 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' TRP . . . . . 0.871 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 3.1 t90 -66.45 -44.44 82.77 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.52 1.137 . . . . 0.0 108.01 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.44 ' HG3' ' N ' ' A' ' 229' ' ' LEU . 7.7 pt20 -71.67 -44.95 63.37 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.533 1.146 . . . . 0.0 110.359 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.678 HD21 ' HA2' ' A' ' 293' ' ' GLY . 0.3 OUTLIER -57.75 -44.76 86.34 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.468 1.105 . . . . 0.0 109.3 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 226' ' ' ASN . 95.7 t -70.34 -38.99 76.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.48 1.113 . . . . 0.0 109.244 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -75.29 -10.18 59.23 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.48 1.113 . . . . 0.0 109.254 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 228' ' ' GLN . . . -80.06 -25.07 40.27 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.451 1.094 . . . . 0.0 109.223 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . 0.463 HG13 ' HD2' ' A' ' 234' ' ' PRO . 61.9 t -70.05 138.14 87.32 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.469 1.106 . . . . 0.0 109.298 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.463 ' HD2' HG13 ' A' ' 233' ' ' VAL . 18.3 Cg_endo -75.02 -50.24 0.13 Allowed 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.478 1.778 . . . . 0.0 110.998 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.66 HD11 HD11 ' A' ' 302' ' ' ILE . 18.2 mt -50.84 -37.13 41.28 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.489 1.118 . . . . 0.0 109.275 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -78.88 -21.99 46.64 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.465 1.103 . . . . 0.0 110.979 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' GLN . . . . . 0.444 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -59.12 -22.72 61.31 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.514 1.134 . . . . 0.0 110.282 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -75.11 -23.27 57.91 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.495 1.122 . . . . 0.0 109.275 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.538 HD21 HG23 ' A' ' 337' ' ' ILE . 16.3 mt -74.51 -179.83 4.26 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.483 1.114 . . . . 0.0 109.275 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . 0.622 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -107.72 -172.6 22.04 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.517 1.136 . . . . 0.0 111.005 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.877 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.1 Cg_endo -75.0 -36.96 2.24 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.5 1.789 . . . . 0.0 111.015 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.09 -34.83 78.48 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.493 1.121 . . . . 0.0 109.327 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.519 HG12 HD12 ' A' ' 247' ' ' ILE . 13.6 t -75.38 -39.21 41.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.531 1.144 . . . . 0.0 109.329 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.622 HD23 ' O ' ' A' ' 240' ' ' GLY . 1.4 mm? -66.28 -37.94 86.62 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.498 1.124 . . . . 0.0 109.253 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 241' ' ' PRO . 94.1 t -68.95 -44.67 81.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.478 1.111 . . . . 0.0 109.274 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -64.74 -36.94 85.93 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.468 1.105 . . . . 0.0 110.301 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.519 HD12 HG12 ' A' ' 243' ' ' VAL . 41.7 mt -69.09 -49.07 65.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.47 1.106 . . . . 0.0 109.285 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 244' ' ' LEU . 63.9 t -62.58 -31.09 50.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 0.0 109.308 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -78.92 -22.67 45.5 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.549 1.155 . . . . 0.0 110.282 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -91.86 -12.59 33.21 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.48 1.113 . . . . 0.0 109.25 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.48 HD22 HD21 ' A' ' 226' ' ' ASN . 0.2 OUTLIER -70.61 148.89 47.63 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.535 1.147 . . . . 0.0 109.318 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 2.4 tpt85 -120.64 116.11 24.68 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.471 1.107 . . . . 0.0 110.288 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.754 ' HB2' HD23 ' A' ' 320' ' ' LEU . . . -80.7 122.28 26.93 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.414 1.072 . . . . 0.0 109.355 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.4 ' O ' ' O ' ' A' ' 319' ' ' LEU . 13.5 ptp180 -130.27 142.97 50.52 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.486 1.116 . . . . 0.0 110.303 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 10.5 m -95.36 129.19 42.59 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.51 1.131 . . . . 0.0 110.383 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.442 HG21 HD11 ' A' ' 319' ' ' LEU . 51.5 t -106.46 117.67 56.52 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.521 1.138 . . . . 0.0 109.276 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.2 Cg_endo -75.03 164.6 32.98 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.473 1.775 . . . . 0.0 110.988 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.501 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -66.85 125.21 25.18 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.495 1.122 . . . . 0.0 109.287 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 99.03 -24.91 30.32 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 124.5 1.125 . . . . 0.0 111.002 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.514 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -63.64 144.74 56.77 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.49 0.759 . . . . 0.0 109.299 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 311' ' ' VAL . 2.7 p -97.54 135.82 30.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 0.0 109.288 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.617 HD12 HG12 ' A' ' 311' ' ' VAL . 12.2 mt -82.3 -49.17 17.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.541 1.15 . . . . 0.0 109.328 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' CYS . . . . . 0.605 ' SG ' HG23 ' A' ' 311' ' ' VAL . 12.8 p -142.96 163.63 32.27 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.522 1.139 . . . . 0.0 108.28 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 1.1 mmt-85 -103.81 178.34 4.59 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.515 1.135 . . . . 0.0 110.313 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.79 142.02 14.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.458 1.099 . . . . 0.0 109.317 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 46.82 43.92 17.12 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.536 1.148 . . . . 0.0 111.009 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.434 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.2 OUTLIER -71.38 166.93 34.32 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.485 0.756 . . . . 0.0 110.311 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.434 ' HD2' ' HB2' ' A' ' 267' ' ' GLU . 18.1 Cg_endo -75.01 86.91 1.37 Allowed 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.487 1.783 . . . . 0.0 111.0 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -45.54 97.9 0.01 OUTLIER Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.499 1.124 . . . . 0.0 110.979 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -170.19 38.11 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.539 0.788 . . . . 0.0 109.284 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.46 144.55 6.42 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.139 . . . . 0.0 110.299 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.504 ' HB2' HD11 ' A' ' 301' ' ' LEU . 2.1 ttt -113.94 146.65 39.78 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.501 1.125 . . . . 0.0 111.008 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.565 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 86.6 m-85 -138.07 136.63 37.0 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.488 1.117 . . . . 0.0 110.984 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . 0.469 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 23.0 m-85 -126.65 133.67 50.92 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.123 . . . . 0.0 110.986 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 36.9 t -89.67 135.2 26.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.495 1.122 . . . . 0.0 109.311 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.566 ' CG2' HD11 ' A' ' 320' ' ' LEU . 9.8 t -110.4 -49.1 6.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.535 1.147 . . . . 0.0 109.334 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -143.59 132.74 23.05 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.483 1.115 . . . . 0.0 110.253 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.99 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 121.95 -169.25 14.72 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.492 1.12 . . . . 0.0 111.023 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 7.6 t -138.33 117.0 12.2 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.555 0.797 . . . . 0.0 110.007 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.469 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 30.0 m -98.76 161.47 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.504 1.127 . . . . 0.0 109.28 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 28.9 t -127.97 151.18 49.44 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.414 1.071 . . . . 0.0 110.018 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 1.4 t -114.81 130.75 68.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.468 1.105 . . . . 0.0 109.328 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.769 ' HB3' ' H ' ' A' ' 310' ' ' THR . . . -77.99 102.14 7.24 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.469 1.106 . . . . 0.0 109.298 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' THR . . . . . 0.655 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.29 -168.46 0.19 Allowed Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.502 1.126 . . . . 0.0 110.403 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.655 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -75.0 3.77 5.33 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.483 1.781 . . . . 0.0 110.936 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -151.45 157.48 34.82 Favored Pre-proline 0 C--N 1.324 -0.529 0 O-C-N 124.501 1.126 . . . . 0.0 109.302 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 94.73 0.96 Allowed 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.493 1.786 . . . . 0.0 110.95 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 281' ' ' SER . 61.5 t -98.94 118.92 46.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 0.0 109.3 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 14.2 mt-10 -124.28 139.11 54.22 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.433 1.083 . . . . 0.0 110.275 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.469 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 3.7 mm? -117.15 140.34 49.64 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.465 1.103 . . . . 0.0 109.299 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -96.5 -162.58 32.75 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.527 1.142 . . . . 0.0 111.061 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 141.47 26.68 Favored 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.567 1.825 . . . . 0.0 110.999 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.678 ' HA2' HD21 ' A' ' 229' ' ' LEU . . . 90.23 6.56 68.7 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.55 1.156 . . . . 0.0 110.971 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -91.69 131.8 36.82 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.484 0.756 . . . . 0.0 109.287 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -119.3 152.71 36.24 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.489 1.118 . . . . 0.0 110.995 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.565 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 45.2 p90 -163.57 145.63 9.58 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.483 1.114 . . . . 0.0 111.02 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . 0.464 ' O ' HD12 ' A' ' 301' ' ' LEU . . . 132.26 -3.53 5.17 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.513 1.133 . . . . 0.0 110.99 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . 0.493 ' HG2' ' CE ' ' A' ' 272' ' ' MET . 1.7 mt-10 -59.41 -46.06 89.76 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.497 0.763 . . . . 0.0 110.294 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . 0.408 ' HB3' ' CG ' ' A' ' 305' ' ' GLU . 0.0 OUTLIER -52.03 -34.36 42.73 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.486 1.116 . . . . 0.0 110.997 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . 0.65 ' HB2' ' NH2' ' A' ' 307' ' ' ARG . . . -69.08 -45.06 71.23 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 0.0 109.289 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.504 HD11 ' HB2' ' A' ' 272' ' ' MET . 1.0 OUTLIER -75.37 -6.96 52.64 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.506 1.128 . . . . 0.0 109.251 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . 0.66 HD11 HD11 ' A' ' 235' ' ' LEU . 3.0 mm -82.25 -55.6 7.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.538 1.149 . . . . 0.0 109.337 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 304' ' ' GLY . 1.6 m -151.57 38.16 0.61 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.468 1.105 . . . . 0.0 110.011 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 36.68 53.14 1.44 Allowed Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.527 1.142 . . . . 0.0 111.005 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' GLU . . . . . 0.408 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 1.3 pt-20 -82.48 157.17 67.95 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.534 0.785 . . . . 0.0 110.312 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.07 133.82 16.95 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.467 1.772 . . . . 0.0 110.982 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . 0.65 ' NH2' ' HB2' ' A' ' 300' ' ' ALA . 0.0 OUTLIER -50.59 -26.0 4.82 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.45 1.094 . . . . 0.0 110.239 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.535 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 0.2 OUTLIER 46.73 39.14 6.71 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.486 1.116 . . . . 0.0 110.025 -180.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 173.91 161.05 0.16 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.514 1.134 . . . . 0.0 109.344 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.769 ' H ' ' HB3' ' A' ' 283' ' ' ALA . 0.6 OUTLIER -109.14 132.87 53.71 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.539 1.149 . . . . 0.0 110.388 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.617 HG12 HD12 ' A' ' 262' ' ' ILE . 44.5 t -111.7 131.56 62.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.483 1.115 . . . . 0.0 109.296 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 6.2 p -141.62 151.64 43.29 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.461 1.101 . . . . 0.0 109.991 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.42 118.48 26.89 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.526 1.141 . . . . 0.0 109.318 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -59.92 -32.24 70.58 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.505 1.128 . . . . 0.0 109.267 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' THR . . . . . 0.665 ' O ' HG23 ' A' ' 317' ' ' VAL . 13.1 t -153.97 -175.58 5.45 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.515 1.135 . . . . 0.0 110.362 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 41.7 p -49.29 92.46 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.531 1.144 . . . . 0.0 110.394 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.99 HG22 ' HA3' ' A' ' 278' ' ' GLY . 53.5 t -109.33 162.41 7.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.472 1.108 . . . . 0.0 109.273 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . 0.433 ' N ' ' CG1' ' A' ' 317' ' ' VAL . 64.0 m -136.29 116.64 13.63 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.514 1.134 . . . . 0.0 109.989 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . 0.469 ' CB ' ' O ' ' A' ' 274' ' ' PHE . 0.2 OUTLIER -132.0 172.25 12.59 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.472 1.107 . . . . 0.0 109.341 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.877 HD22 ' ND2' ' A' ' 226' ' ' ASN . 0.2 OUTLIER -124.66 135.74 53.32 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.495 1.122 . . . . 0.0 109.341 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 45.5 t -93.36 158.25 15.83 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.525 1.141 . . . . 0.0 110.01 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -151.77 94.6 2.0 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.483 1.115 . . . . 0.0 109.329 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . 0.413 ' CD2' ' H ' ' A' ' 323' ' ' HIS . 5.0 p80 -55.39 135.32 50.36 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 0.0 109.624 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 8.1 t -57.78 -17.07 13.53 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.499 1.124 . . . . 0.0 110.0 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -58.31 -36.74 73.82 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.533 1.145 . . . . 0.0 109.297 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -42.61 95.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.491 1.119 . . . . 0.0 109.285 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' PHE . . . . . 0.462 ' HB2' ' CD2' ' A' ' 301' ' ' LEU . 83.7 t80 -65.19 -36.14 83.28 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.46 1.1 . . . . 0.0 110.981 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -69.65 -31.75 70.0 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.464 1.102 . . . . 0.0 110.328 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -69.86 -45.12 68.42 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.538 1.149 . . . . 0.0 110.995 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 1.2 mt -71.27 -30.89 66.84 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.492 1.12 . . . . 0.0 109.274 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' CYS . . . . . 0.412 ' CB ' ' HB2' ' A' ' 338' ' ' ALA . 1.6 m -72.29 -37.52 68.99 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.535 1.147 . . . . 0.0 108.303 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.87 -36.28 64.81 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.44 1.088 . . . . 0.0 110.005 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.77 -33.56 70.9 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.517 1.135 . . . . 0.0 109.98 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' SER . . . . . 0.596 ' CB ' HD12 ' A' ' 337' ' ' ILE . 0.6 OUTLIER -128.68 113.22 19.16 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.531 1.145 . . . . 0.0 109.985 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -22.27 14.97 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.429 1.752 . . . . 0.0 110.988 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -73.53 -31.57 63.75 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.467 1.105 . . . . 0.0 110.337 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.596 HD12 ' CB ' ' A' ' 334' ' ' SER . 60.5 mt -73.69 -45.53 50.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.542 1.151 . . . . 0.0 109.331 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . 0.412 ' HB2' ' CB ' ' A' ' 331' ' ' CYS . . . -69.26 -32.17 71.18 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 0.0 109.298 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -71.4 -38.38 71.46 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.469 1.105 . . . . 0.0 110.334 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.442 ' O ' HG22 ' A' ' 344' ' ' THR . 78.5 mt -73.1 -42.67 58.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.467 1.105 . . . . 0.0 109.341 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.578 ' CZ ' HD13 ' A' ' 235' ' ' LEU . 2.5 t80 -72.39 -30.72 64.93 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.513 1.133 . . . . 0.0 110.997 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . 0.47 ' HG3' ' CD1' ' A' ' 346' ' ' LEU . 0.0 OUTLIER -72.58 -43.21 63.67 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.511 1.132 . . . . 0.0 110.264 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -51.07 63.43 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.461 1.101 . . . . 0.0 109.323 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . 0.545 HG22 ' HA ' ' A' ' 341' ' ' PHE . 9.0 t -65.02 -34.06 77.54 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.513 1.133 . . . . 0.0 110.355 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 341' ' ' PHE . . . -65.22 -43.4 91.62 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.542 1.151 . . . . 0.0 109.291 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.47 ' CD1' ' HG3' ' A' ' 342' ' ' ARG . 0.5 OUTLIER -65.03 -38.87 92.3 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.482 1.114 . . . . 0.0 109.286 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -68.88 -37.95 79.37 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.46 1.1 . . . . 0.0 110.32 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . 0.513 ' HE ' HD21 ' A' ' 235' ' ' LEU . 40.0 mtt-85 . . . . . 0 C--N 1.326 -0.431 0 O-C-N 124.472 1.107 . . . . 0.0 110.345 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 25.3 t80 . . . . . 0 N--CA 1.454 -0.264 0 CA-C-O 120.524 0.202 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.26 -32.58 58.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.485 1.115 . . . . 0.0 109.258 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.34 -35.39 71.17 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.532 1.145 . . . . 0.0 110.291 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.749 ' ND2' HD22 ' A' ' 320' ' ' LEU . 5.3 t-20 -78.95 -30.43 44.6 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.498 1.123 . . . . 0.0 109.25 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' TRP . . . . . 0.893 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 2.5 t90 -67.79 -45.52 74.59 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.502 1.126 . . . . 0.0 107.982 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.658 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 6.1 pt20 -71.54 -34.41 69.99 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.535 1.147 . . . . 0.0 110.339 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 6.2 mt -60.55 -43.83 96.8 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.479 1.112 . . . . 0.0 109.318 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.504 ' O ' HG12 ' A' ' 233' ' ' VAL . 82.7 t -75.5 -45.86 38.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.498 1.124 . . . . 0.0 109.324 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -69.16 -10.26 56.81 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.544 1.152 . . . . 0.0 109.299 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.658 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -80.42 -20.52 43.71 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.459 1.099 . . . . 0.0 109.268 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 230' ' ' VAL . 0.3 OUTLIER -91.74 126.92 52.15 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.491 1.12 . . . . 0.0 109.299 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.405 ' HA ' ' HB2' ' A' ' 237' ' ' GLN . 18.2 Cg_endo -75.01 -0.34 9.85 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.551 1.816 . . . . 0.0 111.029 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -24.12 32.06 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.508 1.13 . . . . 0.0 109.311 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . 0.553 ' CE2' HD13 ' A' ' 247' ' ' ILE . 1.4 m-30 -120.4 -8.49 9.6 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.528 1.143 . . . . 0.0 111.029 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' GLN . . . . . 0.405 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -61.66 -26.71 68.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.464 1.102 . . . . 0.0 110.258 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -74.71 -3.69 32.96 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.539 1.149 . . . . 0.0 109.342 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.594 HD13 HG11 ' A' ' 243' ' ' VAL . 66.5 mt -81.84 -179.32 7.34 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.509 1.131 . . . . 0.0 109.327 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . 0.567 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -100.73 -176.76 29.62 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.5 1.125 . . . . 0.0 111.016 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.942 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.1 Cg_endo -75.05 -38.84 1.39 Allowed 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.469 1.773 . . . . 0.0 110.991 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -66.37 -33.13 75.04 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 0.0 109.286 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.868 HG21 HD11 ' A' ' 337' ' ' ILE . 4.5 t -75.13 -42.02 44.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.503 1.127 . . . . 0.0 109.286 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.567 HD23 ' O ' ' A' ' 240' ' ' GLY . 1.3 mm? -65.34 -37.91 88.52 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.487 1.117 . . . . 0.0 109.271 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.942 HG23 ' O ' ' A' ' 241' ' ' PRO . 58.4 t -71.82 -38.33 65.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.504 1.128 . . . . 0.0 109.247 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -67.64 -40.1 84.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.502 1.126 . . . . 0.0 110.289 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.553 HD13 ' CE2' ' A' ' 236' ' ' PHE . 31.6 mt -68.48 -48.9 70.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.461 1.1 . . . . 0.0 109.312 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.537 ' HA ' HD12 ' A' ' 251' ' ' LEU . 68.6 t -64.32 -33.15 60.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.132 . . . . 0.0 109.286 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.496 ' CG ' ' O ' ' A' ' 245' ' ' VAL . 0.9 OUTLIER -75.84 -22.85 55.84 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.489 1.118 . . . . 0.0 110.332 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.636 ' HB1' ' OD1' ' A' ' 326' ' ' ASP . . . -90.53 -18.08 25.91 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.446 1.091 . . . . 0.0 109.282 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.537 HD12 ' HA ' ' A' ' 248' ' ' VAL . 0.3 OUTLIER -63.4 147.82 50.18 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.475 1.109 . . . . 0.0 109.288 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.97 134.26 55.29 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.541 1.15 . . . . 0.0 110.322 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -80.75 122.46 27.18 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.543 1.152 . . . . 0.0 109.323 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -123.73 123.3 40.21 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.482 1.113 . . . . 0.0 110.301 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 9.3 m -92.13 116.94 29.37 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.533 1.146 . . . . 0.0 110.41 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.489 HG21 HD11 ' A' ' 319' ' ' LEU . 77.4 t -106.67 112.22 63.65 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.548 1.155 . . . . 0.0 109.324 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.529 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.2 Cg_endo -75.0 175.37 11.33 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.501 1.79 . . . . 0.0 110.997 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.574 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -66.97 133.27 49.63 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.499 1.124 . . . . 0.0 109.359 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 90.42 -25.14 13.61 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.456 1.097 . . . . 0.0 110.99 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.529 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -57.66 147.24 28.07 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.53 0.783 . . . . 0.0 109.301 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.7 t -97.25 128.96 48.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.113 . . . . 0.0 109.307 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.795 HD12 HG12 ' A' ' 311' ' ' VAL . 38.7 mt -82.96 -39.17 15.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.467 1.105 . . . . 0.0 109.291 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' CYS . . . . . 0.466 ' SG ' HG23 ' A' ' 311' ' ' VAL . 14.2 p -159.47 151.27 20.46 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.507 1.129 . . . . 0.0 108.27 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 -95.16 -179.46 4.81 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.512 1.133 . . . . 0.0 110.303 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.493 HG23 ' OG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -75.95 139.26 19.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.526 1.141 . . . . 0.0 109.354 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 47.82 51.46 18.15 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.519 1.137 . . . . 0.0 110.999 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.413 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.2 OUTLIER -71.47 164.42 57.83 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.491 0.76 . . . . 0.0 110.306 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.43 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.3 Cg_endo -74.94 78.5 2.86 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.488 1.783 . . . . 0.0 111.045 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 268' ' ' PRO . . . -36.58 96.54 0.01 OUTLIER Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.514 1.134 . . . . 0.0 111.009 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 268' ' ' PRO . 0.3 OUTLIER -170.26 37.6 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.506 0.768 . . . . 0.0 109.283 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . 0.415 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 0.2 OUTLIER -168.09 144.93 4.07 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.484 1.115 . . . . 0.0 110.291 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.487 ' SD ' ' CD1' ' A' ' 301' ' ' LEU . 0.1 OUTLIER -114.85 146.47 41.03 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 0.0 110.948 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.572 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 66.9 m-85 -133.46 136.7 45.31 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.474 1.109 . . . . 0.0 111.037 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . 0.449 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 22.0 m-85 -127.13 131.02 50.88 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.53 1.144 . . . . 0.0 111.046 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.575 HG12 ' HA ' ' A' ' 292' ' ' PRO . 45.7 t -87.07 137.7 20.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.501 1.126 . . . . 0.0 109.295 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.634 ' CG2' HD11 ' A' ' 320' ' ' LEU . 4.2 t -118.56 -40.54 2.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.533 1.145 . . . . 0.0 109.301 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -147.52 136.16 21.87 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.511 1.132 . . . . 0.0 110.339 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.954 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 112.31 -167.33 12.35 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.513 1.133 . . . . 0.0 110.999 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 290' ' ' LEU . 11.2 t -140.97 122.12 14.72 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.569 0.805 . . . . 0.0 109.997 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.467 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 21.1 m -99.27 163.56 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.511 1.132 . . . . 0.0 109.308 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 31.6 t -130.25 151.85 50.32 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.492 1.12 . . . . 0.0 110.03 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.418 ' CG2' ' HB ' ' A' ' 288' ' ' VAL . 0.8 OUTLIER -114.77 129.01 71.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.463 1.102 . . . . 0.0 109.316 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.42 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -80.06 101.06 8.49 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.517 1.135 . . . . 0.0 109.318 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' THR . . . . . 0.661 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -149.04 -168.13 0.18 Allowed Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.554 1.159 . . . . 0.0 110.409 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.661 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.3 Cg_endo -74.98 5.49 3.94 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.448 1.762 . . . . 0.0 111.011 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.443 ' O ' HG23 ' A' ' 288' ' ' VAL . 11.9 m120 -151.59 153.37 31.98 Favored Pre-proline 0 C--N 1.324 -0.529 0 O-C-N 124.511 1.132 . . . . 0.0 109.348 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.95 97.48 1.08 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.509 1.794 . . . . 0.0 111.044 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 286' ' ' ASN . 2.3 t -102.78 119.24 50.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.469 1.106 . . . . 0.0 109.324 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 12.9 mt-10 -124.46 134.8 52.94 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.477 1.11 . . . . 0.0 110.271 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.467 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 3.9 mm? -112.97 141.59 46.62 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.488 1.118 . . . . 0.0 109.336 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -98.12 -164.72 31.13 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.466 1.104 . . . . 0.0 110.953 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' PRO . . . . . 0.575 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.1 Cg_endo -75.0 139.68 24.57 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.541 1.811 . . . . 0.0 111.007 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 96.6 1.93 60.19 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.509 1.131 . . . . 0.0 111.016 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . 0.41 ' CB ' HD12 ' A' ' 290' ' ' LEU . . . -87.64 144.68 26.54 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.529 0.782 . . . . 0.0 109.301 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -134.83 153.11 52.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.468 1.105 . . . . 0.0 110.958 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.572 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 45.9 p90 -163.89 146.25 9.38 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.508 1.13 . . . . 0.0 110.992 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . 0.474 ' O ' HD12 ' A' ' 301' ' ' LEU . . . 137.34 -10.33 3.8 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.455 1.097 . . . . 0.0 111.026 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . 0.44 ' HG2' ' N ' ' A' ' 299' ' ' MET . 0.9 OUTLIER -52.46 -34.85 50.81 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.482 0.754 . . . . 0.0 110.282 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . 0.447 ' HB3' ' CG ' ' A' ' 305' ' ' GLU . 0.5 OUTLIER -64.27 -41.5 96.89 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.458 1.099 . . . . 0.0 111.032 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -63.67 -29.9 71.07 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.473 1.108 . . . . 0.0 109.296 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.487 ' CD1' ' SD ' ' A' ' 272' ' ' MET . 1.2 mt -86.34 -19.04 30.39 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.548 1.155 . . . . 0.0 109.286 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 298' ' ' GLU . 3.9 mm -68.56 -57.4 9.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.426 1.079 . . . . 0.0 109.33 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 304' ' ' GLY . 2.7 m -155.02 44.99 0.5 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.484 1.115 . . . . 0.0 110.021 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 303' ' ' SER . . . 35.4 51.15 0.98 Allowed Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.481 1.113 . . . . 0.0 111.005 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' GLU . . . . . 0.447 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 0.1 OUTLIER -78.76 155.02 78.37 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.504 0.767 . . . . 0.0 110.295 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 130.2 13.08 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.496 1.788 . . . . 0.0 111.003 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . 0.41 ' NE ' ' HG2' ' A' ' 267' ' ' GLU . 0.2 OUTLIER -44.61 -36.37 3.02 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.495 1.122 . . . . 0.0 110.321 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.679 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 0.8 OUTLIER 59.9 42.49 16.21 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.459 1.1 . . . . 0.0 109.967 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' ALA . . . . . 0.679 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 164.59 160.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.517 1.135 . . . . 0.0 109.315 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.493 ' OG1' HG23 ' A' ' 265' ' ' ILE . 0.9 OUTLIER -108.36 137.38 46.43 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.484 1.115 . . . . 0.0 110.387 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.795 HG12 HD12 ' A' ' 262' ' ' ILE . 61.6 t -116.92 131.38 69.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.459 1.1 . . . . 0.0 109.303 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 61.9 p -132.16 159.11 39.92 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.534 1.146 . . . . 0.0 110.008 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -93.6 118.3 31.2 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.547 1.155 . . . . 0.0 109.302 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -58.59 -35.26 72.13 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.499 1.124 . . . . 0.0 109.311 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' THR . . . . . 0.574 ' HA ' ' HB2' ' A' ' 258' ' ' ALA . 9.8 t -155.62 -172.5 4.17 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.491 1.119 . . . . 0.0 110.373 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . 0.426 ' N ' ' OG1' ' A' ' 315' ' ' THR . 32.0 m -49.49 91.33 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.508 1.13 . . . . 0.0 110.396 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.954 HG22 ' HA3' ' A' ' 278' ' ' GLY . 38.6 t -107.79 155.98 8.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.444 1.09 . . . . 0.0 109.281 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 31.0 m -132.56 114.25 14.03 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.491 1.119 . . . . 0.0 110.045 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . 0.489 HD11 HG21 ' A' ' 256' ' ' VAL . 0.2 OUTLIER -129.28 173.29 10.64 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 0.0 109.261 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.749 HD22 ' ND2' ' A' ' 226' ' ' ASN . 0.3 OUTLIER -124.2 138.18 54.44 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.434 1.084 . . . . 0.0 109.303 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 30.9 t -97.59 155.29 17.04 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.501 1.126 . . . . 0.0 109.976 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.739 ' O ' HD13 ' A' ' 322' ' ' LEU . 1.4 tm? -145.69 92.99 2.29 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.441 1.088 . . . . 0.0 109.282 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . 0.509 ' CE1' ' OD1' ' A' ' 326' ' ' ASP . 13.8 p80 -54.99 126.77 25.95 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.464 1.103 . . . . 0.0 109.638 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . 0.407 ' OG ' ' CG ' ' A' ' 270' ' ' ASP . 2.1 p -49.38 -26.92 3.55 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.476 1.11 . . . . 0.0 109.974 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -52.0 -30.46 25.25 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.492 1.12 . . . . 0.0 109.324 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . 0.636 ' OD1' ' HB1' ' A' ' 250' ' ' ALA . 0.2 OUTLIER -70.41 -41.85 72.41 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.448 1.092 . . . . 0.0 109.288 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' PHE . . . . . 0.672 ' CZ ' ' CE2' ' A' ' 341' ' ' PHE . 2.5 t80 -64.82 -38.82 92.28 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.486 1.116 . . . . 0.0 110.994 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -69.53 -34.13 73.8 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.424 1.077 . . . . 0.0 110.252 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 28.7 ttp -71.22 -32.24 68.56 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.465 1.103 . . . . 0.0 111.013 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.518 HD12 HG13 ' A' ' 243' ' ' VAL . 0.2 OUTLIER -72.78 -46.2 54.55 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.546 1.154 . . . . 0.0 109.278 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' CYS . . . . . 0.887 ' SG ' HG22 ' A' ' 337' ' ' ILE . 1.5 m -65.92 -32.38 73.85 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.527 1.142 . . . . 0.0 108.259 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 4.7 t -76.27 -29.8 57.57 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.486 1.116 . . . . 0.0 110.04 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 12.8 t -72.38 -38.19 68.54 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 0.0 109.983 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' SER . . . . . 0.407 ' HA ' ' HD3' ' A' ' 335' ' ' PRO . 0.3 OUTLIER -127.86 130.15 23.66 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.461 1.101 . . . . 0.0 109.97 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 334' ' ' SER . 18.3 Cg_endo -75.0 -23.79 13.45 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.514 1.797 . . . . 0.0 111.035 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.55 -30.27 68.04 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.495 1.122 . . . . 0.0 110.351 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.887 HG22 ' SG ' ' A' ' 331' ' ' CYS . 49.4 mt -73.36 -36.86 50.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.498 1.124 . . . . 0.0 109.317 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -71.53 -34.63 70.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.502 1.126 . . . . 0.0 109.291 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -74.05 -45.13 51.48 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.512 1.132 . . . . 0.0 110.273 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 94.5 mt -69.82 -35.55 65.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.517 1.136 . . . . 0.0 109.316 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.672 ' CE2' ' CZ ' ' A' ' 327' ' ' PHE . 1.6 t80 -69.14 -39.46 78.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.523 1.14 . . . . 0.0 110.996 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.46 -38.05 77.57 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.479 1.112 . . . . 0.0 110.336 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -43.52 78.29 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.516 1.135 . . . . 0.0 109.311 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.91 -40.78 83.36 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.517 1.136 . . . . 0.0 110.414 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -66.37 -38.02 86.62 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.511 1.132 . . . . 0.0 109.282 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 346' ' ' LEU . 9.6 mt -68.59 -35.1 76.9 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.538 1.149 . . . . 0.0 109.344 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -69.69 -40.1 76.53 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.124 . . . . 0.0 110.286 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 13.9 mtt180 . . . . . 0 C--N 1.325 -0.498 0 O-C-N 124.506 1.129 . . . . 0.0 110.314 -179.966 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 43.0 t80 . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.514 0.197 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.78 -37.94 43.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.439 1.087 . . . . 0.0 109.271 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.495 ' O ' HD12 ' A' ' 229' ' ' LEU . 0.0 OUTLIER -68.3 -31.1 70.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.144 . . . . 0.0 110.335 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.967 ' O ' HG12 ' A' ' 230' ' ' VAL . 6.4 t-20 -80.3 -31.55 38.19 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.532 1.145 . . . . 0.0 109.286 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' TRP . . . . . 0.712 ' CZ3' HG23 ' A' ' 245' ' ' VAL . 2.0 t90 -68.68 -43.98 75.0 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.674 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 4.1 pt20 -72.02 -33.82 68.34 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.454 1.096 . . . . 0.0 110.308 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.637 HD21 ' HA2' ' A' ' 293' ' ' GLY . 2.4 mt -64.94 -55.37 19.6 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 0.0 109.269 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.967 HG12 ' O ' ' A' ' 226' ' ' ASN . 5.7 p -65.09 -37.66 80.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.523 1.139 . . . . 0.0 109.34 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 227' ' ' TRP . . . -76.03 -15.1 60.19 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.478 1.111 . . . . 0.0 109.235 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.674 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -80.71 -11.33 59.64 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.503 1.127 . . . . 0.0 109.307 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . 0.729 HG12 ' O ' ' A' ' 230' ' ' VAL . 0.6 OUTLIER -89.02 132.61 37.46 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.547 1.155 . . . . 0.0 109.32 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.432 ' HA ' ' HB2' ' A' ' 237' ' ' GLN . 18.4 Cg_endo -74.97 -0.08 9.51 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.457 1.767 . . . . 0.0 111.028 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.25 -24.4 22.1 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 0.0 109.32 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . 0.61 ' H ' HG13 ' A' ' 233' ' ' VAL . 21.2 m-30 -122.92 8.14 9.32 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.478 1.111 . . . . 0.0 110.987 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' GLN . . . . . 0.432 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 3.0 tt0 -73.16 -19.53 61.1 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.483 1.114 . . . . 0.0 110.286 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.438 ' NZ ' ' HA ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -97.57 4.99 50.14 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.527 1.142 . . . . 0.0 109.326 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.814 HD13 ' CG1' ' A' ' 243' ' ' VAL . 19.3 mt -80.28 -179.42 7.09 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.465 1.103 . . . . 0.0 109.316 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . 0.601 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -103.23 -178.48 26.3 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.499 1.124 . . . . 0.0 110.991 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 -32.9 5.04 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.53 1.805 . . . . 0.0 110.98 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.521 ' HA ' HG12 ' A' ' 245' ' ' VAL . . . -73.62 -32.81 64.26 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.445 1.09 . . . . 0.0 109.297 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.814 ' CG1' HD13 ' A' ' 239' ' ' LEU . 63.0 t -76.6 -38.39 31.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.126 . . . . 0.0 109.271 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.643 ' O ' HG23 ' A' ' 248' ' ' VAL . 3.6 mm? -71.31 -45.47 62.96 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.488 1.118 . . . . 0.0 109.289 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.712 HG23 ' CZ3' ' A' ' 227' ' ' TRP . 3.3 p -64.65 -45.09 96.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.528 1.142 . . . . 0.0 109.317 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.402 ' N ' ' CG1' ' A' ' 245' ' ' VAL . 15.3 tp10 -65.0 -40.89 95.62 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.509 1.13 . . . . 0.0 110.262 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.591 ' CG1' HD13 ' A' ' 330' ' ' LEU . 26.5 mt -65.16 -43.83 95.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.493 1.121 . . . . 0.0 109.303 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 244' ' ' LEU . 75.7 t -69.51 -30.99 47.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.504 1.128 . . . . 0.0 109.277 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -76.87 -19.6 57.27 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.55 1.156 . . . . 0.0 110.324 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.611 ' HB1' ' OD2' ' A' ' 326' ' ' ASP . . . -93.82 -14.84 25.71 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.539 1.149 . . . . 0.0 109.302 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.464 HD22 ' HB2' ' A' ' 320' ' ' LEU . 0.2 OUTLIER -66.12 146.35 54.76 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.541 1.151 . . . . 0.0 109.293 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 320' ' ' LEU . 1.0 OUTLIER -117.82 117.96 30.73 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.555 1.159 . . . . 0.0 110.288 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.737 ' HB2' HD23 ' A' ' 320' ' ' LEU . . . -80.79 125.03 29.56 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.436 1.085 . . . . 0.0 109.289 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -132.56 143.89 50.02 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.491 1.119 . . . . 0.0 110.275 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 20.1 m -96.64 125.93 41.45 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 0.0 110.413 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.792 HG21 HD11 ' A' ' 319' ' ' LEU . 93.4 t -106.39 116.14 59.7 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.537 1.148 . . . . 0.0 109.345 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.483 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.9 162.12 37.86 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.513 1.796 . . . . 0.0 111.026 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.502 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -63.71 125.19 23.52 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.475 1.109 . . . . 0.0 109.317 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 100.7 -25.27 28.96 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.489 1.118 . . . . 0.0 110.988 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.483 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -64.02 139.15 58.74 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.459 0.74 . . . . 0.0 109.295 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 311' ' ' VAL . 2.7 p -93.25 135.64 27.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.466 1.104 . . . . 0.0 109.282 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.785 HD12 HG12 ' A' ' 311' ' ' VAL . 11.2 mt -82.49 -49.35 17.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.531 1.144 . . . . 0.0 109.284 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' CYS . . . . . 0.655 ' SG ' HG23 ' A' ' 311' ' ' VAL . 12.4 p -141.7 162.43 35.5 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.531 1.144 . . . . 0.0 108.255 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -103.93 -179.01 3.83 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.449 1.093 . . . . 0.0 110.28 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.32 137.41 22.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 0.0 109.299 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 47.01 48.91 18.87 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.504 1.128 . . . . 0.0 111.028 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.416 ' OE1' ' C ' ' A' ' 268' ' ' PRO . 0.0 OUTLIER -71.26 162.6 71.71 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.455 0.738 . . . . 0.0 110.333 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 269' ' ' GLY . 18.5 Cg_endo -74.98 78.07 2.98 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.521 1.801 . . . . 0.0 111.041 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . 0.464 ' O ' ' CA ' ' A' ' 304' ' ' GLY . . . -35.23 102.73 0.01 OUTLIER Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.527 1.142 . . . . 0.0 110.973 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -170.33 38.31 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 0.765 . . . . 0.0 109.293 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.45 144.86 2.01 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.131 . . . . 0.0 110.293 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.97 146.56 37.62 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.511 1.132 . . . . 0.0 111.057 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.562 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 20.1 m-85 -137.55 136.78 37.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.486 1.117 . . . . 0.0 111.021 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . 0.484 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 21.4 m-85 -127.25 135.95 51.32 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.537 1.148 . . . . 0.0 111.005 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.531 HG12 ' HA ' ' A' ' 292' ' ' PRO . 25.4 t -93.57 138.65 19.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.46 1.1 . . . . 0.0 109.305 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 2.7 t -115.99 -48.49 4.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.469 1.106 . . . . 0.0 109.274 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -140.2 132.99 29.07 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.528 1.143 . . . . 0.0 110.304 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.933 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 118.34 -173.35 14.83 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.531 1.144 . . . . 0.0 110.997 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 290' ' ' LEU . 8.4 t -134.73 122.29 21.95 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.52 0.776 . . . . 0.0 110.012 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.456 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 26.1 m -100.08 163.86 2.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.492 1.12 . . . . 0.0 109.302 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 31.1 t -129.24 152.51 48.74 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 0.0 109.993 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 1.5 t -115.96 128.87 73.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.467 1.105 . . . . 0.0 109.3 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.619 ' HB3' ' H ' ' A' ' 310' ' ' THR . . . -78.43 101.66 7.4 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.48 1.113 . . . . 0.0 109.319 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' THR . . . . . 0.664 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.9 OUTLIER -148.54 -167.96 0.17 Allowed Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.485 1.116 . . . . 0.0 110.366 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.664 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.5 Cg_endo -74.96 4.77 4.42 Favored 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.524 1.802 . . . . 0.0 111.057 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.444 ' O ' HG23 ' A' ' 288' ' ' VAL . 17.4 m120 -152.0 155.25 33.45 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.477 1.11 . . . . 0.0 109.31 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 96.52 1.02 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.545 1.813 . . . . 0.0 111.032 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 286' ' ' ASN . 2.1 t -101.52 119.54 49.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.536 1.148 . . . . 0.0 109.281 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 14.3 mt-10 -124.29 136.09 53.87 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.484 1.115 . . . . 0.0 110.321 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.456 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 3.8 mm? -115.44 141.77 47.6 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.483 1.115 . . . . 0.0 109.341 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -94.11 -160.21 34.51 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.505 1.128 . . . . 0.0 110.982 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' PRO . . . . . 0.531 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.2 Cg_endo -75.01 148.27 35.01 Favored 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.513 1.796 . . . . 0.0 111.009 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.637 ' HA2' HD21 ' A' ' 229' ' ' LEU . . . 86.46 -0.62 87.06 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.499 1.125 . . . . 0.0 110.984 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -83.49 123.43 29.71 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.478 0.752 . . . . 0.0 109.279 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.481 ' HD2' HD23 ' A' ' 229' ' ' LEU . 3.8 p90 -114.82 152.92 31.33 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.482 1.114 . . . . 0.0 111.006 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.562 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 37.5 p90 -160.57 147.99 15.91 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.518 1.136 . . . . 0.0 111.046 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 134.72 -8.35 4.56 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.548 1.155 . . . . 0.0 111.007 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -52.58 -41.9 64.02 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.458 0.74 . . . . 0.0 110.284 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . 0.466 ' HB3' ' CG ' ' A' ' 305' ' ' GLU . 0.1 OUTLIER -54.92 -41.08 70.54 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.494 1.121 . . . . 0.0 111.006 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . 0.434 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -66.92 -35.7 80.6 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.509 1.131 . . . . 0.0 109.258 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.45 ' O ' ' CZ ' ' A' ' 341' ' ' PHE . 6.5 mt -75.01 -20.31 59.68 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.511 1.132 . . . . 0.0 109.261 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 3.3 mm -73.06 -54.97 14.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.129 . . . . 0.0 109.329 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.85 40.39 0.23 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.456 1.098 . . . . 0.0 110.015 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.464 ' CA ' ' O ' ' A' ' 269' ' ' GLY . . . 39.6 40.65 1.52 Allowed Glycine 0 CA--C 1.531 1.052 0 O-C-N 124.497 1.123 . . . . 0.0 110.989 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' GLU . . . . . 0.466 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 0.0 OUTLIER -66.11 158.65 75.67 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.509 0.77 . . . . 0.0 110.292 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.403 ' O ' ' OE2' ' A' ' 305' ' ' GLU . 18.5 Cg_endo -74.95 130.69 13.56 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.528 1.804 . . . . 0.0 111.02 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.9 -40.89 14.95 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.516 1.135 . . . . 0.0 110.318 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.555 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 0.5 OUTLIER 68.19 34.43 3.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.493 1.121 . . . . 0.0 110.044 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' ALA . . . . . 0.555 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 172.78 161.98 0.12 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.521 1.138 . . . . 0.0 109.282 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.619 ' H ' ' HB3' ' A' ' 283' ' ' ALA . 0.5 OUTLIER -107.71 130.99 54.89 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.538 1.149 . . . . 0.0 110.416 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.785 HG12 HD12 ' A' ' 262' ' ' ILE . 41.6 t -109.75 131.48 60.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.472 1.108 . . . . 0.0 109.343 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 3.2 p -139.2 152.33 47.28 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.11 . . . . 0.0 109.993 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.94 117.17 26.61 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.474 1.109 . . . . 0.0 109.297 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -59.62 -31.48 69.53 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.547 1.154 . . . . 0.0 109.317 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' THR . . . . . 0.739 ' O ' HG23 ' A' ' 317' ' ' VAL . 8.1 t -154.59 -175.36 5.37 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.472 1.108 . . . . 0.0 110.405 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . 0.401 ' H ' HG23 ' A' ' 316' ' ' THR . 65.1 p -49.73 92.81 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.514 1.134 . . . . 0.0 110.392 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.933 HG22 ' HA3' ' A' ' 278' ' ' GLY . 75.8 t -110.23 152.07 12.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.498 1.124 . . . . 0.0 109.31 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 70.3 m -123.96 117.42 24.73 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.548 1.155 . . . . 0.0 109.988 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . 0.792 HD11 HG21 ' A' ' 256' ' ' VAL . 0.2 OUTLIER -134.06 169.38 17.22 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.481 1.113 . . . . 0.0 109.293 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.737 HD23 ' HB2' ' A' ' 253' ' ' ALA . 0.0 OUTLIER -124.35 139.05 54.27 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.473 1.108 . . . . 0.0 109.314 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 3.2 p -95.04 158.17 15.58 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.534 1.146 . . . . 0.0 110.002 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.46 ' O ' HD13 ' A' ' 322' ' ' LEU . 1.5 tm? -151.0 77.69 1.28 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.471 1.107 . . . . 0.0 109.305 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -42.54 141.46 1.01 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.416 1.072 . . . . 0.0 109.577 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -24.82 63.57 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.447 1.092 . . . . 0.0 109.963 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -52.21 -35.87 50.53 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.521 1.138 . . . . 0.0 109.292 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . 0.611 ' OD2' ' HB1' ' A' ' 250' ' ' ALA . 0.4 OUTLIER -71.6 -37.33 70.97 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.542 1.151 . . . . 0.0 109.329 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' PHE . . . . . 0.417 ' CE2' ' CE2' ' A' ' 341' ' ' PHE . 38.4 t80 -66.51 -41.18 89.23 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.484 1.115 . . . . 0.0 111.031 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -71.29 -31.52 67.55 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.503 1.127 . . . . 0.0 110.297 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.403 ' SD ' ' C ' ' A' ' 329' ' ' MET . 15.6 tmm? -68.54 -43.74 76.03 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.548 1.155 . . . . 0.0 111.014 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.591 HD13 ' CG1' ' A' ' 247' ' ' ILE . 5.0 mt -71.39 -37.78 71.53 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.521 1.138 . . . . 0.0 109.265 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' CYS . . . . . 0.422 ' SG ' HG22 ' A' ' 337' ' ' ILE . 73.6 m -65.88 -41.68 91.25 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.531 1.144 . . . . 0.0 108.29 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.4 t -77.55 -24.42 49.86 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.471 1.107 . . . . 0.0 110.01 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 47.6 t -72.21 -39.02 68.87 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.533 1.145 . . . . 0.0 110.034 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' SER . . . . . 0.706 ' CB ' HD12 ' A' ' 337' ' ' ILE . 0.1 OUTLIER -129.03 133.83 25.64 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.482 1.114 . . . . 0.0 109.978 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 334' ' ' SER . 18.4 Cg_endo -74.98 -23.75 13.53 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.54 1.81 . . . . 0.0 110.974 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -72.26 -29.32 63.79 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.5 1.125 . . . . 0.0 110.328 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.706 HD12 ' CB ' ' A' ' 334' ' ' SER . 30.9 mt -72.98 -42.71 59.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.483 1.114 . . . . 0.0 109.281 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.74 -30.72 67.32 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.55 1.157 . . . . 0.0 109.297 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -73.61 -43.76 58.79 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.564 1.165 . . . . 0.0 110.36 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 76.1 mt -70.76 -39.42 75.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.513 1.133 . . . . 0.0 109.298 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.491 ' CD1' ' C ' ' A' ' 341' ' ' PHE . 0.5 OUTLIER -66.95 -41.46 86.91 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.488 1.118 . . . . 0.0 111.005 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 -70.48 -33.41 71.22 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.504 1.128 . . . . 0.0 110.303 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -50.54 66.53 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.504 1.127 . . . . 0.0 109.323 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . 0.455 HG22 ' O ' ' A' ' 341' ' ' PHE . 6.0 t -65.11 -39.12 92.68 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.541 1.151 . . . . 0.0 110.433 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -66.77 -33.78 76.37 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.471 1.107 . . . . 0.0 109.282 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.504 ' HA ' HD23 ' A' ' 346' ' ' LEU . 10.2 mt -71.83 -36.9 70.34 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.514 1.134 . . . . 0.0 109.314 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -76.26 -30.8 57.98 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.535 1.147 . . . . 0.0 110.3 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 7.0 mtt-85 . . . . . 0 C--N 1.325 -0.499 0 O-C-N 124.472 1.107 . . . . 0.0 110.335 179.964 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 46.4 t80 . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 120.515 0.198 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.65 -39.45 60.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.467 1.104 . . . . 0.0 109.321 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.654 ' HG2' HG13 ' A' ' 276' ' ' VAL . 0.1 OUTLIER -69.21 -29.78 67.81 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.493 1.121 . . . . 0.0 110.322 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.448 ' CG ' HG23 ' A' ' 248' ' ' VAL . 39.6 t-20 -78.12 -32.66 50.55 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.452 1.095 . . . . 0.0 109.299 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' TRP . . . . . 0.726 ' CH2' HG23 ' A' ' 245' ' ' VAL . 2.8 t90 -73.99 -42.94 59.66 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.519 1.137 . . . . 0.0 108.026 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.411 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 1.5 pt20 -70.38 -28.79 65.37 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.505 1.128 . . . . 0.0 110.314 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.623 HD12 ' HG3' ' A' ' 225' ' ' ARG . 3.3 mt -69.14 -54.96 12.21 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.515 1.134 . . . . 0.0 109.316 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.608 HG21 ' HB ' ' A' ' 248' ' ' VAL . 33.0 m -65.02 -32.04 56.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.497 1.123 . . . . 0.0 109.323 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -76.13 -24.63 54.91 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.111 . . . . 0.0 109.271 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -80.54 1.21 30.49 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.488 1.117 . . . . 0.0 109.289 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 229' ' ' LEU . 96.7 t -92.07 118.75 68.34 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.518 1.136 . . . . 0.0 109.311 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.417 ' HA ' ' HB2' ' A' ' 237' ' ' GLN . 18.2 Cg_endo -75.0 -21.96 15.3 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.536 1.808 . . . . 0.0 110.989 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.98 -30.56 71.63 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.496 1.123 . . . . 0.0 109.325 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . 0.861 ' HB3' HD12 ' A' ' 239' ' ' LEU . 24.4 m-85 -112.42 20.31 16.81 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.482 1.114 . . . . 0.0 110.985 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' GLN . . . . . 0.417 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 1.0 OUTLIER -68.12 -18.57 64.67 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.485 1.116 . . . . 0.0 110.316 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -86.99 -14.16 42.46 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.465 1.103 . . . . 0.0 109.322 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.861 HD12 ' HB3' ' A' ' 236' ' ' PHE . 55.6 mt -68.5 176.29 2.97 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.507 1.129 . . . . 0.0 109.277 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . 0.604 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -109.63 -171.97 20.53 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.445 1.09 . . . . 0.0 110.974 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -32.39 5.43 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.463 1.77 . . . . 0.0 111.004 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.522 ' HA ' HG12 ' A' ' 245' ' ' VAL . . . -72.9 -32.92 65.69 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.48 1.112 . . . . 0.0 109.309 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.827 ' CG1' HD13 ' A' ' 239' ' ' LEU . 54.5 t -76.82 -38.64 29.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.491 1.119 . . . . 0.0 109.295 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.604 HD23 ' O ' ' A' ' 240' ' ' GLY . 2.9 mm? -71.0 -44.41 65.95 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.521 1.138 . . . . 0.0 109.239 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.726 HG23 ' CH2' ' A' ' 227' ' ' TRP . 3.0 p -66.27 -39.77 85.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.448 1.093 . . . . 0.0 109.271 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -69.87 -40.29 75.8 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.543 1.152 . . . . 0.0 110.319 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.75 ' O ' HD13 ' A' ' 251' ' ' LEU . 46.0 mt -65.63 -55.16 21.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.497 1.123 . . . . 0.0 109.271 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.608 ' HB ' HG21 ' A' ' 230' ' ' VAL . 4.2 p -60.81 -30.63 47.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.54 1.15 . . . . 0.0 109.363 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.517 ' CG ' ' O ' ' A' ' 245' ' ' VAL . 14.3 mmt180 -79.21 -16.84 55.93 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.527 1.142 . . . . 0.0 110.287 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -95.56 -16.05 22.41 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.513 1.133 . . . . 0.0 109.286 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 1.019 HD12 HD23 ' A' ' 322' ' ' LEU . 7.9 mp -65.28 151.76 45.4 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.563 1.164 . . . . 0.0 109.316 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 6.0 tpt85 -121.12 116.18 24.5 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.496 1.123 . . . . 0.0 110.283 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.693 ' HB2' HD23 ' A' ' 320' ' ' LEU . . . -80.59 122.73 27.42 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.493 1.12 . . . . 0.0 109.266 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.45 141.07 52.26 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.48 1.112 . . . . 0.0 110.297 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.2 m -91.51 118.24 30.41 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.494 1.121 . . . . 0.0 110.349 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.664 ' CG1' ' HB2' ' A' ' 313' ' ' ALA . 4.0 t -106.36 114.19 62.47 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.536 1.148 . . . . 0.0 109.329 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.505 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.93 171.64 17.9 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.493 1.786 . . . . 0.0 110.978 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.519 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -67.73 129.13 38.95 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.535 1.147 . . . . 0.0 109.316 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 96.07 -25.55 24.95 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.55 1.156 . . . . 0.0 110.994 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.533 ' HB3' HG13 ' A' ' 256' ' ' VAL . . . -58.95 138.3 57.51 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.516 0.774 . . . . 0.0 109.262 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 9.3 t -83.34 126.65 40.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.496 1.123 . . . . 0.0 109.334 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.61 HD12 HG12 ' A' ' 311' ' ' VAL . 94.9 mt -82.92 -45.49 19.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.476 1.11 . . . . 0.0 109.307 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' CYS . . . . . 0.609 ' SG ' HG23 ' A' ' 311' ' ' VAL . 7.9 p -152.72 143.87 23.13 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.493 1.12 . . . . 0.0 108.321 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -86.81 176.67 7.6 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.513 1.133 . . . . 0.0 110.281 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.444 HG23 ' OG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -78.25 148.56 6.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.492 1.12 . . . . 0.0 109.286 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 37.08 47.44 1.36 Allowed Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.469 1.106 . . . . 0.0 110.981 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.445 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.0 OUTLIER -70.25 165.21 46.19 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.516 0.774 . . . . 0.0 110.3 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 267' ' ' GLU . 18.2 Cg_endo -75.06 76.39 3.44 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.525 1.803 . . . . 0.0 110.983 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 268' ' ' PRO . . . -36.71 105.95 0.04 OUTLIER Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.576 1.173 . . . . 0.0 110.994 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -170.51 37.37 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.481 0.754 . . . . 0.0 109.29 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -172.31 156.83 3.94 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.476 1.11 . . . . 0.0 110.301 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.686 ' HG3' HD12 ' A' ' 301' ' ' LEU . 0.0 OUTLIER -122.6 146.47 47.41 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.467 1.105 . . . . 0.0 111.022 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.591 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 13.6 m-85 -133.21 143.37 49.11 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.471 1.107 . . . . 0.0 111.033 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -133.15 125.2 28.95 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.515 1.134 . . . . 0.0 110.987 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.547 HG22 HD12 ' A' ' 319' ' ' LEU . 56.4 t -78.22 129.32 37.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.431 1.082 . . . . 0.0 109.319 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.838 ' CG2' HD11 ' A' ' 320' ' ' LEU . 59.3 t -101.55 -54.05 7.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.506 1.129 . . . . 0.0 109.323 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.714 ' O ' HG23 ' A' ' 317' ' ' VAL . 15.6 mt-10 -141.83 140.71 33.02 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.542 1.151 . . . . 0.0 110.274 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 113.15 -155.87 16.01 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.526 1.142 . . . . 0.0 111.01 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 290' ' ' LEU . 1.8 m -145.96 139.36 26.13 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.487 0.757 . . . . 0.0 110.001 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.579 HG12 HD11 ' A' ' 262' ' ' ILE . 27.1 m -120.76 135.57 60.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.555 1.159 . . . . 0.0 109.266 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 29.9 t -104.27 139.77 38.81 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.429 1.08 . . . . 0.0 109.968 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 1.3 t -103.88 129.66 55.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.471 1.107 . . . . 0.0 109.322 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.413 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -78.05 101.36 6.92 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.543 1.152 . . . . 0.0 109.358 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' THR . . . . . 0.662 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -149.0 -168.0 0.17 Allowed Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.5 1.125 . . . . 0.0 110.427 -179.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.662 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -75.01 4.43 4.75 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.502 1.79 . . . . 0.0 111.007 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -152.27 154.59 32.37 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.529 1.143 . . . . 0.0 109.309 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 95.12 0.96 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.46 1.769 . . . . 0.0 110.983 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 281' ' ' SER . 19.3 t -100.15 118.39 46.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.56 1.163 . . . . 0.0 109.331 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.407 ' C ' HD22 ' A' ' 290' ' ' LEU . 3.4 mm-40 -125.38 133.74 52.42 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.489 1.118 . . . . 0.0 110.324 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.407 HD22 ' C ' ' A' ' 289' ' ' GLU . 4.6 mm? -114.51 139.71 49.34 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.52 1.138 . . . . 0.0 109.289 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -93.72 -157.43 33.17 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.564 1.165 . . . . 0.0 111.007 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 147.86 34.49 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.509 1.794 . . . . 0.0 111.005 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 85.95 5.85 83.02 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.532 1.145 . . . . 0.0 111.034 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -85.61 146.27 26.95 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.539 0.788 . . . . 0.0 109.332 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 295' ' ' PHE . 1.0 OUTLIER -132.95 152.81 51.87 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.549 1.156 . . . . 0.0 110.99 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.591 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 46.3 p90 -165.77 143.88 5.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.553 1.158 . . . . 0.0 110.958 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 129.59 -6.73 6.22 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.48 1.113 . . . . 0.0 110.994 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -52.09 -48.43 64.71 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.503 0.767 . . . . 0.0 110.275 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . 0.442 ' HB3' ' CG ' ' A' ' 305' ' ' GLU . 0.0 OUTLIER -50.21 -37.45 35.28 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.502 1.126 . . . . 0.0 111.047 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -66.13 -40.34 90.58 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.466 1.104 . . . . 0.0 109.298 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.686 HD12 ' HG3' ' A' ' 272' ' ' MET . 27.7 mt -74.84 -21.64 59.15 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 0.0 109.306 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 15.0 mm -67.16 -57.64 9.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.458 1.099 . . . . 0.0 109.303 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 304' ' ' GLY . 7.4 m -155.96 44.85 0.44 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.532 1.145 . . . . 0.0 109.98 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 35.69 49.9 1.04 Allowed Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.531 1.144 . . . . 0.0 111.041 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' GLU . . . . . 0.442 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 0.0 OUTLIER -80.26 158.8 71.45 Favored Pre-proline 0 C--N 1.326 -0.443 0 O-C-N 124.497 0.763 . . . . 0.0 110.271 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.01 130.25 13.09 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.525 1.802 . . . . 0.0 111.032 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -47.07 -39.34 12.82 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.5 1.125 . . . . 0.0 110.275 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.503 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 15.0 m 67.77 30.34 6.4 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.478 1.111 . . . . 0.0 109.995 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 175.67 162.26 0.3 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.532 1.145 . . . . 0.0 109.299 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.444 ' OG1' HG23 ' A' ' 265' ' ' ILE . 0.9 OUTLIER -113.04 137.6 51.17 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.515 1.135 . . . . 0.0 110.398 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.61 HG12 HD12 ' A' ' 262' ' ' ILE . 95.1 t -109.43 127.62 66.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.504 1.128 . . . . 0.0 109.318 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 48.3 p -121.94 145.28 48.26 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.501 1.126 . . . . 0.0 110.026 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . 0.758 ' HB1' HG12 ' A' ' 317' ' ' VAL . . . -79.53 106.23 11.41 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.536 1.148 . . . . 0.0 109.28 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -52.99 -24.64 9.89 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.473 1.108 . . . . 0.0 109.325 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' THR . . . . . 0.636 ' O ' HG12 ' A' ' 317' ' ' VAL . 8.8 t -168.09 -164.64 0.55 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.495 1.122 . . . . 0.0 110.38 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . 0.438 ' N ' ' OG1' ' A' ' 315' ' ' THR . 29.2 p -61.35 79.11 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.508 1.13 . . . . 0.0 110.443 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.819 HG22 ' CD1' ' A' ' 319' ' ' LEU . 2.7 p -110.74 141.88 24.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.5 1.125 . . . . 0.0 109.277 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . 1.019 ' C ' HD13 ' A' ' 319' ' ' LEU . 53.4 m -117.57 136.51 53.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.454 1.096 . . . . 0.0 109.949 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . 1.019 HD13 ' C ' ' A' ' 318' ' ' SER . 0.0 OUTLIER -135.86 173.77 11.35 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.479 1.112 . . . . 0.0 109.309 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.838 HD11 ' CG2' ' A' ' 276' ' ' VAL . 0.1 OUTLIER -124.22 125.19 44.0 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.528 1.143 . . . . 0.0 109.292 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 272' ' ' MET . 25.8 p -86.97 158.67 19.22 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.518 1.136 . . . . 0.0 110.036 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 1.019 HD23 HD12 ' A' ' 251' ' ' LEU . 3.1 tm? -145.44 86.71 1.76 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.491 1.119 . . . . 0.0 109.311 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . 0.536 ' CE1' ' OD1' ' A' ' 326' ' ' ASP . 6.0 p80 -50.7 137.31 20.26 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.535 1.147 . . . . 0.0 109.605 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.19 -26.11 62.39 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.473 1.108 . . . . 0.0 110.004 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -53.6 -36.76 62.31 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.459 1.1 . . . . 0.0 109.311 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . 0.536 ' OD1' ' CE1' ' A' ' 323' ' ' HIS . 0.6 OUTLIER -64.99 -41.45 95.4 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.485 1.116 . . . . 0.0 109.317 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' PHE . . . . . 0.49 ' CE1' ' CE2' ' A' ' 341' ' ' PHE . 71.9 t80 -66.84 -34.96 78.95 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.439 1.087 . . . . 0.0 110.965 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -69.86 -33.99 73.0 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.482 1.113 . . . . 0.0 110.288 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 30.4 ttp -70.19 -43.88 69.84 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.441 1.088 . . . . 0.0 111.014 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 2.7 mt -71.66 -35.38 70.31 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.505 1.128 . . . . 0.0 109.286 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 41.6 m -72.31 -30.63 64.95 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.52 1.137 . . . . 0.0 108.278 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 33.0 t -75.78 -34.49 60.23 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.518 1.136 . . . . 0.0 110.021 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.48 -36.3 65.79 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.528 1.142 . . . . 0.0 109.97 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.5 114.32 27.25 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 0.0 109.975 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -22.51 14.81 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.448 1.762 . . . . 0.0 111.007 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -71.91 -29.34 64.21 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.562 1.164 . . . . 0.0 110.286 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.671 HD11 HG21 ' A' ' 243' ' ' VAL . 44.5 mt -71.95 -40.14 67.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.134 . . . . 0.0 109.26 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.55 -31.84 65.59 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 0.0 109.278 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -74.95 -42.15 58.2 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.562 1.164 . . . . 0.0 110.288 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 86.3 mt -70.96 -42.81 77.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.486 1.116 . . . . 0.0 109.287 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.49 ' CE2' ' CE1' ' A' ' 327' ' ' PHE . 24.8 t80 -67.46 -39.61 85.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.521 1.138 . . . . 0.0 111.039 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -68.12 -37.32 80.99 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.526 1.141 . . . . 0.0 110.303 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -44.09 84.16 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.52 1.137 . . . . 0.0 109.281 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 341' ' ' PHE . 0.6 OUTLIER -67.99 -32.62 73.15 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.465 1.103 . . . . 0.0 110.377 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -69.91 -41.15 75.07 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.45 1.094 . . . . 0.0 109.333 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' A' ' 346' ' ' LEU . 14.5 mt -65.2 -41.42 94.55 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 0.0 109.283 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -65.81 -37.64 86.81 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.112 . . . . 0.0 110.3 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 28.3 mtt-85 . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.512 1.133 . . . . 0.0 110.325 -179.999 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.4 ' CE1' HG11 ' A' ' 248' ' ' VAL . 1.6 t80 . . . . . 0 N--CA 1.452 -0.332 0 CA-C-O 120.541 0.21 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.57 -35.44 56.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.466 1.104 . . . . 0.0 109.276 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.767 ' O ' HD23 ' A' ' 229' ' ' LEU . 0.5 OUTLIER -70.72 -31.56 68.44 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.478 1.111 . . . . 0.0 110.311 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.455 ' ND2' ' CD1' ' A' ' 320' ' ' LEU . 4.1 m-20 -81.23 -31.57 33.77 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.532 1.145 . . . . 0.0 109.276 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' TRP . . . . . 0.89 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 2.0 t90 -70.61 -43.75 68.67 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.455 ' O ' ' N ' ' A' ' 232' ' ' ALA . 1.5 pt20 -70.89 -37.28 73.0 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.494 1.121 . . . . 0.0 110.278 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.909 HD12 ' HB3' ' A' ' 274' ' ' PHE . 1.6 mm? -60.18 -42.75 95.69 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.51 1.131 . . . . 0.0 109.314 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.688 HG13 ' CD1' ' A' ' 244' ' ' LEU . 12.7 p -74.23 -38.74 48.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.515 1.135 . . . . 0.0 109.284 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -75.15 -11.51 60.1 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.472 1.107 . . . . 0.0 109.33 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 228' ' ' GLN . . . -81.15 -7.83 59.64 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.496 1.123 . . . . 0.0 109.297 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 1.5 t -98.64 130.06 28.74 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.522 1.139 . . . . 0.0 109.298 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 -16.0 20.33 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.472 1.775 . . . . 0.0 110.971 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.677 HD12 ' CE2' ' A' ' 341' ' ' PHE . 0.0 OUTLIER -81.08 -23.84 38.18 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.519 1.137 . . . . 0.0 109.314 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . 0.719 ' CE1' HD13 ' A' ' 247' ' ' ILE . 30.7 m-85 -102.95 -19.22 14.69 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.454 1.096 . . . . 0.0 111.018 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.51 -22.91 67.1 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.463 1.102 . . . . 0.0 110.28 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -76.77 -1.59 28.85 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.502 1.126 . . . . 0.0 109.294 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.586 ' HB3' HG11 ' A' ' 243' ' ' VAL . 8.4 mt -94.38 -179.78 5.03 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.437 1.086 . . . . 0.0 109.278 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -98.45 -174.42 32.61 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.518 1.136 . . . . 0.0 110.969 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.9 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.4 Cg_endo -75.01 -35.48 3.1 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.451 1.764 . . . . 0.0 110.97 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.1 -33.37 75.32 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.461 1.101 . . . . 0.0 109.299 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.795 HG21 HD11 ' A' ' 337' ' ' ILE . 2.7 t -75.18 -42.4 44.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.535 1.147 . . . . 0.0 109.327 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.688 ' CD1' HG13 ' A' ' 230' ' ' VAL . 0.3 OUTLIER -65.63 -36.82 84.8 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.524 1.14 . . . . 0.0 109.289 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 241' ' ' PRO . 87.8 t -69.15 -43.18 81.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.449 1.093 . . . . 0.0 109.278 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -44.17 91.68 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 0.0 110.312 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.719 HD13 ' CE1' ' A' ' 236' ' ' PHE . 90.0 mt -65.6 -37.16 79.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.495 1.122 . . . . 0.0 109.3 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 244' ' ' LEU . 14.4 t -67.54 -34.97 71.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.506 1.128 . . . . 0.0 109.31 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -24.84 59.92 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.49 1.118 . . . . 0.0 110.274 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.472 ' CB ' ' OD1' ' A' ' 326' ' ' ASP . . . -87.22 -21.59 25.75 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.477 1.111 . . . . 0.0 109.291 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.471 HD22 ' HB2' ' A' ' 320' ' ' LEU . 3.0 mt -55.9 136.48 51.56 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.484 1.115 . . . . 0.0 109.283 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.42 134.76 55.06 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.494 1.121 . . . . 0.0 110.265 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.554 ' HA ' HD22 ' A' ' 320' ' ' LEU . . . -80.15 129.6 34.62 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.525 1.141 . . . . 0.0 109.323 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 319' ' ' LEU . 6.7 ttm-85 -133.62 121.28 21.8 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.513 1.133 . . . . 0.0 110.333 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 20.0 m -91.79 116.57 29.0 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.532 1.145 . . . . 0.0 110.436 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.689 HG21 HD11 ' A' ' 319' ' ' LEU . 97.3 t -106.68 113.14 63.22 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.473 1.108 . . . . 0.0 109.263 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.51 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -75.0 171.45 18.31 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.5 1.789 . . . . 0.0 111.04 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.519 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -67.33 128.58 36.93 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.465 1.103 . . . . 0.0 109.325 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 96.85 -25.11 28.11 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.489 1.118 . . . . 0.0 110.992 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.51 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -60.64 149.14 36.04 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.532 0.784 . . . . 0.0 109.306 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.3 t -97.28 131.61 43.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 124.494 1.121 . . . . 0.0 109.331 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.768 HD12 HG12 ' A' ' 311' ' ' VAL . 45.8 mt -83.41 -41.65 17.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.468 1.105 . . . . 0.0 109.309 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' CYS . . . . . 0.423 ' SG ' HG23 ' A' ' 311' ' ' VAL . 14.9 p -158.34 151.09 22.35 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.452 1.095 . . . . 0.0 108.273 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -94.32 -178.81 4.71 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.472 1.108 . . . . 0.0 110.305 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.457 HG23 ' OG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -74.64 143.99 12.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.101 . . . . 0.0 109.321 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 41.47 53.95 4.13 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.537 1.148 . . . . 0.0 110.987 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.409 ' OE1' ' C ' ' A' ' 268' ' ' PRO . 0.3 OUTLIER -70.61 163.5 63.13 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.498 0.764 . . . . 0.0 110.295 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.452 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.1 Cg_endo -75.01 81.43 2.22 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.476 1.777 . . . . 0.0 110.965 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -36.65 95.76 0.01 OUTLIER Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.559 1.162 . . . . 0.0 111.037 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 268' ' ' PRO . 6.8 m-20 -170.83 38.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.519 0.776 . . . . 0.0 109.305 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . 0.411 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 0.0 OUTLIER -170.01 144.62 2.74 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.508 1.13 . . . . 0.0 110.233 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.593 ' SD ' ' CZ ' ' A' ' 274' ' ' PHE . 0.0 OUTLIER -114.4 147.38 39.29 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.126 . . . . 0.0 111.003 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.583 ' HD2' HD13 ' A' ' 319' ' ' LEU . 50.3 m-85 -135.91 137.64 41.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.452 1.095 . . . . 0.0 111.026 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . 0.909 ' HB3' HD12 ' A' ' 229' ' ' LEU . 17.8 m-85 -129.11 130.29 46.27 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.548 1.155 . . . . 0.0 111.014 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 292' ' ' PRO . 29.1 t -86.28 130.48 36.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.488 1.117 . . . . 0.0 109.33 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.636 HG13 ' HD2' ' A' ' 225' ' ' ARG . 2.6 t -110.87 -44.39 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.479 1.112 . . . . 0.0 109.274 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.406 ' O ' HG13 ' A' ' 317' ' ' VAL . 2.9 mt-10 -145.85 132.79 20.2 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 0.0 110.299 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.902 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 117.06 -177.68 16.79 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.545 1.153 . . . . 0.0 111.003 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 290' ' ' LEU . 5.4 t -128.94 121.79 28.81 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.497 0.763 . . . . 0.0 110.014 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.464 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 24.1 m -99.87 161.18 3.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.474 1.109 . . . . 0.0 109.286 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 29.4 t -129.41 149.6 51.12 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.537 1.148 . . . . 0.0 110.006 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 1.4 t -112.45 131.44 63.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.493 1.121 . . . . 0.0 109.331 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.403 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -79.85 101.92 8.81 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.46 1.1 . . . . 0.0 109.268 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' THR . . . . . 0.654 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.41 -168.32 0.18 Allowed Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.508 1.13 . . . . 0.0 110.396 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.654 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.4 Cg_endo -75.0 4.8 4.42 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.491 1.785 . . . . 0.0 111.038 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -151.59 155.69 34.27 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.481 1.113 . . . . 0.0 109.286 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.07 95.85 1.0 Allowed 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.517 1.798 . . . . 0.0 111.029 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 281' ' ' SER . 6.0 t -100.42 119.3 48.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.455 1.097 . . . . 0.0 109.33 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.503 ' C ' HD22 ' A' ' 290' ' ' LEU . 15.1 mt-10 -124.9 141.68 51.96 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.493 1.121 . . . . 0.0 110.332 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.503 HD22 ' C ' ' A' ' 289' ' ' GLU . 4.4 mm? -120.69 142.5 49.43 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.546 1.154 . . . . 0.0 109.276 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -93.79 -163.43 36.34 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.529 1.143 . . . . 0.0 111.023 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' PRO . . . . . 0.537 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.4 Cg_endo -74.94 149.63 37.28 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.502 1.791 . . . . 0.0 110.995 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 86.95 -0.07 85.99 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.481 1.113 . . . . 0.0 110.974 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -79.65 146.21 32.6 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.488 0.757 . . . . 0.0 109.362 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -132.84 152.69 51.78 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.516 1.135 . . . . 0.0 111.012 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.552 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 40.7 p90 -166.57 147.65 6.23 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.496 1.123 . . . . 0.0 110.959 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . 0.467 ' CA ' ' HE3' ' A' ' 272' ' ' MET . . . 129.8 -10.38 6.03 Favored Glycine 0 CA--C 1.531 1.053 0 O-C-N 124.544 1.153 . . . . 0.0 110.995 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -52.57 -41.78 63.89 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.532 0.784 . . . . 0.0 110.316 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . 0.583 ' HA ' HD12 ' A' ' 302' ' ' ILE . 0.8 OUTLIER -54.83 -37.28 65.97 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.503 1.127 . . . . 0.0 111.015 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -67.72 -39.21 84.31 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.496 1.123 . . . . 0.0 109.284 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.467 ' CD1' ' HG3' ' A' ' 272' ' ' MET . 5.7 mt -76.44 -13.67 60.1 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.503 1.127 . . . . 0.0 109.265 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' A' ' 299' ' ' MET . 32.2 mt -77.3 -54.5 12.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.514 1.134 . . . . 0.0 109.295 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.441 ' O ' ' N ' ' A' ' 305' ' ' GLU . 46.4 p -155.07 42.05 0.45 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.506 1.129 . . . . 0.0 109.986 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 37.07 31.56 0.06 OUTLIER Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.501 1.126 . . . . 0.0 110.998 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 303' ' ' SER . 0.1 OUTLIER -61.71 157.12 50.8 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.52 0.777 . . . . 0.0 110.322 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 128.99 11.91 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.51 1.795 . . . . 0.0 111.044 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . 0.423 HH11 ' HB2' ' A' ' 300' ' ' ALA . 0.0 OUTLIER -44.52 -40.29 5.53 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.506 1.129 . . . . 0.0 110.294 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.66 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 22.8 t 64.87 43.31 4.0 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.486 1.117 . . . . 0.0 110.02 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' ALA . . . . . 0.66 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 165.86 159.76 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.48 1.113 . . . . 0.0 109.291 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.457 ' OG1' HG23 ' A' ' 265' ' ' ILE . 1.0 OUTLIER -110.38 133.92 52.8 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.465 1.103 . . . . 0.0 110.416 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.768 HG12 HD12 ' A' ' 262' ' ' ILE . 55.3 t -113.06 129.39 68.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.525 1.14 . . . . 0.0 109.294 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 60.3 p -129.59 156.71 43.76 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.542 1.151 . . . . 0.0 110.02 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -92.53 115.57 28.22 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.515 1.135 . . . . 0.0 109.312 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -59.5 -32.65 70.48 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.481 1.113 . . . . 0.0 109.287 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' THR . . . . . 0.653 ' O ' HG23 ' A' ' 317' ' ' VAL . 11.0 t -154.6 -173.14 4.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.506 1.129 . . . . 0.0 110.385 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . 0.413 HG23 ' H ' ' A' ' 316' ' ' THR . 65.4 p -52.2 88.54 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.503 1.127 . . . . 0.0 110.391 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.902 HG22 ' HA3' ' A' ' 278' ' ' GLY . 68.9 t -103.57 154.35 5.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 O-C-N 124.539 1.149 . . . . 0.0 109.308 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 49.1 m -129.07 113.89 15.69 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.482 1.114 . . . . 0.0 109.998 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . 1.03 ' C ' HD23 ' A' ' 320' ' ' LEU . 0.2 OUTLIER -129.0 170.44 13.46 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.136 . . . . 0.0 109.266 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 1.03 HD23 ' C ' ' A' ' 319' ' ' LEU . 0.6 OUTLIER -121.79 139.87 53.06 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.518 1.136 . . . . 0.0 109.327 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 64.8 p -95.6 158.79 15.3 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.122 . . . . 0.0 109.982 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.503 ' O ' HD13 ' A' ' 322' ' ' LEU . 3.3 tm? -148.64 82.36 1.46 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.496 1.122 . . . . 0.0 109.312 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . 0.572 ' ND1' ' HB3' ' A' ' 325' ' ' ALA . 8.5 p80 -47.63 136.99 9.7 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.504 1.127 . . . . 0.0 109.599 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.95 -20.93 6.89 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.504 1.128 . . . . 0.0 109.981 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . 0.572 ' HB3' ' ND1' ' A' ' 323' ' ' HIS . . . -51.9 -38.24 55.48 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.522 1.139 . . . . 0.0 109.291 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . 0.472 ' OD1' ' CB ' ' A' ' 250' ' ' ALA . 36.0 t70 -63.94 -37.08 86.09 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.541 1.151 . . . . 0.0 109.257 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' PHE . . . . . 0.472 ' CZ ' ' CE2' ' A' ' 341' ' ' PHE . 6.1 t80 -66.96 -40.02 87.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.48 1.112 . . . . 0.0 110.96 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -66.0 -33.24 75.35 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.527 1.142 . . . . 0.0 110.301 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 50.9 ttp -70.91 -39.33 72.79 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.549 1.155 . . . . 0.0 111.004 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.683 HD11 HG13 ' A' ' 247' ' ' ILE . 0.1 OUTLIER -68.7 -39.23 80.58 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.487 1.117 . . . . 0.0 109.293 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 338' ' ' ALA . 19.8 t -70.97 -32.97 69.99 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.45 1.093 . . . . 0.0 108.268 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 19.1 t -72.87 -31.08 64.47 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.482 1.114 . . . . 0.0 110.039 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.9 t -83.3 -37.86 22.88 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.447 1.092 . . . . 0.0 110.022 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.12 107.94 17.94 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.539 1.149 . . . . 0.0 110.009 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -21.01 16.33 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.466 1.772 . . . . 0.0 110.978 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -72.58 -28.52 62.85 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.519 1.137 . . . . 0.0 110.319 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.795 HD11 HG21 ' A' ' 243' ' ' VAL . 46.2 mt -65.46 -32.88 60.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 0.0 109.308 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . 0.589 ' HB2' ' SG ' ' A' ' 331' ' ' CYS . . . -70.74 -35.06 72.5 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.536 1.147 . . . . 0.0 109.31 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -71.42 -34.79 70.63 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.518 1.136 . . . . 0.0 110.338 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.486 ' O ' HG22 ' A' ' 344' ' ' THR . 66.1 mt -73.06 -42.53 59.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.124 . . . . 0.0 109.303 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.677 ' CE2' HD12 ' A' ' 235' ' ' LEU . 1.0 OUTLIER -70.98 -31.2 67.68 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 0.0 111.02 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . 0.491 ' O ' HD12 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -73.24 -41.07 64.13 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.48 1.113 . . . . 0.0 110.282 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.13 -50.51 65.73 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.423 1.077 . . . . 0.0 109.305 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . 0.5 HG22 ' HA ' ' A' ' 341' ' ' PHE . 7.4 t -64.97 -37.68 88.45 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.514 1.134 . . . . 0.0 110.429 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 341' ' ' PHE . . . -65.15 -43.32 92.24 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.504 1.127 . . . . 0.0 109.335 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 342' ' ' ARG . 0.4 OUTLIER -64.9 -35.12 80.13 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 0.0 109.256 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -69.42 -37.77 77.58 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.543 1.152 . . . . 0.0 110.33 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 . . . . . 0 C--N 1.326 -0.442 0 O-C-N 124.464 1.102 . . . . 0.0 110.309 179.967 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 35.3 t80 . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 120.503 0.192 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.74 -35.15 59.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.486 1.117 . . . . 0.0 109.283 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.534 ' HD3' HD23 ' A' ' 229' ' ' LEU . 0.0 OUTLIER -67.6 -36.61 81.2 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.509 1.131 . . . . 0.0 110.323 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.792 ' HB3' HD13 ' A' ' 251' ' ' LEU . 1.6 m-20 -75.1 -30.19 60.83 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.478 1.111 . . . . 0.0 109.288 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' TRP . . . . . 0.679 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 1.6 t90 -67.63 -49.51 62.64 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.505 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 6.0 pt20 -67.22 -30.94 70.99 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.54 1.15 . . . . 0.0 110.312 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.534 HD23 ' HD3' ' A' ' 225' ' ' ARG . 0.6 OUTLIER -64.54 -47.14 79.93 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.508 1.13 . . . . 0.0 109.3 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.778 HG23 ' CD1' ' A' ' 244' ' ' LEU . 34.9 m -70.11 -37.63 72.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.501 1.125 . . . . 0.0 109.304 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -75.83 -14.97 60.3 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.479 1.112 . . . . 0.0 109.308 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -82.27 -25.15 34.3 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.567 1.167 . . . . 0.0 109.337 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 230' ' ' VAL . 0.3 OUTLIER -86.94 133.51 39.11 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.483 1.114 . . . . 0.0 109.311 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 -4.35 15.27 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.498 1.789 . . . . 0.0 111.012 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.98 -24.07 33.08 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.492 1.12 . . . . 0.0 109.32 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . 0.516 ' O ' HD21 ' A' ' 244' ' ' LEU . 17.4 m-30 -119.73 -1.26 10.59 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.467 1.105 . . . . 0.0 110.986 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -71.69 -23.39 61.65 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.513 1.133 . . . . 0.0 110.309 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.442 ' NZ ' ' HA ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -92.55 7.59 42.58 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.482 1.114 . . . . 0.0 109.316 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.566 HD22 HG11 ' A' ' 243' ' ' VAL . 86.4 mt -89.26 179.76 6.04 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.48 1.113 . . . . 0.0 109.265 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . 0.669 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -98.21 -176.94 33.18 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.506 1.129 . . . . 0.0 111.036 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.981 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.3 Cg_endo -75.0 -37.33 2.07 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.5 1.789 . . . . 0.0 110.985 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.84 -34.68 77.19 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.464 1.102 . . . . 0.0 109.3 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.566 HG11 HD22 ' A' ' 239' ' ' LEU . 14.1 t -75.4 -38.02 39.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.514 1.134 . . . . 0.0 109.317 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.778 ' CD1' HG23 ' A' ' 230' ' ' VAL . 1.4 mm? -66.79 -35.84 81.0 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.514 1.133 . . . . 0.0 109.305 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.981 HG23 ' O ' ' A' ' 241' ' ' PRO . 60.9 t -74.39 -38.88 47.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.485 1.116 . . . . 0.0 109.296 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -65.25 -48.39 73.43 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.519 1.137 . . . . 0.0 110.268 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.552 HG13 HD13 ' A' ' 330' ' ' LEU . 32.1 mt -63.15 -43.27 98.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.524 1.14 . . . . 0.0 109.316 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 244' ' ' LEU . 41.2 t -65.29 -38.21 82.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.459 1.1 . . . . 0.0 109.269 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -72.49 -19.25 61.58 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.422 1.076 . . . . 0.0 110.292 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -91.82 -16.3 26.96 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.521 1.138 . . . . 0.0 109.303 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.792 HD13 ' HB3' ' A' ' 226' ' ' ASN . 2.2 mt -66.84 129.27 39.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.495 1.122 . . . . 0.0 109.313 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 320' ' ' LEU . 3.2 tpt85 -110.15 118.08 35.41 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.492 1.12 . . . . 0.0 110.308 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.536 ' HB2' HD23 ' A' ' 320' ' ' LEU . . . -80.15 136.77 36.58 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.458 1.099 . . . . 0.0 109.311 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.47 ' HD2' HD23 ' A' ' 319' ' ' LEU . 0.0 OUTLIER -143.06 139.67 30.6 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.547 1.155 . . . . 0.0 110.339 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.0 m -92.4 117.92 30.41 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.561 1.163 . . . . 0.0 110.373 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.631 HG12 ' CB ' ' A' ' 313' ' ' ALA . 37.1 t -107.33 112.77 62.57 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.499 1.124 . . . . 0.0 109.285 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.457 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.3 Cg_endo -74.99 173.33 14.7 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.485 1.782 . . . . 0.0 111.006 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.633 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -67.37 130.38 42.89 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.543 1.152 . . . . 0.0 109.301 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 95.48 -25.28 25.37 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.519 1.137 . . . . 0.0 111.01 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.608 ' HB3' HG13 ' A' ' 256' ' ' VAL . . . -56.43 140.59 45.27 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.496 0.762 . . . . 0.0 109.326 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.648 HG21 HH21 ' A' ' 264' ' ' ARG . 3.7 t -92.28 127.17 44.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.491 1.119 . . . . 0.0 109.34 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.842 HD12 HG12 ' A' ' 311' ' ' VAL . 40.8 mt -85.03 -41.91 16.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.477 1.111 . . . . 0.0 109.325 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 11.9 p -155.81 148.87 24.43 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.536 1.147 . . . . 0.0 108.296 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' ARG . . . . . 0.648 HH21 HG21 ' A' ' 261' ' ' VAL . 2.0 mmt85 -92.35 178.57 5.8 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.491 1.119 . . . . 0.0 110.329 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.574 HG23 ' OG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -76.42 141.59 15.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.495 1.122 . . . . 0.0 109.304 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 46.23 46.83 16.08 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.52 1.138 . . . . 0.0 111.006 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.453 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.0 OUTLIER -70.19 164.91 48.8 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 124.451 0.736 . . . . 0.0 110.299 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 267' ' ' GLU . 18.4 Cg_endo -75.0 77.04 3.22 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.502 1.791 . . . . 0.0 111.03 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 268' ' ' PRO . . . -35.84 100.21 0.01 OUTLIER Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.452 1.095 . . . . 0.0 111.016 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -169.76 38.09 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.545 0.791 . . . . 0.0 109.315 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -171.33 147.14 2.42 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.129 . . . . 0.0 110.281 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.872 ' HB2' HD11 ' A' ' 301' ' ' LEU . 2.0 ttt -116.67 150.45 38.13 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.479 1.112 . . . . 0.0 111.003 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.577 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 14.8 m-85 -135.43 136.9 41.73 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.453 1.095 . . . . 0.0 110.973 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . 0.47 ' CD1' ' CB ' ' A' ' 295' ' ' PHE . 22.8 m-30 -125.66 124.38 41.02 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.494 1.121 . . . . 0.0 110.959 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.441 HG22 HD12 ' A' ' 319' ' ' LEU . 85.2 t -80.03 135.81 24.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.515 1.134 . . . . 0.0 109.255 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.656 HG12 ' HG3' ' A' ' 277' ' ' GLU . 99.1 t -108.73 -56.01 4.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.461 1.101 . . . . 0.0 109.27 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.656 ' HG3' HG12 ' A' ' 276' ' ' VAL . 16.8 mt-10 -139.98 138.88 35.88 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.456 1.097 . . . . 0.0 110.314 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.01 -154.72 16.59 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.452 1.095 . . . . 0.0 111.03 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 290' ' ' LEU . 3.7 m -150.76 135.92 17.67 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.511 0.771 . . . . 0.0 110.029 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 289' ' ' GLU . 13.6 m -115.16 166.06 9.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.5 1.125 . . . . 0.0 109.321 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 28.8 t -131.33 149.44 52.55 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.457 1.098 . . . . 0.0 110.007 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.51 131.17 66.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.533 1.145 . . . . 0.0 109.304 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.478 ' HB3' ' H ' ' A' ' 310' ' ' THR . . . -79.7 101.87 8.65 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.52 1.137 . . . . 0.0 109.31 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' THR . . . . . 0.648 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.7 OUTLIER -148.27 -168.5 0.19 Allowed Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.458 1.099 . . . . 0.0 110.423 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.648 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.4 Cg_endo -74.95 4.89 4.31 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.533 1.807 . . . . 0.0 111.063 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -151.58 156.65 34.72 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.459 1.1 . . . . 0.0 109.293 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.91 95.37 0.97 Allowed 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.466 1.772 . . . . 0.0 111.032 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 281' ' ' SER . 24.1 t -99.53 118.9 46.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.105 . . . . 0.0 109.346 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.444 ' C ' HD22 ' A' ' 290' ' ' LEU . 14.4 mt-10 -124.76 138.16 54.29 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.511 1.132 . . . . 0.0 110.321 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.444 HD22 ' C ' ' A' ' 289' ' ' GLU . 4.3 mm? -119.84 142.19 48.87 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.51 1.131 . . . . 0.0 109.275 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -96.28 -153.25 29.65 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.53 1.144 . . . . 0.0 110.981 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 151.88 39.98 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.491 1.785 . . . . 0.0 111.021 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 76.99 6.35 85.82 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.52 1.138 . . . . 0.0 110.956 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -87.4 113.72 23.36 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.528 0.781 . . . . 0.0 109.279 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.47 ' CB ' ' CD1' ' A' ' 274' ' ' PHE . 15.1 p90 -107.15 152.98 23.33 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.488 1.117 . . . . 0.0 110.986 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 20.6 p90 -159.07 153.65 24.38 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.465 1.103 . . . . 0.0 110.98 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 123.17 -9.02 8.98 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.522 1.139 . . . . 0.0 111.041 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . 0.438 ' HG2' ' N ' ' A' ' 299' ' ' MET . 0.4 OUTLIER -52.37 -37.21 55.69 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.469 0.747 . . . . 0.0 110.273 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . 0.438 ' N ' ' HG2' ' A' ' 298' ' ' GLU . 1.2 mmt -60.13 -32.09 70.68 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 0.0 110.976 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -75.02 -37.27 61.83 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.446 1.091 . . . . 0.0 109.298 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.872 HD11 ' HB2' ' A' ' 272' ' ' MET . 0.9 OUTLIER -78.11 -11.61 59.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.546 1.154 . . . . 0.0 109.321 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 299' ' ' MET . 35.0 mt -83.82 -52.87 12.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.495 1.122 . . . . 0.0 109.274 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.454 ' O ' ' C ' ' A' ' 304' ' ' GLY . 3.4 m -153.21 39.08 0.51 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.528 1.143 . . . . 0.0 110.02 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 33.07 43.76 0.21 Allowed Glycine 0 CA--C 1.529 0.966 0 O-C-N 124.493 1.121 . . . . 0.0 111.061 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.61 157.71 88.51 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.487 0.757 . . . . 0.0 110.287 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 129.95 12.83 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.503 1.791 . . . . 0.0 111.034 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -46.59 -34.98 5.4 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.506 1.129 . . . . 0.0 110.328 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 1.3 m 60.39 20.53 10.14 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.485 1.115 . . . . 0.0 109.962 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . -171.26 160.66 6.3 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 0.0 109.322 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.574 ' OG1' HG23 ' A' ' 265' ' ' ILE . 0.9 OUTLIER -107.68 137.22 46.1 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.523 1.14 . . . . 0.0 110.372 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.842 HG12 HD12 ' A' ' 262' ' ' ILE . 86.5 t -114.79 127.51 72.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.459 1.1 . . . . 0.0 109.317 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 32.3 m -128.18 159.24 35.79 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.505 1.128 . . . . 0.0 109.96 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . 0.927 ' HB1' HG12 ' A' ' 317' ' ' VAL . . . -90.92 110.45 21.69 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.461 1.101 . . . . 0.0 109.275 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -53.19 -32.06 46.07 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.511 1.132 . . . . 0.0 109.287 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' THR . . . . . 0.633 ' HA ' ' HB2' ' A' ' 258' ' ' ALA . 12.7 t -156.68 -163.74 1.49 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.487 1.117 . . . . 0.0 110.407 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 96.6 m -63.07 76.78 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.48 1.112 . . . . 0.0 110.35 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.927 HG12 ' HB1' ' A' ' 313' ' ' ALA . 2.8 p -107.38 141.14 23.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.491 1.12 . . . . 0.0 109.353 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . 1.015 ' C ' HD13 ' A' ' 319' ' ' LEU . 66.1 m -116.12 134.59 54.77 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.534 1.146 . . . . 0.0 110.04 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . 1.015 HD13 ' C ' ' A' ' 318' ' ' SER . 0.0 OUTLIER -132.54 177.98 7.19 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.49 1.119 . . . . 0.0 109.324 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.728 ' HB2' HD22 ' A' ' 251' ' ' LEU . 0.2 OUTLIER -124.5 128.62 49.24 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.502 1.126 . . . . 0.0 109.326 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 13.1 p -90.12 155.18 19.23 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.534 1.146 . . . . 0.0 110.036 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 322' ' ' LEU . 1.5 tm? -149.02 90.86 1.79 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.517 1.136 . . . . 0.0 109.311 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . 0.534 ' CE1' ' HB2' ' A' ' 326' ' ' ASP . 7.9 p80 -49.98 136.54 18.49 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.538 1.149 . . . . 0.0 109.63 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 43.7 t -59.93 -25.56 65.25 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.545 1.153 . . . . 0.0 109.984 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -57.03 -34.06 67.83 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.496 1.123 . . . . 0.0 109.308 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . 0.534 ' HB2' ' CE1' ' A' ' 323' ' ' HIS . 31.6 t70 -68.83 -37.15 78.98 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.49 1.119 . . . . 0.0 109.337 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' PHE . . . . . 0.572 ' CG ' HD23 ' A' ' 301' ' ' LEU . 33.3 t80 -68.75 -40.38 79.83 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.499 1.124 . . . . 0.0 110.975 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -70.54 -31.92 69.15 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 0.0 110.327 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 17.6 tmm? -69.38 -44.7 70.98 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.467 1.105 . . . . 0.0 111.03 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.552 HD13 HG13 ' A' ' 247' ' ' ILE . 13.3 mt -70.6 -38.86 74.04 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.465 1.103 . . . . 0.0 109.31 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' CYS . . . . . 0.549 ' SG ' HG22 ' A' ' 337' ' ' ILE . 1.8 m -64.43 -38.12 89.9 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.472 1.107 . . . . 0.0 108.279 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 7.6 t -77.24 -26.24 52.39 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.494 1.121 . . . . 0.0 109.98 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.18 -39.2 71.99 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.129 . . . . 0.0 110.057 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.19 129.94 23.36 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.529 1.143 . . . . 0.0 109.979 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -25.44 11.92 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.464 1.771 . . . . 0.0 111.023 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.26 -28.57 67.32 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.123 . . . . 0.0 110.299 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.549 HG22 ' SG ' ' A' ' 331' ' ' CYS . 59.9 mt -71.43 -42.47 73.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.514 1.134 . . . . 0.0 109.294 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.11 -30.49 67.7 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.492 1.12 . . . . 0.0 109.303 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -72.1 -43.51 64.67 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 0.0 110.316 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.404 HG21 ' HB2' ' A' ' 238' ' ' LYS . 68.2 mt -72.08 -40.06 66.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.537 1.148 . . . . 0.0 109.306 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.478 ' CD1' ' O ' ' A' ' 341' ' ' PHE . 0.4 OUTLIER -68.66 -39.33 80.69 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.534 1.146 . . . . 0.0 110.994 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -68.65 -39.08 80.85 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.465 1.103 . . . . 0.0 110.275 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.7 -48.07 70.43 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.526 1.141 . . . . 0.0 109.341 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.24 -41.77 94.04 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.47 1.106 . . . . 0.0 110.424 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -68.65 -34.4 75.65 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.528 1.143 . . . . 0.0 109.315 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 346' ' ' LEU . 13.5 mt -69.9 -33.52 72.3 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.482 1.114 . . . . 0.0 109.262 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.4 -37.01 66.1 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.549 1.156 . . . . 0.0 110.334 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 4.4 mtt85 . . . . . 0 C--N 1.325 -0.457 0 O-C-N 124.527 1.142 . . . . 0.0 110.249 -179.984 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.992 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.13 160.87 14.99 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.499 0.764 . . . . 0.0 109.979 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -151.89 171.61 17.51 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.519 1.137 . . . . 0.0 110.317 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -118.43 168.45 10.63 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.51 1.131 . . . . 0.0 110.294 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 1.1 p -138.24 137.83 43.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.523 1.139 . . . . 0.0 109.31 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -63.84 175.35 1.17 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.492 1.12 . . . . 0.0 110.312 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.86 128.91 16.55 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.504 1.127 . . . . 0.0 110.288 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -112.1 -31.36 2.68 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.492 1.12 . . . . 0.0 110.978 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -91.22 19.27 6.04 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.545 0.791 . . . . 0.0 109.305 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -53.26 -39.29 63.76 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.526 1.141 . . . . 0.0 110.997 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -71.52 -43.22 72.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.515 1.134 . . . . 0.0 109.319 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.716 ' CD ' HD23 ' A' ' 229' ' ' LEU . 0.0 OUTLIER -65.86 -29.05 69.45 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.5 1.125 . . . . 0.0 110.328 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.58 ' ND2' HD22 ' A' ' 320' ' ' LEU . 6.5 t-20 -79.76 -30.37 40.73 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.541 1.151 . . . . 0.0 109.271 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' TRP . . . . . 0.879 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 2.1 t90 -68.09 -43.96 77.33 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.13 . . . . 0.0 107.985 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.619 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 9.8 pt20 -70.63 -36.93 73.69 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.513 1.133 . . . . 0.0 110.315 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.716 HD23 ' CD ' ' A' ' 225' ' ' ARG . 0.6 OUTLIER -60.99 -47.6 85.68 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.488 1.118 . . . . 0.0 109.323 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.791 HG12 ' CD1' ' A' ' 244' ' ' LEU . 64.5 t -73.23 -44.09 56.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.504 1.128 . . . . 0.0 109.307 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -68.28 -13.91 62.61 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.493 1.121 . . . . 0.0 109.282 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.619 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -81.64 -24.89 36.06 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.51 1.131 . . . . 0.0 109.288 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . 0.421 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 91.0 t -64.73 135.03 96.22 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.505 1.128 . . . . 0.0 109.316 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 233' ' ' VAL . 18.3 Cg_endo -75.02 -40.43 0.89 Allowed 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.42 1.747 . . . . 0.0 110.967 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 1.1 tp -63.56 -14.11 48.09 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.445 1.091 . . . . 0.0 109.302 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.474 ' CB ' HD12 ' A' ' 239' ' ' LEU . 16.8 m-30 -113.24 5.28 16.87 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.473 1.108 . . . . 0.0 110.973 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLN . . . . . 0.417 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -73.52 -29.43 62.47 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.492 1.12 . . . . 0.0 110.325 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.426 ' HB3' HG21 ' A' ' 340' ' ' ILE . 0.0 OUTLIER -89.31 7.09 37.42 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.517 1.136 . . . . 0.0 109.298 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.609 ' HB2' HD21 ' A' ' 244' ' ' LEU . 74.4 mt -85.58 176.64 8.09 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.504 1.128 . . . . 0.0 109.265 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . 0.68 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -101.03 176.19 26.78 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.509 1.131 . . . . 0.0 111.03 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.938 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.3 Cg_endo -74.99 -36.35 2.6 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.513 1.796 . . . . 0.0 110.993 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -69.54 -35.12 75.15 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.53 1.144 . . . . 0.0 109.271 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.808 HG21 HD11 ' A' ' 337' ' ' ILE . 57.0 t -73.25 -40.16 56.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.463 1.102 . . . . 0.0 109.297 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.791 ' CD1' HG12 ' A' ' 230' ' ' VAL . 3.5 mm? -67.61 -37.55 82.7 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 0.0 109.269 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.938 HG23 ' O ' ' A' ' 241' ' ' PRO . 74.3 t -65.84 -45.98 89.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.519 1.137 . . . . 0.0 109.328 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -64.89 -40.78 95.64 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.125 . . . . 0.0 110.251 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.758 ' O ' HD13 ' A' ' 251' ' ' LEU . 44.2 mt -62.27 -47.97 90.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.456 1.098 . . . . 0.0 109.306 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.496 HG21 ' HA ' ' A' ' 227' ' ' TRP . 27.3 t -61.98 -34.65 64.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.469 1.105 . . . . 0.0 109.296 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.02 -13.01 60.04 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.463 1.102 . . . . 0.0 110.291 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -99.6 -7.0 26.38 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.502 1.126 . . . . 0.0 109.312 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.758 HD13 ' O ' ' A' ' 247' ' ' ILE . 6.2 mp -75.31 146.51 40.93 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.533 1.146 . . . . 0.0 109.281 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 320' ' ' LEU . 6.1 tpt180 -116.33 113.6 23.17 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.502 1.127 . . . . 0.0 110.314 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.734 ' HB2' HD23 ' A' ' 320' ' ' LEU . . . -80.03 126.79 31.5 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.51 1.131 . . . . 0.0 109.258 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -139.09 137.74 36.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.464 1.102 . . . . 0.0 110.305 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 4.1 m -90.85 123.56 34.48 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.471 1.107 . . . . 0.0 110.385 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.769 ' CG2' HD21 ' A' ' 319' ' ' LEU . 4.7 t -106.8 112.76 63.32 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.467 1.104 . . . . 0.0 109.291 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.482 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.3 Cg_endo -75.03 169.27 22.98 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.524 1.802 . . . . 0.0 111.011 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.689 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -64.92 126.77 29.05 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.496 1.123 . . . . 0.0 109.334 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 100.63 -25.3 28.84 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.486 1.116 . . . . 0.0 111.006 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.499 ' HB3' HG13 ' A' ' 256' ' ' VAL . . . -67.65 131.07 44.9 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.504 0.767 . . . . 0.0 109.303 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 311' ' ' VAL . 2.9 p -87.72 135.43 25.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.529 1.143 . . . . 0.0 109.326 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.649 HD12 HG12 ' A' ' 311' ' ' VAL . 35.6 mt -82.38 -44.12 19.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.542 1.151 . . . . 0.0 109.294 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 10.5 p -152.12 147.07 26.02 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.538 1.149 . . . . 0.0 108.28 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -85.65 -179.9 6.96 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.485 1.115 . . . . 0.0 110.298 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.465 HG23 ' OG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -77.21 134.71 28.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.563 1.164 . . . . 0.0 109.289 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 56.32 51.48 55.85 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.458 1.099 . . . . 0.0 110.969 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.95 165.65 45.3 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.495 0.762 . . . . 0.0 110.298 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.3 Cg_endo -75.01 82.98 1.89 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.45 1.763 . . . . 0.0 111.002 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -38.0 93.31 0.01 OUTLIER Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.534 1.146 . . . . 0.0 110.997 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 268' ' ' PRO . 0.7 OUTLIER -171.61 37.51 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.482 0.754 . . . . 0.0 109.307 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.406 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 1.9 ttt180 -169.81 147.74 3.44 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.49 1.119 . . . . 0.0 110.276 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.878 ' HB2' HD11 ' A' ' 301' ' ' LEU . 2.1 ttm -118.04 156.26 28.9 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.534 1.147 . . . . 0.0 110.986 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.571 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 32.8 m-85 -146.02 136.61 24.15 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.519 1.137 . . . . 0.0 111.023 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . 0.494 ' CZ ' ' SD ' ' A' ' 272' ' ' MET . 19.6 m-85 -125.71 137.8 53.85 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.538 1.149 . . . . 0.0 111.007 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.605 HG22 HD12 ' A' ' 319' ' ' LEU . 4.3 t -94.24 135.34 28.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.473 1.108 . . . . 0.0 109.318 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.497 ' CG2' HD11 ' A' ' 320' ' ' LEU . 42.0 t -109.49 -49.16 7.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.481 1.113 . . . . 0.0 109.246 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -142.04 132.77 25.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.486 1.116 . . . . 0.0 110.281 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.693 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 120.96 -176.35 16.24 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.483 1.115 . . . . 0.0 111.023 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 5.2 t -131.2 118.8 20.95 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.498 0.764 . . . . 0.0 110.026 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.439 HG23 ' HB2' ' A' ' 290' ' ' LEU . 16.2 m -98.43 162.17 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.496 1.122 . . . . 0.0 109.313 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 31.1 t -127.71 153.76 46.13 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.493 1.12 . . . . 0.0 109.957 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 288' ' ' VAL . 0.2 OUTLIER -116.95 129.23 73.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.463 1.102 . . . . 0.0 109.327 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.716 ' HB3' ' H ' ' A' ' 310' ' ' THR . . . -77.97 101.62 6.97 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.469 1.106 . . . . 0.0 109.298 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . 0.651 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.7 OUTLIER -148.62 -168.31 0.18 Allowed Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.568 1.168 . . . . 0.0 110.399 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.651 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -75.07 4.59 4.63 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.474 1.776 . . . . 0.0 110.956 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -151.5 156.67 34.85 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.521 1.138 . . . . 0.0 109.265 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.95 94.79 0.95 Allowed 'Trans proline' 0 C--N 1.36 1.184 0 O-C-N 124.509 1.794 . . . . 0.0 110.987 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 281' ' ' SER . 45.4 t -98.37 118.83 45.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.494 1.121 . . . . 0.0 109.327 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 15.0 mt-10 -125.22 136.96 54.08 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.475 1.109 . . . . 0.0 110.278 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.439 ' HB2' HG23 ' A' ' 280' ' ' VAL . 4.0 mm? -117.23 139.73 50.42 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.474 1.109 . . . . 0.0 109.312 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -90.6 -160.18 36.3 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.497 1.123 . . . . 0.0 111.005 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' PRO . . . . . 0.477 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.2 Cg_endo -75.01 148.21 34.91 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.546 1.814 . . . . 0.0 111.038 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.424 ' HA2' HD21 ' A' ' 229' ' ' LEU . . . 83.61 4.42 89.09 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.569 1.168 . . . . 0.0 110.99 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -86.03 130.67 34.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.472 0.748 . . . . 0.0 109.295 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.485 ' HB3' ' CD1' ' A' ' 274' ' ' PHE . 0.8 OUTLIER -116.16 153.02 32.56 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.504 1.127 . . . . 0.0 110.993 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.592 ' HZ ' HG21 ' A' ' 262' ' ' ILE . 40.4 p90 -159.64 146.17 16.32 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.527 1.142 . . . . 0.0 110.992 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 127.81 -7.07 6.93 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.472 1.107 . . . . 0.0 111.015 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -52.49 -48.76 65.75 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.511 0.771 . . . . 0.0 110.336 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . 0.423 ' HA ' ' CE ' ' A' ' 299' ' ' MET . 3.1 mmt -48.91 -39.26 25.36 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.541 1.151 . . . . 0.0 111.002 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -67.79 -37.42 82.0 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.504 1.128 . . . . 0.0 109.252 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.878 HD11 ' HB2' ' A' ' 272' ' ' MET . 10.6 mt -79.02 -9.07 59.43 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.527 1.142 . . . . 0.0 109.267 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 3.1 mm -82.25 -54.17 10.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.478 1.111 . . . . 0.0 109.294 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 304' ' ' GLY . 1.0 OUTLIER -153.47 42.97 0.58 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 0.0 109.989 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 303' ' ' SER . . . 36.21 42.28 0.58 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.479 1.112 . . . . 0.0 111.042 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.19 157.13 83.43 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.441 0.73 . . . . 0.0 110.276 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.11 131.99 14.78 Favored 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.481 1.779 . . . . 0.0 110.976 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -44.38 -43.32 7.54 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.516 1.135 . . . . 0.0 110.34 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.545 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 25.3 m 67.74 39.41 2.69 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.454 1.096 . . . . 0.0 109.99 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 173.42 160.2 0.14 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.541 1.151 . . . . 0.0 109.307 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.716 ' H ' ' HB3' ' A' ' 283' ' ' ALA . 0.6 OUTLIER -105.19 122.3 45.62 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.505 1.128 . . . . 0.0 110.441 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.649 HG12 HD12 ' A' ' 262' ' ' ILE . 58.6 t -102.7 128.25 55.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.5 1.125 . . . . 0.0 109.3 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 9.7 p -141.24 156.66 45.87 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.557 1.161 . . . . 0.0 110.037 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . 0.543 ' CB ' HG12 ' A' ' 256' ' ' VAL . . . -90.31 124.37 34.84 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.543 1.152 . . . . 0.0 109.284 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -70.45 -26.33 63.59 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.468 1.105 . . . . 0.0 109.293 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' THR . . . . . 0.689 ' HA ' ' HB2' ' A' ' 258' ' ' ALA . 6.2 t -152.98 -169.79 3.44 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.51 1.131 . . . . 0.0 110.415 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 93.0 m -58.67 85.36 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 0.0 110.409 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.693 HG22 ' HA3' ' A' ' 278' ' ' GLY . 48.3 t -105.42 159.45 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.461 1.101 . . . . 0.0 109.246 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . 0.646 ' C ' HD13 ' A' ' 319' ' ' LEU . 49.3 m -136.88 123.62 21.17 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.508 1.13 . . . . 0.0 109.984 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . 0.769 HD21 ' CG2' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -134.56 170.46 15.76 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.508 1.13 . . . . 0.0 109.278 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.734 HD23 ' HB2' ' A' ' 253' ' ' ALA . 0.0 OUTLIER -124.4 131.82 53.51 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.478 1.111 . . . . 0.0 109.295 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 63.5 p -90.15 158.88 17.05 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.552 1.157 . . . . 0.0 110.017 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.839 ' O ' HD13 ' A' ' 322' ' ' LEU . 0.9 OUTLIER -151.23 104.75 3.14 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.52 1.137 . . . . 0.0 109.338 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . 0.495 ' CE1' ' HB2' ' A' ' 326' ' ' ASP . 8.2 p80 -57.55 131.2 49.46 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.538 1.149 . . . . 0.0 109.609 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 23.0 t -58.96 -16.77 19.55 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.488 1.118 . . . . 0.0 109.993 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -66.71 -31.71 72.54 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.431 1.082 . . . . 0.0 109.305 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . 0.553 ' HB3' HD21 ' A' ' 322' ' ' LEU . 35.0 t70 -65.59 -47.52 75.44 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.543 1.152 . . . . 0.0 109.304 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' PHE . . . . . 0.469 ' CZ ' ' CE2' ' A' ' 341' ' ' PHE . 1.8 t80 -65.38 -35.74 81.88 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.431 1.082 . . . . 0.0 110.999 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -71.13 -32.29 68.8 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.505 1.128 . . . . 0.0 110.286 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 14.9 tmm? -68.29 -44.82 74.65 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.451 1.094 . . . . 0.0 110.991 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.62 HD13 HG13 ' A' ' 247' ' ' ILE . 2.4 mt -73.85 -31.57 63.25 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.504 1.128 . . . . 0.0 109.34 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 28.7 t -69.84 -38.14 76.41 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 0.0 108.322 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 11.3 t -76.86 -29.07 55.69 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.492 1.12 . . . . 0.0 109.984 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.9 -38.7 73.02 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.5 1.125 . . . . 0.0 109.974 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.8 124.07 32.51 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.483 1.114 . . . . 0.0 109.998 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 -27.87 9.64 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.417 1.746 . . . . 0.0 110.991 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.86 -32.61 72.4 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 0.0 110.315 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.808 HD11 HG21 ' A' ' 243' ' ' VAL . 71.2 mt -75.14 -32.88 27.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.506 1.129 . . . . 0.0 109.316 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.29 -34.97 66.04 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.447 1.092 . . . . 0.0 109.295 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -73.77 -43.42 59.04 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.531 1.144 . . . . 0.0 110.308 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.426 HG21 ' HB3' ' A' ' 238' ' ' LYS . 97.7 mt -71.64 -38.06 65.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 0.0 109.339 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.514 ' O ' HG22 ' A' ' 344' ' ' THR . 4.7 t80 -67.0 -39.22 87.07 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 0.0 111.042 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.06 -35.59 69.33 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.506 1.129 . . . . 0.0 110.311 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -46.17 83.66 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.45 1.094 . . . . 0.0 109.307 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 341' ' ' PHE . 6.6 t -71.23 -33.98 70.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.543 1.152 . . . . 0.0 110.399 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -70.21 -37.23 75.02 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.452 1.095 . . . . 0.0 109.366 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.472 ' HA ' HD23 ' A' ' 346' ' ' LEU . 12.4 mt -71.43 -37.02 71.49 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.523 1.139 . . . . 0.0 109.29 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -72.68 -37.34 67.91 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.487 1.117 . . . . 0.0 110.335 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -72.46 -40.16 67.21 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.559 1.162 . . . . 0.0 110.251 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.5 -34.73 70.37 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.498 1.124 . . . . 0.0 110.314 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -43.65 -46.33 7.25 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 124.495 1.122 . . . . 0.0 110.96 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -154.81 121.19 5.33 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.546 0.792 . . . . 0.0 109.276 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -65.51 173.31 2.76 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.504 1.127 . . . . 0.0 109.308 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -120.18 120.13 35.27 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.116 . . . . 0.0 109.326 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 49.9 m -154.91 172.38 18.14 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.508 1.13 . . . . 0.0 110.007 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.457 0 O-C-N 124.48 1.113 . . . . 0.0 109.321 179.971 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.028 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.17 165.05 11.3 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.487 0.757 . . . . 0.0 109.977 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -128.75 170.43 13.34 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.527 1.142 . . . . 0.0 110.296 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -88.23 154.03 20.75 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.487 1.117 . . . . 0.0 110.323 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 61.8 t -138.32 134.43 43.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.539 1.149 . . . . 0.0 109.277 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -89.35 162.7 15.67 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.489 1.118 . . . . 0.0 110.3 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.11 120.08 5.76 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.523 1.14 . . . . 0.0 110.235 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -113.86 -32.47 2.06 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.468 1.105 . . . . 0.0 110.965 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -91.09 17.17 8.4 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.499 0.764 . . . . 0.0 109.326 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -52.78 -39.03 61.93 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.566 1.166 . . . . 0.0 110.997 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.12 -40.05 50.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.494 1.121 . . . . 0.0 109.322 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.465 ' HD3' ' CD1' ' A' ' 229' ' ' LEU . 0.0 OUTLIER -66.22 -31.87 72.95 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.519 1.137 . . . . 0.0 110.339 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.641 ' ND2' HD22 ' A' ' 320' ' ' LEU . 12.4 t-20 -80.61 -30.84 36.78 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.538 1.149 . . . . 0.0 109.335 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' TRP . . . . . 0.928 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 2.8 t90 -67.24 -42.66 83.61 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.127 . . . . 0.0 107.994 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.406 ' HG3' ' N ' ' A' ' 229' ' ' LEU . 8.9 pt20 -71.02 -40.77 71.56 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.478 1.111 . . . . 0.0 110.333 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.465 ' CD1' ' HD3' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -61.87 -48.65 79.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.471 1.107 . . . . 0.0 109.304 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.516 HG13 ' CD1' ' A' ' 244' ' ' LEU . 5.7 p -68.09 -39.63 81.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.503 1.127 . . . . 0.0 109.309 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -72.11 -16.53 62.01 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.502 1.126 . . . . 0.0 109.264 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 228' ' ' GLN . . . -81.25 -10.45 59.59 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.473 1.108 . . . . 0.0 109.282 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 6.7 t -80.85 121.04 80.54 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.561 1.163 . . . . 0.0 109.29 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 -18.35 18.75 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.501 1.79 . . . . 0.0 111.018 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.538 HD21 HD11 ' A' ' 302' ' ' ILE . 5.7 tp -75.87 -20.96 57.67 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.511 1.132 . . . . 0.0 109.281 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.488 ' CD2' HD12 ' A' ' 239' ' ' LEU . 3.3 m-85 -108.97 8.9 26.55 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.495 1.122 . . . . 0.0 110.998 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.26 -19.92 65.58 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.572 1.17 . . . . 0.0 110.311 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.526 ' CB ' HG21 ' A' ' 340' ' ' ILE . 69.5 mmtt -80.63 -17.95 49.64 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.523 1.139 . . . . 0.0 109.313 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.726 HD22 HG11 ' A' ' 243' ' ' VAL . 75.1 mt -70.49 172.81 7.82 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.457 1.098 . . . . 0.0 109.284 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . 0.54 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -107.42 -172.54 22.26 Favored Glycine 0 CA--C 1.529 0.952 0 O-C-N 124.509 1.131 . . . . 0.0 111.07 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.912 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.3 Cg_endo -75.05 -35.16 3.27 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.487 1.783 . . . . 0.0 110.986 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -69.56 -34.08 73.66 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.475 1.11 . . . . 0.0 109.301 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.726 HG11 HD22 ' A' ' 239' ' ' LEU . 3.6 t -74.93 -40.58 45.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.493 1.12 . . . . 0.0 109.298 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.784 ' O ' HG23 ' A' ' 248' ' ' VAL . 0.7 OUTLIER -64.83 -40.1 94.65 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.478 1.111 . . . . 0.0 109.262 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.928 HG22 ' CZ2' ' A' ' 227' ' ' TRP . 63.0 t -70.65 -42.13 77.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.459 1.099 . . . . 0.0 109.299 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -64.95 -35.65 81.86 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.492 1.12 . . . . 0.0 110.262 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.432 HD12 HG12 ' A' ' 243' ' ' VAL . 36.7 mt -71.75 -44.84 68.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.559 1.162 . . . . 0.0 109.321 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 244' ' ' LEU . 96.4 t -68.17 -32.15 54.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.454 1.096 . . . . 0.0 109.292 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.93 -21.97 46.48 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.493 1.121 . . . . 0.0 110.327 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.511 ' HB3' ' OD1' ' A' ' 326' ' ' ASP . . . -89.94 -21.26 22.55 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.473 1.108 . . . . 0.0 109.276 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.411 ' CD2' ' HB2' ' A' ' 322' ' ' LEU . 0.2 OUTLIER -67.3 149.77 49.92 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.469 1.106 . . . . 0.0 109.304 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -121.08 119.57 32.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.442 1.088 . . . . 0.0 110.334 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.563 ' HB2' HD23 ' A' ' 320' ' ' LEU . . . -80.99 122.83 27.77 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.495 1.122 . . . . 0.0 109.324 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.96 142.9 49.12 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.506 1.129 . . . . 0.0 110.293 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.3 m -94.18 125.36 38.77 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.496 1.123 . . . . 0.0 110.359 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.524 HG12 ' CB ' ' A' ' 313' ' ' ALA . 47.6 t -106.92 112.44 63.32 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.534 1.146 . . . . 0.0 109.334 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.3 Cg_endo -75.01 171.38 18.43 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.485 1.781 . . . . 0.0 110.993 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.589 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -66.25 130.21 42.44 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.487 1.117 . . . . 0.0 109.336 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 94.97 -25.09 25.52 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.478 1.111 . . . . 0.0 111.031 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.517 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -64.75 119.94 11.53 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.527 0.781 . . . . 0.0 109.297 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.17 136.03 24.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.539 1.15 . . . . 0.0 109.284 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.974 HD12 HG12 ' A' ' 311' ' ' VAL . 39.9 mt -82.12 -52.64 13.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.492 1.12 . . . . 0.0 109.334 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 17.1 p -147.43 146.26 29.51 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.512 1.133 . . . . 0.0 108.291 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -83.36 -177.8 6.86 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.115 . . . . 0.0 110.291 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.54 HG23 ' CB ' ' A' ' 310' ' ' THR . 0.0 OUTLIER -76.08 133.21 31.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.507 1.129 . . . . 0.0 109.301 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 55.5 53.9 38.14 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.486 1.116 . . . . 0.0 110.983 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.81 165.75 43.65 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.467 0.745 . . . . 0.0 110.313 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.486 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.3 Cg_endo -75.01 87.12 1.35 Allowed 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.498 1.788 . . . . 0.0 110.947 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -39.79 93.4 0.01 OUTLIER Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.506 1.129 . . . . 0.0 111.02 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 268' ' ' PRO . 17.9 p30 -170.82 38.48 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.513 0.773 . . . . 0.0 109.261 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.401 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 12.8 mtt180 -169.51 154.45 5.63 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.477 1.11 . . . . 0.0 110.309 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.41 ' SD ' ' CD1' ' A' ' 301' ' ' LEU . 1.2 ttt -126.09 149.66 48.75 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.506 1.129 . . . . 0.0 110.985 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 296' ' ' PHE . 12.1 m-85 -135.63 138.2 42.65 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.475 1.109 . . . . 0.0 110.98 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -128.36 126.15 40.12 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.552 1.158 . . . . 0.0 110.973 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 1.034 HG22 HD22 ' A' ' 319' ' ' LEU . 41.7 t -85.47 129.64 37.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.467 1.104 . . . . 0.0 109.298 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.809 ' CG2' HD11 ' A' ' 320' ' ' LEU . 46.3 t -104.94 -46.97 9.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.467 1.105 . . . . 0.0 109.322 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.814 ' O ' HG23 ' A' ' 317' ' ' VAL . 0.0 OUTLIER -148.52 140.51 23.9 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.482 1.114 . . . . 0.0 110.336 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 116.46 -154.1 17.02 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.554 1.159 . . . . 0.0 110.994 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 290' ' ' LEU . 4.5 m -147.83 131.4 16.79 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.466 0.745 . . . . 0.0 109.967 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 20.3 m -117.17 135.58 57.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.484 1.115 . . . . 0.0 109.332 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 29.3 t -102.5 149.6 24.23 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.519 1.137 . . . . 0.0 109.983 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.463 HG13 HG22 ' A' ' 311' ' ' VAL . 0.4 OUTLIER -113.35 130.42 67.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.502 1.127 . . . . 0.0 109.291 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.666 ' HB3' ' H ' ' A' ' 310' ' ' THR . . . -76.77 101.84 6.0 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.541 1.15 . . . . 0.0 109.31 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . 0.648 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -149.07 -168.63 0.19 Allowed Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.47 1.106 . . . . 0.0 110.427 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.648 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -75.01 3.83 5.28 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.553 1.817 . . . . 0.0 110.975 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -151.91 157.68 34.22 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.533 1.146 . . . . 0.0 109.325 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 92.59 0.98 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.533 1.807 . . . . 0.0 111.0 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.443 ' O ' HG23 ' A' ' 282' ' ' VAL . 29.0 t -95.49 118.97 42.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.506 1.129 . . . . 0.0 109.311 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.54 ' C ' HD22 ' A' ' 290' ' ' LEU . 14.2 mt-10 -124.34 138.69 54.35 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.482 1.114 . . . . 0.0 110.313 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.54 HD22 ' C ' ' A' ' 289' ' ' GLU . 4.4 mm? -121.37 140.92 51.48 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.464 1.103 . . . . 0.0 109.311 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -97.55 -155.01 29.91 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.459 1.1 . . . . 0.0 110.985 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.94 147.04 33.65 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.498 1.789 . . . . 0.0 111.018 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 85.26 5.77 85.0 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.474 1.109 . . . . 0.0 111.011 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -90.44 121.42 32.39 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.495 0.762 . . . . 0.0 109.323 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -116.16 152.89 32.8 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.541 1.151 . . . . 0.0 110.994 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.558 ' CZ ' ' HB3' ' A' ' 273' ' ' PHE . 33.7 p90 -163.71 148.95 10.88 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.486 1.116 . . . . 0.0 111.018 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 132.98 -11.58 5.1 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.454 1.096 . . . . 0.0 110.976 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -52.82 -44.91 67.01 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.452 0.737 . . . . 0.0 110.3 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.67 -39.21 57.81 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.438 1.086 . . . . 0.0 110.965 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . 0.457 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -68.49 -39.03 81.48 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.516 1.135 . . . . 0.0 109.304 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.55 HD22 ' CB ' ' A' ' 327' ' ' PHE . 13.3 mt -76.76 -8.78 57.96 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.516 1.135 . . . . 0.0 109.334 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . 0.538 HD11 HD21 ' A' ' 235' ' ' LEU . 6.5 mm -85.01 -52.95 11.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.488 1.117 . . . . 0.0 109.341 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 304' ' ' GLY . 0.4 OUTLIER -153.51 41.13 0.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.5 1.125 . . . . 0.0 109.967 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 36.48 36.4 0.15 Allowed Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.494 1.121 . . . . 0.0 110.956 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.93 155.76 85.84 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.511 0.771 . . . . 0.0 110.266 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 130.87 13.63 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.539 1.81 . . . . 0.0 110.999 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -45.16 -31.32 1.4 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.528 1.143 . . . . 0.0 110.288 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 2.4 m 59.1 33.1 22.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 0.0 110.03 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 176.35 160.63 0.34 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.498 1.124 . . . . 0.0 109.317 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.666 ' H ' ' HB3' ' A' ' 283' ' ' ALA . 0.7 OUTLIER -109.98 127.2 54.65 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.471 1.107 . . . . 0.0 110.396 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.974 HG12 HD12 ' A' ' 262' ' ' ILE . 57.6 t -107.21 131.64 56.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.496 1.122 . . . . 0.0 109.301 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 1.9 p -137.03 150.55 48.16 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.473 1.108 . . . . 0.0 110.036 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . 0.842 ' HB1' HG12 ' A' ' 317' ' ' VAL . . . -80.04 111.09 16.05 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.518 1.137 . . . . 0.0 109.278 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -58.61 -26.69 63.96 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.461 1.101 . . . . 0.0 109.285 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' THR . . . . . 0.589 ' HA ' ' HB2' ' A' ' 258' ' ' ALA . 8.8 t -160.18 -164.01 1.21 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.514 1.133 . . . . 0.0 110.379 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . 0.433 ' N ' ' OG1' ' A' ' 315' ' ' THR . 65.2 m -64.08 74.61 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.504 1.128 . . . . 0.0 110.417 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.859 HG22 ' CD2' ' A' ' 319' ' ' LEU . 2.7 p -104.14 137.81 31.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.125 . . . . 0.0 109.319 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . 0.464 ' C ' HD23 ' A' ' 319' ' ' LEU . 71.1 m -106.19 134.83 48.7 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.542 1.151 . . . . 0.0 109.972 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . 1.034 HD22 HG22 ' A' ' 275' ' ' VAL . 0.0 OUTLIER -141.5 174.23 10.75 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.535 1.147 . . . . 0.0 109.319 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.809 HD11 ' CG2' ' A' ' 276' ' ' VAL . 0.6 OUTLIER -124.83 134.01 52.9 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.517 1.135 . . . . 0.0 109.262 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 29.5 t -98.03 146.82 25.15 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.529 1.143 . . . . 0.0 109.972 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.411 ' HB2' ' CD2' ' A' ' 251' ' ' LEU . 2.2 tm? -138.06 104.64 5.29 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.518 1.136 . . . . 0.0 109.318 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . 0.44 ' ND1' ' HB3' ' A' ' 325' ' ' ALA . 5.8 p80 -63.71 134.31 55.12 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.557 1.161 . . . . 0.0 109.631 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 86.4 p -55.56 -18.47 7.55 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.54 1.15 . . . . 0.0 109.978 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 0.44 ' HB3' ' ND1' ' A' ' 323' ' ' HIS . . . -58.12 -36.99 73.73 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.466 1.104 . . . . 0.0 109.291 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . 0.511 ' OD1' ' HB3' ' A' ' 250' ' ' ALA . 27.2 t0 -65.32 -38.87 91.5 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.499 1.125 . . . . 0.0 109.312 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' PHE . . . . . 0.55 ' CB ' HD22 ' A' ' 301' ' ' LEU . 17.7 t80 -68.63 -35.64 77.55 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.478 1.111 . . . . 0.0 110.991 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -69.33 -33.84 73.74 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.5 1.125 . . . . 0.0 110.326 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.418 ' O ' ' CB ' ' A' ' 333' ' ' SER . 32.2 ttp -70.59 -43.21 69.85 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.457 1.098 . . . . 0.0 110.987 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 2.6 mt -70.58 -34.7 72.47 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.435 1.085 . . . . 0.0 109.342 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 1.3 m -73.22 -44.12 60.14 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.473 1.108 . . . . 0.0 108.3 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 7.6 t -73.09 -27.86 61.96 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.529 1.143 . . . . 0.0 110.04 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 329' ' ' MET . 11.7 t -74.04 -38.38 64.03 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.537 1.148 . . . . 0.0 110.028 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . 0.636 ' HB2' HD12 ' A' ' 337' ' ' ILE . 0.3 OUTLIER -126.92 120.52 22.72 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 0.0 109.977 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 -23.62 13.57 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.503 1.791 . . . . 0.0 111.038 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -72.32 -33.66 67.52 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.481 1.113 . . . . 0.0 110.263 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.679 HG23 HD21 ' A' ' 239' ' ' LEU . 87.3 mt -71.07 -40.34 75.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.556 1.16 . . . . 0.0 109.337 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.98 -30.7 64.02 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.443 1.089 . . . . 0.0 109.286 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.89 -37.34 70.16 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.529 1.143 . . . . 0.0 110.294 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.526 HG21 ' CB ' ' A' ' 238' ' ' LYS . 30.6 mt -72.93 -45.64 54.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.526 1.141 . . . . 0.0 109.295 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -67.65 -30.9 70.57 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.463 1.102 . . . . 0.0 110.997 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -72.54 -44.58 61.95 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.133 . . . . 0.0 110.258 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -45.26 76.88 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.521 1.138 . . . . 0.0 109.371 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.53 -40.12 92.57 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 0.0 110.409 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -69.09 -32.96 72.75 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.135 . . . . 0.0 109.28 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.428 ' HA ' HD23 ' A' ' 346' ' ' LEU . 13.1 mt -73.64 -31.18 63.37 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.519 1.137 . . . . 0.0 109.308 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -72.72 -40.56 66.03 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.14 . . . . 0.0 110.353 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -69.83 -40.9 75.6 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.466 1.104 . . . . 0.0 110.273 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 350' ' ' GLY . 0.0 OUTLIER -73.11 -34.7 66.32 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.479 1.112 . . . . 0.0 110.316 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 349' ' ' ARG . . . -37.04 -46.97 1.3 Allowed Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.536 1.147 . . . . 0.0 111.0 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -154.61 121.6 5.56 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.48 0.753 . . . . 0.0 109.341 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -62.9 166.91 5.14 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.498 1.123 . . . . 0.0 109.345 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -102.63 120.72 41.04 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.538 1.149 . . . . 0.0 109.309 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 10.7 m -64.12 138.62 58.54 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.47 1.106 . . . . 0.0 109.973 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.446 0 O-C-N 124.46 1.1 . . . . 0.0 109.287 179.963 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.048 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 25.5 p -60.56 140.58 57.29 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.528 0.781 . . . . 0.0 109.994 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.82 173.1 7.24 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.54 1.15 . . . . 0.0 110.278 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -110.57 170.42 8.1 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.485 1.116 . . . . 0.0 110.29 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 32.9 m -131.67 166.98 27.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.464 1.103 . . . . 0.0 109.303 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 15.2 mtt180 -107.66 170.85 7.73 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.506 1.129 . . . . 0.0 110.264 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.27 137.4 35.85 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.532 1.145 . . . . 0.0 110.341 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -110.32 -26.05 5.03 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.517 1.135 . . . . 0.0 110.987 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -99.12 17.23 20.35 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.505 0.768 . . . . 0.0 109.294 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.564 ' CE1' ' HD3' ' A' ' 249' ' ' ARG . 68.3 t80 -53.78 -39.89 65.8 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.481 1.113 . . . . 0.0 110.969 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.62 -39.29 81.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.474 1.109 . . . . 0.0 109.315 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.66 ' HD2' HD12 ' A' ' 229' ' ' LEU . 0.1 OUTLIER -67.66 -34.41 76.87 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.512 1.132 . . . . 0.0 110.281 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.995 ' O ' HG12 ' A' ' 230' ' ' VAL . 36.9 t30 -78.73 -30.49 45.89 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.506 1.129 . . . . 0.0 109.271 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' TRP . . . . . 0.632 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 5.5 t90 -66.99 -44.4 80.5 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.522 1.139 . . . . 0.0 108.011 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.537 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 11.1 pt20 -71.78 -33.99 69.06 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.444 1.09 . . . . 0.0 110.332 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.66 HD12 ' HD2' ' A' ' 225' ' ' ARG . 0.3 OUTLIER -65.63 -55.39 17.84 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.544 1.152 . . . . 0.0 109.308 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.995 HG12 ' O ' ' A' ' 226' ' ' ASN . 7.4 p -65.51 -35.01 74.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.509 1.131 . . . . 0.0 109.287 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.475 ' CB ' ' O ' ' A' ' 227' ' ' TRP . . . -75.29 -18.88 59.94 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.485 1.115 . . . . 0.0 109.297 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.537 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -80.72 -20.31 43.12 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.102 . . . . 0.0 109.264 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 229' ' ' LEU . 60.3 t -62.78 128.58 92.08 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.507 1.13 . . . . 0.0 109.308 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.426 ' HA ' ' HB2' ' A' ' 237' ' ' GLN . 18.4 Cg_endo -74.99 -35.97 2.83 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.485 1.782 . . . . 0.0 111.078 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.756 HD22 ' HG3' ' A' ' 298' ' ' GLU . 1.2 tp -63.91 -19.22 64.94 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.5 1.125 . . . . 0.0 109.323 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.662 ' CG ' HD12 ' A' ' 239' ' ' LEU . 4.3 m-30 -114.28 8.5 16.77 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.468 1.105 . . . . 0.0 110.988 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' GLN . . . . . 0.426 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 1.5 mt-30 -71.18 -22.61 62.01 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.508 1.13 . . . . 0.0 110.304 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -83.41 -19.37 36.11 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.476 1.11 . . . . 0.0 109.265 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.751 HD22 HG11 ' A' ' 243' ' ' VAL . 67.7 mt -63.79 -179.98 0.44 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.549 1.155 . . . . 0.0 109.296 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . 0.651 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -103.95 178.2 24.66 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.487 1.117 . . . . 0.0 111.04 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.543 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.2 Cg_endo -75.02 -34.54 3.72 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.486 1.782 . . . . 0.0 111.006 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -71.8 -35.4 69.96 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.499 1.125 . . . . 0.0 109.337 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.751 HG11 HD22 ' A' ' 239' ' ' LEU . 71.6 t -72.73 -40.62 61.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.528 1.142 . . . . 0.0 109.291 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 240' ' ' GLY . 3.9 mm? -69.08 -40.51 78.39 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.515 1.134 . . . . 0.0 109.308 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.632 HG22 ' CZ2' ' A' ' 227' ' ' TRP . 20.5 t -66.17 -37.05 78.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.487 1.117 . . . . 0.0 109.296 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -74.3 -30.78 62.23 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.55 1.156 . . . . 0.0 110.298 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 44.2 mt -70.93 -48.59 55.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.542 1.151 . . . . 0.0 109.308 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.67 HG23 ' ND2' ' A' ' 226' ' ' ASN . 14.5 p -65.56 -36.14 76.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.525 1.14 . . . . 0.0 109.286 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.564 ' HD3' ' CE1' ' A' ' 223' ' ' PHE . 1.4 mmm180 -72.44 -25.2 61.37 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.495 1.122 . . . . 0.0 110.311 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -91.41 0.33 57.53 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.472 1.108 . . . . 0.0 109.261 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.402 HD22 ' HB2' ' A' ' 320' ' ' LEU . 0.1 OUTLIER -83.69 151.61 25.18 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 0.0 109.269 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.08 125.16 46.57 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.46 1.1 . . . . 0.0 110.291 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -82.97 122.72 28.66 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.523 1.139 . . . . 0.0 109.267 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.405 ' O ' ' O ' ' A' ' 319' ' ' LEU . 0.0 OUTLIER -127.72 139.35 52.74 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.436 1.085 . . . . 0.0 110.265 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 6.6 m -95.55 128.07 42.11 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.479 1.112 . . . . 0.0 110.405 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.588 HG21 HD11 ' A' ' 319' ' ' LEU . 22.0 t -106.54 115.78 60.13 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.458 1.099 . . . . 0.0 109.251 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.504 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.95 154.44 42.76 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.52 1.8 . . . . 0.0 111.036 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.489 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -57.51 126.27 26.59 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.475 1.11 . . . . 0.0 109.266 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 98.7 -25.19 29.01 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.511 1.132 . . . . 0.0 110.995 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.504 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -66.3 146.58 54.44 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.479 0.752 . . . . 0.0 109.254 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 311' ' ' VAL . 2.4 p -97.18 136.29 28.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.461 1.101 . . . . 0.0 109.319 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.687 HD12 HG12 ' A' ' 311' ' ' VAL . 7.4 mt -81.65 -45.42 20.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.489 1.118 . . . . 0.0 109.33 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' CYS . . . . . 0.643 ' SG ' HG23 ' A' ' 311' ' ' VAL . 14.1 p -147.4 153.53 39.73 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.479 1.112 . . . . 0.0 108.331 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.41 179.91 5.0 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.513 1.133 . . . . 0.0 110.304 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.67 135.95 25.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.471 1.107 . . . . 0.0 109.311 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 52.27 53.55 30.77 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.539 1.149 . . . . 0.0 111.027 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.417 ' CD ' ' CD ' ' A' ' 268' ' ' PRO . 5.7 mm-40 -71.57 166.1 42.73 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.512 0.772 . . . . 0.0 110.313 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.517 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.2 Cg_endo -74.96 82.52 1.98 Allowed 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.515 1.797 . . . . 0.0 111.024 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . 0.424 ' HA2' ' HB1' ' A' ' 300' ' ' ALA . . . -36.86 92.39 0.01 OUTLIER Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.471 1.107 . . . . 0.0 110.976 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 268' ' ' PRO . 36.6 m-20 -171.92 37.84 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.526 0.78 . . . . 0.0 109.322 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.8 148.57 2.93 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.476 1.11 . . . . 0.0 110.299 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.747 ' HB2' HD11 ' A' ' 301' ' ' LEU . 2.1 ttt -123.26 146.65 47.68 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.543 1.152 . . . . 0.0 110.971 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.568 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 92.4 m-85 -133.4 136.98 45.6 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.512 1.133 . . . . 0.0 110.982 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . 0.501 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 20.5 m-85 -124.72 135.06 52.69 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.451 1.094 . . . . 0.0 111.004 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.534 HG12 ' HA ' ' A' ' 292' ' ' PRO . 38.6 t -90.43 137.93 20.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.471 1.107 . . . . 0.0 109.321 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.661 ' CG2' HD11 ' A' ' 320' ' ' LEU . 3.4 t -115.86 -48.99 4.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.484 1.115 . . . . 0.0 109.329 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.419 ' O ' HG13 ' A' ' 317' ' ' VAL . 3.9 mm-40 -139.01 136.57 35.47 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.51 1.131 . . . . 0.0 110.306 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.942 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 110.87 -173.31 15.93 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.486 1.116 . . . . 0.0 110.957 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 290' ' ' LEU . 5.5 t -134.34 126.67 30.14 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.481 0.754 . . . . 0.0 109.992 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.437 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 17.4 m -104.18 166.32 3.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.485 1.116 . . . . 0.0 109.286 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 30.8 t -129.81 154.79 46.9 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.502 1.126 . . . . 0.0 110.022 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.449 ' CG2' ' HB ' ' A' ' 288' ' ' VAL . 0.5 OUTLIER -118.03 127.84 75.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.502 1.126 . . . . 0.0 109.301 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.413 ' HB3' ' H ' ' A' ' 310' ' ' THR . . . -77.0 101.37 5.99 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.44 1.088 . . . . 0.0 109.338 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . 0.651 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.63 -168.35 0.18 Allowed Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.525 1.141 . . . . 0.0 110.392 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.651 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.3 Cg_endo -74.97 4.17 4.96 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.528 1.804 . . . . 0.0 111.017 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.443 ' O ' HG23 ' A' ' 288' ' ' VAL . 5.1 m120 -150.68 156.16 36.13 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.509 1.131 . . . . 0.0 109.299 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 94.19 0.96 Allowed 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.517 1.798 . . . . 0.0 111.032 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.449 ' HB ' ' CG2' ' A' ' 282' ' ' VAL . 2.1 t -98.13 119.26 45.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.54 1.15 . . . . 0.0 109.322 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 13.9 mt-10 -124.5 135.44 53.21 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.547 1.154 . . . . 0.0 110.337 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.437 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 3.9 mm? -115.3 142.61 46.45 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.52 1.137 . . . . 0.0 109.308 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -97.96 -162.56 30.98 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.434 1.084 . . . . 0.0 111.025 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' PRO . . . . . 0.534 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.2 Cg_endo -75.0 144.99 30.91 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.467 1.772 . . . . 0.0 110.999 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 90.21 -1.84 80.43 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.502 1.126 . . . . 0.0 111.022 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -83.76 139.31 32.8 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.51 0.77 . . . . 0.0 109.321 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.405 ' CB ' ' CD1' ' A' ' 274' ' ' PHE . 1.5 p90 -126.4 152.74 45.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.491 1.119 . . . . 0.0 110.998 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.568 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 33.4 p90 -160.85 149.71 16.6 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.446 1.091 . . . . 0.0 111.013 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . 0.657 ' O ' HD12 ' A' ' 301' ' ' LEU . . . 126.23 -8.55 7.5 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.479 1.112 . . . . 0.0 111.025 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.756 ' HG3' HD22 ' A' ' 235' ' ' LEU . 27.0 tt0 -52.87 -44.19 66.66 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.525 0.779 . . . . 0.0 110.283 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . 0.464 ' HB3' ' CG ' ' A' ' 305' ' ' GLU . 0.0 OUTLIER -56.34 -37.13 69.59 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.497 1.123 . . . . 0.0 111.037 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . 0.424 ' HB1' ' HA2' ' A' ' 269' ' ' GLY . . . -66.36 -38.38 87.46 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.503 1.127 . . . . 0.0 109.227 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.747 HD11 ' HB2' ' A' ' 272' ' ' MET . 1.8 mp -81.98 -10.22 59.32 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.124 . . . . 0.0 109.328 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 3.9 mm -76.9 -56.42 8.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.464 1.102 . . . . 0.0 109.33 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 305' ' ' GLU . 1.5 m -151.53 48.37 0.81 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.526 1.141 . . . . 0.0 109.992 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 303' ' ' SER . . . 36.57 31.66 0.05 OUTLIER Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.516 1.135 . . . . 0.0 110.99 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . 0.464 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 0.0 OUTLIER -65.24 151.67 93.41 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.517 0.775 . . . . 0.0 110.28 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 129.51 12.45 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.434 1.755 . . . . 0.0 111.022 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.88 -22.92 0.93 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.491 1.119 . . . . 0.0 110.288 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.695 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 27.4 m 41.79 57.24 3.18 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.566 1.166 . . . . 0.0 110.03 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' ALA . . . . . 0.695 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 162.68 159.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.463 1.102 . . . . 0.0 109.349 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.413 ' H ' ' HB3' ' A' ' 283' ' ' ALA . 0.3 OUTLIER -112.7 122.06 46.56 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.509 1.131 . . . . 0.0 110.408 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.687 HG12 HD12 ' A' ' 262' ' ' ILE . 23.0 t -102.79 131.51 50.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.524 1.14 . . . . 0.0 109.302 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 261' ' ' VAL . 33.8 p -138.37 154.07 48.93 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.494 1.121 . . . . 0.0 109.984 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -91.15 120.55 32.19 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.497 1.123 . . . . 0.0 109.297 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -61.94 -33.79 74.91 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.481 1.113 . . . . 0.0 109.316 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' THR . . . . . 0.605 ' O ' HG23 ' A' ' 317' ' ' VAL . 9.9 t -149.78 -176.22 5.34 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.517 1.136 . . . . 0.0 110.425 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 13.9 p -49.8 92.36 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.525 1.14 . . . . 0.0 110.361 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.942 HG22 ' HA3' ' A' ' 278' ' ' GLY . 43.0 t -108.56 158.49 8.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.509 1.131 . . . . 0.0 109.312 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 68.4 m -132.92 118.16 18.56 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.487 1.117 . . . . 0.0 110.014 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . 0.588 HD11 HG21 ' A' ' 256' ' ' VAL . 0.2 OUTLIER -131.65 172.94 11.65 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.49 1.119 . . . . 0.0 109.286 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.661 HD11 ' CG2' ' A' ' 276' ' ' VAL . 0.0 OUTLIER -125.1 137.14 54.19 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.451 1.095 . . . . 0.0 109.31 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 4.0 t -95.51 156.41 16.34 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.463 1.102 . . . . 0.0 110.021 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.94 103.51 3.22 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 0.0 109.289 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . 0.56 ' CE1' ' HB2' ' A' ' 326' ' ' ASP . 9.1 p80 -57.72 136.46 56.88 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.494 1.121 . . . . 0.0 109.584 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 42.0 t -62.12 -21.46 65.03 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.448 1.092 . . . . 0.0 109.984 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -62.97 -30.43 71.57 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.506 1.129 . . . . 0.0 109.307 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . 0.868 ' O ' HD12 ' A' ' 330' ' ' LEU . 27.7 t70 -65.98 -47.91 73.0 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.506 1.129 . . . . 0.0 109.339 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' PHE . . . . . 0.503 ' CZ ' ' CE2' ' A' ' 341' ' ' PHE . 2.5 t80 -64.95 -34.26 78.0 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.494 1.121 . . . . 0.0 110.996 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.486 ' O ' ' CB ' ' A' ' 332' ' ' SER . 67.5 mt-30 -70.53 -33.37 71.1 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.509 1.13 . . . . 0.0 110.264 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 14.3 tmm? -68.98 -44.83 72.08 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.513 1.133 . . . . 0.0 110.989 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.868 HD12 ' O ' ' A' ' 326' ' ' ASP . 0.6 OUTLIER -73.47 -41.87 62.61 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.479 1.112 . . . . 0.0 109.275 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' CYS . . . . . 0.407 ' HG ' ' HD2' ' A' ' 341' ' ' PHE . 22.7 t -66.11 -38.57 88.52 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.479 1.112 . . . . 0.0 108.257 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 328' ' ' GLN . 38.7 t -76.72 -25.62 53.77 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.462 1.101 . . . . 0.0 109.953 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 17.7 t -71.73 -38.87 70.4 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.123 . . . . 0.0 110.034 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . 0.442 ' CB ' HD12 ' A' ' 337' ' ' ILE . 0.2 OUTLIER -115.19 127.65 26.63 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.477 1.11 . . . . 0.0 109.965 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 334' ' ' SER . 18.2 Cg_endo -75.0 -28.8 8.86 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.525 1.803 . . . . 0.0 110.981 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -67.22 -29.82 69.58 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.502 1.126 . . . . 0.0 110.263 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.54 HD11 HG21 ' A' ' 243' ' ' VAL . 87.4 mt -75.0 -34.46 32.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.543 1.152 . . . . 0.0 109.257 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.73 -30.65 64.35 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.528 1.142 . . . . 0.0 109.3 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -74.93 -46.23 37.1 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.491 1.119 . . . . 0.0 110.317 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 87.4 mt -71.59 -36.45 59.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.459 1.099 . . . . 0.0 109.278 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.511 ' CB ' ' O ' ' A' ' 337' ' ' ILE . 6.0 t80 -67.39 -41.96 84.14 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.514 1.134 . . . . 0.0 110.991 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . 0.467 ' HG3' ' CD1' ' A' ' 346' ' ' LEU . 0.7 OUTLIER -70.63 -35.84 73.15 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.492 1.12 . . . . 0.0 110.26 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -50.86 65.36 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.492 1.12 . . . . 0.0 109.277 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.511 HG22 ' O ' ' A' ' 341' ' ' PHE . 10.2 t -65.04 -33.02 75.03 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.474 1.108 . . . . 0.0 110.389 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -66.09 -44.92 83.0 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.484 1.115 . . . . 0.0 109.283 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.467 ' CD1' ' HG3' ' A' ' 342' ' ' ARG . 1.0 OUTLIER -65.34 -36.46 84.1 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.502 1.126 . . . . 0.0 109.329 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -73.53 -35.4 65.55 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.499 1.124 . . . . 0.0 110.317 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.95 -44.69 60.84 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.495 1.122 . . . . 0.0 110.255 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -34.82 78.21 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.453 1.096 . . . . 0.0 110.312 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -38.18 -46.65 1.91 Allowed Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.529 1.143 . . . . 0.0 110.989 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -154.31 121.9 5.82 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.499 0.764 . . . . 0.0 109.31 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -64.12 169.07 4.72 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.509 1.131 . . . . 0.0 109.329 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -106.42 120.7 42.58 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.473 1.108 . . . . 0.0 109.316 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.64 121.32 15.13 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.471 1.107 . . . . 0.0 110.021 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.493 0 O-C-N 124.468 1.105 . . . . 0.0 109.317 -179.925 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.985 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 18.1 p -129.53 171.48 12.54 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.473 0.749 . . . . 0.0 109.964 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -114.64 146.48 40.8 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.464 1.103 . . . . 0.0 110.309 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -115.27 157.29 23.97 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.447 1.092 . . . . 0.0 110.326 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 34.8 m -112.12 171.67 3.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.504 1.127 . . . . 0.0 109.286 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.57 164.9 11.68 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.532 1.145 . . . . 0.0 110.327 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 3.2 mtt-85 -140.99 143.64 34.58 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.484 1.115 . . . . 0.0 110.341 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -110.32 -17.72 9.18 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.51 1.131 . . . . 0.0 111.005 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.413 ' O ' ' OD1' ' A' ' 226' ' ' ASN . 0.7 OUTLIER -102.2 16.85 24.91 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.427 0.722 . . . . 0.0 109.315 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.492 ' O ' ' CB ' ' A' ' 227' ' ' TRP . 28.9 t80 -53.12 -32.4 47.19 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.488 1.117 . . . . 0.0 111.007 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -86.39 -21.06 7.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.519 1.137 . . . . 0.0 109.311 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.779 ' O ' HD12 ' A' ' 229' ' ' LEU . 0.0 OUTLIER -77.33 -44.15 30.5 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.527 1.142 . . . . 0.0 110.284 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.513 ' O ' HG13 ' A' ' 230' ' ' VAL . 18.4 p-10 -81.02 -30.73 34.85 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.52 1.137 . . . . 0.0 109.317 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' TRP . . . . . 1.027 ' CZ3' HG23 ' A' ' 245' ' ' VAL . 1.0 OUTLIER -68.86 -45.27 71.5 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 0.0 107.981 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.606 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 3.5 pt20 -71.98 -32.18 67.0 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.568 1.167 . . . . 0.0 110.282 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.779 HD12 ' O ' ' A' ' 225' ' ' ARG . 1.2 mt -63.4 -47.71 80.84 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.534 1.146 . . . . 0.0 109.306 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.822 ' O ' HG22 ' A' ' 233' ' ' VAL . 34.1 m -66.98 -41.24 87.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.483 1.115 . . . . 0.0 109.324 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -76.76 -11.4 59.83 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.535 1.147 . . . . 0.0 109.277 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -81.24 -26.01 36.18 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.479 1.112 . . . . 0.0 109.298 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . 0.822 HG22 ' O ' ' A' ' 230' ' ' VAL . 34.1 m -86.46 135.9 35.85 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.493 1.121 . . . . 0.0 109.279 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.41 ' HA ' ' HB2' ' A' ' 237' ' ' GLN . 18.4 Cg_endo -74.94 -13.48 21.54 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.497 1.788 . . . . 0.0 111.046 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.86 -28.65 66.9 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.485 1.116 . . . . 0.0 109.334 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.498 ' HA ' ' CD1' ' A' ' 239' ' ' LEU . 11.6 m-30 -110.82 -17.01 13.44 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.518 1.136 . . . . 0.0 111.033 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' GLN . . . . . 0.41 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 0.3 OUTLIER -59.4 -26.65 65.31 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.467 1.104 . . . . 0.0 110.335 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -83.45 7.56 16.54 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.465 1.103 . . . . 0.0 109.291 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.5 HD13 HG11 ' A' ' 243' ' ' VAL . 34.0 mt -101.65 -179.48 4.03 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.538 1.149 . . . . 0.0 109.294 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -92.06 176.84 39.4 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.479 1.112 . . . . 0.0 110.992 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -30.34 7.24 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.457 1.767 . . . . 0.0 111.009 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.505 ' HA ' HG12 ' A' ' 245' ' ' VAL . . . -70.91 -31.49 68.13 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 0.0 109.322 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.746 ' CG2' HD11 ' A' ' 337' ' ' ILE . 2.7 t -76.89 -43.0 33.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.504 1.128 . . . . 0.0 109.327 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.589 ' O ' HG12 ' A' ' 248' ' ' VAL . 0.2 OUTLIER -67.3 -45.16 77.34 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.529 1.143 . . . . 0.0 109.321 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 1.027 HG23 ' CZ3' ' A' ' 227' ' ' TRP . 2.9 p -64.49 -44.83 96.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.529 1.143 . . . . 0.0 109.32 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.405 ' N ' ' CG1' ' A' ' 245' ' ' VAL . 19.7 tp10 -66.01 -34.66 78.61 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.45 1.094 . . . . 0.0 110.301 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.538 ' CG1' HD13 ' A' ' 330' ' ' LEU . 15.5 mt -68.81 -55.17 16.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.548 1.155 . . . . 0.0 109.31 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.946 ' HA ' HD12 ' A' ' 251' ' ' LEU . 13.7 p -64.81 -30.36 50.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.532 1.145 . . . . 0.0 109.318 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.484 ' CG ' ' O ' ' A' ' 245' ' ' VAL . 5.8 mmm180 -70.17 -28.76 65.58 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.526 1.141 . . . . 0.0 110.308 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.542 ' HB1' ' OD2' ' A' ' 326' ' ' ASP . . . -86.86 -21.06 26.61 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.475 1.109 . . . . 0.0 109.309 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.946 HD12 ' HA ' ' A' ' 248' ' ' VAL . 1.7 mt -54.72 144.85 20.88 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.527 1.142 . . . . 0.0 109.256 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.66 124.88 50.82 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.485 1.116 . . . . 0.0 110.302 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -81.94 124.25 29.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.486 1.116 . . . . 0.0 109.267 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.46 136.56 48.04 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.523 1.139 . . . . 0.0 110.295 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 55.7 m -94.16 125.04 38.55 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 0.0 110.384 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.489 HG21 HD11 ' A' ' 319' ' ' LEU . 42.1 t -106.8 113.95 62.23 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.47 1.106 . . . . 0.0 109.301 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.492 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.2 Cg_endo -75.03 158.11 42.27 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.49 1.784 . . . . 0.0 110.983 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.499 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -57.85 125.39 22.82 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.491 1.119 . . . . 0.0 109.314 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 101.52 -24.08 32.85 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.513 1.133 . . . . 0.0 110.99 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.492 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -61.35 147.44 44.75 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.554 0.796 . . . . 0.0 109.291 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.9 t -97.11 131.3 44.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.51 1.131 . . . . 0.0 109.298 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.744 HD12 HG12 ' A' ' 311' ' ' VAL . 86.2 mt -83.11 -47.96 17.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.457 1.098 . . . . 0.0 109.33 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 14.3 p -153.88 145.48 23.26 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.478 1.111 . . . . 0.0 108.289 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -89.25 178.96 6.22 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.542 1.151 . . . . 0.0 110.28 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.467 HG23 ' OG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -77.89 130.69 35.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.48 1.112 . . . . 0.0 109.261 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 59.9 49.4 78.94 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.497 1.123 . . . . 0.0 111.012 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.12 164.3 58.11 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.521 0.777 . . . . 0.0 110.325 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.5 Cg_endo -74.98 80.6 2.39 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.517 1.799 . . . . 0.0 111.043 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 268' ' ' PRO . . . -37.14 95.82 0.01 OUTLIER Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.488 1.117 . . . . 0.0 111.024 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 268' ' ' PRO . 1.0 OUTLIER -170.2 37.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.499 0.764 . . . . 0.0 109.311 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 6.5 ttt180 -171.57 146.33 2.17 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.506 1.129 . . . . 0.0 110.309 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.757 ' HB2' HD11 ' A' ' 301' ' ' LEU . 2.6 ttt -116.69 146.51 42.71 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.533 1.146 . . . . 0.0 111.023 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.561 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 44.5 m-85 -133.92 137.03 44.64 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.124 . . . . 0.0 111.023 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . 0.437 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 21.1 m-85 -126.38 133.48 51.3 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.519 1.137 . . . . 0.0 111.003 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.74 HG22 HD22 ' A' ' 319' ' ' LEU . 3.2 t -91.07 133.11 33.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.475 1.109 . . . . 0.0 109.294 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.672 ' CG2' HD11 ' A' ' 320' ' ' LEU . 40.2 t -110.27 -35.35 2.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.576 1.173 . . . . 0.0 109.268 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.767 ' O ' HG13 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -156.27 137.84 14.09 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.516 1.135 . . . . 0.0 110.309 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.869 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 117.15 -177.53 16.7 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.483 1.114 . . . . 0.0 110.987 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 2.7 m -126.35 113.49 16.98 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.478 0.752 . . . . 0.0 109.97 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 289' ' ' GLU . 32.7 m -99.26 135.1 35.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.493 1.121 . . . . 0.0 109.325 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 29.3 t -104.16 148.49 26.23 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.475 1.109 . . . . 0.0 109.997 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 288' ' ' VAL . 1.7 t -112.27 128.92 68.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.482 1.113 . . . . 0.0 109.319 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.415 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -77.34 100.96 6.11 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.538 1.149 . . . . 0.0 109.282 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . 0.661 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.9 OUTLIER -149.37 -167.99 0.17 Allowed Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.455 1.097 . . . . 0.0 110.382 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.661 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.4 Cg_endo -75.0 3.93 5.19 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.51 1.794 . . . . 0.0 111.028 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.415 ' O ' HG23 ' A' ' 288' ' ' VAL . 26.4 m120 -152.21 154.82 32.76 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.448 1.093 . . . . 0.0 109.276 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 95.48 0.98 Allowed 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.515 1.797 . . . . 0.0 110.981 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 286' ' ' ASN . 1.3 t -100.03 118.53 46.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.491 1.119 . . . . 0.0 109.303 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 2.5 mm-40 -125.16 133.53 52.76 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.498 1.124 . . . . 0.0 110.312 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.427 HD13 ' HA ' ' A' ' 290' ' ' LEU . 4.4 mm? -115.41 139.66 49.82 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.506 1.129 . . . . 0.0 109.324 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -95.77 -155.96 31.31 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.502 1.126 . . . . 0.0 110.98 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' PRO . . . . . 0.419 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.2 Cg_endo -75.05 138.37 22.82 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.53 1.805 . . . . 0.0 110.972 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 95.23 6.19 60.2 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.481 1.113 . . . . 0.0 110.965 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -90.58 130.75 36.58 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.461 0.742 . . . . 0.0 109.238 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 295' ' ' PHE . 2.3 p90 -120.75 152.92 37.7 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.506 1.129 . . . . 0.0 111.018 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.561 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 36.9 p90 -164.72 148.27 8.92 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.13 . . . . 0.0 110.975 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . 0.592 ' O ' HD12 ' A' ' 301' ' ' LEU . . . 128.07 -8.45 6.74 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.457 1.098 . . . . 0.0 110.989 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -54.94 -53.35 56.76 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.474 0.749 . . . . 0.0 110.319 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -46.98 -35.03 6.12 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.512 1.133 . . . . 0.0 110.979 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . 0.458 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -68.74 -46.91 67.64 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.515 1.134 . . . . 0.0 109.324 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.757 HD11 ' HB2' ' A' ' 272' ' ' MET . 1.1 mp -75.21 -3.21 31.76 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.475 1.11 . . . . 0.0 109.312 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . 0.42 HD13 ' CZ ' ' A' ' 341' ' ' PHE . 8.8 mm -86.85 -54.35 8.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.509 1.131 . . . . 0.0 109.296 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 304' ' ' GLY . 0.9 OUTLIER -149.44 40.89 0.86 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.47 1.106 . . . . 0.0 110.036 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 37.03 34.04 0.1 OUTLIER Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.54 1.15 . . . . 0.0 110.989 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.72 155.23 89.88 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.502 0.766 . . . . 0.0 110.266 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 129.66 12.52 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.468 1.773 . . . . 0.0 111.013 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.98 -29.64 1.52 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.503 1.127 . . . . 0.0 110.273 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.506 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 0.1 OUTLIER 50.65 40.88 25.01 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.444 1.09 . . . . 0.0 109.957 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 175.26 160.82 0.24 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.497 1.123 . . . . 0.0 109.311 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.467 ' OG1' HG23 ' A' ' 265' ' ' ILE . 0.9 OUTLIER -117.78 123.43 45.97 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.539 1.149 . . . . 0.0 110.392 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.744 HG12 HD12 ' A' ' 262' ' ' ILE . 95.1 t -103.99 131.39 52.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.506 1.129 . . . . 0.0 109.279 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 65.2 p -131.54 151.27 51.72 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.475 1.109 . . . . 0.0 109.997 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.26 109.65 19.65 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.515 1.134 . . . . 0.0 109.282 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -56.41 -32.19 64.61 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.503 1.127 . . . . 0.0 109.304 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' THR . . . . . 0.843 ' O ' HG23 ' A' ' 317' ' ' VAL . 8.2 t -153.86 -171.76 3.99 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.526 1.141 . . . . 0.0 110.416 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . 0.452 ' N ' ' OG1' ' A' ' 315' ' ' THR . 43.1 p -54.74 87.91 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.554 1.159 . . . . 0.0 110.39 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.869 HG22 ' HA3' ' A' ' 278' ' ' GLY . 44.9 t -107.71 144.25 16.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.482 1.113 . . . . 0.0 109.265 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 69.1 m -117.99 117.87 30.4 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.529 1.143 . . . . 0.0 109.958 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . 0.74 HD22 HG22 ' A' ' 275' ' ' VAL . 0.0 OUTLIER -128.48 173.33 10.32 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.49 1.119 . . . . 0.0 109.328 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.672 HD11 ' CG2' ' A' ' 276' ' ' VAL . 0.2 OUTLIER -124.49 136.3 53.9 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.471 1.107 . . . . 0.0 109.298 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 14.1 t -96.23 154.63 17.15 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.513 1.133 . . . . 0.0 110.01 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.468 ' HB2' ' CD2' ' A' ' 251' ' ' LEU . 1.2 tm? -145.28 87.66 1.82 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.506 1.129 . . . . 0.0 109.268 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . 0.414 ' ND1' ' HB3' ' A' ' 325' ' ' ALA . 10.4 p80 -49.69 139.1 13.34 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.557 1.16 . . . . 0.0 109.602 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 36.0 t -59.52 -23.87 63.17 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.466 1.104 . . . . 0.0 110.006 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 0.414 ' HB3' ' ND1' ' A' ' 323' ' ' HIS . . . -55.95 -31.03 62.58 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.474 1.108 . . . . 0.0 109.325 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . 0.542 ' OD2' ' HB1' ' A' ' 250' ' ' ALA . 2.6 t70 -70.11 -38.88 75.72 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.532 1.145 . . . . 0.0 109.357 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -67.5 -36.51 81.23 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.517 1.136 . . . . 0.0 110.965 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -70.32 -37.01 74.63 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.525 1.14 . . . . 0.0 110.297 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 5.1 ttp -68.86 -40.39 79.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 0.0 111.009 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.538 HD13 ' CG1' ' A' ' 247' ' ' ILE . 9.3 mt -72.14 -34.52 68.6 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.462 1.101 . . . . 0.0 109.299 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 16.0 m -74.18 -33.32 63.41 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.488 1.117 . . . . 0.0 108.318 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 8.6 t -75.91 -36.52 59.41 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.129 . . . . 0.0 110.004 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 10.0 t -74.51 -34.34 63.01 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.487 1.117 . . . . 0.0 110.03 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . 0.798 ' CB ' HD12 ' A' ' 337' ' ' ILE . 0.3 OUTLIER -128.1 114.62 20.22 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.562 1.164 . . . . 0.0 110.036 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -18.95 18.29 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.499 1.789 . . . . 0.0 111.013 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -72.37 -28.92 63.33 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 0.0 110.329 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.798 HD12 ' CB ' ' A' ' 334' ' ' SER . 46.2 mt -72.69 -41.43 62.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.554 1.159 . . . . 0.0 109.257 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.97 -32.41 65.18 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.455 1.097 . . . . 0.0 109.27 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.53 -39.75 62.16 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.491 1.12 . . . . 0.0 110.293 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 48.6 mt -73.23 -42.69 57.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.551 1.157 . . . . 0.0 109.286 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.42 ' CZ ' HD13 ' A' ' 302' ' ' ILE . 46.7 t80 -69.24 -34.26 74.55 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.55 1.157 . . . . 0.0 111.009 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . 0.461 ' HG3' ' CD1' ' A' ' 346' ' ' LEU . 1.4 ttp-105 -72.78 -39.54 66.64 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.538 1.149 . . . . 0.0 110.276 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -50.59 65.93 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.509 1.13 . . . . 0.0 109.291 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 7.6 t -65.37 -32.98 74.9 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.47 1.106 . . . . 0.0 110.453 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -66.74 -44.99 80.05 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.521 1.138 . . . . 0.0 109.334 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.461 ' CD1' ' HG3' ' A' ' 342' ' ' ARG . 0.6 OUTLIER -65.14 -37.03 86.12 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.503 1.127 . . . . 0.0 109.289 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.08 -39.22 92.89 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.472 1.107 . . . . 0.0 110.31 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 49.6 mtt-85 -72.8 -43.3 62.92 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.481 1.113 . . . . 0.0 110.296 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 350' ' ' GLY . 0.0 OUTLIER -71.46 -34.52 70.29 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 0.0 110.311 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 349' ' ' ARG . . . -36.08 -46.99 1.0 Allowed Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.547 1.155 . . . . 0.0 110.966 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -155.19 120.64 4.99 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.482 0.754 . . . . 0.0 109.325 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -60.46 170.05 1.51 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.469 1.105 . . . . 0.0 109.258 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -115.79 132.25 56.7 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.492 1.12 . . . . 0.0 109.33 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 48.3 m -77.95 125.93 30.09 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.545 1.153 . . . . 0.0 110.014 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.47 0 O-C-N 124.472 1.108 . . . . 0.0 109.303 -179.973 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.999 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 5.4 m -97.11 149.99 21.35 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.501 0.765 . . . . 0.0 110.012 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -154.94 146.56 23.23 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.51 1.131 . . . . 0.0 110.279 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.6 157.52 18.42 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.451 1.095 . . . . 0.0 110.299 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.1 m -107.24 166.38 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.488 1.118 . . . . 0.0 109.309 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 7.9 mtt85 -103.66 168.59 9.05 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.497 1.123 . . . . 0.0 110.329 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.55 154.36 39.33 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.504 1.127 . . . . 0.0 110.319 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -110.73 19.05 26.36 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.516 1.135 . . . . 0.0 111.002 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.2 19.64 6.76 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.496 0.762 . . . . 0.0 109.283 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -52.98 -36.61 60.45 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.48 1.113 . . . . 0.0 111.046 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.98 -33.29 58.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.471 1.107 . . . . 0.0 109.339 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.764 ' HD2' HG13 ' A' ' 276' ' ' VAL . 0.0 OUTLIER -67.91 -35.02 77.74 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.498 1.124 . . . . 0.0 110.308 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.681 ' OD1' HD13 ' A' ' 320' ' ' LEU . 3.7 m-20 -77.46 -30.44 53.23 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.487 1.117 . . . . 0.0 109.279 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' TRP . . . . . 0.79 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 1.9 t90 -67.58 -44.81 77.26 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.513 1.133 . . . . 0.0 108.04 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 5.7 pt20 -71.14 -35.75 71.81 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.493 1.12 . . . . 0.0 110.307 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.607 HD23 ' HD3' ' A' ' 225' ' ' ARG . 0.8 OUTLIER -61.45 -47.43 85.76 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.509 1.131 . . . . 0.0 109.323 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.621 HG12 HD13 ' A' ' 244' ' ' LEU . 99.7 t -71.76 -40.76 70.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.473 1.108 . . . . 0.0 109.274 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.58 -15.94 62.81 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.481 1.113 . . . . 0.0 109.251 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -81.34 -11.09 59.42 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.553 1.158 . . . . 0.0 109.31 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 229' ' ' LEU . 31.2 t -89.64 123.33 66.81 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.514 1.134 . . . . 0.0 109.308 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 -16.09 20.31 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.481 1.78 . . . . 0.0 110.997 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.759 HD12 ' CE2' ' A' ' 341' ' ' PHE . 0.0 OUTLIER -79.6 -24.66 41.85 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.498 1.124 . . . . 0.0 109.268 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.4 ' CB ' HD12 ' A' ' 239' ' ' LEU . 3.4 m-30 -108.51 -11.88 15.08 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.537 1.148 . . . . 0.0 111.022 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.66 -24.65 66.87 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.488 1.118 . . . . 0.0 110.338 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -74.62 -4.45 37.21 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.516 1.135 . . . . 0.0 109.333 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.557 HD22 HG11 ' A' ' 243' ' ' VAL . 12.5 mt -85.0 -179.65 7.1 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.45 1.094 . . . . 0.0 109.321 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . 0.633 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -103.24 -172.66 26.15 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.489 1.118 . . . . 0.0 111.012 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.906 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.2 Cg_endo -75.02 -36.14 2.71 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.464 1.77 . . . . 0.0 111.02 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.04 -35.31 78.04 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.533 1.146 . . . . 0.0 109.299 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.636 HG21 HD11 ' A' ' 337' ' ' ILE . 13.0 t -75.33 -36.58 36.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.451 1.095 . . . . 0.0 109.258 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.633 HD23 ' O ' ' A' ' 240' ' ' GLY . 1.6 mm? -70.54 -35.48 73.16 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.499 1.125 . . . . 0.0 109.304 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.906 HG23 ' O ' ' A' ' 241' ' ' PRO . 96.4 t -72.85 -38.28 56.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.473 1.108 . . . . 0.0 109.334 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -69.06 -49.7 55.1 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.514 1.134 . . . . 0.0 110.235 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.513 HD12 HG12 ' A' ' 243' ' ' VAL . 14.1 mt -63.13 -35.63 72.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.502 1.127 . . . . 0.0 109.319 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 244' ' ' LEU . 4.6 t -67.51 -41.13 85.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.526 1.141 . . . . 0.0 109.309 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -77.23 -13.03 60.01 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.489 1.118 . . . . 0.0 110.298 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -89.18 -17.46 29.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.461 1.101 . . . . 0.0 109.311 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.59 HD23 ' HB2' ' A' ' 322' ' ' LEU . 3.2 mt -65.89 144.53 56.75 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.456 1.097 . . . . 0.0 109.294 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 320' ' ' LEU . 0.0 OUTLIER -119.75 133.15 55.72 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.535 1.147 . . . . 0.0 110.284 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.657 ' HA ' HD23 ' A' ' 320' ' ' LEU . . . -80.63 130.91 35.38 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.462 1.101 . . . . 0.0 109.284 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.22 125.03 19.63 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.489 1.118 . . . . 0.0 110.295 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 13.4 m -91.07 116.53 28.88 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.49 1.119 . . . . 0.0 110.381 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.626 HG12 ' CB ' ' A' ' 313' ' ' ALA . 24.4 t -107.05 111.63 63.5 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 124.533 1.145 . . . . 0.0 109.315 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.96 176.38 9.98 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.482 1.78 . . . . 0.0 111.039 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.521 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -67.8 134.14 50.44 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.505 1.128 . . . . 0.0 109.304 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 89.15 -25.53 10.13 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.501 1.126 . . . . 0.0 110.981 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.547 ' HB3' HG13 ' A' ' 256' ' ' VAL . . . -55.43 148.49 15.15 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.489 0.758 . . . . 0.0 109.285 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 2.7 t -96.93 129.7 46.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.536 1.148 . . . . 0.0 109.309 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.793 HD12 HG12 ' A' ' 311' ' ' VAL . 65.7 mt -84.81 -45.77 17.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.533 1.145 . . . . 0.0 109.303 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 13.5 p -154.97 149.71 26.58 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.486 1.116 . . . . 0.0 108.333 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -89.53 175.9 7.1 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.128 . . . . 0.0 110.308 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.503 HD13 ' H ' ' A' ' 265' ' ' ILE . 0.2 OUTLIER -76.97 141.16 16.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.503 1.127 . . . . 0.0 109.321 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 45.67 49.46 12.11 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.524 1.14 . . . . 0.0 110.974 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.472 ' HG3' ' N ' ' A' ' 268' ' ' PRO . 2.9 pt-20 -73.1 173.75 5.58 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.48 0.753 . . . . 0.0 110.275 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.472 ' N ' ' HG3' ' A' ' 267' ' ' GLU . 18.2 Cg_endo -75.01 97.1 1.05 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.493 1.786 . . . . 0.0 110.967 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -50.88 89.46 0.01 OUTLIER Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.465 1.103 . . . . 0.0 110.964 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 268' ' ' PRO . 40.6 m-20 -170.39 38.36 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.48 0.753 . . . . 0.0 109.3 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -171.23 149.21 2.78 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.504 1.128 . . . . 0.0 110.353 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.489 ' SD ' ' CD1' ' A' ' 301' ' ' LEU . 8.3 ptm -138.74 146.97 42.1 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.5 1.125 . . . . 0.0 110.97 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.575 ' HB2' ' CE1' ' A' ' 296' ' ' PHE . 34.0 m-85 -124.98 151.48 45.46 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.528 1.143 . . . . 0.0 110.943 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . 0.502 ' CD1' ' HB3' ' A' ' 295' ' ' PHE . 23.6 m-85 -129.48 124.89 35.14 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.497 1.123 . . . . 0.0 110.99 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 1.074 HG22 HD23 ' A' ' 319' ' ' LEU . 76.2 t -79.7 138.19 20.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.477 1.11 . . . . 0.0 109.278 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.764 HG13 ' HD2' ' A' ' 225' ' ' ARG . 2.9 t -116.14 -47.54 4.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.443 1.089 . . . . 0.0 109.304 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.479 ' O ' HG23 ' A' ' 317' ' ' VAL . 5.9 mt-10 -145.62 135.9 23.94 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.533 1.146 . . . . 0.0 110.318 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.404 ' HA3' ' HB ' ' A' ' 317' ' ' VAL . . . 115.63 -155.11 16.5 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.535 1.147 . . . . 0.0 110.99 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 3.1 m -151.32 138.62 19.36 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.461 0.742 . . . . 0.0 109.982 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.474 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 17.6 m -117.59 166.77 11.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.496 1.122 . . . . 0.0 109.287 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 29.4 t -131.9 155.47 47.83 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.475 1.109 . . . . 0.0 109.983 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.508 HG13 HG22 ' A' ' 311' ' ' VAL . 0.3 OUTLIER -119.12 129.37 75.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.474 1.109 . . . . 0.0 109.308 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.4 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -77.77 101.85 6.9 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.512 1.133 . . . . 0.0 109.271 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . 0.649 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.39 -168.62 0.19 Allowed Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.509 1.13 . . . . 0.0 110.392 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.649 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -74.98 4.88 4.33 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.469 1.773 . . . . 0.0 110.965 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -151.83 157.12 34.53 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.455 1.097 . . . . 0.0 109.31 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.98 94.89 0.96 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.488 1.783 . . . . 0.0 110.981 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 281' ' ' SER . 31.2 t -99.04 119.45 47.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.498 1.123 . . . . 0.0 109.323 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 14.4 mt-10 -124.33 136.89 54.44 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.491 1.119 . . . . 0.0 110.296 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.474 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 3.9 mm? -114.76 142.83 45.99 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.533 1.145 . . . . 0.0 109.288 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -98.44 -164.97 30.78 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.497 1.123 . . . . 0.0 110.981 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' PRO . . . . . 0.642 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.3 Cg_endo -74.98 156.23 43.07 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.454 1.765 . . . . 0.0 110.974 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.433 ' HA2' HD21 ' A' ' 229' ' ' LEU . . . 77.37 2.17 78.44 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.508 1.13 . . . . 0.0 110.973 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . 0.406 ' HB1' HD12 ' A' ' 290' ' ' LEU . . . -87.79 136.05 33.12 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.518 0.775 . . . . 0.0 109.325 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.502 ' HB3' ' CD1' ' A' ' 274' ' ' PHE . 0.7 OUTLIER -123.76 153.05 41.47 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.508 1.13 . . . . 0.0 110.983 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.575 ' CE1' ' HB2' ' A' ' 273' ' ' PHE . 51.7 p90 -163.52 143.35 8.54 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.515 1.134 . . . . 0.0 110.962 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . 0.469 ' HA3' ' CB ' ' A' ' 272' ' ' MET . . . 137.57 -14.31 3.67 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.499 1.125 . . . . 0.0 110.943 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -52.84 -44.41 66.72 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.514 0.773 . . . . 0.0 110.311 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . 0.487 ' CE ' HD12 ' A' ' 302' ' ' ILE . 0.1 OUTLIER -47.37 -39.11 14.41 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.487 1.117 . . . . 0.0 111.003 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -72.64 -37.16 68.08 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.489 1.118 . . . . 0.0 109.31 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.489 ' CD1' ' SD ' ' A' ' 272' ' ' MET . 4.5 mt -76.67 -5.47 48.06 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.485 1.116 . . . . 0.0 109.34 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . 0.674 HG23 ' HB1' ' A' ' 345' ' ' ALA . 22.0 mt -91.81 -51.43 11.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.475 1.109 . . . . 0.0 109.261 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.442 ' O ' ' C ' ' A' ' 304' ' ' GLY . 1.2 m -151.94 41.01 0.65 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.506 1.129 . . . . 0.0 109.954 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 34.7 39.97 0.18 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.498 1.123 . . . . 0.0 110.99 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . 0.425 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 0.5 OUTLIER -68.17 151.05 97.48 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.505 0.768 . . . . 0.0 110.292 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 132.36 15.37 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.532 1.806 . . . . 0.0 111.03 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . 0.425 ' NH2' ' HA2' ' A' ' 297' ' ' GLY . 10.5 mmp_? -44.39 -44.92 8.65 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.436 1.085 . . . . 0.0 110.309 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.57 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 0.3 OUTLIER 66.31 38.18 4.58 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.483 1.114 . . . . 0.0 109.991 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' ALA . . . . . 0.57 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 171.73 160.88 0.1 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.532 1.145 . . . . 0.0 109.308 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.89 125.48 52.85 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.529 1.143 . . . . 0.0 110.409 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.793 HG12 HD12 ' A' ' 262' ' ' ILE . 77.7 t -103.3 127.7 56.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 0.0 109.318 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 87.5 p -127.86 157.45 40.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.516 1.135 . . . . 0.0 109.994 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . 0.821 ' HB1' ' CG1' ' A' ' 317' ' ' VAL . . . -89.19 112.99 24.14 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.502 1.126 . . . . 0.0 109.319 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -54.3 -32.71 57.12 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.55 1.156 . . . . 0.0 109.35 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' THR . . . . . 0.68 ' O ' HG12 ' A' ' 317' ' ' VAL . 9.8 t -158.63 -159.05 0.75 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.462 1.101 . . . . 0.0 110.44 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . 0.443 ' N ' ' OG1' ' A' ' 315' ' ' THR . 86.6 m -66.03 81.26 0.08 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.525 1.141 . . . . 0.0 110.38 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.821 ' CG1' ' HB1' ' A' ' 313' ' ' ALA . 1.3 p -108.26 140.98 24.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.491 1.12 . . . . 0.0 109.265 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 49.2 m -112.3 127.73 56.07 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.511 1.132 . . . . 0.0 110.003 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . 1.074 HD23 HG22 ' A' ' 275' ' ' VAL . 0.0 OUTLIER -134.81 174.71 10.28 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.555 1.159 . . . . 0.0 109.295 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.681 HD13 ' OD1' ' A' ' 226' ' ' ASN . 1.0 OUTLIER -124.18 135.27 53.35 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.499 1.124 . . . . 0.0 109.312 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 53.9 p -96.86 150.66 20.49 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.531 1.144 . . . . 0.0 109.994 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.59 ' HB2' HD23 ' A' ' 251' ' ' LEU . 2.6 tm? -146.17 104.02 3.77 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.529 1.143 . . . . 0.0 109.304 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -65.15 138.53 58.34 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.448 1.092 . . . . 0.0 109.578 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . 0.426 ' HA ' HD21 ' A' ' 301' ' ' LEU . 89.2 p -59.81 -19.65 52.03 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.48 1.113 . . . . 0.0 109.985 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -51.22 -35.36 36.3 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.514 1.134 . . . . 0.0 109.261 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . 0.585 ' OD1' HD11 ' A' ' 322' ' ' LEU . 3.2 p-10 -65.84 -38.38 88.72 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.508 1.13 . . . . 0.0 109.295 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -67.85 -37.79 82.33 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.5 1.125 . . . . 0.0 110.981 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -68.81 -32.49 72.23 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.515 1.134 . . . . 0.0 110.31 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 15.6 tmm? -70.58 -43.2 69.9 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.519 1.137 . . . . 0.0 111.022 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.82 -31.2 61.63 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.124 . . . . 0.0 109.278 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' CYS . . . . . 0.422 ' CB ' ' HB2' ' A' ' 338' ' ' ALA . 1.8 m -75.0 -39.74 61.03 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.457 1.098 . . . . 0.0 108.297 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 26.3 t -70.8 -32.55 69.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.53 1.144 . . . . 0.0 110.013 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 31.9 t -79.16 -35.68 41.59 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.511 1.132 . . . . 0.0 109.988 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 1.5 m -128.96 109.16 18.3 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.522 1.139 . . . . 0.0 109.972 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 -20.26 17.04 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.504 1.792 . . . . 0.0 111.052 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.453 ' O ' ' CG1' ' A' ' 340' ' ' ILE . 1.2 tt0 -66.1 -37.26 85.31 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 0.0 110.347 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.636 HD11 HG21 ' A' ' 243' ' ' VAL . 88.1 mt -75.97 -42.8 39.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.44 1.088 . . . . 0.0 109.285 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . 0.422 ' HB2' ' CB ' ' A' ' 331' ' ' CYS . . . -64.83 -45.23 87.02 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.484 1.115 . . . . 0.0 109.315 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.52 -33.37 74.0 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.49 1.119 . . . . 0.0 110.314 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.453 ' CG1' ' O ' ' A' ' 336' ' ' GLU . 21.1 mt -70.17 -40.66 78.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.519 1.137 . . . . 0.0 109.341 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.759 ' CE2' HD12 ' A' ' 235' ' ' LEU . 2.7 t80 -69.08 -35.13 76.15 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.499 1.125 . . . . 0.0 111.036 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 27.7 ttt-85 -70.37 -38.94 74.85 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.494 1.121 . . . . 0.0 110.318 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -51.07 63.16 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.535 1.147 . . . . 0.0 109.328 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.46 HG22 ' HA ' ' A' ' 341' ' ' PHE . 13.1 t -68.64 -33.32 73.82 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.497 1.123 . . . . 0.0 110.43 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . 0.674 ' HB1' HG23 ' A' ' 302' ' ' ILE . . . -70.18 -36.44 74.66 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.445 1.091 . . . . 0.0 109.301 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 346' ' ' LEU . 11.7 mt -69.28 -40.94 77.47 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.471 1.107 . . . . 0.0 109.318 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -68.42 -34.05 75.31 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.486 1.116 . . . . 0.0 110.323 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 34.3 mtt-85 -73.05 -42.83 62.67 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.474 1.109 . . . . 0.0 110.285 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 4.9 tpt85 -68.54 -39.13 81.23 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.513 1.133 . . . . 0.0 110.266 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -39.84 -46.65 3.1 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.509 1.131 . . . . 0.0 110.979 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -155.0 120.67 5.08 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.477 0.751 . . . . 0.0 109.264 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -60.04 166.74 2.63 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.475 1.109 . . . . 0.0 109.303 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -102.8 135.45 44.44 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.509 1.131 . . . . 0.0 109.268 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 58.1 m -135.08 168.21 19.54 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.535 1.147 . . . . 0.0 109.984 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.463 0 O-C-N 124.469 1.106 . . . . 0.0 109.297 -179.992 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.993 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.91 159.29 37.87 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.51 0.771 . . . . 0.0 110.019 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -135.63 170.09 16.5 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.549 1.156 . . . . 0.0 110.275 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -124.09 134.43 53.38 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.473 1.108 . . . . 0.0 110.307 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 1.4 p -137.87 157.59 32.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.511 1.132 . . . . 0.0 109.309 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 37.2 mtp180 -81.65 144.67 31.04 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.444 1.09 . . . . 0.0 110.28 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.83 172.67 6.76 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 0.0 110.302 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -75.78 -11.89 84.26 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.48 1.112 . . . . 0.0 110.984 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -109.47 13.15 24.19 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.499 0.764 . . . . 0.0 109.306 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -52.76 -34.5 53.35 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.483 1.114 . . . . 0.0 110.954 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.55 -39.64 40.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.124 . . . . 0.0 109.252 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.401 ' HG3' HD12 ' A' ' 229' ' ' LEU . 13.6 tpp85 -68.37 -30.64 69.63 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.115 . . . . 0.0 110.275 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.705 HD21 HD22 ' A' ' 320' ' ' LEU . 2.2 m-20 -79.3 -41.4 28.12 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.408 1.068 . . . . 0.0 109.302 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' TRP . . . . . 0.485 ' O ' HG22 ' A' ' 230' ' ' VAL . 4.5 t90 -66.68 -44.52 81.54 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.527 1.142 . . . . 0.0 107.977 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.611 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 2.6 pt20 -67.71 -31.63 71.71 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.478 1.111 . . . . 0.0 110.31 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.401 HD12 ' HG3' ' A' ' 225' ' ' ARG . 1.6 mt -63.54 -45.08 92.2 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.514 1.133 . . . . 0.0 109.316 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.87 HG23 HD12 ' A' ' 244' ' ' LEU . 35.2 m -74.55 -38.78 46.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.528 1.143 . . . . 0.0 109.33 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -75.42 -11.78 60.11 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.47 1.106 . . . . 0.0 109.336 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -81.32 -23.99 37.44 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.525 1.14 . . . . 0.0 109.247 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . 0.583 HG12 ' O ' ' A' ' 230' ' ' VAL . 0.4 OUTLIER -81.35 130.93 60.23 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.475 1.109 . . . . 0.0 109.263 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.42 ' HA ' ' HB2' ' A' ' 237' ' ' GLN . 18.2 Cg_endo -75.02 -16.75 19.98 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.513 1.796 . . . . 0.0 110.982 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.455 HD21 HD11 ' A' ' 302' ' ' ILE . 0.1 OUTLIER -63.34 -30.04 71.24 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.456 1.098 . . . . 0.0 109.33 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.539 ' HB3' HD12 ' A' ' 239' ' ' LEU . 16.1 m-30 -112.95 17.08 19.18 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.538 1.149 . . . . 0.0 111.003 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' GLN . . . . . 0.42 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 2.1 mt-30 -70.01 -20.02 63.29 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.549 1.155 . . . . 0.0 110.282 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -92.58 -12.37 31.94 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.508 1.13 . . . . 0.0 109.302 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.744 HD22 HG11 ' A' ' 243' ' ' VAL . 46.0 mt -70.11 179.26 2.41 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.46 1.1 . . . . 0.0 109.276 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . 0.691 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -109.79 -174.89 20.94 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.509 1.131 . . . . 0.0 111.006 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 -32.84 5.13 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.485 1.782 . . . . 0.0 111.065 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.507 ' HA ' HG12 ' A' ' 245' ' ' VAL . . . -73.09 -33.2 65.47 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.457 1.098 . . . . 0.0 109.284 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.744 HG11 HD22 ' A' ' 239' ' ' LEU . 63.5 t -77.09 -36.59 24.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.474 1.109 . . . . 0.0 109.334 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.87 HD12 HG23 ' A' ' 230' ' ' VAL . 3.8 mm? -72.57 -42.65 64.4 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.497 1.123 . . . . 0.0 109.289 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.507 HG12 ' HA ' ' A' ' 242' ' ' ALA . 2.8 p -68.21 -39.51 81.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.465 1.103 . . . . 0.0 109.261 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -70.88 -40.99 71.91 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.52 1.138 . . . . 0.0 110.284 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.649 ' CG1' HD13 ' A' ' 330' ' ' LEU . 25.6 mt -66.56 -51.97 51.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.503 1.127 . . . . 0.0 109.278 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.706 ' HA ' HD12 ' A' ' 251' ' ' LEU . 10.0 p -62.87 -30.74 50.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.48 1.113 . . . . 0.0 109.315 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.454 ' CG ' ' O ' ' A' ' 245' ' ' VAL . 16.6 mmm-85 -73.55 -25.77 60.54 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.542 1.151 . . . . 0.0 110.283 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -85.2 -17.98 35.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 0.0 109.297 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.706 HD12 ' HA ' ' A' ' 248' ' ' VAL . 0.3 OUTLIER -59.41 144.24 47.43 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 0.0 109.339 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 320' ' ' LEU . 3.2 mmm180 -118.18 135.09 54.45 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.558 1.161 . . . . 0.0 110.331 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -80.68 123.18 27.96 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.532 1.145 . . . . 0.0 109.303 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.6 ttm-85 -125.05 123.49 39.9 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.462 1.101 . . . . 0.0 110.34 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 50.2 m -91.51 117.65 29.89 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.484 1.115 . . . . 0.0 110.428 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.506 ' CG2' HD21 ' A' ' 319' ' ' LEU . 2.6 t -109.41 113.46 58.36 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.524 1.14 . . . . 0.0 109.285 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -75.0 168.71 24.24 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.543 1.812 . . . . 0.0 111.011 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.555 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -65.93 126.34 28.24 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.524 1.14 . . . . 0.0 109.286 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 100.59 -25.32 28.75 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.489 1.118 . . . . 0.0 111.003 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.49 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -67.27 145.08 55.52 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.497 0.763 . . . . 0.0 109.301 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 5.8 t -94.82 135.02 30.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.504 1.128 . . . . 0.0 109.299 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.806 HD12 HG12 ' A' ' 311' ' ' VAL . 17.8 mt -82.95 -42.74 18.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.541 1.151 . . . . 0.0 109.29 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' CYS . . . . . 0.604 ' SG ' HG23 ' A' ' 311' ' ' VAL . 11.3 p -152.4 142.61 22.4 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.49 1.119 . . . . 0.0 108.289 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 3.4 mmt85 -84.87 178.58 7.56 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.5 1.125 . . . . 0.0 110.277 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.425 ' CG2' ' HB ' ' A' ' 310' ' ' THR . 0.1 OUTLIER -76.57 137.44 22.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.513 1.133 . . . . 0.0 109.327 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 52.95 50.81 49.34 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.46 1.1 . . . . 0.0 111.026 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -70.37 163.89 58.6 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.486 0.756 . . . . 0.0 110.302 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.507 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.3 Cg_endo -74.98 82.77 1.93 Allowed 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.532 1.806 . . . . 0.0 111.051 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . 0.44 ' CA ' ' HB1' ' A' ' 300' ' ' ALA . . . -36.07 93.16 0.01 OUTLIER Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.477 1.111 . . . . 0.0 110.994 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 268' ' ' PRO . 12.3 m-20 -171.63 37.93 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.528 0.781 . . . . 0.0 109.335 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.426 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 3.3 mtp180 -169.89 144.54 2.79 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.537 1.148 . . . . 0.0 110.359 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.857 ' HB2' HD11 ' A' ' 301' ' ' LEU . 2.2 ttt -118.34 147.63 43.3 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.505 1.128 . . . . 0.0 110.99 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.571 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 28.4 m-85 -135.8 136.65 40.86 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.506 1.128 . . . . 0.0 111.006 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 319' ' ' LEU . 22.1 m-85 -125.98 127.49 46.0 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.117 . . . . 0.0 110.998 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.611 HG22 HD12 ' A' ' 319' ' ' LEU . 13.7 t -83.96 135.03 25.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.481 1.113 . . . . 0.0 109.319 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.441 HG12 ' HG2' ' A' ' 277' ' ' GLU . 40.3 t -111.75 -49.42 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.492 1.12 . . . . 0.0 109.355 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.581 ' O ' HG13 ' A' ' 317' ' ' VAL . 7.8 mm-40 -139.67 137.96 35.65 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.52 1.137 . . . . 0.0 110.337 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.822 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 112.75 -175.47 16.82 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.491 1.12 . . . . 0.0 111.003 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 290' ' ' LEU . 3.6 m -131.17 120.26 23.05 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.497 0.763 . . . . 0.0 109.964 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.452 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 28.9 m -99.03 164.67 2.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.505 1.128 . . . . 0.0 109.293 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 31.6 t -131.97 148.13 52.5 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.476 1.11 . . . . 0.0 110.017 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -111.26 129.93 65.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.44 1.087 . . . . 0.0 109.295 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.502 ' HB2' HG22 ' A' ' 310' ' ' THR . . . -77.96 101.87 7.08 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.505 1.128 . . . . 0.0 109.306 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . 0.647 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -147.76 -168.55 0.19 Allowed Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.466 1.104 . . . . 0.0 110.427 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.647 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.4 Cg_endo -74.99 4.89 4.33 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.57 1.826 . . . . 0.0 111.025 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.419 ' O ' HG23 ' A' ' 288' ' ' VAL . 10.9 m120 -151.37 157.29 35.01 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.496 1.123 . . . . 0.0 109.271 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.1 93.85 0.97 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.51 1.795 . . . . 0.0 110.98 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 281' ' ' SER . 4.1 t -97.94 119.37 45.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.115 . . . . 0.0 109.293 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.565 ' C ' HD22 ' A' ' 290' ' ' LEU . 15.4 mt-10 -124.7 140.25 53.11 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.557 1.161 . . . . 0.0 110.315 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.565 HD22 ' C ' ' A' ' 289' ' ' GLU . 4.5 mm? -121.81 141.71 50.95 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.505 1.128 . . . . 0.0 109.304 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -96.9 -160.06 31.69 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.498 1.124 . . . . 0.0 111.038 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' PRO . . . . . 0.481 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.2 Cg_endo -75.03 142.02 27.24 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.478 1.778 . . . . 0.0 110.982 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 91.46 4.39 68.19 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.508 1.13 . . . . 0.0 111.002 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -92.04 127.76 37.63 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.436 0.727 . . . . 0.0 109.293 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.454 ' CB ' ' CD1' ' A' ' 274' ' ' PHE . 2.4 p90 -114.36 152.8 30.9 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.468 1.105 . . . . 0.0 110.979 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.681 ' HZ ' HG21 ' A' ' 262' ' ' ILE . 33.7 p90 -158.07 148.75 20.67 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.534 1.146 . . . . 0.0 111.018 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 123.54 -5.64 9.25 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.474 1.109 . . . . 0.0 110.955 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -55.83 -46.31 78.14 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.504 0.767 . . . . 0.0 110.305 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 36.9 mmt -51.89 -37.14 51.21 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 0.0 110.984 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . 0.44 ' HB1' ' CA ' ' A' ' 269' ' ' GLY . . . -67.42 -41.27 85.11 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.489 1.118 . . . . 0.0 109.278 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.857 HD11 ' HB2' ' A' ' 272' ' ' MET . 1.5 mt -77.32 -11.32 59.82 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.563 1.164 . . . . 0.0 109.331 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . 0.5 HD13 ' HA ' ' A' ' 302' ' ' ILE . 7.0 mm -77.17 -56.09 8.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.483 1.114 . . . . 0.0 109.272 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.46 ' O ' ' N ' ' A' ' 305' ' ' GLU . 53.2 p -151.32 48.37 0.83 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.458 1.099 . . . . 0.0 110.026 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 303' ' ' SER . . . 35.08 34.22 0.05 OUTLIER Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.574 1.172 . . . . 0.0 110.991 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . 0.46 ' N ' ' O ' ' A' ' 303' ' ' SER . 0.0 OUTLIER -70.24 151.52 95.84 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.522 0.778 . . . . 0.0 110.297 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 134.15 17.46 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.477 1.777 . . . . 0.0 110.991 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -44.39 -42.47 6.94 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.468 1.105 . . . . 0.0 110.322 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 2.2 t 67.35 28.56 7.84 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 0.0 110.009 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . -176.61 160.55 2.01 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.447 1.092 . . . . 0.0 109.282 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.502 HG22 ' HB2' ' A' ' 283' ' ' ALA . 0.3 OUTLIER -108.59 123.64 49.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.512 1.132 . . . . 0.0 110.392 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.806 HG12 HD12 ' A' ' 262' ' ' ILE . 43.5 t -103.17 130.31 53.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.52 1.138 . . . . 0.0 109.298 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 56.9 p -134.94 157.42 46.94 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.463 1.102 . . . . 0.0 109.993 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . 0.505 ' CB ' HG12 ' A' ' 256' ' ' VAL . . . -95.52 116.13 28.39 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.457 1.098 . . . . 0.0 109.299 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -60.22 -33.42 72.23 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.496 1.123 . . . . 0.0 109.276 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' THR . . . . . 0.831 ' O ' HG23 ' A' ' 317' ' ' VAL . 10.2 t -149.77 -173.49 4.43 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.436 1.085 . . . . 0.0 110.403 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 316' ' ' THR . 43.8 p -53.76 88.18 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.513 1.133 . . . . 0.0 110.417 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.834 HG12 ' CD1' ' A' ' 319' ' ' LEU . 57.8 t -107.56 145.82 14.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.533 1.145 . . . . 0.0 109.257 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . 0.741 ' C ' HD13 ' A' ' 319' ' ' LEU . 50.3 m -122.95 118.31 27.53 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.492 1.12 . . . . 0.0 109.982 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . 0.834 ' CD1' HG12 ' A' ' 317' ' ' VAL . 0.0 OUTLIER -126.22 175.09 8.04 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.125 . . . . 0.0 109.309 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.705 HD22 HD21 ' A' ' 226' ' ' ASN . 0.5 OUTLIER -124.55 130.95 53.4 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.441 1.088 . . . . 0.0 109.314 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 73.6 p -92.23 157.06 16.89 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 0.0 109.997 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -148.55 92.03 1.96 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.458 1.099 . . . . 0.0 109.293 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . 0.461 ' ND1' ' HB3' ' A' ' 325' ' ' ALA . 5.8 p80 -54.61 135.18 46.77 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.534 1.146 . . . . 0.0 109.615 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 3.4 t -53.66 -26.45 22.52 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.505 1.128 . . . . 0.0 109.984 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 0.461 ' HB3' ' ND1' ' A' ' 323' ' ' HIS . . . -50.66 -35.48 30.99 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.546 1.154 . . . . 0.0 109.285 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -64.73 -41.5 95.9 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.517 1.136 . . . . 0.0 109.318 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' PHE . . . . . 0.465 ' CE1' ' CE2' ' A' ' 341' ' ' PHE . 80.3 t80 -67.38 -32.77 73.91 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.467 1.105 . . . . 0.0 111.046 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -70.49 -37.71 74.24 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.469 1.106 . . . . 0.0 110.343 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 16.5 tmm? -67.98 -41.34 82.48 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.467 1.104 . . . . 0.0 111.032 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.649 HD13 ' CG1' ' A' ' 247' ' ' ILE . 6.4 mt -73.23 -35.03 66.22 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.492 1.12 . . . . 0.0 109.284 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' CYS . . . . . 0.812 ' SG ' ' HB2' ' A' ' 338' ' ' ALA . 41.4 t -68.84 -35.19 76.64 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.499 1.125 . . . . 0.0 108.296 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.8 t -72.97 -39.2 66.33 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.127 . . . . 0.0 109.979 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.2 t -73.49 -28.43 61.91 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.503 1.127 . . . . 0.0 109.979 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . 0.466 ' CB ' HD12 ' A' ' 337' ' ' ILE . 0.5 OUTLIER -128.92 103.78 18.71 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 124.51 1.131 . . . . 0.0 110.016 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -21.64 15.61 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.469 1.773 . . . . 0.0 111.01 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.87 -28.78 60.79 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.539 1.149 . . . . 0.0 110.312 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.638 HD11 HG21 ' A' ' 243' ' ' VAL . 34.4 mt -68.69 -30.84 48.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.126 . . . . 0.0 109.302 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . 0.812 ' HB2' ' SG ' ' A' ' 331' ' ' CYS . . . -69.81 -37.54 76.29 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.476 1.11 . . . . 0.0 109.34 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -72.87 -36.73 67.45 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.458 1.099 . . . . 0.0 110.326 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 31.1 mt -71.68 -42.71 71.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.445 1.091 . . . . 0.0 109.305 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.465 ' CE2' ' CE1' ' A' ' 327' ' ' PHE . 40.2 t80 -66.95 -36.88 83.22 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.45 1.094 . . . . 0.0 111.04 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -72.94 -34.79 66.77 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.489 1.118 . . . . 0.0 110.269 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -50.75 65.3 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.511 1.132 . . . . 0.0 109.344 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 341' ' ' PHE . 8.8 t -65.13 -38.0 89.22 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.498 1.124 . . . . 0.0 110.372 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -67.17 -35.74 80.31 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.536 1.147 . . . . 0.0 109.301 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.508 ' HA ' HD23 ' A' ' 346' ' ' LEU . 9.3 mt -71.48 -33.87 69.66 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.492 1.12 . . . . 0.0 109.317 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.6 -34.73 70.13 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.531 1.145 . . . . 0.0 110.285 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 39.0 mtt-85 -71.8 -44.04 64.63 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.48 1.112 . . . . 0.0 110.328 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.01 -34.67 76.95 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.453 1.096 . . . . 0.0 110.288 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -37.31 -44.01 1.09 Allowed Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.556 1.16 . . . . 0.0 111.003 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -154.59 123.16 6.12 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.452 0.736 . . . . 0.0 109.329 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -61.01 164.3 5.11 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.51 1.132 . . . . 0.0 109.281 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -111.17 122.98 49.27 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.516 1.135 . . . . 0.0 109.302 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 15.7 m -151.41 167.77 26.93 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.532 1.145 . . . . 0.0 109.994 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.457 0 O-C-N 124.539 1.149 . . . . 0.0 109.292 179.988 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.988 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 1.4 t -142.35 157.75 44.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.509 0.77 . . . . 0.0 110.004 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -117.11 174.04 6.33 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.494 1.121 . . . . 0.0 110.309 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -150.86 154.55 37.43 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.511 1.132 . . . . 0.0 110.291 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 9.7 p -146.62 166.2 7.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.452 1.095 . . . . 0.0 109.308 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.96 173.41 11.82 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.521 1.138 . . . . 0.0 110.331 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 61.3 mtt-85 -140.54 179.42 6.68 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.545 1.153 . . . . 0.0 110.313 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -110.32 -42.37 1.17 Allowed Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.51 1.131 . . . . 0.0 111.012 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -93.11 19.91 7.43 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.45 0.735 . . . . 0.0 109.322 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -58.17 -34.35 70.23 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.499 1.125 . . . . 0.0 110.989 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.86 -36.56 52.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.532 1.145 . . . . 0.0 109.309 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.659 ' HD2' HG13 ' A' ' 276' ' ' VAL . 0.0 OUTLIER -67.48 -37.05 82.3 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.511 1.132 . . . . 0.0 110.296 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.823 ' O ' HG23 ' A' ' 230' ' ' VAL . 4.0 t30 -76.37 -30.64 57.63 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.551 1.157 . . . . 0.0 109.29 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' TRP . . . . . 0.866 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 3.0 t90 -66.31 -45.59 79.84 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.485 1.116 . . . . 0.0 108.019 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.628 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 6.4 pt20 -71.27 -34.82 71.06 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.517 1.135 . . . . 0.0 110.35 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.547 HD21 ' HA2' ' A' ' 293' ' ' GLY . 0.3 OUTLIER -63.56 -48.49 77.24 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.482 1.114 . . . . 0.0 109.267 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 226' ' ' ASN . 38.3 t -69.89 -43.08 79.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.432 1.082 . . . . 0.0 109.271 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.34 -16.63 63.01 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.476 1.11 . . . . 0.0 109.309 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.628 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -80.67 -19.32 45.5 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.448 1.092 . . . . 0.0 109.332 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 229' ' ' LEU . 84.4 t -81.25 137.02 49.17 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.485 1.116 . . . . 0.0 109.276 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.468 ' HD2' HG13 ' A' ' 233' ' ' VAL . 18.3 Cg_endo -75.01 -40.32 0.93 Allowed 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.59 1.837 . . . . 0.0 111.001 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.659 HD12 ' HB2' ' A' ' 298' ' ' GLU . 11.0 mt -60.81 -15.48 30.42 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.444 1.09 . . . . 0.0 109.333 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.649 ' CE1' HD13 ' A' ' 247' ' ' ILE . 1.4 m-85 -106.56 -22.94 12.61 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.51 1.131 . . . . 0.0 110.959 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' GLN . . . . . 0.404 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 0.4 OUTLIER -64.1 -18.73 64.69 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.483 1.115 . . . . 0.0 110.362 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -75.15 -9.67 58.76 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.498 1.124 . . . . 0.0 109.252 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.71 HD13 HG11 ' A' ' 243' ' ' VAL . 12.0 mt -96.66 -179.19 4.51 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.493 1.12 . . . . 0.0 109.325 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . 0.419 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -100.99 -173.56 29.0 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.487 1.117 . . . . 0.0 110.976 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.849 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.3 Cg_endo -74.97 -34.47 3.83 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.474 1.776 . . . . 0.0 110.98 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.96 -36.41 80.03 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.502 1.126 . . . . 0.0 109.311 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.71 HG11 HD13 ' A' ' 239' ' ' LEU . 3.0 t -72.64 -42.83 62.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.53 1.144 . . . . 0.0 109.296 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.76 ' CD1' HG12 ' A' ' 230' ' ' VAL . 0.9 OUTLIER -66.37 -37.68 85.83 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.502 1.126 . . . . 0.0 109.287 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.866 HG22 ' CZ2' ' A' ' 227' ' ' TRP . 53.6 t -66.11 -42.94 92.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.497 1.123 . . . . 0.0 109.287 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.59 -45.24 87.81 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.507 1.129 . . . . 0.0 110.302 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.649 HD13 ' CE1' ' A' ' 236' ' ' PHE . 38.3 mt -62.93 -45.41 98.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.439 1.087 . . . . 0.0 109.259 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 244' ' ' LEU . 45.6 t -62.8 -33.39 59.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 0.0 109.297 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -77.34 -19.48 56.26 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.514 1.134 . . . . 0.0 110.277 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -95.91 2.86 53.86 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.469 1.106 . . . . 0.0 109.308 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.612 HD22 HD21 ' A' ' 226' ' ' ASN . 0.2 OUTLIER -87.17 148.31 25.23 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.524 1.14 . . . . 0.0 109.328 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.34 126.82 50.39 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.512 1.132 . . . . 0.0 110.265 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.481 ' HB2' HD23 ' A' ' 320' ' ' LEU . . . -83.26 122.75 28.83 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.509 1.131 . . . . 0.0 109.318 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.57 134.79 47.93 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.49 1.119 . . . . 0.0 110.289 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 52.3 m -93.46 121.05 34.46 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.505 1.128 . . . . 0.0 110.414 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.871 HG21 HD11 ' A' ' 319' ' ' LEU . 92.2 t -106.79 113.72 62.49 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.513 1.133 . . . . 0.0 109.329 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.497 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.98 173.48 14.43 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.44 1.758 . . . . 0.0 110.976 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.584 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -66.06 131.04 45.27 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.506 1.128 . . . . 0.0 109.322 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 94.24 -25.52 21.93 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.537 1.148 . . . . 0.0 110.969 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.497 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -57.92 146.28 32.75 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.518 0.775 . . . . 0.0 109.302 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.433 HG21 HH21 ' A' ' 264' ' ' ARG . 3.7 t -97.33 131.58 43.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.486 1.116 . . . . 0.0 109.301 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.775 HD12 HG12 ' A' ' 311' ' ' VAL . 67.9 mt -84.44 -42.27 16.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.5 1.125 . . . . 0.0 109.281 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' CYS . . . . . 0.491 ' SG ' HG23 ' A' ' 311' ' ' VAL . 14.0 p -157.5 148.91 21.82 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.492 1.12 . . . . 0.0 108.311 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ARG . . . . . 0.433 HH21 HG21 ' A' ' 261' ' ' VAL . 3.3 mmt85 -88.16 179.85 6.3 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.484 1.115 . . . . 0.0 110.315 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.507 HG23 ' CB ' ' A' ' 310' ' ' THR . 0.0 OUTLIER -77.96 140.07 17.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.447 1.092 . . . . 0.0 109.301 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 47.78 50.1 20.89 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.498 1.123 . . . . 0.0 111.012 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.448 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.0 OUTLIER -70.75 164.06 58.8 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.451 0.736 . . . . 0.0 110.301 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.448 ' HD2' ' HB2' ' A' ' 267' ' ' GLU . 18.1 Cg_endo -75.01 91.78 1.01 Allowed 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.474 1.776 . . . . 0.0 110.942 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -43.93 94.4 0.01 OUTLIER Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.489 1.118 . . . . 0.0 110.945 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 268' ' ' PRO . 0.5 OUTLIER -170.2 38.28 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.471 0.748 . . . . 0.0 109.286 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.402 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 6.0 mtt180 -170.34 145.17 2.64 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.483 1.115 . . . . 0.0 110.313 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.739 ' HB2' HD11 ' A' ' 301' ' ' LEU . 12.1 ttt -117.96 147.28 43.31 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.527 1.142 . . . . 0.0 110.964 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.569 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 56.9 m-85 -136.28 136.52 39.87 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.531 1.145 . . . . 0.0 110.998 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . 0.472 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 20.5 m-85 -125.71 134.3 51.84 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.495 1.122 . . . . 0.0 111.009 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.586 HG22 HD23 ' A' ' 319' ' ' LEU . 4.5 t -91.94 129.76 42.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.517 1.135 . . . . 0.0 109.323 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.659 HG13 ' HD2' ' A' ' 225' ' ' ARG . 13.9 t -105.63 -44.02 7.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.515 1.134 . . . . 0.0 109.307 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.64 ' O ' HG13 ' A' ' 317' ' ' VAL . 0.0 OUTLIER -148.84 134.33 18.6 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.139 . . . . 0.0 110.308 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.849 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 121.06 178.65 15.95 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.44 1.087 . . . . 0.0 111.042 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 314' ' ' ALA . 3.3 m -124.15 114.96 20.35 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.532 0.783 . . . . 0.0 109.974 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.472 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 25.5 m -96.73 163.33 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.492 1.12 . . . . 0.0 109.35 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 30.5 t -129.25 154.64 46.62 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.453 1.096 . . . . 0.0 110.032 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.24 130.04 73.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.519 1.137 . . . . 0.0 109.271 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.61 ' HB3' ' H ' ' A' ' 310' ' ' THR . . . -77.46 102.15 6.75 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.475 1.11 . . . . 0.0 109.269 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . 0.644 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.51 -168.67 0.19 Allowed Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.492 1.12 . . . . 0.0 110.413 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.644 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.3 Cg_endo -74.96 4.33 4.82 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.527 1.804 . . . . 0.0 110.993 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -151.84 157.75 34.27 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.526 1.141 . . . . 0.0 109.282 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 94.26 0.96 Allowed 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.464 1.771 . . . . 0.0 110.995 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 281' ' ' SER . 21.2 t -98.34 119.42 46.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.517 1.136 . . . . 0.0 109.334 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.562 ' C ' HD22 ' A' ' 290' ' ' LEU . 14.7 mt-10 -124.1 140.83 52.59 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 0.0 110.306 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.562 HD22 ' C ' ' A' ' 289' ' ' GLU . 4.5 mm? -121.38 141.02 51.37 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.498 1.124 . . . . 0.0 109.3 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -93.97 -157.25 32.94 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.521 1.138 . . . . 0.0 110.95 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' PRO . . . . . 0.469 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.1 Cg_endo -75.02 148.8 35.68 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.511 1.795 . . . . 0.0 111.01 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.547 ' HA2' HD21 ' A' ' 229' ' ' LEU . . . 83.0 5.9 88.86 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.498 1.124 . . . . 0.0 111.018 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -86.68 122.76 31.03 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.511 0.771 . . . . 0.0 109.328 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -114.86 153.18 30.92 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 0.0 110.954 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.569 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 32.7 p90 -163.29 149.65 12.1 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.535 1.147 . . . . 0.0 111.004 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 129.57 -9.74 6.13 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.539 1.149 . . . . 0.0 110.986 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.659 ' HB2' HD12 ' A' ' 235' ' ' LEU . 12.1 pt-20 -52.36 -45.26 65.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.548 0.793 . . . . 0.0 110.29 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . 0.418 ' N ' ' HG3' ' A' ' 298' ' ' GLU . 0.1 OUTLIER -52.4 -38.3 58.64 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.546 1.154 . . . . 0.0 111.039 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . 0.441 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -67.64 -38.16 83.46 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.498 1.123 . . . . 0.0 109.284 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.739 HD11 ' HB2' ' A' ' 272' ' ' MET . 0.8 OUTLIER -76.57 -14.39 60.01 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.485 1.116 . . . . 0.0 109.333 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . 0.417 ' HA ' ' CE2' ' A' ' 341' ' ' PHE . 11.0 mm -76.79 -55.5 10.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.49 1.119 . . . . 0.0 109.332 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 304' ' ' GLY . 0.5 OUTLIER -153.78 42.16 0.54 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.422 1.076 . . . . 0.0 110.011 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 35.82 43.09 0.58 Allowed Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.48 1.113 . . . . 0.0 111.012 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.17 157.61 88.1 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.549 0.793 . . . . 0.0 110.306 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 129.61 12.45 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.547 1.814 . . . . 0.0 110.968 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -43.92 -36.7 2.53 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.457 1.098 . . . . 0.0 110.272 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 8.0 t 66.75 23.16 10.19 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.49 1.119 . . . . 0.0 109.996 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . -179.11 160.93 1.09 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 0.0 109.318 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.61 ' H ' ' HB3' ' A' ' 283' ' ' ALA . 0.8 OUTLIER -108.55 137.33 46.67 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.5 1.125 . . . . 0.0 110.395 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.775 HG12 HD12 ' A' ' 262' ' ' ILE . 57.5 t -110.87 131.05 63.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.525 1.14 . . . . 0.0 109.31 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 96.5 p -130.19 153.95 48.04 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.524 1.14 . . . . 0.0 109.992 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -94.46 107.26 19.24 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.521 1.138 . . . . 0.0 109.312 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 279' ' ' SER . . . -50.75 -33.4 22.95 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.48 1.112 . . . . 0.0 109.305 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' THR . . . . . 0.633 ' O ' HG23 ' A' ' 317' ' ' VAL . 9.8 t -148.28 -170.03 3.49 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.486 1.116 . . . . 0.0 110.388 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . 0.448 ' N ' ' OG1' ' A' ' 315' ' ' THR . 0.0 OUTLIER -61.37 78.08 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.532 1.145 . . . . 0.0 110.373 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.849 HG22 ' HA3' ' A' ' 278' ' ' GLY . 44.5 t -94.65 140.18 17.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.481 1.113 . . . . 0.0 109.275 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 49.3 m -111.16 117.57 33.59 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.502 1.126 . . . . 0.0 110.0 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . 0.871 HD11 HG21 ' A' ' 256' ' ' VAL . 0.1 OUTLIER -128.67 173.18 10.53 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.486 1.116 . . . . 0.0 109.302 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.665 HD13 ' OD1' ' A' ' 226' ' ' ASN . 0.7 OUTLIER -124.46 133.85 53.23 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.554 1.159 . . . . 0.0 109.269 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 19.9 t -96.09 157.57 15.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.527 1.142 . . . . 0.0 110.001 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.789 HD21 ' CB ' ' A' ' 326' ' ' ASP . 1.4 tm? -150.01 103.67 3.22 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.436 1.085 . . . . 0.0 109.34 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . 0.487 ' ND1' ' HB3' ' A' ' 325' ' ' ALA . 0.3 OUTLIER -62.15 138.35 58.39 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.478 1.111 . . . . 0.0 109.587 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 22.8 t -54.21 -22.36 11.33 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.549 1.156 . . . . 0.0 109.973 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 0.487 ' HB3' ' ND1' ' A' ' 323' ' ' HIS . . . -52.59 -36.61 56.53 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.457 1.098 . . . . 0.0 109.28 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . 0.789 ' CB ' HD21 ' A' ' 322' ' ' LEU . 8.0 t70 -63.77 -46.15 86.55 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.475 1.109 . . . . 0.0 109.299 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' PHE . . . . . 0.578 ' CG ' HD23 ' A' ' 301' ' ' LEU . 20.1 t80 -65.41 -31.17 72.13 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.503 1.127 . . . . 0.0 111.049 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -70.71 -32.36 69.53 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.523 1.14 . . . . 0.0 110.334 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.494 ' O ' ' CB ' ' A' ' 333' ' ' SER . 37.1 ttp -74.5 -37.49 63.1 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.536 1.147 . . . . 0.0 110.998 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.633 HD12 HG13 ' A' ' 243' ' ' VAL . 0.1 OUTLIER -72.5 -42.52 64.75 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 0.0 109.273 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' CYS . . . . . 0.803 ' SG ' ' HB2' ' A' ' 338' ' ' ALA . 26.1 t -66.04 -45.13 82.51 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 0.0 108.318 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 44.4 t -73.3 -22.84 60.26 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.509 1.131 . . . . 0.0 110.031 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 329' ' ' MET . 9.1 t -78.43 -39.44 38.78 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.438 1.086 . . . . 0.0 109.977 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.24 121.6 20.62 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.13 . . . . 0.0 110.05 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 -26.15 11.25 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.535 1.808 . . . . 0.0 111.028 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.74 -29.18 69.66 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.484 1.115 . . . . 0.0 110.274 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.67 HD11 HG21 ' A' ' 243' ' ' VAL . 96.9 mt -74.59 -35.89 39.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.534 1.146 . . . . 0.0 109.294 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . 0.803 ' HB2' ' SG ' ' A' ' 331' ' ' CYS . . . -68.0 -43.54 78.63 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.51 1.131 . . . . 0.0 109.311 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -69.21 -35.33 76.09 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.475 1.109 . . . . 0.0 110.322 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 17.3 mt -70.94 -41.51 77.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.515 1.134 . . . . 0.0 109.27 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.475 ' CE2' ' O ' ' A' ' 301' ' ' LEU . 27.8 t80 -67.73 -34.7 77.36 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.472 1.107 . . . . 0.0 111.02 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -72.48 -37.02 68.57 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.538 1.149 . . . . 0.0 110.294 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.59 -51.81 60.79 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.505 1.128 . . . . 0.0 109.316 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 9.9 t -65.91 -38.86 89.8 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.475 1.109 . . . . 0.0 110.362 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -68.52 -34.83 76.55 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.527 1.142 . . . . 0.0 109.283 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' A' ' 346' ' ' LEU . 12.0 mt -68.64 -36.85 79.15 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.489 1.118 . . . . 0.0 109.328 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.05 -35.67 69.39 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.462 1.101 . . . . 0.0 110.262 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -73.15 -45.0 59.24 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.474 1.109 . . . . 0.0 110.265 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . 0.474 ' O ' ' C ' ' A' ' 350' ' ' GLY . 0.1 OUTLIER -72.63 -33.34 66.56 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.482 1.114 . . . . 0.0 110.283 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . 0.474 ' C ' ' O ' ' A' ' 349' ' ' ARG . . . -31.75 -39.06 0.05 OUTLIER Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.459 1.1 . . . . 0.0 110.961 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 349' ' ' ARG . . . -127.61 119.93 27.01 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.519 0.776 . . . . 0.0 109.262 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -59.94 157.72 12.09 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.5 1.125 . . . . 0.0 109.315 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -150.6 130.83 13.6 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.499 1.125 . . . . 0.0 109.292 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.15 139.11 35.28 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.466 1.104 . . . . 0.0 110.049 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.476 1.11 . . . . 0.0 109.287 -179.965 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.032 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 11.8 p -154.69 145.09 22.1 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.52 0.776 . . . . 0.0 110.027 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -138.85 170.47 15.93 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.122 . . . . 0.0 110.337 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.98 131.19 12.76 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.501 1.126 . . . . 0.0 110.278 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 15.8 m -107.2 137.41 38.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.525 1.141 . . . . 0.0 109.294 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -115.77 126.18 53.7 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.512 1.133 . . . . 0.0 110.292 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.47 175.67 5.4 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.477 1.111 . . . . 0.0 110.313 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -104.89 8.31 45.96 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.478 1.111 . . . . 0.0 111.015 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -91.97 20.12 6.07 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.488 0.758 . . . . 0.0 109.284 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -52.72 -37.8 59.77 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.525 1.141 . . . . 0.0 111.022 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.16 -40.98 78.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.522 1.139 . . . . 0.0 109.27 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.823 ' HG2' HG13 ' A' ' 276' ' ' VAL . 0.0 OUTLIER -67.13 -29.39 69.1 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.529 1.143 . . . . 0.0 110.303 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.754 ' OD1' HD13 ' A' ' 320' ' ' LEU . 4.9 t30 -79.24 -30.88 43.39 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.496 1.123 . . . . 0.0 109.322 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' TRP . . . . . 0.546 ' HA ' HG21 ' A' ' 248' ' ' VAL . 2.6 t90 -70.64 -46.65 62.91 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 4.5 pt20 -68.12 -31.87 71.77 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 0.0 110.263 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 3.5 mt -64.36 -45.59 87.11 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.134 . . . . 0.0 109.257 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.568 HG23 ' CD1' ' A' ' 244' ' ' LEU . 33.1 m -73.55 -36.63 48.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.464 1.103 . . . . 0.0 109.328 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -74.98 -15.55 60.66 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.522 1.139 . . . . 0.0 109.245 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -80.83 -1.87 44.94 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.511 1.132 . . . . 0.0 109.322 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 4.9 t -101.03 118.85 59.58 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.501 1.126 . . . . 0.0 109.276 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 -17.92 19.04 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.494 1.787 . . . . 0.0 110.989 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.684 HD23 ' CZ ' ' A' ' 348' ' ' ARG . 0.1 OUTLIER -65.06 -29.46 70.35 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.574 1.171 . . . . 0.0 109.302 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.415 ' HB3' HD12 ' A' ' 239' ' ' LEU . 15.4 m-85 -113.74 19.76 16.44 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.44 1.087 . . . . 0.0 111.0 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.22 -23.43 62.01 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.515 1.134 . . . . 0.0 110.345 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 50.0 mmtt -80.2 0.7 31.35 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.456 1.097 . . . . 0.0 109.295 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.776 HD13 HG11 ' A' ' 243' ' ' VAL . 15.1 mt -82.13 175.18 10.53 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.542 1.151 . . . . 0.0 109.29 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -107.73 -173.8 22.17 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.478 1.111 . . . . 0.0 110.981 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.94 -33.66 4.5 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.46 1.769 . . . . 0.0 111.051 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.5 ' HA ' HG12 ' A' ' 245' ' ' VAL . . . -71.22 -31.97 68.23 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.482 1.114 . . . . 0.0 109.318 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.776 HG11 HD13 ' A' ' 239' ' ' LEU . 4.8 t -75.9 -42.17 39.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.486 1.116 . . . . 0.0 109.272 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.568 ' CD1' HG23 ' A' ' 230' ' ' VAL . 0.6 OUTLIER -67.24 -46.22 74.42 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.476 1.11 . . . . 0.0 109.289 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' A' ' 242' ' ' ALA . 2.8 p -65.05 -45.14 95.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.497 1.123 . . . . 0.0 109.273 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.405 ' N ' ' CG1' ' A' ' 245' ' ' VAL . 4.9 tp10 -64.87 -36.12 83.33 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.114 . . . . 0.0 110.325 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.502 HD12 HG12 ' A' ' 243' ' ' VAL . 26.4 mt -67.85 -48.0 77.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.514 1.134 . . . . 0.0 109.329 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.546 HG21 ' HA ' ' A' ' 227' ' ' TRP . 55.2 t -63.26 -33.07 58.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.123 . . . . 0.0 109.323 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.1 mmm180 -74.61 -25.13 59.04 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.434 1.084 . . . . 0.0 110.294 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.458 ' HB3' ' OD1' ' A' ' 326' ' ' ASP . . . -87.15 -18.54 30.18 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.481 1.113 . . . . 0.0 109.344 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.82 146.16 54.72 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.575 1.172 . . . . 0.0 109.321 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -120.54 135.08 55.19 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 0.0 110.368 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -80.57 122.4 27.0 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.459 1.099 . . . . 0.0 109.262 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.7 ttm-85 -124.25 121.95 36.43 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.543 1.152 . . . . 0.0 110.276 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.6 m -91.28 117.81 29.96 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 0.0 110.373 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.576 HG21 HD11 ' A' ' 319' ' ' LEU . 69.3 t -106.69 112.02 63.71 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.461 1.101 . . . . 0.0 109.329 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.516 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.97 173.65 14.14 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.472 1.775 . . . . 0.0 111.023 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.524 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -67.51 131.33 45.44 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.488 1.117 . . . . 0.0 109.263 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 93.27 -25.39 20.59 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 124.556 1.16 . . . . 0.0 110.984 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.516 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -61.07 149.04 38.31 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.52 0.776 . . . . 0.0 109.332 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.2 t -97.47 131.35 44.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.483 1.114 . . . . 0.0 109.324 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.774 HD12 HG12 ' A' ' 311' ' ' VAL . 43.3 mt -83.9 -40.09 15.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.53 1.144 . . . . 0.0 109.308 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' CYS . . . . . 0.405 ' SG ' HG23 ' A' ' 311' ' ' VAL . 13.8 p -156.12 150.71 25.89 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.503 1.127 . . . . 0.0 108.276 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ARG . . . . . 0.402 ' HA ' ' OG1' ' A' ' 310' ' ' THR . 16.6 mmt180 -94.42 179.67 5.21 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.566 1.166 . . . . 0.0 110.339 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.51 HG23 ' OG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -77.49 140.34 17.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.467 1.104 . . . . 0.0 109.326 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 46.54 52.71 10.64 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.5 1.125 . . . . 0.0 111.045 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.458 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.2 OUTLIER -71.03 168.08 23.86 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.548 0.793 . . . . 0.0 110.357 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 267' ' ' GLU . 18.4 Cg_endo -74.98 88.49 1.23 Allowed 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.458 1.767 . . . . 0.0 111.005 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . 0.401 ' O ' ' CA ' ' A' ' 304' ' ' GLY . . . -45.23 93.5 0.01 OUTLIER Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.553 1.158 . . . . 0.0 110.988 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 268' ' ' PRO . 0.6 OUTLIER -170.47 36.68 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.51 0.771 . . . . 0.0 109.345 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -173.35 162.27 4.32 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.566 1.166 . . . . 0.0 110.295 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.471 ' CE ' ' CZ ' ' A' ' 274' ' ' PHE . 9.3 ptm -145.84 146.66 31.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.538 1.149 . . . . 0.0 110.996 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.566 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 33.2 m-85 -128.37 154.08 46.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.484 1.115 . . . . 0.0 111.017 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . 0.505 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 23.6 m-85 -129.87 137.37 50.39 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.481 1.113 . . . . 0.0 111.017 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.58 HG12 ' HA ' ' A' ' 292' ' ' PRO . 42.7 t -90.71 136.72 23.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.52 1.137 . . . . 0.0 109.295 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.823 HG13 ' HG2' ' A' ' 225' ' ' ARG . 39.8 t -116.03 -43.78 3.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.535 1.147 . . . . 0.0 109.326 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -146.61 136.74 23.55 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.517 1.136 . . . . 0.0 110.272 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.95 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 114.46 -173.22 14.72 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.502 1.126 . . . . 0.0 111.004 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 3.2 m -134.9 119.92 18.65 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.539 0.788 . . . . 0.0 109.989 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.421 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 16.5 m -99.0 165.82 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.499 1.125 . . . . 0.0 109.323 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 30.5 t -131.52 154.97 48.23 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.504 1.128 . . . . 0.0 110.009 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.429 HG13 HG22 ' A' ' 311' ' ' VAL . 0.7 OUTLIER -118.92 131.21 72.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.503 1.127 . . . . 0.0 109.306 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -79.41 102.03 8.48 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 0.0 109.325 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . 0.655 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.18 -168.25 0.18 Allowed Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.525 1.14 . . . . 0.0 110.391 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.655 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -75.04 4.48 4.72 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.566 1.824 . . . . 0.0 110.964 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.411 ' O ' HG23 ' A' ' 288' ' ' VAL . 35.2 m120 -151.75 157.2 34.59 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.548 1.155 . . . . 0.0 109.263 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.06 95.36 0.98 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.472 1.775 . . . . 0.0 110.937 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 281' ' ' SER . 4.6 t -99.39 119.23 47.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.47 1.106 . . . . 0.0 109.263 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 15.8 mt-10 -124.44 135.85 53.58 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.426 1.079 . . . . 0.0 110.29 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.506 HD12 ' CB ' ' A' ' 294' ' ' ALA . 3.9 mm? -115.11 142.11 47.1 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.451 1.095 . . . . 0.0 109.307 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -98.79 -161.24 29.82 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.494 1.121 . . . . 0.0 110.983 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' PRO . . . . . 0.58 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.2 Cg_endo -75.0 145.88 31.98 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.491 1.785 . . . . 0.0 110.999 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 88.09 4.63 77.9 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.459 1.099 . . . . 0.0 110.95 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . 0.506 ' CB ' HD12 ' A' ' 290' ' ' LEU . . . -91.25 127.77 36.81 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.501 0.765 . . . . 0.0 109.315 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.451 ' HB3' ' CD1' ' A' ' 274' ' ' PHE . 1.2 p90 -116.34 153.38 32.09 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.52 1.138 . . . . 0.0 110.987 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 48.1 p90 -161.63 146.38 13.19 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.452 1.095 . . . . 0.0 110.977 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 300' ' ' ALA . . . 129.66 -9.99 6.09 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 124.527 1.142 . . . . 0.0 111.001 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -52.77 -51.21 61.54 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.457 0.74 . . . . 0.0 110.295 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.2 mmt -50.48 -32.89 19.37 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.523 1.139 . . . . 0.0 111.008 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 297' ' ' GLY . . . -68.85 -42.64 76.84 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.535 1.147 . . . . 0.0 109.337 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.458 HD11 ' SD ' ' A' ' 272' ' ' MET . 6.0 mt -75.01 -11.68 60.16 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.475 1.109 . . . . 0.0 109.283 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . 0.482 HD13 ' CZ ' ' A' ' 341' ' ' PHE . 14.5 mm -77.83 -56.63 7.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.484 1.115 . . . . 0.0 109.291 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 304' ' ' GLY . 2.4 m -151.46 42.57 0.74 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.445 1.091 . . . . 0.0 110.0 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 34.93 51.21 0.82 Allowed Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.462 1.101 . . . . 0.0 110.969 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.58 151.34 80.15 Favored Pre-proline 0 C--N 1.326 -0.436 0 O-C-N 124.524 0.779 . . . . 0.0 110.33 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 130.29 13.11 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.461 1.769 . . . . 0.0 110.955 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -44.04 -33.09 1.34 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.536 1.147 . . . . 0.0 110.301 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 59.38 15.9 4.73 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.525 1.14 . . . . 0.0 109.989 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . -170.15 160.75 8.17 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.544 1.153 . . . . 0.0 109.333 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.51 ' OG1' HG23 ' A' ' 265' ' ' ILE . 0.9 OUTLIER -110.29 139.68 45.23 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.469 1.106 . . . . 0.0 110.42 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.774 HG12 HD12 ' A' ' 262' ' ' ILE . 91.1 t -115.57 131.62 67.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.493 1.121 . . . . 0.0 109.269 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 56.3 p -128.6 153.75 46.92 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.491 1.119 . . . . 0.0 110.018 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . 0.418 ' CB ' HG12 ' A' ' 256' ' ' VAL . . . -90.95 114.3 26.75 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.556 1.16 . . . . 0.0 109.286 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -57.73 -35.19 70.34 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.521 1.138 . . . . 0.0 109.304 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' THR . . . . . 0.589 ' O ' HG23 ' A' ' 317' ' ' VAL . 8.7 t -153.96 -173.91 4.76 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.559 1.162 . . . . 0.0 110.424 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 29.0 m -49.9 91.36 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 0.0 110.378 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.95 HG22 ' HA3' ' A' ' 278' ' ' GLY . 41.6 t -106.75 154.54 7.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.53 1.144 . . . . 0.0 109.31 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 69.3 m -129.79 114.93 16.55 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.534 1.146 . . . . 0.0 109.965 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . 0.576 HD11 HG21 ' A' ' 256' ' ' VAL . 0.2 OUTLIER -130.43 173.17 11.09 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.484 1.115 . . . . 0.0 109.289 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.754 HD13 ' OD1' ' A' ' 226' ' ' ASN . 0.8 OUTLIER -124.29 136.41 54.11 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.532 1.145 . . . . 0.0 109.29 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.477 ' HB2' ' CE2' ' A' ' 273' ' ' PHE . 36.7 t -96.07 148.53 22.58 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.466 1.104 . . . . 0.0 110.02 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.483 ' O ' HD13 ' A' ' 322' ' ' LEU . 3.0 tm? -146.49 98.54 3.09 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.5 1.125 . . . . 0.0 109.302 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -60.02 146.9 41.02 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.485 1.116 . . . . 0.0 109.582 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 37.8 t -63.68 -13.71 45.39 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.504 1.127 . . . . 0.0 110.02 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 0.4 ' HA ' ' NE2' ' A' ' 328' ' ' GLN . . . -61.67 -27.8 68.94 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.486 1.116 . . . . 0.0 109.331 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . 0.458 ' OD1' ' HB3' ' A' ' 250' ' ' ALA . 0.6 OUTLIER -74.66 -39.52 61.99 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.504 1.127 . . . . 0.0 109.277 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' PHE . . . . . 0.483 ' C ' ' CD1' ' A' ' 327' ' ' PHE . 0.8 OUTLIER -70.47 -42.68 71.11 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.504 1.127 . . . . 0.0 110.995 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.4 ' NE2' ' HA ' ' A' ' 325' ' ' ALA . 1.8 pt20 -67.15 -35.61 80.07 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.512 1.133 . . . . 0.0 110.266 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 17.9 tmm? -66.8 -42.12 86.48 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.515 1.135 . . . . 0.0 110.985 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.443 HD13 ' CG1' ' A' ' 247' ' ' ILE . 5.2 mt -72.51 -37.42 68.38 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.456 1.097 . . . . 0.0 109.307 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' CYS . . . . . 0.642 ' HB3' ' HB2' ' A' ' 338' ' ' ALA . 6.2 m -72.57 -31.64 65.4 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.478 1.111 . . . . 0.0 108.329 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 47.1 t -71.83 -37.91 70.25 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 0.0 109.981 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 42.6 t -72.17 -36.0 69.16 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.464 1.103 . . . . 0.0 109.981 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -123.02 114.32 29.53 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.51 1.131 . . . . 0.0 110.005 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -19.04 18.2 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.537 1.809 . . . . 0.0 111.005 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -72.57 -32.13 65.8 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.548 1.155 . . . . 0.0 110.31 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.474 HG23 ' CD2' ' A' ' 239' ' ' LEU . 77.6 mt -74.87 -44.95 44.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.485 1.116 . . . . 0.0 109.286 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . 0.642 ' HB2' ' HB3' ' A' ' 331' ' ' CYS . . . -66.6 -35.33 79.94 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.131 . . . . 0.0 109.338 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.478 ' O ' ' CG ' ' A' ' 343' ' ' LYS . 50.2 mm-40 -72.3 -42.78 65.09 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.516 1.135 . . . . 0.0 110.279 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 58.5 mt -68.35 -36.52 75.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.523 1.14 . . . . 0.0 109.256 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.666 ' CE1' HD12 ' A' ' 235' ' ' LEU . 49.7 t80 -69.55 -37.2 76.94 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.101 . . . . 0.0 110.982 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -69.76 -37.99 76.6 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.474 1.109 . . . . 0.0 110.335 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . 0.478 ' CG ' ' O ' ' A' ' 339' ' ' GLU . 0.5 OUTLIER -65.0 -50.65 65.45 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.496 1.123 . . . . 0.0 109.344 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 341' ' ' PHE . 4.5 t -64.83 -32.86 74.76 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.51 1.131 . . . . 0.0 110.4 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -70.07 -39.05 75.85 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.466 1.104 . . . . 0.0 109.29 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.43 ' HA ' HD23 ' A' ' 346' ' ' LEU . 12.6 mt -68.93 -34.04 74.71 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.434 1.084 . . . . 0.0 109.312 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.75 -31.68 61.87 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.467 1.105 . . . . 0.0 110.299 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . 0.684 ' CZ ' HD23 ' A' ' 235' ' ' LEU . 7.0 mtt180 -72.31 -43.94 63.44 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.535 1.147 . . . . 0.0 110.304 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 350' ' ' GLY . 0.0 OUTLIER -72.44 -34.76 68.03 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.479 1.112 . . . . 0.0 110.302 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 349' ' ' ARG . . . -37.4 -45.12 1.28 Allowed Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.512 1.132 . . . . 0.0 110.987 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -155.01 121.9 5.46 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.51 0.77 . . . . 0.0 109.283 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -63.51 168.53 4.56 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.484 1.115 . . . . 0.0 109.336 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -113.51 120.9 42.57 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.498 1.124 . . . . 0.0 109.282 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 67.3 m -73.2 145.09 46.51 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.447 1.092 . . . . 0.0 109.969 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.529 1.143 . . . . 0.0 109.294 -179.987 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.974 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 1.1 t -80.22 134.45 36.12 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.47 0.747 . . . . 0.0 109.997 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -105.09 170.89 7.61 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.471 1.107 . . . . 0.0 110.27 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.72 167.05 11.9 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.492 1.12 . . . . 0.0 110.319 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 58.4 t -120.4 155.02 23.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.527 1.142 . . . . 0.0 109.309 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.6 153.99 17.54 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.491 1.119 . . . . 0.0 110.318 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.83 141.65 50.34 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.502 1.126 . . . . 0.0 110.289 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -99.36 -19.53 20.56 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.498 1.124 . . . . 0.0 110.988 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 10.4 p30 -97.15 19.36 13.1 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.495 0.762 . . . . 0.0 109.316 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -53.91 -41.98 68.24 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.14 . . . . 0.0 110.967 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.81 -35.89 44.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.543 1.152 . . . . 0.0 109.289 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.648 ' CD ' HD23 ' A' ' 229' ' ' LEU . 0.0 OUTLIER -69.32 -32.12 71.02 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.559 1.162 . . . . 0.0 110.333 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.677 ' O ' HG23 ' A' ' 230' ' ' VAL . 46.6 t30 -79.89 -30.63 40.19 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.471 1.107 . . . . 0.0 109.256 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' TRP . . . . . 0.866 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 2.5 t90 -67.8 -43.65 79.19 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.538 1.149 . . . . 0.0 107.974 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -71.03 -38.38 72.58 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.585 1.178 . . . . 0.0 110.339 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.651 HD21 ' HA2' ' A' ' 293' ' ' GLY . 1.2 mm? -62.43 -46.25 89.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.146 . . . . 0.0 109.3 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.737 HG12 HD13 ' A' ' 244' ' ' LEU . 59.1 t -72.69 -37.01 54.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.466 1.104 . . . . 0.0 109.316 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -73.5 -15.86 61.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.487 1.117 . . . . 0.0 109.328 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -81.86 -12.74 58.33 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.511 1.132 . . . . 0.0 109.318 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 38.2 t -70.9 132.3 86.86 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.122 . . . . 0.0 109.298 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.407 ' HA ' ' HB2' ' A' ' 237' ' ' GLN . 18.2 Cg_endo -74.98 -30.4 7.23 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.482 1.78 . . . . 0.0 110.979 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 1.059 HD11 HD11 ' A' ' 302' ' ' ILE . 0.7 OUTLIER -68.87 -28.21 66.5 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.447 1.092 . . . . 0.0 109.29 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.713 ' CG ' HD12 ' A' ' 239' ' ' LEU . 13.8 m-30 -104.63 14.32 30.04 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.497 1.123 . . . . 0.0 111.016 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' GLN . . . . . 0.407 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 1.4 tt0 -72.17 -26.15 61.97 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.492 1.12 . . . . 0.0 110.286 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.468 ' HB2' ' CG2' ' A' ' 340' ' ' ILE . 6.6 mmpt? -100.47 7.62 44.06 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.528 1.143 . . . . 0.0 109.314 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.713 HD12 ' CG ' ' A' ' 236' ' ' PHE . 16.9 mt -81.51 171.24 14.92 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 0.0 109.258 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . 0.583 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -95.16 173.68 31.82 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.51 1.131 . . . . 0.0 110.981 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.928 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.2 Cg_endo -75.05 -35.29 3.19 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.494 1.786 . . . . 0.0 111.015 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.4 -34.66 76.41 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.474 1.109 . . . . 0.0 109.3 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.805 HG21 HD11 ' A' ' 337' ' ' ILE . 25.6 t -74.17 -42.07 51.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.44 1.087 . . . . 0.0 109.301 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.737 HD13 HG12 ' A' ' 230' ' ' VAL . 2.1 mm? -64.81 -34.58 78.68 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.511 1.132 . . . . 0.0 109.293 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.928 HG23 ' O ' ' A' ' 241' ' ' PRO . 70.4 t -70.72 -44.56 76.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.547 1.155 . . . . 0.0 109.311 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -65.3 -31.18 72.18 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.478 1.111 . . . . 0.0 110.293 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 56.0 mt -75.14 -40.54 44.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.451 1.095 . . . . 0.0 109.317 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 244' ' ' LEU . 55.8 t -70.96 -33.32 51.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.503 1.127 . . . . 0.0 109.309 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.427 ' NH1' ' HB3' ' A' ' 249' ' ' ARG . 5.6 mmm180 -78.94 -25.84 43.63 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.471 1.107 . . . . 0.0 110.275 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.446 ' HB1' ' OD2' ' A' ' 326' ' ' ASP . . . -86.87 -21.68 26.21 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.523 1.139 . . . . 0.0 109.332 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.49 152.35 30.31 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.46 1.1 . . . . 0.0 109.339 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -121.13 119.1 31.41 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.495 1.122 . . . . 0.0 110.299 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.755 ' HB2' HD23 ' A' ' 320' ' ' LEU . . . -81.17 122.43 27.37 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.502 1.126 . . . . 0.0 109.298 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.96 142.75 50.38 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.453 1.096 . . . . 0.0 110.299 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 4.5 m -96.64 125.83 41.39 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.517 1.136 . . . . 0.0 110.386 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.517 HG12 ' CB ' ' A' ' 313' ' ' ALA . 86.7 t -106.58 115.73 60.17 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.473 1.108 . . . . 0.0 109.3 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.507 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.5 Cg_endo -74.96 168.41 24.89 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.535 1.808 . . . . 0.0 111.038 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.523 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -66.81 128.5 36.53 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.511 1.132 . . . . 0.0 109.302 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 96.06 -25.57 24.85 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.486 1.116 . . . . 0.0 110.989 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.507 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -64.35 134.1 53.96 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.505 0.767 . . . . 0.0 109.313 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 312' ' ' SER . 2.5 p -90.21 134.98 27.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.485 1.116 . . . . 0.0 109.295 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.822 HD12 HG12 ' A' ' 311' ' ' VAL . 11.3 mt -82.47 -52.6 13.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.121 . . . . 0.0 109.377 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' CYS . . . . . 0.653 ' SG ' HG23 ' A' ' 311' ' ' VAL . 14.0 p -137.48 157.68 46.03 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.511 1.132 . . . . 0.0 108.31 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 1.8 mmt85 -100.98 178.43 4.67 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.58 1.175 . . . . 0.0 110.302 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.559 HD13 ' H ' ' A' ' 265' ' ' ILE . 0.2 OUTLIER -77.74 130.73 35.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.56 1.162 . . . . 0.0 109.308 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 59.9 47.51 90.64 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.533 1.146 . . . . 0.0 111.028 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.417 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.2 OUTLIER -71.53 164.37 58.38 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.473 0.749 . . . . 0.0 110.302 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.449 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.3 Cg_endo -74.96 81.52 2.18 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.469 1.773 . . . . 0.0 111.05 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 268' ' ' PRO . . . -37.08 95.86 0.01 OUTLIER Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.537 1.148 . . . . 0.0 111.039 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 268' ' ' PRO . 51.5 m-20 -170.45 38.67 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.507 0.769 . . . . 0.0 109.288 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.471 ' HD3' ' CE1' ' A' ' 273' ' ' PHE . 3.8 ttm180 -170.78 151.83 3.55 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.505 1.128 . . . . 0.0 110.298 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.522 ' SD ' HD11 ' A' ' 301' ' ' LEU . 3.4 ttt -121.5 155.33 35.17 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.505 1.128 . . . . 0.0 111.031 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.568 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 25.8 m-85 -140.42 136.74 33.37 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.49 1.119 . . . . 0.0 111.006 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . 0.402 ' CE2' HG22 ' A' ' 230' ' ' VAL . 20.0 m-85 -128.47 126.84 41.32 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.476 1.11 . . . . 0.0 111.018 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 1.061 HG22 HD22 ' A' ' 319' ' ' LEU . 53.9 t -85.58 132.71 31.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.459 1.1 . . . . 0.0 109.32 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.556 HG21 HD11 ' A' ' 320' ' ' LEU . 48.3 t -107.15 -52.84 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.485 1.116 . . . . 0.0 109.302 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.647 ' O ' HG23 ' A' ' 317' ' ' VAL . 11.0 mt-10 -139.81 137.9 35.37 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.51 1.131 . . . . 0.0 110.254 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.402 ' HA3' ' HB ' ' A' ' 317' ' ' VAL . . . 116.27 -158.0 14.7 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.458 1.099 . . . . 0.0 110.952 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 8.7 t -148.3 134.07 18.95 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.54 0.788 . . . . 0.0 109.998 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 11.3 m -114.02 165.41 9.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.516 1.135 . . . . 0.0 109.283 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 29.3 t -131.59 148.54 52.62 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.529 1.143 . . . . 0.0 109.991 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.468 HG23 HG12 ' A' ' 288' ' ' VAL . 0.6 OUTLIER -110.91 129.79 65.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.461 1.101 . . . . 0.0 109.262 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.546 ' HB2' HG22 ' A' ' 310' ' ' THR . . . -78.52 101.46 7.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.479 1.112 . . . . 0.0 109.32 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . 0.659 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.9 OUTLIER -147.14 -168.05 0.17 Allowed Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.505 1.128 . . . . 0.0 110.38 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.659 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.6 Cg_endo -74.96 3.98 5.12 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.502 1.791 . . . . 0.0 111.022 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -150.37 157.2 37.03 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.482 1.114 . . . . 0.0 109.302 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.91 94.1 0.95 Allowed 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.493 1.786 . . . . 0.0 110.989 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.468 HG12 HG23 ' A' ' 282' ' ' VAL . 72.1 t -98.09 118.94 45.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.544 1.152 . . . . 0.0 109.29 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.501 ' C ' HD22 ' A' ' 290' ' ' LEU . 13.0 mt-10 -125.11 134.49 52.44 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.443 1.089 . . . . 0.0 110.291 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.501 HD22 ' C ' ' A' ' 289' ' ' GLU . 2.6 mm? -116.73 141.48 48.15 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.536 1.148 . . . . 0.0 109.308 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -95.72 -158.47 32.36 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.518 1.136 . . . . 0.0 110.974 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' PRO . . . . . 0.461 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.3 Cg_endo -75.02 152.63 40.88 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.466 1.772 . . . . 0.0 110.994 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.651 ' HA2' HD21 ' A' ' 229' ' ' LEU . . . 79.66 6.78 88.91 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.501 1.125 . . . . 0.0 110.971 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -88.98 128.71 35.7 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.489 0.758 . . . . 0.0 109.278 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -117.45 153.01 33.84 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.471 1.107 . . . . 0.0 111.005 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.568 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 45.5 p90 -166.28 145.7 5.94 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.512 1.133 . . . . 0.0 111.024 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 300' ' ' ALA . . . 133.21 -10.53 5.06 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.514 1.133 . . . . 0.0 111.004 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.504 ' CD ' HD13 ' A' ' 235' ' ' LEU . 32.8 tt0 -52.75 -53.22 51.05 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.493 0.761 . . . . 0.0 110.242 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -47.58 -35.56 9.32 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.467 1.104 . . . . 0.0 110.99 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 297' ' ' GLY . . . -68.4 -43.21 77.75 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.513 1.133 . . . . 0.0 109.327 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.522 HD11 ' SD ' ' A' ' 272' ' ' MET . 1.2 mt -77.26 -5.98 51.41 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.498 1.124 . . . . 0.0 109.285 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . 1.059 HD11 HD11 ' A' ' 235' ' ' LEU . 8.1 mm -83.37 -53.92 10.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 0.0 109.282 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 304' ' ' GLY . 78.5 p -151.89 43.2 0.72 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.511 1.132 . . . . 0.0 109.968 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 303' ' ' SER . . . 36.16 35.0 0.09 OUTLIER Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.474 1.109 . . . . 0.0 111.009 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 303' ' ' SER . 0.1 OUTLIER -62.4 151.55 82.36 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.498 0.763 . . . . 0.0 110.318 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 127.57 10.79 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.435 1.755 . . . . 0.0 110.974 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . 0.402 ' NE ' ' HG2' ' A' ' 267' ' ' GLU . 0.0 OUTLIER -46.16 -24.9 0.51 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 0.0 110.295 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 43.18 36.85 1.07 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.475 1.11 . . . . 0.0 110.012 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . -177.99 161.07 1.5 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.474 1.108 . . . . 0.0 109.283 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.546 HG22 ' HB2' ' A' ' 283' ' ' ALA . 0.3 OUTLIER -113.89 121.4 43.87 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.472 1.107 . . . . 0.0 110.355 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.822 HG12 HD12 ' A' ' 262' ' ' ILE . 31.5 t -102.69 131.79 50.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.116 . . . . 0.0 109.267 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 261' ' ' VAL . 6.0 p -136.11 158.29 44.76 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.538 1.149 . . . . 0.0 110.007 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . 0.877 ' HB1' HG12 ' A' ' 317' ' ' VAL . . . -88.29 111.86 22.17 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.471 1.107 . . . . 0.0 109.259 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -55.55 -26.34 42.87 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.507 1.129 . . . . 0.0 109.286 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' THR . . . . . 0.694 ' O ' HG12 ' A' ' 317' ' ' VAL . 10.0 t -164.43 -165.08 0.9 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.49 1.119 . . . . 0.0 110.41 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . 0.418 ' N ' ' OG1' ' A' ' 315' ' ' THR . 31.5 p -60.26 80.7 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.516 1.135 . . . . 0.0 110.426 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.877 HG12 ' HB1' ' A' ' 313' ' ' ALA . 2.5 p -113.0 138.5 42.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.129 . . . . 0.0 109.266 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . 0.62 ' C ' HD23 ' A' ' 319' ' ' LEU . 49.7 m -107.26 139.05 42.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.556 1.16 . . . . 0.0 109.998 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . 1.061 HD22 HG22 ' A' ' 275' ' ' VAL . 0.0 OUTLIER -143.73 173.51 11.61 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.498 1.124 . . . . 0.0 109.306 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.755 HD23 ' HB2' ' A' ' 253' ' ' ALA . 1.2 mp -124.37 133.99 53.26 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.448 1.092 . . . . 0.0 109.308 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 20.9 t -97.99 151.34 20.41 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.469 1.106 . . . . 0.0 109.985 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.457 HD13 ' C ' ' A' ' 322' ' ' LEU . 3.2 tm? -144.8 106.87 4.32 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.494 1.121 . . . . 0.0 109.34 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . 0.421 ' CE1' ' HB2' ' A' ' 326' ' ' ASP . 10.2 p80 -66.4 132.99 49.55 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.502 1.126 . . . . 0.0 109.615 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 96.1 p -56.64 -21.95 30.91 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.469 1.106 . . . . 0.0 110.004 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -58.84 -35.47 72.98 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.5 1.125 . . . . 0.0 109.29 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . 0.446 ' OD2' ' HB1' ' A' ' 250' ' ' ALA . 23.8 t70 -66.1 -41.05 91.13 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.502 1.126 . . . . 0.0 109.34 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' PHE . . . . . 0.482 ' CD1' ' O ' ' A' ' 327' ' ' PHE . 2.6 t80 -70.53 -29.77 66.34 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.47 1.106 . . . . 0.0 110.998 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -70.92 -45.73 63.74 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.523 1.139 . . . . 0.0 110.319 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.454 ' HG3' ' N ' ' A' ' 330' ' ' LEU . 3.9 ptm -66.47 -34.6 78.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.49 1.119 . . . . 0.0 110.978 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.454 ' N ' ' HG3' ' A' ' 329' ' ' MET . 16.5 mt -72.77 -37.74 67.54 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.486 1.116 . . . . 0.0 109.275 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' CYS . . . . . 0.402 ' O ' ' O ' ' A' ' 334' ' ' SER . 14.2 t -66.26 -41.47 89.85 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.549 1.156 . . . . 0.0 108.336 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.28 -23.36 51.15 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.486 1.116 . . . . 0.0 109.992 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 19.9 t -71.65 -39.33 70.42 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.532 1.145 . . . . 0.0 110.032 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . 0.402 ' O ' ' O ' ' A' ' 331' ' ' CYS . 0.1 OUTLIER -121.98 131.9 24.34 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.491 1.12 . . . . 0.0 109.957 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -28.5 9.14 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.495 1.787 . . . . 0.0 110.999 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.78 -28.57 67.72 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.477 1.111 . . . . 0.0 110.259 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.805 HD11 HG21 ' A' ' 243' ' ' VAL . 95.7 mt -72.28 -35.77 53.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.486 1.116 . . . . 0.0 109.254 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.22 -33.98 65.64 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.536 1.147 . . . . 0.0 109.309 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -74.54 -42.35 59.0 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.511 1.132 . . . . 0.0 110.272 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.468 ' CG2' ' HB2' ' A' ' 238' ' ' LYS . 43.2 mt -71.7 -40.24 70.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.524 1.14 . . . . 0.0 109.27 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.481 ' CE2' ' CZ ' ' A' ' 327' ' ' PHE . 10.2 t80 -70.04 -34.94 73.89 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.547 1.154 . . . . 0.0 111.009 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.18 -41.47 73.7 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.484 1.115 . . . . 0.0 110.257 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.05 -40.57 71.58 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.498 1.124 . . . . 0.0 109.295 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.1 m -67.46 -42.39 83.12 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.457 1.098 . . . . 0.0 110.403 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -70.87 -35.08 72.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.557 1.161 . . . . 0.0 109.293 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 346' ' ' LEU . 15.8 mt -71.46 -31.99 67.79 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.546 1.154 . . . . 0.0 109.277 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -73.71 -39.02 64.64 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.539 1.149 . . . . 0.0 110.281 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 16.0 mtt-85 -70.24 -39.68 74.9 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.477 1.111 . . . . 0.0 110.349 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 350' ' ' GLY . 0.0 OUTLIER -72.79 -36.79 67.68 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.495 1.122 . . . . 0.0 110.271 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 349' ' ' ARG . . . -35.69 -46.53 0.85 Allowed Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.513 1.133 . . . . 0.0 111.005 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -155.3 122.57 5.53 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.5 0.765 . . . . 0.0 109.312 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -64.34 163.69 12.59 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.481 1.113 . . . . 0.0 109.319 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -110.24 121.48 45.37 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.519 1.137 . . . . 0.0 109.295 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 3.6 m -62.01 136.8 58.11 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.537 1.148 . . . . 0.0 109.997 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.465 0 O-C-N 124.562 1.164 . . . . 0.0 109.301 -179.981 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.976 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 74.1 m -122.14 165.98 15.27 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.484 0.755 . . . . 0.0 110.039 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -111.55 160.35 17.26 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.529 1.143 . . . . 0.0 110.317 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -93.8 170.6 9.44 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.505 1.128 . . . . 0.0 110.291 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 9.7 p -120.5 162.95 18.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.515 1.135 . . . . 0.0 109.314 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.32 161.88 25.96 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.473 1.108 . . . . 0.0 110.309 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.93 165.0 16.63 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.486 1.116 . . . . 0.0 110.322 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -80.04 -39.58 16.07 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.498 1.124 . . . . 0.0 110.998 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -98.5 14.8 26.99 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.458 0.74 . . . . 0.0 109.307 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -53.91 -37.39 63.75 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.542 1.151 . . . . 0.0 110.982 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -71.16 -37.76 67.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.525 1.14 . . . . 0.0 109.27 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.475 ' O ' HD12 ' A' ' 229' ' ' LEU . 0.0 OUTLIER -66.57 -33.14 75.02 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.536 1.147 . . . . 0.0 110.334 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.877 ' ND2' HD22 ' A' ' 320' ' ' LEU . 10.4 t-20 -79.21 -30.3 43.24 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.471 1.107 . . . . 0.0 109.321 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' TRP . . . . . 0.871 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 3.1 t90 -66.45 -44.44 82.77 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.52 1.137 . . . . 0.0 108.01 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.44 ' HG3' ' N ' ' A' ' 229' ' ' LEU . 7.7 pt20 -71.67 -44.95 63.37 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.533 1.146 . . . . 0.0 110.359 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.678 HD21 ' HA2' ' A' ' 293' ' ' GLY . 0.3 OUTLIER -57.75 -44.76 86.34 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.468 1.105 . . . . 0.0 109.3 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 226' ' ' ASN . 95.7 t -70.34 -38.99 76.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.48 1.113 . . . . 0.0 109.244 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -75.29 -10.18 59.23 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.48 1.113 . . . . 0.0 109.254 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 228' ' ' GLN . . . -80.06 -25.07 40.27 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.451 1.094 . . . . 0.0 109.223 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . 0.463 HG13 ' HD2' ' A' ' 234' ' ' PRO . 61.9 t -70.05 138.14 87.32 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.469 1.106 . . . . 0.0 109.298 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.463 ' HD2' HG13 ' A' ' 233' ' ' VAL . 18.3 Cg_endo -75.02 -50.24 0.13 Allowed 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.478 1.778 . . . . 0.0 110.998 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.66 HD11 HD11 ' A' ' 302' ' ' ILE . 18.2 mt -50.84 -37.13 41.28 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.489 1.118 . . . . 0.0 109.275 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -78.88 -21.99 46.64 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.465 1.103 . . . . 0.0 110.979 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' GLN . . . . . 0.444 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -59.12 -22.72 61.31 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.514 1.134 . . . . 0.0 110.282 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -75.11 -23.27 57.91 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.495 1.122 . . . . 0.0 109.275 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.538 HD21 HG23 ' A' ' 337' ' ' ILE . 16.3 mt -74.51 -179.83 4.26 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.483 1.114 . . . . 0.0 109.275 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . 0.622 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -107.72 -172.6 22.04 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.517 1.136 . . . . 0.0 111.005 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.877 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.1 Cg_endo -75.0 -36.96 2.24 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.5 1.789 . . . . 0.0 111.015 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.09 -34.83 78.48 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.493 1.121 . . . . 0.0 109.327 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.519 HG12 HD12 ' A' ' 247' ' ' ILE . 13.6 t -75.38 -39.21 41.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.531 1.144 . . . . 0.0 109.329 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.622 HD23 ' O ' ' A' ' 240' ' ' GLY . 1.4 mm? -66.28 -37.94 86.62 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.498 1.124 . . . . 0.0 109.253 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 241' ' ' PRO . 94.1 t -68.95 -44.67 81.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.478 1.111 . . . . 0.0 109.274 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -64.74 -36.94 85.93 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.468 1.105 . . . . 0.0 110.301 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.519 HD12 HG12 ' A' ' 243' ' ' VAL . 41.7 mt -69.09 -49.07 65.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.47 1.106 . . . . 0.0 109.285 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 244' ' ' LEU . 63.9 t -62.58 -31.09 50.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 0.0 109.308 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -78.92 -22.67 45.5 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.549 1.155 . . . . 0.0 110.282 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -91.86 -12.59 33.21 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.48 1.113 . . . . 0.0 109.25 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.48 HD22 HD21 ' A' ' 226' ' ' ASN . 0.2 OUTLIER -70.61 148.89 47.63 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.535 1.147 . . . . 0.0 109.318 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 2.4 tpt85 -120.64 116.11 24.68 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.471 1.107 . . . . 0.0 110.288 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.754 ' HB2' HD23 ' A' ' 320' ' ' LEU . . . -80.7 122.28 26.93 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.414 1.072 . . . . 0.0 109.355 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.4 ' O ' ' O ' ' A' ' 319' ' ' LEU . 13.5 ptp180 -130.27 142.97 50.52 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.486 1.116 . . . . 0.0 110.303 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 10.5 m -95.36 129.19 42.59 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.51 1.131 . . . . 0.0 110.383 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.442 HG21 HD11 ' A' ' 319' ' ' LEU . 51.5 t -106.46 117.67 56.52 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.521 1.138 . . . . 0.0 109.276 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.2 Cg_endo -75.03 164.6 32.98 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.473 1.775 . . . . 0.0 110.988 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.501 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -66.85 125.21 25.18 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.495 1.122 . . . . 0.0 109.287 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 99.03 -24.91 30.32 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 124.5 1.125 . . . . 0.0 111.002 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.514 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -63.64 144.74 56.77 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.49 0.759 . . . . 0.0 109.299 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 311' ' ' VAL . 2.7 p -97.54 135.82 30.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 0.0 109.288 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.617 HD12 HG12 ' A' ' 311' ' ' VAL . 12.2 mt -82.3 -49.17 17.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.541 1.15 . . . . 0.0 109.328 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' CYS . . . . . 0.605 ' SG ' HG23 ' A' ' 311' ' ' VAL . 12.8 p -142.96 163.63 32.27 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.522 1.139 . . . . 0.0 108.28 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 1.1 mmt-85 -103.81 178.34 4.59 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.515 1.135 . . . . 0.0 110.313 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.79 142.02 14.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.458 1.099 . . . . 0.0 109.317 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 46.82 43.92 17.12 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.536 1.148 . . . . 0.0 111.009 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.434 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.2 OUTLIER -71.38 166.93 34.32 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.485 0.756 . . . . 0.0 110.311 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.434 ' HD2' ' HB2' ' A' ' 267' ' ' GLU . 18.1 Cg_endo -75.01 86.91 1.37 Allowed 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.487 1.783 . . . . 0.0 111.0 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -45.54 97.9 0.01 OUTLIER Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.499 1.124 . . . . 0.0 110.979 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -170.19 38.11 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.539 0.788 . . . . 0.0 109.284 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.46 144.55 6.42 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.139 . . . . 0.0 110.299 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.504 ' HB2' HD11 ' A' ' 301' ' ' LEU . 2.1 ttt -113.94 146.65 39.78 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.501 1.125 . . . . 0.0 111.008 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.565 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 86.6 m-85 -138.07 136.63 37.0 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.488 1.117 . . . . 0.0 110.984 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . 0.469 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 23.0 m-85 -126.65 133.67 50.92 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.123 . . . . 0.0 110.986 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 36.9 t -89.67 135.2 26.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.495 1.122 . . . . 0.0 109.311 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.566 ' CG2' HD11 ' A' ' 320' ' ' LEU . 9.8 t -110.4 -49.1 6.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.535 1.147 . . . . 0.0 109.334 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -143.59 132.74 23.05 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.483 1.115 . . . . 0.0 110.253 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.99 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 121.95 -169.25 14.72 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.492 1.12 . . . . 0.0 111.023 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 7.6 t -138.33 117.0 12.2 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.555 0.797 . . . . 0.0 110.007 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.469 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 30.0 m -98.76 161.47 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.504 1.127 . . . . 0.0 109.28 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 28.9 t -127.97 151.18 49.44 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.414 1.071 . . . . 0.0 110.018 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 1.4 t -114.81 130.75 68.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.468 1.105 . . . . 0.0 109.328 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.769 ' HB3' ' H ' ' A' ' 310' ' ' THR . . . -77.99 102.14 7.24 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.469 1.106 . . . . 0.0 109.298 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . 0.655 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.29 -168.46 0.19 Allowed Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.502 1.126 . . . . 0.0 110.403 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.655 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -75.0 3.77 5.33 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.483 1.781 . . . . 0.0 110.936 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -151.45 157.48 34.82 Favored Pre-proline 0 C--N 1.324 -0.529 0 O-C-N 124.501 1.126 . . . . 0.0 109.302 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 94.73 0.96 Allowed 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.493 1.786 . . . . 0.0 110.95 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 281' ' ' SER . 61.5 t -98.94 118.92 46.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 0.0 109.3 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 14.2 mt-10 -124.28 139.11 54.22 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.433 1.083 . . . . 0.0 110.275 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.469 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 3.7 mm? -117.15 140.34 49.64 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.465 1.103 . . . . 0.0 109.299 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -96.5 -162.58 32.75 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.527 1.142 . . . . 0.0 111.061 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 141.47 26.68 Favored 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.567 1.825 . . . . 0.0 110.999 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.678 ' HA2' HD21 ' A' ' 229' ' ' LEU . . . 90.23 6.56 68.7 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.55 1.156 . . . . 0.0 110.971 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -91.69 131.8 36.82 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.484 0.756 . . . . 0.0 109.287 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -119.3 152.71 36.24 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.489 1.118 . . . . 0.0 110.995 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.565 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 45.2 p90 -163.57 145.63 9.58 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.483 1.114 . . . . 0.0 111.02 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . 0.464 ' O ' HD12 ' A' ' 301' ' ' LEU . . . 132.26 -3.53 5.17 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.513 1.133 . . . . 0.0 110.99 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.493 ' HG2' ' CE ' ' A' ' 272' ' ' MET . 1.7 mt-10 -59.41 -46.06 89.76 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.497 0.763 . . . . 0.0 110.294 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . 0.408 ' HB3' ' CG ' ' A' ' 305' ' ' GLU . 0.0 OUTLIER -52.03 -34.36 42.73 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.486 1.116 . . . . 0.0 110.997 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . 0.65 ' HB2' ' NH2' ' A' ' 307' ' ' ARG . . . -69.08 -45.06 71.23 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 0.0 109.289 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.504 HD11 ' HB2' ' A' ' 272' ' ' MET . 1.0 OUTLIER -75.37 -6.96 52.64 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.506 1.128 . . . . 0.0 109.251 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . 0.66 HD11 HD11 ' A' ' 235' ' ' LEU . 3.0 mm -82.25 -55.6 7.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.538 1.149 . . . . 0.0 109.337 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 304' ' ' GLY . 1.6 m -151.57 38.16 0.61 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.468 1.105 . . . . 0.0 110.011 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 36.68 53.14 1.44 Allowed Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.527 1.142 . . . . 0.0 111.005 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . 0.408 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 1.3 pt-20 -82.48 157.17 67.95 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.534 0.785 . . . . 0.0 110.312 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.07 133.82 16.95 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.467 1.772 . . . . 0.0 110.982 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . 0.65 ' NH2' ' HB2' ' A' ' 300' ' ' ALA . 0.0 OUTLIER -50.59 -26.0 4.82 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.45 1.094 . . . . 0.0 110.239 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.535 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 0.2 OUTLIER 46.73 39.14 6.71 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.486 1.116 . . . . 0.0 110.025 -180.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 173.91 161.05 0.16 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.514 1.134 . . . . 0.0 109.344 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.769 ' H ' ' HB3' ' A' ' 283' ' ' ALA . 0.6 OUTLIER -109.14 132.87 53.71 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.539 1.149 . . . . 0.0 110.388 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.617 HG12 HD12 ' A' ' 262' ' ' ILE . 44.5 t -111.7 131.56 62.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.483 1.115 . . . . 0.0 109.296 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 6.2 p -141.62 151.64 43.29 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.461 1.101 . . . . 0.0 109.991 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.42 118.48 26.89 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.526 1.141 . . . . 0.0 109.318 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -59.92 -32.24 70.58 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.505 1.128 . . . . 0.0 109.267 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' THR . . . . . 0.665 ' O ' HG23 ' A' ' 317' ' ' VAL . 13.1 t -153.97 -175.58 5.45 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.515 1.135 . . . . 0.0 110.362 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 41.7 p -49.29 92.46 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.531 1.144 . . . . 0.0 110.394 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.99 HG22 ' HA3' ' A' ' 278' ' ' GLY . 53.5 t -109.33 162.41 7.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.472 1.108 . . . . 0.0 109.273 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . 0.433 ' N ' ' CG1' ' A' ' 317' ' ' VAL . 64.0 m -136.29 116.64 13.63 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.514 1.134 . . . . 0.0 109.989 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . 0.469 ' CB ' ' O ' ' A' ' 274' ' ' PHE . 0.2 OUTLIER -132.0 172.25 12.59 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.472 1.107 . . . . 0.0 109.341 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.877 HD22 ' ND2' ' A' ' 226' ' ' ASN . 0.2 OUTLIER -124.66 135.74 53.32 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.495 1.122 . . . . 0.0 109.341 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 45.5 t -93.36 158.25 15.83 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.525 1.141 . . . . 0.0 110.01 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -151.77 94.6 2.0 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.483 1.115 . . . . 0.0 109.329 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . 0.413 ' CD2' ' H ' ' A' ' 323' ' ' HIS . 5.0 p80 -55.39 135.32 50.36 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 0.0 109.624 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 8.1 t -57.78 -17.07 13.53 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.499 1.124 . . . . 0.0 110.0 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -58.31 -36.74 73.82 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.533 1.145 . . . . 0.0 109.297 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -42.61 95.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.491 1.119 . . . . 0.0 109.285 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' PHE . . . . . 0.462 ' HB2' ' CD2' ' A' ' 301' ' ' LEU . 83.7 t80 -65.19 -36.14 83.28 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.46 1.1 . . . . 0.0 110.981 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -69.65 -31.75 70.0 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.464 1.102 . . . . 0.0 110.328 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -69.86 -45.12 68.42 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.538 1.149 . . . . 0.0 110.995 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 1.2 mt -71.27 -30.89 66.84 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.492 1.12 . . . . 0.0 109.274 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' CYS . . . . . 0.412 ' CB ' ' HB2' ' A' ' 338' ' ' ALA . 1.6 m -72.29 -37.52 68.99 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.535 1.147 . . . . 0.0 108.303 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.87 -36.28 64.81 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.44 1.088 . . . . 0.0 110.005 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.77 -33.56 70.9 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.517 1.135 . . . . 0.0 109.98 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . 0.596 ' CB ' HD12 ' A' ' 337' ' ' ILE . 0.6 OUTLIER -128.68 113.22 19.16 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.531 1.145 . . . . 0.0 109.985 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -22.27 14.97 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.429 1.752 . . . . 0.0 110.988 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -73.53 -31.57 63.75 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.467 1.105 . . . . 0.0 110.337 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.596 HD12 ' CB ' ' A' ' 334' ' ' SER . 60.5 mt -73.69 -45.53 50.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.542 1.151 . . . . 0.0 109.331 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . 0.412 ' HB2' ' CB ' ' A' ' 331' ' ' CYS . . . -69.26 -32.17 71.18 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 0.0 109.298 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -71.4 -38.38 71.46 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.469 1.105 . . . . 0.0 110.334 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.442 ' O ' HG22 ' A' ' 344' ' ' THR . 78.5 mt -73.1 -42.67 58.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.467 1.105 . . . . 0.0 109.341 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.578 ' CZ ' HD13 ' A' ' 235' ' ' LEU . 2.5 t80 -72.39 -30.72 64.93 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.513 1.133 . . . . 0.0 110.997 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . 0.47 ' HG3' ' CD1' ' A' ' 346' ' ' LEU . 0.0 OUTLIER -72.58 -43.21 63.67 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.511 1.132 . . . . 0.0 110.264 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -51.07 63.43 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.461 1.101 . . . . 0.0 109.323 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.545 HG22 ' HA ' ' A' ' 341' ' ' PHE . 9.0 t -65.02 -34.06 77.54 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.513 1.133 . . . . 0.0 110.355 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 341' ' ' PHE . . . -65.22 -43.4 91.62 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.542 1.151 . . . . 0.0 109.291 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.47 ' CD1' ' HG3' ' A' ' 342' ' ' ARG . 0.5 OUTLIER -65.03 -38.87 92.3 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.482 1.114 . . . . 0.0 109.286 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -68.88 -37.95 79.37 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.46 1.1 . . . . 0.0 110.32 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . 0.513 ' HE ' HD21 ' A' ' 235' ' ' LEU . 40.0 mtt-85 -72.43 -42.97 64.46 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.472 1.107 . . . . 0.0 110.345 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . 0.405 ' O ' ' C ' ' A' ' 350' ' ' GLY . 0.0 OUTLIER -72.56 -34.77 67.72 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.464 1.103 . . . . 0.0 110.31 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 349' ' ' ARG . . . -37.35 -47.95 1.57 Allowed Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.514 1.133 . . . . 0.0 110.99 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -154.95 120.07 4.94 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.555 0.797 . . . . 0.0 109.263 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -61.16 171.67 1.26 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.473 1.108 . . . . 0.0 109.297 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -134.16 123.28 24.12 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.439 1.087 . . . . 0.0 109.322 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 68.7 m -152.69 162.7 40.9 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.472 1.107 . . . . 0.0 109.991 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.53 0 O-C-N 124.572 1.17 . . . . 0.0 109.362 179.977 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.009 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 24.1 p -86.7 158.12 19.5 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.51 0.771 . . . . 0.0 109.997 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -141.34 147.47 38.16 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.53 1.144 . . . . 0.0 110.323 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.61 171.81 16.06 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.512 1.132 . . . . 0.0 110.315 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.57 178.98 3.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.509 1.13 . . . . 0.0 109.344 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -78.37 160.55 27.74 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.502 1.126 . . . . 0.0 110.268 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.27 157.2 45.01 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.521 1.138 . . . . 0.0 110.33 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -119.92 -37.67 0.75 Allowed Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.543 1.152 . . . . 0.0 110.983 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 35.0 p30 -92.09 19.38 6.89 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.459 0.741 . . . . 0.0 109.287 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -56.09 -40.5 73.76 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.518 1.137 . . . . 0.0 111.034 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.26 -32.58 58.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.485 1.115 . . . . 0.0 109.258 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.34 -35.39 71.17 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.532 1.145 . . . . 0.0 110.291 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.749 ' ND2' HD22 ' A' ' 320' ' ' LEU . 5.3 t-20 -78.95 -30.43 44.6 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.498 1.123 . . . . 0.0 109.25 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' TRP . . . . . 0.893 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 2.5 t90 -67.79 -45.52 74.59 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.502 1.126 . . . . 0.0 107.982 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.658 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 6.1 pt20 -71.54 -34.41 69.99 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.535 1.147 . . . . 0.0 110.339 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 6.2 mt -60.55 -43.83 96.8 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.479 1.112 . . . . 0.0 109.318 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.504 ' O ' HG12 ' A' ' 233' ' ' VAL . 82.7 t -75.5 -45.86 38.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.498 1.124 . . . . 0.0 109.324 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -69.16 -10.26 56.81 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.544 1.152 . . . . 0.0 109.299 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.658 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -80.42 -20.52 43.71 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.459 1.099 . . . . 0.0 109.268 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 230' ' ' VAL . 0.3 OUTLIER -91.74 126.92 52.15 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.491 1.12 . . . . 0.0 109.299 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.405 ' HA ' ' HB2' ' A' ' 237' ' ' GLN . 18.2 Cg_endo -75.01 -0.34 9.85 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.551 1.816 . . . . 0.0 111.029 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -24.12 32.06 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.508 1.13 . . . . 0.0 109.311 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.553 ' CE2' HD13 ' A' ' 247' ' ' ILE . 1.4 m-30 -120.4 -8.49 9.6 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.528 1.143 . . . . 0.0 111.029 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' GLN . . . . . 0.405 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 0.0 OUTLIER -61.66 -26.71 68.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.464 1.102 . . . . 0.0 110.258 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -74.71 -3.69 32.96 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.539 1.149 . . . . 0.0 109.342 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.594 HD13 HG11 ' A' ' 243' ' ' VAL . 66.5 mt -81.84 -179.32 7.34 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.509 1.131 . . . . 0.0 109.327 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . 0.567 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -100.73 -176.76 29.62 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.5 1.125 . . . . 0.0 111.016 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.942 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.1 Cg_endo -75.05 -38.84 1.39 Allowed 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.469 1.773 . . . . 0.0 110.991 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -66.37 -33.13 75.04 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 0.0 109.286 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.868 HG21 HD11 ' A' ' 337' ' ' ILE . 4.5 t -75.13 -42.02 44.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.503 1.127 . . . . 0.0 109.286 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.567 HD23 ' O ' ' A' ' 240' ' ' GLY . 1.3 mm? -65.34 -37.91 88.52 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.487 1.117 . . . . 0.0 109.271 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.942 HG23 ' O ' ' A' ' 241' ' ' PRO . 58.4 t -71.82 -38.33 65.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.504 1.128 . . . . 0.0 109.247 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -67.64 -40.1 84.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.502 1.126 . . . . 0.0 110.289 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.553 HD13 ' CE2' ' A' ' 236' ' ' PHE . 31.6 mt -68.48 -48.9 70.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.461 1.1 . . . . 0.0 109.312 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.537 ' HA ' HD12 ' A' ' 251' ' ' LEU . 68.6 t -64.32 -33.15 60.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.132 . . . . 0.0 109.286 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.496 ' CG ' ' O ' ' A' ' 245' ' ' VAL . 0.9 OUTLIER -75.84 -22.85 55.84 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.489 1.118 . . . . 0.0 110.332 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.636 ' HB1' ' OD1' ' A' ' 326' ' ' ASP . . . -90.53 -18.08 25.91 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.446 1.091 . . . . 0.0 109.282 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.537 HD12 ' HA ' ' A' ' 248' ' ' VAL . 0.3 OUTLIER -63.4 147.82 50.18 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.475 1.109 . . . . 0.0 109.288 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.97 134.26 55.29 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.541 1.15 . . . . 0.0 110.322 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -80.75 122.46 27.18 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.543 1.152 . . . . 0.0 109.323 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -123.73 123.3 40.21 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.482 1.113 . . . . 0.0 110.301 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 9.3 m -92.13 116.94 29.37 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.533 1.146 . . . . 0.0 110.41 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.489 HG21 HD11 ' A' ' 319' ' ' LEU . 77.4 t -106.67 112.22 63.65 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.548 1.155 . . . . 0.0 109.324 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.529 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.2 Cg_endo -75.0 175.37 11.33 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.501 1.79 . . . . 0.0 110.997 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.574 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -66.97 133.27 49.63 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.499 1.124 . . . . 0.0 109.359 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 90.42 -25.14 13.61 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.456 1.097 . . . . 0.0 110.99 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.529 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -57.66 147.24 28.07 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.53 0.783 . . . . 0.0 109.301 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.7 t -97.25 128.96 48.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.113 . . . . 0.0 109.307 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.795 HD12 HG12 ' A' ' 311' ' ' VAL . 38.7 mt -82.96 -39.17 15.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.467 1.105 . . . . 0.0 109.291 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' CYS . . . . . 0.466 ' SG ' HG23 ' A' ' 311' ' ' VAL . 14.2 p -159.47 151.27 20.46 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.507 1.129 . . . . 0.0 108.27 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 -95.16 -179.46 4.81 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.512 1.133 . . . . 0.0 110.303 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.493 HG23 ' OG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -75.95 139.26 19.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.526 1.141 . . . . 0.0 109.354 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 47.82 51.46 18.15 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.519 1.137 . . . . 0.0 110.999 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.413 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.2 OUTLIER -71.47 164.42 57.83 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.491 0.76 . . . . 0.0 110.306 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.43 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.3 Cg_endo -74.94 78.5 2.86 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.488 1.783 . . . . 0.0 111.045 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 268' ' ' PRO . . . -36.58 96.54 0.01 OUTLIER Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.514 1.134 . . . . 0.0 111.009 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 268' ' ' PRO . 0.3 OUTLIER -170.26 37.6 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.506 0.768 . . . . 0.0 109.283 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.415 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 0.2 OUTLIER -168.09 144.93 4.07 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.484 1.115 . . . . 0.0 110.291 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.487 ' SD ' ' CD1' ' A' ' 301' ' ' LEU . 0.1 OUTLIER -114.85 146.47 41.03 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 0.0 110.948 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.572 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 66.9 m-85 -133.46 136.7 45.31 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.474 1.109 . . . . 0.0 111.037 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . 0.449 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 22.0 m-85 -127.13 131.02 50.88 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.53 1.144 . . . . 0.0 111.046 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.575 HG12 ' HA ' ' A' ' 292' ' ' PRO . 45.7 t -87.07 137.7 20.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.501 1.126 . . . . 0.0 109.295 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.634 ' CG2' HD11 ' A' ' 320' ' ' LEU . 4.2 t -118.56 -40.54 2.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.533 1.145 . . . . 0.0 109.301 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -147.52 136.16 21.87 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.511 1.132 . . . . 0.0 110.339 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.954 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 112.31 -167.33 12.35 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.513 1.133 . . . . 0.0 110.999 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 290' ' ' LEU . 11.2 t -140.97 122.12 14.72 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.569 0.805 . . . . 0.0 109.997 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.467 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 21.1 m -99.27 163.56 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.511 1.132 . . . . 0.0 109.308 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 31.6 t -130.25 151.85 50.32 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.492 1.12 . . . . 0.0 110.03 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.418 ' CG2' ' HB ' ' A' ' 288' ' ' VAL . 0.8 OUTLIER -114.77 129.01 71.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.463 1.102 . . . . 0.0 109.316 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.42 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -80.06 101.06 8.49 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.517 1.135 . . . . 0.0 109.318 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . 0.661 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -149.04 -168.13 0.18 Allowed Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.554 1.159 . . . . 0.0 110.409 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.661 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.3 Cg_endo -74.98 5.49 3.94 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.448 1.762 . . . . 0.0 111.011 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.443 ' O ' HG23 ' A' ' 288' ' ' VAL . 11.9 m120 -151.59 153.37 31.98 Favored Pre-proline 0 C--N 1.324 -0.529 0 O-C-N 124.511 1.132 . . . . 0.0 109.348 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.95 97.48 1.08 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.509 1.794 . . . . 0.0 111.044 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 286' ' ' ASN . 2.3 t -102.78 119.24 50.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.469 1.106 . . . . 0.0 109.324 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 12.9 mt-10 -124.46 134.8 52.94 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.477 1.11 . . . . 0.0 110.271 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.467 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 3.9 mm? -112.97 141.59 46.62 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.488 1.118 . . . . 0.0 109.336 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -98.12 -164.72 31.13 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.466 1.104 . . . . 0.0 110.953 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' PRO . . . . . 0.575 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.1 Cg_endo -75.0 139.68 24.57 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.541 1.811 . . . . 0.0 111.007 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 96.6 1.93 60.19 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.509 1.131 . . . . 0.0 111.016 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . 0.41 ' CB ' HD12 ' A' ' 290' ' ' LEU . . . -87.64 144.68 26.54 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.529 0.782 . . . . 0.0 109.301 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -134.83 153.11 52.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.468 1.105 . . . . 0.0 110.958 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.572 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 45.9 p90 -163.89 146.25 9.38 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.508 1.13 . . . . 0.0 110.992 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . 0.474 ' O ' HD12 ' A' ' 301' ' ' LEU . . . 137.34 -10.33 3.8 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.455 1.097 . . . . 0.0 111.026 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.44 ' HG2' ' N ' ' A' ' 299' ' ' MET . 0.9 OUTLIER -52.46 -34.85 50.81 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.482 0.754 . . . . 0.0 110.282 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . 0.447 ' HB3' ' CG ' ' A' ' 305' ' ' GLU . 0.5 OUTLIER -64.27 -41.5 96.89 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.458 1.099 . . . . 0.0 111.032 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -63.67 -29.9 71.07 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.473 1.108 . . . . 0.0 109.296 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.487 ' CD1' ' SD ' ' A' ' 272' ' ' MET . 1.2 mt -86.34 -19.04 30.39 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.548 1.155 . . . . 0.0 109.286 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 298' ' ' GLU . 3.9 mm -68.56 -57.4 9.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.426 1.079 . . . . 0.0 109.33 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 304' ' ' GLY . 2.7 m -155.02 44.99 0.5 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.484 1.115 . . . . 0.0 110.021 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 303' ' ' SER . . . 35.4 51.15 0.98 Allowed Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.481 1.113 . . . . 0.0 111.005 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . 0.447 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 0.1 OUTLIER -78.76 155.02 78.37 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.504 0.767 . . . . 0.0 110.295 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 130.2 13.08 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.496 1.788 . . . . 0.0 111.003 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . 0.41 ' NE ' ' HG2' ' A' ' 267' ' ' GLU . 0.2 OUTLIER -44.61 -36.37 3.02 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.495 1.122 . . . . 0.0 110.321 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.679 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 0.8 OUTLIER 59.9 42.49 16.21 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.459 1.1 . . . . 0.0 109.967 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' ALA . . . . . 0.679 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 164.59 160.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.517 1.135 . . . . 0.0 109.315 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.493 ' OG1' HG23 ' A' ' 265' ' ' ILE . 0.9 OUTLIER -108.36 137.38 46.43 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.484 1.115 . . . . 0.0 110.387 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.795 HG12 HD12 ' A' ' 262' ' ' ILE . 61.6 t -116.92 131.38 69.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.459 1.1 . . . . 0.0 109.303 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 61.9 p -132.16 159.11 39.92 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.534 1.146 . . . . 0.0 110.008 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -93.6 118.3 31.2 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.547 1.155 . . . . 0.0 109.302 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -58.59 -35.26 72.13 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.499 1.124 . . . . 0.0 109.311 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' THR . . . . . 0.574 ' HA ' ' HB2' ' A' ' 258' ' ' ALA . 9.8 t -155.62 -172.5 4.17 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.491 1.119 . . . . 0.0 110.373 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . 0.426 ' N ' ' OG1' ' A' ' 315' ' ' THR . 32.0 m -49.49 91.33 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.508 1.13 . . . . 0.0 110.396 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.954 HG22 ' HA3' ' A' ' 278' ' ' GLY . 38.6 t -107.79 155.98 8.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.444 1.09 . . . . 0.0 109.281 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 31.0 m -132.56 114.25 14.03 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.491 1.119 . . . . 0.0 110.045 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . 0.489 HD11 HG21 ' A' ' 256' ' ' VAL . 0.2 OUTLIER -129.28 173.29 10.64 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 0.0 109.261 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.749 HD22 ' ND2' ' A' ' 226' ' ' ASN . 0.3 OUTLIER -124.2 138.18 54.44 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.434 1.084 . . . . 0.0 109.303 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 30.9 t -97.59 155.29 17.04 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.501 1.126 . . . . 0.0 109.976 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.739 ' O ' HD13 ' A' ' 322' ' ' LEU . 1.4 tm? -145.69 92.99 2.29 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.441 1.088 . . . . 0.0 109.282 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . 0.509 ' CE1' ' OD1' ' A' ' 326' ' ' ASP . 13.8 p80 -54.99 126.77 25.95 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.464 1.103 . . . . 0.0 109.638 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . 0.407 ' OG ' ' CG ' ' A' ' 270' ' ' ASP . 2.1 p -49.38 -26.92 3.55 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.476 1.11 . . . . 0.0 109.974 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -52.0 -30.46 25.25 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.492 1.12 . . . . 0.0 109.324 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . 0.636 ' OD1' ' HB1' ' A' ' 250' ' ' ALA . 0.2 OUTLIER -70.41 -41.85 72.41 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.448 1.092 . . . . 0.0 109.288 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' PHE . . . . . 0.672 ' CZ ' ' CE2' ' A' ' 341' ' ' PHE . 2.5 t80 -64.82 -38.82 92.28 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.486 1.116 . . . . 0.0 110.994 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -69.53 -34.13 73.8 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.424 1.077 . . . . 0.0 110.252 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 28.7 ttp -71.22 -32.24 68.56 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.465 1.103 . . . . 0.0 111.013 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.518 HD12 HG13 ' A' ' 243' ' ' VAL . 0.2 OUTLIER -72.78 -46.2 54.55 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.546 1.154 . . . . 0.0 109.278 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' CYS . . . . . 0.887 ' SG ' HG22 ' A' ' 337' ' ' ILE . 1.5 m -65.92 -32.38 73.85 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.527 1.142 . . . . 0.0 108.259 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 4.7 t -76.27 -29.8 57.57 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.486 1.116 . . . . 0.0 110.04 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 12.8 t -72.38 -38.19 68.54 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 0.0 109.983 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . 0.407 ' HA ' ' HD3' ' A' ' 335' ' ' PRO . 0.3 OUTLIER -127.86 130.15 23.66 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.461 1.101 . . . . 0.0 109.97 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 334' ' ' SER . 18.3 Cg_endo -75.0 -23.79 13.45 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.514 1.797 . . . . 0.0 111.035 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.55 -30.27 68.04 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.495 1.122 . . . . 0.0 110.351 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.887 HG22 ' SG ' ' A' ' 331' ' ' CYS . 49.4 mt -73.36 -36.86 50.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.498 1.124 . . . . 0.0 109.317 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -71.53 -34.63 70.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.502 1.126 . . . . 0.0 109.291 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -74.05 -45.13 51.48 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.512 1.132 . . . . 0.0 110.273 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 94.5 mt -69.82 -35.55 65.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.517 1.136 . . . . 0.0 109.316 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.672 ' CE2' ' CZ ' ' A' ' 327' ' ' PHE . 1.6 t80 -69.14 -39.46 78.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.523 1.14 . . . . 0.0 110.996 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.46 -38.05 77.57 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.479 1.112 . . . . 0.0 110.336 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -43.52 78.29 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.516 1.135 . . . . 0.0 109.311 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.91 -40.78 83.36 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.517 1.136 . . . . 0.0 110.414 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -66.37 -38.02 86.62 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.511 1.132 . . . . 0.0 109.282 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 346' ' ' LEU . 9.6 mt -68.59 -35.1 76.9 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.538 1.149 . . . . 0.0 109.344 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -69.69 -40.1 76.53 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.124 . . . . 0.0 110.286 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 13.9 mtt180 -70.19 -40.22 74.74 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.506 1.129 . . . . 0.0 110.314 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.72 -34.74 67.31 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.509 1.131 . . . . 0.0 110.327 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -38.37 -50.29 2.3 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.532 1.145 . . . . 0.0 110.986 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -153.67 121.1 5.85 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.471 0.748 . . . . 0.0 109.31 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -61.11 166.28 3.74 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.496 1.122 . . . . 0.0 109.287 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -119.3 120.15 36.12 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.491 1.119 . . . . 0.0 109.319 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 1.5 t -132.64 169.83 16.08 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.461 1.101 . . . . 0.0 110.027 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.537 1.148 . . . . 0.0 109.289 179.994 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.023 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 18.6 m -128.34 171.97 11.52 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.55 0.794 . . . . 0.0 110.029 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -100.78 172.65 6.93 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.581 1.176 . . . . 0.0 110.267 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -116.06 163.05 16.5 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.524 1.14 . . . . 0.0 110.324 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.619 HG13 ' HE ' ' A' ' 220' ' ' ARG . 11.2 p -151.61 159.73 3.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.498 1.124 . . . . 0.0 109.269 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.37 162.87 14.08 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.445 1.091 . . . . 0.0 110.339 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.619 ' HE ' HG13 ' A' ' 218' ' ' VAL . 2.6 mpt_? -136.75 158.63 44.01 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.446 1.091 . . . . 0.0 110.334 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -108.99 -34.4 2.57 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.509 1.13 . . . . 0.0 110.983 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.527 ' OD2' HG11 ' A' ' 276' ' ' VAL . 25.2 m-20 -92.07 19.39 6.86 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.457 0.739 . . . . 0.0 109.263 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -54.52 -40.05 68.22 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.455 1.097 . . . . 0.0 111.018 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.78 -37.94 43.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.439 1.087 . . . . 0.0 109.271 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.495 ' O ' HD12 ' A' ' 229' ' ' LEU . 0.0 OUTLIER -68.3 -31.1 70.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.144 . . . . 0.0 110.335 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.967 ' O ' HG12 ' A' ' 230' ' ' VAL . 6.4 t-20 -80.3 -31.55 38.19 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.532 1.145 . . . . 0.0 109.286 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' TRP . . . . . 0.712 ' CZ3' HG23 ' A' ' 245' ' ' VAL . 2.0 t90 -68.68 -43.98 75.0 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.674 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 4.1 pt20 -72.02 -33.82 68.34 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.454 1.096 . . . . 0.0 110.308 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.637 HD21 ' HA2' ' A' ' 293' ' ' GLY . 2.4 mt -64.94 -55.37 19.6 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 0.0 109.269 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.967 HG12 ' O ' ' A' ' 226' ' ' ASN . 5.7 p -65.09 -37.66 80.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.523 1.139 . . . . 0.0 109.34 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 227' ' ' TRP . . . -76.03 -15.1 60.19 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.478 1.111 . . . . 0.0 109.235 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.674 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -80.71 -11.33 59.64 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.503 1.127 . . . . 0.0 109.307 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . 0.729 HG12 ' O ' ' A' ' 230' ' ' VAL . 0.6 OUTLIER -89.02 132.61 37.46 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.547 1.155 . . . . 0.0 109.32 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.432 ' HA ' ' HB2' ' A' ' 237' ' ' GLN . 18.4 Cg_endo -74.97 -0.08 9.51 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.457 1.767 . . . . 0.0 111.028 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.25 -24.4 22.1 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 0.0 109.32 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.61 ' H ' HG13 ' A' ' 233' ' ' VAL . 21.2 m-30 -122.92 8.14 9.32 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.478 1.111 . . . . 0.0 110.987 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' GLN . . . . . 0.432 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 3.0 tt0 -73.16 -19.53 61.1 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.483 1.114 . . . . 0.0 110.286 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.438 ' NZ ' ' HA ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -97.57 4.99 50.14 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.527 1.142 . . . . 0.0 109.326 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.814 HD13 ' CG1' ' A' ' 243' ' ' VAL . 19.3 mt -80.28 -179.42 7.09 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.465 1.103 . . . . 0.0 109.316 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . 0.601 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -103.23 -178.48 26.3 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.499 1.124 . . . . 0.0 110.991 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 -32.9 5.04 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.53 1.805 . . . . 0.0 110.98 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.521 ' HA ' HG12 ' A' ' 245' ' ' VAL . . . -73.62 -32.81 64.26 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.445 1.09 . . . . 0.0 109.297 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.814 ' CG1' HD13 ' A' ' 239' ' ' LEU . 63.0 t -76.6 -38.39 31.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.126 . . . . 0.0 109.271 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.643 ' O ' HG23 ' A' ' 248' ' ' VAL . 3.6 mm? -71.31 -45.47 62.96 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.488 1.118 . . . . 0.0 109.289 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.712 HG23 ' CZ3' ' A' ' 227' ' ' TRP . 3.3 p -64.65 -45.09 96.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.528 1.142 . . . . 0.0 109.317 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.402 ' N ' ' CG1' ' A' ' 245' ' ' VAL . 15.3 tp10 -65.0 -40.89 95.62 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.509 1.13 . . . . 0.0 110.262 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.591 ' CG1' HD13 ' A' ' 330' ' ' LEU . 26.5 mt -65.16 -43.83 95.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.493 1.121 . . . . 0.0 109.303 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 244' ' ' LEU . 75.7 t -69.51 -30.99 47.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.504 1.128 . . . . 0.0 109.277 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -76.87 -19.6 57.27 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.55 1.156 . . . . 0.0 110.324 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.611 ' HB1' ' OD2' ' A' ' 326' ' ' ASP . . . -93.82 -14.84 25.71 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.539 1.149 . . . . 0.0 109.302 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.464 HD22 ' HB2' ' A' ' 320' ' ' LEU . 0.2 OUTLIER -66.12 146.35 54.76 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.541 1.151 . . . . 0.0 109.293 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 320' ' ' LEU . 1.0 OUTLIER -117.82 117.96 30.73 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.555 1.159 . . . . 0.0 110.288 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.737 ' HB2' HD23 ' A' ' 320' ' ' LEU . . . -80.79 125.03 29.56 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.436 1.085 . . . . 0.0 109.289 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -132.56 143.89 50.02 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.491 1.119 . . . . 0.0 110.275 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 20.1 m -96.64 125.93 41.45 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 0.0 110.413 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.792 HG21 HD11 ' A' ' 319' ' ' LEU . 93.4 t -106.39 116.14 59.7 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.537 1.148 . . . . 0.0 109.345 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.483 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.9 162.12 37.86 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.513 1.796 . . . . 0.0 111.026 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.502 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -63.71 125.19 23.52 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.475 1.109 . . . . 0.0 109.317 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 100.7 -25.27 28.96 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.489 1.118 . . . . 0.0 110.988 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.483 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -64.02 139.15 58.74 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.459 0.74 . . . . 0.0 109.295 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 311' ' ' VAL . 2.7 p -93.25 135.64 27.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.466 1.104 . . . . 0.0 109.282 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.785 HD12 HG12 ' A' ' 311' ' ' VAL . 11.2 mt -82.49 -49.35 17.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.531 1.144 . . . . 0.0 109.284 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' CYS . . . . . 0.655 ' SG ' HG23 ' A' ' 311' ' ' VAL . 12.4 p -141.7 162.43 35.5 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.531 1.144 . . . . 0.0 108.255 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -103.93 -179.01 3.83 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.449 1.093 . . . . 0.0 110.28 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.32 137.41 22.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 0.0 109.299 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 47.01 48.91 18.87 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.504 1.128 . . . . 0.0 111.028 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.416 ' OE1' ' C ' ' A' ' 268' ' ' PRO . 0.0 OUTLIER -71.26 162.6 71.71 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.455 0.738 . . . . 0.0 110.333 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 269' ' ' GLY . 18.5 Cg_endo -74.98 78.07 2.98 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.521 1.801 . . . . 0.0 111.041 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . 0.464 ' O ' ' CA ' ' A' ' 304' ' ' GLY . . . -35.23 102.73 0.01 OUTLIER Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.527 1.142 . . . . 0.0 110.973 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -170.33 38.31 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 0.765 . . . . 0.0 109.293 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.45 144.86 2.01 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.131 . . . . 0.0 110.293 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.97 146.56 37.62 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.511 1.132 . . . . 0.0 111.057 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.562 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 20.1 m-85 -137.55 136.78 37.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.486 1.117 . . . . 0.0 111.021 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . 0.484 ' O ' ' CB ' ' A' ' 319' ' ' LEU . 21.4 m-85 -127.25 135.95 51.32 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.537 1.148 . . . . 0.0 111.005 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.531 HG12 ' HA ' ' A' ' 292' ' ' PRO . 25.4 t -93.57 138.65 19.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.46 1.1 . . . . 0.0 109.305 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.527 HG11 ' OD2' ' A' ' 222' ' ' ASP . 2.7 t -115.99 -48.49 4.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.469 1.106 . . . . 0.0 109.274 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -140.2 132.99 29.07 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.528 1.143 . . . . 0.0 110.304 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.933 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 118.34 -173.35 14.83 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.531 1.144 . . . . 0.0 110.997 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 290' ' ' LEU . 8.4 t -134.73 122.29 21.95 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.52 0.776 . . . . 0.0 110.012 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.456 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 26.1 m -100.08 163.86 2.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.492 1.12 . . . . 0.0 109.302 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 31.1 t -129.24 152.51 48.74 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 0.0 109.993 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 1.5 t -115.96 128.87 73.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.467 1.105 . . . . 0.0 109.3 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.619 ' HB3' ' H ' ' A' ' 310' ' ' THR . . . -78.43 101.66 7.4 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.48 1.113 . . . . 0.0 109.319 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . 0.664 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.9 OUTLIER -148.54 -167.96 0.17 Allowed Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.485 1.116 . . . . 0.0 110.366 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.664 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.5 Cg_endo -74.96 4.77 4.42 Favored 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.524 1.802 . . . . 0.0 111.057 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.444 ' O ' HG23 ' A' ' 288' ' ' VAL . 17.4 m120 -152.0 155.25 33.45 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.477 1.11 . . . . 0.0 109.31 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 96.52 1.02 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.545 1.813 . . . . 0.0 111.032 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 286' ' ' ASN . 2.1 t -101.52 119.54 49.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.536 1.148 . . . . 0.0 109.281 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 280' ' ' VAL . 14.3 mt-10 -124.29 136.09 53.87 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.484 1.115 . . . . 0.0 110.321 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.456 ' HB2' ' CG2' ' A' ' 280' ' ' VAL . 3.8 mm? -115.44 141.77 47.6 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.483 1.115 . . . . 0.0 109.341 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -94.11 -160.21 34.51 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.505 1.128 . . . . 0.0 110.982 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' PRO . . . . . 0.531 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.2 Cg_endo -75.01 148.27 35.01 Favored 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.513 1.796 . . . . 0.0 111.009 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.637 ' HA2' HD21 ' A' ' 229' ' ' LEU . . . 86.46 -0.62 87.06 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.499 1.125 . . . . 0.0 110.984 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -83.49 123.43 29.71 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.478 0.752 . . . . 0.0 109.279 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.481 ' HD2' HD23 ' A' ' 229' ' ' LEU . 3.8 p90 -114.82 152.92 31.33 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.482 1.114 . . . . 0.0 111.006 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.562 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 37.5 p90 -160.57 147.99 15.91 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.518 1.136 . . . . 0.0 111.046 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 134.72 -8.35 4.56 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.548 1.155 . . . . 0.0 111.007 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -52.58 -41.9 64.02 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.458 0.74 . . . . 0.0 110.284 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . 0.466 ' HB3' ' CG ' ' A' ' 305' ' ' GLU . 0.1 OUTLIER -54.92 -41.08 70.54 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.494 1.121 . . . . 0.0 111.006 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . 0.434 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -66.92 -35.7 80.6 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.509 1.131 . . . . 0.0 109.258 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.45 ' O ' ' CZ ' ' A' ' 341' ' ' PHE . 6.5 mt -75.01 -20.31 59.68 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.511 1.132 . . . . 0.0 109.261 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 3.3 mm -73.06 -54.97 14.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.129 . . . . 0.0 109.329 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.85 40.39 0.23 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.456 1.098 . . . . 0.0 110.015 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.464 ' CA ' ' O ' ' A' ' 269' ' ' GLY . . . 39.6 40.65 1.52 Allowed Glycine 0 CA--C 1.531 1.052 0 O-C-N 124.497 1.123 . . . . 0.0 110.989 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . 0.466 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 0.0 OUTLIER -66.11 158.65 75.67 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.509 0.77 . . . . 0.0 110.292 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.403 ' O ' ' OE2' ' A' ' 305' ' ' GLU . 18.5 Cg_endo -74.95 130.69 13.56 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.528 1.804 . . . . 0.0 111.02 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.9 -40.89 14.95 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.516 1.135 . . . . 0.0 110.318 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.555 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 0.5 OUTLIER 68.19 34.43 3.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.493 1.121 . . . . 0.0 110.044 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' ALA . . . . . 0.555 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 172.78 161.98 0.12 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.521 1.138 . . . . 0.0 109.282 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.619 ' H ' ' HB3' ' A' ' 283' ' ' ALA . 0.5 OUTLIER -107.71 130.99 54.89 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.538 1.149 . . . . 0.0 110.416 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.785 HG12 HD12 ' A' ' 262' ' ' ILE . 41.6 t -109.75 131.48 60.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.472 1.108 . . . . 0.0 109.343 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 3.2 p -139.2 152.33 47.28 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.11 . . . . 0.0 109.993 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.94 117.17 26.61 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.474 1.109 . . . . 0.0 109.297 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -59.62 -31.48 69.53 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.547 1.154 . . . . 0.0 109.317 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' THR . . . . . 0.739 ' O ' HG23 ' A' ' 317' ' ' VAL . 8.1 t -154.59 -175.36 5.37 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.472 1.108 . . . . 0.0 110.405 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . 0.401 ' H ' HG23 ' A' ' 316' ' ' THR . 65.1 p -49.73 92.81 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.514 1.134 . . . . 0.0 110.392 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.933 HG22 ' HA3' ' A' ' 278' ' ' GLY . 75.8 t -110.23 152.07 12.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.498 1.124 . . . . 0.0 109.31 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 70.3 m -123.96 117.42 24.73 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.548 1.155 . . . . 0.0 109.988 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . 0.792 HD11 HG21 ' A' ' 256' ' ' VAL . 0.2 OUTLIER -134.06 169.38 17.22 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.481 1.113 . . . . 0.0 109.293 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.737 HD23 ' HB2' ' A' ' 253' ' ' ALA . 0.0 OUTLIER -124.35 139.05 54.27 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.473 1.108 . . . . 0.0 109.314 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 3.2 p -95.04 158.17 15.58 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.534 1.146 . . . . 0.0 110.002 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.46 ' O ' HD13 ' A' ' 322' ' ' LEU . 1.5 tm? -151.0 77.69 1.28 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.471 1.107 . . . . 0.0 109.305 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -42.54 141.46 1.01 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.416 1.072 . . . . 0.0 109.577 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -24.82 63.57 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.447 1.092 . . . . 0.0 109.963 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -52.21 -35.87 50.53 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.521 1.138 . . . . 0.0 109.292 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . 0.611 ' OD2' ' HB1' ' A' ' 250' ' ' ALA . 0.4 OUTLIER -71.6 -37.33 70.97 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.542 1.151 . . . . 0.0 109.329 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' PHE . . . . . 0.417 ' CE2' ' CE2' ' A' ' 341' ' ' PHE . 38.4 t80 -66.51 -41.18 89.23 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.484 1.115 . . . . 0.0 111.031 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -71.29 -31.52 67.55 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.503 1.127 . . . . 0.0 110.297 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.403 ' SD ' ' C ' ' A' ' 329' ' ' MET . 15.6 tmm? -68.54 -43.74 76.03 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.548 1.155 . . . . 0.0 111.014 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.591 HD13 ' CG1' ' A' ' 247' ' ' ILE . 5.0 mt -71.39 -37.78 71.53 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.521 1.138 . . . . 0.0 109.265 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' CYS . . . . . 0.422 ' SG ' HG22 ' A' ' 337' ' ' ILE . 73.6 m -65.88 -41.68 91.25 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.531 1.144 . . . . 0.0 108.29 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.4 t -77.55 -24.42 49.86 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.471 1.107 . . . . 0.0 110.01 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 47.6 t -72.21 -39.02 68.87 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.533 1.145 . . . . 0.0 110.034 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . 0.706 ' CB ' HD12 ' A' ' 337' ' ' ILE . 0.1 OUTLIER -129.03 133.83 25.64 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.482 1.114 . . . . 0.0 109.978 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 334' ' ' SER . 18.4 Cg_endo -74.98 -23.75 13.53 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.54 1.81 . . . . 0.0 110.974 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -72.26 -29.32 63.79 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.5 1.125 . . . . 0.0 110.328 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.706 HD12 ' CB ' ' A' ' 334' ' ' SER . 30.9 mt -72.98 -42.71 59.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.483 1.114 . . . . 0.0 109.281 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.74 -30.72 67.32 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.55 1.157 . . . . 0.0 109.297 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -73.61 -43.76 58.79 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.564 1.165 . . . . 0.0 110.36 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 76.1 mt -70.76 -39.42 75.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.513 1.133 . . . . 0.0 109.298 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.491 ' CD1' ' C ' ' A' ' 341' ' ' PHE . 0.5 OUTLIER -66.95 -41.46 86.91 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.488 1.118 . . . . 0.0 111.005 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 -70.48 -33.41 71.22 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.504 1.128 . . . . 0.0 110.303 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -50.54 66.53 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.504 1.127 . . . . 0.0 109.323 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.455 HG22 ' O ' ' A' ' 341' ' ' PHE . 6.0 t -65.11 -39.12 92.68 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.541 1.151 . . . . 0.0 110.433 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -66.77 -33.78 76.37 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.471 1.107 . . . . 0.0 109.282 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.504 ' HA ' HD23 ' A' ' 346' ' ' LEU . 10.2 mt -71.83 -36.9 70.34 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.514 1.134 . . . . 0.0 109.314 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -76.26 -30.8 57.98 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.535 1.147 . . . . 0.0 110.3 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 7.0 mtt-85 -72.05 -41.12 67.83 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.472 1.107 . . . . 0.0 110.335 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.81 -34.86 67.14 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.519 1.137 . . . . 0.0 110.272 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -38.58 -48.87 2.38 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.515 1.135 . . . . 0.0 110.976 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -154.92 121.97 5.53 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.514 0.773 . . . . 0.0 109.246 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -64.68 175.95 1.29 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.484 1.115 . . . . 0.0 109.29 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -143.1 120.03 11.31 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.502 1.126 . . . . 0.0 109.347 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 3.6 m -155.0 170.2 22.31 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.526 1.141 . . . . 0.0 109.985 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.45 1.094 . . . . 0.0 109.334 179.982 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.988 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.66 172.72 6.67 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.534 0.785 . . . . 0.0 110.013 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.89 168.74 11.81 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.495 1.122 . . . . 0.0 110.291 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -128.78 155.63 44.83 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.547 1.155 . . . . 0.0 110.303 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 14.7 p -151.77 145.72 15.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.477 1.111 . . . . 0.0 109.293 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.35 158.45 41.54 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.483 1.114 . . . . 0.0 110.31 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -121.98 159.4 27.04 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.563 1.164 . . . . 0.0 110.278 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -96.6 -37.81 4.65 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.552 1.157 . . . . 0.0 111.045 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 226' ' ' ASN . 41.2 p30 -91.59 18.44 7.43 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.542 0.79 . . . . 0.0 109.293 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -53.58 -40.87 65.99 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.521 1.138 . . . . 0.0 110.98 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.65 -39.45 60.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.467 1.104 . . . . 0.0 109.321 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.654 ' HG2' HG13 ' A' ' 276' ' ' VAL . 0.1 OUTLIER -69.21 -29.78 67.81 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.493 1.121 . . . . 0.0 110.322 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.448 ' CG ' HG23 ' A' ' 248' ' ' VAL . 39.6 t-20 -78.12 -32.66 50.55 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.452 1.095 . . . . 0.0 109.299 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' TRP . . . . . 0.726 ' CH2' HG23 ' A' ' 245' ' ' VAL . 2.8 t90 -73.99 -42.94 59.66 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.519 1.137 . . . . 0.0 108.026 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.411 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 1.5 pt20 -70.38 -28.79 65.37 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.505 1.128 . . . . 0.0 110.314 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.623 HD12 ' HG3' ' A' ' 225' ' ' ARG . 3.3 mt -69.14 -54.96 12.21 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.515 1.134 . . . . 0.0 109.316 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.608 HG21 ' HB ' ' A' ' 248' ' ' VAL . 33.0 m -65.02 -32.04 56.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.497 1.123 . . . . 0.0 109.323 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -76.13 -24.63 54.91 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.111 . . . . 0.0 109.271 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -80.54 1.21 30.49 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.488 1.117 . . . . 0.0 109.289 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 229' ' ' LEU . 96.7 t -92.07 118.75 68.34 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.518 1.136 . . . . 0.0 109.311 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.417 ' HA ' ' HB2' ' A' ' 237' ' ' GLN . 18.2 Cg_endo -75.0 -21.96 15.3 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.536 1.808 . . . . 0.0 110.989 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.98 -30.56 71.63 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.496 1.123 . . . . 0.0 109.325 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.861 ' HB3' HD12 ' A' ' 239' ' ' LEU . 24.4 m-85 -112.42 20.31 16.81 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.482 1.114 . . . . 0.0 110.985 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' GLN . . . . . 0.417 ' HB2' ' HA ' ' A' ' 234' ' ' PRO . 1.0 OUTLIER -68.12 -18.57 64.67 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.485 1.116 . . . . 0.0 110.316 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -86.99 -14.16 42.46 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.465 1.103 . . . . 0.0 109.322 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.861 HD12 ' HB3' ' A' ' 236' ' ' PHE . 55.6 mt -68.5 176.29 2.97 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.507 1.129 . . . . 0.0 109.277 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . 0.604 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -109.63 -171.97 20.53 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.445 1.09 . . . . 0.0 110.974 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -32.39 5.43 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.463 1.77 . . . . 0.0 111.004 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.522 ' HA ' HG12 ' A' ' 245' ' ' VAL . . . -72.9 -32.92 65.69 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.48 1.112 . . . . 0.0 109.309 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.827 ' CG1' HD13 ' A' ' 239' ' ' LEU . 54.5 t -76.82 -38.64 29.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.491 1.119 . . . . 0.0 109.295 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.604 HD23 ' O ' ' A' ' 240' ' ' GLY . 2.9 mm? -71.0 -44.41 65.95 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.521 1.138 . . . . 0.0 109.239 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.726 HG23 ' CH2' ' A' ' 227' ' ' TRP . 3.0 p -66.27 -39.77 85.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.448 1.093 . . . . 0.0 109.271 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -69.87 -40.29 75.8 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.543 1.152 . . . . 0.0 110.319 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.75 ' O ' HD13 ' A' ' 251' ' ' LEU . 46.0 mt -65.63 -55.16 21.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.497 1.123 . . . . 0.0 109.271 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.608 ' HB ' HG21 ' A' ' 230' ' ' VAL . 4.2 p -60.81 -30.63 47.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.54 1.15 . . . . 0.0 109.363 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.517 ' CG ' ' O ' ' A' ' 245' ' ' VAL . 14.3 mmt180 -79.21 -16.84 55.93 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.527 1.142 . . . . 0.0 110.287 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -95.56 -16.05 22.41 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.513 1.133 . . . . 0.0 109.286 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 1.019 HD12 HD23 ' A' ' 322' ' ' LEU . 7.9 mp -65.28 151.76 45.4 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.563 1.164 . . . . 0.0 109.316 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 6.0 tpt85 -121.12 116.18 24.5 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.496 1.123 . . . . 0.0 110.283 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.693 ' HB2' HD23 ' A' ' 320' ' ' LEU . . . -80.59 122.73 27.42 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.493 1.12 . . . . 0.0 109.266 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.45 141.07 52.26 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.48 1.112 . . . . 0.0 110.297 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.2 m -91.51 118.24 30.41 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.494 1.121 . . . . 0.0 110.349 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.664 ' CG1' ' HB2' ' A' ' 313' ' ' ALA . 4.0 t -106.36 114.19 62.47 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.536 1.148 . . . . 0.0 109.329 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.505 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -74.93 171.64 17.9 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.493 1.786 . . . . 0.0 110.978 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.519 ' CB ' ' HA ' ' A' ' 315' ' ' THR . . . -67.73 129.13 38.95 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.535 1.147 . . . . 0.0 109.316 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 96.07 -25.55 24.95 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.55 1.156 . . . . 0.0 110.994 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.533 ' HB3' HG13 ' A' ' 256' ' ' VAL . . . -58.95 138.3 57.51 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.516 0.774 . . . . 0.0 109.262 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 9.3 t -83.34 126.65 40.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.496 1.123 . . . . 0.0 109.334 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.61 HD12 HG12 ' A' ' 311' ' ' VAL . 94.9 mt -82.92 -45.49 19.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.476 1.11 . . . . 0.0 109.307 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' CYS . . . . . 0.609 ' SG ' HG23 ' A' ' 311' ' ' VAL . 7.9 p -152.72 143.87 23.13 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.493 1.12 . . . . 0.0 108.321 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -86.81 176.67 7.6 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.513 1.133 . . . . 0.0 110.281 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.444 HG23 ' OG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -78.25 148.56 6.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.492 1.12 . . . . 0.0 109.286 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 37.08 47.44 1.36 Allowed Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.469 1.106 . . . . 0.0 110.981 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.445 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.0 OUTLIER -70.25 165.21 46.19 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.516 0.774 . . . . 0.0 110.3 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 267' ' ' GLU . 18.2 Cg_endo -75.06 76.39 3.44 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.525 1.803 . . . . 0.0 110.983 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 268' ' ' PRO . . . -36.71 105.95 0.04 OUTLIER Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.576 1.173 . . . . 0.0 110.994 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -170.51 37.37 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.481 0.754 . . . . 0.0 109.29 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -172.31 156.83 3.94 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.476 1.11 . . . . 0.0 110.301 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.686 ' HG3' HD12 ' A' ' 301' ' ' LEU . 0.0 OUTLIER -122.6 146.47 47.41 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.467 1.105 . . . . 0.0 111.022 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.591 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 13.6 m-85 -133.21 143.37 49.11 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.471 1.107 . . . . 0.0 111.033 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -133.15 125.2 28.95 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.515 1.134 . . . . 0.0 110.987 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.547 HG22 HD12 ' A' ' 319' ' ' LEU . 56.4 t -78.22 129.32 37.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.431 1.082 . . . . 0.0 109.319 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.838 ' CG2' HD11 ' A' ' 320' ' ' LEU . 59.3 t -101.55 -54.05 7.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.506 1.129 . . . . 0.0 109.323 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.714 ' O ' HG23 ' A' ' 317' ' ' VAL . 15.6 mt-10 -141.83 140.71 33.02 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.542 1.151 . . . . 0.0 110.274 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 113.15 -155.87 16.01 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.526 1.142 . . . . 0.0 111.01 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 290' ' ' LEU . 1.8 m -145.96 139.36 26.13 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.487 0.757 . . . . 0.0 110.001 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.579 HG12 HD11 ' A' ' 262' ' ' ILE . 27.1 m -120.76 135.57 60.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.555 1.159 . . . . 0.0 109.266 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 29.9 t -104.27 139.77 38.81 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.429 1.08 . . . . 0.0 109.968 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 1.3 t -103.88 129.66 55.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.471 1.107 . . . . 0.0 109.322 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.413 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -78.05 101.36 6.92 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.543 1.152 . . . . 0.0 109.358 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . 0.662 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -149.0 -168.0 0.17 Allowed Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.5 1.125 . . . . 0.0 110.427 -179.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.662 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.2 Cg_endo -75.01 4.43 4.75 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.502 1.79 . . . . 0.0 111.007 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -152.27 154.59 32.37 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.529 1.143 . . . . 0.0 109.309 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 95.12 0.96 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.46 1.769 . . . . 0.0 110.983 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 281' ' ' SER . 19.3 t -100.15 118.39 46.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.56 1.163 . . . . 0.0 109.331 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.407 ' C ' HD22 ' A' ' 290' ' ' LEU . 3.4 mm-40 -125.38 133.74 52.42 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.489 1.118 . . . . 0.0 110.324 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.407 HD22 ' C ' ' A' ' 289' ' ' GLU . 4.6 mm? -114.51 139.71 49.34 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.52 1.138 . . . . 0.0 109.289 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -93.72 -157.43 33.17 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.564 1.165 . . . . 0.0 111.007 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 147.86 34.49 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.509 1.794 . . . . 0.0 111.005 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 85.95 5.85 83.02 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.532 1.145 . . . . 0.0 111.034 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -85.61 146.27 26.95 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.539 0.788 . . . . 0.0 109.332 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 295' ' ' PHE . 1.0 OUTLIER -132.95 152.81 51.87 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.549 1.156 . . . . 0.0 110.99 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.591 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 46.3 p90 -165.77 143.88 5.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.553 1.158 . . . . 0.0 110.958 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 129.59 -6.73 6.22 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.48 1.113 . . . . 0.0 110.994 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -52.09 -48.43 64.71 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.503 0.767 . . . . 0.0 110.275 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . 0.442 ' HB3' ' CG ' ' A' ' 305' ' ' GLU . 0.0 OUTLIER -50.21 -37.45 35.28 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.502 1.126 . . . . 0.0 111.047 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -66.13 -40.34 90.58 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.466 1.104 . . . . 0.0 109.298 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.686 HD12 ' HG3' ' A' ' 272' ' ' MET . 27.7 mt -74.84 -21.64 59.15 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 0.0 109.306 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 15.0 mm -67.16 -57.64 9.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.458 1.099 . . . . 0.0 109.303 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 304' ' ' GLY . 7.4 m -155.96 44.85 0.44 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.532 1.145 . . . . 0.0 109.98 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 35.69 49.9 1.04 Allowed Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.531 1.144 . . . . 0.0 111.041 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . 0.442 ' CG ' ' HB3' ' A' ' 299' ' ' MET . 0.0 OUTLIER -80.26 158.8 71.45 Favored Pre-proline 0 C--N 1.326 -0.443 0 O-C-N 124.497 0.763 . . . . 0.0 110.271 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.01 130.25 13.09 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.525 1.802 . . . . 0.0 111.032 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -47.07 -39.34 12.82 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.5 1.125 . . . . 0.0 110.275 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.503 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 15.0 m 67.77 30.34 6.4 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.478 1.111 . . . . 0.0 109.995 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 175.67 162.26 0.3 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.532 1.145 . . . . 0.0 109.299 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.444 ' OG1' HG23 ' A' ' 265' ' ' ILE . 0.9 OUTLIER -113.04 137.6 51.17 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.515 1.135 . . . . 0.0 110.398 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.61 HG12 HD12 ' A' ' 262' ' ' ILE . 95.1 t -109.43 127.62 66.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.504 1.128 . . . . 0.0 109.318 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 48.3 p -121.94 145.28 48.26 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.501 1.126 . . . . 0.0 110.026 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . 0.758 ' HB1' HG12 ' A' ' 317' ' ' VAL . . . -79.53 106.23 11.41 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.536 1.148 . . . . 0.0 109.28 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -52.99 -24.64 9.89 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.473 1.108 . . . . 0.0 109.325 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' THR . . . . . 0.636 ' O ' HG12 ' A' ' 317' ' ' VAL . 8.8 t -168.09 -164.64 0.55 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.495 1.122 . . . . 0.0 110.38 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . 0.438 ' N ' ' OG1' ' A' ' 315' ' ' THR . 29.2 p -61.35 79.11 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.508 1.13 . . . . 0.0 110.443 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.819 HG22 ' CD1' ' A' ' 319' ' ' LEU . 2.7 p -110.74 141.88 24.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.5 1.125 . . . . 0.0 109.277 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . 1.019 ' C ' HD13 ' A' ' 319' ' ' LEU . 53.4 m -117.57 136.51 53.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.454 1.096 . . . . 0.0 109.949 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . 1.019 HD13 ' C ' ' A' ' 318' ' ' SER . 0.0 OUTLIER -135.86 173.77 11.35 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.479 1.112 . . . . 0.0 109.309 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.838 HD11 ' CG2' ' A' ' 276' ' ' VAL . 0.1 OUTLIER -124.22 125.19 44.0 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.528 1.143 . . . . 0.0 109.292 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 272' ' ' MET . 25.8 p -86.97 158.67 19.22 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.518 1.136 . . . . 0.0 110.036 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 1.019 HD23 HD12 ' A' ' 251' ' ' LEU . 3.1 tm? -145.44 86.71 1.76 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.491 1.119 . . . . 0.0 109.311 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . 0.536 ' CE1' ' OD1' ' A' ' 326' ' ' ASP . 6.0 p80 -50.7 137.31 20.26 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.535 1.147 . . . . 0.0 109.605 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.19 -26.11 62.39 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.473 1.108 . . . . 0.0 110.004 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -53.6 -36.76 62.31 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.459 1.1 . . . . 0.0 109.311 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . 0.536 ' OD1' ' CE1' ' A' ' 323' ' ' HIS . 0.6 OUTLIER -64.99 -41.45 95.4 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.485 1.116 . . . . 0.0 109.317 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' PHE . . . . . 0.49 ' CE1' ' CE2' ' A' ' 341' ' ' PHE . 71.9 t80 -66.84 -34.96 78.95 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.439 1.087 . . . . 0.0 110.965 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -69.86 -33.99 73.0 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.482 1.113 . . . . 0.0 110.288 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 30.4 ttp -70.19 -43.88 69.84 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.441 1.088 . . . . 0.0 111.014 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 2.7 mt -71.66 -35.38 70.31 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.505 1.128 . . . . 0.0 109.286 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' CYS . . . . . . . . . . . . . 41.6 m -72.31 -30.63 64.95 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.52 1.137 . . . . 0.0 108.278 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 33.0 t -75.78 -34.49 60.23 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.518 1.136 . . . . 0.0 110.021 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.48 -36.3 65.79 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.528 1.142 . . . . 0.0 109.97 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.5 114.32 27.25 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 0.0 109.975 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -22.51 14.81 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.448 1.762 . . . . 0.0 111.007 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -71.91 -29.34 64.21 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.562 1.164 . . . . 0.0 110.286 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.671 HD11 HG21 ' A' ' 243' ' ' VAL . 44.5 mt -71.95 -40.14 67.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.134 . . . . 0.0 109.26 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.55 -31.84 65.59 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 0.0 109.278 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -74.95 -42.15 58.2 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.562 1.164 . . . . 0.0 110.288 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . . . . . . . . . 86.3 mt -70.96 -42.81 77.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.486 1.116 . . . . 0.0 109.287 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.49 ' CE2' ' CE1' ' A' ' 327' ' ' PHE . 24.8 t80 -67.46 -39.61 85.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.521 1.138 . . . . 0.0 111.039 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -68.12 -37.32 80.99 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.526 1.141 . . . . 0.0 110.303 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -44.09 84.16 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.52 1.137 . . . . 0.0 109.281 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 341' ' ' PHE . 0.6 OUTLIER -67.99 -32.62 73.15 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.465 1.103 . . . . 0.0 110.377 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -69.91 -41.15 75.07 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.45 1.094 . . . . 0.0 109.333 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' A' ' 346' ' ' LEU . 14.5 mt -65.2 -41.42 94.55 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.468 1.105 . . . . 0.0 109.283 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -65.81 -37.64 86.81 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.112 . . . . 0.0 110.3 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 28.3 mtt-85 -72.76 -44.72 61.26 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.512 1.133 . . . . 0.0 110.325 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -34.77 77.56 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.515 1.134 . . . . 0.0 110.302 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -37.52 -46.22 1.48 Allowed Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.53 1.144 . . . . 0.0 111.046 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -155.01 120.03 4.9 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.575 0.809 . . . . 0.0 109.3 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -60.61 172.24 0.95 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.501 1.125 . . . . 0.0 109.313 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -130.13 125.15 34.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.503 1.127 . . . . 0.0 109.317 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 29.7 p -129.65 154.76 46.8 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.496 1.123 . . . . 0.0 110.01 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.499 0 O-C-N 124.521 1.138 . . . . 0.0 109.278 -179.982 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.986 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 13.1 m -139.5 167.72 21.45 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.44 0.729 . . . . 0.0 110.025 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.72 170.9 12.74 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.529 1.143 . . . . 0.0 110.314 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -121.86 162.71 20.48 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.502 1.126 . . . . 0.0 110.301 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 76.0 t -145.65 150.22 15.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.555 1.159 . . . . 0.0 109.3 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -68.1 174.52 3.79 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.528 1.142 . . . . 0.0 110.299 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 10.9 mtt180 -140.9 157.45 45.35 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.456 1.097 . . . . 0.0 110.233 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -111.08 -33.15 2.42 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.478 1.111 . . . . 0.0 110.985 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 41.8 p30 -94.68 19.62 9.71 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.519 0.776 . . . . 0.0 109.293 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.4 ' CE1' HG11 ' A' ' 248' ' ' VAL . 1.6 t80 -56.36 -38.63 71.69 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.499 1.124 . . . . 0.0 111.024 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.57 -35.44 56.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.466 1.104 . . . . 0.0 109.276 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.767 ' O ' HD23 ' A' ' 229' ' ' LEU . 0.5 OUTLIER -70.72 -31.56 68.44 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.478 1.111 . . . . 0.0 110.311 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.455 ' ND2' ' CD1' ' A' ' 320' ' ' LEU . 4.1 m-20 -81.23 -31.57 33.77 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.532 1.145 . . . . 0.0 109.276 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' TRP . . . . . 0.89 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 2.0 t90 -70.61 -43.75 68.67 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.455 ' O ' ' N ' ' A' ' 232' ' ' ALA . 1.5 pt20 -70.89 -37.28 73.0 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.494 1.121 . . . . 0.0 110.278 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.909 HD12 ' HB3' ' A' ' 274' ' ' PHE . 1.6 mm? -60.18 -42.75 95.69 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.51 1.131 . . . . 0.0 109.314 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.688 HG13 ' CD1' ' A' ' 244' ' ' LEU . 12.7 p -74.23 -38.74 48.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.515 1.135 . . . . 0.0 109.284 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -75.15 -11.51 60.1 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.472 1.107 . . . . 0.0 109.33 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 228' ' ' GLN . . . -81.15 -7.83 59.64 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.496 1.123 . . . . 0.0 109.297 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 1.5 t -98.64 130.06 28.74 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.522 1.139 . . . . 0.0 109.298 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 -16.0 20.33 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.472 1.775 . . . . 0.0 110.971 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.677 HD12 ' CE2' ' A' ' 341' ' ' PHE . 0.0 OUTLIER -81.08 -23.84 38.18 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.519 1.137 . . . . 0.0 109.314 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.719 ' CE1' HD13 ' A' ' 247' ' ' ILE . 30.7 m-85 -102.95 -19.22 14.69 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.454 1.096 . . . . 0.0 111.018 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.51 -22.91 67.1 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.463 1.102 . . . . 0.0 110.28 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -76.77 -1.59 28.85 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.502 1.126 . . . . 0.0 109.294 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.586 ' HB3' HG11 ' A' ' 243' ' ' VAL . 8.4 mt -94.38 -179.78 5.03 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.437 1.086 . . . . 0.0 109.278 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -98.45 -174.42 32.61 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.518 1.136 . . . . 0.0 110.969 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.9 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.4 Cg_endo -75.01 -35.48 3.1 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.451 1.764 . . . . 0.0 110.97 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.1 -33.37 75.32 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.461 1.101 . . . . 0.0 109.299 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.795 HG21 HD11 ' A' ' 337' ' ' ILE . 2.7 t -75.18 -42.4 44.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.535 1.147 . . . . 0.0 109.327 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.688 ' CD1' HG13 ' A' ' 230' ' ' VAL . 0.3 OUTLIER -65.63 -36.82 84.8 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.524 1.14 . . . . 0.0 109.289 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 241' ' ' PRO . 87.8 t -69.15 -43.18 81.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.449 1.093 . . . . 0.0 109.278 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -44.17 91.68 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 0.0 110.312 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.719 HD13 ' CE1' ' A' ' 236' ' ' PHE . 90.0 mt -65.6 -37.16 79.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.495 1.122 . . . . 0.0 109.3 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 244' ' ' LEU . 14.4 t -67.54 -34.97 71.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.506 1.128 . . . . 0.0 109.31 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -24.84 59.92 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.49 1.118 . . . . 0.0 110.274 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.472 ' CB ' ' OD1' ' A' ' 326' ' ' ASP . . . -87.22 -21.59 25.75 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.477 1.111 . . . . 0.0 109.291 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.471 HD22 ' HB2' ' A' ' 320' ' ' LEU . 3.0 mt -55.9 136.48 51.56 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.484 1.115 . . . . 0.0 109.283 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.42 134.76 55.06 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.494 1.121 . . . . 0.0 110.265 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.554 ' HA ' HD22 ' A' ' 320' ' ' LEU . . . -80.15 129.6 34.62 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.525 1.141 . . . . 0.0 109.323 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 319' ' ' LEU . 6.7 ttm-85 -133.62 121.28 21.8 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.513 1.133 . . . . 0.0 110.333 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 20.0 m -91.79 116.57 29.0 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.532 1.145 . . . . 0.0 110.436 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.689 HG21 HD11 ' A' ' 319' ' ' LEU . 97.3 t -106.68 113.14 63.22 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.473 1.108 . . . . 0.0 109.263 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.51 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.4 Cg_endo -75.0 171.45 18.31 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.5 1.789 . . . . 0.0 111.04 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.519 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -67.33 128.58 36.93 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.465 1.103 . . . . 0.0 109.325 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 96.85 -25.11 28.11 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.489 1.118 . . . . 0.0 110.992 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.51 ' CB ' ' HD2' ' A' ' 257' ' ' PRO . . . -60.64 149.14 36.04 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.532 0.784 . . . . 0.0 109.306 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.3 t -97.28 131.61 43.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 124.494 1.121 . . . . 0.0 109.331 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.768 HD12 HG12 ' A' ' 311' ' ' VAL . 45.8 mt -83.41 -41.65 17.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.468 1.105 . . . . 0.0 109.309 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' CYS . . . . . 0.423 ' SG ' HG23 ' A' ' 311' ' ' VAL . 14.9 p -158.34 151.09 22.35 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.452 1.095 . . . . 0.0 108.273 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -94.32 -178.81 4.71 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.472 1.108 . . . . 0.0 110.305 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.457 HG23 ' OG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -74.64 143.99 12.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.101 . . . . 0.0 109.321 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 41.47 53.95 4.13 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.537 1.148 . . . . 0.0 110.987 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.409 ' OE1' ' C ' ' A' ' 268' ' ' PRO . 0.3 OUTLIER -70.61 163.5 63.13 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.498 0.764 . . . . 0.0 110.295 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.452 ' O ' ' N ' ' A' ' 270' ' ' ASP . 18.1 Cg_endo -75.01 81.43 2.22 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.476 1.777 . . . . 0.0 110.965 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -36.65 95.76 0.01 OUTLIER Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.559 1.162 . . . . 0.0 111.037 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 268' ' ' PRO . 6.8 m-20 -170.83 38.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.519 0.776 . . . . 0.0 109.305 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.411 ' CG ' ' HA ' ' A' ' 323' ' ' HIS . 0.0 OUTLIER -170.01 144.62 2.74 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.508 1.13 . . . . 0.0 110.233 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.593 ' SD ' ' CZ ' ' A' ' 274' ' ' PHE . 0.0 OUTLIER -114.4 147.38 39.29 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.126 . . . . 0.0 111.003 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.583 ' HD2' HD13 ' A' ' 319' ' ' LEU . 50.3 m-85 -135.91 137.64 41.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.452 1.095 . . . . 0.0 111.026 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . 0.909 ' HB3' HD12 ' A' ' 229' ' ' LEU . 17.8 m-85 -129.11 130.29 46.27 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.548 1.155 . . . . 0.0 111.014 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 292' ' ' PRO . 29.1 t -86.28 130.48 36.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.488 1.117 . . . . 0.0 109.33 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.636 HG13 ' HD2' ' A' ' 225' ' ' ARG . 2.6 t -110.87 -44.39 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.479 1.112 . . . . 0.0 109.274 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.406 ' O ' HG13 ' A' ' 317' ' ' VAL . 2.9 mt-10 -145.85 132.79 20.2 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 0.0 110.299 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.902 ' HA3' HG22 ' A' ' 317' ' ' VAL . . . 117.06 -177.68 16.79 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.545 1.153 . . . . 0.0 111.003 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 290' ' ' LEU . 5.4 t -128.94 121.79 28.81 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.497 0.763 . . . . 0.0 110.014 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.464 ' CG2' ' HB2' ' A' ' 290' ' ' LEU . 24.1 m -99.87 161.18 3.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.474 1.109 . . . . 0.0 109.286 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 29.4 t -129.41 149.6 51.12 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.537 1.148 . . . . 0.0 110.006 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 1.4 t -112.45 131.44 63.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.493 1.121 . . . . 0.0 109.331 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.403 ' C ' ' CG2' ' A' ' 284' ' ' THR . . . -79.85 101.92 8.81 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.46 1.1 . . . . 0.0 109.268 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . 0.654 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.8 OUTLIER -148.41 -168.32 0.18 Allowed Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.508 1.13 . . . . 0.0 110.396 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.654 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.4 Cg_endo -75.0 4.8 4.42 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.491 1.785 . . . . 0.0 111.038 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -151.59 155.69 34.27 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.481 1.113 . . . . 0.0 109.286 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.07 95.85 1.0 Allowed 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.517 1.798 . . . . 0.0 111.029 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 281' ' ' SER . 6.0 t -100.42 119.3 48.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.455 1.097 . . . . 0.0 109.33 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.503 ' C ' HD22 ' A' ' 290' ' ' LEU . 15.1 mt-10 -124.9 141.68 51.96 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.493 1.121 . . . . 0.0 110.332 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.503 HD22 ' C ' ' A' ' 289' ' ' GLU . 4.4 mm? -120.69 142.5 49.43 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.546 1.154 . . . . 0.0 109.276 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -93.79 -163.43 36.34 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.529 1.143 . . . . 0.0 111.023 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' PRO . . . . . 0.537 ' HA ' HG12 ' A' ' 275' ' ' VAL . 18.4 Cg_endo -74.94 149.63 37.28 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.502 1.791 . . . . 0.0 110.995 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 86.95 -0.07 85.99 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.481 1.113 . . . . 0.0 110.974 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -79.65 146.21 32.6 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.488 0.757 . . . . 0.0 109.362 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -132.84 152.69 51.78 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.516 1.135 . . . . 0.0 111.012 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.552 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 40.7 p90 -166.57 147.65 6.23 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.496 1.123 . . . . 0.0 110.959 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . 0.467 ' CA ' ' HE3' ' A' ' 272' ' ' MET . . . 129.8 -10.38 6.03 Favored Glycine 0 CA--C 1.531 1.053 0 O-C-N 124.544 1.153 . . . . 0.0 110.995 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -52.57 -41.78 63.89 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.532 0.784 . . . . 0.0 110.316 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . 0.583 ' HA ' HD12 ' A' ' 302' ' ' ILE . 0.8 OUTLIER -54.83 -37.28 65.97 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.503 1.127 . . . . 0.0 111.015 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -67.72 -39.21 84.31 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.496 1.123 . . . . 0.0 109.284 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.467 ' CD1' ' HG3' ' A' ' 272' ' ' MET . 5.7 mt -76.44 -13.67 60.1 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.503 1.127 . . . . 0.0 109.265 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' A' ' 299' ' ' MET . 32.2 mt -77.3 -54.5 12.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.514 1.134 . . . . 0.0 109.295 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.441 ' O ' ' N ' ' A' ' 305' ' ' GLU . 46.4 p -155.07 42.05 0.45 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.506 1.129 . . . . 0.0 109.986 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 37.07 31.56 0.06 OUTLIER Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.501 1.126 . . . . 0.0 110.998 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 303' ' ' SER . 0.1 OUTLIER -61.71 157.12 50.8 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.52 0.777 . . . . 0.0 110.322 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 128.99 11.91 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.51 1.795 . . . . 0.0 111.044 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . 0.423 HH11 ' HB2' ' A' ' 300' ' ' ALA . 0.0 OUTLIER -44.52 -40.29 5.53 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.506 1.129 . . . . 0.0 110.294 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.66 ' O ' ' HB2' ' A' ' 309' ' ' ALA . 22.8 t 64.87 43.31 4.0 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.486 1.117 . . . . 0.0 110.02 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' ALA . . . . . 0.66 ' HB2' ' O ' ' A' ' 308' ' ' SER . . . 165.86 159.76 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.48 1.113 . . . . 0.0 109.291 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.457 ' OG1' HG23 ' A' ' 265' ' ' ILE . 1.0 OUTLIER -110.38 133.92 52.8 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.465 1.103 . . . . 0.0 110.416 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.768 HG12 HD12 ' A' ' 262' ' ' ILE . 55.3 t -113.06 129.39 68.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.525 1.14 . . . . 0.0 109.294 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 60.3 p -129.59 156.71 43.76 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.542 1.151 . . . . 0.0 110.02 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -92.53 115.57 28.22 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.515 1.135 . . . . 0.0 109.312 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -59.5 -32.65 70.48 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.481 1.113 . . . . 0.0 109.287 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' THR . . . . . 0.653 ' O ' HG23 ' A' ' 317' ' ' VAL . 11.0 t -154.6 -173.14 4.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.506 1.129 . . . . 0.0 110.385 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . 0.413 HG23 ' H ' ' A' ' 316' ' ' THR . 65.4 p -52.2 88.54 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.503 1.127 . . . . 0.0 110.391 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.902 HG22 ' HA3' ' A' ' 278' ' ' GLY . 68.9 t -103.57 154.35 5.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 O-C-N 124.539 1.149 . . . . 0.0 109.308 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 49.1 m -129.07 113.89 15.69 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.482 1.114 . . . . 0.0 109.998 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . 1.03 ' C ' HD23 ' A' ' 320' ' ' LEU . 0.2 OUTLIER -129.0 170.44 13.46 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.136 . . . . 0.0 109.266 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 1.03 HD23 ' C ' ' A' ' 319' ' ' LEU . 0.6 OUTLIER -121.79 139.87 53.06 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.518 1.136 . . . . 0.0 109.327 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 64.8 p -95.6 158.79 15.3 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.122 . . . . 0.0 109.982 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.503 ' O ' HD13 ' A' ' 322' ' ' LEU . 3.3 tm? -148.64 82.36 1.46 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.496 1.122 . . . . 0.0 109.312 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . 0.572 ' ND1' ' HB3' ' A' ' 325' ' ' ALA . 8.5 p80 -47.63 136.99 9.7 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.504 1.127 . . . . 0.0 109.599 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.95 -20.93 6.89 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.504 1.128 . . . . 0.0 109.981 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 0.572 ' HB3' ' ND1' ' A' ' 323' ' ' HIS . . . -51.9 -38.24 55.48 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.522 1.139 . . . . 0.0 109.291 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . 0.472 ' OD1' ' CB ' ' A' ' 250' ' ' ALA . 36.0 t70 -63.94 -37.08 86.09 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.541 1.151 . . . . 0.0 109.257 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' PHE . . . . . 0.472 ' CZ ' ' CE2' ' A' ' 341' ' ' PHE . 6.1 t80 -66.96 -40.02 87.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.48 1.112 . . . . 0.0 110.96 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -66.0 -33.24 75.35 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.527 1.142 . . . . 0.0 110.301 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 50.9 ttp -70.91 -39.33 72.79 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.549 1.155 . . . . 0.0 111.004 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.683 HD11 HG13 ' A' ' 247' ' ' ILE . 0.1 OUTLIER -68.7 -39.23 80.58 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.487 1.117 . . . . 0.0 109.293 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 338' ' ' ALA . 19.8 t -70.97 -32.97 69.99 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.45 1.093 . . . . 0.0 108.268 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 19.1 t -72.87 -31.08 64.47 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.482 1.114 . . . . 0.0 110.039 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.9 t -83.3 -37.86 22.88 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.447 1.092 . . . . 0.0 110.022 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.12 107.94 17.94 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.539 1.149 . . . . 0.0 110.009 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -21.01 16.33 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.466 1.772 . . . . 0.0 110.978 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -72.58 -28.52 62.85 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.519 1.137 . . . . 0.0 110.319 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.795 HD11 HG21 ' A' ' 243' ' ' VAL . 46.2 mt -65.46 -32.88 60.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 0.0 109.308 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . 0.589 ' HB2' ' SG ' ' A' ' 331' ' ' CYS . . . -70.74 -35.06 72.5 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.536 1.147 . . . . 0.0 109.31 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -71.42 -34.79 70.63 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.518 1.136 . . . . 0.0 110.338 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.486 ' O ' HG22 ' A' ' 344' ' ' THR . 66.1 mt -73.06 -42.53 59.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.124 . . . . 0.0 109.303 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.677 ' CE2' HD12 ' A' ' 235' ' ' LEU . 1.0 OUTLIER -70.98 -31.2 67.68 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 0.0 111.02 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . 0.491 ' O ' HD12 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -73.24 -41.07 64.13 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.48 1.113 . . . . 0.0 110.282 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.13 -50.51 65.73 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.423 1.077 . . . . 0.0 109.305 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.5 HG22 ' HA ' ' A' ' 341' ' ' PHE . 7.4 t -64.97 -37.68 88.45 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.514 1.134 . . . . 0.0 110.429 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 341' ' ' PHE . . . -65.15 -43.32 92.24 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.504 1.127 . . . . 0.0 109.335 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 342' ' ' ARG . 0.4 OUTLIER -64.9 -35.12 80.13 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 0.0 109.256 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -69.42 -37.77 77.58 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.543 1.152 . . . . 0.0 110.33 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -72.64 -43.87 62.63 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.464 1.102 . . . . 0.0 110.309 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.61 -34.68 77.48 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.549 1.156 . . . . 0.0 110.273 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -38.21 -48.56 2.13 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.501 1.126 . . . . 0.0 111.014 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -154.77 120.98 5.28 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.536 0.786 . . . . 0.0 109.296 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -61.48 171.15 1.55 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.469 1.106 . . . . 0.0 109.333 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -116.43 123.17 46.86 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.49 1.119 . . . . 0.0 109.308 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 89.9 p -129.04 160.6 32.26 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.514 1.134 . . . . 0.0 109.996 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.481 1.113 . . . . 0.0 109.338 179.961 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.002 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 2.0 m -139.63 162.72 34.43 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.509 0.77 . . . . 0.0 110.01 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -137.69 171.05 15.01 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.467 1.104 . . . . 0.0 110.345 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.64 153.71 44.98 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.522 1.139 . . . . 0.0 110.286 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.7 p -109.42 145.06 16.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.48 1.113 . . . . 0.0 109.317 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.5 165.31 8.1 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.483 1.114 . . . . 0.0 110.295 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.9 mmt85 -126.13 157.74 37.3 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.493 1.121 . . . . 0.0 110.278 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -116.04 -32.73 1.63 Allowed Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.496 1.122 . . . . 0.0 111.008 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 16.3 p30 -97.27 14.04 27.41 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.537 0.787 . . . . 0.0 109.318 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -53.61 -38.59 64.15 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.507 1.129 . . . . 0.0 110.966 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.74 -35.15 59.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.486 1.117 . . . . 0.0 109.283 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.534 ' HD3' HD23 ' A' ' 229' ' ' LEU . 0.0 OUTLIER -67.6 -36.61 81.2 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.509 1.131 . . . . 0.0 110.323 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.792 ' HB3' HD13 ' A' ' 251' ' ' LEU . 1.6 m-20 -75.1 -30.19 60.83 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.478 1.111 . . . . 0.0 109.288 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' TRP . . . . . 0.679 ' CZ2' HG22 ' A' ' 245' ' ' VAL . 1.6 t90 -67.63 -49.51 62.64 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.505 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 6.0 pt20 -67.22 -30.94 70.99 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.54 1.15 . . . . 0.0 110.312 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.534 HD23 ' HD3' ' A' ' 225' ' ' ARG . 0.6 OUTLIER -64.54 -47.14 79.93 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.508 1.13 . . . . 0.0 109.3 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.778 HG23 ' CD1' ' A' ' 244' ' ' LEU . 34.9 m -70.11 -37.63 72.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.501 1.125 . . . . 0.0 109.304 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -75.83 -14.97 60.3 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.479 1.112 . . . . 0.0 109.308 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 228' ' ' GLN . . . -82.27 -25.15 34.3 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.567 1.167 . . . . 0.0 109.337 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 230' ' ' VAL . 0.3 OUTLIER -86.94 133.51 39.11 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.483 1.114 . . . . 0.0 109.311 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 -4.35 15.27 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.498 1.789 . . . . 0.0 111.012 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.98 -24.07 33.08 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.492 1.12 . . . . 0.0 109.32 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.516 ' O ' HD21 ' A' ' 244' ' ' LEU . 17.4 m-30 -119.73 -1.26 10.59 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.467 1.105 . . . . 0.0 110.986 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -71.69 -23.39 61.65 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.513 1.133 . . . . 0.0 110.309 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.442 ' NZ ' ' HA ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -92.55 7.59 42.58 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.482 1.114 . . . . 0.0 109.316 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.566 HD22 HG11 ' A' ' 243' ' ' VAL . 86.4 mt -89.26 179.76 6.04 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.48 1.113 . . . . 0.0 109.265 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . 0.669 ' O ' HD23 ' A' ' 244' ' ' LEU . . . -98.21 -176.94 33.18 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.506 1.129 . . . . 0.0 111.036 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.981 ' O ' HG23 ' A' ' 245' ' ' VAL . 18.3 Cg_endo -75.0 -37.33 2.07 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.5 1.789 . . . . 0.0 110.985 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.84 -34.68 77.19 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.464 1.102 . . . . 0.0 109.3 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.566 HG11 HD22 ' A' ' 239' ' ' LEU . 14.1 t -75.4 -38.02 39.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.514 1.134 . . . . 0.0 109.317 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.778 ' CD1' HG23 ' A' ' 230' ' ' VAL . 1.4 mm? -66.79 -35.84 81.0 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.514 1.133 . . . . 0.0 109.305 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.981 HG23 ' O ' ' A' ' 241' ' ' PRO . 60.9 t -74.39 -38.88 47.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.485 1.116 . . . . 0.0 109.296 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -65.25 -48.39 73.43 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.519 1.137 . . . . 0.0 110.268 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.552 HG13 HD13 ' A' ' 330' ' ' LEU . 32.1 mt -63.15 -43.27 98.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.524 1.14 . . . . 0.0 109.316 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 244' ' ' LEU . 41.2 t -65.29 -38.21 82.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.459 1.1 . . . . 0.0 109.269 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -72.49 -19.25 61.58 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.422 1.076 . . . . 0.0 110.292 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -91.82 -16.3 26.96 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.521 1.138 . . . . 0.0 109.303 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.792 HD13 ' HB3' ' A' ' 226' ' ' ASN . 2.2 mt -66.84 129.27 39.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.495 1.122 . . . . 0.0 109.313 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 320' ' ' LEU . 3.2 tpt85 -110.15 118.08 35.41 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.492 1.12 . . . . 0.0 110.308 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.536 ' HB2' HD23 ' A' ' 320' ' ' LEU . . . -80.15 136.77 36.58 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.458 1.099 . . . . 0.0 109.311 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.47 ' HD2' HD23 ' A' ' 319' ' ' LEU . 0.0 OUTLIER -143.06 139.67 30.6 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.547 1.155 . . . . 0.0 110.339 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.0 m -92.4 117.92 30.41 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.561 1.163 . . . . 0.0 110.373 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.631 HG12 ' CB ' ' A' ' 313' ' ' ALA . 37.1 t -107.33 112.77 62.57 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.499 1.124 . . . . 0.0 109.285 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.457 ' HD2' ' CB ' ' A' ' 260' ' ' ALA . 18.3 Cg_endo -74.99 173.33 14.7 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.485 1.782 . . . . 0.0 111.006 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.633 ' HB2' ' HA ' ' A' ' 315' ' ' THR . . . -67.37 130.38 42.89 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.543 1.152 . . . . 0.0 109.301 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 95.48 -25.28 25.37 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.519 1.137 . . . . 0.0 111.01 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.608 ' HB3' HG13 ' A' ' 256' ' ' VAL . . . -56.43 140.59 45.27 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.496 0.762 . . . . 0.0 109.326 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.648 HG21 HH21 ' A' ' 264' ' ' ARG . 3.7 t -92.28 127.17 44.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.491 1.119 . . . . 0.0 109.34 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.842 HD12 HG12 ' A' ' 311' ' ' VAL . 40.8 mt -85.03 -41.91 16.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.477 1.111 . . . . 0.0 109.325 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' CYS . . . . . . . . . . . . . 11.9 p -155.81 148.87 24.43 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.536 1.147 . . . . 0.0 108.296 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' ARG . . . . . 0.648 HH21 HG21 ' A' ' 261' ' ' VAL . 2.0 mmt85 -92.35 178.57 5.8 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.491 1.119 . . . . 0.0 110.329 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.574 HG23 ' OG1' ' A' ' 310' ' ' THR . 0.1 OUTLIER -76.42 141.59 15.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.495 1.122 . . . . 0.0 109.304 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 46.23 46.83 16.08 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.52 1.138 . . . . 0.0 111.006 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.453 ' HB2' ' HD2' ' A' ' 268' ' ' PRO . 0.0 OUTLIER -70.19 164.91 48.8 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 124.451 0.736 . . . . 0.0 110.299 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 267' ' ' GLU . 18.4 Cg_endo -75.0 77.04 3.22 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.502 1.791 . . . . 0.0 111.03 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 268' ' ' PRO . . . -35.84 100.21 0.01 OUTLIER Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.452 1.095 . . . . 0.0 111.016 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -169.76 38.09 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.545 0.791 . . . . 0.0 109.315 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -171.33 147.14 2.42 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.129 . . . . 0.0 110.281 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.872 ' HB2' HD11 ' A' ' 301' ' ' LEU . 2.0 ttt -116.67 150.45 38.13 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.479 1.112 . . . . 0.0 111.003 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.577 ' HB2' ' CE2' ' A' ' 296' ' ' PHE . 14.8 m-85 -135.43 136.9 41.73 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.453 1.095 . . . . 0.0 110.973 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . 0.47 ' CD1' ' CB ' ' A' ' 295' ' ' PHE . 22.8 m-30 -125.66 124.38 41.02 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.494 1.121 . . . . 0.0 110.959 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.441 HG22 HD12 ' A' ' 319' ' ' LEU . 85.2 t -80.03 135.81 24.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.515 1.134 . . . . 0.0 109.255 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.656 HG12 ' HG3' ' A' ' 277' ' ' GLU . 99.1 t -108.73 -56.01 4.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.461 1.101 . . . . 0.0 109.27 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.656 ' HG3' HG12 ' A' ' 276' ' ' VAL . 16.8 mt-10 -139.98 138.88 35.88 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.456 1.097 . . . . 0.0 110.314 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.01 -154.72 16.59 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.452 1.095 . . . . 0.0 111.03 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 290' ' ' LEU . 3.7 m -150.76 135.92 17.67 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.511 0.771 . . . . 0.0 110.029 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 289' ' ' GLU . 13.6 m -115.16 166.06 9.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.5 1.125 . . . . 0.0 109.321 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 288' ' ' VAL . 28.8 t -131.33 149.44 52.55 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.457 1.098 . . . . 0.0 110.007 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.51 131.17 66.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.533 1.145 . . . . 0.0 109.304 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.478 ' HB3' ' H ' ' A' ' 310' ' ' THR . . . -79.7 101.87 8.65 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.52 1.137 . . . . 0.0 109.31 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . 0.648 ' CB ' ' CD ' ' A' ' 285' ' ' PRO . 0.7 OUTLIER -148.27 -168.5 0.19 Allowed Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.458 1.099 . . . . 0.0 110.423 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.648 ' CD ' ' CB ' ' A' ' 284' ' ' THR . 18.4 Cg_endo -74.95 4.89 4.31 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.533 1.807 . . . . 0.0 111.063 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -151.58 156.65 34.72 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.459 1.1 . . . . 0.0 109.293 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.91 95.37 0.97 Allowed 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.466 1.772 . . . . 0.0 111.032 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 281' ' ' SER . 24.1 t -99.53 118.9 46.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.105 . . . . 0.0 109.346 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.444 ' C ' HD22 ' A' ' 290' ' ' LEU . 14.4 mt-10 -124.76 138.16 54.29 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.511 1.132 . . . . 0.0 110.321 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.444 HD22 ' C ' ' A' ' 289' ' ' GLU . 4.3 mm? -119.84 142.19 48.87 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.51 1.131 . . . . 0.0 109.275 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -96.28 -153.25 29.65 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.53 1.144 . . . . 0.0 110.981 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 151.88 39.98 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.491 1.785 . . . . 0.0 111.021 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 76.99 6.35 85.82 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.52 1.138 . . . . 0.0 110.956 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -87.4 113.72 23.36 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.528 0.781 . . . . 0.0 109.279 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.47 ' CB ' ' CD1' ' A' ' 274' ' ' PHE . 15.1 p90 -107.15 152.98 23.33 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.488 1.117 . . . . 0.0 110.986 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' A' ' 273' ' ' PHE . 20.6 p90 -159.07 153.65 24.38 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.465 1.103 . . . . 0.0 110.98 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 123.17 -9.02 8.98 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.522 1.139 . . . . 0.0 111.041 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.438 ' HG2' ' N ' ' A' ' 299' ' ' MET . 0.4 OUTLIER -52.37 -37.21 55.69 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.469 0.747 . . . . 0.0 110.273 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . 0.438 ' N ' ' HG2' ' A' ' 298' ' ' GLU . 1.2 mmt -60.13 -32.09 70.68 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 0.0 110.976 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 304' ' ' GLY . . . -75.02 -37.27 61.83 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.446 1.091 . . . . 0.0 109.298 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.872 HD11 ' HB2' ' A' ' 272' ' ' MET . 0.9 OUTLIER -78.11 -11.61 59.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.546 1.154 . . . . 0.0 109.321 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 299' ' ' MET . 35.0 mt -83.82 -52.87 12.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.495 1.122 . . . . 0.0 109.274 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.454 ' O ' ' C ' ' A' ' 304' ' ' GLY . 3.4 m -153.21 39.08 0.51 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.528 1.143 . . . . 0.0 110.02 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 300' ' ' ALA . . . 33.07 43.76 0.21 Allowed Glycine 0 CA--C 1.529 0.966 0 O-C-N 124.493 1.121 . . . . 0.0 111.061 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.61 157.71 88.51 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.487 0.757 . . . . 0.0 110.287 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 129.95 12.83 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.503 1.791 . . . . 0.0 111.034 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -46.59 -34.98 5.4 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.506 1.129 . . . . 0.0 110.328 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 1.3 m 60.39 20.53 10.14 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.485 1.115 . . . . 0.0 109.962 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . -171.26 160.66 6.3 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 0.0 109.322 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.574 ' OG1' HG23 ' A' ' 265' ' ' ILE . 0.9 OUTLIER -107.68 137.22 46.1 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.523 1.14 . . . . 0.0 110.372 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.842 HG12 HD12 ' A' ' 262' ' ' ILE . 86.5 t -114.79 127.51 72.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.459 1.1 . . . . 0.0 109.317 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 32.3 m -128.18 159.24 35.79 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.505 1.128 . . . . 0.0 109.96 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . 0.927 ' HB1' HG12 ' A' ' 317' ' ' VAL . . . -90.92 110.45 21.69 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.461 1.101 . . . . 0.0 109.275 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -53.19 -32.06 46.07 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.511 1.132 . . . . 0.0 109.287 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' THR . . . . . 0.633 ' HA ' ' HB2' ' A' ' 258' ' ' ALA . 12.7 t -156.68 -163.74 1.49 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.487 1.117 . . . . 0.0 110.407 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 96.6 m -63.07 76.78 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.48 1.112 . . . . 0.0 110.35 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.927 HG12 ' HB1' ' A' ' 313' ' ' ALA . 2.8 p -107.38 141.14 23.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.491 1.12 . . . . 0.0 109.353 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . 1.015 ' C ' HD13 ' A' ' 319' ' ' LEU . 66.1 m -116.12 134.59 54.77 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.534 1.146 . . . . 0.0 110.04 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . 1.015 HD13 ' C ' ' A' ' 318' ' ' SER . 0.0 OUTLIER -132.54 177.98 7.19 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.49 1.119 . . . . 0.0 109.324 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.728 ' HB2' HD22 ' A' ' 251' ' ' LEU . 0.2 OUTLIER -124.5 128.62 49.24 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.502 1.126 . . . . 0.0 109.326 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 13.1 p -90.12 155.18 19.23 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.534 1.146 . . . . 0.0 110.036 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 322' ' ' LEU . 1.5 tm? -149.02 90.86 1.79 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.517 1.136 . . . . 0.0 109.311 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . 0.534 ' CE1' ' HB2' ' A' ' 326' ' ' ASP . 7.9 p80 -49.98 136.54 18.49 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.538 1.149 . . . . 0.0 109.63 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 43.7 t -59.93 -25.56 65.25 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.545 1.153 . . . . 0.0 109.984 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . -57.03 -34.06 67.83 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.496 1.123 . . . . 0.0 109.308 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . 0.534 ' HB2' ' CE1' ' A' ' 323' ' ' HIS . 31.6 t70 -68.83 -37.15 78.98 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.49 1.119 . . . . 0.0 109.337 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' PHE . . . . . 0.572 ' CG ' HD23 ' A' ' 301' ' ' LEU . 33.3 t80 -68.75 -40.38 79.83 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.499 1.124 . . . . 0.0 110.975 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -70.54 -31.92 69.15 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 0.0 110.327 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . . . . . . . . . 17.6 tmm? -69.38 -44.7 70.98 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.467 1.105 . . . . 0.0 111.03 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.552 HD13 HG13 ' A' ' 247' ' ' ILE . 13.3 mt -70.6 -38.86 74.04 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.465 1.103 . . . . 0.0 109.31 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' CYS . . . . . 0.549 ' SG ' HG22 ' A' ' 337' ' ' ILE . 1.8 m -64.43 -38.12 89.9 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.472 1.107 . . . . 0.0 108.279 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 7.6 t -77.24 -26.24 52.39 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.494 1.121 . . . . 0.0 109.98 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.18 -39.2 71.99 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.129 . . . . 0.0 110.057 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.19 129.94 23.36 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.529 1.143 . . . . 0.0 109.979 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -25.44 11.92 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.464 1.771 . . . . 0.0 111.023 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.26 -28.57 67.32 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.123 . . . . 0.0 110.299 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.549 HG22 ' SG ' ' A' ' 331' ' ' CYS . 59.9 mt -71.43 -42.47 73.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.514 1.134 . . . . 0.0 109.294 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.11 -30.49 67.7 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.492 1.12 . . . . 0.0 109.303 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -72.1 -43.51 64.67 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 0.0 110.316 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.404 HG21 ' HB2' ' A' ' 238' ' ' LYS . 68.2 mt -72.08 -40.06 66.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.537 1.148 . . . . 0.0 109.306 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.478 ' CD1' ' O ' ' A' ' 341' ' ' PHE . 0.4 OUTLIER -68.66 -39.33 80.69 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.534 1.146 . . . . 0.0 110.994 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -68.65 -39.08 80.85 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.465 1.103 . . . . 0.0 110.275 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.7 -48.07 70.43 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.526 1.141 . . . . 0.0 109.341 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.24 -41.77 94.04 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.47 1.106 . . . . 0.0 110.424 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -68.65 -34.4 75.65 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.528 1.143 . . . . 0.0 109.315 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 346' ' ' LEU . 13.5 mt -69.9 -33.52 72.3 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.482 1.114 . . . . 0.0 109.262 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.4 -37.01 66.1 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.549 1.156 . . . . 0.0 110.334 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 4.4 mtt85 -69.67 -38.97 77.28 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.527 1.142 . . . . 0.0 110.249 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 350' ' ' GLY . 0.0 OUTLIER -72.21 -34.79 68.62 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.465 1.103 . . . . 0.0 110.321 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 349' ' ' ARG . . . -37.81 -46.68 1.71 Allowed Glycine 0 CA--C 1.529 0.966 0 O-C-N 124.476 1.11 . . . . 0.0 111.033 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -153.89 120.03 5.4 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.517 0.775 . . . . 0.0 109.284 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -61.92 164.4 6.53 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.527 1.142 . . . . 0.0 109.321 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' ALA . . . . . . . . . . . . . . . -124.01 170.18 10.91 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.483 1.114 . . . . 0.0 109.296 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 3.1 m -70.51 148.0 48.72 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.502 1.126 . . . . 0.0 109.992 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.464 0 O-C-N 124.499 1.125 . . . . 0.0 109.304 179.995 . . . . . . . . 0 0 . 1 stop_ save_